Citrus Sinensis ID: 012989
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 452 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.367 | 0.195 | 0.801 | 3e-76 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.367 | 0.203 | 0.722 | 9e-71 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.365 | 0.195 | 0.733 | 3e-69 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.331 | 0.224 | 0.710 | 7e-69 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.365 | 0.193 | 0.739 | 3e-68 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.367 | 0.199 | 0.698 | 2e-67 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.365 | 0.201 | 0.709 | 2e-67 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.365 | 0.195 | 0.696 | 1e-66 | |
| O64783 | 814 | G-type lectin S-receptor- | no | no | 0.365 | 0.202 | 0.703 | 3e-66 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.327 | 0.221 | 0.670 | 7e-66 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 285 bits (730), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 133/166 (80%), Positives = 146/166 (87%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+L DG+EIAVKRLS SGQG+ EFKNE+ LIAKLQH+NLVRLLGCC +G E +L+YEY
Sbjct: 545 KGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEY 604
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MPNKSLD FLFD TK A +DWK R SII GIARGLLYLH DSRLR+IHRDLK SNVLLD
Sbjct: 605 MPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDA 664
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
EMNPKISDFGMARIF GNQNEANT RVVGTYGYM+PEYAMEG+FSV
Sbjct: 665 EMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSV 710
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 9e-71, Method: Compositional matrix adjust.
Identities = 120/166 (72%), Positives = 148/166 (89%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L DG+EIAVKRLS +SGQG++EFKNEV LIAKLQH+NLVRLLGCC+ G E +LIYEY
Sbjct: 516 KGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEY 575
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MPNKSLD F+FD + +LDWK+R++IING+ARG+LYLH+DSRLR+IHRDLK NVLLD+
Sbjct: 576 MPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDN 635
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MNPKISDFG+A+ F G+Q+E++TNRVVGTYGYM PEYA++G FSV
Sbjct: 636 DMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSV 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 121/165 (73%), Positives = 142/165 (86%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G ++G+EIAVKRLS S QGL+EFKNE+ LIAKLQH+NLVRLLGCC++ NE +L+YEY
Sbjct: 541 KGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEY 600
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MPNKSLD FLFD +K LDW++R +I GIARGLLYLH DSRL++IHRDLK SN+LLD
Sbjct: 601 MPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDT 660
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
EMNPKISDFGMARIF+ Q+ ANT RVVGTYGYMAPEYAMEG+FS
Sbjct: 661 EMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFS 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 118/166 (71%), Positives = 140/166 (84%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L+DG E+AVKRLS+SSGQG EFKNEV L+AKLQH+NLVRLLG CLDG E +L+YEY
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD FLFD K QLDW RR II G+ARG+LYLH+DSRL +IHRDLK SN+LLD
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MNPKI+DFGMARIF +Q E NT+R+VGTYGYM+PEYAM G +S+
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSM 529
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 122/165 (73%), Positives = 142/165 (86%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+ +EIAVKRLSR SGQGL+EFKNEV LIAKLQH+NLVRLLG C+ G E LL+YEY
Sbjct: 548 KGMFPGDQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEY 607
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MP+KSLD F+FD +LDWK R +II GIARGLLYLH+DSRLR+IHRDLKTSN+LLD
Sbjct: 608 MPHKSLDFFIFDRKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDE 667
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
EMNPKISDFG+ARIF G++ ANTNRVVGTYGYM+PEYA+EG+FS
Sbjct: 668 EMNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFS 712
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 256 bits (654), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 116/166 (69%), Positives = 143/166 (86%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+L + EIAVKRLSR+SGQG++EFKNEV LI+KLQH+NLVR+LGCC++ E +L+YEY
Sbjct: 531 KGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEY 590
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD F+F + A+LDW +R+ I+ GIARG+LYLH+DSRLR+IHRDLK SN+LLD
Sbjct: 591 LPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDS 650
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
EM PKISDFGMARIF GNQ E T+RVVGT+GYMAPEYAMEG FS+
Sbjct: 651 EMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSI 696
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (654), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 117/165 (70%), Positives = 140/165 (84%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L +G+EIAVKRLSR+SGQGL+E NEV +I+KLQH+NLV+LLGCC+ G E +L+YE+
Sbjct: 525 KGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEF 584
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MP KSLD +LFDS + LDWK R +IINGI RGLLYLH DSRLR+IHRDLK SN+LLD
Sbjct: 585 MPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDE 644
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ PKISDFG+ARIF GN++EANT RVVGTYGYMAPEYAM G+FS
Sbjct: 645 NLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFS 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 115/165 (69%), Positives = 138/165 (83%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L +G+EIAVKRLSR SGQGL+E NEV +I+KLQH+NLV+LLGCC++G E +L+YEY
Sbjct: 540 KGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEY 599
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MP KSLD +LFD K LDWK R +I+ GI RGLLYLH DSRL++IHRDLK SN+LLD
Sbjct: 600 MPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDE 659
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+NPKISDFG+ARIF N++EANT RVVGTYGYM+PEYAMEG FS
Sbjct: 660 NLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFS 704
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 116/165 (70%), Positives = 139/165 (84%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L DGKEIA+KRLS +SGQGL+EF NE+ LI+KLQH+NLVRLLGCC++G E LLIYE+
Sbjct: 517 KGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEF 576
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M NKSL+ F+FDSTK +LDW +R II GIA GLLYLH DS LRV+HRD+K SN+LLD
Sbjct: 577 MANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDE 636
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
EMNPKISDFG+AR+F G Q++ANT RVVGT GYM+PEYA G+FS
Sbjct: 637 EMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFS 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 7e-66, Method: Compositional matrix adjust.
Identities = 112/167 (67%), Positives = 140/167 (83%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L+ G E+AVKRLS++SGQG +EFKNE L++KLQHKNLVRLLG CL+G E +L+YE+
Sbjct: 361 RGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEF 420
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD FLFD K +LDW RR +II GIARG+LYLH+DSRL +IHRDLK SN+LLD
Sbjct: 421 VPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 480
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVN 442
+MNPKI+DFGMARIF +Q++ANT R+ GT+GYM+PEYAM G FS+
Sbjct: 481 DMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMK 527
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 452 | ||||||
| 356575783 | 619 | PREDICTED: cysteine-rich receptor-like p | 0.949 | 0.693 | 0.477 | 1e-114 | |
| 3021268 | 1240 | putative protein [Arabidopsis thaliana] | 0.900 | 0.328 | 0.466 | 1e-111 | |
| 224100081 | 468 | predicted protein [Populus trichocarpa] | 0.878 | 0.848 | 0.492 | 1e-110 | |
| 3021279 | 581 | serine/threonine kinase [Arabidopsis tha | 0.953 | 0.741 | 0.451 | 1e-106 | |
| 356575775 | 620 | PREDICTED: serine/threonine kinase-relat | 0.891 | 0.65 | 0.468 | 1e-106 | |
| 296089261 | 615 | unnamed protein product [Vitis vinifera] | 0.944 | 0.694 | 0.465 | 1e-104 | |
| 356568443 | 659 | PREDICTED: cysteine-rich receptor-like p | 0.944 | 0.647 | 0.429 | 1e-100 | |
| 224076497 | 591 | predicted protein [Populus trichocarpa] | 0.880 | 0.673 | 0.444 | 1e-100 | |
| 356574376 | 585 | PREDICTED: LOW QUALITY PROTEIN: cysteine | 0.904 | 0.699 | 0.474 | 1e-99 | |
| 296090138 | 461 | unnamed protein product [Vitis vinifera] | 0.915 | 0.898 | 0.442 | 1e-97 |
| >gi|356575783|ref|XP_003556016.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 4 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1070), Expect = e-114, Method: Compositional matrix adjust.
Identities = 228/477 (47%), Positives = 295/477 (61%), Gaps = 48/477 (10%)
Query: 4 QVIFVFVTALSLQISLTRADDKPTYIYHNCPSTNFTPNSAYQSNLNLLLSTLRSNATRGS 63
++IF+FV L + +A PT++ +CPS T NS +Q N+ L S+L SNAT +
Sbjct: 8 KLIFLFVLVNFLSFATPKAQQVPTFLAQDCPSNGTTANSTFQINIRTLFSSLSSNATANN 67
Query: 64 SDKFSKGFYNTT-AGHEP-NKVYGLFLCRGDLGTENCQSCVNFATSETAQ--LCPFGKEY 119
FYN+T AG P + VYGLF+CRGD+ + C CV AT + + C K+
Sbjct: 68 V------FYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQCSLSKQA 121
Query: 120 IIGYEECLLRYSNISFFSAVDTSFRLSQWNAENSPGRL-FDQLVWNLMNEAVNQALSTTK 178
+I Y+EC++RYSN SFFS VDT + N+ N + F +L+++ MNE ++A K
Sbjct: 122 VIWYDECMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEAAIGAK 181
Query: 179 MFTTVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSCNF 238
+ T + N + QTLY LVQCTPDLS C CL AI L CC K GGR+ PSCN
Sbjct: 182 KYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILNPSCNV 241
Query: 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSK-EICV---------------------- 275
RY+LY FY T++ P PP+ S + ++ EI
Sbjct: 242 RYDLYPFYR-TNVSA--PPASVPPTDSSNSGAETEISAVESLRFDFSTIEAATDKFSDAN 298
Query: 276 -----------QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 324
+G+L G+E+AVKRLS++SGQG EFKNEV ++AKLQHKNLVRLLG CL
Sbjct: 299 KLGEGGFGEVYKGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCL 358
Query: 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
+G E +L+YE++ NKSLD LFD K LDW RR I+ GIARG+ YLHEDSRL++IHR
Sbjct: 359 EGEEKILVYEFVANKSLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHR 418
Query: 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
DLK SNVLLD +MNPKISDFGMARIF +Q +ANTNR+VGTYGYM+PEYAM G +S
Sbjct: 419 DLKASNVLLDGDMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSA 475
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3021268|emb|CAA18463.1| putative protein [Arabidopsis thaliana] gi|7269163|emb|CAB79271.1| putative protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-111, Method: Compositional matrix adjust.
Identities = 227/487 (46%), Positives = 294/487 (60%), Gaps = 80/487 (16%)
Query: 26 PTYIYHNCPS-TNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTAGHEPNKVY 84
P Y+ H+CP+ T ++ NS Y +NL LLS+ A+R +S +S GF N AG P++V
Sbjct: 623 PFYLNHDCPNRTTYSSNSTYSTNLKTLLSSF---ASRNAS--YSTGFQNIRAGQTPDRVT 677
Query: 85 GLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGYEECLLRYSNISFFSAVDTSFR 144
GLFLCRGDL E C +CV F+ +E+ CP +E + YEEC+LRYS+ +F S V
Sbjct: 678 GLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGE 737
Query: 145 LSQWNAEN-----SPGRLFDQLVWNLMNEAVNQALSTTKMFTTVKKNYTASQTLYSLVQC 199
L N N + F LV + MN+A N+A ++++ F+T+K T+ QTLY LVQC
Sbjct: 738 LIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQC 797
Query: 200 TPDLSRDDCSRCLRLAIS---PLDGCCSIKIGGRVRYPSCNFRYELYQFYNDTSIGTL-- 254
TPDL+R DC CL +I+ PL +IG R +PSCN RYELY FYN+T+IGT
Sbjct: 798 TPDLARQDCFSCLTSSINRMMPL-----FRIGARQFWPSCNSRYELYAFYNETAIGTPSP 852
Query: 255 -------LPAVFSPPSPGSV---------------TSSKEI------------------- 273
P + SP P V S+ E+
Sbjct: 853 PPLFPGSTPPLTSPSIPALVGYCFLAQRTKKTFDTASASEVGDDMATADSLQLDYRTIQT 912
Query: 274 ------------------CVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315
+G ++GKE+AVKRLS++S QG EFK EV ++AKLQH+N
Sbjct: 913 ATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRN 972
Query: 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE 375
LVRLLG L G E +L+YEYMPNKSLD LFD TK QLDW +R +II GIARG+LYLH+
Sbjct: 973 LVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQ 1032
Query: 376 DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
DSRL +IHRDLK SN+LLD ++NPKI+DFGMARIF +Q + NT+R+VGTYGYMAPEYAM
Sbjct: 1033 DSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAM 1092
Query: 436 EGVFSVN 442
G FS+
Sbjct: 1093 HGQFSMK 1099
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100081|ref|XP_002334411.1| predicted protein [Populus trichocarpa] gi|222872074|gb|EEF09205.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1036), Expect = e-110, Method: Compositional matrix adjust.
Identities = 229/465 (49%), Positives = 288/465 (61%), Gaps = 68/465 (14%)
Query: 18 SLTRADDKPTYIYHNCP-STNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTA 76
+LT A + +++H C +T F NS YQ+NLN+LLS+L NATR + GFYN +
Sbjct: 15 ALTEAQE-IIFLHHICSNTTTFVRNSPYQANLNILLSSLAGNATRNDIN----GFYNAST 69
Query: 77 GHEPNKVYGLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGYEECLLRYSNISFF 136
GH+ +VYGLFLCRGD+ E CQ CVN AT++ Q CP KE II Y++C LRYSN + F
Sbjct: 70 GHDLYEVYGLFLCRGDVSVEVCQECVNRATNDVVQRCPILKEAIIWYDQCFLRYSNSNIF 129
Query: 137 SAVDTSFRLSQWNAENSPGRL-FDQLVWNLMNEAVNQALST---TKMFTTVKKNYTASQT 192
S++ + +WN +N + F+ V + +++A +A S + F YT ++
Sbjct: 130 SSLSQTPWYVKWNTQNITDNVKFNMRVVDSISDAAKEAASAPSGERKFAAKTVTYTWEES 189
Query: 193 LYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSCNFRYELYQFYNDTSI- 251
LY LVQCTPDLS+ DC+RCL L IS + GGRV +PSCN R+E+Y FYN+T++
Sbjct: 190 LYVLVQCTPDLSKYDCNRCLNLTISYISVWSKNAQGGRVLFPSCNSRFEIYSFYNETAVV 249
Query: 252 ---------------GTLLP----AVFSPPSP-----GSVTS--------------SKEI 273
LL A P G VTS +K+
Sbjct: 250 PLPPPPLSPPPLSPPDQLLDWAGRATVGDDYPDKDIQGEVTSQDLPLIRLDVINEATKQF 309
Query: 274 CVQGILADG-------------KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLL 320
+ L G KE+AVKRLSR+SGQG +EF NEV LIAKLQH+NLVRLL
Sbjct: 310 SDENKLGQGGFGPVYRGTLEDGKEVAVKRLSRTSGQGQREFLNEVVLIAKLQHRNLVRLL 369
Query: 321 GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380
GCCL+ NE LLIYEYMPN +S G LDW+RR+SIINGIARGLLYLHEDSRLR
Sbjct: 370 GCCLEKNEKLLIYEYMPNN------MNSRNGVLLDWQRRLSIINGIARGLLYLHEDSRLR 423
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
+IHRDLKTSN+LLD+EMNPKISDFGMARIF GN +EANTNR+VGT
Sbjct: 424 IIHRDLKTSNILLDYEMNPKISDFGMARIFGGNPSEANTNRIVGT 468
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3021279|emb|CAA18474.1| serine/threonine kinase [Arabidopsis thaliana] gi|7269175|emb|CAB79282.1| serine/threonine kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1007), Expect = e-106, Method: Compositional matrix adjust.
Identities = 222/492 (45%), Positives = 298/492 (60%), Gaps = 61/492 (12%)
Query: 1 MNMQVIFVFVTALSLQISLTRADDKPTYIYHNCP-STNFTPNSAYQSNLNLLLSTLRSNA 59
M+ + F+F+ S S+T + Y+YHNC +T F+ NS Y +NL TL S+
Sbjct: 1 MSSLISFIFLFLFS---SITASAQNTFYLYHNCSVTTTFSSNSTYSTNLK----TLLSSL 53
Query: 60 TRGSSDKFSKGFYNTTAGHEPNKVYGLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEY 119
+ ++ +S GF TAG P++V GLFLCR D+ +E C+SCV FA +ET CP KE
Sbjct: 54 SSLNASSYSTGFQTATAGQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEG 113
Query: 120 IIGYEECLLRYSNISFFSAVDTS---FRLSQWNAENSPGRLFDQLVWNLMNEAVNQALST 176
+ YE+CLLRYSN + + ++T F S N + F LV MN A +A +
Sbjct: 114 VFYYEQCLLRYSNRNIVATLNTDGGMFMQSARNPLSVKQDQFRDLVLTPMNLAAVEAARS 173
Query: 177 TKMFTTVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSC 236
K + K + ASQ+LY +V+CTPDL DC CL++ I+ + KIGGR+ PSC
Sbjct: 174 FKKWAVRKIDLNASQSLYGMVRCTPDLREQDCLDCLKIGINQV---TYDKIGGRILLPSC 230
Query: 237 NFRYELYQFYNDTSIGTLL-----PAVFSPPSPGSVTSSKEICV---------------- 275
RY+ Y FYN++++GT PAVFS + T +++ V
Sbjct: 231 ASRYDNYAFYNESNVGTPQDSSPRPAVFSVRAKNKRTLNEKEPVAEDGNDITTAGSLQFD 290
Query: 276 --------------------------QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIA 309
+G L+ G ++AVKRLS++SGQG +EF+NEV ++A
Sbjct: 291 FKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVA 350
Query: 310 KLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARG 369
KLQH+NLV+LLG CL+G E +L+YE++PNKSLD FLFDST +LDW RR II GIARG
Sbjct: 351 KLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARG 410
Query: 370 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429
+LYLH+DSRL +IHRDLK N+LLD +MNPKI+DFGMARIF +Q EA T RVVGTYGYM
Sbjct: 411 ILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYM 470
Query: 430 APEYAMEGVFSV 441
+PEYAM G FS+
Sbjct: 471 SPEYAMYGQFSM 482
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575775|ref|XP_003556012.1| PREDICTED: serine/threonine kinase-related protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1001), Expect = e-106, Method: Compositional matrix adjust.
Identities = 214/457 (46%), Positives = 273/457 (59%), Gaps = 54/457 (11%)
Query: 26 PTYIYHNCPS--TNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTAG-HEPNK 82
PTY H C +++ PN+ +++NLN+LLS+L SNAT GFY T ++
Sbjct: 28 PTYSAHACSDEGSHYRPNTTFETNLNILLSSLVSNAT------LHHGFYRTNVSLGTSDE 81
Query: 83 VYGLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGYEECLLRYSNISFFSAVDTS 142
V GLFLCRGD+ C CV A C + II Y+EC+LRYSN S + S
Sbjct: 82 VKGLFLCRGDVTPSLCLDCVTAAAKNITNFCTNQTQSIIWYDECMLRYSNSSTLDNIVPS 141
Query: 143 FRL-SQWNAENSPGRLFDQLVWNLMNEAVNQAL---STTKMFTTVKKNYTASQTLYSLVQ 198
+ ++ + +S F+ ++ + +N+ +AL S+ K F T + N+T+S LY+L Q
Sbjct: 142 VGMKNEQSVSDSDYARFNDVLASTLNDLKQEALNSSSSGKKFATKEANFTSSMKLYTLAQ 201
Query: 199 CTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSCNFRYELYQFYNDTSIGTLLPAV 258
CTPDLS DC+ C +I CC K G RV P C+ RYELY FYN +S+ L
Sbjct: 202 CTPDLSTSDCNTCFSSSIGGFPNCCDGKRGARVLLPGCSVRYELYPFYNVSSVSHL---- 257
Query: 259 FSPPSPGSVTS-------------------------SKE---------ICVQGILADGKE 284
PSP SV S E + +G+ +G+E
Sbjct: 258 ---PSPSSVADDLTDVGDVESLQFDLATVEAATDRFSDENKIGQGGFGVVYKGVFPNGQE 314
Query: 285 IAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
IAVKRLS +S QG EF+NE L+AKLQH+NLVRLLG CL+G E +LIYEY+PNKSLD F
Sbjct: 315 IAVKRLSVTSLQGAVEFRNEAALVAKLQHRNLVRLLGFCLEGQEKILIYEYIPNKSLDRF 374
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
LFD K +LDW RR II GIARG+ YLHEDS+LR+IHRDLK SNVLLD MNPKISDF
Sbjct: 375 LFDPVKQRELDWSRRYKIIVGIARGIQYLHEDSQLRIIHRDLKASNVLLDENMNPKISDF 434
Query: 405 GMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
GMA+IF +Q + NT R+VGTYGYM+PEYAM G FSV
Sbjct: 435 GMAKIFQADQTQVNTGRIVGTYGYMSPEYAMRGQFSV 471
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296089261|emb|CBI39033.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 386 bits (992), Expect = e-104, Method: Compositional matrix adjust.
Identities = 226/486 (46%), Positives = 287/486 (59%), Gaps = 59/486 (12%)
Query: 5 VIFVFVTALSLQISLTRADDKPTYIYHNCPST-NFTPNSAYQSNLNLLLSTLRSNATRGS 63
V+ F+++L + KP Y C N+ PNS YQ NLNLLL++L SNA +
Sbjct: 10 VLLFFLSSL-----IIHGSPKPDLFYSLCTENGNYEPNSTYQYNLNLLLTSLSSNAATLN 64
Query: 64 SDKFSKGFYNTTAGHEPNKVYGLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGY 123
KF +N TAG P+ VYGL+LCRGD+ CQ+CV A+ E CP KE I Y
Sbjct: 65 GRKF----HNQTAGQAPDMVYGLYLCRGDVTDAVCQNCVQTASQEILTKCPNRKEVISWY 120
Query: 124 EECLLRYSNISFFSAVDTSFRLSQWNA--ENSPGRLFDQLVWNLMNEAVNQAL---STTK 178
++C+ RYSN S FS ++ ++ N P R FDQ+V M + +A S
Sbjct: 121 DQCMFRYSNRSIFSIMEERPSVTGSNELEMEDPDR-FDQIVNETMVGMIEKATYNSSERD 179
Query: 179 MFTTVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSCNF 238
MF T + + AS +Y L QCTPDLS DC RCL S + CC K G R+ PSCNF
Sbjct: 180 MFETGEAKFNASTKIYGLAQCTPDLSGSDCRRCLENIFSRIPNCCYGKQGARILGPSCNF 239
Query: 239 RYELYQFYND----------------TSIGTLLPAVFSPPSPGSVTSSKEI--------- 273
RYE+Y FY D S P+ F S ++ +
Sbjct: 240 RYEVYPFYGDFAAAAPLAPSPLSPPEGSKSDSTPSAFGEDSQSMDSTMDSLLFDLKTLRA 299
Query: 274 ------------------CVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315
+G+L+ G EIA+KRLSR+SGQG +EFKNE+ L+AKLQH+N
Sbjct: 300 ATNNFSDANKIGEGGFGAVYKGLLSSGLEIAIKRLSRNSGQGTEEFKNEIALLAKLQHRN 359
Query: 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE 375
LVRLLG CL+ E +L+YE++PNKSLD FLFD+ K +QLDW R II GIARGLLYLHE
Sbjct: 360 LVRLLGFCLEAKEKILVYEFVPNKSLDYFLFDTDKQSQLDWPTRHKIIVGIARGLLYLHE 419
Query: 376 DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
+SRL++IHRDLK SN+LLD ++NPKISDFGMARIF Q++ANT R+VGTYGYM+PEYAM
Sbjct: 420 ESRLKIIHRDLKASNILLDSKLNPKISDFGMARIFFMEQSQANTTRIVGTYGYMSPEYAM 479
Query: 436 EGVFSV 441
G FSV
Sbjct: 480 HGQFSV 485
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568443|ref|XP_003552420.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 371 bits (953), Expect = e-100, Method: Compositional matrix adjust.
Identities = 217/505 (42%), Positives = 281/505 (55%), Gaps = 78/505 (15%)
Query: 9 FVTALSLQISLTRADDKPTYIYH---NCPSTNFTPNSAYQSNLNLLLSTLRSNATRGSSD 65
F+ L L I + A P+Y Y N + N+T NS YQ+NLN LLSTL S+
Sbjct: 11 FLCCLYLIIVICEASFGPSYEYSKYCNNSNGNYTANSIYQTNLNTLLSTLTSHT------ 64
Query: 66 KFSKGFYNTTAGHEPNKVYGLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGYEE 125
+ GFYN + G +KVY + LCRGD+ + C+SC+N + +LCP E I E+
Sbjct: 65 EIDYGFYNFSHGQNSDKVYAIGLCRGDVKPDECRSCLNNSRVSLTRLCPKQFEAIKWEEK 124
Query: 126 CLLRYSNISFFSAVDTSFRLSQWNAENSP-GRLFDQLVWNLMNEAVNQALS--TTKMFTT 182
C+LRYSN + F +D SF N N+ F++++ L+ ++A S + + +
Sbjct: 125 CMLRYSNRAIFHTMDASFSYPMSNINNATDAEEFNKVLGELLRNLSDKAASGDSRRKYAA 184
Query: 183 VKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSCNFRYEL 242
+ QT+Y LVQCTPDLSR DC CL +++ K+G V PSCN RYE+
Sbjct: 185 DTAVFANLQTIYGLVQCTPDLSRQDCGDCLHWSLADFGNVFKNKVGAVVLRPSCNVRYEI 244
Query: 243 YQFYND-------------------TSIGTLLPAVFSPPSPGSVTS----SKEICVQGIL 279
Y FY++ T+I ++P V + S +++ + +L
Sbjct: 245 YPFYDEPTPSASVPLSLKEKGNSLRTTIAIIVPTVLVVVALLIFISIYFRRRKLARKNLL 304
Query: 280 ADGKEIA-------------------------------------------VKRLSRSSGQ 296
AD E+A VKRLS SGQ
Sbjct: 305 ADEIELAESLQFNLDTIKVATNNFSDSNKLGEGGFGAVYQGRLSNGQVIAVKRLSSDSGQ 364
Query: 297 GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDW 356
G EFKNEV L+AKLQH+NLVRLLG L+G E LL+YE++PNKSLD F+FD TK A+LDW
Sbjct: 365 GGVEFKNEVLLLAKLQHRNLVRLLGFSLEGKEKLLVYEFVPNKSLDYFIFDPTKKARLDW 424
Query: 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 416
RR II GIARGLLYLHEDSRLR+IHRDLK SNVLLD EM PKISDFGMAR+ Q +
Sbjct: 425 DRRYKIIRGIARGLLYLHEDSRLRIIHRDLKASNVLLDEEMIPKISDFGMARLIVAGQTQ 484
Query: 417 ANTNRVVGTYGYMAPEYAMEGVFSV 441
NT+RVVGTYGYMAPEY M G FS+
Sbjct: 485 ENTSRVVGTYGYMAPEYIMHGQFSI 509
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076497|ref|XP_002304952.1| predicted protein [Populus trichocarpa] gi|222847916|gb|EEE85463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 370 bits (951), Expect = e-100, Method: Compositional matrix adjust.
Identities = 206/463 (44%), Positives = 271/463 (58%), Gaps = 65/463 (14%)
Query: 36 TNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTAGHEPNKVYGLFLCRGDLGT 95
+N+ NS +Q+NL L+++L SNA+ SK +NT+ G +P++VY ++C +
Sbjct: 28 SNYIDNSPFQNNLETLMASLSSNAS------VSK-IFNTSTGIDPDRVYAQYMCLNYVTN 80
Query: 96 ENCQSCVNFATSETAQLCPFGKEYIIGYEECLLRYSNISFFSAVDTSFRLSQWNAENSPG 155
E+C++CV A+ + QLCP K+ ++ E C LRYSN F +D S + Q+N +N
Sbjct: 81 ESCRTCVAAASQDIRQLCPGDKKAVVWEELCQLRYSNQRFLGHLDVSGNVPQYNPKNISN 140
Query: 156 RLFDQLVWN-LMNEAVNQAL--STTKMFTTVKKNYTASQTLYSLVQCTPDLSRDDCSRCL 212
LV N +++ + +A + M+ T + +T S + +SLVQC+ DLS +DC CL
Sbjct: 141 PEHLSLVVNKILSSLIKKAAFDPSANMYATRDEPFTDSDSFFSLVQCSTDLSPNDCYTCL 200
Query: 213 RLAISPLDGCCSIKIGGRVRYPSCNFRYELYQFYNDTSIGTLLPA--------------- 257
+A+ + CC G RV SC RYELY FY+ + + P
Sbjct: 201 EVAVKNVTTCCYFSRGARVLSRSCYLRYELYDFYDGATESSKSPVTGKGTNLLIDQLRHG 260
Query: 258 ---VFSPPSPGSVT-----------------------------SSKEICVQG-------- 277
VF P+ S + QG
Sbjct: 261 KFRVFDHPNHNDFQNQDFQRDGLNDRESAIMDLASINAATDNFSETNLLGQGGFGPVYKG 320
Query: 278 ILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
IL+DGKE+AVKRLS SS QG EF NEV LI KLQHKNLV+LLG C+DG E LL+YE+MP
Sbjct: 321 ILSDGKEVAVKRLSDSSEQGKNEFTNEVLLIMKLQHKNLVKLLGFCVDGEEKLLVYEFMP 380
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
N SLD+ LFD KGAQL W+ RI IINGIA+G LYLHEDSRLR+IHRDLK SN+LLD+ M
Sbjct: 381 NNSLDVVLFDPRKGAQLSWRSRIHIINGIAKGTLYLHEDSRLRIIHRDLKASNILLDNNM 440
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
NPKISDFGMARI N+ EANT R+ GTYGYMAPEYAMEG++S
Sbjct: 441 NPKISDFGMARIMEANEGEANTVRIAGTYGYMAPEYAMEGLYS 483
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574376|ref|XP_003555324.1| PREDICTED: LOW QUALITY PROTEIN: cysteine-rich receptor-like protein kinase 15-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 369 bits (948), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 211/445 (47%), Positives = 275/445 (61%), Gaps = 36/445 (8%)
Query: 26 PTYIYHNCPS-TNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTAGHEPNKVY 84
P Y + CP+ T++ N +Q+NL +LL++L SN ++ S G YN+ G V
Sbjct: 28 PVYNANYCPNNTSYNSNVTFQTNLRVLLASLVSNVSQ------SDGSYNSAMGMGTTSVA 81
Query: 85 -GLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGYEECLLRYSNISFF-SAVDTS 142
G FLCRGD+ CQ C+ A +E +LCP E II Y+EC LR++N F +++D
Sbjct: 82 SGQFLCRGDVSPATCQDCIASAATEITRLCPNKTESIIWYDECTLRFTNRYFAPTSIDPG 141
Query: 143 FRLSQ-WNAENSPGRLFDQLVWNLMNEAVNQALST--TKMFTTVKKNYTAS---QTLYSL 196
RLS N S F+Q ++ L+NE V +A ++ + F T + + S +T+Y+L
Sbjct: 142 ARLSDDKNISASDLDSFNQTLFGLLNELVEEAANSQSARKFATGESEFAGSSPERTVYAL 201
Query: 197 VQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSCNFRYELYQFYNDT------S 250
+C P L+ C CL+ A+S L CC K G R CN RYEL+QFYN + S
Sbjct: 202 TECEPSLTIAQCEECLQNAVSTLPSCCGGKQGARALLAWCNVRYELFQFYNTSGSSAPSS 261
Query: 251 IG----TLLPAVFSPPSPGSVTS--SKEICV---------QGILADGKEIAVKRLSRSSG 295
+G TL F P+ + T S E + +GIL DG+EIAVK+LS+SSG
Sbjct: 262 VGEESDTLESLQFGLPTVEAATKKFSHENRIGEGGFGEVYKGILPDGREIAVKKLSQSSG 321
Query: 296 QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLD 355
QG EFKNE+ LIAKLQH+NLV LLG CL+ E +LIYE++ NKSLD FLFD K +LD
Sbjct: 322 QGATEFKNEILLIAKLQHRNLVTLLGFCLEEQEKMLIYEFVSNKSLDYFLFDPRKSCELD 381
Query: 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415
W R II GI G+LYLHE SRL+VIHRDLK SNVLLD MNPKISDFGMARI + +Q+
Sbjct: 382 WTTRYKIIEGITHGILYLHEHSRLKVIHRDLKPSNVLLDSIMNPKISDFGMARIVAIDQH 441
Query: 416 EANTNRVVGTYGYMAPEYAMEGVFS 440
+ TNR+VGTYGYM+PEYAM G FS
Sbjct: 442 QEKTNRIVGTYGYMSPEYAMHGQFS 466
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296090138|emb|CBI39957.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 363 bits (931), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 204/461 (44%), Positives = 282/461 (61%), Gaps = 47/461 (10%)
Query: 6 IFVFVTALSLQISLTRADDKPTYIYHNC-PSTNFTPNSAYQSNLNLLLSTLRSNATRGSS 64
I F+ A+++ +S+ A + T+ H C S N++ NS Y ++LN++LS+L +NA+R
Sbjct: 7 ILFFLCAVTIHLSIGTAQVRFTFKKHACVASGNYSANSTYSTSLNIVLSSLSANASRPDR 66
Query: 65 DKFSKGFYNTTAGHEPN-KVYGLFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGY 123
FYNTTAG P+ KVYG+FLCRGD + CQ CV A+ + CP KE II +
Sbjct: 67 ------FYNTTAGLSPDDKVYGIFLCRGDTKPQLCQDCVKAASEDLVNRCPNQKEAIIWF 120
Query: 124 EECLLRYSNISFFSAVDTSFRLSQWN--AENSPGRLFDQLVWNLMNEAVNQALSTT--KM 179
+ C++RY+N + FS ++ R S + A S F++++ +LM+ V +A+S + M
Sbjct: 121 DVCMVRYANRAIFSYMEQRPRGSAQSPTAIRSDSGEFNRILGDLMDRLVTRAVSGSPQDM 180
Query: 180 FTTVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVRYPSCNFR 239
F + T + LY LVQCTPD+S+ C+ CLR A+ + CC + GGRV PSC R
Sbjct: 181 FAIEEVKVTDFRNLYGLVQCTPDISQHFCNVCLRNALGDIPTCCGWREGGRVLAPSCTIR 240
Query: 240 YELYQFY--NDTSIG---------------TLLPAVFSPPSPGSVTSSKEICV------- 275
YE F+ N T++ T+ P S S +T++
Sbjct: 241 YESGPFFETNGTTVPSSPPATSSSQPPTNPTIAPGKRSKISKIVLTTAVHFATNNFSNGN 300
Query: 276 -----------QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 324
+G+L++G+EIAVKRLS+ + QG EFKNEV L+AKLQH+NL+RLLG CL
Sbjct: 301 TLGRGGFGDVYKGVLSNGQEIAVKRLSKKTDQGEPEFKNEVLLLAKLQHRNLIRLLGFCL 360
Query: 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
DG E LLIYE++PN SLD F+FD LDW+RR II GIARGLLYLHEDSRLR++H
Sbjct: 361 DGEERLLIYEFLPNSSLDHFIFDPANRVCLDWERRHRIIKGIARGLLYLHEDSRLRIVHC 420
Query: 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
DLK SN+LLD +MNPKISDFGMAR+FS ++ AN +R+ GT
Sbjct: 421 DLKASNILLDEDMNPKISDFGMARLFSMDETHANASRIAGT 461
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 452 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.367 | 0.248 | 0.710 | 3e-112 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.367 | 0.245 | 0.674 | 3.4e-109 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.367 | 0.245 | 0.656 | 1e-107 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.367 | 0.257 | 0.674 | 5.1e-104 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.367 | 0.2 | 0.674 | 1.1e-103 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.367 | 0.245 | 0.656 | 4.1e-100 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.367 | 0.251 | 0.632 | 7.6e-99 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.367 | 0.248 | 0.674 | 3.9e-87 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.365 | 0.248 | 0.620 | 8.1e-87 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.367 | 0.244 | 0.636 | 2.5e-83 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 3.0e-112, Sum P(2) = 3.0e-112
Identities = 118/166 (71%), Positives = 140/166 (84%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L+DG E+AVKRLS+SSGQG EFKNEV L+AKLQH+NLVRLLG CLDG E +L+YEY
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD FLFD K QLDW RR II G+ARG+LYLH+DSRL +IHRDLK SN+LLD
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MNPKI+DFGMARIF +Q E NT+R+VGTYGYM+PEYAM G +S+
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSM 529
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 3.4e-109, Sum P(2) = 3.4e-109
Identities = 112/166 (67%), Positives = 137/166 (82%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G ++GKE+AVKRLS++S QG EFK EV ++AKLQH+NLVRLLG L G E +L+YEY
Sbjct: 369 KGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEY 428
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MPNKSLD LFD TK QLDW +R +II GIARG+LYLH+DSRL +IHRDLK SN+LLD
Sbjct: 429 MPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 488
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
++NPKI+DFGMARIF +Q + NT+R+VGTYGYMAPEYAM G FS+
Sbjct: 489 DINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSM 534
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.0e-107, Sum P(2) = 1.0e-107
Identities = 109/166 (65%), Positives = 136/166 (81%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L G+ +A+KRLS+ S QG +EFKNEV ++AKLQH+NL +LLG CLDG E +L+YE+
Sbjct: 363 KGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEF 422
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD FLFD+ K LDW+RR II GIARG+LYLH DSRL +IHRDLK SN+LLD
Sbjct: 423 VPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDA 482
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+M+PKISDFGMARIF +Q +ANT R+VGTYGYM+PEYA+ G +SV
Sbjct: 483 DMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSV 528
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 5.1e-104, Sum P(2) = 5.1e-104
Identities = 112/166 (67%), Positives = 139/166 (83%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L+ G ++AVKRLS++SGQG +EF+NEV ++AKLQH+NLV+LLG CL+G E +L+YE+
Sbjct: 342 KGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEF 401
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD FLFDST +LDW RR II GIARG+LYLH+DSRL +IHRDLK N+LLD
Sbjct: 402 VPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDD 461
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MNPKI+DFGMARIF +Q EA T RVVGTYGYM+PEYAM G FS+
Sbjct: 462 DMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSM 507
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 1.1e-103, Sum P(2) = 1.1e-103
Identities = 112/166 (67%), Positives = 137/166 (82%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G G ++AVKRLS++SGQG +EF+NEV ++AKLQH+NLVRLLG CL+G E +L+YE+
Sbjct: 524 KGTFPSGVQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEF 583
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ NKSLD FLFD+T QLDW RR II GIARG+LYLH+DSRL +IHRDLK N+LLD
Sbjct: 584 VHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDA 643
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MNPK++DFGMARIF +Q EANT RVVGTYGYMAPEYAM G FS+
Sbjct: 644 DMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSM 689
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 4.1e-100, Sum P(2) = 4.1e-100
Identities = 109/166 (65%), Positives = 136/166 (81%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+GI G ++AVKRLS++SGQG +EF NEV ++AKLQH+NLVRLLG CL+ +E +L+YE+
Sbjct: 367 KGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEF 426
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD F+FDST + LDW RR II GIARG+LYLH+DSRL +IHRDLK N+LL
Sbjct: 427 VPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGD 486
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MN KI+DFGMARIF +Q EANT R+VGTYGYM+PEYAM G FS+
Sbjct: 487 DMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSM 532
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 560 (202.2 bits), Expect = 7.6e-99, Sum P(2) = 7.6e-99
Identities = 105/166 (63%), Positives = 133/166 (80%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G ++G E+AVKRLS++S QG EFKNEV ++A L+HKNLVR+LG ++ E +L+YEY
Sbjct: 352 KGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEY 411
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ NKSLD FLFD K QL W +R II GIARG+LYLH+DSRL +IHRDLK SN+LLD
Sbjct: 412 VENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 471
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MNPKI+DFGMARIF +Q + NT+R+VGTYGYM+PEYAM G FS+
Sbjct: 472 DMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSM 517
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 3.9e-87, Sum P(2) = 3.9e-87
Identities = 112/166 (67%), Positives = 140/166 (84%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G L+ G E+AVKRLS++SGQG +EFKNE L++KLQHKNLVRLLG CL+G E +L+YE+
Sbjct: 361 RGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEF 420
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+PNKSLD FLFD K +LDW RR +II GIARG+LYLH+DSRL +IHRDLK SN+LLD
Sbjct: 421 VPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 480
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+MNPKI+DFGMARIF +Q++ANT R+ GT+GYM+PEYAM G FS+
Sbjct: 481 DMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSM 526
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 8.1e-87, Sum P(2) = 8.1e-87
Identities = 103/166 (62%), Positives = 135/166 (81%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+L+DG++IAVKRLS+++ QG EFKNE L+AKLQH+NLV+LLG ++G E LL+YE+
Sbjct: 360 KGVLSDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEF 419
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+P+ SLD F+FD +G +L+W+ R II G+ARGLLYLH+DSRLR+IHRDLK SN+LLD
Sbjct: 420 LPHTSLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDE 479
Query: 396 EMNPKISDFGMARIFS-GNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
EM PKI+DFGMAR+F + + TNR+VGT+GYMAPEY M G FS
Sbjct: 480 EMTPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFS 525
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 2.5e-83, Sum P(2) = 2.5e-83
Identities = 107/168 (63%), Positives = 131/168 (77%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+ G+EIAVKRLS +SGQG EFKNE+ L+AKLQH+NLVRL+G C+ G E LL+YE+
Sbjct: 373 KGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEF 432
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ N SLD F+FD+ K LDW R +I GIARGLLYLHEDSR R+IHRDLK SN+LLD
Sbjct: 433 IKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQ 492
Query: 396 EMNPKISDFGMARIFSGNQNEAN--TNRVVGTYGYMAPEYAMEGVFSV 441
EMNPKI+DFG+A++F Q + T+R+ GTYGYMAPEYAM G FSV
Sbjct: 493 EMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSV 540
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 452 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-30 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-20 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 55/154 (35%), Positives = 84/154 (54%), Gaps = 9/154 (5%)
Query: 281 DGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
GK++A+K + + S L+E E+ ++ KL H N+V+L G D N L L+ EY
Sbjct: 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMN 398
SL L ++ L + I+ I GL YLH +IHRDLK N+LLD
Sbjct: 77 SLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGK 131
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG++++ + +++ T +VGT YMAPE
Sbjct: 132 VKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 56/154 (36%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 281 DGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
GK +AVK L + S + Q + E+ ++ +L H N+VRL+ D + L L+ EY
Sbjct: 23 TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEG 82
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
L +L L I I RGL YLH +IHRDLK N+LLD
Sbjct: 83 GDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDENGV 136
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI+DFG+A+ + + T VGT YMAPE
Sbjct: 137 VKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 55/159 (34%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 284 EIAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
E+AVK L +S Q ++EF E ++ KL H N+V+LLG C + L+++ EYMP L
Sbjct: 30 EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLL 89
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
+L + +L +S IARG+ YL IHRDL N L+ + KIS
Sbjct: 90 DYLRK-NRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 145
Query: 403 DFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
DFG++R ++ + + ++ +MAPE EG F+
Sbjct: 146 DFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFT 182
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 54/159 (33%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 284 EIAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
E+AVK L +S Q ++EF E ++ KL H N+V+LLG C + L ++ EYM L
Sbjct: 30 EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLL 89
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
+L +L +S IARG+ YL IHRDL N L+ + KIS
Sbjct: 90 SYL--RKNRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 144
Query: 403 DFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
DFG++R ++ + ++ +MAPE EG F+
Sbjct: 145 DFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGKFT 181
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 286 AVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
AVK L S + ++F E ++ KL H N+VRLLG C + L L+ EYM L +
Sbjct: 27 AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86
Query: 345 L------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
L F S + + L K +S IA+G+ YL + +HRDL N L+ ++
Sbjct: 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLV 143
Query: 399 PKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
KISDFG++R ++ + T + +MAPE +G+F+
Sbjct: 144 VKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTS 186
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 8e-36
Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 8/161 (4%)
Query: 284 EIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
++AVK L + + +EF E +++ KL H N+VRLLG C G L ++ EYMP L
Sbjct: 30 KVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLL 89
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
FL G +L K + + IA+G+ YL +HRDL N L+ + KIS
Sbjct: 90 DFL--RKHGEKLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKIS 144
Query: 403 DFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVN 442
DFG++R I+ + + +MAPE +G F+
Sbjct: 145 DFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDGKFTSK 184
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 50/153 (32%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 281 DGKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
GK +A+K + + + +E E+ ++ KL+H N+VRL D ++L L+ EY
Sbjct: 23 TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L L D R + I L YLH ++HRDLK N+LLD + +
Sbjct: 83 DL-FDLLKKRGRLSEDEAR--FYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHV 136
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG+AR + VGT YMAPE
Sbjct: 137 KLADFGLARQLDPGE---KLTTFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-30
Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 281 DGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYM 336
G+ +AVK LS S + L+ + E+ +++ LQH N+VR G D N L + EY+
Sbjct: 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
SL L K +L I GL YLH ++HRD+K +N+L+D +
Sbjct: 84 SGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSD 137
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG A+ + T V GT +MAPE
Sbjct: 138 GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-28
Identities = 48/110 (43%), Positives = 61/110 (55%), Gaps = 8/110 (7%)
Query: 30 YHNCPSTN----FTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTAGHEPNKVYG 85
+H C S T NS ++SNLN LLS+L SNA + KGF T+G P+ VYG
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNA----ASSSGKGFAAGTSGAAPDTVYG 56
Query: 86 LFLCRGDLGTENCQSCVNFATSETAQLCPFGKEYIIGYEECLLRYSNISF 135
L CRGDL +C+SC+ A SE + CP K I Y+ C LRY + F
Sbjct: 57 LAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 54/165 (32%), Positives = 85/165 (51%), Gaps = 11/165 (6%)
Query: 282 GKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMPN 338
G+++AVK L+ S Q +F+ E+ ++ L H+N+V+ G C G L LI EY+P+
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL +L Q++ KR + + I +G+ YL R IHRDL N+L++ E
Sbjct: 93 GSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDL 147
Query: 399 PKISDFGMARIFSGNQN--EANTNRVVGTYGYMAPEYAMEGVFSV 441
KISDFG+A++ +++ + Y APE FS
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSS 191
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 10/153 (6%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
GKE+A+K + S + ++ NE+ ++ K +H N+V+ G L +EL ++ E+ S
Sbjct: 24 TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83
Query: 341 LDLFLFDSTKGAQLDWKRRIS-IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L L + + I+ + + +GL YLH +IHRD+K +N+LL +
Sbjct: 84 LKDLLKSTNQTLTESQ---IAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEV 137
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG++ S + N +VGT +MAPE
Sbjct: 138 KLIDFGLSAQLSDTK---ARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 18/158 (11%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
A GKE+A+K++ R Q + NE+ ++ +H N+V L G+EL ++ EYM
Sbjct: 42 ATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100
Query: 340 SL----DLFLFDSTKGAQLDWKRRIS-IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
SL + +I+ + + +GL YLH VIHRD+K+ N+LL
Sbjct: 101 SLTDIITQNFVRMNEP-------QIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLS 150
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ + K++DFG A + +++ N+ VVGT +MAPE
Sbjct: 151 KDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 281 DGKEIAVKR--LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
DGK +K LS S + ++ NEV ++ KL H N+++ + +L ++ EY
Sbjct: 24 DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 339 KSLDLFLFDSTKGAQ-------LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
L + K + LDW ++ + L YLH +++HRD+K N+
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCL------ALKYLHSR---KILHRDIKPQNI 134
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L K+ DFG++++ S + A T VVGT Y++PE
Sbjct: 135 FLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 281 DGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
G +A+K++S + L+ E+ L+ L+H N+V+ +G + L +I EY N
Sbjct: 24 TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL + + + + +GL YLHE VIHRD+K +N+L +
Sbjct: 84 GSLRQIIKKFGPFPESLVAVYVY---QVLQGLAYLHEQG---VIHRDIKAANILTTKDGV 137
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE-YAMEGV 438
K++DFG+A + + + VVGT +MAPE M G
Sbjct: 138 VKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGA 176
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 7e-23
Identities = 56/168 (33%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G G+++AVK L S Q F E +++ L+H NLV+LLG L GN L ++ EY
Sbjct: 24 LGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81
Query: 336 MPNKSLDLFLFDSTKG-AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
M SL +L ++G A + +++ + G+ YL E +HRDL NVL+
Sbjct: 82 MAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVS 136
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTY--GYMAPEYAMEGVFS 440
++ K+SDFG+A+ EA+ + G + APE E FS
Sbjct: 137 EDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFS 177
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 9/131 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361
E+ L+ KL+H N+VRL + +++EYM + DL + + +
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKC 104
Query: 362 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421
+ + GL YLH + ++HRD+K SN+L++++ K++DFG+AR ++ + TNR
Sbjct: 105 YMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 422 VVGTYGYMAPE 432
V+ T Y PE
Sbjct: 162 VI-TLWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 285 IAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K L + + QEF+ E L++ LQH N+V LLG C +++EY+ + L
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 344 FLF-------------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
FL D T + LD + I IA G+ YL S +HRDL N
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARN 154
Query: 391 VLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
L+ + KISDFG++R I+S + + ++ +M PE + G F+
Sbjct: 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTT 205
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 8e-22
Identities = 43/131 (32%), Positives = 70/131 (53%), Gaps = 12/131 (9%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS-- 361
E++L+ +L+H N+V+LL +L L++EY + L +L + + I
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 362 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421
++ G+A Y H S R++HRDLK N+L++ + K++DFG+AR F T+
Sbjct: 107 LLRGLA----YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHE 158
Query: 422 VVGTYGYMAPE 432
VV T Y APE
Sbjct: 159 VV-TLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 28/186 (15%)
Query: 274 CVQGILADGKEI-AVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
C + KE+ AVK L ++ ++ F+ E L+ QH+N+V+ G C +G+ ++
Sbjct: 26 CYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85
Query: 332 IYEYMPNKSLDLFL------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRL 379
++EYM + L+ FL DS G +L + + I IA G++YL +
Sbjct: 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG-ELTLSQLLQIAVQIASGMVYL---ASQ 141
Query: 380 RVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGT----YGYMAPEYA 434
+HRDL T N L+ +++ KI DFGM+R +++ + RV G +M PE
Sbjct: 142 HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT-----TDYYRVGGHTMLPIRWMPPESI 196
Query: 435 MEGVFS 440
M F+
Sbjct: 197 MYRKFT 202
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 95.2 bits (235), Expect = 2e-21
Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 281 DGKEIAVKRLSR---SSGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLDGNELLLIYEYM 336
D K +A+K L++ S + ++ F E+ ++A L H N+V+L D L L+ EY+
Sbjct: 21 DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
SL+ L + L + I+ I L YLH +IHRD+K N+LLD +
Sbjct: 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRD 137
Query: 397 MN-PKISDFGMARIFSGNQNEAN----TNRVVGTYGYMAPE 432
K+ DFG+A++ + ++ + VGT GYMAPE
Sbjct: 138 GRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
|
Length = 384 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 62/184 (33%), Positives = 96/184 (52%), Gaps = 18/184 (9%)
Query: 265 GSVTSSKEICVQGILAD--GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 322
GSV E+C L D G+ +AVK+L S+ + L++F+ E+ ++ LQH N+V+ G
Sbjct: 18 GSV----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGV 73
Query: 323 CLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380
C L L+ EY+P SL +L +LD ++ + + I +G+ YL R
Sbjct: 74 CYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GSKR 128
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVG---TYGYMAPEYAMEG 437
+HRDL T N+L++ E KI DFG+ ++ ++ E R G + Y APE E
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTES 186
Query: 438 VFSV 441
FSV
Sbjct: 187 KFSV 190
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 17/169 (10%)
Query: 285 IAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
+AVK L +S Q+F+ E L+ LQH+++VR G C +G LL+++EYM + L+ F
Sbjct: 38 VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97
Query: 345 L---------FDSTKGA---QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
L + QL + ++I + IA G++YL + L +HRDL T N L
Sbjct: 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCL 154
Query: 393 LDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ + KI DFGM+R I+S + R + +M PE + F+
Sbjct: 155 VGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLPIRWMPPESILYRKFT 202
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 281 DGKEIAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
GK A+K++ + ++ E+ + + +V+ G E+ ++ EYM
Sbjct: 25 TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84
Query: 340 SLDLFLFDSTKGAQLDWKRRI--SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
SL L K + I I +GL YLH ++ +IHRD+K SN+L++ +
Sbjct: 85 SLADLLKKVGK-----IPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKG 137
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI+DFG++++ ++ NT VGT YM+PE
Sbjct: 138 EVKIADFGISKVLENTLDQCNTF--VGTVTYMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 33/168 (19%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY----- 335
G+ +A+K + + LQE E++++ + +V+ G +L ++ EY
Sbjct: 27 TGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84
Query: 336 ------MPNKSLDLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKT 388
+ NK+L + I+ I +GL YLH + IHRD+K
Sbjct: 85 VSDIMKITNKTLT--------------EEEIAAILYQTLKGLEYLH---SNKKIHRDIKA 127
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436
N+LL+ E K++DFG++ + + NT V+GT +MAPE E
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 6/166 (3%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+ + +A+K L Q+F+ EV + +L+HK+L+ L C G + +I E
Sbjct: 24 EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M SL FL S +G L I + +A G+ YL E IHRDL N+L+
Sbjct: 84 MEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGE 139
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
++ K++DFG+AR+ + ++ ++ Y + APE A G FS
Sbjct: 140 DLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFST 183
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 281 DGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
GK +AVK + + +Q + E+ ++ K +V G + ++ + EYM
Sbjct: 25 TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
SLD L + +I+ + +GL YLHE ++IHRD+K SN+L++
Sbjct: 85 SLDKILKEVQGRIPERILGKIA--VAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQI 140
Query: 400 KISDFGMARIFSGN--QNEANTNRVVGTYGYMAPE 432
K+ DFG+ SG + A T VGT YMAPE
Sbjct: 141 KLCDFGV----SGQLVNSLAKTF--VGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-20
Identities = 47/162 (29%), Positives = 86/162 (53%), Gaps = 15/162 (9%)
Query: 284 EIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+A+K L + + +E +E ++A + H ++VRLLG CL +++ LI + MP L
Sbjct: 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLL 96
Query: 343 LFLFDSTK--GAQ--LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
++ + G+Q L+W +I A+G+ YL E R++HRDL NVL+ +
Sbjct: 97 DYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEEK---RLVHRDLAARNVLVKTPQH 147
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
KI+DFG+A++ ++ E + +MA E + +++
Sbjct: 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-19
Identities = 36/98 (36%), Positives = 48/98 (48%), Gaps = 2/98 (2%)
Query: 149 NAENSPGRLFDQLVWNLMNEAVNQALSTT-KMFTTVKKNYTASQTLYSLVQCTPDLSRDD 207
+ F+ + L++ + A S++ K F + A T+Y L QC DLS D
Sbjct: 10 GNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGT-SGAAPDTVYGLAQCRGDLSASD 68
Query: 208 CSRCLRLAISPLDGCCSIKIGGRVRYPSCNFRYELYQF 245
C CL A+S L CC K GGR+ Y SC RYE Y F
Sbjct: 69 CRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 54/159 (33%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 280 ADGKEIAVKR--LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
AD + A+K+ LS+ + + +E +E ++AKL ++R LD +L ++ EY
Sbjct: 23 ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82
Query: 338 NKSLDLFLFDSTKGAQLD----WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
N L L +G L W+ I I+ G+A +LH +++HRD+K+ N+ L
Sbjct: 83 NGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLA----HLHSK---KILHRDIKSLNLFL 134
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
D N KI D G+A++ S N N ANT +VGT Y++PE
Sbjct: 135 DAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
++AVK L + + F E ++ KL+H LV+L C + + ++ EYM SL
Sbjct: 32 KVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
FL G +L + + + IA G+ YL IHRDL N+L+ + KI+D
Sbjct: 91 FLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIAD 146
Query: 404 FGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFSV 441
FG+AR+ ++ A G + APE A G F++
Sbjct: 147 FGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTI 183
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 52/130 (40%), Positives = 75/130 (57%), Gaps = 9/130 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLF-DSTKGAQLDWKRRISI 362
E++L+ +L H N+VRLL N+L L++E++ LDL + DS+ LD S
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422
+ + +G+ Y H S RV+HRDLK N+L+D E K++DFG+AR F G T+ V
Sbjct: 105 LYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEV 160
Query: 423 VGTYGYMAPE 432
V T Y APE
Sbjct: 161 V-TLWYRAPE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 10/160 (6%)
Query: 282 GKEIAVKRLS-RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+ +A+K + + +++ + E+ +++ + + + G L G++L +I EY S
Sbjct: 26 NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
D K +LD I+ + GL YLHE+ IHRD+K +N+LL E + K
Sbjct: 86 C----LDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVK 138
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
++DFG++ + ++ NT VGT +MAPE + +
Sbjct: 139 LADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYD 176
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 50/131 (38%), Positives = 68/131 (51%), Gaps = 12/131 (9%)
Query: 282 GKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMPN 338
G+ +AVK L R GQ +K E+ ++ L H+N+V+ GCC + L LI EY+P
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 339 KSLDLFLFDSTKG-AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
SL +L AQL + I G+ YLH IHRDL NVLLD++
Sbjct: 93 GSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR 144
Query: 398 NPKISDFGMAR 408
KI DFG+A+
Sbjct: 145 LVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 46/153 (30%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 272 EICVQGILADGKE---IAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN 327
E+C + GK+ +A+K L + SS + +F E +++ + H N++RL G
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78
Query: 328 ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
+++I EYM N SLD FL + + + ++ GIA G+ YL S + +HRDL
Sbjct: 79 PVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLA 133
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420
N+L++ + K+SDFG++R ++ T
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 285 IAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
IA+K + + +Q E+ L + L+H+N+V+ LG + + E +P SL
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95
Query: 345 LFDSTKGAQLDWKRRISIING--IARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKI 401
L +K L + I I GL YLH+ +++HRD+K NVL++ + KI
Sbjct: 96 L--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKI 150
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV 438
SDFG ++ +G T GT YMAPE +G
Sbjct: 151 SDFGTSKRLAGINPCTET--FTGTLQYMAPEVIDKGP 185
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 278 ILADGKE---IAVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIY 333
IL G +AVK L + ++ Q +EF E L++ H N+V+LLG CL +I
Sbjct: 19 ILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78
Query: 334 EYMPNKSLDLFLFD----STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
E M L +L D L K + I +A+G +YL ++ IHRDL
Sbjct: 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAAR 135
Query: 390 NVLL-----DHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
N L+ D + KI DFG+AR I+ + ++ +MAPE ++G F+
Sbjct: 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-WMAPESLLDGKFT 191
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 50/131 (38%), Positives = 77/131 (58%), Gaps = 10/131 (7%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL--FLFDSTKGAQLDWKRRIS 361
E++L+ +LQH N+V L + + L LI+E++ S+DL +L KG +D + S
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKS 105
Query: 362 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421
+ I +G+L+ H RV+HRDLK N+L+D++ K++DFG+AR F G T+
Sbjct: 106 YLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHE 161
Query: 422 VVGTYGYMAPE 432
VV T Y APE
Sbjct: 162 VV-TLWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 14/163 (8%)
Query: 281 DGKEIAVKRL--SRSSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEY 335
DGKE A+K+ + G+ Q E+ L+ +L+H+N+V L+ L+ + + L+++Y
Sbjct: 26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85
Query: 336 MPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
+ + F K + S++ I G+ YLH + V+HRDLK +N+L+
Sbjct: 86 AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVM 142
Query: 395 HEMNP----KISDFGMARIF-SGNQNEANTNRVVGTYGYMAPE 432
E KI D G+AR+F + + A+ + VV T Y APE
Sbjct: 143 GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 279 LADGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
L G+ +AVK R+ + + ++E +E+ ++ L+H NLV+ G + ++ + EY
Sbjct: 22 LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81
Query: 337 PNKSLDLFLFDSTKGAQLDWK--RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
+L+ L G LD R + + GL YLH ++HRD+K +N+ LD
Sbjct: 82 SGGTLEELL---EHGRILDEHVIRVYT--LQLLEGLAYLHSH---GIVHRDIKPANIFLD 133
Query: 395 HEMNPKISDFGMARIFSGNQNEANT--NRVVGTYGYMAPE 432
H K+ DFG A N + GT YMAPE
Sbjct: 134 HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 54/169 (31%), Positives = 83/169 (49%), Gaps = 25/169 (14%)
Query: 285 IAVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK L +S +F+ E L+A+ H N+V+LLG C G + L++EYM L+
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 344 FLFDSTKGAQ-------------------LDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
FL + AQ L ++ I +A G+ YL E + +HR
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR 154
Query: 385 DLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPE 432
DL T N L+ M KI+DFG++R I+S + +A+ N + +M PE
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPE 202
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 53/155 (34%), Positives = 76/155 (49%), Gaps = 31/155 (20%)
Query: 265 GSVTSSKEICVQGI--LADGKEI--AVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRL 319
GSV V+G+ + GKE+ AVK L + G +EF E +++A+L H +VRL
Sbjct: 9 GSV-------VKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIIN------GIARGLLYL 373
+G C G L+L+ E P L +L +R I + + +A G+ YL
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYLKK---------RREIPVSDLKELAHQVAMGMAYL 111
Query: 374 HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408
+HRDL NVLL + KISDFGM+R
Sbjct: 112 ESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 279 LADGKEIAVKRLS-----RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIY 333
L DG AVK +S ++ + +++ + E+ L++KLQH N+V+ LG + + L +
Sbjct: 22 LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81
Query: 334 EYMPNKSLDLFL--FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
E +P SL L + S + R I GL YLH+ +HRD+K +N+
Sbjct: 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR---NTVHRDIKGANI 133
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L+D K++DFGMA+ + G+ +MAPE
Sbjct: 134 LVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 55/164 (33%), Positives = 89/164 (54%), Gaps = 19/164 (11%)
Query: 282 GKEIAVKRLSRSSGQG---------LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
G+ +AVK++ S L E+ L+ +LQH+N+V+ LG LD + L +
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
EY+P S+ L + GA + R + + I +GL YLH +R +IHRD+K +N+L
Sbjct: 85 LEYVPGGSVAALL--NNYGAFEETLVR-NFVRQILKGLNYLH--NR-GIIHRDIKGANIL 138
Query: 393 LDHEMNPKISDFGMARIFSGN--QNEANTNR--VVGTYGYMAPE 432
+D++ KISDFG+++ N + N R + G+ +MAPE
Sbjct: 139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 278 ILADGKEIAVKR--LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G+ +A+K+ L R G + E+ + QH +V+LL G+ +L+ EY
Sbjct: 21 DRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
MP+ L L D + + + + +G+ Y+H ++HRDLK +N+L+
Sbjct: 81 MPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGIMHRDLKPANLLISA 134
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ KI+DFG+AR+FS + +++ V T Y APE
Sbjct: 135 DGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 4e-17
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 270 SKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG 326
K + V+ GK A+K L + + ++ E +++++ H +V+L
Sbjct: 7 GKVLLVR-KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE 65
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGA-QLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385
+L L+ EY P +LF S +G + R I L YLH L +I+RD
Sbjct: 66 EKLYLVLEYAPGG--ELFSHLSKEGRFSEERARFY--AAEIVLALEYLH---SLGIIYRD 118
Query: 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
LK N+LLD + + K++DFG+A+ S + NT GT Y+APE +
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 282 GKEIAVKR-----LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G+E+AVK+ S + + + + E+ L+ LQH+ +V+ GC D L + EYM
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
P S+ L GA + R I G+ YLH + ++HRD+K +N+L D
Sbjct: 87 PGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLHSN---MIVHRDIKGANILRDSA 140
Query: 397 MNPKISDFGMA-RIFSGNQNEANTNRVVGTYGYMAPE 432
N K+ DFG + R+ + + V GT +M+PE
Sbjct: 141 GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 49/141 (34%), Positives = 83/141 (58%), Gaps = 15/141 (10%)
Query: 285 IAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K L+ ++G + EF +E ++A + H +LVRLLG CL + L+ + MP+ L
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLD 97
Query: 344 FLFDSTK--GAQL--DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
++ + G+QL +W +I A+G++YL E R++HRDL NVL+ +
Sbjct: 98 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHV 148
Query: 400 KISDFGMARIFSGNQNEANTN 420
KI+DFG+AR+ G++ E N +
Sbjct: 149 KITDFGLARLLEGDEKEYNAD 169
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 50/151 (33%), Positives = 85/151 (56%), Gaps = 11/151 (7%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
K+I V+++++ Q NE ++ L H N++ L+ L+++ EY P +L
Sbjct: 31 KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKI 401
++ + LD +I++ + LL LH ++HRDLKT N+LLD H+M KI
Sbjct: 88 EYIQKRCN-SLLDED---TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKI 143
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DFG+++I S ++++A T VVGT Y++PE
Sbjct: 144 GDFGISKILS-SKSKAYT--VVGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-17
Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 15/167 (8%)
Query: 285 IAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
+AVK L +S ++F E L+ LQH+++V+ G C++G+ L++++EYM + L+ F
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 345 L----------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
L + + A+L + + I IA G++YL + +HRDL T N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 154
Query: 395 HEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ KI DFGM+R ++S + + ++ +M PE M F+
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFT 200
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 15/167 (8%)
Query: 285 IAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK L + + +F E+ ++++L++ N++RLLG C+ + L +I EYM N L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 344 FLFDSTKGAQLDWKRRISIIN---------GIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
FL + I ++ IA G+ YL + L +HRDL T N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 395 HEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ KI+DFGM+R ++SG+ R V +MA E + G F+
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQ-GRAVLPIRWMAWESILLGKFT 209
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 263 SPGSVTSSKEI-------CVQGIL--ADGKEIAVKRLSRSSG---QGLQEFKNEVTLIAK 310
P +T K I +GIL KE+AV + G + Q+F +E +++ +
Sbjct: 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ 62
Query: 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGL 370
H N++RL G ++I EYM N +LD +L D + + + ++ GIA G+
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGM 120
Query: 371 LYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410
YL S + +HRDL N+L++ + K+SDFG++R+
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 7/165 (4%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G ++A+K L + S + F E L+ +LQH LVRL + + +I EYM
Sbjct: 25 GYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV-VTQEPIYIITEYM 82
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
N SL FL + +G +L + I + IA G+ ++ R IHRDL+ +N+L+
Sbjct: 83 ENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSET 138
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+ KI+DFG+AR+ N+ A + APE G F++
Sbjct: 139 LCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTI 182
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 18/170 (10%)
Query: 285 IAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
+AVK L + ++F+ E L+ LQH+++V+ G C DG+ L++++EYM + L+ F
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 345 LFDSTKGA-------------QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
L A +L + + I + IA G++YL + +HRDL T N
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNC 154
Query: 392 LLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
L+ + KI DFGM+R ++S + + ++ +M PE M F+
Sbjct: 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFT 203
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 9/154 (5%)
Query: 272 EICVQGILADGKE---IAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN 327
E+C + GK +A+K L + + ++F +E +++ + H N++ L G
Sbjct: 19 EVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78
Query: 328 ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
++++ EYM N SLD FL Q + + ++ GIA G+ YL S + +HRDL
Sbjct: 79 PVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLA 133
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421
N+L++ + K+SDFG++R+ + A T R
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 54/165 (32%), Positives = 79/165 (47%), Gaps = 6/165 (3%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G + ++AVK L + +Q F E L+ LQH LVRL + +I EYM
Sbjct: 25 GYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
SL FL S +G ++ + I IA G+ Y+ R IHRDL+ +NVL+
Sbjct: 84 AKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSES 139
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
+ KI+DFG+AR+ N+ A + APE G F++
Sbjct: 140 LMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTI 183
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 18/161 (11%)
Query: 279 LADGKEIAVKR--LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
L+D + A+K L S + ++ NE+ ++A + H N++ LDGN+L ++ EY
Sbjct: 22 LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81
Query: 337 PNKSLDLFLFDSTKGA-----QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
P L + K Q W+ I + RGL LHE +++HRDLK++N+
Sbjct: 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQ----LLRGLQALHE---QKILHRDLKSANI 134
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
LL KI D G++++ N A T +GT YMAPE
Sbjct: 135 LLVANDLVKIGDLGISKVLKKNM--AKT--QIGTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKN--EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
G+ +A+K++ E+ L+ +L H N+++LL +L L++E+M
Sbjct: 23 TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-- 80
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
DL+ + L S + + +GL + H ++HRDLK N+L++ E
Sbjct: 81 -DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGV 136
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG+AR F T+ VV T Y APE
Sbjct: 137 LKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 12/169 (7%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+ + +AVK L + ++F E ++ KL+H L++L C + ++ E
Sbjct: 24 EGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M SL +L G L + I + +A G+ YL + IHRDL NVL+
Sbjct: 83 MKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGE 138
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFSV 441
K++DFG+AR+ + EA G + APE A+ FS+
Sbjct: 139 NNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 46/142 (32%), Positives = 72/142 (50%), Gaps = 12/142 (8%)
Query: 300 EFKNEVTLIAKLQH---KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDW 356
+ + EV L+++L+ N+ + G L G L +I EY S+ + K +
Sbjct: 45 DIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAE 100
Query: 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 416
K II + L Y+H+ VIHRD+K +N+L+ + N K+ DFG+A + NQN
Sbjct: 101 KYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNS 155
Query: 417 ANTNRVVGTYGYMAPEYAMEGV 438
+ + VGT +MAPE EG
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGK 177
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 269 SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
S+ +C+ + G+++AVK++ Q + NEV ++ QH N+V + L G+E
Sbjct: 31 STGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L ++ E++ +L D +++ ++ ++ + + L +LH VIHRD+K+
Sbjct: 91 LWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKS 143
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNR--VVGTYGYMAPE 432
++LL + K+SDFG F ++ R +VGT +MAPE
Sbjct: 144 DSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 50/162 (30%), Positives = 85/162 (52%), Gaps = 14/162 (8%)
Query: 277 GILADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G L K++ R + S + ++ + E+ L+A+L H +++R+LG + + L E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISI--INGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
M S+ L S GA +K + I + RGL YLHE+ ++IHRD+K +N+L+
Sbjct: 85 MAGGSVSHLL--SKYGA---FKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLI 136
Query: 394 DHE-MNPKISDFGMARIFSGNQNEAN--TNRVVGTYGYMAPE 432
D +I+DFG A + A +++GT +MAPE
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 48/168 (28%), Positives = 91/168 (54%), Gaps = 15/168 (8%)
Query: 265 GSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 324
G+V ++ ++ A G+E+A+K+++ + NE+ ++ + +H N+V L L
Sbjct: 33 GTVYTAIDV------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
G+EL ++ EY+ SL D +D + ++ + L +LH + +VIHR
Sbjct: 87 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139
Query: 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
D+K+ N+LL + + K++DFG + Q++ +T +VGT +MAPE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 9e-16
Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 32/176 (18%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFK-----NEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYE 334
KE A+K L + Q ++E K E ++ +L H +++L D L + E
Sbjct: 25 TNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
Y PN L ++ K LD K I L YLH +IHRDLK N+LLD
Sbjct: 83 YAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLD 136
Query: 395 HEMNPKISDFGMARIFSGNQ------------------NEANTNRVVGTYGYMAPE 432
+M+ KI+DFG A++ N N VGT Y++PE
Sbjct: 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 22/134 (16%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS-- 361
E+ ++ + H N+V+ E+ ++ E+M SL+ G + ++ ++
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADV 173
Query: 362 ---IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 418
I++GIA YLH R ++HRD+K SN+L++ N KI+DFG++RI Q
Sbjct: 174 ARQILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDP 224
Query: 419 TNRVVGTYGYMAPE 432
N VGT YM+PE
Sbjct: 225 CNSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
KE+ + RLS ++ NE+ +++ LQH N++ +D N LL+ EY +L
Sbjct: 31 KEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL- 86
Query: 343 LFLFD---STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
+D KG + + + + I + Y+H+ ++HRD+KT N+ L
Sbjct: 87 ---YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLI 140
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG+++I + A T VVGT YM+PE
Sbjct: 141 KLGDFGISKILGSEYSMAET--VVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 44/134 (32%), Positives = 70/134 (52%), Gaps = 6/134 (4%)
Query: 276 QGILADGKEIAVKRLSRSSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYE 334
+G+L E+AVK + L ++F E ++ + H N+V+L+G C+ + ++ E
Sbjct: 13 KGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
+P SL FL K +L K+ + + A G+ YL +S+ IHRDL N L+
Sbjct: 73 LVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIHRDLAARNCLVG 127
Query: 395 HEMNPKISDFGMAR 408
KISDFGM+R
Sbjct: 128 ENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 42/131 (32%), Positives = 60/131 (45%), Gaps = 11/131 (8%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS-- 361
EV ++ +L+H+N+V L L L++EY+ L+L L S G D R
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQ 108
Query: 362 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421
++ IA Y H +IHRD+K N+L+ K+ DFG AR T+
Sbjct: 109 LLQAIA----YCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161
Query: 422 VVGTYGYMAPE 432
V T Y APE
Sbjct: 162 VA-TRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 13/163 (7%)
Query: 264 PGSVTSSKEI-------CVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316
P +T +EI G + +++A+K + R ++F E ++ KL H L
Sbjct: 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKL 61
Query: 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED 376
V+L G C + + + L++E+M + L +L + + + + + + G+ YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 377 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 419
+ VIHRDL N L+ K+SDFGM R +Q ++T
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 31/195 (15%)
Query: 262 PSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLG 321
+PG T + I L D E ++ +EFK+E + ++LQH N+V LLG
Sbjct: 29 TAPGEQTQAVAI---KTLKDKAEGPLR----------EEFKHEAMMRSRLQHPNIVCLLG 75
Query: 322 CCLDGNELLLIYEYMPNKSLDLFLF-------------DSTKGAQLDWKRRISIINGIAR 368
L +I+ Y + L FL D T + L+ + I+ IA
Sbjct: 76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAA 135
Query: 369 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYG 427
G+ +L S V+H+DL T NVL+ ++N KISD G+ R +++ + + N ++
Sbjct: 136 GMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR- 191
Query: 428 YMAPEYAMEGVFSVN 442
+M+PE M G FS++
Sbjct: 192 WMSPEAIMYGKFSID 206
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 15/177 (8%)
Query: 275 VQGILADGKEIAVKRLSR---SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
+G D E+ V + S Q +F E +++K H+N+VRL+G + +
Sbjct: 27 YRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86
Query: 332 IYEYMPNKSLDLFLFDS----TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
+ E M L FL ++ + + L K + +A+G YL E+ IHRD+
Sbjct: 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIA 143
Query: 388 TSNVLLDHEMNP----KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
N LL + P KI+DFGMAR R + +M PE ++G+F+
Sbjct: 144 ARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT 199
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 269 SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
S+ +C+ + + GK +AVK++ Q + NEV ++ QH+N+V + L G+E
Sbjct: 32 STGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE 91
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L ++ E++ +L D +++ ++ ++ + + L LH VIHRD+K+
Sbjct: 92 LWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKS 144
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNR--VVGTYGYMAPE 432
++LL H+ K+SDFG F ++ R +VGT +MAPE
Sbjct: 145 DSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 45/133 (33%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 285 IAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK L S ++F EV ++++L N+ RLLG C L +I EYM N L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 344 FL--------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
FL + L + + + IA G+ YL L +HRDL T N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 396 EMNPKISDFGMAR 408
KI+DFGM+R
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 53/174 (30%), Positives = 86/174 (49%), Gaps = 22/174 (12%)
Query: 285 IAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK L ++ +F EV ++++L+ N++RLLG C+D + L +I EYM N L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 344 FL----------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
FL + + + + + IA G+ YL S L +HRDL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 388 TSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
T N L+ + KI+DFGM+R +++G+ R V +MA E + G F+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFT 218
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 276 QGILADGKE--IAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
+GI +G E + VK L ++ + LQ EF+ E+ + KL HKN+VRLLG C + +I
Sbjct: 27 KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86
Query: 333 YEYMPNKSLDLFL------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
EY L FL + K L K+++++ IA G+ +L S R +HRDL
Sbjct: 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDL 143
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
N L+ + K+S +++ N + ++APE E FS
Sbjct: 144 AARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLAPEAVQEDDFS 196
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 45/129 (34%), Positives = 75/129 (58%), Gaps = 7/129 (5%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E++L+ +L H N+V+LL N+L L++E++ ++ L F+ D++ + + S +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYL 106
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ +GL + H RV+HRDLK N+L++ E K++DFG+AR F G T+ VV
Sbjct: 107 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 162
Query: 424 GTYGYMAPE 432
T Y APE
Sbjct: 163 -TLWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 276 QGILADGKEI-AVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIY 333
+GI KE+ A+K + + +++ + E+T++++ + R G L G +L +I
Sbjct: 22 KGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81
Query: 334 EYMPNKS-LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
EY+ S LDL K L+ +I+ I +GL YLH + R IHRD+K +NVL
Sbjct: 82 EYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVL 133
Query: 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF 439
L + + K++DFG+A + Q + NT VGT +MAPE + +
Sbjct: 134 LSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAY 178
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 41/171 (23%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKN-----------EVTLIAKLQHKNLVRLLGCCLDGNEL 329
G+ +A+K++ L E K E+ L+ +L+H N++ LL + +
Sbjct: 24 TGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI 77
Query: 330 LLIYEYMP--------NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381
L++E+M +KS+ L D K S + RGL YLH +
Sbjct: 78 NLVFEFMETDLEKVIKDKSIVL--------TPADIK---SYMLMTLRGLEYLH---SNWI 123
Query: 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+HRDLK +N+L+ + K++DFG+AR F G+ N T++VV T Y APE
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 47/154 (30%), Positives = 86/154 (55%), Gaps = 9/154 (5%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+A G+E+A+K+++ + NE+ ++ +L++ N+V L L G+EL ++ EY+
Sbjct: 41 VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL D +D + ++ + L +LH + +VIHRD+K+ NVLL + +
Sbjct: 101 GSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGS 153
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG + Q++ +T +VGT +MAPE
Sbjct: 154 VKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 44/140 (31%), Positives = 61/140 (43%), Gaps = 29/140 (20%)
Query: 303 NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDW----KR 358
NE ++ +L H LV L D + L+ +DL L G L + K
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLV--------VDLLL-----GGDLRYHLSQKV 95
Query: 359 RIS------IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 412
+ S I I L YLH +IHRD+K N+LLD + + I+DF +A +
Sbjct: 96 KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152
Query: 413 NQNEANTNRVVGTYGYMAPE 432
+ T GT GYMAPE
Sbjct: 153 DT---LTTSTSGTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 279 LADGKEIAVKRLS---RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
L DG+ +A+K++ + Q+ E+ L+ +L H N+++ L ++ NEL ++ E
Sbjct: 24 LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRI-SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
L + K +L +R I + L ++H R++HRD+K +NV +
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT 140
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ D G+ R FS A++ +VGT YM+PE
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 45/139 (32%), Positives = 74/139 (53%), Gaps = 13/139 (9%)
Query: 285 IAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK L + + + +F E+ ++++L+ N++RLL C+ + L +I EYM N L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 344 FL--------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
FL + + + I + IA G+ YL S L +HRDL T N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 396 EMNPKISDFGMAR-IFSGN 413
KI+DFGM+R ++SG+
Sbjct: 166 NYTIKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 265 GSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCC 323
GSVT + + G A+K ++ LQ + E+ + + +V+ G
Sbjct: 15 GSVTKCR------LKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 324 LD--GNELLLIYEYMPNKSLD-LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380
LD + + + EY SLD ++ +G ++ K I + +GL YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---K 125
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+IHRD+K SN+LL + K+ DFG+ SG + GT YMAPE
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 9/167 (5%)
Query: 281 DGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD-GNELLLIY-EYM 336
DGK + K + + + Q+ +EV ++ +L+H N+VR +D N+ L I EY
Sbjct: 24 DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83
Query: 337 PNKSLDLFLFDSTKGAQ-LDWKRRISIINGIARGLLYLH--EDSRLRVIHRDLKTSNVLL 393
L + K + ++ + I+ + L H D V+HRDLK +N+ L
Sbjct: 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL 143
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
D N K+ DFG+A+I + + A T VGT YM+PE +
Sbjct: 144 DANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNHMSYD 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 24/165 (14%)
Query: 282 GKEIAVKRL---SRSSGQGLQE-------FKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
G+ +AVK++ + +G+ ++E+ + L H N+V+ LG L +
Sbjct: 26 GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
EY+P S+ L + + + + GL YLH ++HRDLK N+
Sbjct: 86 FLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNL 139
Query: 392 LLDHEMNPKISDFGMAR----IFSGNQNEANTNRVVGTYGYMAPE 432
L+D + KISDFG+++ I+ +QN + G+ +MAPE
Sbjct: 140 LVDADGICKISDFGISKKSDDIYDNDQN----MSMQGSVFWMAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 12/166 (7%)
Query: 271 KEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNEL 329
IC L + +++A+KR+ Q + E + EV +++ H N+V+ + G+EL
Sbjct: 19 AAIC----LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL 74
Query: 330 LLIYEYMPNKS-LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L+ Y+ S LD+ +G LD +++ + +GL YLH + + IHRD+K
Sbjct: 75 WLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKA 130
Query: 389 SNVLLDHEMNPKISDFGM-ARIFSGNQNEANT-NRVVGTYGYMAPE 432
N+LL + + KI+DFG+ A + G VGT +MAPE
Sbjct: 131 GNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 51/133 (38%), Positives = 72/133 (54%), Gaps = 14/133 (10%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL---FDSTKGAQLDWKRRI 360
E++L+ ++QH N+VRL L L++EY LDL L DS+ + +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIK 105
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANT 419
+ + I RG+ Y H S RV+HRDLK N+L+D N K++DFG+AR F G T
Sbjct: 106 TYLYQILRGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFT 161
Query: 420 NRVVGTYGYMAPE 432
+ VV T Y APE
Sbjct: 162 HEVV-TLWYRAPE 173
|
Length = 294 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 272 EICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
E+C + A GK A K+L + +G Q NE ++ K+ + +V L ++
Sbjct: 8 EVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD 67
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L L+ M L +++ + R I I GL +LH + R+++RDLK
Sbjct: 68 LCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKP 123
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
NVLLD N +ISD G+A G + GT GYMAPE V+
Sbjct: 124 ENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYD 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 272 EICVQGILADGKE---IAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN 327
E+C + GK +A+K L S + + ++F +E +++ + H N++ L G
Sbjct: 19 EVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78
Query: 328 ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
+++I E+M N +LD FL Q + + ++ GIA G+ YL E + +HRDL
Sbjct: 79 PVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNE 416
N+L++ + K+SDFG++R + ++
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSD 162
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 36/132 (27%), Positives = 69/132 (52%), Gaps = 5/132 (3%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
+AVK L + ++EF E ++ +++H NLV+LLG C +I E+M +L
Sbjct: 31 SLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
+L + + +++ + + I+ + YL + + IHRDL N L+ K+
Sbjct: 90 LDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKV 145
Query: 402 SDFGMARIFSGN 413
+DFG++R+ +G+
Sbjct: 146 ADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 18/164 (10%)
Query: 279 LADGKEIAVKRLS-RSSGQGL-QEFKNEVTLIAKLQ---HKNLVRLLGCCL---DGNE-- 328
L G+ +A+K++ S +G+ E+ L+ +L+ H N+VRLL C E
Sbjct: 21 LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L L++E++ ++ L +L L + ++ + RG+ +LH R++HRDLK
Sbjct: 81 LTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKP 135
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+L+ + KI+DFG+ARI+S E VV T Y APE
Sbjct: 136 QNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 264 PGSVTSSKEICVQ--GILADGK-----EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316
P +T KE+ G++ GK ++A+K + R +F E ++ KL H NL
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED 376
V+L G C + ++ EYM N L +L + +W + + + + + YL +
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESN 119
Query: 377 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408
IHRDL N L+ + K+SDFG+AR
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 45/163 (27%), Positives = 85/163 (52%), Gaps = 15/163 (9%)
Query: 278 ILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+A G+ +A+K + G + + E++++ + +H N+V G L ++L ++ EY
Sbjct: 24 DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83
Query: 338 NKSLDLFLFDSTKGA----QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
SL ++ T+G Q+ + R ++ +GL YLHE IHRD+K +N+LL
Sbjct: 84 GGSLQD-IYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---TGKIHRDIKGANILL 134
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436
+ + K++DFG++ + + + +GT +MAPE A
Sbjct: 135 TEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAV 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 21/183 (11%)
Query: 272 EICVQGILAD--GKEIAVKRLS-RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
E +G++ +A+K ++ +S + EF NE +++ + ++VRLLG G
Sbjct: 24 EGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83
Query: 329 LLLIYEYMPNKSLDLFL-------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381
L++ E M L +L ++ ++ I + IA G+ YL +
Sbjct: 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKF 140
Query: 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT----YGYMAPEYAMEG 437
+HRDL N ++ ++ KI DFGM R + E + R G +MAPE +G
Sbjct: 141 VHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDG 196
Query: 438 VFS 440
VF+
Sbjct: 197 VFT 199
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 14/160 (8%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G LA K I K S + L+++ E+ ++A H +V+LLG +L ++ E+
Sbjct: 37 GALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
P ++D + + +G + +I +I + L YLH +++IHRDLK NVLL
Sbjct: 92 PGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTL 145
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
+ + K++DFG++ + + +GT +MAPE M
Sbjct: 146 DGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVM 183
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 18/140 (12%)
Query: 304 EVTLIAKLQHKNLVRLLGCC----LDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLD 355
E+ ++ L+H+N+V L+ C N L++E+ + DL S K +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFT 117
Query: 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415
++ + GL Y+H R +++HRD+K +N+L+ + K++DFG+AR FS ++N
Sbjct: 118 LSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 416 EAN---TNRVVGTYGYMAPE 432
TNRVV T Y PE
Sbjct: 175 SKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 44/129 (34%), Positives = 60/129 (46%), Gaps = 14/129 (10%)
Query: 285 IAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK L + +F E ++ L H+NL+RL G L + L+++ E P SL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84
Query: 344 FLFDSTKGAQLDWKRRISIING----IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L G L IS + IA G+ YL R IHRDL N+LL +
Sbjct: 85 RLRKDALGHFL-----ISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKV 136
Query: 400 KISDFGMAR 408
KI DFG+ R
Sbjct: 137 KIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 285 IAVKRLSRSSGQGLQEFKN---EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
+A+K++S S Q +++++ EV + KL+H N ++ GC L + L+ EY +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
DL +++ ++ +G +GL YLH + +IHRD+K N+LL K+
Sbjct: 103 DLLEVHKKPLQEVEIA---AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL 156
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DFG A I A N VGT +MAPE
Sbjct: 157 GDFGSASIM------APANXFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 269 SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
S+ +C+ GK++AVK++ Q + NEV ++ H+N+V + L G+E
Sbjct: 34 STGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L ++ E++ +L D +++ ++ ++ + R L YLH VIHRD+K+
Sbjct: 94 LWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKS 146
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++LL + K+SDFG S + +VGT +MAPE
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVS--KEVPKRKSLVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 23/146 (15%)
Query: 300 EFKNEVTLIAKL-QHKNLVRLLGCCL------DGNELLLIYEYMPNKSLDLFLFDSTKGA 352
E K E ++ K H N+ G + + ++L L+ E S+ D KG
Sbjct: 48 EIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKGL 103
Query: 353 QLDWKRRIS------IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 406
+R+ I+ RGL YLHE+ +VIHRD+K N+LL K+ DFG+
Sbjct: 104 -RKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159
Query: 407 ARIFSGNQNEANTNRVVGTYGYMAPE 432
+ NT +GT +MAPE
Sbjct: 160 SAQLDSTLGRRNT--FIGTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 285 IAVKRLSRSSGQGLQEFKN---EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
+A+K++S S Q +++++ EV + +++H N + GC L + L+ EY +
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
DL +++ +I +G +GL YLH + +IHRD+K N+LL K+
Sbjct: 113 DLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKL 166
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+DFG A I S N VGT +MAPE
Sbjct: 167 ADFGSASIAS------PANSFVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 14/172 (8%)
Query: 263 SPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAK-LQHKNLVRLLG 321
+ ++ + KEI V A GK+ R + + + +EVT+I + L+H N+VR
Sbjct: 24 NGQNLLALKEINVHN-PAFGKD------KRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76
Query: 322 CCLDGNELLLIYEYMPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380
L+ + L ++ + + L + F K + +R +I + L YLH++ R
Sbjct: 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-- 134
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++HRDL +N++L + I+DFG+A+ Q E+ VVGT Y PE
Sbjct: 135 IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 44/143 (30%), Positives = 78/143 (54%), Gaps = 11/143 (7%)
Query: 298 LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS-LDLFLFDSTKGAQLDW 356
+++ + E+T++++ + + G L G +L +I EY+ S LDL + D
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDE 100
Query: 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE 416
+ +++ I +GL YLH + + IHRD+K +NVLL + + K++DFG+A + Q +
Sbjct: 101 FQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 417 ANTNRVVGTYGYMAPEYAMEGVF 439
NT VGT +MAPE + +
Sbjct: 158 RNT--FVGTPFWMAPEVIQQSAY 178
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
++AVK L + + F E ++ KL+H LV+L + + ++ EYM SL
Sbjct: 32 KVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-VSEEPIYIVTEYMSKGSLLD 89
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
FL D +G L + + +A G+ Y+ R+ IHRDL+++N+L+ + KI+D
Sbjct: 90 FLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIAD 145
Query: 404 FGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
FG+AR+ N+ A + APE A+ G F++
Sbjct: 146 FGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 182
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 20/174 (11%)
Query: 285 IAVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K L ++ Q EF+ E +L+A+L H N+V LLG + +++EY+ L
Sbjct: 37 VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE 96
Query: 344 FLF--------------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
FL D T + LD + I IA G+ YL S +H+DL
Sbjct: 97 FLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAAR 153
Query: 390 NVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVN 442
N+L+ +++ KISD G++R I+S + ++ +M PE M G FS +
Sbjct: 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSD 206
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 269 SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
S+ +C+ G+++AVK + Q + NEV ++ QH+N+V + L G E
Sbjct: 33 STGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L ++ E++ +L D +L+ ++ ++ + + L YLH VIHRD+K+
Sbjct: 93 LWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKS 145
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++LL + K+SDFG S ++ +VGT +MAPE
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQIS--KDVPKRKSLVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 286 AVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345
A K + S + L++F E+ ++++ +H N+V L N+L ++ E+ +LD +
Sbjct: 34 AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM 93
Query: 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG 405
+ +G R + + L +LH +VIHRDLK N+LL + + K++DFG
Sbjct: 94 LELERGLTEPQIRYVC--RQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG 148
Query: 406 M-ARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
+ A+ S Q + +GT +MAPE
Sbjct: 149 VSAKNKSTLQKR---DTFIGTPYWMAPEVVA 176
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 58/171 (33%), Positives = 86/171 (50%), Gaps = 18/171 (10%)
Query: 285 IAVKRLS-RSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+AVK L ++ + L + +E+ L+ + +HKN++ LLG C L +I EY +L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 343 LFL-----------FDSTKGA--QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
FL FD TK QL +K +S +ARG+ YL +SR R IHRDL
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAAR 163
Query: 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
NVL+ + KI+DFG+AR T+ +MAPE + V++
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT 214
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 48/131 (36%), Positives = 75/131 (57%), Gaps = 10/131 (7%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQ--LDWKRRIS 361
E++L+ +L+H+N+VRL N+L+L++EYM DL + T G + LD S
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKS 104
Query: 362 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421
+ +G+ + HE+ RV+HRDLK N+L++ K++DFG+AR F G +N
Sbjct: 105 FTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNE 160
Query: 422 VVGTYGYMAPE 432
VV T Y AP+
Sbjct: 161 VV-TLWYRAPD 170
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 285 IAVKRLSRSSGQGLQEFKN---EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
+AVK++S S Q +++++ EV + +L+H N + GC L + L+ EY +
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
DL L +I +G +GL YLH + IHRD+K N+LL K+
Sbjct: 109 DLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKL 162
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+DFG A S N VGT +MAPE
Sbjct: 163 ADFGSASKSS------PANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 18/171 (10%)
Query: 277 GILADGKEIAVKRLSRSSGQGL------QEFKNEVTLIAKLQHKNLVRLLGCCLDGNELL 330
G+ G+ IAVK++ + L ++ + EV L+ L+H N+V+ LG CLD N +
Sbjct: 19 GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWKRRI-SIINGIARGLLYLHEDSRLRVIHRDLKTS 389
+ E++P S+ L + + + I++G+A YLH + V+HRD+K +
Sbjct: 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC---VVHRDIKGN 131
Query: 390 NVLLDHEMNPKISDFGMAR---IFSGNQNEANTNRVV-GTYGYMAPEYAME 436
NV+L K+ DFG AR + +N + + GT +MAPE E
Sbjct: 132 NVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 44/136 (32%), Positives = 77/136 (56%), Gaps = 8/136 (5%)
Query: 282 GKEIAVKRLS-RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMPN 338
G+++AVK L S G + + K E+ ++ L H+N+V+ G C + GN + LI E++P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL +L +++ K+++ I +G+ YL SR + +HRDL NVL++ E
Sbjct: 93 GSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQ 147
Query: 399 PKISDFGMARIFSGNQ 414
KI DFG+ + ++
Sbjct: 148 VKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
G+++AVK + Q F E ++ KL HKNLVRLLG L N L ++ E M +L
Sbjct: 29 GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85
Query: 342 DLFLFDSTKG-AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
FL T+G A + + + +A G+ YL +++HRDL N+L+ + K
Sbjct: 86 VNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+SDFG+AR+ + +++ + APE FS
Sbjct: 141 VSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFS 175
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 33/168 (19%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL-----GCCLDGN 327
G+++A+K++S F + E+ L+ L+H+N++ LL D N
Sbjct: 25 GRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77
Query: 328 ELLLIYEYMPNKSLDLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
++ ++ E M DL + S + L + I RGL YLH + VIHRDL
Sbjct: 78 DVYIVTELME---TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDL 129
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVVGTYGYMAPE 432
K SN+L++ + KI DFG+AR +++E T VV T Y APE
Sbjct: 130 KPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 15/141 (10%)
Query: 285 IAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNEL------LLIYEYM 336
+AVK +L + ++EF +E + H N+++L+G C + + L ++I +M
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 337 PNKSLDLFLFDSTKGAQ---LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
+ L FL S G L + + + IA G+ YL S IHRDL N +L
Sbjct: 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCML 146
Query: 394 DHEMNPKISDFGMAR-IFSGN 413
+M ++DFG+++ I+SG+
Sbjct: 147 REDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 4e-13
Identities = 45/154 (29%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+A G+E+A+K+++ + NE+ ++ + ++ N+V L L G+EL ++ EY+
Sbjct: 41 IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL D +D + ++ + L +LH + +VIHRD+K+ N+LL + +
Sbjct: 101 GSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGS 153
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG + Q++ +T +VGT +MAPE
Sbjct: 154 VKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 285 IAVKRLSRSSGQGLQEFKNEVTLIAKL----QHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+AVK L + + ++ + V+ + + +HKN++ LLG C L ++ EY + +
Sbjct: 45 VAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 341 LDLFL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
L FL L K +S +ARG+ +L S+ + IHRDL
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASK-KCIHRDLA 159
Query: 388 TSNVLL--DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
NVL+ DH M KI+DFG+AR T +MAPE + V++
Sbjct: 160 ARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 42/132 (31%), Positives = 72/132 (54%), Gaps = 8/132 (6%)
Query: 281 DGKEIAVKRLS-RSSGQGLQEFK-NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ +A+KR+ +G+ E+ L+ +L+HKN+VRL +L L++EY +
Sbjct: 24 THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-D 82
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
+ L + FDS G +D + S + + +GL + H V+HRDLK N+L++
Sbjct: 83 QDLKKY-FDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGE 137
Query: 399 PKISDFGMARIF 410
K++DFG+AR F
Sbjct: 138 LKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN-ELLLIYEYMPNKS 340
G ++AVK + + Q F E +++ +L+H NLV+LLG ++ L ++ EYM S
Sbjct: 29 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
L +L S + L + + + YL ++ +HRDL NVL+ + K
Sbjct: 87 LVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAK 142
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+SDFG+ + S Q+ + APE E FS
Sbjct: 143 VSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFS 177
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 283 KEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS- 340
K +A+K + + +++ + E+T++++ + + G L +L +I EY+ S
Sbjct: 30 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
LDL + LD + +I+ I +GL YLH + + IHRD+K +NVLL K
Sbjct: 90 LDLL-----EPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVK 141
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF 439
++DFG+A + Q N VGT +MAPE + +
Sbjct: 142 LADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY 178
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 52/138 (37%), Positives = 73/138 (52%), Gaps = 24/138 (17%)
Query: 304 EVTLIAKLQHKNLVRLL----GCCLDGNELLLIYEYMPNKSLDLF-LFDSTKG----AQL 354
E+TL+ L+H N+V L G LD + L+ EY DL L D+ +Q+
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQ---DLASLLDNMPTPFSESQV 110
Query: 355 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 414
++ + RGL YLHE+ +IHRDLK SN+LL + KI+DFG+AR + G
Sbjct: 111 K-----CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLP 161
Query: 415 NEANTNRVVGTYGYMAPE 432
+ T +VV T Y APE
Sbjct: 162 AKPMTPKVV-TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 272 EICVQGILADGKEIAVK-----RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG 326
E+C + GK A K RL + SG+ + + E+ + K+ +V L
Sbjct: 8 EVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESK 65
Query: 327 NELLLIYEYMPNKSLDLFLFD-STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385
L L+ M L +++ +G L+ +R I I G+L+LH + +++RD
Sbjct: 66 THLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLHS---MDIVYRD 120
Query: 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+K NVLLD + N ++SD G+A + + GT GYMAPE E +S
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYS 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 15/151 (9%)
Query: 285 IAVKRLSRSSGQGLQEFKN---EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
+A+K++S S Q +++++ EV + +L+H N + GC L + L+ EY +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSAS 102
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
D+ L K Q +I +G +GL YLH R IHRD+K N+LL K+
Sbjct: 103 DI-LEVHKKPLQEV--EIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKL 156
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+DFG A + S AN+ VGT +MAPE
Sbjct: 157 ADFGSASLVS----PANS--FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 282 GKEIAVKRLSRSSGQG---LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
G A+K + ++ + + E ++++ Q +V+L L L+ EY+P
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77
Query: 339 KSLDLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
DL L ++ D R I I L YLH +IHRDLK N+L+D
Sbjct: 78 G--DLASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNG 130
Query: 398 NPKISDFG------MARIFSGNQNEANTNRVVGTYGYMAPE 432
+ K++DFG + R + N +E R+VGT Y+APE
Sbjct: 131 HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 25/178 (14%)
Query: 285 IAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK L ++ L++ +E L+ ++ H ++++L G C LLLI EY SL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 344 FLFDSTK----GAQLDWKRRISIING-----------------IARGLLYLHEDSRLRVI 382
FL +S K D R S ++ I+RG+ YL E ++++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLV 149
Query: 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
HRDL NVL+ KISDFG++R + ++ +MA E + +++
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
++AVK + S ++ F E ++ LQH LV+L + + +I E+M SL
Sbjct: 32 KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLD 89
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
FL S +G++ + I IA G+ ++ + + IHRDL+ +N+L+ + KI+D
Sbjct: 90 FL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145
Query: 404 FGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
FG+AR+ N+ A + APE G F++
Sbjct: 146 FGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTI 182
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLD-----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKR 358
E+ ++ KL+H N+V L+ ++ + +Y P DL +L +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 359 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN----- 413
+ + G+ YLHE+ ++HRD+K +N+L+D++ KI+DFG+AR + G
Sbjct: 117 IKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 414 ----QNEAN-TNRVVGTYGYMAPE 432
TN VV T Y PE
Sbjct: 174 GGGGGGTRKYTNLVV-TRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 7/149 (4%)
Query: 285 IAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K + RS Q QE + + + L H +VRLLG C G L L+ + P SL L
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSL-L 96
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
+ + LD +R ++ IA+G+ YL E R++HR+L N+LL + +I+D
Sbjct: 97 DHVRQHRDS-LDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152
Query: 404 FGMARIFSGNQNEANTNRVVGTYGYMAPE 432
FG+A + + + + +MA E
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K L + + F E ++ KL+H+ LV+L + + ++ EYM SL
Sbjct: 32 RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLD 89
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
FL G L + + + IA G+ Y+ R+ +HRDL+ +N+L+ + K++D
Sbjct: 90 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 145
Query: 404 FGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
FG+AR+ N+ A + APE A+ G F++
Sbjct: 146 FGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 182
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 285 IAVKRLSR-SSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+AVK L ++ + L + +E+ ++ + +HKN++ LLG C L ++ EY +L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 343 LFL-----------FDSTK--GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
+L FD+ K QL +K +S +ARG+ YL + + IHRDL
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
NVL+ + KI+DFG+AR T +MAPE + V++
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT 214
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 285 IAVKRLS-RSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+AVK L ++ + L + +E+ ++ + +HKN++ LLG C L +I EY +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 343 LFL-----------FDSTK--GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
+L +D + Q+ +K +S +ARG+ YL + + IHRDL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
NVL+ KI+DFG+AR + T +MAPE + V++
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 4e-12
Identities = 43/154 (27%), Positives = 84/154 (54%), Gaps = 9/154 (5%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+A G+E+A+++++ + NE+ ++ + ++ N+V L L G+EL ++ EY+
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL D +D + ++ + L +LH + +VIHRD+K+ N+LL + +
Sbjct: 102 GSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG + Q++ + +VGT +MAPE
Sbjct: 155 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 282 GKEIAVKRL-----SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYE 334
G+E+AVK++ S+ + + + + E+ L+ L+H +V+ GC D E L + E
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 335 YMPNKSLDLFLFDSTKG-AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
YMP S+ D K L I +G+ YLH + ++HRD+K +N+L
Sbjct: 87 YMPGGSIK----DQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILR 139
Query: 394 DHEMNPKISDFGMA-RIFSGNQNEANTNRVVGTYGYMAPE 432
D N K+ DFG + RI + + V GT +M+PE
Sbjct: 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 15/156 (9%)
Query: 281 DGKEI-AVKRLSRSSGQGLQEFK---NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
D EI A+KR+ +S L E + E ++ + + LV+LL D L L EY+
Sbjct: 24 DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
P L + G + R + + LH L IHRDLK N L+D
Sbjct: 84 PGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH---ELGYIHRDLKPENFLIDAS 137
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ K++DFG++ G AN+ VVG+ YMAPE
Sbjct: 138 GHIKLTDFGLS---KGIVTYANS--VVGSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 284 EIAVKRL---SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNK 339
++AVK L + SS + + +E+ +++ L H+N+V LLG C G +L+I EY
Sbjct: 67 KVAVKMLKPTAHSSER--EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L FL + + L + +S +A+G+ +L + IHRDL NVLL H
Sbjct: 125 DLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
KI DFG+AR + N +MAPE V++
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF 222
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD-LFLFDSTKGAQLDWKRRISI 362
E+ ++ +L+H+NLV L+ L L++E++ + LD L + + LD R
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKY 105
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422
+ I RG+ + H + +IHRD+K N+L+ K+ DFG AR + E T+
Sbjct: 106 LFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTD-Y 160
Query: 423 VGTYGYMAPE 432
V T Y APE
Sbjct: 161 VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 41/142 (28%), Positives = 74/142 (52%), Gaps = 15/142 (10%)
Query: 284 EIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNEL------LLIYEY 335
++AVK +++ + +++F +E + + H N++RL+G CL E ++I +
Sbjct: 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87
Query: 336 MPNKSLDLFLFDSTKGAQ---LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
M + L FL S G L + + + IA G+ YL S IHRDL N +
Sbjct: 88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCM 144
Query: 393 LDHEMNPKISDFGMA-RIFSGN 413
L+ MN ++DFG++ +I++G+
Sbjct: 145 LNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
++A+K L + + F E ++ KL+H LV L + + ++ E+M SL
Sbjct: 32 KVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-VSEEPIYIVTEFMGKGSLLD 89
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
FL + G L + + + IA G+ Y+ R+ IHRDL+ +N+L+ + KI+D
Sbjct: 90 FLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIAD 145
Query: 404 FGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
FG+AR+ N+ A + APE A+ G F++
Sbjct: 146 FGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 182
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 13/188 (6%)
Query: 265 GSVTSSKEICVQGILADGKE--IAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLG 321
GS E +G++ D E +A+K ++ ++ + EF NE +++ + ++VRLLG
Sbjct: 17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 76
Query: 322 CCLDGNELLLIYEYMPNKSLDLFLF-------DSTKGAQLDWKRRISIINGIARGLLYLH 374
G L+I E M L +L ++ A K+ I + IA G+ YL+
Sbjct: 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN 136
Query: 375 EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA 434
+ + +HRDL N ++ + KI DFGM R + + +M+PE
Sbjct: 137 AN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 193
Query: 435 MEGVFSVN 442
+GVF+
Sbjct: 194 KDGVFTTY 201
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 38/148 (25%)
Query: 298 LQEFKNEVTLIAKLQHKNLVRLLGC--CLDGNELLLIYEYMPNKSLDL-------FLFDS 348
LQE + H N+V+LL + ++ L++EYM DL L D
Sbjct: 60 LQELGD---------HPNIVKLLNVIKAENDKDIYLVFEYMET---DLHAVIRANILEDV 107
Query: 349 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408
K I+ + + L Y+H S VIHRDLK SN+LL+ + K++DFG+AR
Sbjct: 108 HK---------RYIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
Query: 409 IFSGNQNEANTNRV----VGTYGYMAPE 432
S E N V V T Y APE
Sbjct: 156 SLS-ELEENPENPVLTDYVATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 282 GKEIAVKRL-----SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYE 334
G+E+A K++ S + + + + E+ L+ LQH+ +V+ GC D E L + E
Sbjct: 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86
Query: 335 YMPNKSLDLFLFDSTK--GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
YMP S+ D K GA + R I G+ YLH + ++HRD+K +N+L
Sbjct: 87 YMPGGSVK----DQLKAYGALTESVTR-KYTRQILEGMSYLHSN---MIVHRDIKGANIL 138
Query: 393 LDHEMNPKISDFGMA-RIFSGNQNEANTNRVVGTYGYMAPE 432
D N K+ DFG + R+ + + V GT +M+PE
Sbjct: 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 17/139 (12%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELL----------LIYEYMPNKSLDLFLFDSTKGAQ 353
E+ ++ +L H+N+V L D + L L++EYM + DL +
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVH 112
Query: 354 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 413
S + + GL Y H+ + L HRD+K SN+LL+++ K++DFG+AR+++
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 414 QNEANTNRVVGTYGYMAPE 432
++ TN+V+ T Y PE
Sbjct: 170 ESRPYTNKVI-TLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 9/165 (5%)
Query: 272 EICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
E+ + A GK A K+L++ +G + E ++AK+ + +V L +
Sbjct: 8 EVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD 67
Query: 329 LLLIYEYMPNKSLDLFLFD-STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
L L+ M L +++ + R I GL +LH+ R+I+RDLK
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLK 124
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
NVLLD++ N +ISD G+A Q++ T GT G+MAPE
Sbjct: 125 PENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 6/125 (4%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
++A+K + ++F E ++ KL H LV+L G C L ++ E+M N L
Sbjct: 30 KVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
+L + +L +S+ + G+ YL +S IHRDL N L+ K+SD
Sbjct: 89 YL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSD 143
Query: 404 FGMAR 408
FGM R
Sbjct: 144 FGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 6/130 (4%)
Query: 280 ADGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
AD +AVK + L+ +F E ++ + H N+VRL+G C + ++ E +
Sbjct: 18 ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV-- 75
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
+ D F T+G +L K I ++ A G+ YL IHRDL N L+ +
Sbjct: 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNV 132
Query: 399 PKISDFGMAR 408
KISDFGM+R
Sbjct: 133 LKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 272 EICVQGILADGKE---IAVKRLSRSSGQGLQE--FKNEVTLIAKLQHKNLVRLLGCCLDG 326
E+C + K +A+ L R+ Q F E + + H N+VRL G G
Sbjct: 20 ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
N ++++ EYM N +LD FL QL + + ++ G+A G+ YL E + +H+ L
Sbjct: 79 NTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGL 133
Query: 387 KTSNVLLDHEMNPKISDFG 405
VL++ ++ KIS F
Sbjct: 134 AAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 52/167 (31%), Positives = 76/167 (45%), Gaps = 16/167 (9%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAK------LQHKNLVRLLGCCLDGNELLLIYE 334
G+ AVK L + LQ+ E T+ K H L +L C + L + E
Sbjct: 19 SGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME 76
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
++ L +F K + D R I L++LH+ +I+RDLK NVLLD
Sbjct: 77 FVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLD 130
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
HE + K++DFGM + G N T+ GT Y+APE E ++
Sbjct: 131 HEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 11/137 (8%)
Query: 277 GILADGK-----EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
G++ GK ++A+K + S EF E ++ KL H+ LV+L G C + +
Sbjct: 18 GVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
+ EYM N L +L + K Q + + + + G+ YL + IHRDL N
Sbjct: 77 VTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHRDLAARNC 131
Query: 392 LLDHEMNPKISDFGMAR 408
L+D + K+SDFG++R
Sbjct: 132 LVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 31/67 (46%), Positives = 39/67 (58%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I GL +LHE +I+RDLK NVLLD E + KI+DFGM + G T+ GT
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGT 159
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 160 PDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 9/132 (6%)
Query: 281 DGKEI--AVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNEL-LLIYEYM 336
DG++I AVK L+R + + +++F E ++ H N++ LLG CL L++ YM
Sbjct: 20 DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
+ L F+ T + K I +A+G+ YL + +HRDL N +LD
Sbjct: 80 KHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDES 134
Query: 397 MNPKISDFGMAR 408
K++DFG+AR
Sbjct: 135 FTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 6/134 (4%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYE 334
+G L D +AVK Q L+ +F +E ++ + H N+V+L+G C + ++ E
Sbjct: 13 KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
+P D F K +L K+ + A G+ YL + IHRDL N L+
Sbjct: 73 LVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVG 127
Query: 395 HEMNPKISDFGMAR 408
KISDFGM+R
Sbjct: 128 ENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 4e-11
Identities = 46/139 (33%), Positives = 65/139 (46%), Gaps = 27/139 (19%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361
NE ++ ++H LV L G D + L L+ EY+P +LF + L R
Sbjct: 49 LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG--ELF-------SHLRKSGRFP 99
Query: 362 IINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 413
+AR L YLH L +++RDLK N+LLD + KI+DFG A+ G
Sbjct: 100 --EPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG- 153
Query: 414 QNEANTNRVVGTYGYMAPE 432
T + GT Y+APE
Sbjct: 154 ----RTYTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 26/183 (14%)
Query: 265 GSVTSSKEICVQGILA------DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318
GSV+ K I ++A K K++ R E+ ++ + + +V
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-----------ELQIMHECRSPYIVS 67
Query: 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSR 378
G L+ N + + E+M SLD KG + + I + GL YL+
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--V 122
Query: 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV 438
R++HRD+K SN+L++ K+ DFG+ SG + + VGT YM+PE G
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADTFVGTSTYMSPERIQGGK 178
Query: 439 FSV 441
++V
Sbjct: 179 YTV 181
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 281 DGKEIAVKRLS--RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
DGK+ +K+L+ +S + + + E L+++L+H N+V + LL I
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 339 KSLDLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
DL+ KG L + + IA L YLHE ++HRDLKT NV L
Sbjct: 84 GG-DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTN 139
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ D G+AR+ + A+T ++GT YM+PE
Sbjct: 140 IIKVGDLGIARVLENQCDMAST--LIGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G+LA K I K S + L+++ E+ ++A H N+V+LL N L ++ E+
Sbjct: 30 GVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
++D + + + + +I ++ L YLHE+ ++IHRDLK N+L
Sbjct: 85 AGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTL 138
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
+ + K++DFG++ + + +GT +MAPE M
Sbjct: 139 DGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVM 176
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 34/129 (26%), Positives = 58/129 (44%), Gaps = 9/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E L+ + H +++R+ + G ++ +P+ S DL+ + + + L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
I GL YLH R+IHRD+KT N+ ++ I D G A+ +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 424 GTYGYMAPE 432
GT APE
Sbjct: 218 GTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 25/144 (17%)
Query: 299 QEFKNEVTLIAKLQHK----NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQL 354
+N++ K+ H+ +V G E+ + E+M SLD L K A
Sbjct: 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKA-- 93
Query: 355 DWKRRI--SIINGIA----RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408
RI +I+ I+ RGL YL E + +++HRD+K SN+L++ K+ DFG+
Sbjct: 94 ---GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-- 146
Query: 409 IFSGNQNEANTNRVVGTYGYMAPE 432
SG ++ N VGT YM+PE
Sbjct: 147 --SGQLIDSMANSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 43/137 (31%), Positives = 76/137 (55%), Gaps = 15/137 (10%)
Query: 285 IAVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K L +S + +E +E ++A + + ++ RLLG CL + + LI + MP L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD 97
Query: 344 FLFDSTK--GAQ--LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
++ + G+Q L+W +I A+G+ YL E R++HRDL NVL+ +
Sbjct: 98 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEER---RLVHRDLAARNVLVKTPQHV 148
Query: 400 KISDFGMARIFSGNQNE 416
KI+DFG+A++ ++ E
Sbjct: 149 KITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 49/156 (31%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN-----------ELL 330
K +AVK++ + Q ++ E+ +I +L H N+V++ EL
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 331 LIY---EYM-------------PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLH 374
+Y EYM + LF++ QL RGL Y+H
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMY------QL------------LRGLKYIH 131
Query: 375 EDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARI 409
+ V+HRDLK +NV ++ E + KI DFG+ARI
Sbjct: 132 SAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 28/140 (20%)
Query: 304 EVTLIAKLQHKNLVRL----LGCCLDGNELLLIYEYMPN--KSL-----DLFLFDSTKGA 352
E+ ++ KLQH N+V + +G LD ++ ++ EY+ + KSL FL K
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVK-- 109
Query: 353 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 412
++ + G+ +LH++ ++HRDLKTSN+LL++ KI DFG+AR +
Sbjct: 110 --------CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
Query: 413 NQNEANTNRVVGTYGYMAPE 432
T VV T Y APE
Sbjct: 159 PLKPY-TQLVV-TLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 20/173 (11%)
Query: 284 EIAVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
++AVK L S ++ + L + +E+ ++ + +HKN++ LLG C L +I EY +L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 342 DLFLF-------------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
+L QL +K +S +ARG+ YL + + IHRDL
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 389 SNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
NVL+ + KI+DFG+AR I + + TN + +MAPE + +++
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYT 220
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 282 GKEIAVKRL---SRSSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDG-----NELL 330
G+ +A+KR+ + G L + EV ++ L+ H N+VRL C +L
Sbjct: 27 GRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L++E++ ++ L +L D + + ++ + RGL +LH RV+HRDLK N
Sbjct: 86 LVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 140
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+L+ K++DFG+ARI+S + VV T Y APE ++ ++
Sbjct: 141 ILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYA 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGN------ELLLIYEYM 336
++A ++ +G +E K E+ ++ K H+N+ G + N +L L+ E+
Sbjct: 32 QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
S+ L +TKG L + I I RGL +LH+ +VIHRD+K NVLL
Sbjct: 92 GAGSVT-DLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN 147
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG++ NT +GT +MAPE
Sbjct: 148 AEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
KEI L++ + + K EV L+AK++H N+V + L ++ EY L
Sbjct: 31 KEID---LTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDL- 86
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKI 401
+ + +G + +S I+ GL ++H+ +++HRD+K+ N+ L M K+
Sbjct: 87 MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKL 143
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DFG+AR + + A T VGT Y++PE
Sbjct: 144 GDFGIARQLNDSMELAYT--CVGTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 282 GKEIAVKRL-----SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYE 334
G+E+AVK++ S + + + + E+ L+ L H+ +V+ GC D E L + E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
+MP S+ L + GA + R I G+ YLH + ++HRD+K +N+L D
Sbjct: 87 HMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGVSYLHSN---MIVHRDIKGANILRD 140
Query: 395 HEMNPKISDFGMAR-----IFSGNQNEANTNRVVGTYGYMAPE 432
N K+ DFG ++ SG V GT +M+PE
Sbjct: 141 SVGNVKLGDFGASKRLQTICLSG----TGMKSVTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 279 LADGKEIAVKRLS---RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
L D K +A+K++ + Q+ E+ L+ +L H N+++ L ++ NEL ++ E
Sbjct: 24 LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83
Query: 336 MPNKSLDLFLFDSTKGAQLD-----WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L + K +L WK + + + + H SR RV+HRD+K +N
Sbjct: 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE------HMHSR-RVMHRDIKPAN 136
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436
V + K+ D G+ R FS A++ +VGT YM+PE E
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 16/183 (8%)
Query: 255 LPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSR--SSGQGLQEFKNEVTLIAKLQ 312
LP ++ + +C G+++A+K+LSR S + E+TL+ +Q
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 313 HKNLVRLLG---CCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARG 369
H+N++ LL + G+E Y MP DL G L + ++ + G
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCG 129
Query: 370 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429
L Y+H +IHRDLK N+ ++ + KI DFG+AR +A V T Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYR 181
Query: 430 APE 432
APE
Sbjct: 182 APE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 42/140 (30%), Positives = 70/140 (50%), Gaps = 18/140 (12%)
Query: 284 EIAVKRLSRSSGQG-LQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
+ A+KR+ + + ++F E+ ++ KL H N++ LLG C L L EY P+ +L
Sbjct: 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 95
Query: 342 DLFLFDS-------------TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
FL S + + L ++ + +ARG+ YL S+ + IHRDL
Sbjct: 96 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAA 152
Query: 389 SNVLLDHEMNPKISDFGMAR 408
N+L+ KI+DFG++R
Sbjct: 153 RNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 49/200 (24%)
Query: 255 LPAVFSPPSP------GSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKN---EV 305
+P + SP G V S+ + G+++A+K+LSR Q K E+
Sbjct: 13 VPDRYQNLSPVGSGAYGQVCSAFDTKT------GRKVAIKKLSRPF-QSAIHAKRTYREL 65
Query: 306 TLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL----DLFLFDSTKGAQLDW---KR 358
L+ + H+N++ LL + P SL D++L GA L+ +
Sbjct: 66 RLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQ 113
Query: 359 RIS------IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 412
++S ++ I RGL Y+H +IHRDLK SN+ ++ + KI DFG+AR
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR---- 166
Query: 413 NQNEANTNRVVGTYGYMAPE 432
+ V T Y APE
Sbjct: 167 -HTDDEMTGYVATRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 14/166 (8%)
Query: 272 EICVQGILADGKEIAVKRLS-----RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG 326
E+C + A GK A K+L + G+ + NE ++ K+ + +V L
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSLAYAYETK 72
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
+ L L+ M L +++ D +R + I GL LH R R+++RDL
Sbjct: 73 DALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLH---RERIVYRDL 128
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K N+LLD + +ISD G+A + E R VGT GYMAPE
Sbjct: 129 KPENILLDDYGHIRISDLGLA--VEIPEGETIRGR-VGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 272 EICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
E+C + A GK A K+L + +G NE ++ K+ + +V L +
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L L+ M L ++ + A + R + I GL LH++ R+++RDLK
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKP 130
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LLD + +ISD G+A Q VGT GYMAPE
Sbjct: 131 ENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 24/161 (14%)
Query: 281 DGKEIAVKRLSRSS--GQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+ A+K + + G QE +E ++ + H +V+L D + ++ EY
Sbjct: 17 KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCL 76
Query: 338 NKSL-----DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
L D LFD A+ I + YLH +I+RDLK N+L
Sbjct: 77 GGELWTILRDRGLFDEYT-ARF-------YIACVVLAFEYLH---NRGIIYRDLKPENLL 125
Query: 393 LDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGYMAPE 432
LD K+ DFG A+ + SG + T GT Y+APE
Sbjct: 126 LDSNGYVKLVDFGFAKKLKSGQK----TWTFCGTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 282 GKEIAVKRLSRSSGQ-GLQ-EFKNEVTLIAKLQ---HKNLVRLLGCCLDGN-----ELLL 331
G +A+K + + + GL EV L+ +L+ H N+VRL+ C ++ L
Sbjct: 25 GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
++E++ ++ L +L D L + ++ RGL +LH + ++HRDLK N+
Sbjct: 85 VFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI 139
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
L+ K++DFG+ARI+S + VV T Y APE ++ ++
Sbjct: 140 LVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLLQSTYA 185
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 20/164 (12%)
Query: 282 GKEIAVKRLSRSSGQGLQE---FKNEVTLIAKLQHKNLVRLL--GCCLDGNELLLIYEYM 336
G E+A+K L + + + F+ E L A+L H N+V LL G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--- 393
P ++L L + GA L ++ + L H ++HRDLK N+++
Sbjct: 62 PGRTLREVL--AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115
Query: 394 DHEMNPKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPE 432
+ K+ DFG+ + G ++ T V+GT Y APE
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 30/70 (42%), Positives = 38/70 (54%), Gaps = 9/70 (12%)
Query: 365 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN--QNEANTNRV 422
I + L YLH +L VIHRD+K SNVL++ K+ DFG+ SG + A T
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGI----SGYLVDSVAKTID- 163
Query: 423 VGTYGYMAPE 432
G YMAPE
Sbjct: 164 AGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 38/108 (35%), Positives = 55/108 (50%), Gaps = 8/108 (7%)
Query: 303 NEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF-LFDSTKGAQLDWKRRI 360
EV + KL H N+V+L + +EL ++EYM +L+ L KG
Sbjct: 46 REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIR 102
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408
SII I +GL ++H + HRDLK N+L+ KI+DFG+AR
Sbjct: 103 SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKN----EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+ G A+K L +S + N ++ + + + +L + L L+ EY
Sbjct: 19 STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ L + G DW ++ I + G+ LH+ +IHRD+K N+L+D
Sbjct: 79 LNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQ 132
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV 438
+ K++DFG++R N+ + VGT Y+APE + GV
Sbjct: 133 TGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGV 168
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 55/163 (33%), Positives = 80/163 (49%), Gaps = 28/163 (17%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
G +AVK+LSR F+N+ AK ++ LV LL C N + L+ + P KSL
Sbjct: 46 GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 342 ----DLFLFDSTKGA--------QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
D++L A +LD +R ++ + G+ +LH +IHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+++ + KI DFG+AR + N T VV Y Y APE
Sbjct: 153 NIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPE 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 55/184 (29%), Positives = 82/184 (44%), Gaps = 52/184 (28%)
Query: 276 QGIL--AD----GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL 320
QGI+ A G+ +A+K+LSR F+N E+ L+ + HKN++ LL
Sbjct: 29 QGIVCAAYDTVTGQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 321 GCCLDGNELLLIYEYMPNKSLDLF--------LFDSTK----GAQLDWKRRISIINGIAR 368
+ P KSL+ F L D+ LD +R ++ +
Sbjct: 82 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129
Query: 369 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGY 428
G+ +LH +IHRDLK SN+++ + KI DFG+AR + T VV Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 183
Query: 429 MAPE 432
APE
Sbjct: 184 RAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 42/161 (26%), Positives = 83/161 (51%), Gaps = 22/161 (13%)
Query: 281 DGKEIAVKRL--SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
DGK+ +K + S+ S + +E + EV +++ ++H N+V+ + L ++ +Y
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 339 KSLDLF-LFDSTKGAQ------LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
DL+ ++ +G LDW +I + L ++H+ +++HRD+K+ N+
Sbjct: 84 G--DLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHDR---KILHRDIKSQNI 132
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L + K+ DFG+AR+ + A T +GT Y++PE
Sbjct: 133 FLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-GAQLDWKRRISI 362
E L++KL H +V+ L+ + +I EY + LD L + G L +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422
+ G+ Y+H+ R++HRDLK N+ L + + KI DFG++R+ G+ + A T
Sbjct: 112 FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--F 165
Query: 423 VGTYGYMAPE 432
GT YM+PE
Sbjct: 166 TGTPYYMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 282 GKEIAVKRL-SRSSGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLDGNELLLIYEYMPNK 339
G +AVKR+ S + + ++ ++ + +V+ G + + E M +
Sbjct: 29 GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DI 87
Query: 340 SLDLFLFDSTKGAQLDWKRRI--SIINGIA----RGLLYLHEDSRLRVIHRDLKTSNVLL 393
SLD F K K I I+ IA + L YL E+ L++IHRD+K SN+LL
Sbjct: 88 SLDKF----YKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILL 141
Query: 394 DHEMNPKISDFGMARIFSGN-QNEANTNRVVGTYGYMAPE 432
D N K+ DFG+ SG + R G YMAPE
Sbjct: 142 DRNGNIKLCDFGI----SGQLVDSIAKTRDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 32/69 (46%), Positives = 40/69 (57%), Gaps = 9/69 (13%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSGNQNEANTNRVV 423
IA GL +LH +I+RDLK NV+LD E + KI+DFGM + IF G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 424 GTYGYMAPE 432
GT Y+APE
Sbjct: 163 GTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 12/130 (9%)
Query: 284 EIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+ VK L S+ Q F EV +L H N+++ LG C++ LL+ E+ P L
Sbjct: 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83
Query: 343 LFLFDSTKG-----AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
+L S +G AQ D +R++ +A GLL+LH + IH DL N L ++
Sbjct: 84 NYL-RSNRGMVAQMAQKDVLQRMA--CEVASGLLWLH---QADFIHSDLALRNCQLTADL 137
Query: 398 NPKISDFGMA 407
+ KI D+G+A
Sbjct: 138 SVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 30/69 (43%), Positives = 39/69 (56%), Gaps = 5/69 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT--NRVV 423
+ RGL Y+H + VIHRDLK SN+L++ + +I DFGMAR S + E V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 424 GTYGYMAPE 432
T Y APE
Sbjct: 173 ATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
KEI RL G + EV+L+ L+H N+V L L L++EY+ +K L
Sbjct: 37 KEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLK 91
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
++ D G + + I RGL Y H R +V+HRDLK N+L++ K++
Sbjct: 92 QYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLA 146
Query: 403 DFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DFG+AR S + +N VV T Y P+
Sbjct: 147 DFGLARAKS-VPTKTYSNEVV-TLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 16/177 (9%)
Query: 234 PSCNFRYELYQFYNDTSIGTLLP---AVFSPPSPGSVTSSKEICVQGILADGKEIAVKRL 290
P + E + + + +++ + S +PGS +C + K++ VK +
Sbjct: 69 PQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGS-EGEVFVCTKHGDEQRKKVIVKAV 127
Query: 291 SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK 350
+ G E+ ++ + H+ ++ L+ + + ++ MP DLF +
Sbjct: 128 TGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRS 179
Query: 351 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 407
G L ++ I+I + L YLH +IHRD+KT N+ LD N + DFG A
Sbjct: 180 GP-LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 282 GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNEL------LLIY 333
+++AVK L S ++EF E + + H N+++L+G L ++I
Sbjct: 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 334 EYMPNKSLDLFLFDSTKGAQ---LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
+M + L FL S G + L + + + IA G+ YL S IHRDL N
Sbjct: 87 PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARN 143
Query: 391 VLLDHEMNPKISDFGMAR-IFSGN 413
+L+ M ++DFG+++ I+SG+
Sbjct: 144 CMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 42/142 (29%), Positives = 63/142 (44%), Gaps = 27/142 (19%)
Query: 299 QEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKR 358
Q NE ++ ++ H ++RL D L ++ EY+P L +L +S
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---------G 96
Query: 359 RISIINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410
R S N L YLH +++RDLK N+LLD E + K++DFG A+
Sbjct: 97 RFS--NSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 411 SGNQNEANTNRVVGTYGYMAPE 432
T + GT Y+APE
Sbjct: 152 RD-----RTWTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 15/146 (10%)
Query: 304 EVTLIAKLQHKNLVRLLGCCL-DGNELLLIYEYMPNKSLDLFL-----FDSTKGAQLDWK 357
E L+ L H+N++ +L C+ DG ++Y YM +L LFL ++ L +
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 358 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQN- 415
+ + + IA G+ YLH + VIH+D+ N ++D E+ KI+D ++R +F + +
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 416 -EANTNRVVGTYGYMAPEYAMEGVFS 440
N NR V +MA E + +S
Sbjct: 175 LGDNENRPV---KWMALESLVNKEYS 197
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
KEI RL G + EV+L+ L+H N+V L L L++EY+ +K L
Sbjct: 37 KEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLK 91
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
+L D G ++ + + RGL Y H R +V+HRDLK N+L++ K++
Sbjct: 92 QYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLA 146
Query: 403 DFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DFG+AR S + +N VV T Y P+
Sbjct: 147 DFGLARAKS-IPTKTYSNEVV-TLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 39/208 (18%)
Query: 243 YQFYNDTSIGTL--LPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQE 300
FY T+ +P + SP + +C G +AVK+LSR Q +
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIH 59
Query: 301 FKN---EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL----DLFLFDSTKGAQ 353
K E+ L+ ++H+N++ LL + P +SL D++L GA
Sbjct: 60 AKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGAD 107
Query: 354 LDWKRRIS---------IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
L+ + +I I RGL Y+H +IHRDLK SN+ ++ + KI DF
Sbjct: 108 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 164
Query: 405 GMARIFSGNQNEANTNRVVGTYGYMAPE 432
G+AR + V T Y APE
Sbjct: 165 GLAR-----HTDDEMTGYVATRWYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 279 LADGKEIAVKRLS---RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
L DG +A+K++ + + E+ L+ +L H N+++ ++ NEL ++ E
Sbjct: 24 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83
Query: 336 MPNKSLDLFLFDSTKGAQLD-----WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L + K +L WK + + + + H SR RV+HRD+K +N
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE------HMHSR-RVMHRDIKPAN 136
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436
V + K+ D G+ R FS A++ +VGT YM+PE E
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 44/135 (32%), Positives = 61/135 (45%), Gaps = 10/135 (7%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361
K + L AK H L L C + L + EY+ L +F + + D R
Sbjct: 46 KRILALAAK--HPFLTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF 100
Query: 362 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421
+ L++LH VI+RDLK N+LLD E + K++DFGM + G N T
Sbjct: 101 YAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTT 155
Query: 422 VVGTYGYMAPEYAME 436
GT Y+APE E
Sbjct: 156 FCGTPDYIAPEILQE 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 33/73 (45%), Positives = 47/73 (64%), Gaps = 7/73 (9%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I GL ++H +R V++RDLK +N+LLD + +ISD G+A FS + A+ VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 426 YGYMAPEYAMEGV 438
+GYMAPE +GV
Sbjct: 159 HGYMAPEVLQKGV 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 51/165 (30%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 272 EICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
E+C + A GK A K+L + +G NE ++ K+ + +V L +
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA 74
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L L+ M L +++ D +R I + GL L R R+++RDLK
Sbjct: 75 LCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKP 130
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNR-VVGTYGYMAPE 432
N+LLD + +ISD G+A E T R VGT GYMAPE
Sbjct: 131 ENILLDDRGHIRISDLGLAVQIP----EGETVRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 285 IAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+AVK ++ S S + EF NE +++ ++VRLLG G L++ E M + L
Sbjct: 39 VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 98
Query: 344 FLFDSTKGAQLD-------WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
+L A+ + + I + IA G+ YL+ + +HRDL N ++ H+
Sbjct: 99 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
KI DFGM R + + +MAPE +GVF+
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT 199
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 35/133 (26%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 284 EIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
++A+K L + + ++ E E ++ +L + +VR++G C + L+L+ E L+
Sbjct: 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLN 82
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
FL S K ++ + +++ ++ G+ YL + +HRDL NVLL ++ KIS
Sbjct: 83 KFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKIS 137
Query: 403 DFGMARIFSGNQN 415
DFG+++ + +
Sbjct: 138 DFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 9/138 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E+ ++ + +V G E+ + E+M SLD L ++ + + + ++SI
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI- 110
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ RGL YL E + +++HRD+K SN+L++ K+ DFG+ SG ++ N V
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFV 163
Query: 424 GTYGYMAPEYAMEGVFSV 441
GT YM+PE +SV
Sbjct: 164 GTRSYMSPERLQGTHYSV 181
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 62/200 (31%), Positives = 85/200 (42%), Gaps = 27/200 (13%)
Query: 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGL 298
RYEL + + G + A + S + K + + K+I KR R + L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK--KITNVF--SKKILAKRALREL-KLL 55
Query: 299 QEFKNEVTLIAKLQHKNLVRL--LGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQL 354
+ F+ HKN+ L + G NEL L E M DL + G L
Sbjct: 56 RHFRG---------HKNITCLYDMDIVFPGNFNELYLYEELM---EADLHQIIRS-GQPL 102
Query: 355 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN- 413
S I I GL Y+H + V+HRDLK N+L++ + KI DFG+AR FS N
Sbjct: 103 TDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
Query: 414 -QNEANTNRVVGTYGYMAPE 432
+N V T Y APE
Sbjct: 160 GENAGFMTEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
L G+ AVK + G + E+ ++ + +H N+V G L +L + EY
Sbjct: 31 LHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90
Query: 339 KSL-DLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
SL D++ + Q+ + R ++ +GL YLH ++ HRD+K +N+LL
Sbjct: 91 GSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM---HRDIKGANILLTDN 142
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA 434
+ K++DFG+A + A +GT +MAPE A
Sbjct: 143 GDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVA 178
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 43/137 (31%), Positives = 76/137 (55%), Gaps = 15/137 (10%)
Query: 285 IAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K L +S + +E +E ++A + + RLLG CL + + L+ + MP L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLD 97
Query: 344 FLFDSTK--GAQ--LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
++ ++ G+Q L+W +I A+G+ YL E +R++HRDL NVL+ +
Sbjct: 98 YVRENKDRIGSQDLLNWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHV 148
Query: 400 KISDFGMARIFSGNQNE 416
KI+DFG+AR+ ++ E
Sbjct: 149 KITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 272 EICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
E+C + A GK A KRL + +G NE ++ K+ + +V L +
Sbjct: 15 EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 74
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L L+ M L +++ + +R + I GL LH ++ ++RDLK
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHREN---TVYRDLKP 130
Query: 389 SNVLLDHEMNPKISDFGMA-RIFSGNQNEANTNRVVGTYGYMAPE 432
N+LLD + +ISD G+A +I G VGT GYMAPE
Sbjct: 131 ENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 20/148 (13%)
Query: 278 ILADGKEI--AVKRLSR-SSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIY 333
I DG ++ A+K L +S ++F E+ ++ KL H N++ LLG C + L +
Sbjct: 23 IKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82
Query: 334 EYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLR 380
EY P +L FL S + L ++ + + +A G+ YL E +
Sbjct: 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---Q 139
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMAR 408
IHRDL NVL+ + KI+DFG++R
Sbjct: 140 FIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
G+ A+K + G+ + E+ ++ +H N+V G L ++L + E+ SL
Sbjct: 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93
Query: 342 -DLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
D++ + +Q+ + R ++ +GL YLH + +HRD+K +N+LL +
Sbjct: 94 QDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNGHV 145
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA 434
K++DFG++ + A +GT +MAPE A
Sbjct: 146 KLADFGVSAQITATI--AKRKSFIGTPYWMAPEVA 178
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 47/143 (32%), Positives = 68/143 (47%), Gaps = 17/143 (11%)
Query: 299 QEFKNEVTLIAKL-QHKNLVRLLGCCL------DGNELLLIYEYMPNKSLDLFLFDSTKG 351
+E K E+ ++ K H+N+ G + ++L L+ E+ S+ L +TKG
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT-DLVKNTKG 115
Query: 352 AQL--DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409
L DW I I RGL +LH +VIHRD+K NVLL K+ DFG++
Sbjct: 116 NALKEDWIAYIC--REILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170
Query: 410 FSGNQNEANTNRVVGTYGYMAPE 432
NT +GT +MAPE
Sbjct: 171 LDRTVGRRNT--FIGTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 286 AVKRLSR-SSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
A+KR+ +S ++F E+ ++ KL H N++ LLG C L L EY P+ +L
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 344 FLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
FL S + L ++ + +ARG+ YL + + IHRDL N
Sbjct: 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARN 142
Query: 391 VLLDHEMNPKISDFGMAR 408
+L+ KI+DFG++R
Sbjct: 143 ILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 31/67 (46%), Positives = 39/67 (58%), Gaps = 8/67 (11%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I RGL Y+H V+HRDLK SN+L++ + KI DFG+ARI Q+ T V
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTR 169
Query: 426 YGYMAPE 432
Y Y APE
Sbjct: 170 Y-YRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 283 KEIAVKRLSRSSGQGL--QEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
K +AVK L + E E ++ +L + +VR++G C + +L+ E
Sbjct: 23 KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGP 81
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
L+ FL K + K +++ ++ G+ YL E + +HRDL NVLL + K
Sbjct: 82 LNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135
Query: 401 ISDFGMARIFSGNQN 415
ISDFG+++ ++N
Sbjct: 136 ISDFGLSKALGADEN 150
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCC-----LDGNELLLIYE 334
DG AVK L S +E + E ++ L H N+V+ G L G +L L+ E
Sbjct: 46 DGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104
Query: 335 YMPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
S+ +L G +LD I+ G GL +LH + R+IHRD+K +N+LL
Sbjct: 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILL 161
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
E K+ DFG++ + + NT+ VGT +MAPE
Sbjct: 162 TTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 27/70 (38%), Positives = 39/70 (55%), Gaps = 4/70 (5%)
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422
I I L +LH+ L +I+RD+K N+LLD E + ++DFG+++ F E
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSF 166
Query: 423 VGTYGYMAPE 432
GT YMAPE
Sbjct: 167 CGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 285 IAVKRLSRSSGQGLQEFKN----EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+A+K+ S +E K E+ ++ L+ +N+V L +L L++EY+
Sbjct: 29 VAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
L+L L + G + R S I + + + + H++ ++HRD+K N+L+ H K
Sbjct: 87 LEL-LEEMPNGVPPEKVR--SYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLK 140
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ DFG AR S + AN V T Y +PE
Sbjct: 141 LCDFGFARNLS-EGSNANYTEYVATRWYRSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 28/159 (17%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL- 341
KEI RL +SS +++ + E L+AK++H N+V L ++ EY L
Sbjct: 31 KEI---RLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLM 86
Query: 342 --------DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
LF D+ L W ++ + G+ ++HE RV+HRD+K+ N+ L
Sbjct: 87 QKIKLQRGKLFPEDTI----LQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFL 133
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG AR+ + A T VGT Y+ PE
Sbjct: 134 TQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 282 GKEIAVKRLSRSSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCCLDG-----NELLLIYEY 335
G ++A+K++S Q Q E+ ++ + +H+N++ +L N++ ++ E
Sbjct: 30 GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M DL+ T+ L + I RGL Y+H + V+HRDLK SN+LL+
Sbjct: 90 MET---DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNT 141
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRV---VGTYGYMAPE 432
+ KI DFG+ARI +T + V T Y APE
Sbjct: 142 NCDLKICDFGLARIAD--PEHDHTGFLTEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 303 NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISI 362
+E+ + KLQH N+V+L+G C LI+EY+ K+L L L W+RR I
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKI 785
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
GIA+ L +LH V+ +L +++D + P +
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 11/139 (7%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-GAQLDWKRRISI 362
E+ ++ + +V G E+ + E+M SLD L + + Q+ K I++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422
I +GL YL E + +++HRD+K SN+L++ K+ DFG+ SG ++ N
Sbjct: 113 I----KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSF 162
Query: 423 VGTYGYMAPEYAMEGVFSV 441
VGT YM+PE +SV
Sbjct: 163 VGTRSYMSPERLQGTHYSV 181
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 32/72 (44%), Positives = 46/72 (63%), Gaps = 7/72 (9%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I GL ++H +R V++RDLK +N+LLD + +ISD G+A FS + A+ VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 426 YGYMAPEYAMEG 437
+GYMAPE +G
Sbjct: 159 HGYMAPEVLQKG 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 334 EYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
EYM SLD + I + +GL +L E+ +IHRD+K +NVL+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLV 136
Query: 394 DHEMNPKISDFGMARIFSGN--QNEANTNRVVGTYGYMAPE 432
+ K+ DFG+ SGN + A TN +G YMAPE
Sbjct: 137 NGNGQVKLCDFGV----SGNLVASLAKTN--IGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 44/199 (22%)
Query: 255 LPAVFSPPSP------GSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKN----- 303
+ + P P G V S+K +++A+K+++ + F N
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKN------SETNEKVAIKKIANA-------FDNRIDAK 49
Query: 304 ----EVTLIAKLQHKNLVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQ- 353
E+ L+ L H+N++ + N++ ++YE M D L + +Q
Sbjct: 50 RTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQT 104
Query: 354 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 413
L + + RGL Y+H + V+HRDLK SN+LL+ + KI DFG+AR S
Sbjct: 105 LSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
Query: 414 QNEANTNRVVGTYGYMAPE 432
+ T VV T Y APE
Sbjct: 162 -GDFMTEYVV-TRWYRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 29/67 (43%), Positives = 41/67 (61%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I GL +LH+ +I+RDLK NVLLD + + KI+DFGM + + +A+T GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 160 PDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E+ ++ +L+H NLV L+ +L L++EY + L+ L + +G + II
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRG--VPEHLIKKII 106
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ + + H + IHRD+K N+L+ + K+ DFG ARI +G + V
Sbjct: 107 WQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYV 161
Query: 424 GTYGYMAPE 432
T Y APE
Sbjct: 162 ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 29/70 (41%), Positives = 41/70 (58%), Gaps = 4/70 (5%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I RGL YLH ++HRD+K N+L++ KI DFG+AR+ ++++ T VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 426 YGYMAPEYAM 435
Y Y APE M
Sbjct: 169 Y-YRAPEILM 177
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 31/164 (18%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
G ++A+K+L R F++E L AK ++ L RLL N + L+ + P+ SL
Sbjct: 40 GAKVAIKKLYRP-------FQSE--LFAKRAYREL-RLLKHMKHENVIGLLDVFTPDLSL 89
Query: 342 DLF-------------LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
D F L K +L R ++ + +GL Y+H +IHRDLK
Sbjct: 90 DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKP 146
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+ ++ + KI DFG+AR Q ++ V T Y APE
Sbjct: 147 GNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 26/143 (18%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL-------DLFLFDSTKGAQL 354
K E ++ ++H +V L+ G +L LI EY+ L +F+ D+
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTAC---- 103
Query: 355 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSG 412
++ I+ L +LH + +I+RDLK N+LLD + + K++DFG+ + I G
Sbjct: 104 ------FYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154
Query: 413 NQNEANTNRVVGTYGYMAPEYAM 435
T+ GT YMAPE M
Sbjct: 155 ----TVTHTFCGTIEYMAPEILM 173
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 43/184 (23%)
Query: 265 GSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKN---EVTLIAKLQHKNLVRLLG 321
GSV S+ + ++ +++AVK+LSR Q L + E+ L+ ++H+N++ LL
Sbjct: 29 GSVCSAYDTRLR------QKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 322 CCLDGNELLLIYEYMPNKSLD----LFLFDSTKGAQLD---WKRRIS------IINGIAR 368
+ P S++ ++L + GA L+ +++S +I + R
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 369 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGY 428
GL Y+H +IHRDLK SNV ++ + +I DFG+AR Q + V T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWY 181
Query: 429 MAPE 432
APE
Sbjct: 182 RAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 9/130 (6%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFK--NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+G+ +A+K +S + +G+ F E +L+ L+H N+V L L ++EYM
Sbjct: 29 NGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-- 85
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
DL + L + + RGL Y+H ++HRDLK N+L+ +
Sbjct: 86 -HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGE 141
Query: 399 PKISDFGMAR 408
K++DFG+AR
Sbjct: 142 LKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 21/166 (12%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFK-NEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMP 337
D KE A+K++ G G+ E+ L+ +L+H N++ L L ++ + L+++Y
Sbjct: 27 DEKEYALKQIE---GTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83
Query: 338 NKSLDLFLFDSTKGA-----QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
+ + F A QL S++ I G+ YLH + V+HRDLK +N+L
Sbjct: 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANIL 140
Query: 393 LDHEMNP-----KISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPE 432
+ E P KI+D G AR+F+ A+ + VV T+ Y APE
Sbjct: 141 VMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 28/162 (17%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+ +A+K+LSR F+N+ AK ++ LV L+ C N + L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 343 LF--------LFDSTK----GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
F L D+ +LD +R ++ + G+ +LH +IHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+++ + KI DFG+AR + + T VV Y Y APE
Sbjct: 157 IVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 284 EIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
++ VK L S+ Q +F E LQH NL++ LG C + LL+ E+ P L
Sbjct: 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 343 LFLFDSTKGAQLDWKRRI--SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
+L K + + IA GLL+LH+++ IH DL N LL ++ K
Sbjct: 84 GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVK 140
Query: 401 ISDFGMA 407
I D+G++
Sbjct: 141 IGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFK-NEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMP 337
DGK+ L + G G+ E+ L+ +L+H N++ L L ++ L+++Y
Sbjct: 24 DGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLY-----LHEDSRLRVIHRDLKTSNVL 392
+ + F A K+ + + G+ + LLY +H V+HRDLK +N+L
Sbjct: 84 HDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 140
Query: 393 LDHEMNP-----KISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPE 432
+ E P KI+D G AR+F+ A+ + VV T+ Y APE
Sbjct: 141 VMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E +L+ L+H N+V L L L++EY+ + L ++ D G + R+ +
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRLFLF 110
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408
+ RGL Y H + RV+HRDLK N+L+ K++DFG+AR
Sbjct: 111 Q-LLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGC-----CLDGNELLLIYE 334
+G + AVK L +E + E ++ L H N+V+ G +G++L L+ E
Sbjct: 42 NGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100
Query: 335 YMPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
S+ DL +G +++ I++ GL +LH + + IHRD+K +N+LL
Sbjct: 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILL 157
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
E K+ DFG++ + + NT+ VGT +MAPE
Sbjct: 158 TTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 28/162 (17%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+ +A+K+LSR F+N+ AK ++ LV L+ C N + L+ + P KSL+
Sbjct: 43 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92
Query: 343 LF--------LFDSTK----GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
F L D+ +LD +R ++ + G+ +LH +IHRDLK SN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+++ + KI DFG+AR + + T VV Y Y APE
Sbjct: 150 IVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 38/120 (31%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLY 372
H LV L C + L + E++ L +F + +L + I+ L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNF 111
Query: 373 LHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
LHE +I+RDLK NVLLD E + K++D+GM + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
EV+L+ L+H N+V L L L++EY+ + DL + G + +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFM 109
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ RGL Y H + +++HRDLK N+L++ + K++DFG+AR S + +N VV
Sbjct: 110 FQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKS-VPTKTYSNEVV 165
Query: 424 GTYGYMAPE 432
T Y P+
Sbjct: 166 -TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 8/104 (7%)
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L + EY+ L +F + D R I GL +LH +++RDLK
Sbjct: 71 LFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKL 124
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LLD + + KI+DFGM + +A T GT Y+APE
Sbjct: 125 DNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 29/68 (42%), Positives = 40/68 (58%), Gaps = 7/68 (10%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV-VG 424
I+ GL +LH +I+RDLK NV+LD E + KI+DFGM + + + T R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 425 TYGYMAPE 432
T Y+APE
Sbjct: 164 TPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 27/67 (40%), Positives = 40/67 (59%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
IA L YLH L +I+RDLK N+LLD + + ++DFG+ + G ++ T+ GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 30/69 (43%), Positives = 40/69 (57%), Gaps = 9/69 (13%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR--IFSGNQNEANTNRVV 423
IA GL +LH +I+RDLK NV+LD E + KI+DFGM + ++ G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 424 GTYGYMAPE 432
GT Y+APE
Sbjct: 163 GTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 16/136 (11%)
Query: 282 GKEIAVKR-LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL-DGNELLLIYEYMPNK 339
G+E++V + S + F +L+++L HK+LV+L G C+ D N ++ EY+
Sbjct: 28 GQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFG 85
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DH 395
LD+FL L WK + + +A L YL ED +L +H ++ N+L+ +
Sbjct: 86 PLDVFLHREKNNVSLHWK--LDVAKQLASALHYL-EDKKL--VHGNVCGKNILVARYGLN 140
Query: 396 EMNP---KISDFGMAR 408
E K+SD G+
Sbjct: 141 EGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLY 372
H LV L C + L + EY+ L +F + +L + I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 373 LHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
LHE +I+RDLK NVLLD E + K++D+GM + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 42/133 (31%), Positives = 68/133 (51%), Gaps = 12/133 (9%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF--LFDSTKGAQLDWKRR 359
K E ++A++ H +V+L +L LI +++ + DLF L + D K
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 103
Query: 360 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 419
++ +A L +LH L +I+RDLK N+LLD E + K++DFG+++ +E
Sbjct: 104 LA---ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKA 155
Query: 420 NRVVGTYGYMAPE 432
GT YMAPE
Sbjct: 156 YSFCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 38/118 (32%), Positives = 56/118 (47%), Gaps = 10/118 (8%)
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
L + E++ L +F + D R I GL +LH +I+RDL
Sbjct: 69 EHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDL 122
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE--YAMEGVFSVN 442
K NV+LD + + KI+DFGM + N A+T GT Y+APE ++ FSV+
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYTFSVD 178
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 13/132 (9%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
E+ +K L +S + F +++++L HK+LV G C+ G+E +++ EY+ SLD
Sbjct: 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-----N 398
+L + + WK + + +A L +L + + H ++ NVLL E N
Sbjct: 89 YLKKNKNLINISWK--LEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGN 143
Query: 399 P---KISDFGMA 407
P K+SD G++
Sbjct: 144 PPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 9/124 (7%)
Query: 309 AKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIAR 368
+H LV L C + + + EY DL + T R + +
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTD--VFSEPRAVFYAACVVL 112
Query: 369 GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGY 428
GL YLHE+ ++++RDLK N+LLD E KI+DFG+ + G + +T GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEF 167
Query: 429 MAPE 432
+APE
Sbjct: 168 LAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 33/78 (42%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN--Q 414
K ++I+ L YL E VIHRD+K SN+LLD N K+ DFG+ SG
Sbjct: 118 KMTVAIVKA----LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGI----SGRLVD 167
Query: 415 NEANTNRVVGTYGYMAPE 432
++A T R G YMAPE
Sbjct: 168 SKAKT-RSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 6e-07
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 281 DGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+GK +A+K RL G + E +L+ L+H N+V L L L++EY+
Sbjct: 29 NGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-- 85
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
DL + L + + + RGL Y+H+ ++HRDLK N+L+
Sbjct: 86 -HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGE 141
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG+AR S + +N VV T Y P+
Sbjct: 142 LKLADFGLARAKS-VPSHTYSNEVV-TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 19/110 (17%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E ++ + H ++++L G LI +P DL+ + L KR I+I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY-------LAAKRNIAIC 182
Query: 364 NGIA------RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 407
+ +A R + YLHE+ R+IHRD+K N+ ++H + + DFG A
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 25/169 (14%)
Query: 279 LADGKEIAVKR-LSRSSGQGLQEFK-NEVTLIAKLQHKN-LVRLLGCCLDGNE------- 328
GK +A+K+ +G+ E++L+ L +VRLL ++ E
Sbjct: 23 KNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL--DVEHVEEKNGKPS 80
Query: 329 LLLIYEYMPNKSLDLFLF-DSTKGAQ---LDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
L L++EY+ DL F DS L K S + + +G+ + H + V+HR
Sbjct: 81 LYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHR 134
Query: 385 DLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DLK N+L+D + KI+D G+ R FS ++ T+ +V T Y APE
Sbjct: 135 DLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYTHEIV-TLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 279 LADGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
L + +AVK + LQ + +E+ ++ K ++ G N + + E+M
Sbjct: 23 LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIA----RGLLYLHEDSRLRVIHRDLKTSNVLL 393
SLD++ K ++ IA +GL YL L+++HRD+K SN+L+
Sbjct: 83 GGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLV 128
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ K+ DFG++ + A T VGT YMAPE
Sbjct: 129 NTRGQVKLCDFGVSTQLV--NSIAKT--YVGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 7/126 (5%)
Query: 284 EIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
+AVK + ++E F E ++ + H ++V+L+G + N + ++ E P L
Sbjct: 36 AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELR 94
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
+L LD I ++ L YL R +HRD+ NVL+ K+
Sbjct: 95 SYL--QVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLG 149
Query: 403 DFGMAR 408
DFG++R
Sbjct: 150 DFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVT----LIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+DG AVK L + + +E + + L+ L+H LV L +L + +Y
Sbjct: 18 SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ +LF + L+ + R +A + YLH L +I+RDLK N+LLD
Sbjct: 78 VNGG--ELFFHLQRERCFLEPRARFYAAE-VASAIGYLHS---LNIIYRDLKPENILLDS 131
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ + ++DFG+ + G + E T+ GT Y+APE
Sbjct: 132 QGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 26/67 (38%), Positives = 40/67 (59%), Gaps = 4/67 (5%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L +LH +L +++RD+K N+LLD E + ++DFG+++ F + E T GT
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGT 169
Query: 426 YGYMAPE 432
YMAPE
Sbjct: 170 IEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L YLH V++RD+K N++LD + + KI+DFG+ + G + A GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 280 ADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
A G A+K + +S + + + F+ E +++ + +L D + L L+ EY
Sbjct: 24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIIN-GIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
P DL + Q D + +A +L +H ++ +HRD+K NVL+D
Sbjct: 84 PGG--DLLSLLNRYEDQFDE----DMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ K++DFG A + N+ N+ VGT Y+APE
Sbjct: 138 TGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 27/94 (28%), Positives = 38/94 (40%), Gaps = 27/94 (28%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA------------------ 407
IA +L L +L IHRD+K N+L+D + + K++DFG+
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 408 ---------RIFSGNQNEANTNRVVGTYGYMAPE 432
R Q N VGT Y+APE
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 16/103 (15%)
Query: 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS-------II 363
LQH N+++ LG C++ LL++EY L +L +Q W RR S +
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMA 105
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 406
IA G+ ++H + +H DL N L ++ K+ D+G+
Sbjct: 106 CEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 8/117 (6%)
Query: 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE 375
LV L C + L L+ EY+ L +F + +L + I L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 376 DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+I+RDLK NVLLD + + K++D+GM + G T+ GT Y+APE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 372 YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAP 431
YLH +I+RDLK N+LLD++ + K++DFG A+ + T + GT Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 432 E 432
E
Sbjct: 185 E 185
|
Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L +LH +L +I+RD+K N+LLD + ++DFG+++ F ++ E GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169
Query: 426 YGYMAPEYAMEG 437
YMAP+ G
Sbjct: 170 IEYMAPDIVRGG 181
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKN--EVTLIAKLQ-HKNLVRLLGCCLD--GNELLLIYEY 335
GK A+K + + + L++ N E+ + +L H N++RL+ D L L++E
Sbjct: 23 TGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81
Query: 336 MPNKSLDLFLFDSTKGAQ--LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
M D+ L++ KG + L KR S + + + L ++H R + HRD+K N+L+
Sbjct: 82 M-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILI 133
Query: 394 DHEMNPKISDFGMAR 408
+ K++DFG R
Sbjct: 134 KDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 24/67 (35%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
A L L + VI+RDLK N+LLD++ + + DFG+ ++ + ++ NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 157 PEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 27/67 (40%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L YLH S V++RDLK N++LD + + KI+DFG+ + G ++ A GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 26/67 (38%), Positives = 37/67 (55%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L YLH V++RDLK N++LD + + KI+DFG+ + G + A GT
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 8e-06
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 25/155 (16%)
Query: 287 VKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYE---YMPNKSLDL 343
VK SR++ Q +NE+ + +L H+N++++ E +L E YM + D
Sbjct: 200 VKAGSRAAIQ----LENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247
Query: 344 FLFDSTKGAQLDWKRRI------SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L+ DWK R +I+ + + Y+H+ ++IHRD+K N+ L+ +
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ DFG A F + EA VGT +PE
Sbjct: 305 KIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPE 338
|
Length = 501 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 26/66 (39%), Positives = 34/66 (51%), Gaps = 4/66 (6%)
Query: 368 RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI-FSGNQNEANTNRVVGTY 426
R L Y+H + V HRDLK N+L + + KI DFG+AR+ F+ V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 427 GYMAPE 432
Y APE
Sbjct: 171 WYRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 25/67 (37%), Positives = 38/67 (56%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L YLH ++++RDLK N++LD + + KI+DFG+ + G + A GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 29/132 (21%), Positives = 52/132 (39%), Gaps = 20/132 (15%)
Query: 282 GKEIAVKR--LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
+AVK+ L S + L+ + E+ +LQH N++ + + +EL ++ M
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84
Query: 340 SLDLFL-------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
S + L A I+ + L Y+H IHR +K S++L
Sbjct: 85 SCEDLLKTHFPEGLPELAIAF--------ILKDVLNALDYIH---SKGFIHRSVKASHIL 133
Query: 393 LDHEMNPKISDF 404
L + +S
Sbjct: 134 LSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 8/110 (7%)
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
++L L+ +YM L L K + R I + L +LH+ +++RDL
Sbjct: 69 SDLYLVTDYMSGGELFWHL---QKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDL 122
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436
K N+LLD + + DFG+++ + + TN GT Y+APE ++
Sbjct: 123 KPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLD 170
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 3/74 (4%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
+A +L + +L +HRD+K NVLLD + +++DFG + +N VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQSNVAVGT 166
Query: 426 YGYMAPEY--AMEG 437
Y++PE AME
Sbjct: 167 PDYISPEILQAMED 180
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 33/151 (21%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS-- 361
E+ ++ +++H+N++ L+ ++G+ + L+ + M S +D K R++
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTES 119
Query: 362 ----IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF------- 410
I+ I GL LH+ +HRDL +N+ ++ + KI+DFG+AR +
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 411 ------SGNQNEANTNRVVGTYGYMAPEYAM 435
+ + E T++VV T Y APE M
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPELLM 206
|
Length = 335 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 23/142 (16%)
Query: 279 LADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
GK A+K L +S L K E ++A+ +V L D L LI E+
Sbjct: 23 KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82
Query: 336 MPNKSL-------DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
+P L D F D T+ +A +L + +L IHRD+K
Sbjct: 83 LPGGDLMTMLIKYDTFSEDVTRFY-------------MAECVLAIEAVHKLGFIHRDIKP 129
Query: 389 SNVLLDHEMNPKISDFGMARIF 410
N+L+D + K+SDFG++ F
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVT----LIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
DGK AVK L + +E K+ + L+ ++H LV L +L + +++
Sbjct: 19 DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
L F + R IA L YLH + +++RDLK N+LLD +
Sbjct: 79 NGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQ 132
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ ++DFG+ + G T GT Y+APE
Sbjct: 133 GHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
IA L YLH L +++RDLK N+LLD + + ++DFG+ + ++ T+ GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 24/156 (15%)
Query: 285 IAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
+A+KR +S + + +E ++ + H V L G D + L L+ E++
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 342 DLFLFDSTKGAQLDWKRRISIINGI-----ARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
FL +R N + A+ +L L +++RDLK N+LLD +
Sbjct: 119 FTFL-----------RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD 167
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K++DFG A++ + T + GT Y+APE
Sbjct: 168 GFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 12/113 (10%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360
F +++ ++ HK++V L G C+ E +++ E++ LDLF+ + WK ++
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV 110
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-----DHEMNP--KISDFGM 406
+ +A L YL ED L +H ++ T N+LL D E P K+SD G+
Sbjct: 111 A--KQLASALSYL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 28/87 (32%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 354 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 413
LD + +S +A+G+ +L + IHRDL N+LL H KI DFG+AR +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 414 QNEANTNRVVGTYGYMAPEYAMEGVFS 440
N +MAPE V++
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYT 294
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 21/63 (33%), Positives = 36/63 (57%)
Query: 370 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429
LL +H +IHRD+K++N+LL K+ DFG +++++ ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 430 APE 432
APE
Sbjct: 213 APE 215
|
Length = 496 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 14/134 (10%)
Query: 303 NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISI 362
+E L+ +L H ++ LL + G L+ +P DL+ + + L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 363 INGIARGLL----YLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 418
+ +AR LL Y+H + +IHRD+KT NVL++ + + DFG A G+ +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 419 TNRVVGTYGYMAPE 432
+ GT APE
Sbjct: 319 HYGIAGTVDTNAPE 332
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 25/81 (30%), Positives = 39/81 (48%), Gaps = 3/81 (3%)
Query: 360 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 419
+S +ARG+ +L + +HRDL NVLL KI DFG+AR + N +
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 420 NRVVGTYGYMAPEYAMEGVFS 440
+MAPE + +++
Sbjct: 297 GSTFLPVKWMAPESIFDNLYT 317
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 26/73 (35%), Positives = 40/73 (54%), Gaps = 3/73 (4%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
IA +L +H +L +HRD+K NVLLD + +++DFG + ++ VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGT 166
Query: 426 YGYMAPEY--AME 436
Y++PE AME
Sbjct: 167 PDYISPEILQAME 179
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 8/132 (6%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360
F E ++A +V+L D L ++ EYMP DL S W R
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFY 147
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420
+ A +L L + IHRD+K N+LLD + K++DFG + + +
Sbjct: 148 T-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCD 201
Query: 421 RVVGTYGYMAPE 432
VGT Y++PE
Sbjct: 202 TAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 26/114 (22%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCC------LDGNELLLIYEYMPNKSLDLFLFDSTKGAQLD 355
+ E ++AK R G +D + L++ EY+ + L L
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409
+ R ++ + R + LH+ ++H DL TSN++L DFG+
Sbjct: 91 EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 37/132 (28%), Positives = 56/132 (42%), Gaps = 8/132 (6%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360
F E ++A +V+L D L ++ EYMP DL S W +
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG--DLVNLMSNYDVPEKWAKFY 147
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420
+ A +L L + +IHRD+K N+LLD + K++DFG +
Sbjct: 148 T-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD-ETGMVRCD 201
Query: 421 RVVGTYGYMAPE 432
VGT Y++PE
Sbjct: 202 TAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 3/76 (3%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
+A+G+ +L + IHRD+ NVLL KI DFG+AR + N
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 426 YGYMAPEYAMEGVFSV 441
+MAPE + V++V
Sbjct: 278 VKWMAPESIFDCVYTV 293
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 26/75 (34%), Positives = 38/75 (50%), Gaps = 3/75 (4%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
+ARG+ +L SR + IHRDL N+LL KI DFG+AR + +
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 426 YGYMAPEYAMEGVFS 440
+MAPE + V++
Sbjct: 239 LKWMAPESIFDKVYT 253
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 26/131 (19%), Positives = 49/131 (37%), Gaps = 14/131 (10%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV--RLLGCCLDGNELLLIYEYMPN 338
++ +K S + + + EV ++ L K L ++L L+ E++
Sbjct: 20 KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
++LD + + +A L LH+ L + H DL N+L+D
Sbjct: 78 ETLD-----EVSEEEKEDIAEQ-----LAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127
Query: 399 PKISDFGMARI 409
I D+ A
Sbjct: 128 LGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 19/47 (40%), Positives = 32/47 (68%), Gaps = 3/47 (6%)
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409
I+ +A L YLH +IHRDLK N+L+ +E + K++DFG++++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 25/136 (18%)
Query: 282 GKEIAVKRLSRSS----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
G A+K+L +S Q + + E ++A+ + +V+L D N L LI EY+P
Sbjct: 26 GHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84
Query: 338 NKSL-------DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
+ D F + + + IA +L + +L IHRD+K N
Sbjct: 85 GGDMMTLLMKKDTF---TEEETRF----------YIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 391 VLLDHEMNPKISDFGM 406
+LLD + + K+SDFG+
Sbjct: 132 LLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 26/75 (34%), Positives = 38/75 (50%), Gaps = 3/75 (4%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
+ARG+ +L SR + IHRDL N+LL KI DFG+AR + +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 426 YGYMAPEYAMEGVFS 440
+MAPE + V++
Sbjct: 240 LKWMAPESIFDKVYT 254
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 36/181 (19%)
Query: 282 GKEIAVKRLSRS-SGQGL--QEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ +A+K++ S L + F E + A L H +V + C DG+ +Y MP
Sbjct: 27 SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMPY 83
Query: 339 ------KSL--DLFLFDSTK---GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
KSL ++ +S + +SI + I + Y+H S+ V+HRDLK
Sbjct: 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SK-GVLHRDLK 140
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNE----------------ANTNRVVGTYGYMAP 431
N+LL I D+G A + + ++VGT YMAP
Sbjct: 141 PDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200
Query: 432 E 432
E
Sbjct: 201 E 201
|
Length = 932 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 3/76 (3%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
+A+G+ +L SR + IHRDL N+LL KI DFG+AR + +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 426 YGYMAPEYAMEGVFSV 441
+MAPE + V+++
Sbjct: 245 LKWMAPETIFDRVYTI 260
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 265 GSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 324
GS K + +L D ++ A R +E+ +A H +V+
Sbjct: 89 GSDPKEKVVAKFVMLNDERQAAYAR-------------SELHCLAACDHFGIVKHFDDFK 135
Query: 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLY-----LHEDSRL 379
++LLLI EY L+ K + K + L Y L E
Sbjct: 136 SDDKLLLIMEYGSGGDLN-------KQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 380 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+++HRDLK++N+ L K+ DFG ++ +S + + + GT Y+APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 26/93 (27%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360
F +L++++ H +L + G C+ G+E +++ E++ + LD+ L + WK I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
++ +A L YL ED L +H ++ N+LL
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 23/55 (41%), Positives = 33/55 (60%), Gaps = 7/55 (12%)
Query: 357 KRRISIINGIAR----GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 407
KR I++I G+ R GL LH R+ ++HRD+K N+L+ + KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 39/133 (29%), Positives = 59/133 (44%), Gaps = 10/133 (7%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360
F E ++A + +V+L D L ++ EYMP DL S W R
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG--DLVNLMSNYDIPEKWARFY 147
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA-RIFSGNQNEANT 419
A +L L + IHRD+K N+LLD + K++DFG ++ + +T
Sbjct: 148 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202
Query: 420 NRVVGTYGYMAPE 432
VGT Y++PE
Sbjct: 203 --AVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 452 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.98 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.93 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.46 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.38 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.52 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.25 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.11 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.01 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.89 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| PLN02236 | 344 | choline kinase | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.36 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.17 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.82 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.82 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.8 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.75 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.47 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.32 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.25 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.07 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.95 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.87 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.82 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.59 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.06 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.96 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.81 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=323.52 Aligned_cols=186 Identities=27% Similarity=0.456 Sum_probs=163.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.|+...-+|.|+|++||.+ ++..++.+||||.+.+. .+...+.+..|+++|+.|+||||
T Consensus 11 ~y~~~~~iG~GsfavVykg-------------------~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nI 71 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKG-------------------RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNI 71 (429)
T ss_pred cceehhhccCcceEEEEEe-------------------EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcce
Confidence 5565555677777666655 66778899999999877 56677789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|.++++.+.++.+|||||||.||+|..+++ ..+.+++..++.++.||+.||++||+++ ||||||||+||||+..
T Consensus 72 V~l~d~~~~~~~i~lVMEyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~ 145 (429)
T KOG0595|consen 72 VRLLDCIEDDDFIYLVMEYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTT 145 (429)
T ss_pred eeEEEEEecCCeEEEEEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccC
Confidence 999999999999999999999999999994 4557999999999999999999999999 9999999999999875
Q ss_pred ------CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 ------MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
-.+||+|||+|+...+. ......+|++.|||||+++.++|+.|+|+||+|+||
T Consensus 146 ~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 146 ARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTIL 204 (429)
T ss_pred CCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHH
Confidence 45899999999987533 334567999999999999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.49 Aligned_cols=198 Identities=27% Similarity=0.373 Sum_probs=177.1
Q ss_pred cccEEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHH
Q 012989 227 IGGRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKN 303 (452)
Q Consensus 227 ~g~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~ 303 (452)
++..|..+.- .||+...|+|+|+|..+|.+ .+..+|+.||+|++.+. .....+.+.+
T Consensus 8 ip~~i~D~~~-~~Y~~g~~LGkGgFA~cYe~-------------------~~~~tge~~A~KvVpk~~l~k~~~reKv~~ 67 (592)
T KOG0575|consen 8 IPEVIEDPRS-KRYKRGRFLGKGGFARCYEA-------------------RDLDTGEVVAVKVVPKKLLKKPKQREKVLN 67 (592)
T ss_pred CCCeeecCCc-ceeeeeeeeccCcceEEEEE-------------------EEcCCCcEEEEEEeehHHhcCcchHHHHHH
Confidence 4556666666 99999999999999666644 56678999999999874 4556788999
Q ss_pred HHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 012989 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383 (452)
Q Consensus 304 E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH 383 (452)
||+|.+.|+|||||+++++|++.++.|||.|+|+.++|..++ ++.+.+++.+++.+++||+.||.|||+++ |||
T Consensus 68 EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiH 141 (592)
T KOG0575|consen 68 EIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIH 141 (592)
T ss_pred HHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---cee
Confidence 999999999999999999999999999999999999999998 46678999999999999999999999999 999
Q ss_pred cCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||..|+|++++.++||+|||+|..+..+. ......+|||.|.|||++.....+..+||||+||||
T Consensus 142 RDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvm 208 (592)
T KOG0575|consen 142 RDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVM 208 (592)
T ss_pred cccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHH
Confidence 9999999999999999999999999876443 334457999999999999998999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=300.03 Aligned_cols=179 Identities=27% Similarity=0.350 Sum_probs=158.3
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceeeeEecCC-eEEEEEEecCCCCh
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN-ELLLIYEYMPNKSL 341 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~E~~~~~~L 341 (452)
.++.|.+|.|+...+..+++.+|+|.+... ++...+++.+|+++++..+||+||++|+.|..+. .+.|+||||++|+|
T Consensus 86 ~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSL 165 (364)
T KOG0581|consen 86 VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSL 165 (364)
T ss_pred hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCH
Confidence 344555666667788889999999999544 4555678999999999999999999999999998 59999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
+.++. ..+.+++...-.|+.++++||.|||+ ++ ||||||||+|||++.+|.+||+|||.++.+.+. ..+
T Consensus 166 d~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~ 235 (364)
T KOG0581|consen 166 DDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IAN 235 (364)
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcc
Confidence 99984 34679999999999999999999995 77 999999999999999999999999999886544 456
Q ss_pred ccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 421 RVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++||..|||||.+.+..|+.++||||||+.|
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsl 267 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSL 267 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHH
Confidence 78999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=299.61 Aligned_cols=189 Identities=22% Similarity=0.325 Sum_probs=157.0
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-------cHHHHHHHHHHH
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-------GLQEFKNEVTLI 308 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-------~~~~~~~E~~~l 308 (452)
-+-.|.+.+-+|.|.+|.|- .+...++|+.||||++.+..-. ....+.+|+++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vk-------------------la~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieIL 230 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVK-------------------LAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEIL 230 (475)
T ss_pred hcceeEeeeeecCCceeEEE-------------------EEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHH
Confidence 34456666677777775554 5567789999999999865211 123357999999
Q ss_pred HcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 309 AKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 309 ~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
++|+|||||+++++|+..+..||||||++||.|.+.+ ..++.+.+..-+.+++||+.|+.|||++| |+||||||
T Consensus 231 kkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKP 304 (475)
T KOG0615|consen 231 KKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKP 304 (475)
T ss_pred HhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCc
Confidence 9999999999999999999999999999999998888 45567888899999999999999999999 99999999
Q ss_pred CCeEECCC---CCeeEccccccccccCCCccccccccccccccccccccccCCC--ce-eeeeeeeeeeC
Q 012989 389 SNVLLDHE---MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF--SV-NRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s~-~~DvwSlG~il 452 (452)
+|||+..+ -.+||+|||+|+..... .....++|||.|.|||++.+... ++ +.|+||+||||
T Consensus 305 eNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvL 371 (475)
T KOG0615|consen 305 ENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVL 371 (475)
T ss_pred ceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceE
Confidence 99999877 56999999999986532 33556899999999999976553 33 68999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=298.95 Aligned_cols=193 Identities=24% Similarity=0.381 Sum_probs=164.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.|++..-+|.|+||.|+++ ....+|..||.|.++-. +....+.+..|+.+|++|+||||
T Consensus 20 ~y~Il~~IG~GsFg~vykv-------------------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNI 80 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKV-------------------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNI 80 (375)
T ss_pred HHHHHHHHcCCcchheEEe-------------------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchH
Confidence 4777777788888777755 56779999999998744 45567789999999999999999
Q ss_pred cceee-eEecCCe-EEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCeEecCCCCCCeE
Q 012989 317 VRLLG-CCLDGNE-LLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDS-RLRVIHRDLKTSNVL 392 (452)
Q Consensus 317 v~l~~-~~~~~~~-~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g-~~~ivH~Dlkp~NIl 392 (452)
|++++ .|..+.+ ++||||++.+|+|.+++... +..+.+++..+|+++.|++.||.++|..- +..|+||||||.||+
T Consensus 81 VqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIF 160 (375)
T KOG0591|consen 81 VQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIF 160 (375)
T ss_pred HHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheE
Confidence 99998 5555555 99999999999999988653 35667999999999999999999999832 123999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+|.+||+|||+++.+..... .....+|||.||+||.+.+.+|+.||||||+||++
T Consensus 161 l~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCll 218 (375)
T KOG0591|consen 161 LTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLL 218 (375)
T ss_pred EcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHH
Confidence 99999999999999998865433 34568999999999999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.25 Aligned_cols=174 Identities=25% Similarity=0.362 Sum_probs=155.1
Q ss_pred ccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 271 KEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
|+|+..+...+++.+|+|++++. ...+....+.|..+|.+++||+||+++..|++.+.+|||+||+.||.|...+
T Consensus 39 GkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL-- 116 (357)
T KOG0598|consen 39 GKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL-- 116 (357)
T ss_pred ceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH--
Confidence 44445566689999999999876 3445678899999999999999999999999999999999999999998888
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
++.+.|++..+..++.+|+.||.|||+.| ||||||||+|||+|.+|+++|+|||+++..... ......++||+.
T Consensus 117 -~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~e 190 (357)
T KOG0598|consen 117 -QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPE 190 (357)
T ss_pred -HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCcc
Confidence 56678999999999999999999999999 999999999999999999999999999864332 233445899999
Q ss_pred cccccccccCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||++++..|+..+|+||||++|
T Consensus 191 YmAPEil~~~gy~~~vDWWsLGill 215 (357)
T KOG0598|consen 191 YMAPEILLGKGYDKAVDWWSLGILL 215 (357)
T ss_pred ccChHHHhcCCCCcccchHhHHHHH
Confidence 9999999999999999999999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=300.72 Aligned_cols=195 Identities=25% Similarity=0.380 Sum_probs=166.5
Q ss_pred EccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHH
Q 012989 232 RYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIA 309 (452)
Q Consensus 232 ~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~ 309 (452)
+.+.|.-.||....+|+|.+|.||++ ++..+|+.||+|++..+. +....-..+||.||+
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkA-------------------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr 171 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKA-------------------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILR 171 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEe-------------------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHH
Confidence 45677788888888999999888876 567799999999998764 344555679999999
Q ss_pred cCCCCCccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 310 KLQHKNLVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 310 ~l~h~~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
+|.||||++|.+..... ..+|||+|||+. +|.-++. ...-.|++.+++.+++||+.||+|+|.+| |+|||||
T Consensus 172 ~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK 245 (560)
T KOG0600|consen 172 RLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIK 245 (560)
T ss_pred hcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeecccc
Confidence 99999999999998876 689999999987 5555552 34556999999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
.+|||||++|.+||+|||+|+.+.......-+++ +-|++|+|||+++|. .|+.+.|+||.||||
T Consensus 246 ~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~r-VvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl 310 (560)
T KOG0600|consen 246 GSNILIDNNGVLKIADFGLARFYTPSGSAPYTSR-VVTLWYRPPELLLGATSYGTAVDLWSVGCIL 310 (560)
T ss_pred ccceEEcCCCCEEeccccceeeccCCCCcccccc-eEEeeccChHHhcCCcccccceeehhhhHHH
Confidence 9999999999999999999998876665544444 449999999999874 599999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.21 Aligned_cols=188 Identities=27% Similarity=0.417 Sum_probs=163.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~ 315 (452)
.||+..+++|+|.+|+||.+ .+..+|+.||||+++..+. .......+||+.|+.++|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka-------------------~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~n 62 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKA-------------------RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPN 62 (318)
T ss_pred chhhhhhhhcCcceEEEEEE-------------------EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcc
Confidence 48888888999988888766 5677999999999986632 22445789999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+.++++|...+.+.||+||++. +|+..+++ +...++...++.++.++++||+|||++. |+||||||.|+|++.
T Consensus 63 Ii~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 63 IIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISS 136 (318)
T ss_pred hhhhhhhccCCCceEEEEEeccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcC
Confidence 99999999999999999999965 89998865 4567999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+|.+||+|||+++.+......... .+-|.+|+|||++.| ..|+...|+||.||||
T Consensus 137 ~g~lKiADFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~ 192 (318)
T KOG0659|consen 137 DGQLKIADFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIF 192 (318)
T ss_pred CCcEEeecccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHH
Confidence 999999999999998766544433 256999999999976 5589999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.36 Aligned_cols=187 Identities=23% Similarity=0.328 Sum_probs=158.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+||.....|+|++|+|+ .+++..+|+.||||++.... +...+-.++|+++|++|+|+|+
T Consensus 3 kYE~LgkvGEGSYGvV~-------------------KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NL 63 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVM-------------------KCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENL 63 (396)
T ss_pred HHhhhhccccCcceEEE-------------------EeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchH
Confidence 56666666666666555 45667799999999987542 3334557899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|.++++|.....++||+||++..-|+++- .....++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+
T Consensus 64 VnLiEVFrrkrklhLVFE~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~ 137 (396)
T KOG0593|consen 64 VNLIEVFRRKRKLHLVFEYCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQN 137 (396)
T ss_pred HHHHHHHHhcceeEEEeeecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecC
Confidence 99999999999999999999987777765 33456899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+|+.+.. +....+..+.|.+|+|||++.+ .+|....|||++||++
T Consensus 138 gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~ 192 (396)
T KOG0593|consen 138 GVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVF 192 (396)
T ss_pred CcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHH
Confidence 9999999999998764 2333445677999999999987 7899999999999985
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=294.41 Aligned_cols=174 Identities=47% Similarity=0.833 Sum_probs=149.9
Q ss_pred EEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCC-eEEEEEEecCCCChhhhhccCCCCCCC
Q 012989 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN-ELLLIYEYMPNKSLDLFLFDSTKGAQL 354 (452)
Q Consensus 276 ~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~E~~~~~~L~~~l~~~~~~~~l 354 (452)
++.+.+++.||||++.........+|.+|+.++.+++|||+|+|+++|.+.+ +.+||+||+++|+|++.++..... .+
T Consensus 93 kG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L 171 (361)
T KOG1187|consen 93 KGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PL 171 (361)
T ss_pred EEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CC
Confidence 4567788999999887664431455999999999999999999999999998 599999999999999999764433 89
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc-ccccccccccc
Q 012989 355 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV-VGTYGYMAPEY 433 (452)
Q Consensus 355 ~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~ 433 (452)
+|..+++|+.++++||+|||+....+||||||||+|||+|++.++||+|||+++..... ....... .||.+|++||+
T Consensus 172 ~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy 249 (361)
T KOG1187|consen 172 DWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEY 249 (361)
T ss_pred CHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhh
Confidence 99999999999999999999987678999999999999999999999999999654431 1111112 78999999999
Q ss_pred cccCCCceeeeeeeeeeeC
Q 012989 434 AMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 434 ~~~~~~s~~~DvwSlG~il 452 (452)
+..+..+.|+||||||++|
T Consensus 250 ~~~g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 250 ASTGKLTEKSDVYSFGVVL 268 (361)
T ss_pred hccCCcCcccccccchHHH
Confidence 9999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=293.43 Aligned_cols=177 Identities=27% Similarity=0.432 Sum_probs=158.4
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
+.+.+|.|+.+....+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+++|+||||++||+|.+.+
T Consensus 282 gqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV 361 (550)
T KOG0578|consen 282 GQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV 361 (550)
T ss_pred ccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh
Confidence 34444455555777889999999999887777788999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 425 (452)
....+++.++..|++++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..... .....+||
T Consensus 362 ----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGT 432 (550)
T KOG0578|consen 362 ----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGT 432 (550)
T ss_pred ----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCC
Confidence 3445999999999999999999999999 99999999999999999999999999988766544 34557999
Q ss_pred cccccccccccCCCceeeeeeeeeee
Q 012989 426 YGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 426 ~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
|.|||||++....|++|.||||||+|
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIM 458 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIM 458 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhH
Confidence 99999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=292.83 Aligned_cols=193 Identities=28% Similarity=0.394 Sum_probs=165.3
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l 311 (452)
.+--.|...+.+|.|++.+|+.+ ....+++++|||++.+. .+...+-+..|-.+|.+|
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A-------------------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L 130 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLA-------------------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQL 130 (604)
T ss_pred CChhhcchhheeccccceeEEEe-------------------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHh
Confidence 34455666667777777666655 56678999999999865 233345577899999999
Q ss_pred -CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 312 -QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 312 -~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
.||.|++|+-.|+++..+|+|+||+++|+|.+++ .+-+.|++..++.++.||+.||+|||++| ||||||||+|
T Consensus 131 ~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPEN 204 (604)
T KOG0592|consen 131 SGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPEN 204 (604)
T ss_pred hCCCCeEEEEEEeecccceEEEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhh
Confidence 8999999999999999999999999999999999 45578999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCcc---------ccc--cccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNE---------ANT--NRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|.++++||.|||.|+.+...... ... ..++||..|++||++..+..++.+|+|+|||||
T Consensus 205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCil 277 (604)
T KOG0592|consen 205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCIL 277 (604)
T ss_pred eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHH
Confidence 99999999999999999987644322 111 458999999999999999999999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.07 Aligned_cols=188 Identities=22% Similarity=0.421 Sum_probs=167.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
..|||+.+-+|.|.+|.|-.+ .....|+.||||.|.++ ++++.-++.+||+||..|+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A-------------------~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH 112 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLA-------------------YEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH 112 (668)
T ss_pred hhHHHHHHHhcCCcccceeeh-------------------hhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC
Confidence 468999988888888766655 44567999999999876 45566678999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++|++|+..+.+.|||||..+|.|.+++ ...+.|++.+++.+++||.+|+.|+|+++ ++|||||.+|||+
T Consensus 113 PhII~IyEVFENkdKIvivMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILL 186 (668)
T KOG0611|consen 113 PHIIQIYEVFENKDKIVIVMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILL 186 (668)
T ss_pred CceeehhhhhcCCceEEEEEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheee
Confidence 99999999999999999999999999999999 55677999999999999999999999998 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
|.++++||+|||++..+...+ ....++|++-|++||++.+.+| .+..|-||||++|
T Consensus 187 D~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLL 243 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLL 243 (668)
T ss_pred cCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHH
Confidence 999999999999998876543 3456899999999999999998 5569999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=292.70 Aligned_cols=188 Identities=24% Similarity=0.382 Sum_probs=160.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC----Cc-ccHHHHHHHHHHHHcCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS----SG-QGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~----~~-~~~~~~~~E~~~l~~l~ 312 (452)
.+|+..+.+|.|++|.|+ ...+..+++.||||++++. .. ...+.+.+|+.+++.++
T Consensus 17 g~y~~~~~lG~GsfgkV~-------------------~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~ 77 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVK-------------------LAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR 77 (370)
T ss_pred CceeeeeeecCCCCeeEE-------------------EeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc
Confidence 466777777777765555 4566778899999987764 12 23556778999999998
Q ss_pred -CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 313 -HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 313 -h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
||||+++++++.....+++||||+.||.|.+++. ..+++.+.++..+++||+.|++|||++| |+||||||+||
T Consensus 78 ~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENi 151 (370)
T KOG0583|consen 78 SHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENI 151 (370)
T ss_pred cCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHE
Confidence 9999999999999999999999999999999994 3567999999999999999999999999 99999999999
Q ss_pred EECCC-CCeeEccccccccccCCCccccccccccccccccccccccCC-Cc-eeeeeeeeeeeC
Q 012989 392 LLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FS-VNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DvwSlG~il 452 (452)
|++.+ +++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+|+||
T Consensus 152 lld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 152 LLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVIL 213 (370)
T ss_pred EecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHH
Confidence 99999 999999999998763 2233455679999999999999877 86 669999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=293.67 Aligned_cols=188 Identities=26% Similarity=0.344 Sum_probs=160.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHH-HHHHHHHHHHcCC-CC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQ-HK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~-~~~~E~~~l~~l~-h~ 314 (452)
..||.+.+-+|.|+||.|+.+ ....+++.||||+++++-....+ .=++|++.|++|+ ||
T Consensus 9 m~RY~~i~klGDGTfGsV~la-------------------~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hp 69 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLA-------------------KSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHP 69 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEe-------------------eecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCC
Confidence 458888888888888777755 55668889999999877433222 2357999999998 99
Q ss_pred CccceeeeEecCC-eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 315 NLVRLLGCCLDGN-ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 315 ~iv~l~~~~~~~~-~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
||+++.+++.+.+ .+++|||||+. +|.+++++. ++.|++..++.|+.||++||+|+|++| +.|||+||+|||+
T Consensus 70 niikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi 143 (538)
T KOG0661|consen 70 NIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILI 143 (538)
T ss_pred cchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEe
Confidence 9999999999888 99999999955 899988653 788999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcccccccccccccccccccc-ccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA-MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwSlG~il 452 (452)
..+..+||+|||+|+.+.... ..+..+.|.+|+|||++ ..+.|+.+.|+|++|||+
T Consensus 144 ~~~~~iKiaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 144 SGNDVIKIADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIM 200 (538)
T ss_pred cccceeEecccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHH
Confidence 999999999999999875443 34456889999999988 467899999999999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.53 Aligned_cols=168 Identities=33% Similarity=0.569 Sum_probs=145.5
Q ss_pred cCCee-eEEEEeecCCcc--cHHHHHHHHHHHHcCCCCCccceeeeEecCC-eEEEEEEecCCCChhhhhccCCCCCCCC
Q 012989 280 ADGKE-IAVKRLSRSSGQ--GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN-ELLLIYEYMPNKSLDLFLFDSTKGAQLD 355 (452)
Q Consensus 280 ~~~~~-vAiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~E~~~~~~L~~~l~~~~~~~~l~ 355 (452)
..|.. ||||++...... ..+.|.+|+.+|.+++|||||++++++..+. ..+|||||+++|+|..+++.. ....++
T Consensus 62 ~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~ 140 (362)
T KOG0192|consen 62 WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLP 140 (362)
T ss_pred eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCC
Confidence 35666 999999865322 2568999999999999999999999999988 799999999999999999653 467899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC-CeeEccccccccccCCCcccccccccccccccccccc
Q 012989 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA 434 (452)
Q Consensus 356 ~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 434 (452)
+..++.|+.||++||+|||+++. ||||||||+|||++.++ ++||+|||+++...... .......||+.|||||++
T Consensus 141 ~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~ 216 (362)
T KOG0192|consen 141 LKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVL 216 (362)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhh
Confidence 99999999999999999999873 89999999999999997 99999999998654322 223336899999999999
Q ss_pred c--cCCCceeeeeeeeeeeC
Q 012989 435 M--EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 435 ~--~~~~s~~~DvwSlG~il 452 (452)
. ...|+.|+||||||++|
T Consensus 217 ~~~~~~~~~K~DvySFgIvl 236 (362)
T KOG0192|consen 217 RGEKSPYTEKSDVYSFGIVL 236 (362)
T ss_pred cCCCCcCCccchhhhHHHHH
Confidence 9 56899999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=293.27 Aligned_cols=187 Identities=26% Similarity=0.428 Sum_probs=167.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|.+|+.+|.|++|.||+++ ...+.+.||||.+.+. .+++...+.+|++|++.|+|||
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgr-------------------rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpn 62 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGR-------------------RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPN 62 (808)
T ss_pred cchhHHHHhcCCccceeeecc-------------------cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcc
Confidence 378899999999999999874 3457899999999875 4455677999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+.++++|++..+.|+|.||+.| +|..++ ...+.++++.+..|+.|++.||.|||+.+ |+|||+||+|||++.
T Consensus 63 iv~m~esfEt~~~~~vVte~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~ 135 (808)
T KOG0597|consen 63 IVEMLESFETSAHLWVVTEYAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEK 135 (808)
T ss_pred hhhHHHhhcccceEEEEehhhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecC
Confidence 99999999999999999999988 999999 55677999999999999999999999998 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+++|++|||+++....+. ....+.-|||-|||||++.+++|+..+|+||+||||
T Consensus 136 ~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcil 190 (808)
T KOG0597|consen 136 GGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCIL 190 (808)
T ss_pred CCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHH
Confidence 9999999999999765432 234556899999999999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=268.90 Aligned_cols=185 Identities=28% Similarity=0.379 Sum_probs=161.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-.|+...-+|.|+||. |-+.+...+|..+|+|++++.. -...+...+|..+|+.+.|
T Consensus 43 l~dfe~~~tlGtGSFGr-------------------V~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~ 103 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGR-------------------VHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH 103 (355)
T ss_pred hhhhhheeeeccCccce-------------------EEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC
Confidence 34555556666666654 4455677789999999998763 3345678899999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|+++++++.+.+.+.++|||||.+||.|..++ ++.++|++..++.++.||+.||+|||+.+ |++|||||+|||+
T Consensus 104 PFlv~l~~t~~d~~~lymvmeyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLl 177 (355)
T KOG0616|consen 104 PFLVKLYGTFKDNSNLYMVMEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLL 177 (355)
T ss_pred ceeEEEEEeeccCCeEEEEEeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeee
Confidence 99999999999999999999999999999999 45567999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
|.+|.+||+|||+|+..... +...+|||.|+|||++....+..++|.|+||++
T Consensus 178 D~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVL 230 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVL 230 (355)
T ss_pred ccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHH
Confidence 99999999999999976432 456899999999999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=276.86 Aligned_cols=200 Identities=23% Similarity=0.334 Sum_probs=169.4
Q ss_pred cEEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHH
Q 012989 229 GRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTL 307 (452)
Q Consensus 229 ~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~ 307 (452)
....++.+.-.||+...+|.|..++|+.++.. ..++.||||++..+. ....+.+.+|+..
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~-------------------p~~e~VAIK~inLEkc~~~ld~l~kE~~~ 77 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCI-------------------PTNEVVAIKIINLEKCNNDLDALRKEVQT 77 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeec-------------------ccCCEEEEEEeehhhhhhhHHHHHHHHHH
Confidence 34556677789999999999998888877653 467999999998663 3346889999999
Q ss_pred HHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 308 IAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 308 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
|+.++||||++++..|..++.+|+||.||.+|++.++++..- ...+++..+..|.+++++||.|||++| .||||||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvK 153 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVK 153 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccc
Confidence 999999999999999999999999999999999999986543 345999999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccc-cCCCccccc-cccccccccccccccc--cCCCceeeeeeeeeee
Q 012989 388 TSNVLLDHEMNPKISDFGMARIF-SGNQNEANT-NRVVGTYGYMAPEYAM--EGVFSVNRMFLVSEFF 451 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~-~~~~~~~~~-~~~~gt~~y~aPE~~~--~~~~s~~~DvwSlG~i 451 (452)
+.||||+.+|.+||+|||.+-.+ ......... +.++||+.|||||+++ ...|+.|+||||||+.
T Consensus 154 AgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGIT 221 (516)
T KOG0582|consen 154 AGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGIT 221 (516)
T ss_pred cccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHH
Confidence 99999999999999999976443 322221122 5679999999999974 3569999999999974
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=284.50 Aligned_cols=191 Identities=23% Similarity=0.308 Sum_probs=162.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-.|++...+|.|++ |.|++++...+|+.+|+|++++. .....+.++.|-.+|....+
T Consensus 140 ~~DFe~Lk~IgkGAf-------------------GeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds 200 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAF-------------------GEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDS 200 (550)
T ss_pred cccchhheeeccccc-------------------eeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCC
Confidence 345666666666666 55557788889999999999876 34556788999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|.||+|+..|++.+++||||||++||++..+| .+.+.|++..++.++.+++-|++.||+.| +|||||||+|+||
T Consensus 201 ~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLi 274 (550)
T KOG0605|consen 201 PWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLI 274 (550)
T ss_pred CcEEEEEEEecCCCeeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheee
Confidence 99999999999999999999999999999999 56678999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCC---------------------Cccc-----c-------------------cccccccccc
Q 012989 394 DHEMNPKISDFGMARIFSGN---------------------QNEA-----N-------------------TNRVVGTYGY 428 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~---------------------~~~~-----~-------------------~~~~~gt~~y 428 (452)
|..|++||+||||+.-+... .... . ....+|||.|
T Consensus 275 D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDY 354 (550)
T KOG0605|consen 275 DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDY 354 (550)
T ss_pred cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccc
Confidence 99999999999998543210 0000 0 1234899999
Q ss_pred ccccccccCCCceeeeeeeeeeeC
Q 012989 429 MAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 429 ~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||++++..|+..+|+||||||+
T Consensus 355 iAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 355 IAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred cchHHHhcCCCCccccHHHHHHHH
Confidence 999999999999999999999985
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=270.05 Aligned_cols=188 Identities=24% Similarity=0.337 Sum_probs=157.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~ 315 (452)
-.|+...-+++|++|.||++ ++..+++.||+|+++.+.. .-.-.-++||.+|.+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRa-------------------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~N 136 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRA-------------------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPN 136 (419)
T ss_pred HHHHHHhhcccCcceeEEEe-------------------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCC
Confidence 36777777788888777766 4567899999999986532 22334578999999999999
Q ss_pred ccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 316 LVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 316 iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
||.+.++.... +.+||||||++. +|..++... ..+|...+++-++.|+++||+|||.+. |+||||||+|+|+
T Consensus 137 IV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm 210 (419)
T KOG0663|consen 137 IVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLL 210 (419)
T ss_pred eeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheee
Confidence 99999988754 579999999976 777777433 367999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
++.|.+||+|||+|+.++.... ..+..+-|.+|+|||++++. .|+...|+||+|||+
T Consensus 211 ~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~ 268 (419)
T KOG0663|consen 211 SHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIF 268 (419)
T ss_pred ccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHH
Confidence 9999999999999999876632 23345669999999999875 489999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=273.61 Aligned_cols=192 Identities=25% Similarity=0.364 Sum_probs=156.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|...+++|.|++|.|+.+ ...++|+..|||.+...+....+.+.+|+.+|.+|+||||
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~-------------------~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~I 76 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLA-------------------TNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNI 76 (313)
T ss_pred cchhhhhccccCccceEEEEE-------------------EecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCE
Confidence 455677777777777666644 4556689999999887643336779999999999999999
Q ss_pred cceeeeEecCC--eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDGN--ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|++++...... .+++.|||+++|+|.+++.... ..+++..++.+.+||++||+|||++| ||||||||+|||++
T Consensus 77 V~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 77 VQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLD 151 (313)
T ss_pred EeeCCccccccCeeeEeeeeccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEe
Confidence 99999855444 6999999999999999994422 26999999999999999999999999 99999999999999
Q ss_pred C-CCCeeEccccccccccCC-CccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 395 H-EMNPKISDFGMARIFSGN-QNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~-~~~~kl~DFG~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
. ++.+||+|||+++..... ..........||+.|||||++.++ ....++||||+||++
T Consensus 152 ~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtV 212 (313)
T KOG0198|consen 152 PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTV 212 (313)
T ss_pred CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEE
Confidence 9 799999999999876541 111223356899999999999854 344599999999974
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.12 Aligned_cols=185 Identities=25% Similarity=0.340 Sum_probs=159.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-C---
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-H--- 313 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h--- 313 (452)
.||++.+++|.|.||.|.++ .+.++++.||||+++.+ +.-..+-..|+.+|..|+ |
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~-------------------~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~ 245 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKA-------------------YDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPD 245 (586)
T ss_pred EEEEEEEEecccccceeEEE-------------------EecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCC
Confidence 39999999999999877755 66789999999999765 333455677999999996 4
Q ss_pred --CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 314 --KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 314 --~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
-|+|+++++|...+|.|||+|.+ ..+|.++++.. +...|+...++.|++||+.+|.+||+.+ |||+||||+||
T Consensus 246 ~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENI 320 (586)
T KOG0667|consen 246 DKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENI 320 (586)
T ss_pred CCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhhe
Confidence 38999999999999999999999 55999999664 4556999999999999999999999999 99999999999
Q ss_pred EECCCC--CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEM--NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+...+ .+||||||++....... ...+.+..|+|||++++.+|+.+.||||||||+
T Consensus 321 LL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIl 378 (586)
T KOG0667|consen 321 LLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCIL 378 (586)
T ss_pred eeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhH
Confidence 997554 59999999998753322 245668999999999999999999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=285.49 Aligned_cols=180 Identities=24% Similarity=0.347 Sum_probs=157.5
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
.++.|..|.|-.+.+..+|+..|||++.+. .......+.+||.+|+.|.||||++++++|+.+.++|+|.||++||-
T Consensus 19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGE 98 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGE 98 (786)
T ss_pred cccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCch
Confidence 344555566667788899999999999876 23335668999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
|.+++ ...+++++.++.++++||+.|+.|+|..+ |+||||||+|+|+|.++++||+|||+|..-.+++- ..
T Consensus 99 LFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---Le 169 (786)
T KOG0588|consen 99 LFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LE 169 (786)
T ss_pred hHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc---cc
Confidence 99998 45678999999999999999999999999 99999999999999999999999999987544332 34
Q ss_pred ccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 421 RVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
.-||.|+|++||+++|.+| +.++||||-|+||
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVIL 202 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVIL 202 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHH
Confidence 5699999999999999998 5569999999986
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.16 Aligned_cols=189 Identities=27% Similarity=0.387 Sum_probs=155.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCC-
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKN- 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~- 315 (452)
.|+..+.+|.|.+|+||. .....+|+.||+|++..... .......+|+.+|+.|+|+|
T Consensus 12 ~~~~~eklGeGtyg~Vyk-------------------ar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~ 72 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYK-------------------ARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANH 72 (323)
T ss_pred HHHHHHHhCCCCceEEEE-------------------EEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcc
Confidence 344444566666665554 46677899999999986643 34456789999999999999
Q ss_pred ccceeeeEecCC------eEEEEEEecCCCChhhhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 316 LVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDSTKG-AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 316 iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
|+.+++++...+ ..++|+||++. +|..++...... ..++...++.+++||+.||+|||+++ |+||||||
T Consensus 73 iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKP 148 (323)
T KOG0594|consen 73 IVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKP 148 (323)
T ss_pred eEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCc
Confidence 999999999877 79999999955 788887543322 46888999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+||||+++|.+||+|||+|+.+.-+.. .....++|.+|+|||++++. .|+...||||+|||+
T Consensus 149 QNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 149 QNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF 211 (323)
T ss_pred ceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence 999999999999999999997653322 24456789999999999886 689999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.20 Aligned_cols=180 Identities=29% Similarity=0.487 Sum_probs=152.6
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
+.|.+|.|+. +.......||+|.++.. ....+.|.+|+++|++|+|++||++++++..+..++|||||++.|+|.+++
T Consensus 215 G~G~FG~V~~-g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yL 292 (468)
T KOG0197|consen 215 GSGQFGEVWL-GKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYL 292 (468)
T ss_pred cCCccceEEE-EEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHh
Confidence 4455566554 33444558999999765 344578899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 425 (452)
+. ..+..+...+.+.++.||++|++||++++ +|||||-..|||++++..+||+|||+++...++.......... +
T Consensus 293 r~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf-P 367 (468)
T KOG0197|consen 293 RT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF-P 367 (468)
T ss_pred hh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC-C
Confidence 65 34567999999999999999999999999 9999999999999999999999999999655444333332222 7
Q ss_pred cccccccccccCCCceeeeeeeeeeeC
Q 012989 426 YGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 426 ~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..|.|||.+..+.||.||||||||++|
T Consensus 368 IkWtAPEa~~~~~FS~kSDVWSFGVlL 394 (468)
T KOG0197|consen 368 IKWTAPEALNYGKFSSKSDVWSFGVLL 394 (468)
T ss_pred ceecCHHHHhhCCcccccceeehhhhH
Confidence 899999999999999999999999986
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=280.17 Aligned_cols=189 Identities=23% Similarity=0.297 Sum_probs=157.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++...+|.|++|.|+. .....+++.||||++.+. .....+.+.+|+++++.++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~-------------------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 62 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRL-------------------VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62 (377)
T ss_pred CceEeEEEeecCCEEEEE-------------------EEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCC
Confidence 467777788888866654 456678999999998654 2334567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+.++.+.|+||||+++++|.+++. ....+++..++.++.||+.||+|||+.| |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~ 136 (377)
T cd05629 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDR 136 (377)
T ss_pred cceEEEEEEcCCeeEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECC
Confidence 9999999999999999999999999999883 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcc---------------------------------------------cccccccccccccc
Q 012989 396 EMNPKISDFGMARIFSGNQNE---------------------------------------------ANTNRVVGTYGYMA 430 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~a 430 (452)
++.+||+|||+++.+...... ......+||+.|+|
T Consensus 137 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 216 (377)
T cd05629 137 GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIA 216 (377)
T ss_pred CCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccC
Confidence 999999999998643211000 00012469999999
Q ss_pred ccccccCCCceeeeeeeeeeeC
Q 012989 431 PEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 431 PE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.+..++.++|||||||+|
T Consensus 217 PE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 217 PEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred HHHHccCCCCCceeeEecchhh
Confidence 9999999999999999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=278.41 Aligned_cols=189 Identities=22% Similarity=0.300 Sum_probs=159.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|+..+.+|.|++|.|+.+ ....+++.||||++.+.. ......+.+|+.++.+++|+|
T Consensus 2 ~y~~~~~LG~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~ 62 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLV-------------------QKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62 (363)
T ss_pred CceEeEEEEeCCCEEEEEE-------------------EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCC
Confidence 4677778888888766643 555678999999997542 233456889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+.+...+++||||+++++|.+++. +...+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~ 136 (363)
T cd05628 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDS 136 (363)
T ss_pred cceEEEEEecCCeEEEEEcCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECC
Confidence 9999999999999999999999999999884 3457999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcc---------------------------------ccccccccccccccccccccCCCcee
Q 012989 396 EMNPKISDFGMARIFSGNQNE---------------------------------ANTNRVVGTYGYMAPEYAMEGVFSVN 442 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~ 442 (452)
++++||+|||+++.+...... ......+||+.|+|||++.+..++.+
T Consensus 137 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ 216 (363)
T cd05628 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL 216 (363)
T ss_pred CCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc
Confidence 999999999998754321100 00123579999999999999999999
Q ss_pred eeeeeeeeeC
Q 012989 443 RMFLVSEFFF 452 (452)
Q Consensus 443 ~DvwSlG~il 452 (452)
+|||||||+|
T Consensus 217 ~DvwSlGvil 226 (363)
T cd05628 217 CDWWSLGVIM 226 (363)
T ss_pred hhhhhhHHHH
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=278.33 Aligned_cols=189 Identities=20% Similarity=0.294 Sum_probs=158.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|+....+|.|++|.|+.+ ....+++.||||++.+.. ....+.+.+|+.+++.++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~-------------------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~ 62 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLA-------------------CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62 (381)
T ss_pred CceEEEEEeecCCEEEEEE-------------------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCC
Confidence 4677777888888766644 556788999999997642 334567899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+.+++++++||||+++++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 63 iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~ 136 (381)
T cd05626 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDL 136 (381)
T ss_pred eeeeEEEEecCCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECC
Confidence 9999999999999999999999999999883 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcc---------------------------------------------cccccccccccccc
Q 012989 396 EMNPKISDFGMARIFSGNQNE---------------------------------------------ANTNRVVGTYGYMA 430 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~a 430 (452)
++++||+|||+++.+...... ......+||+.|+|
T Consensus 137 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 216 (381)
T cd05626 137 DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216 (381)
T ss_pred CCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccC
Confidence 999999999997643211000 00123579999999
Q ss_pred ccccccCCCceeeeeeeeeeeC
Q 012989 431 PEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 431 PE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.+..++.++|||||||||
T Consensus 217 PE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 217 PEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred HHHHcCCCCCCccceeehhhHH
Confidence 9999988899999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=278.76 Aligned_cols=179 Identities=24% Similarity=0.345 Sum_probs=159.2
Q ss_pred CCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 265 GSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 265 ~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
++.|.+|+|.......+++.+|||.+++. ...+.+..+.|.+|+... +||.++.++..|++.+++|+||||+.||+
T Consensus 376 LGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggd 455 (694)
T KOG0694|consen 376 LGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGD 455 (694)
T ss_pred eccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCc
Confidence 35666777888888889999999999987 466778899999999888 59999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
+..+. ..+.|++..+..++..|+.||.|||++| ||+||||.+|||+|.+|++||+|||+++.--. ....+.
T Consensus 456 m~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~Ts 526 (694)
T KOG0694|consen 456 LMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRTS 526 (694)
T ss_pred EEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC--CCCccc
Confidence 55444 4467999999999999999999999999 99999999999999999999999999986332 233566
Q ss_pred ccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 421 RVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++|||.|||||++.+..|+...|+|||||+|
T Consensus 527 TfCGTpey~aPEil~e~~Yt~aVDWW~lGVLl 558 (694)
T KOG0694|consen 527 TFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLL 558 (694)
T ss_pred cccCChhhcChhhhccCcccchhhHHHHHHHH
Confidence 79999999999999999999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=264.70 Aligned_cols=188 Identities=26% Similarity=0.397 Sum_probs=153.5
Q ss_pred CCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--------------cccHHHHHHHHHHHHcCCCCCccceeeeEe
Q 012989 259 FSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--------------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 324 (452)
Q Consensus 259 ~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 324 (452)
|......+.|.+|.|.++....+++.||||++.+.. ....+...+||.+|+++.|||||+|+++..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 445556677778888888999999999999997542 112467899999999999999999999988
Q ss_pred cC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEc
Q 012989 325 DG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402 (452)
Q Consensus 325 ~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~ 402 (452)
+. +.+|||+||+..|.+...- .....+++.++++|+++++.||+|||.+| ||||||||+|+|++.+|++||+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred CcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEee
Confidence 65 5799999999988764322 22233999999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCC---CccccccccccccccccccccccCC---C-ceeeeeeeeeeeC
Q 012989 403 DFGMARIFSGN---QNEANTNRVVGTYGYMAPEYAMEGV---F-SVNRMFLVSEFFF 452 (452)
Q Consensus 403 DFG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-s~~~DvwSlG~il 452 (452)
|||.+..+... .......+.+|||.|+|||+..++. + +.+.||||+||.|
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 99999876322 1122234478999999999987633 3 5679999999865
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=276.95 Aligned_cols=189 Identities=23% Similarity=0.322 Sum_probs=158.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+....+|.|++|.|+. .....+++.||||++.... ......+.+|+.+++.++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~-------------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~ 62 (364)
T cd05599 2 DFESIKVIGRGAFGEVRL-------------------VQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62 (364)
T ss_pred CceEEEEEEecCCEEEEE-------------------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCC
Confidence 477777888888876654 4556688999999997542 234456889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..+.++++||||+++++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDA 136 (364)
T ss_pred CcceEEEEEcCCeEEEEECCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECC
Confidence 9999999999999999999999999999884 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccc------------------------------------cccccccccccccccccccCCC
Q 012989 396 EMNPKISDFGMARIFSGNQNEA------------------------------------NTNRVVGTYGYMAPEYAMEGVF 439 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 439 (452)
++.+||+|||+++.+....... .....+||+.|+|||++.+..+
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (364)
T cd05599 137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216 (364)
T ss_pred CCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC
Confidence 9999999999987543221100 0112469999999999999999
Q ss_pred ceeeeeeeeeeeC
Q 012989 440 SVNRMFLVSEFFF 452 (452)
Q Consensus 440 s~~~DvwSlG~il 452 (452)
+.++|||||||+|
T Consensus 217 ~~~~DiwSlG~il 229 (364)
T cd05599 217 NKECDWWSLGVIM 229 (364)
T ss_pred CCeeeeecchhHH
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=277.53 Aligned_cols=189 Identities=20% Similarity=0.304 Sum_probs=158.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+....+|.|++|.|+.+ ....+++.||||++.+.. ....+.+.+|+.++++++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a-------------------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~ 62 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLA-------------------RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62 (382)
T ss_pred CcEEEEEEEeCCCEEEEEE-------------------EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCc
Confidence 5778888888888776644 455688999999987542 234567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..++..++||||+++++|.+++. +...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~ 136 (382)
T cd05625 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDR 136 (382)
T ss_pred CCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999998884 3356899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCc---------------------------------------------ccccccccccccccc
Q 012989 396 EMNPKISDFGMARIFSGNQN---------------------------------------------EANTNRVVGTYGYMA 430 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~a 430 (452)
++++||+|||++..+..... .......+||+.|+|
T Consensus 137 ~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 216 (382)
T cd05625 137 DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIA 216 (382)
T ss_pred CCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCC
Confidence 99999999999754321000 000123479999999
Q ss_pred ccccccCCCceeeeeeeeeeeC
Q 012989 431 PEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 431 PE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.+..++.++|||||||+|
T Consensus 217 PE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 217 PEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred HHHhcCCCCCCeeeEEechHHH
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.00 Aligned_cols=189 Identities=19% Similarity=0.298 Sum_probs=156.8
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|++...+|.|++|.|+. .....+++.||||++.+.. ....+.+.+|+.+++.++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~-------------------a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~ 62 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCL-------------------VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62 (376)
T ss_pred CceEEEEEEeCCCeEEEE-------------------EEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCC
Confidence 466777777777766654 4556679999999986532 233566889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..++.+++||||+++++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~ 136 (376)
T cd05598 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDR 136 (376)
T ss_pred cceEEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECC
Confidence 9999999999999999999999999999883 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCc-----------------------------------------ccccccccccccccccccc
Q 012989 396 EMNPKISDFGMARIFSGNQN-----------------------------------------EANTNRVVGTYGYMAPEYA 434 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~ 434 (452)
++.+||+|||++..+..... .......+||+.|+|||++
T Consensus 137 ~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 216 (376)
T cd05598 137 DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216 (376)
T ss_pred CCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH
Confidence 99999999999754321000 0001134799999999999
Q ss_pred ccCCCceeeeeeeeeeeC
Q 012989 435 MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 435 ~~~~~s~~~DvwSlG~il 452 (452)
.+..++.++|||||||+|
T Consensus 217 ~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 217 LRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred cCCCCCcceeeeecccee
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.79 Aligned_cols=178 Identities=23% Similarity=0.257 Sum_probs=151.9
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|.++.|+......+++.||||++.+. .......+.+|+.+++.++||||+++++.+..++..++||||+++++|..
T Consensus 5 ~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 84 (323)
T cd05571 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFF 84 (323)
T ss_pred eCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 344455666677788999999999754 23344668899999999999999999999999999999999999999988
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
++. ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... .......
T Consensus 85 ~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~ 156 (323)
T cd05571 85 HLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFC 156 (323)
T ss_pred HHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccccee
Confidence 883 3456899999999999999999999999 9999999999999999999999999987532211 1223457
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+.|+|||++.+..++.++|||||||+|
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il 185 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhh
Confidence 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=272.44 Aligned_cols=190 Identities=25% Similarity=0.383 Sum_probs=165.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-.|+..+.+|.|.||..+.. ++..++..+++|++... +.......++|+.++++++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lv-------------------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~ 64 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLV-------------------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPN 64 (426)
T ss_pred chhhhhhhcCccccchhhhh-------------------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCC
Confidence 35777778888888777644 44557789999998765 3444456889999999999999
Q ss_pred ccceeeeEecCCe-EEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 316 LVRLLGCCLDGNE-LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 316 iv~l~~~~~~~~~-~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||.+.+.|+.++. .+|||+|++||+|.+.+.+. ++..|+++.+..|+.|++.|+.|||++. |+|||||+.||+++
T Consensus 65 iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 65 IVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLT 140 (426)
T ss_pred eeeeccchhcCCceEEEEEeecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhcc
Confidence 9999999999888 99999999999999999664 3677999999999999999999999888 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||.|||+++....... .....+||+.||+||++.+.+|..|+|||||||++
T Consensus 141 k~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~ 196 (426)
T KOG0589|consen 141 KDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCL 196 (426)
T ss_pred ccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchH
Confidence 999999999999998765442 34457899999999999999999999999999974
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=263.67 Aligned_cols=187 Identities=25% Similarity=0.395 Sum_probs=153.9
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-.++|+..+.+|.|+||.|+.+. ...++++||||++-.+.+.. .+|+++|+.+.|||
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~-------------------~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpN 78 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAK-------------------LRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPN 78 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEE-------------------EcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcC
Confidence 45789999999999999888663 34568999999987653321 36999999999999
Q ss_pred ccceeeeEecCC-----eEEEEEEecCCCChhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDGN-----ELLLIYEYMPNKSLDLFLFD-STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~~-----~~~lv~E~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
||++..+|.... ...+||||++. +|.+.++. ...+..++.-.++-+..||++||.|||+.| |+||||||+
T Consensus 79 IV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPq 154 (364)
T KOG0658|consen 79 IVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQ 154 (364)
T ss_pred eeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChh
Confidence 999998887432 35689999976 78777743 223567888999999999999999999999 999999999
Q ss_pred CeEECCC-CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|+|+|.+ |.+||+|||.|+.+..+.+.. ...-|..|+|||++.+ ..|+.+.||||.||++
T Consensus 155 NlLvD~~tg~LKicDFGSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~ 216 (364)
T KOG0658|consen 155 NLLVDPDTGVLKICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVM 216 (364)
T ss_pred eEEEcCCCCeEEeccCCcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHH
Confidence 9999977 889999999999887655432 3345899999999976 4599999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=270.33 Aligned_cols=184 Identities=24% Similarity=0.331 Sum_probs=159.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++...+|.|++|.|+.+ ....+++.||||++.+.. ......+.+|+.+++.++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~ 62 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLA-------------------KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62 (333)
T ss_pred CcEEEEEEeecCCeEEEEE-------------------EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCC
Confidence 5777888888888776644 455678999999997542 234567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..++||||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~ 136 (333)
T cd05600 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDA 136 (333)
T ss_pred CccEEEEEEcCCEEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECC
Confidence 9999999999999999999999999999983 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 137 ~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 188 (333)
T cd05600 137 SGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188 (333)
T ss_pred CCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHH
Confidence 99999999999976533 22345789999999999988999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=270.47 Aligned_cols=185 Identities=23% Similarity=0.318 Sum_probs=159.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
-.|++...+|.|++|.|+.+ ....+++.||||++.+.. ....+.+.+|+.++++++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 78 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIA-------------------KHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78 (329)
T ss_pred hheEEEEEEEecCCeEEEEE-------------------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCC
Confidence 45777778888888766644 455678999999987542 23456788999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..++..++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~ 152 (329)
T PTZ00263 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLD 152 (329)
T ss_pred CCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEC
Confidence 99999999999999999999999999998884 3456899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 153 ~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 205 (329)
T PTZ00263 153 NKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLL 205 (329)
T ss_pred CCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHH
Confidence 9999999999999865332 1235789999999999998999999999999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=259.95 Aligned_cols=187 Identities=26% Similarity=0.385 Sum_probs=160.4
Q ss_pred CCCCCCCCCCCCccEEEEEEecCCeeeEEEEee--cCCcccHHHHHHHHHHHHcCCCCCccceeeeEec-----CCeEEE
Q 012989 259 FSPPSPGSVTSSKEICVQGILADGKEIAVKRLS--RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD-----GNELLL 331 (452)
Q Consensus 259 ~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----~~~~~l 331 (452)
+......+.|.+|-|+-..+..+|+.||||++. -.+....++..+|+++|+.++|+||+.+++.+.. -+.+|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 344566777888888888899999999999998 3456677889999999999999999999999876 246999
Q ss_pred EEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccccc
Q 012989 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 411 (452)
Q Consensus 332 v~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 411 (452)
|+|++ +.+|...+ +.+..++...+..++.||+.||+|+|+.+ |+||||||.|++++.+..+||+|||+|+...
T Consensus 104 V~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 104 VFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred ehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecc
Confidence 99999 56899988 44555999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccccccccccccccccccccc-cCCCceeeeeeeeeeeC
Q 012989 412 GNQNEANTNRVVGTYGYMAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 412 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
........+..+-|.+|.|||++. ...|+...||||.||||
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~ 218 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL 218 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence 542233335567799999999875 56799999999999996
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=271.21 Aligned_cols=189 Identities=22% Similarity=0.308 Sum_probs=158.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|+....+|.|++|.|+.+ ....+++.||||++... .......+.+|+.++..++||+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 62 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLV-------------------QKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62 (360)
T ss_pred CceEEEEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCC
Confidence 4677777888888766543 55567899999999753 2334567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..+..+++||||+++++|.+++. +...+++..++.++.||+.||+|||+.| |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~ 136 (360)
T cd05627 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDA 136 (360)
T ss_pred EeeEEEEEEcCCEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECC
Confidence 9999999999999999999999999999883 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCc---------------------------------cccccccccccccccccccccCCCcee
Q 012989 396 EMNPKISDFGMARIFSGNQN---------------------------------EANTNRVVGTYGYMAPEYAMEGVFSVN 442 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~ 442 (452)
++++||+|||+++.+..... .......+||+.|+|||++.+..++.+
T Consensus 137 ~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 216 (360)
T cd05627 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL 216 (360)
T ss_pred CCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc
Confidence 99999999999875432110 001123579999999999999999999
Q ss_pred eeeeeeeeeC
Q 012989 443 RMFLVSEFFF 452 (452)
Q Consensus 443 ~DvwSlG~il 452 (452)
+|||||||+|
T Consensus 217 ~DiwSlGvil 226 (360)
T cd05627 217 CDWWSLGVIM 226 (360)
T ss_pred ceecccccee
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=266.04 Aligned_cols=179 Identities=22% Similarity=0.268 Sum_probs=152.7
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
+.|.++.|+......+++.||||++.+. .......+.+|+.+++.++||||+++++.+..++..++||||+++++|.
T Consensus 4 G~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~ 83 (328)
T cd05593 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF 83 (328)
T ss_pred eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHH
Confidence 3445566666677788999999999754 2334567889999999999999999999999999999999999999998
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 84 ~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~ 155 (328)
T cd05593 84 FHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTF 155 (328)
T ss_pred HHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccc
Confidence 8873 3456899999999999999999999999 9999999999999999999999999987532221 122345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil 185 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHH
Confidence 789999999999988999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=267.43 Aligned_cols=184 Identities=23% Similarity=0.307 Sum_probs=157.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+....+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.+++.++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 62 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLV-------------------RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62 (291)
T ss_pred CceeeeeeecCCCeEEEEE-------------------EEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCc
Confidence 4667777777777666544 455678999999987542 234566889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+.++...++||||+++++|.+++. ....+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~ 136 (291)
T cd05612 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDK 136 (291)
T ss_pred HhhhHhhhccCCeEEEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECC
Confidence 9999999999999999999999999999884 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 137 ~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 188 (291)
T cd05612 137 EGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188 (291)
T ss_pred CCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 999999999998865332 2235689999999999988899999999999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=271.80 Aligned_cols=188 Identities=22% Similarity=0.284 Sum_probs=158.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.+|++...+|.|++|.|+.+ ....+++.+|+|++.+. .....+.+.+|+.+++.++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp 103 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLV-------------------RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103 (370)
T ss_pred HHCeEEEEEEecCCeEEEEE-------------------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCC
Confidence 57888888999998777644 45567899999998753 223345688999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..+...++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~ 176 (370)
T cd05621 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLD 176 (370)
T ss_pred CEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEC
Confidence 999999999999999999999999999998832 35889999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccC----CCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG----VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++....... ........||+.|+|||++.+. .++.++||||+||+|
T Consensus 177 ~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~il 237 (370)
T cd05621 177 KHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred CCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHH
Confidence 99999999999998754322 1122345799999999998653 378999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=270.22 Aligned_cols=189 Identities=23% Similarity=0.346 Sum_probs=161.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++...+|.|++|.|+.+ ....+++.||||++.+.. ......+.+|+.+++.++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~ 62 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLV-------------------RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62 (350)
T ss_pred CceEEEEEEeCCcEEEEEE-------------------EECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCC
Confidence 6888888888888777654 455579999999997542 244567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..+++.++||||+++++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~ 136 (350)
T cd05573 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDA 136 (350)
T ss_pred ccchhhheecCCeEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECC
Confidence 99999999999999999999999999998843 357999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCC---------------------------ccccccccccccccccccccccCCCceeeeeeee
Q 012989 396 EMNPKISDFGMARIFSGNQ---------------------------NEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVS 448 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 448 (452)
++.+||+|||++....... .........||+.|+|||++.+..++.++|||||
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 216 (350)
T cd05573 137 DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216 (350)
T ss_pred CCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEec
Confidence 9999999999997654332 0112234578999999999999999999999999
Q ss_pred eeeC
Q 012989 449 EFFF 452 (452)
Q Consensus 449 G~il 452 (452)
||+|
T Consensus 217 G~il 220 (350)
T cd05573 217 GVIL 220 (350)
T ss_pred chhh
Confidence 9986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=264.09 Aligned_cols=178 Identities=22% Similarity=0.265 Sum_probs=152.4
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|.++.|+......+++.||+|++.+. .......+.+|+.++++++||||+++++.+...+..++||||+++++|.+
T Consensus 3 ~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 82 (312)
T cd05585 3 KGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH 82 (312)
T ss_pred cCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHH
Confidence 345566666677778999999998753 23445678899999999999999999999999999999999999999998
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......
T Consensus 83 ~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 83 HLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 884 3456899999999999999999999999 9999999999999999999999999987543222 1233457
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+.|+|||++.+..++.++|||||||+|
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil 183 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLL 183 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHH
Confidence 89999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=261.59 Aligned_cols=187 Identities=25% Similarity=0.370 Sum_probs=157.0
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i 316 (452)
|+....+|.|++|.|+ ......+++.||+|.+.... ......+.+|+.++++++|++|
T Consensus 2 f~~~~~lg~G~~g~V~-------------------~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i 62 (285)
T cd05631 2 FRHYRVLGKGGFGEVC-------------------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV 62 (285)
T ss_pred ceEEEEEecCCCEEEE-------------------EEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcE
Confidence 5566677777776555 44566789999999987542 2233467899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..++..++||||+++++|...+... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~ 138 (285)
T cd05631 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDR 138 (285)
T ss_pred EEEEEEEccCCeEEEEEEecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCC
Confidence 99999999999999999999999998777432 2346899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++....... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 139 ~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil 191 (285)
T cd05631 139 GHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLI 191 (285)
T ss_pred CCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHH
Confidence 999999999998654322 12345789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=263.58 Aligned_cols=178 Identities=22% Similarity=0.258 Sum_probs=150.4
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|.++.|+...+..+++.||+|++.+. .......+.+|+++++.++||||+++++.+..++..++||||+++++|..
T Consensus 5 ~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 84 (325)
T cd05594 5 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFF 84 (325)
T ss_pred eCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 344455556667778999999999764 23345667889999999999999999999999999999999999999988
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
++. ....+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 ~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~ 156 (325)
T cd05594 85 HLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTF 156 (325)
T ss_pred HHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccc
Confidence 873 34568999999999999999999997 67 9999999999999999999999999987533221 112335
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|||||||+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il 186 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 186 (325)
T ss_pred cCCcccCCHHHHccCCCCCcccccccccee
Confidence 789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=265.71 Aligned_cols=178 Identities=22% Similarity=0.264 Sum_probs=151.1
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|.++.|+......+++.||+|++... .......+.+|+.+++.++||||+++++.+...+..++||||+++++|..
T Consensus 5 ~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 84 (323)
T cd05595 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 84 (323)
T ss_pred eCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHH
Confidence 344555666667778999999999754 23345567889999999999999999999999999999999999999988
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......
T Consensus 85 ~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~ 156 (323)
T cd05595 85 HLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFC 156 (323)
T ss_pred HHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccccc
Confidence 773 3456899999999999999999999999 9999999999999999999999999987532221 1223457
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+.|+|||++.+..++.++|||||||+|
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil 185 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHH
Confidence 89999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=257.92 Aligned_cols=191 Identities=22% Similarity=0.284 Sum_probs=160.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
++++...+|.|..|+|| +++...++..+|+|++.+. ......+...|-+||+.++||.
T Consensus 78 ~f~llk~LG~GdiG~Vy-------------------L~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPF 138 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVY-------------------LVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPF 138 (459)
T ss_pred HHHHHHHcCCCCceeEE-------------------EEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCc
Confidence 55666667777776665 4556667799999999876 3455667888999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
++.||..|+.++..||+||||+||+|+.+.+. +.++.|++..++.++.+++-||+|||-.| ||.|||||+||||.+
T Consensus 139 lPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvre 214 (459)
T KOG0610|consen 139 LPTLYASFETDKYSCLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVRE 214 (459)
T ss_pred cchhhheeeccceeEEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEec
Confidence 99999999999999999999999999987754 56778999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccC----------------------------------CC--------------------ccccccc
Q 012989 396 EMNPKISDFGMARIFSG----------------------------------NQ--------------------NEANTNR 421 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~----------------------------------~~--------------------~~~~~~~ 421 (452)
+|++.|+||.++..... .+ .....+.
T Consensus 215 dGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnS 294 (459)
T KOG0610|consen 215 DGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNS 294 (459)
T ss_pred CCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccc
Confidence 99999999998743210 00 0012345
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||-.|.|||++.+...+.+.|+|+||++|
T Consensus 295 FVGThEYlAPEvI~G~GHgsAVDWWtfGIfl 325 (459)
T KOG0610|consen 295 FVGTHEYLAPEVIRGEGHGSAVDWWTFGIFL 325 (459)
T ss_pred cccccccccceeeecCCCCchhhHHHHHHHH
Confidence 7999999999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=269.52 Aligned_cols=198 Identities=24% Similarity=0.356 Sum_probs=158.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
-||++.+.+|.|++|.||.+.... .....+++.||||++.... ....+.+.+|+.+++.+ +|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~--------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 72 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFG--------------IDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEec--------------cCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcc
Confidence 478889999999999988663100 0112346789999987542 33456789999999999 8999
Q ss_pred ccceeeeEecC-CeEEEEEEecCCCChhhhhccCCC--------------------------------------------
Q 012989 316 LVRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDSTK-------------------------------------------- 350 (452)
Q Consensus 316 iv~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~~-------------------------------------------- 350 (452)
|+++++.+... ..+++||||+++++|.+++.....
T Consensus 73 iv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (338)
T cd05102 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPS 152 (338)
T ss_pred eeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccc
Confidence 99999988764 468999999999999988854211
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCc
Q 012989 351 ---------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415 (452)
Q Consensus 351 ---------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 415 (452)
...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 153 TSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred cCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc
Confidence 135888899999999999999999999 99999999999999999999999999986543322
Q ss_pred cccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 416 EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 416 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
........+++.|+|||++.+..++.++|||||||+|
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 266 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 266 (338)
T ss_pred hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHH
Confidence 2222234557889999999988999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=266.76 Aligned_cols=189 Identities=23% Similarity=0.313 Sum_probs=159.8
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l 311 (452)
...-.|+....+|.|++|.|+.+.. ...++..||+|++.+. .....+.+.+|+.+++.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~------------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l 88 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATY------------------KNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEE------------------ECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC
Confidence 3455788888889999887775421 1123468999998654 233456788999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++...+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 89 ~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NI 162 (340)
T PTZ00426 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENL 162 (340)
T ss_pred CCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHE
Confidence 99999999999999999999999999999999884 3456899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++++||+|||+++..... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 163 Ll~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 218 (340)
T PTZ00426 163 LLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218 (340)
T ss_pred EECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHH
Confidence 9999999999999999765321 2345789999999999988899999999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=263.50 Aligned_cols=209 Identities=25% Similarity=0.343 Sum_probs=164.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.||+..+.+|.|++|.|+.+.......... ..+.......++..||||.+... ......++.+|+.++++++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~---~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPT---LQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCccccc---ccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 378888899999999999775432211111 01111112234568999998765 33345679999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST----------------KGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
+++++++...+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--- 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--- 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 999999999999999999999999988874321 1134788899999999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||++|
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 230 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence 999999999999999999999999999865443322223334567899999999888999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=278.73 Aligned_cols=193 Identities=20% Similarity=0.224 Sum_probs=163.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecC-CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILAD-GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~-~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+|++...+|.|++|.++.+ ....+ ++.||+|.+..........+.+|+.+++.++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a-------------------~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpni 127 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVA-------------------TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGI 127 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEE-------------------EEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE
Confidence 35888888999998877655 33334 67899998766655555678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
+++++.+..++..+|||||+++++|.+++... .....+++.++..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 128 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~ 204 (478)
T PTZ00267 128 VKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMP 204 (478)
T ss_pred eEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECC
Confidence 99999999999999999999999998877432 23456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||+|
T Consensus 205 ~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l 261 (478)
T PTZ00267 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261 (478)
T ss_pred CCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHH
Confidence 999999999999876544332334456799999999999999999999999999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=269.88 Aligned_cols=176 Identities=30% Similarity=0.406 Sum_probs=153.3
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
.++.|++|.|+++.+..+.+.||||++.-. +...++++++|+.+|++|+|||++.+.++|......|||||||-| +
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-S 111 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-S 111 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-c
Confidence 345566677778889999999999999754 445578899999999999999999999999999999999999966 5
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
-.+++. ...+++.+-++..|..+.+.||.|||+++ .||||||..|||+++.|.|||+|||.+.... ..+
T Consensus 112 AsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAn 180 (948)
T KOG0577|consen 112 ASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA------PAN 180 (948)
T ss_pred HHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC------chh
Confidence 556552 23467899999999999999999999999 9999999999999999999999999997643 346
Q ss_pred ccccccccccccccc---cCCCceeeeeeeeeee
Q 012989 421 RVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFF 451 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~i 451 (452)
.++|||.|||||+++ .+.|+.|.||||||+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGIT 214 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccch
Confidence 789999999999985 5889999999999985
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=263.66 Aligned_cols=189 Identities=23% Similarity=0.320 Sum_probs=158.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++...+|.|++|.|+.+ ....+++.||||+++... ....+.+.+|+.+++.++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~ 62 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVV-------------------REKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62 (330)
T ss_pred CceEEEEEEeccCEEEEEE-------------------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCC
Confidence 4777778888888766644 455688999999997642 234566889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~ 137 (330)
T cd05601 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDR 137 (330)
T ss_pred CcceeeEEecCCeEEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECC
Confidence 999999999999999999999999999988432 356999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccc------cCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM------EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++..+...... ......||+.|+|||++. ...++.++|||||||||
T Consensus 138 ~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 138 TGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred CCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 999999999999876443222 222347899999999986 45678999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=265.22 Aligned_cols=187 Identities=25% Similarity=0.393 Sum_probs=164.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..|...+++|.|.||.||++ .+..+++.||||++... .....+.+.+|+.+|.+++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~-------------------~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~i 73 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKA-------------------IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNI 73 (467)
T ss_pred cccccchhccccccceeeee-------------------eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchH
Confidence 45666677888888777766 45678999999999876 45557889999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
.++|+.+..+..+|++|||+.||++.+.+ +.+..+++.++..|+++++.||.|||.++ .+|||||+.|||+..+
T Consensus 74 t~yygsyl~g~~LwiiMey~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 74 TEYYGSYLKGTKLWIIMEYCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSES 147 (467)
T ss_pred HhhhhheeecccHHHHHHHhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEecc
Confidence 99999999999999999999999999988 44555688999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
|.+||.|||.+.......... ..++||+.|||||++....|+.|+||||||+.
T Consensus 148 g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGIT 200 (467)
T KOG0201|consen 148 GDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGIT 200 (467)
T ss_pred CcEEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHH
Confidence 999999999998766544333 56899999999999998899999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=259.98 Aligned_cols=180 Identities=24% Similarity=0.353 Sum_probs=156.5
Q ss_pred CCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 265 GSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 265 ~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
++.|.+|.|+-..+.++|+.||||+|.+. .++....+.+|+.||+++.||.||.+.-.|++.+.+++|||-+.|.-|+
T Consensus 572 LGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLE 651 (888)
T KOG4236|consen 572 LGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLE 651 (888)
T ss_pred ccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHH
Confidence 45556666666678889999999999865 3445578999999999999999999999999999999999999887777
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC---CCeeEccccccccccCCCccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMARIFSGNQNEANT 419 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~ 419 (452)
.++ ....+++++...+.++.||+.||.|||-++ |+|+||||+|||+... ..+||+|||+|++++...- .
T Consensus 652 MIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---R 723 (888)
T KOG4236|consen 652 MIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---R 723 (888)
T ss_pred HHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh---h
Confidence 776 345567999999999999999999999999 9999999999999765 4599999999999865443 3
Q ss_pred cccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 420 NRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 420 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
...+|||.|.|||++++..|...-|+||.|+|+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIi 756 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVII 756 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEE
Confidence 456999999999999999999999999999984
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=267.40 Aligned_cols=188 Identities=23% Similarity=0.277 Sum_probs=157.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|++...+|.|++|.|+.+ ....+++.+|+|++.+. .......+.+|+.+++.++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~-------------------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp 103 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLV-------------------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103 (371)
T ss_pred hhcEEEEEEeecCCeEEEEE-------------------EECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCC
Confidence 57888888888888776644 55668899999998653 223345678999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..+...++||||+++++|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~ 176 (371)
T cd05622 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD 176 (371)
T ss_pred CCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEC
Confidence 999999999999999999999999999998832 34889999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccC----CCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG----VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlG~il 452 (452)
.++++||+|||+++....... .......||+.|+|||++.+. .++.++|||||||+|
T Consensus 177 ~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvil 237 (371)
T cd05622 177 KSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (371)
T ss_pred CCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHH
Confidence 999999999999986543221 122345799999999998653 378999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-33 Score=253.64 Aligned_cols=195 Identities=28% Similarity=0.369 Sum_probs=162.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecC--CeeeEEEEeecCC--cccHHHHHHHHHHHHcCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILAD--GKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~--~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~ 312 (452)
...||...++|.|.+|.||++.. ....+ .+.+|||+++... +.......+|+.+++.|+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~-----------------~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~ 85 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVR-----------------KNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK 85 (438)
T ss_pred HHHhhccceecccccceeeEeee-----------------ccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc
Confidence 45788999999999999998732 11223 3489999997652 233466789999999999
Q ss_pred CCCccceeeeEec-CCeEEEEEEecCCCChhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 313 HKNLVRLLGCCLD-GNELLLIYEYMPNKSLDLFLFDST--KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 313 h~~iv~l~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
||||+.+..+|.. +...||++||.+. +|..+++... +.+.++...++.|+.||+.|+.|||++. |+||||||.
T Consensus 86 h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPa 161 (438)
T KOG0666|consen 86 HPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPA 161 (438)
T ss_pred CCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcc
Confidence 9999999999887 7789999999987 6766665432 3467999999999999999999999998 999999999
Q ss_pred CeEECCC----CCeeEccccccccccCCCcc-ccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 390 NVLLDHE----MNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~----~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|||+..+ |.+||+|||+++.+.+.-.. ......+-|.+|+|||++++. .|+.+.|||+.||||
T Consensus 162 NIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 162 NILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF 230 (438)
T ss_pred eEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence 9999877 88999999999998766433 245556779999999999874 589999999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=267.03 Aligned_cols=188 Identities=22% Similarity=0.284 Sum_probs=157.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|+....+|.|++|.|+.+ ....+++.||+|++.+. .......+.+|+.+++.++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~ 103 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLV-------------------RHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCC
Confidence 47888888888888776644 45567899999999753 223345678999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..+...++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~ 176 (370)
T cd05596 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLD 176 (370)
T ss_pred CcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEc
Confidence 999999999999999999999999999998832 35889999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccC----CCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG----VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||+|
T Consensus 177 ~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvil 237 (370)
T cd05596 177 KSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred CCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHH
Confidence 999999999999976543221 122345789999999998643 478999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=242.33 Aligned_cols=196 Identities=26% Similarity=0.333 Sum_probs=164.4
Q ss_pred cEEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHH
Q 012989 229 GRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEV 305 (452)
Q Consensus 229 ~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~ 305 (452)
.+....+---+||+...+|.|.||. |+..+..+++..||+|++.+. ..+-..++.+|+
T Consensus 13 ~~~~~~~~l~dfeigr~LgkgkFG~-------------------vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREi 73 (281)
T KOG0580|consen 13 SRATKTWTLDDFEIGRPLGKGKFGN-------------------VYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREI 73 (281)
T ss_pred cccccccchhhccccccccCCcccc-------------------EeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhhee
Confidence 3334444445566666666666654 445566778999999999765 233456789999
Q ss_pred HHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 012989 306 TLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385 (452)
Q Consensus 306 ~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~D 385 (452)
+|-..|+||||.++|++|.+....||++||.++|.+...+.+ .....+++.....+++|++.||.|+|..+ +||||
T Consensus 74 EIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRd 149 (281)
T KOG0580|consen 74 EIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRD 149 (281)
T ss_pred EeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCC
Confidence 999999999999999999999999999999999999988854 35667999999999999999999999998 99999
Q ss_pred CCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 386 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
|||+|+|++.++.+||+|||.+..-. .......+||..|.+||+..+...+.+.|+|++|++
T Consensus 150 iKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl 211 (281)
T KOG0580|consen 150 IKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVL 211 (281)
T ss_pred CCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHH
Confidence 99999999999999999999987643 223445799999999999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=262.33 Aligned_cols=191 Identities=22% Similarity=0.288 Sum_probs=158.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC----CcccHHHHHHHHHHHHcC-CC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS----SGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~~E~~~l~~l-~h 313 (452)
.|++.+.+|.|++|.||.+.. .....+++.||+|++.+. .....+.+.+|+.+++.+ +|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~----------------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 64 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRK----------------VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQS 64 (332)
T ss_pred CceEEEEEeecCCEEEEEEEE----------------cccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCC
Confidence 377888999999988875421 112346889999998753 223345688899999999 59
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|+|+++++.+...+..++||||+++++|.+++. ....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 65 ~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili 138 (332)
T cd05614 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILL 138 (332)
T ss_pred CCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEE
Confidence 999999999999999999999999999988883 3456899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||+|
T Consensus 139 ~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 197 (332)
T cd05614 139 DSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI 197 (332)
T ss_pred CCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhh
Confidence 9999999999999986543322 122345789999999998765 478899999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=259.29 Aligned_cols=179 Identities=23% Similarity=0.289 Sum_probs=148.7
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHH-HHHcCCCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVT-LIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.|.++.|+......+++.+|||++.+. .......+..|.. +++.++||||+++++.+...+..++||||+++++|
T Consensus 4 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 83 (325)
T cd05604 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83 (325)
T ss_pred eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCH
Confidence 3445566666677788999999998754 2233345555654 56778999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
..++. ....+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 84 ~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (325)
T cd05604 84 FFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTT 155 (325)
T ss_pred HHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCccc
Confidence 88773 4456999999999999999999999999 9999999999999999999999999987532211 12234
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 186 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVL 186 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCcccccccee
Confidence 5789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=247.70 Aligned_cols=187 Identities=24% Similarity=0.340 Sum_probs=160.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-.|++.+.+|+|+|+.|++.. +..+|+.+|+|+++.. +..+.+.+.+|++|-+.|+|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~-------------------~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~ 71 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCV-------------------HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 71 (355)
T ss_pred hhhhHHHHHccCchHHHHHHH-------------------hccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCc
Confidence 357777889999998887653 3357899999988744 4457789999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..|||+|+++|+.|-.-+ .....+++..+-.+++||+++|.|+|.++ |||||+||+|+|+-.
T Consensus 72 IvrL~~ti~~~~~~ylvFe~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLAS 145 (355)
T KOG0033|consen 72 IVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLAS 145 (355)
T ss_pred EeehhhhhcccceeEEEEecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeee
Confidence 999999999999999999999999985444 22355889999999999999999999999 999999999999965
Q ss_pred CCC---eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMN---PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..+ +||+|||++..+. .......++|||.|||||++...+|+..+|||+-|+||
T Consensus 146 K~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViL 202 (355)
T KOG0033|consen 146 KAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 202 (355)
T ss_pred ccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHH
Confidence 543 9999999998876 33345567999999999999999999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=257.80 Aligned_cols=188 Identities=22% Similarity=0.373 Sum_probs=158.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|++...+|.|++|.|+.+ ....+++.||+|++... .....+.+.+|+.+++.++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 62 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKC-------------------RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62 (287)
T ss_pred CceEEEEecccCCEEEEEE-------------------EECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccc
Confidence 6788888888888766644 45567899999998754 23345678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..++..++||||++++++..+. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~ 136 (287)
T cd07848 63 VELKEAFRRRGKLYLVFEYVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHN 136 (287)
T ss_pred cchhhhEecCCEEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC
Confidence 99999999999999999999998777654 23356899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ .......||+.|+|||++.+..++.++|||||||+|
T Consensus 137 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil 191 (287)
T cd07848 137 DVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191 (287)
T ss_pred CcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHH
Confidence 9999999999987543221 122335789999999999988899999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=260.78 Aligned_cols=189 Identities=20% Similarity=0.259 Sum_probs=157.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++.+.+|.|++|.|+.+ ....+++.||+|++.+. .......+.+|+.++..++|++
T Consensus 2 ~y~i~~~lG~G~fg~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~ 62 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVV-------------------KMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62 (331)
T ss_pred CceEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCC
Confidence 5777888888888766543 45567899999998753 2233455888999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..|+||||+++++|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~ 137 (331)
T cd05624 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDM 137 (331)
T ss_pred EeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcC
Confidence 99999999999999999999999999999843 2346899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc-----CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+...... ......||+.|+|||++.+ +.++.++||||||++|
T Consensus 138 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil 198 (331)
T cd05624 138 NGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCM 198 (331)
T ss_pred CCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhh
Confidence 999999999999765433221 1223578999999999865 5688999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=260.33 Aligned_cols=178 Identities=22% Similarity=0.314 Sum_probs=150.8
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.|.++.|+......+++.||||++++. .......+..|..+++.+ +||||+++++.+...+.+++||||+++++|.
T Consensus 5 ~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~ 84 (329)
T cd05588 5 RGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLM 84 (329)
T ss_pred eCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHH
Confidence 344556666677778999999999864 233445688999999998 7999999999999999999999999999998
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.++. +...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 85 ~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 156 (329)
T cd05588 85 FHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTF 156 (329)
T ss_pred HHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccc
Confidence 8773 3456999999999999999999999999 999999999999999999999999998742211 1223345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|+|||||+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 186 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLM 186 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHH
Confidence 789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=271.12 Aligned_cols=191 Identities=24% Similarity=0.368 Sum_probs=164.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+.-|+..+++|.|++|.|+.. ++..+|+.||||.+.+. .....+...+|+++|++|+|+|
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rg-------------------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~N 72 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRG-------------------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPN 72 (732)
T ss_pred CcceeehhhhcCCccceeeee-------------------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchh
Confidence 345666777888888777755 45678999999999875 4556788899999999999999
Q ss_pred ccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
||+++++=++. ....+|||||.||+|...+..++....|++.+++.++..+..||.|||++| |+||||||+
T Consensus 73 IVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~ 149 (732)
T KOG4250|consen 73 IVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPG 149 (732)
T ss_pred hhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCC
Confidence 99999986644 468999999999999999998888899999999999999999999999999 999999999
Q ss_pred CeEEC--CCCC--eeEccccccccccCCCccccccccccccccccccccc-cCCCceeeeeeeeeeeC
Q 012989 390 NVLLD--HEMN--PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~--~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
||++- .+|+ -||+|||.|+..+++. .....+||..|.+||++. .+.|+...|.|||||+|
T Consensus 150 NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvtl 214 (732)
T KOG4250|consen 150 NIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTL 214 (732)
T ss_pred cEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHH
Confidence 99984 3333 7999999999876655 455689999999999998 48899999999999975
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=264.15 Aligned_cols=192 Identities=24% Similarity=0.338 Sum_probs=165.3
Q ss_pred EccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc---ccHHHHHHHHHHH
Q 012989 232 RYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG---QGLQEFKNEVTLI 308 (452)
Q Consensus 232 ~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~E~~~l 308 (452)
....+..+|++...+|.|.||.|+.+ ....+|+.+|+|.+.+... ...+.+.+|+.+|
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~-------------------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il 89 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLC-------------------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAIL 89 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEE-------------------EecCCCceeEEEEeehhhccccccHHHHHHHHHHH
Confidence 34556667888888888888766644 5566799999999987643 2456899999999
Q ss_pred HcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 309 AKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 309 ~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
++++ |||||.+++.|++....++|||++.||.|.+.+... .+++..+..+++|++.++.|||+.| |+|||||
T Consensus 90 ~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlK 162 (382)
T KOG0032|consen 90 QQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLK 162 (382)
T ss_pred HhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCC
Confidence 9998 999999999999999999999999999998888543 3999999999999999999999999 9999999
Q ss_pred CCCeEECCC----CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHE----MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~----~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|+|+... +.+|++|||++..... .......+||+.|+|||++....|+..+||||+|+|+
T Consensus 163 pEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~ 228 (382)
T KOG0032|consen 163 PENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVIL 228 (382)
T ss_pred HHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHH
Confidence 999999644 4699999999988755 3345567999999999999999999999999999974
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=261.17 Aligned_cols=189 Identities=20% Similarity=0.284 Sum_probs=157.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++...+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|+.+++.++|+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~ 62 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVV-------------------KMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62 (331)
T ss_pred CceEEEEEEecCCeEEEEE-------------------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCC
Confidence 5777888888888766643 55567899999998753 2234456889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..+++.++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~ 137 (331)
T cd05597 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDK 137 (331)
T ss_pred CCceEEEEecCCeEEEEEecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECC
Confidence 99999999999999999999999999998843 2456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc-----CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++..+...... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l 198 (331)
T cd05597 138 NGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCM 198 (331)
T ss_pred CCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHH
Confidence 999999999998765433221 1223468999999999863 4578899999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=259.51 Aligned_cols=179 Identities=23% Similarity=0.322 Sum_probs=150.6
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.|.++.|+......+++.||+|++++. .......+.+|+.++.++ +||||+++++.+...+..++||||+++++|
T Consensus 4 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L 83 (329)
T cd05618 4 GRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83 (329)
T ss_pred eeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCH
Confidence 3444555666677778999999999864 233445678899988877 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 84 ~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (329)
T cd05618 84 MFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST 155 (329)
T ss_pred HHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence 88773 3456999999999999999999999999 9999999999999999999999999987532211 12234
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 186 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLM 186 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHH
Confidence 5789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=258.99 Aligned_cols=178 Identities=24% Similarity=0.334 Sum_probs=147.9
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.|.+|.|+......+++.||||+++.. .....+.+..|..++..+ +||||+++++.+..+...++||||+++++|.
T Consensus 5 ~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~ 84 (316)
T cd05592 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLM 84 (316)
T ss_pred eCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHH
Confidence 344455555566778899999999754 223345566677777654 8999999999999999999999999999998
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 ~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~ 156 (316)
T cd05592 85 FHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTF 156 (316)
T ss_pred HHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccccc
Confidence 8883 3456899999999999999999999999 9999999999999999999999999997643322 223345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|||||||+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il 186 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLL 186 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHH
Confidence 789999999999998999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=260.89 Aligned_cols=185 Identities=24% Similarity=0.371 Sum_probs=152.3
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHH---cCCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIA---KLQH 313 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~---~l~h 313 (452)
|++...+|.|++|.|+ ......+++.||||++++.. ....+.+.+|++++. .++|
T Consensus 1 y~i~~~lg~G~~g~Vy-------------------~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~h 61 (324)
T cd05589 1 FRCLAVLGRGHFGKVL-------------------LAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61 (324)
T ss_pred CeEEEEEeecCCEEEE-------------------EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCC
Confidence 4556667777776655 44556688999999997542 333456777777664 5679
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++..++..++||||+++++|...+. ...+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 62 p~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill 134 (324)
T cd05589 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLL 134 (324)
T ss_pred CChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEE
Confidence 999999999999999999999999999988773 346999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+|
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il 191 (324)
T cd05589 135 DTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI 191 (324)
T ss_pred CCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHH
Confidence 999999999999987532221 122345789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=258.10 Aligned_cols=179 Identities=25% Similarity=0.333 Sum_probs=150.0
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.|.++.|+......+++.||||++.+. .....+.+..|.++++.+ +||||+++++.+..++..++||||+++++|
T Consensus 4 G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L 83 (321)
T cd05591 4 GKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDL 83 (321)
T ss_pred ccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcH
Confidence 3344455556666778899999999764 233455677899998876 799999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
...+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 84 ~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05591 84 MFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTT 155 (321)
T ss_pred HHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccc
Confidence 88873 3456899999999999999999999999 9999999999999999999999999987543222 12234
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 186 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLM 186 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHH
Confidence 5789999999999988999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=257.80 Aligned_cols=178 Identities=25% Similarity=0.306 Sum_probs=147.4
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHH-HHHcCCCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVT-LIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.|.++.|+......+++.||||++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++++|.
T Consensus 5 ~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 84 (323)
T cd05575 5 KGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELF 84 (323)
T ss_pred eCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHH
Confidence 3445566666777789999999997542 222344555554 567899999999999999999999999999999998
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.++. ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 ~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 156 (323)
T cd05575 85 FHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTF 156 (323)
T ss_pred HHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccccc
Confidence 8883 3456899999999999999999999999 9999999999999999999999999987532221 223345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|||||||+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il 186 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVL 186 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhh
Confidence 789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=257.63 Aligned_cols=178 Identities=24% Similarity=0.285 Sum_probs=146.7
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHH-HHHcCCCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVT-LIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.|.++.|+......+++.||+|++.+.. ......+..|.. +++.++||||+++++.+...+..++||||+++++|.
T Consensus 5 ~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (321)
T cd05603 5 KGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELF 84 (321)
T ss_pred eCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHH
Confidence 3444556566677789999999987542 222344555554 678899999999999999999999999999999998
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
..+. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 85 ~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 156 (321)
T cd05603 85 FHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTF 156 (321)
T ss_pred HHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccccc
Confidence 8773 3456889999999999999999999998 9999999999999999999999999987532221 223345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|||||||+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il 186 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVL 186 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhh
Confidence 789999999999988999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=253.13 Aligned_cols=181 Identities=27% Similarity=0.359 Sum_probs=153.3
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|+++.|+...+..+++.||+|++.+.. ....+.+..|+.+++.++|+||+++++.+..+...++||||+++++|..
T Consensus 3 ~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 82 (280)
T cd05608 3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRY 82 (280)
T ss_pred CCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHH
Confidence 4555667677777889999999987542 2234567889999999999999999999999999999999999999987
Q ss_pred hhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 344 FLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 344 ~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.+... .....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..+..... .....
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 157 (280)
T cd05608 83 HIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGY 157 (280)
T ss_pred HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccccc
Confidence 76432 23456999999999999999999999999 99999999999999999999999999976543322 22335
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++||||||++|
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il 187 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTL 187 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHH
Confidence 789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=257.23 Aligned_cols=165 Identities=27% Similarity=0.359 Sum_probs=142.0
Q ss_pred cCCeeeEEEEeecC----CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCC
Q 012989 280 ADGKEIAVKRLSRS----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLD 355 (452)
Q Consensus 280 ~~~~~vAiK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~ 355 (452)
.+++.||||++++. .......+.+|+.+++.++||||+++++.+..++..++||||+++++|.+++. ....++
T Consensus 22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~ 98 (323)
T cd05584 22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFM 98 (323)
T ss_pred CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH---HcCCCC
Confidence 46889999998753 22334567899999999999999999999999999999999999999988883 345688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccc
Q 012989 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435 (452)
Q Consensus 356 ~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 435 (452)
+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 99 ~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 99 EDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhcc
Confidence 9999999999999999999999 9999999999999999999999999987543222 1223357899999999999
Q ss_pred cCCCceeeeeeeeeeeC
Q 012989 436 EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 436 ~~~~s~~~DvwSlG~il 452 (452)
+..++.++|||||||+|
T Consensus 174 ~~~~~~~~DiwslG~il 190 (323)
T cd05584 174 RSGHGKAVDWWSLGALM 190 (323)
T ss_pred CCCCCCcceecccHHHH
Confidence 88899999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=264.14 Aligned_cols=173 Identities=25% Similarity=0.410 Sum_probs=153.5
Q ss_pred eeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeee
Q 012989 243 YQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 322 (452)
Q Consensus 243 ~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 322 (452)
.+.+|.|..|.|+.+++ .++.||||+++.- =..+|+=|++|+||||+.+.++
T Consensus 129 LeWlGSGaQGAVF~Grl---------------------~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL---------------------HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhhccCcccceeeeec---------------------cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeee
Confidence 45678888888887654 5789999998532 2357888999999999999999
Q ss_pred EecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEc
Q 012989 323 CLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402 (452)
Q Consensus 323 ~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~ 402 (452)
+.....+|||||||..|.|...+ +.+..+.......|..+|+.|+.|||.+. |||||||.-||||..+..+||+
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIs 254 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKIS 254 (904)
T ss_pred ecCCceeEEeeeccccccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEec
Confidence 99999999999999999999999 45677899999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 403 DFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 403 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||-++...+. .....++||..|||||++++.+.+.|.|||||||+|
T Consensus 255 DFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVL 301 (904)
T KOG4721|consen 255 DFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVL 301 (904)
T ss_pred cccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHH
Confidence 99999876544 334568999999999999999999999999999986
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=258.15 Aligned_cols=178 Identities=26% Similarity=0.383 Sum_probs=149.6
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.|.++.|+......+++.||||++.+. .....+.+..|..++..+ +||||+++++.+...+.+++||||+++++|.
T Consensus 5 ~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~ 84 (320)
T cd05590 5 KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM 84 (320)
T ss_pred eCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHH
Confidence 344455556667778999999998754 233456677888888876 7999999999999999999999999999998
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.++. +...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 ~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~ 156 (320)
T cd05590 85 FHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTF 156 (320)
T ss_pred HHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccccc
Confidence 8873 3456999999999999999999999999 9999999999999999999999999987532221 122345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|||||||+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il 186 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLL 186 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHH
Confidence 789999999999988999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=259.48 Aligned_cols=186 Identities=24% Similarity=0.319 Sum_probs=154.7
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC-CC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH-KN 315 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h-~~ 315 (452)
|+....+|.|++|.|+.+ ....+++.||||++.+. .....+.+..|.++++.++| ++
T Consensus 2 y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~ 62 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLA-------------------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62 (324)
T ss_pred ceEEEEEeeccCeEEEEE-------------------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCc
Confidence 566677788887766644 45567889999999754 23445678889999999976 46
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..|+||||+++++|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 136 (324)
T cd05587 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDA 136 (324)
T ss_pred eeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcC
Confidence 8889999999999999999999999988883 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||+|
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (324)
T cd05587 137 EGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (324)
T ss_pred CCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHH
Confidence 9999999999986532211 122345789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=258.74 Aligned_cols=186 Identities=23% Similarity=0.318 Sum_probs=153.9
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcC-CCCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
|+....+|.|++|.|+. .....+++.||||++.+.. ....+.+..|..++..+ +|++
T Consensus 2 f~~~~~lg~G~~g~Vy~-------------------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~ 62 (323)
T cd05616 2 FNFLMVLGKGSFGKVML-------------------AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62 (323)
T ss_pred ceEEEEEeeCCCeEEEE-------------------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCe
Confidence 55666777777766654 3555678899999987642 23345567788888877 5899
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..++||||+++++|...+. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~ 136 (323)
T cd05616 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDS 136 (323)
T ss_pred EeeEEEEEecCCEEEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECC
Confidence 9999999999999999999999999988873 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+|
T Consensus 137 ~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 191 (323)
T cd05616 137 EGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (323)
T ss_pred CCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHH
Confidence 9999999999987543221 122345789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=258.28 Aligned_cols=188 Identities=22% Similarity=0.287 Sum_probs=160.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
--|++.+-+|.|-|.+|-. +++.-+|+.||||++.+.. .-....+.+|++.|+.++|||
T Consensus 18 GLYDLekTlG~GHFAVVKL-------------------ArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpN 78 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKL-------------------ARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPN 78 (864)
T ss_pred eeehhhhhhcCCceehhhh-------------------hhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcC
Confidence 3567777777777755544 4566799999999998763 334567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC-
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD- 394 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~- 394 (452)
||+||++..++..+|||+|+-++|+|.+++.+. ...+.+..+++++.||+.|+.|+|+.. +|||||||+|+++-
T Consensus 79 iVRLYEViDTQTKlyLiLELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFE 153 (864)
T KOG4717|consen 79 IVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFE 153 (864)
T ss_pred eeeeeehhcccceEEEEEEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEee
Confidence 999999999999999999999999999999654 445999999999999999999999998 99999999999775
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCce-eeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV-NRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~~DvwSlG~il 452 (452)
.-|-+||.|||++..|.+.+ ..+..+|++.|-|||++++..|+. +.||||||+||
T Consensus 154 KlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVIL 209 (864)
T KOG4717|consen 154 KLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVIL 209 (864)
T ss_pred ecCceEeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHH
Confidence 45889999999998875543 455679999999999999999965 59999999986
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=256.93 Aligned_cols=178 Identities=24% Similarity=0.277 Sum_probs=146.0
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHH-HHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEV-TLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.|.++.|+......+++.||+|++.+.. ......+..|. .+++.++||||+++++.+...+..++||||+++++|.
T Consensus 5 ~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (325)
T cd05602 5 KGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF 84 (325)
T ss_pred eCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHH
Confidence 3444555566677788999999987542 22223444444 4567889999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.++. ....+++..++.++.||++||+|||++| |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 85 ~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~ 156 (325)
T cd05602 85 YHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTF 156 (325)
T ss_pred HHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccc
Confidence 8883 3456889999999999999999999999 9999999999999999999999999987543221 123345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.||+.|+|||++.+..++.++|||||||+|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il 186 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVL 186 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHH
Confidence 789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=256.38 Aligned_cols=188 Identities=23% Similarity=0.310 Sum_probs=155.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|+....+|.|++|.|+.+ ....+++.||+|++.... ......+.+|+.++++++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 65 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKG-------------------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65 (288)
T ss_pred ccceEeeEEecCCCEEEEEE-------------------EECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCE
Confidence 46888888888888777654 455678999999987543 2334568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++...+..++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~ 139 (288)
T cd07871 66 VTLHDIIHTERCLTLVFEYLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEK 139 (288)
T ss_pred eeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCC
Confidence 9999999999999999999976 78777732 2345789999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++...... .......|++.|+|||++.+ ..++.++||||+||+|
T Consensus 140 ~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 194 (288)
T cd07871 140 GELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 194 (288)
T ss_pred CCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHH
Confidence 999999999987643222 11233467999999999865 5689999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=255.60 Aligned_cols=165 Identities=25% Similarity=0.298 Sum_probs=143.2
Q ss_pred cCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHH
Q 012989 280 ADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWK 357 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~ 357 (452)
.+++.||+|++.+.. ......+.+|++++++++||||+++++.+..++..|+||||+++++|.+++. +...+++.
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~ 98 (318)
T cd05582 22 DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEE 98 (318)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHH
Confidence 468999999997642 2234567889999999999999999999999999999999999999988883 34568999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC
Q 012989 358 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 437 (452)
.++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.
T Consensus 99 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~ 173 (318)
T cd05582 99 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRR 173 (318)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCC
Confidence 99999999999999999999 9999999999999999999999999987653321 122345789999999999888
Q ss_pred CCceeeeeeeeeeeC
Q 012989 438 VFSVNRMFLVSEFFF 452 (452)
Q Consensus 438 ~~s~~~DvwSlG~il 452 (452)
.++.++|||||||+|
T Consensus 174 ~~~~~~DiwslG~il 188 (318)
T cd05582 174 GHTQSADWWSFGVLM 188 (318)
T ss_pred CCCCccceeccceEe
Confidence 899999999999985
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=266.80 Aligned_cols=182 Identities=18% Similarity=0.258 Sum_probs=154.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.+|++.+.+|.|++|.|+.+ .+..+++.||||.... ..+.+|++++++|+||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~-------------------~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv 146 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFAC-------------------IDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSII 146 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEE-------------------EECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCC
Confidence 46999999999998777644 5667899999997532 3578899999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++..+...++|||++. ++|..++. ....+++.+++.|+.||+.||.|||+++ |+||||||+|||++.++
T Consensus 147 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~ 219 (391)
T PHA03212 147 QLKGTFTYNKFTCLILPRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPG 219 (391)
T ss_pred CEeEEEEECCeeEEEEecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCC
Confidence 99999999999999999995 57776663 3356899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||+|
T Consensus 220 ~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 273 (391)
T PHA03212 220 DVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVL 273 (391)
T ss_pred CEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHH
Confidence 99999999987533221 1122345799999999999998999999999999975
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=257.60 Aligned_cols=188 Identities=24% Similarity=0.309 Sum_probs=153.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++.... ......+.+|+.+++.++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 65 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKG-------------------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65 (303)
T ss_pred ccceEeeeEEecCCEEEEEE-------------------EECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCc
Confidence 46777888888888766644 455678999999987543 2233567889999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~ 139 (303)
T cd07869 66 VLLHDIIHTKETLTLVFEYVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDT 139 (303)
T ss_pred CeEEEEEecCCeEEEEEECCCc-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 9999999999999999999965 66555532 3356899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++||||+||+|
T Consensus 140 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 194 (303)
T cd07869 140 GELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIF 194 (303)
T ss_pred CCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHH
Confidence 999999999987543221 12233567999999999865 4578899999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=262.16 Aligned_cols=188 Identities=23% Similarity=0.361 Sum_probs=153.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
||++...+|.|++|.|+.+ .+..+++.||||++... ......++.+|+.++++++||||
T Consensus 1 ry~i~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 61 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSA-------------------IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61 (338)
T ss_pred CeEEEEEEeecCCeEEEEE-------------------EECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCE
Confidence 6888888888888776644 45568899999998743 22344568899999999999999
Q ss_pred cceeeeEecC-----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 317 VRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 317 v~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+++++++... ...++||||++ ++|.+++. ....+++..++.++.||++||.|||+++ |+||||||+||
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 134 (338)
T cd07859 62 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNI 134 (338)
T ss_pred eeecceEeccCCCCCceEEEEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHe
Confidence 9999987643 35899999995 57887773 3456999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCcc-cccccccccccccccccccc--CCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 135 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl 198 (338)
T cd07859 135 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 198 (338)
T ss_pred EECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence 9999999999999999764332211 12234578999999999865 6789999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=257.72 Aligned_cols=179 Identities=23% Similarity=0.328 Sum_probs=151.8
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.|.++.|+......+++.||+|++.+. .....+.+.+|+.++.++ +||+|+++++.+...+.+++||||+++++|
T Consensus 4 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 83 (327)
T cd05617 4 GRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83 (327)
T ss_pred eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcH
Confidence 3445566666677788999999999864 233456688999999888 699999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 84 ~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (327)
T cd05617 84 MFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTST 155 (327)
T ss_pred HHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceec
Confidence 88773 3456999999999999999999999999 999999999999999999999999998753221 112234
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 186 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLM 186 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHH
Confidence 5789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=261.74 Aligned_cols=187 Identities=25% Similarity=0.379 Sum_probs=160.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-|.+.+-+|.|.++.|. ...+..++..||||.+++. +....+.+.+|+++|+.|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~-------------------La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPn 116 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVK-------------------LARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPN 116 (596)
T ss_pred cceeeeeeeccceeEEEE-------------------eeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcc
Confidence 345555666666665444 5567778999999999876 3444566889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
||+++.+.+.+..+|+||||+.++.+.+++. +.....+.++..++.|++++++|||+++ |||||||.+|||++.
T Consensus 117 Ivkl~~v~~t~~~lylV~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~ 190 (596)
T KOG0586|consen 117 IVKLFSVIETEATLYLVMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDE 190 (596)
T ss_pred eeeeeeeeeecceeEEEEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhccccc
Confidence 9999999999999999999999999999994 4555777999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
+.++||+|||++..+... .....++|++.|+|||++.+..| .+.+|+||+|++|
T Consensus 191 ~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvl 245 (596)
T KOG0586|consen 191 NMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVL 245 (596)
T ss_pred ccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhh
Confidence 999999999999988633 33456799999999999998887 5679999999986
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=258.97 Aligned_cols=186 Identities=23% Similarity=0.338 Sum_probs=154.1
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCC-CCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQ-HKN 315 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~ 315 (452)
|+....+|.|++|.|+ ......+++.||||++.+. .....+.+..|..+++.+. |++
T Consensus 2 f~~~~~lg~G~~g~Vy-------------------~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~ 62 (323)
T cd05615 2 FNFLMVLGKGSFGKVM-------------------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62 (323)
T ss_pred ceEEEEEEecCCeEEE-------------------EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCc
Confidence 4556667777776655 4455668999999998754 2334456788999998885 577
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..++||||+++++|..++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~ 136 (323)
T cd05615 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDS 136 (323)
T ss_pred hhheeeEEecCCEEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECC
Confidence 8899999999999999999999999988883 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+|
T Consensus 137 ~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (323)
T cd05615 137 EGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191 (323)
T ss_pred CCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHH
Confidence 9999999999987543221 122345689999999999988999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=242.95 Aligned_cols=168 Identities=29% Similarity=0.425 Sum_probs=145.2
Q ss_pred EEEecCCeeeEEEEeecCC-----cc---cHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhhhc
Q 012989 276 QGILADGKEIAVKRLSRSS-----GQ---GLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLF 346 (452)
Q Consensus 276 ~~~~~~~~~vAiK~~~~~~-----~~---~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~ 346 (452)
+-+..++.++|+|++.... +. -.+.-.+|+.||+++ .||+|+++.++++++...++|+|.++.|.|.+++
T Consensus 36 ci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL- 114 (411)
T KOG0599|consen 36 CIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL- 114 (411)
T ss_pred hhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh-
Confidence 3455688999999987432 11 134456899999998 6999999999999999999999999999999999
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccc
Q 012989 347 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 347 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
...-.+++.+...|++||+++++|||.++ ||||||||+|||++++.++||+|||+++.+..+. .....+|||
T Consensus 115 --ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTP 186 (411)
T KOG0599|consen 115 --TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTP 186 (411)
T ss_pred --hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCC
Confidence 45567999999999999999999999999 9999999999999999999999999999875443 345579999
Q ss_pred ccccccccc------cCCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAM------EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~------~~~~s~~~DvwSlG~il 452 (452)
+|.|||.+. ...|+...|+|+.|+|+
T Consensus 187 gYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 187 GYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred cccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 999999984 45588889999999985
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=259.07 Aligned_cols=187 Identities=22% Similarity=0.292 Sum_probs=159.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...+|.|++|.|+.+ ....++..+|+|.+... .....+.+.+|++++++++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 65 (331)
T cd06649 5 DDFERISELGAGNGGVVTKV-------------------QHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65 (331)
T ss_pred ccceEEEeecCCCCEEEEEE-------------------EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCC
Confidence 46777888888888776644 45567899999998765 23345679999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~ 140 (331)
T cd06649 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSR 140 (331)
T ss_pred CeEEEEEEECCEEEEEeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCC
Confidence 999999999999999999999999999884 3456899999999999999999999852 29999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++....... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 141 ~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il 192 (331)
T cd06649 141 GEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192 (331)
T ss_pred CcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHH
Confidence 999999999987653321 2345689999999999988999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=252.76 Aligned_cols=188 Identities=25% Similarity=0.378 Sum_probs=158.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+....+|.|++|.|+.+ ....+++.||+|++.... ......+.+|+.+++.++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 61 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCAC-------------------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61 (285)
T ss_pred CceEEEEEecCCCeEEEEE-------------------EEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCC
Confidence 4777888888888766644 455678999999987542 222345788999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..++..++||||+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~ 137 (285)
T cd05605 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDD 137 (285)
T ss_pred EeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECC
Confidence 999999999999999999999999998877432 2346899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++|+|||++........ .....|++.|+|||++.+..++.++||||+|++|
T Consensus 138 ~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l 191 (285)
T cd05605 138 YGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLI 191 (285)
T ss_pred CCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHH
Confidence 99999999999876543221 2334789999999999988999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=254.42 Aligned_cols=181 Identities=27% Similarity=0.361 Sum_probs=159.8
Q ss_pred CCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 265 GSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 265 ~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
.+.|++|+|+-+....+|+.+|+|++.++ ...+....++|-.+|++++.+.||.+-..|++.+.++|||..|.||+|
T Consensus 193 lGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDL 272 (591)
T KOG0986|consen 193 LGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDL 272 (591)
T ss_pred EecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCce
Confidence 34445567777788899999999998765 344556688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
.-.|..... ..|+++.++.++.+|+-||++||+.+ ||.|||||+|||+|+.|+++|+|+|+|..+...+... .
T Consensus 273 kfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~---~ 345 (591)
T KOG0986|consen 273 KFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR---G 345 (591)
T ss_pred eEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCccc---c
Confidence 988866443 57999999999999999999999998 9999999999999999999999999999887655433 3
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||.+|||||++.++.|+...|.|||||+|
T Consensus 346 rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCll 376 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLL 376 (591)
T ss_pred ccCcccccCHHHHcCCcccCCccHHHHHhHH
Confidence 4899999999999999999999999999985
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=257.87 Aligned_cols=189 Identities=19% Similarity=0.270 Sum_probs=156.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|++...+|.|++|.|+.+ ....+++.+|+|++.+. .......+.+|+.++..++|++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~ 62 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVV-------------------KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62 (332)
T ss_pred CceEEEEEEeCCCeEEEEE-------------------EECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCC
Confidence 4777788888888776643 44557889999998643 2223445888999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+.+++||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 63 i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~ 137 (332)
T cd05623 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDM 137 (332)
T ss_pred EeeEEEEEecCCEEEEEEeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECC
Confidence 99999999999999999999999999999843 2346899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++..+..... .......||+.|+|||++. ...++.++|||||||+|
T Consensus 138 ~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil 198 (332)
T cd05623 138 NGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCM 198 (332)
T ss_pred CCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHH
Confidence 99999999999876533221 1223357899999999985 35689999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=255.87 Aligned_cols=179 Identities=23% Similarity=0.316 Sum_probs=149.5
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.|.++.|+......+++.||+|++++.. ....+.+..|..++..+ +||||+++++.+..+++.++||||+++++|
T Consensus 4 g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L 83 (316)
T cd05620 4 GKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDL 83 (316)
T ss_pred eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcH
Confidence 34445666666777789999999997642 23445677788888765 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 84 ~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05620 84 MFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST 155 (316)
T ss_pred HHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence 88873 3456899999999999999999999999 9999999999999999999999999987432211 12234
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 186 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLL 186 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHH
Confidence 5789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=272.40 Aligned_cols=193 Identities=19% Similarity=0.261 Sum_probs=162.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.||++...+|.|++|.||.+ ....+++.||||++... +......+.+|+.++..++|+|
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a-------------------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~ 92 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCA-------------------KRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92 (496)
T ss_pred CCEEEEEEEecCCCEEEEEE-------------------EEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCc
Confidence 49999999999999877644 55668999999998754 3344567889999999999999
Q ss_pred ccceeeeEecCC--------eEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 316 LVRLLGCCLDGN--------ELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 316 iv~l~~~~~~~~--------~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
|+++++.+.... .+++||||+++++|.+++... .....+++..++.++.|++.+|.|||+.+ |+||||
T Consensus 93 iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDL 169 (496)
T PTZ00283 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDI 169 (496)
T ss_pred EEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 999988776432 378999999999999888542 23457999999999999999999999998 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|||++.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||+|
T Consensus 170 KP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvil 235 (496)
T PTZ00283 170 KSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL 235 (496)
T ss_pred CHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999999999999876544333333456799999999999999999999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=254.17 Aligned_cols=178 Identities=22% Similarity=0.280 Sum_probs=146.0
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcC---CCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKL---QHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
.|.++.|+......+++.||||++.+.. ......+..|..++..+ +||||+++++.+......++||||+++++
T Consensus 3 ~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~ 82 (330)
T cd05586 3 KGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGE 82 (330)
T ss_pred CCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCCh
Confidence 4455666666777889999999987542 22233455677777665 69999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
|..++. +...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 83 L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 154 (330)
T cd05586 83 LFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN 154 (330)
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence 988873 3456899999999999999999999999 9999999999999999999999999987543221 1233
Q ss_pred ccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 421 RVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
...||+.|+|||++.+. .++.++|||||||+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil 187 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEE
Confidence 45789999999998754 479999999999985
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=264.37 Aligned_cols=197 Identities=27% Similarity=0.389 Sum_probs=157.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i 316 (452)
+|++.+.+|.|++|.|+.+.... .+...+++.||||++... .....+.+.+|+.+++.+ +|+||
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~--------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFG--------------LGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104 (374)
T ss_pred HceehheecCCCcccEEEEEEec--------------CCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCce
Confidence 67777888888888877553110 012235568999999754 233456788999999999 89999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-----------------------------------------------
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST----------------------------------------------- 349 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----------------------------------------------- 349 (452)
+++++.+......++||||+++++|.++++...
T Consensus 105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 999999999999999999999999988874321
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 350 --------------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 350 --------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
...++++.+++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~ 261 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARD 261 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeee
Confidence 1135788999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 410 FSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 410 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..............+++.|+|||++.+..++.++|||||||+|
T Consensus 262 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil 304 (374)
T cd05106 262 IMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304 (374)
T ss_pred ccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHH
Confidence 5433222222223356789999999888999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=257.50 Aligned_cols=186 Identities=23% Similarity=0.300 Sum_probs=157.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|+....+|.|++|.|+. .....+++.+|+|.+... .....+.+.+|++++++++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~-------------------~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 65 (333)
T cd06650 5 DDFEKISELGAGNGGVVFK-------------------VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65 (333)
T ss_pred hhhheeccccCCCCEEEEE-------------------EEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcc
Confidence 4677777777777766654 455567889999988765 23345678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEECC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~ 395 (452)
+++++++..+++.++||||+++++|.+++. ....+++..+..++.|++.+|.|||+. + |+|+||||+|||++.
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~ 139 (333)
T cd06650 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNS 139 (333)
T ss_pred cceeEEEEECCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcC
Confidence 999999999999999999999999999884 345689999999999999999999974 6 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++..+.... .....||..|+|||++.+..++.++|||||||++
T Consensus 140 ~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 192 (333)
T cd06650 140 RGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192 (333)
T ss_pred CCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999987653221 2234689999999999988899999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=253.53 Aligned_cols=179 Identities=23% Similarity=0.327 Sum_probs=149.4
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.|.+|.|+......+++.||||+++... ....+.+..|..++..+ +||||+++++.+...+..++||||+++++|
T Consensus 4 G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L 83 (316)
T cd05619 4 GKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL 83 (316)
T ss_pred eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence 34455666666777789999999997642 23345567788888764 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
..++. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 84 ~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05619 84 MFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT 155 (316)
T ss_pred HHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence 98883 3456899999999999999999999999 9999999999999999999999999987532221 12234
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 186 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLL 186 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHH
Confidence 5789999999999998999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=272.22 Aligned_cols=195 Identities=24% Similarity=0.291 Sum_probs=158.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 315 (452)
..|+++.+.+.+|+|+.||.+ .+...+.++|+|++-..++...+.+++||.+|++|+ |+|
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla-------------------~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~n 96 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLA-------------------QDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKN 96 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEE-------------------EecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCc
Confidence 457777788888888777655 455566999999998778888899999999999996 999
Q ss_pred ccceeeeEe-c------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 316 LVRLLGCCL-D------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 316 iv~l~~~~~-~------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||.+++... . .-+++|+||||.|+.|-+++..... ..|++.++++|+.|+++|+.+||... .+|||||||-
T Consensus 97 IV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKi 174 (738)
T KOG1989|consen 97 IVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKI 174 (738)
T ss_pred eeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCC-Cccchhhhhh
Confidence 999999432 1 2368999999999999888854333 34999999999999999999999985 7899999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCc-ccc------cccccccccccccccc---ccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQN-EAN------TNRVVGTYGYMAPEYA---MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlG~il 452 (452)
+||||..+++.||+|||.+........ ... .-...-|+.|+|||++ .+..++.|+|||+|||+|
T Consensus 175 ENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclL 248 (738)
T KOG1989|consen 175 ENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLL 248 (738)
T ss_pred hheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHH
Confidence 999999999999999999864322211 100 0012459999999998 577899999999999986
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=261.94 Aligned_cols=197 Identities=27% Similarity=0.351 Sum_probs=158.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i 316 (452)
+|+..+.+|.|++|.|+.+.... .....++..||||+++... ....+.+.+|+.+++.+ +||||
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~--------------~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnI 101 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYG--------------LFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI 101 (375)
T ss_pred HeehhheecCCccceEEEEEEec--------------cccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcce
Confidence 67778888888888887653100 0122356789999987542 33456788999999999 89999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-----------------------------------------------
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST----------------------------------------------- 349 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----------------------------------------------- 349 (452)
+++++.+..++..++||||+++++|.+++....
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 999999999999999999999999988885321
Q ss_pred -------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccc
Q 012989 350 -------------------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404 (452)
Q Consensus 350 -------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DF 404 (452)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Df 258 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDF 258 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecC
Confidence 1125788999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 405 GMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 405 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+++...............++..|+|||.+.+..++.++||||||++|
T Consensus 259 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l 306 (375)
T cd05104 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 306 (375)
T ss_pred ccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHH
Confidence 999866443322222223456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=266.38 Aligned_cols=185 Identities=19% Similarity=0.258 Sum_probs=154.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|.+...++.|++|.||.+ .+..+++.||||.... ..+.+|++++++|+|+||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a-------------------~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnI 222 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFES-------------------SHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAV 222 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEE-------------------EECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCC
Confidence 457888888888888777654 4455788999996422 346789999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++|||++. ++|..++.. ....+++.+++.|+.||+.||.|||++| |+||||||+|||++.+
T Consensus 223 v~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~ 296 (461)
T PHA03211 223 LALLDVRVVGGLTCLVLPKYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGP 296 (461)
T ss_pred CcEEEEEEECCEEEEEEEccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCC
Confidence 999999999999999999996 577666632 2346999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||+|
T Consensus 297 ~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL 352 (461)
T PHA03211 297 EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVI 352 (461)
T ss_pred CCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHH
Confidence 99999999999876443322223345799999999999999999999999999985
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=253.34 Aligned_cols=178 Identities=26% Similarity=0.346 Sum_probs=149.3
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.|.++.|+......+++.||||++.+. .......+..|..+++.+ +||||+++++.+...+++++||||+++++|.
T Consensus 5 ~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (318)
T cd05570 5 KGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLM 84 (318)
T ss_pred eCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHH
Confidence 344455555566678899999999764 233456678899999888 7999999999999999999999999999998
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
..+. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 85 ~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 156 (318)
T cd05570 85 FHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTF 156 (318)
T ss_pred HHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccce
Confidence 8873 3456999999999999999999999999 9999999999999999999999999986532211 122345
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+.|+|||++.+..++.++|+|||||+|
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil 186 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLL 186 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHH
Confidence 789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=245.73 Aligned_cols=185 Identities=25% Similarity=0.407 Sum_probs=163.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
-|++...+|+|++|+|+++. +...|..+|||++..+ .+.+++.+|+.+|++.+.|++|+
T Consensus 34 VFDi~~KLGEGSYGSV~KAI-------------------H~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVK 92 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAI-------------------HRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVK 92 (502)
T ss_pred HHHHHHHhcCCcchHHHHHH-------------------HhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhh
Confidence 45666778888888888775 3457999999998754 46789999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+|+.+.....+|+|||||..|+..++++. +++++++.++..+++..++||+|||... -||||||..|||++.+|+
T Consensus 93 YYGSYFK~sDLWIVMEYCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~ 167 (502)
T KOG0574|consen 93 YYGSYFKHSDLWIVMEYCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGI 167 (502)
T ss_pred hhhhhccCCceEeehhhcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccch
Confidence 99999999999999999999999999953 5678999999999999999999999876 899999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
.||+|||.+..+.+ .-...+...||+.|||||++..-.|+.++||||||+.
T Consensus 168 AKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGIT 218 (502)
T KOG0574|consen 168 AKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGIT 218 (502)
T ss_pred hhhhhccccchhhh--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcch
Confidence 99999999976543 2334556799999999999999999999999999974
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=268.30 Aligned_cols=191 Identities=30% Similarity=0.455 Sum_probs=158.7
Q ss_pred eecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccceeeeE
Q 012989 245 FYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCC 323 (452)
Q Consensus 245 f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~ 323 (452)
-+|+|.||.|+.+....+.+ ..+...||||.++..... ..++|++|++++..|+|||||++++++
T Consensus 493 eLGegaFGkVf~a~~~~l~p--------------~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 493 ELGEGAFGKVFLAEAYGLLP--------------GQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred hhcCchhhhhhhhhccCCCC--------------CccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 46777777777665332211 135678999999877544 788999999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCChhhhhccCC-------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 324 LDGNELLLIYEYMPNKSLDLFLFDST-------K----GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 324 ~~~~~~~lv~E~~~~~~L~~~l~~~~-------~----~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
..++..++|+||+..|+|.++++... . ..+|+..+.+.|+.||+.|++||-++. +|||||-..|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 99999999999999999999996432 1 234899999999999999999999998 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|.++..|||+|||+++.+-..+.........=+.+|||||.++.++||.+||||||||+|
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvL 695 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVL 695 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhh
Confidence 999999999999999875433332222122337899999999999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=247.25 Aligned_cols=193 Identities=23% Similarity=0.297 Sum_probs=157.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+|++.+.+|+|++|.|+.+.. +.....+..||+|.++... ......+.+|+.++++++||||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~----------------~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 68 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCL----------------KLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEE----------------ecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCc
Confidence 4678888899999998876531 1112356789999987652 3334578999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..+++.++||||+++++|++++... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.+
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~ 143 (266)
T cd05064 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSD 143 (266)
T ss_pred CeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCC
Confidence 99999999999999999999999999988432 346899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+|++|||.+........ .......++..|+|||.+.+..++.++|||||||++
T Consensus 144 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 198 (266)
T cd05064 144 LVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVM 198 (266)
T ss_pred CcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHH
Confidence 9999999998765322111 111122346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=262.24 Aligned_cols=187 Identities=19% Similarity=0.310 Sum_probs=157.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|++...+|.|++|.||.+.. .....++.||+|.+... ....+|++++++++||||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~-----------------~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~i 148 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTK-----------------HGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAI 148 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEE-----------------cCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCc
Confidence 35799999999999988875421 12235688999988643 345689999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+......+++||++. ++|..++ .....+++.+++.|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 149 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~ 221 (392)
T PHA03207 149 INLIHAYRWKSTVCMVMPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEP 221 (392)
T ss_pred cceeeeEeeCCEEEEEehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCC
Confidence 999999999999999999986 4677766 34466999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||+|
T Consensus 222 ~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil 277 (392)
T PHA03207 222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVL 277 (392)
T ss_pred CCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHH
Confidence 99999999999876544333333456799999999999999999999999999985
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.24 Aligned_cols=193 Identities=23% Similarity=0.316 Sum_probs=160.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
-||++...+|.|++|.|+.+ .+..+++.||||++.... ....+++.+|++++++++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA-------------------~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HP 62 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLA-------------------YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62 (932)
T ss_pred CCeEEEEEEecCCCEEEEEE-------------------EECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCc
Confidence 47899999999999877755 445678999999987542 23356789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST--------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
||+++++.+..++..++||||++|++|.+++.... ....+++..++.++.||++||+|||+++ |+||||
T Consensus 63 NIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDL 139 (932)
T PRK13184 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDL 139 (932)
T ss_pred CcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 99999999999999999999999999998875321 1234667788999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCc----------------cccccccccccccccccccccCCCceeeeeeeeee
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQN----------------EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEF 450 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 450 (452)
||+|||++.++.+||+|||+++....... .......+||+.|+|||++.+..++.++|||||||
T Consensus 140 KPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGV 219 (932)
T PRK13184 140 KPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219 (932)
T ss_pred chheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHH
Confidence 99999999999999999999986521110 01122357999999999999999999999999999
Q ss_pred eC
Q 012989 451 FF 452 (452)
Q Consensus 451 il 452 (452)
+|
T Consensus 220 IL 221 (932)
T PRK13184 220 IL 221 (932)
T ss_pred HH
Confidence 85
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=261.10 Aligned_cols=198 Identities=24% Similarity=0.331 Sum_probs=158.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCC-CCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQ-HKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~ 315 (452)
.+|++.+.+|.|++|.|+.+..... .....+..||||++.... ....+.+.+|+++++++. |||
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~--------------~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~Hpn 102 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGL--------------SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102 (400)
T ss_pred cceehhheecCCCCceEEEEEEccc--------------CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCC
Confidence 3667778888898888875532100 011235679999997543 334567999999999996 999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC----------------------------------------------
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST---------------------------------------------- 349 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---------------------------------------------- 349 (452)
|+++++++......+|||||+++++|.+++....
T Consensus 103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 9999999999999999999999999988875321
Q ss_pred -----------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 350 -----------------------------------------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 350 -----------------------------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
....+++.+++.++.||++||+|||+.+ |+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iv 259 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CV 259 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 0134788899999999999999999998 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||||+|||++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||++|
T Consensus 260 H~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil 329 (400)
T cd05105 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329 (400)
T ss_pred CCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHH
Confidence 9999999999999999999999999876443332233334567889999999888999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=248.13 Aligned_cols=187 Identities=28% Similarity=0.420 Sum_probs=150.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEe-cCCeeeEEEEeecCC--cccHHHHHHHHHHHHcC---C
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGIL-ADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKL---Q 312 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~-~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l---~ 312 (452)
||++...+|.|++|.||.+ .+. .+++.||||++.... ......+.+|+.+++.+ +
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 62 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKA-------------------RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62 (290)
T ss_pred CcceeeEeccCCCeEEEEE-------------------EEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccC
Confidence 6788888888888777755 232 346889999987542 22334567788887776 6
Q ss_pred CCCccceeeeEe-----cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 313 HKNLVRLLGCCL-----DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 313 h~~iv~l~~~~~-----~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
||||+++++++. ....+++||||+++ +|.+++... ....+++..++.++.||+.||.|||+++ |+|||||
T Consensus 63 hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlk 137 (290)
T cd07862 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLK 137 (290)
T ss_pred CCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCC
Confidence 999999999885 24568999999964 787777432 2345899999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||++.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||+|
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 199 (290)
T cd07862 138 PQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 199 (290)
T ss_pred HHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHH
Confidence 99999999999999999999765433 223345689999999999888999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=258.04 Aligned_cols=183 Identities=30% Similarity=0.484 Sum_probs=156.4
Q ss_pred ceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccce
Q 012989 242 LYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRL 319 (452)
Q Consensus 242 ~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l 319 (452)
+.+-+|.|.||+||++.. .-.||||+++.. ++...+.|++|+..+++-+|.||+-+
T Consensus 396 l~~rIGsGsFGtV~Rg~w----------------------hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLF 453 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRW----------------------HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLF 453 (678)
T ss_pred ccceeccccccceeeccc----------------------ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheee
Confidence 455689999999988764 346999999876 45567889999999999999999999
Q ss_pred eeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 320 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
.+++..+.. .||..||+|.+|..+++.. ...|+..+.+.|++||++|+.|||.++ |||||||..||++.++++|
T Consensus 454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 454 MGACMNPPL-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred ehhhcCCce-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence 999998887 9999999999999999653 466999999999999999999999999 9999999999999999999
Q ss_pred eEccccccccccCCCcccccccccccccccccccccc---CCCceeeeeeeeeeeC
Q 012989 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME---GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 400 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il 452 (452)
||+|||++..-.............|...|||||+++. .+|++.+||||||+++
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence 9999999875443333333444567889999999963 5689999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=244.40 Aligned_cols=179 Identities=26% Similarity=0.367 Sum_probs=150.1
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|+++.|+......+|+.||+|.+.... ......+..|++++++++||||+++++.+..+.+.++||||+++++|..
T Consensus 3 ~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 82 (277)
T cd05607 3 KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKY 82 (277)
T ss_pred CCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHH
Confidence 4455666666777789999999986432 2223456679999999999999999999999999999999999999988
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 ~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~ 155 (277)
T cd05607 83 HIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRA 155 (277)
T ss_pred HHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccC
Confidence 77432 3345899999999999999999999999 99999999999999999999999999876543321 22346
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.|+|||++.+..++.++||||+||+|
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l 184 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSI 184 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHH
Confidence 89999999999988899999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=246.75 Aligned_cols=188 Identities=26% Similarity=0.382 Sum_probs=157.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+.++.+|.|++|.|+ ......+++.||+|.+.... ......+.+|+.++++++|++
T Consensus 1 ~f~~~~~ig~G~~g~v~-------------------~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~ 61 (285)
T cd05630 1 TFRQYRVLGKGGFGEVC-------------------ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61 (285)
T ss_pred CceeeEEeecCCCeEEE-------------------EEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCC
Confidence 36677777887776655 44666789999999987542 222345778999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+...+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 62 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~ 137 (285)
T cd05630 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDD 137 (285)
T ss_pred eeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECC
Confidence 999999999999999999999999998887432 2345899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++
T Consensus 138 ~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l 191 (285)
T cd05630 138 HGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 191 (285)
T ss_pred CCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHH
Confidence 9999999999987643222 12234789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=245.56 Aligned_cols=187 Identities=25% Similarity=0.369 Sum_probs=156.5
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i 316 (452)
|+.+..+|.|++|.|| ......+++.+|+|.+.... ......+.+|+.+++.++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy-------------------~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i 62 (285)
T cd05632 2 FRQYRVLGKGGFGEVC-------------------ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV 62 (285)
T ss_pred ceEEEEEecCCCeEEE-------------------EEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCc
Confidence 5667778888876665 34556689999999987542 2233557889999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..++..++||||+++++|..++... ....+++..+..++.|++.+|.|||+.+ |+||||||+||+++.+
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~ 138 (285)
T cd05632 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDY 138 (285)
T ss_pred eeEEEEEecCCEEEEEEEeccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCC
Confidence 99999999999999999999999998877542 2346999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++....... ......|+..|+|||.+.+..++.++|+||||++|
T Consensus 139 ~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l 191 (285)
T cd05632 139 GHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLI 191 (285)
T ss_pred CCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHH
Confidence 999999999987643221 12234689999999999988999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=245.76 Aligned_cols=197 Identities=25% Similarity=0.404 Sum_probs=160.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|.+...+|.|++|.|+.+..... ....+++.||||.+...... ..+.+.+|+++++.++|+||+
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~--------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 71 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHL--------------EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccc--------------cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCch
Confidence 577778888898888886632110 00135688999998765433 457899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-----------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-----------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
++++.+......++||||+++++|.+++.... ....+++..+..++.||+.+|.+||+++ ++||||
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dl 148 (280)
T cd05049 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDL 148 (280)
T ss_pred heeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecccc
Confidence 99999999999999999999999999885421 2345889999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+||+++.++.+||+|||+++...............+++.|+|||++.++.++.++||||||++|
T Consensus 149 kp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05049 149 ATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214 (280)
T ss_pred ccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHH
Confidence 999999999999999999998765333222222233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=246.56 Aligned_cols=198 Identities=23% Similarity=0.348 Sum_probs=159.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...+|.|++|.|+.+..... ....+++.||||++.... .....++.+|+.+++.++||||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~--------------~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 71 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGV--------------VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccC--------------CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe
Confidence 4688889999999998886532110 011346789999986432 2345568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++++.+......++||||+++++|.+++..... ...+++..++.++.|++.+|.|||+.+ ++|+||||+
T Consensus 72 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~ 148 (277)
T cd05062 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAAR 148 (277)
T ss_pred eeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchh
Confidence 9999999999999999999999999998854221 234678899999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||++|
T Consensus 149 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 149 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred eEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 999999999999999998765433322222223457889999999988999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=254.96 Aligned_cols=185 Identities=28% Similarity=0.340 Sum_probs=152.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++... .......+.+|+.+++.++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 80 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAA-------------------FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80 (359)
T ss_pred hhceEEEEEeecCCCEEEEEE-------------------EEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCC
Confidence 458888888888888776644 45567899999998654 233456788999999999999
Q ss_pred CccceeeeEecCC------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++++.... ..++||||+++ +|...+. ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 81 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp 151 (359)
T cd07876 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 151 (359)
T ss_pred CEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCH
Confidence 9999999987543 57999999976 4544441 24888999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 152 ~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 212 (359)
T cd07876 152 SNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212 (359)
T ss_pred HHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHH
Confidence 99999999999999999997543221 22335789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=252.72 Aligned_cols=197 Identities=25% Similarity=0.370 Sum_probs=159.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i 316 (452)
||++.+.+|.|++|.||.+.... .....+++.||+|++.... ....+.+.+|+.+++++ +|+||
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~--------------~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~ni 73 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFG--------------IEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV 73 (337)
T ss_pred HhhhhcccccCcCceEEeccccc--------------cccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcch
Confidence 89999999999999998764211 0122356899999987542 23345688899999999 89999
Q ss_pred cceeeeEecC-CeEEEEEEecCCCChhhhhccCCC---------------------------------------------
Q 012989 317 VRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDSTK--------------------------------------------- 350 (452)
Q Consensus 317 v~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~~--------------------------------------------- 350 (452)
+++++++... ..++++|||+++++|.+++.....
T Consensus 74 v~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred hheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 9999987654 568899999999999888743211
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc
Q 012989 351 -------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 417 (452)
Q Consensus 351 -------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 417 (452)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~ 230 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchh
Confidence 136899999999999999999999998 9999999999999999999999999998764333222
Q ss_pred cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 418 NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 418 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
......++..|+|||++.+..++.++|||||||+|
T Consensus 231 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l 265 (337)
T cd05054 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 265 (337)
T ss_pred hccCCCCCccccCcHHhcCCCCCccccHHHHHHHH
Confidence 23334567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=239.32 Aligned_cols=182 Identities=25% Similarity=0.357 Sum_probs=148.4
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
+.+.++.|+......+++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|.++
T Consensus 4 g~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 83 (252)
T cd05084 4 GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 83 (252)
T ss_pred CcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHH
Confidence 34445555555666789999999876542 33456799999999999999999999999999999999999999999998
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccc
Q 012989 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVG 424 (452)
Q Consensus 345 l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 424 (452)
+.. ....+++.+++.++.|++.+|.|||+++ |+|+||||+||+++.++.+||+|||++................+
T Consensus 84 ~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 84 LRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 843 2345899999999999999999999999 99999999999999999999999999875432211111111123
Q ss_pred ccccccccccccCCCceeeeeeeeeeeC
Q 012989 425 TYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 425 t~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+..|+|||.+.++.++.++||||||++|
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il 186 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILL 186 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHH
Confidence 4679999999888999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=252.32 Aligned_cols=170 Identities=24% Similarity=0.336 Sum_probs=139.6
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
+.|+......+++.||||++.... ....+.+.+|+++++.++|+||+++++++...+.+++||||+++++|....
T Consensus 88 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~---- 163 (353)
T PLN00034 88 GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH---- 163 (353)
T ss_pred eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc----
Confidence 444444556688999999986543 333567899999999999999999999999999999999999999886432
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 429 (452)
..++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ......||..|+
T Consensus 164 ---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~ 235 (353)
T PLN00034 164 ---IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYM 235 (353)
T ss_pred ---cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCcccc
Confidence 3567888899999999999999999 99999999999999999999999999986543211 123357899999
Q ss_pred ccccccc-----CCCceeeeeeeeeeeC
Q 012989 430 APEYAME-----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~-----~~~s~~~DvwSlG~il 452 (452)
|||++.. ...+.++|||||||+|
T Consensus 236 aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 236 SPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred CccccccccccCcCCCcchhHHHHHHHH
Confidence 9998742 2345689999999975
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=249.40 Aligned_cols=194 Identities=23% Similarity=0.364 Sum_probs=156.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+|+....+|+|++|.|+.+.... ........||||.++.. .....+++.+|+.+++.++||||
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~---------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 71 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIP---------------EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEec---------------CCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCC
Confidence 367888889999998887663211 00112345899998754 23445778999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+... ..++++||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 72 v~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~ 145 (316)
T cd05108 72 CRLLGICLTS-TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTP 145 (316)
T ss_pred CeEEEEEcCC-CceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCC
Confidence 9999998765 567999999999999988532 345889999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+.............++..|++||++.+..++.++||||||++|
T Consensus 146 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l 201 (316)
T cd05108 146 QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201 (316)
T ss_pred CcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHH
Confidence 99999999999876544332222223346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=245.77 Aligned_cols=209 Identities=24% Similarity=0.329 Sum_probs=164.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...+|.|++|.|+.+............ .........+..||+|.+.... ....+.+.+|++++++++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~---~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKA---FAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccc---cccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 37888889999999999876433221111000 0011233456789999987653 3456778999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST--------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
+++++++..+...+++||++++++|..++.... ....+++..++.++.|++.||.|||+++ |+|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 999999999999999999999999999885432 1236899999999999999999999998 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 222 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHH
Confidence 9999999999999999998765433322223344567889999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=245.13 Aligned_cols=196 Identities=24% Similarity=0.385 Sum_probs=157.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.|+....+|+|++|.|+.+... .....+++.+++|.+.... ......+.+|+.+++.++||||+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~---------------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 70 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLY---------------LPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70 (283)
T ss_pred hceeeeeccccCCcceEEEEEe---------------cCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCee
Confidence 3566677888888887765310 0112356889999987543 33446788999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDST--------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH 383 (452)
++++++..+...++||||+++++|.+++.... ....+++.+++.++.|++.+|+|||+++ |+|
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H 147 (283)
T cd05090 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVH 147 (283)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eeh
Confidence 99999999999999999999999998884321 1235789999999999999999999999 999
Q ss_pred cCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++|
T Consensus 148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred hccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 999999999999999999999999865433322223334457789999999888899999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=237.03 Aligned_cols=181 Identities=23% Similarity=0.329 Sum_probs=152.8
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
++|.++.|.-+..+.++.++|||++.+.....+.++.+|++++.+. .|+||++|+++|+++..+|||||-+.||+|...
T Consensus 87 GeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLsh 166 (463)
T KOG0607|consen 87 GEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSH 166 (463)
T ss_pred cCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHH
Confidence 4555566667788899999999999998777889999999999998 599999999999999999999999999999888
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC---eeEccccccccccCCC-----cc
Q 012989 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISDFGMARIFSGNQ-----NE 416 (452)
Q Consensus 345 l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~~~~~~-----~~ 416 (452)
| .+.+.|++.++..++++|+.||.+||.+| |.||||||+|||-....+ +||+||.+..-+.... ..
T Consensus 167 I---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 167 I---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred H---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 8 45567999999999999999999999999 999999999999865544 8999998875432221 11
Q ss_pred ccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 417 ANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 417 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+.....+|+..|||||+.- .-.|+.++|.||||+||
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIl 281 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVIL 281 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHH
Confidence 2234568999999999872 34489999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=243.17 Aligned_cols=161 Identities=17% Similarity=0.291 Sum_probs=138.5
Q ss_pred CCeeeEEEEeecCCccc---HHHHHHHHHHHHcCCCCCccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCC
Q 012989 281 DGKEIAVKRLSRSSGQG---LQEFKNEVTLIAKLQHKNLVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQ 353 (452)
Q Consensus 281 ~~~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~ 353 (452)
+|+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+++++|.+++.. ...
T Consensus 42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~ 118 (283)
T PHA02988 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKD 118 (283)
T ss_pred CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCC
Confidence 78999999997653332 4678899999999999999999999876 3578999999999999999843 456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccc
Q 012989 354 LDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432 (452)
Q Consensus 354 l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 432 (452)
+++...+.++.|++.||.+||+. + ++||||||+|||++.++.+||+|||+++...... ....|+..|+|||
T Consensus 119 ~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE 190 (283)
T PHA02988 119 LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYK 190 (283)
T ss_pred CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHH
Confidence 89999999999999999999984 6 8899999999999999999999999988654321 2346789999999
Q ss_pred cccc--CCCceeeeeeeeeeeC
Q 012989 433 YAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 433 ~~~~--~~~s~~~DvwSlG~il 452 (452)
++.+ ..++.++|||||||++
T Consensus 191 ~~~~~~~~~~~k~Di~SlGvil 212 (283)
T PHA02988 191 MLNDIFSEYTIKDDIYSLGVVL 212 (283)
T ss_pred HhhhccccccchhhhhHHHHHH
Confidence 9975 6899999999999975
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=240.84 Aligned_cols=194 Identities=24% Similarity=0.373 Sum_probs=158.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|+..+.+|.|++|.||.+... ....+...||||.+.... ......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~----------------~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 67 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLK----------------LPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67 (266)
T ss_pred HHceeeeEecCCccceEEEEEEc----------------cCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCc
Confidence 35778888899999888765321 111245689999987543 3345678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+...+..+++|||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~ 142 (266)
T cd05033 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSN 142 (266)
T ss_pred ceEeEEEecCCceEEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 99999999999999999999999999988432 346899999999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l 198 (266)
T cd05033 143 LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 198 (266)
T ss_pred CCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHH
Confidence 99999999999877532222222223446789999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-31 Score=258.93 Aligned_cols=187 Identities=23% Similarity=0.371 Sum_probs=161.3
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccce
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRL 319 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l 319 (452)
|++..-+|.|.||.||++.. ..++-.-|.|+|...+....+.++-||+||....||+||+|
T Consensus 34 WeIiGELGDGAFGKVyKA~n-------------------ket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkL 94 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVN-------------------KETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKL 94 (1187)
T ss_pred HHHHhhhcCccchhhhhhhc-------------------ccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHH
Confidence 45555677888888887742 23455568899988888889999999999999999999999
Q ss_pred eeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 320 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
++.|...+.+||+.|||.||-.+.++- .-+..|++.++.-+++|++.||.|||++. |||||||..|||++-+|.+
T Consensus 95 l~ayy~enkLwiliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdi 169 (1187)
T KOG0579|consen 95 LSAYYFENKLWILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDI 169 (1187)
T ss_pred HHHHhccCceEEEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcE
Confidence 999999999999999999999998874 35678999999999999999999999999 9999999999999999999
Q ss_pred eEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 400 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+|+|||.+... .........++|||.|||||+.+ ..+|++++||||||+.|
T Consensus 170 rLADFGVSAKn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITL 225 (1187)
T KOG0579|consen 170 RLADFGVSAKN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITL 225 (1187)
T ss_pred eeecccccccc--hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHH
Confidence 99999987542 22334455689999999999874 68899999999999865
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=241.41 Aligned_cols=197 Identities=25% Similarity=0.427 Sum_probs=157.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|++.+.+|.|++|.|+.+..... ........||+|.+.... ......+.+|+.++++++||||+
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~ 71 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGP--------------NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecC--------------CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccc
Confidence 566677778888877775532110 001234789999987543 33456789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~ 384 (452)
++++++......+++|||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ ++|+
T Consensus 72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~ 148 (283)
T cd05048 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148 (283)
T ss_pred eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 999999999999999999999999988854321 145889999999999999999999999 9999
Q ss_pred CCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 385 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+|
T Consensus 149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il 216 (283)
T cd05048 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216 (283)
T ss_pred ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHH
Confidence 99999999999999999999999765433322223344668899999999888999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=260.45 Aligned_cols=186 Identities=22% Similarity=0.333 Sum_probs=149.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|+....+|.|++|.|+.+ ....+++.||||++.... ....+|+.+++.++||||
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~-------------------~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~ni 121 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEA-------------------ICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINI 121 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEE-------------------EECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCC
Confidence 357999999999999877754 344578999999886432 234579999999999999
Q ss_pred cceeeeEecC--------CeEEEEEEecCCCChhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 317 VRLLGCCLDG--------NELLLIYEYMPNKSLDLFLFD-STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 317 v~l~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
+++++++... ..+++||||+++ +|..++.. ......+++..++.++.||+.||.|||+++ |+|||||
T Consensus 122 v~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLK 197 (440)
T PTZ00036 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLK 197 (440)
T ss_pred cceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcC
Confidence 9999887532 247799999976 56555432 234567999999999999999999999999 9999999
Q ss_pred CCCeEECCCC-CeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|+|||++.++ .+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||+|
T Consensus 198 p~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 261 (440)
T PTZ00036 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII 261 (440)
T ss_pred HHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 9999999765 699999999987643322 2235689999999998764 689999999999985
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=243.67 Aligned_cols=187 Identities=27% Similarity=0.406 Sum_probs=150.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcC---CC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKL---QH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l---~h 313 (452)
||+....+|.|++|.|+.+ .+..+++.||+|.+.... ......+.+|+.+++.+ +|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h 61 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKA-------------------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61 (288)
T ss_pred CceEeeEEeecCCeEEEEE-------------------EECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCC
Confidence 5777778888887766644 556689999999987542 22234566788877766 69
Q ss_pred CCccceeeeEec-----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 314 KNLVRLLGCCLD-----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 314 ~~iv~l~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
|||+++++++.. ....+++||++++ +|..++... ....+++..++.++.||+.||.|||+.| |+||||||
T Consensus 62 ~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp 136 (288)
T cd07863 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKP 136 (288)
T ss_pred CCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 999999998764 3458999999975 777776432 2345899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++.+.... ......||..|+|||++.+..++.++||||+||+|
T Consensus 137 ~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 197 (288)
T cd07863 137 ENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197 (288)
T ss_pred HHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHH
Confidence 99999999999999999998654322 12234679999999999988999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=244.30 Aligned_cols=197 Identities=26% Similarity=0.413 Sum_probs=160.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|.+...++.|++|.++.+..... ....++..+++|.+........+.+.+|+.++++++|+||++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~--------------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 71 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNL--------------SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeecc--------------CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcce
Confidence 566677788888887775531100 012356679999987666556678999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~D 385 (452)
+++++......++||||+++++|.+++.... ....+++..++.++.||+.+|+|||+++ |+|||
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~d 148 (291)
T cd05094 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRD 148 (291)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 9999999999999999999999999885421 1245899999999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 386 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++
T Consensus 149 lkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (291)
T cd05094 149 LATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215 (291)
T ss_pred cCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHH
Confidence 9999999999999999999999765433222222334567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=250.08 Aligned_cols=161 Identities=30% Similarity=0.417 Sum_probs=138.7
Q ss_pred eEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHH
Q 012989 285 IAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361 (452)
Q Consensus 285 vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~ 361 (452)
||||..+.. ......++++|+++|++++|||||+++|+...+..++||||++.||+|.+++... ...++..+...
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~ 266 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLR 266 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHH
Confidence 899998753 3566788999999999999999999999999999999999999999999999542 23699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCce
Q 012989 362 IINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441 (452)
Q Consensus 362 i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ 441 (452)
++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+|||+++.-.......... --+..|+|||.+..+.|+.
T Consensus 267 ~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~--klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 267 FCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLK--KLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred HHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcceeeccccc--cCcceecChhhhccCcccc
Confidence 9999999999999999 9999999999999999999999999987532111111011 1268899999999999999
Q ss_pred eeeeeeeeeeC
Q 012989 442 NRMFLVSEFFF 452 (452)
Q Consensus 442 ~~DvwSlG~il 452 (452)
++|||||||++
T Consensus 342 kTDV~sfGV~~ 352 (474)
T KOG0194|consen 342 KTDVWSFGVLL 352 (474)
T ss_pred ccchhheeeeE
Confidence 99999999974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=219.26 Aligned_cols=187 Identities=26% Similarity=0.384 Sum_probs=156.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.|+..+.+|+|.+|+|++++ ...+++.||+|.+..+ ++.-....++|+-+++.++|.||
T Consensus 3 ~ydkmekigegtygtvfkar-------------------n~~t~eivalkrvrlddddegvpssalreicllkelkhkni 63 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKAR-------------------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63 (292)
T ss_pred chHHHHhhcCCcceeeEecc-------------------cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcce
Confidence 45556677888888777664 4567899999998765 33445678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|+++++...+..+-+|+|||.. +|..+. ..-++.++.+.++.++.|+++||.++|+++ +.||||||+|.||+.+
T Consensus 64 vrl~dvlhsdkkltlvfe~cdq-dlkkyf--dslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~n 137 (292)
T KOG0662|consen 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRN 137 (292)
T ss_pred eehhhhhccCceeEEeHHHhhH-HHHHHH--HhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccC
Confidence 9999999999999999999954 666655 234567999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
|.+||+|||+++.++-+-... ...+-|.+|.+|+++.+.. |+...|+||-||||
T Consensus 138 gelkladfglarafgipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcif 192 (292)
T KOG0662|consen 138 GELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192 (292)
T ss_pred CcEEecccchhhhcCCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHH
Confidence 999999999999886543322 2345599999999998755 79999999999986
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=242.96 Aligned_cols=208 Identities=24% Similarity=0.340 Sum_probs=162.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
||++...+|.|++|.|+.+.......... ..........++..+|+|.+... .....+.+.+|+.+++.++|+||+
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~---~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMD---KDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hceeeeeccCCCCCeEEeccccccccccc---ccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 68888899999999999764322111000 00111122334567999998754 334456799999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDST--------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
++++++..++..++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999999999999999999999998885422 1234788899999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||+++.+.............+++.|++||...++.++.++|+|||||+|
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l 222 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHH
Confidence 999999999999999998865433222222233446789999998888999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=241.35 Aligned_cols=198 Identities=26% Similarity=0.368 Sum_probs=158.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
.+|+....+|.|++|.|+.+...... .......+|+|.+... .......+.+|+.+++++ +|+|
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~--------------~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 77 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLD--------------NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCC--------------CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCC
Confidence 46778888888988887755321100 0134578999998754 333456688999999999 7999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-------------TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
|+++++++..++..+++|||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+
T Consensus 78 i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---iv 154 (293)
T cd05053 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CI 154 (293)
T ss_pred eeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 999999999999999999999999999888532 22456899999999999999999999998 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++
T Consensus 155 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 224 (293)
T cd05053 155 HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224 (293)
T ss_pred ccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHH
Confidence 9999999999999999999999999876543322222222346789999999888999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=240.12 Aligned_cols=187 Identities=26% Similarity=0.370 Sum_probs=156.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++...++.|++|.|+. .....+++.||+|++..........+.+|+.++++++||||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~-------------------~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~ 70 (267)
T cd06646 10 DYELIQRVGSGTYGDVYK-------------------ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70 (267)
T ss_pred hcchhheeecCCCeEEEE-------------------EEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeee
Confidence 566666777777765554 3555688999999997665555667889999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+..++..++||||+++++|.+++. ....+++..+..++.|++.+|+|||+.+ |+||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~ 144 (267)
T cd06646 71 YFGSYLSREKLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGD 144 (267)
T ss_pred eeEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCC
Confidence 9999999999999999999999998883 3456899999999999999999999998 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
+||+|||++..+..... ......|++.|+|||.+. ...++.++|+|||||+|
T Consensus 145 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il 199 (267)
T cd06646 145 VKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199 (267)
T ss_pred EEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHH
Confidence 99999999986543221 122346789999999874 45578899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=253.02 Aligned_cols=179 Identities=28% Similarity=0.402 Sum_probs=158.8
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
+.|++|.|+-.++..+...+|||.+..++....+.+.+||.+-++|+|.|||++++.+..++++-|.||-.+||+|..++
T Consensus 584 GKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLL 663 (1226)
T KOG4279|consen 584 GKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLL 663 (1226)
T ss_pred ecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHH
Confidence 45667777777888899999999999887778888999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC-CCCCeeEccccccccccCCCcccccccc
Q 012989 346 FDSTKGAQL--DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 346 ~~~~~~~~l--~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
+ .+++++ ++.++-.+.+||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++.+..-. +-+..+
T Consensus 664 r--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF 736 (1226)
T KOG4279|consen 664 R--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF 736 (1226)
T ss_pred H--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence 4 467888 88999999999999999999998 99999999999996 56889999999998875443 334567
Q ss_pred ccccccccccccccC--CCceeeeeeeeeee
Q 012989 423 VGTYGYMAPEYAMEG--VFSVNRMFLVSEFF 451 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~--~~s~~~DvwSlG~i 451 (452)
-||..|||||++-.+ .|..++|||||||.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT 767 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCT 767 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccce
Confidence 899999999999654 48889999999996
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=241.25 Aligned_cols=197 Identities=27% Similarity=0.429 Sum_probs=158.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|.+...+|.|++|.|+.+..... ....++..+|+|.+........+.+.+|+.++++++||||++
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~--------------~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 71 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNL--------------CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccC--------------CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 355566777888877765421000 012346679999987766666778999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDST----------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
+++++...+..++||||+++++|.+++.... ....+++..++.++.||+.+|+|||+++ ++||||||
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp 148 (288)
T cd05093 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLAT 148 (288)
T ss_pred EEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCc
Confidence 9999999999999999999999998885321 2235899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|+|||||++
T Consensus 149 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred ceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 9999999999999999998765433222222233457789999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=252.97 Aligned_cols=185 Identities=26% Similarity=0.326 Sum_probs=152.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||+....+|.|++|.|+.+ .+..+++.||||++... .......+.+|+.+++.++||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 76 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAA-------------------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76 (355)
T ss_pred hhceeEEEEeeecCCEEEEEE-------------------EecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCC
Confidence 458888888888888777654 34457889999998754 233456788999999999999
Q ss_pred CccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++++... ...++||||+++ +|...+. ..+++..++.++.|++.||.|||++| |+||||||
T Consensus 77 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp 147 (355)
T cd07874 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147 (355)
T ss_pred chhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 999999988644 357999999976 5555552 24889999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 148 ~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il 208 (355)
T cd07874 148 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208 (355)
T ss_pred HHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHH
Confidence 99999999999999999997643321 22335789999999999998999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=235.03 Aligned_cols=189 Identities=22% Similarity=0.345 Sum_probs=158.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|++...+|.|++|.++ ......+++.+|+|.+... .....+.+.+|+.+++.++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~-------------------~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 61 (255)
T cd08219 1 QYNVLRVVGEGSFGRAL-------------------LVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61 (255)
T ss_pred CceEEEEeeccCCeEEE-------------------EEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcc
Confidence 46667777777776555 4455667899999998653 344567788999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+..++..+++|||+++++|.+++.. .....+++..++.++.||+.||.+||+++ |+|+||||+||+++.++
T Consensus 62 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~ 137 (255)
T cd08219 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNG 137 (255)
T ss_pred eEEEEEEECCEEEEEEeeCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCC
Confidence 999999999999999999999999887743 23456899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++|+|||.+........ ......|++.|+|||++.+..++.++|+||||+++
T Consensus 138 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 190 (255)
T cd08219 138 KVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCIL 190 (255)
T ss_pred cEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhh
Confidence 999999999876543221 12235688999999999888899999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=250.70 Aligned_cols=183 Identities=26% Similarity=0.342 Sum_probs=149.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||+....+|.|++|.|+ ......+++.||||++.... ....+.+.+|+.+++.++|||
T Consensus 15 ~~y~~~~~lg~G~~g~V~-------------------~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 75 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVC-------------------SAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75 (343)
T ss_pred hhhhhheecccCCCeEEE-------------------EEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCc
Confidence 366666677777776555 44556688999999987542 223456788999999999999
Q ss_pred ccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++... ...+++||++ +++|..++. ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 76 iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~ 147 (343)
T cd07878 76 VIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPS 147 (343)
T ss_pred hhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999987643 3579999988 678887762 346999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||+|
T Consensus 148 Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (343)
T cd07878 148 NVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred hEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHH
Confidence 999999999999999999865432 223568999999999876 5689999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=243.33 Aligned_cols=187 Identities=27% Similarity=0.420 Sum_probs=161.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.||+....++.|++|.++.+ ....+++.|+||.+........+.+.+|+.+++.++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~-------------------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 79 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTA-------------------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79 (296)
T ss_pred ceEEEEEEEecCCCeEEEEE-------------------EEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCcee
Confidence 57888888888888776644 44567899999999776555667889999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+......++|+||+++++|..++. ...+++.++..++.|++.+|++||+.+ ++|+||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~ 152 (296)
T cd06655 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDG 152 (296)
T ss_pred eeeeeEecCceEEEEEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCC
Confidence 99999999999999999999999999883 235899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||++........ ......|+..|+|||.+.+..++.++|+|||||++
T Consensus 153 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil 205 (296)
T cd06655 153 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205 (296)
T ss_pred CEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHH
Confidence 999999999876543322 12234678999999999888899999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=236.47 Aligned_cols=189 Identities=23% Similarity=0.352 Sum_probs=160.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
||+....+|.|.+|.++ ......+++.+++|.+... +.....++.+|+.++++++|+||
T Consensus 1 ~y~~~~~ig~g~~g~v~-------------------~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i 61 (256)
T cd08221 1 HYIPIRVLGKGAFGEAT-------------------LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61 (256)
T ss_pred CceEeeEecccCCceEE-------------------EEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCe
Confidence 57777777777776544 4456678899999998754 34455678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++......+++|||+++++|.+++... ....+++.+++.++.|++.+|.|||+.+ ++|+||||+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKA 137 (256)
T ss_pred eEEEeEEecCCeEEEEEEecCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCC
Confidence 99999999999999999999999999988542 2456899999999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ ......|++.|+|||++.+..++.++|+||||+++
T Consensus 138 ~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~ 191 (256)
T cd08221 138 GLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVL 191 (256)
T ss_pred CCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHH
Confidence 9999999999987644332 22345689999999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=243.69 Aligned_cols=190 Identities=24% Similarity=0.382 Sum_probs=161.5
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-..||+..+.++.|++|.++.+ ....+++.|++|.+........+.+.+|+.+++.++|+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~ 77 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTA-------------------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEE-------------------EECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCC
Confidence 33458888888888888766644 44567899999999876555667899999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..+.+.++||||+++++|.+++. ...+++.++..++.|++.||.|||+.+ |+|+||||+||+++
T Consensus 78 ~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~ 150 (296)
T cd06654 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 150 (296)
T ss_pred CEeeEEEEEEeCCEEEEeecccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEc
Confidence 99999999999999999999999999999883 235889999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++......... .....|++.|+|||.+.+..++.++|||||||+|
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil 206 (296)
T cd06654 151 MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206 (296)
T ss_pred CCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHH
Confidence 9999999999998765432211 2234678999999999888899999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.18 Aligned_cols=185 Identities=25% Similarity=0.319 Sum_probs=152.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++... .......+.+|+.+++.++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 83 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAA-------------------YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83 (364)
T ss_pred hcceeEEEEeecCCCeEEEEE-------------------EECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCC
Confidence 458888888888888777644 44557889999998754 233456788999999999999
Q ss_pred CccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++++... ...++||||+++ +|...+. ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 84 ~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp 154 (364)
T cd07875 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154 (364)
T ss_pred CccccceeecccccccccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCH
Confidence 999999987643 357999999976 5655552 24889999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 155 ~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 215 (364)
T cd07875 155 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215 (364)
T ss_pred HHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHH
Confidence 99999999999999999997653321 22335789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=241.99 Aligned_cols=184 Identities=28% Similarity=0.396 Sum_probs=157.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+..+.++.|++|.++.+ ....+++.+|+|.+.+.. ....+.+.+|++++++++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 62 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLV-------------------RHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62 (290)
T ss_pred ceEEEEEeecCCCeEEEEE-------------------EEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCC
Confidence 4666777777777666543 455678999999987542 234567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+......++||||+++++|.+++. ....+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.
T Consensus 63 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~ 136 (290)
T cd05580 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDS 136 (290)
T ss_pred ccceeeEEEcCCeEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECC
Confidence 9999999999999999999999999998883 3456899999999999999999999998 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++...... .....|++.|+|||.+.+..++.++|+||||+++
T Consensus 137 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 188 (290)
T cd05580 137 DGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188 (290)
T ss_pred CCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHH
Confidence 999999999998875433 2234679999999999888899999999999874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=237.23 Aligned_cols=187 Identities=24% Similarity=0.370 Sum_probs=156.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+....+|.|++|.++ ......+++.||+|.++.........+.+|+.+++.++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~-------------------~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~ 70 (267)
T cd06645 10 DFELIQRIGSGTYGDVY-------------------KARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70 (267)
T ss_pred HHHHHHHhCCCCCeEEE-------------------EEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeee
Confidence 45555566666665554 44556688999999987665555667889999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+..++..++||||+++++|.+++. ....+++.+++.++.|++.+|.|||+.| ++|+||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 144 (267)
T cd06645 71 YFGSYLRRDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGH 144 (267)
T ss_pred EEEEEEeCCEEEEEEeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999883 3456999999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
+||+|||++....... .......|+..|+|||++. ...++.++|+|||||+|
T Consensus 145 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il 199 (267)
T cd06645 145 VKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITA 199 (267)
T ss_pred EEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHH
Confidence 9999999987654321 1223457899999999874 55688999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=244.26 Aligned_cols=203 Identities=25% Similarity=0.361 Sum_probs=161.5
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-C
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-Q 312 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~ 312 (452)
....+|++.+.+|.|++|.|+.+....... ....++..||+|.+... .......+.+|+.+++.+ +
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~------------~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK------------DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCC------------CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhcc
Confidence 345577788888999998887653211000 01124568999998754 234456789999999999 8
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRL 379 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~ 379 (452)
||||+++++.+......++||||+++++|.+++.... ....+++.+++.++.||++||.|||++|
T Consensus 80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-- 157 (304)
T cd05101 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-- 157 (304)
T ss_pred CCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999999885422 1245788999999999999999999999
Q ss_pred CeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 380 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||++|
T Consensus 158 -ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 229 (304)
T cd05101 158 -CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229 (304)
T ss_pred -eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHH
Confidence 999999999999999999999999999876543322222233457789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=245.55 Aligned_cols=188 Identities=24% Similarity=0.343 Sum_probs=154.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+|++...+|.|++|.|+.+ ....+++.||+|.++... ......+.+|+.++++++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 66 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKG-------------------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66 (309)
T ss_pred CceEEEEEecccCCEEEEEE-------------------EecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCc
Confidence 46888888888888877754 344578899999987553 2334567889999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..++..++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~ 140 (309)
T cd07872 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINER 140 (309)
T ss_pred ceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 9999999999999999999976 67666633 2345889999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... ......+|+.|+|||++.+ ..++.++||||||++|
T Consensus 141 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 195 (309)
T cd07872 141 GELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 195 (309)
T ss_pred CCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999876433221 1223467899999998865 4689999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=240.10 Aligned_cols=198 Identities=23% Similarity=0.339 Sum_probs=160.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+|++...+|.|++|.|+.+...... ...++..||+|.+.... ......+.+|+.+++.++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~--------------~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i 71 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVV--------------KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccC--------------CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCce
Confidence 36777788899999888765321100 01346789999986542 3345678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++++++......++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 72 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~ 148 (277)
T cd05032 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAAR 148 (277)
T ss_pred eEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChh
Confidence 999999999999999999999999999885422 1234788999999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||+++...............++..|+|||.+.++.++.++|||||||++
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred eEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 999999999999999998765443322222334568899999999888899999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=227.01 Aligned_cols=196 Identities=24% Similarity=0.256 Sum_probs=161.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+.||.+...+|.|++.-|+.. ....+++.+|+|++.-.+.++.+..++|++..++++||||
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV-------------------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~v 80 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLV-------------------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNV 80 (302)
T ss_pred CceEEEeeeecCCCceeeeee-------------------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcch
Confidence 569999999999998666533 4567899999999987777888999999999999999999
Q ss_pred cceeeeEecC-----CeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 317 VRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 317 v~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
++++++...+ +..||+++|...|+|.+.+.... ++..+++.+++.|+.+|.+||++||+.. .++.||||||.|
T Consensus 81 l~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~N 159 (302)
T KOG2345|consen 81 LRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPAN 159 (302)
T ss_pred HHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcce
Confidence 9998876533 45999999999999988875533 4557999999999999999999999985 479999999999
Q ss_pred eEECCCCCeeEccccccccccCC---Cccc----ccccccccccccccccc---ccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGN---QNEA----NTNRVVGTYGYMAPEYA---MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~---~~~~----~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlG~il 452 (452)
||+.+.+.++|.|||.+....-. .... ......-|..|+|||++ .+...+.++|||||||.|
T Consensus 160 ILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 160 ILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred eEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 99999999999999998654211 0000 01112348999999998 467789999999999975
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=243.08 Aligned_cols=207 Identities=24% Similarity=0.322 Sum_probs=160.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.||++.+.+|.|++|.|+.+........- .............||+|.+... .....+.+.+|++++++++|+||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~-----~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFL-----GEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhc-----cccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 47888889999999999876432110000 0000001113345899998754 33345679999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST---------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
+++++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+|||
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 156 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLA 156 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccC
Confidence 999999999999999999999999998884321 1124788999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||+++.++.+||+|||++................++..|+|||.+.++.++.++|+||||++|
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l 221 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHH
Confidence 99999999999999999998765433222222334557889999999888999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=238.29 Aligned_cols=193 Identities=22% Similarity=0.376 Sum_probs=155.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.|++...+|.|++|.++.+... ....++..||||.+... .....+.+..|+.+++.++||||+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~----------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~ 68 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLK----------------LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEe----------------cCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcc
Confidence 4677888888888877755311 11122356999998754 344467899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+..+...++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~ 143 (269)
T cd05065 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNL 143 (269)
T ss_pred eEEEEECCCCceEEEEecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCC
Confidence 999999999999999999999999998843 2346899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccc---cccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVV---GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||++................ .+..|+|||.+.+..++.++||||||++|
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l 201 (269)
T cd05065 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201 (269)
T ss_pred cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHH
Confidence 99999999987654332221111111 14579999999989999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=250.81 Aligned_cols=186 Identities=24% Similarity=0.340 Sum_probs=150.0
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
|+..+.+|.|++|.|+ ...+..+++.||||++... .....+++.+|+.+++.++||||+
T Consensus 2 ~~~~~~lg~G~~g~V~-------------------~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 62 (372)
T cd07853 2 VEPDRPIGYGAFGVVW-------------------SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62 (372)
T ss_pred CcccceeeeCCCEEEE-------------------EEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4455566666665555 4455668999999998653 223456788999999999999999
Q ss_pred ceeeeEecCC-----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 318 RLLGCCLDGN-----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 318 ~l~~~~~~~~-----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
++++++...+ +.++||||+.+ +|...+ .....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 63 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil 135 (372)
T cd07853 63 SALDILQPPHIDPFEEIYVVTELMQS-DLHKII---VSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLL 135 (372)
T ss_pred CHhheecCCCccccceEEEEeecccc-CHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEE
Confidence 9999998776 79999999964 676666 23456999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++....... .......+|+.|+|||++.+. .++.++||||+||||
T Consensus 136 i~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 195 (372)
T cd07853 136 VNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195 (372)
T ss_pred ECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHH
Confidence 99999999999999986543322 122234678999999998764 479999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=269.95 Aligned_cols=197 Identities=28% Similarity=0.462 Sum_probs=159.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.-+...++|.|.||.||.+.+..... .. ....||||.+++. +.+...+|++|..+|++++|||||
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~-------------~~-~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPG-------------SV-SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCC-------------Cc-cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCccee
Confidence 33455677777777777664432110 00 0345899999876 566778899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDST----KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
++++++.+....+|++|||++|+|..++++.+ ....++..+.+.++.||++|++||++++ +|||||..+|+|+
T Consensus 759 ~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL 835 (1025)
T KOG1095|consen 759 SLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLL 835 (1025)
T ss_pred eEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheee
Confidence 99999999999999999999999999997753 2456899999999999999999999998 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+....+||+|||+|+.+-..........-.=+..|||||.++.+.|+.|+|||||||+|
T Consensus 836 ~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVll 894 (1025)
T KOG1095|consen 836 DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLL 894 (1025)
T ss_pred cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHH
Confidence 99999999999999954433322222221225789999999999999999999999985
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=236.14 Aligned_cols=188 Identities=25% Similarity=0.395 Sum_probs=155.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++.+.+|.|++|.|+.+. ..+++.||||.+.... ...+.+.+|+.++++++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~--------------------~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 65 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGL--------------------WNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQ 65 (261)
T ss_pred heeeEEEecccCCccEEEEE--------------------ecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccc
Confidence 46777788888887766442 2356789999986543 34567899999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++...+..++||||+++++|.+++... ....+++..+..++.|++.+|.+||+.+ |+|+||||+||+++.++.
T Consensus 66 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 141 (261)
T cd05068 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNI 141 (261)
T ss_pred eeEEEecCCCeeeeeecccCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCC
Confidence 999999999999999999999999988542 2456899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||+++.+...... .......+..|+|||.+.+..++.++|+||||+++
T Consensus 142 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 194 (261)
T cd05068 142 CKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILL 194 (261)
T ss_pred EEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHH
Confidence 999999999876532211 11112234679999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=241.30 Aligned_cols=186 Identities=31% Similarity=0.469 Sum_probs=158.5
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHH--HHHHHHHHHHcCCCCCcc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQ--EFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~--~~~~E~~~l~~l~h~~iv 317 (452)
|+....+|.|++|.|+.+ ....+++.+|+|++......... ...+|+.++++++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~-------------------~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~ 61 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKA-------------------KNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIV 61 (260)
T ss_dssp EEEEEEEEEESSEEEEEE-------------------EETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBC
T ss_pred CEEeEEEEeCCCEEEEEE-------------------EECCCCeEEEEEEeccccccccccchhhhhhhccccccccccc
Confidence 677888888988777654 55668889999999877543322 345699999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++......++|||++++++|.+++. ....+++.+++.++.||+++|.+||+.+ |+|+||||+||+++.++
T Consensus 62 ~~~~~~~~~~~~~~v~~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~ 135 (260)
T PF00069_consen 62 QILDVFQDDNYLYIVMEYCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENG 135 (260)
T ss_dssp HEEEEEEESSEEEEEEEEETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTS
T ss_pred ccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccc
Confidence 99999999999999999999999999884 4566899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccc-cCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
.++|+|||.+..... .........++..|+|||++. +..++.++|+||+|+++
T Consensus 136 ~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 189 (260)
T PF00069_consen 136 EVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIIL 189 (260)
T ss_dssp EEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHH
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999876421 222334457799999999998 88899999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=241.43 Aligned_cols=194 Identities=27% Similarity=0.468 Sum_probs=157.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+..+.+|.|++|.|+.+.... ....+++.||||++........+.+.+|++++++++||||++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~---------------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 69 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDP---------------LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69 (284)
T ss_pred cceeeeeccCCCCceEEEEEecC---------------CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeE
Confidence 67778888999998887553211 123468899999987766666778999999999999999999
Q ss_pred eeeeEec--CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 319 LLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 319 l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.. ....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~ 144 (284)
T cd05081 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESE 144 (284)
T ss_pred EEEEEccCCCCceEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCC
Confidence 9998654 3468999999999999998843 2345899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccc-ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEAN-TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.......... .....++..|+|||++.+..++.++|+||||++|
T Consensus 145 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 201 (284)
T cd05081 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201 (284)
T ss_pred CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHH
Confidence 9999999999987643322111 1112335569999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=240.51 Aligned_cols=192 Identities=29% Similarity=0.436 Sum_probs=154.7
Q ss_pred cc-cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RY-ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry-~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
|| +....+|.|++|.|+.+.+. .....+++.||+|.+.... ......+.+|+++++.++||||
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~---------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 68 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYD---------------PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68 (283)
T ss_pred hhceeceecccCCCcEEEEeeEc---------------cccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCE
Confidence 55 77788889998887644221 1223467889999987553 2345678899999999999999
Q ss_pred cceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
+++++++... ...+++|||+++++|.+++.. ..+++.+++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~ 141 (283)
T cd05080 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLD 141 (283)
T ss_pred eeEEEEEecCCCceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEc
Confidence 9999987653 468999999999999998832 35899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCcccc-ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEAN-TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++.......... .....++..|+|||.+.+..++.++||||||+++
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l 200 (283)
T cd05080 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTL 200 (283)
T ss_pred CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHH
Confidence 999999999999986643322111 1122456779999999888899999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=243.16 Aligned_cols=190 Identities=25% Similarity=0.387 Sum_probs=161.9
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-..+|+..+.+|.|++|.++.+ ....+++.||+|.+........+.+.+|+.+++.++|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~ 76 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTA-------------------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP 76 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEE-------------------EECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCC
Confidence 33468888888888888766544 44567899999999876555567789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..+++.++||||+++++|.+++.. ..+++.++..++.|++.+|.|||+.+ ++|+||||+|||++
T Consensus 77 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~ 149 (297)
T cd06656 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLG 149 (297)
T ss_pred CEeeEEEEEecCCEEEEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 999999999999999999999999999998832 45789999999999999999999998 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++......... .....|++.|+|||.+.+..++.++|+||||++|
T Consensus 150 ~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil 205 (297)
T cd06656 150 MDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205 (297)
T ss_pred CCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHH
Confidence 9999999999998765433221 2234678999999999988899999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=242.32 Aligned_cols=197 Identities=25% Similarity=0.367 Sum_probs=157.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc-ccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|++.+.+|.|++|.|+.+..... ....+++.||||++..... ...+.+.+|+.++..++||||+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~--------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv 71 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGT--------------APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecC--------------CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcC
Confidence 466677788888887775532110 0112467899999875532 2346688999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~ 384 (452)
++++.+......++++||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||
T Consensus 72 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~ 148 (283)
T cd05091 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHK 148 (283)
T ss_pred eEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---cccc
Confidence 99999999999999999999999988874211 1235889999999999999999999999 9999
Q ss_pred CCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 385 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||+||+++.++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||+|
T Consensus 149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 216 (283)
T cd05091 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216 (283)
T ss_pred ccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHH
Confidence 99999999999999999999998865433322222334557899999999888999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=250.14 Aligned_cols=181 Identities=20% Similarity=0.282 Sum_probs=150.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.+|++...+|.|++|.||.+ ....+++.||+|+.... ....|+.++++++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv 120 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVA-------------------TKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVI 120 (357)
T ss_pred cCcEEEEEecCCCCeEEEEE-------------------EECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCc
Confidence 46888888888888777654 44556788999975432 235699999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++......++|||++.+ +|..++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++
T Consensus 121 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~ 194 (357)
T PHA03209 121 RMKDTLVSGAITCMVLPHYSS-DLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVD 194 (357)
T ss_pred ChhheEEeCCeeEEEEEccCC-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCC
Confidence 999999999999999999965 67666632 3456999999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||+|
T Consensus 195 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl 246 (357)
T PHA03209 195 QVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVL 246 (357)
T ss_pred CEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHH
Confidence 9999999998743221 122335689999999999999999999999999975
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=239.54 Aligned_cols=193 Identities=24% Similarity=0.439 Sum_probs=154.7
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
|++...+++|++|.|+.+.+.. ....+++.||+|.+.... ......+.+|+.+++.++||||++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~---------------~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 70 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDP---------------EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70 (284)
T ss_pred hhhceecCCCCceeEEEEEEcc---------------CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeee
Confidence 4556667777777766442110 123467889999987553 344567999999999999999999
Q ss_pred eeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 319 LLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 319 l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++... ...++||||+++++|.+++... ...+++.+++.++.||+.+|+|||++| ++||||||+||+++.+
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 145 (284)
T cd05079 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 145 (284)
T ss_pred eeeEEecCCCCceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCC
Confidence 99998875 5689999999999999988432 235899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+...... .......|+..|+|||.+.+..++.++||||||+++
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il 202 (284)
T cd05079 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTL 202 (284)
T ss_pred CCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhh
Confidence 99999999999876443221 112234567789999999888899999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=238.62 Aligned_cols=168 Identities=23% Similarity=0.341 Sum_probs=144.0
Q ss_pred ccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 271 KEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
+.|+...+..+++.||||.+... .....+.+.+|+.++++++||||+++++.+..++..++||||+++++|..+.
T Consensus 15 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~---- 90 (279)
T cd06619 15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR---- 90 (279)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh----
Confidence 33444456678899999998755 3334567899999999999999999999999999999999999999986542
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 429 (452)
.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+... ......||..|+
T Consensus 91 ---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~ 160 (279)
T cd06619 91 ---KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYM 160 (279)
T ss_pred ---cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhc
Confidence 3688899999999999999999999 999999999999999999999999998765432 123357899999
Q ss_pred cccccccCCCceeeeeeeeeeeC
Q 012989 430 APEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||.+.+..++.++|+||||+++
T Consensus 161 aPE~~~~~~~~~~~DvwslG~~l 183 (279)
T cd06619 161 APERISGEQYGIHSDVWSLGISF 183 (279)
T ss_pred CceeecCCCCCCcchHHHHHHHH
Confidence 99999988999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=242.55 Aligned_cols=167 Identities=28% Similarity=0.413 Sum_probs=134.4
Q ss_pred cCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEec--CCeEEEEEEecCCCChhhhhccC------CCC
Q 012989 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDS------TKG 351 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~------~~~ 351 (452)
.+++.||+|.+.... ....+.+|+.++++++||||+++++.+.. +...+++|||+++ +|.+++... ...
T Consensus 26 ~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 102 (317)
T cd07868 26 KDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 102 (317)
T ss_pred CCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCc
Confidence 467889999986542 23567889999999999999999999864 4578999999865 676665321 122
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----CCCCCeeEccccccccccCCCc-ccccccccccc
Q 012989 352 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISDFGMARIFSGNQN-EANTNRVVGTY 426 (452)
Q Consensus 352 ~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~ 426 (452)
..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+..... ........||+
T Consensus 103 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~ 179 (317)
T cd07868 103 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179 (317)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccc
Confidence 35899999999999999999999999 9999999999999 4567899999999987654322 12233467899
Q ss_pred cccccccccc-CCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
.|+|||++.+ ..++.++||||+||+|
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwslG~il 206 (317)
T cd07868 180 WYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred cccCCHHHcCCCCcCchhhHHHHHHHH
Confidence 9999999876 4589999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=237.44 Aligned_cols=168 Identities=22% Similarity=0.381 Sum_probs=139.0
Q ss_pred CeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCe------EEEEEEecCCCChhhhhccCC---C
Q 012989 282 GKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE------LLLIYEYMPNKSLDLFLFDST---K 350 (452)
Q Consensus 282 ~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~------~~lv~E~~~~~~L~~~l~~~~---~ 350 (452)
+..||||+++... ....+.+.+|+.+++.++||||+++++.+..... .+++|||+++++|..++.... .
T Consensus 27 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~ 106 (273)
T cd05035 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106 (273)
T ss_pred cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC
Confidence 4789999987542 3345678999999999999999999998765543 799999999999988874432 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccc
Q 012989 351 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMA 430 (452)
Q Consensus 351 ~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 430 (452)
...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+|
T Consensus 107 ~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (273)
T cd05035 107 PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183 (273)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccC
Confidence 346899999999999999999999998 99999999999999999999999999987644332222222334678999
Q ss_pred ccccccCCCceeeeeeeeeeeC
Q 012989 431 PEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 431 PE~~~~~~~s~~~DvwSlG~il 452 (452)
||.+.+..++.++|||||||++
T Consensus 184 pe~~~~~~~~~~~Dv~SlG~il 205 (273)
T cd05035 184 IESLADRVYTSKSDVWAFGVTM 205 (273)
T ss_pred HhhcccCCCCcccchHHHHHHH
Confidence 9999888899999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=242.38 Aligned_cols=185 Identities=23% Similarity=0.286 Sum_probs=154.8
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.|+....+|.|++|.|+ ......+++.+|+|.+... ......++.+|++++++++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~-------------------~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 62 (308)
T cd06615 2 DFEKLGELGAGNGGVVT-------------------KVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62 (308)
T ss_pred CceEEeeccCCCCeEEE-------------------EEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCC
Confidence 35666666777766555 4455667889999998754 233345688999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~ 396 (452)
++++.+..+++.++||||+++++|.+++.. ...+++..+..++.|++++|.|||+ .+ ++|+||||+|||++.+
T Consensus 63 ~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~ 136 (308)
T cd06615 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSR 136 (308)
T ss_pred eEEEEEeeCCEEEEEeeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecC
Confidence 999999999999999999999999999843 3568999999999999999999997 57 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++...... ......|++.|+|||.+.+..++.++|+||||++|
T Consensus 137 ~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 188 (308)
T cd06615 137 GEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188 (308)
T ss_pred CcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHH
Confidence 99999999998754322 12335789999999999888899999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=240.70 Aligned_cols=198 Identities=24% Similarity=0.341 Sum_probs=158.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-||++...+|.|++|.|+.+..... .....+..||+|.+.... ......+.+|+.+++.++||||
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 71 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDI--------------IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEecc--------------CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCe
Confidence 4788889999999998886531100 001235689999886543 2334568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++++.+..+...++||||+++++|.+++..... ...++...+..++.||+.||.|||+++ |+||||||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~ 148 (288)
T cd05061 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAAR 148 (288)
T ss_pred eeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChh
Confidence 9999999999999999999999999999854221 234567889999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||+++...............++..|+|||.+.++.++.++|+|||||++
T Consensus 149 nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 149 NCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred eEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 999999999999999998765433222222233457789999999988999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=237.38 Aligned_cols=194 Identities=23% Similarity=0.371 Sum_probs=155.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|.|++|.|+.+... ....++..+|+|.++... ....+.+.+|+.++++++||||
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~----------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 67 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLK----------------LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEe----------------cCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 36777788888888777644210 001234579999987542 3345678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++||||+++++|.+++.. ....+++.+++.++.|++.+|.+||+.+ ++||||||+|||++.+
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~ 142 (267)
T cd05066 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSN 142 (267)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCC
Confidence 9999999999999999999999999998843 2346899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccc-ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEAN-TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++..+........ .....++..|++||.+.+..++.++|+||||+++
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l 199 (267)
T cd05066 143 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 199 (267)
T ss_pred CeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHH
Confidence 9999999999987654322111 1112335689999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=238.96 Aligned_cols=189 Identities=25% Similarity=0.386 Sum_probs=151.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCe----eeEEEEeecCC-cccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGK----EIAVKRLSRSS-GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~----~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h 313 (452)
.|+....+|.|++|.||.+. ...+++ .+++|.+.... .....++..|+.+++.++|
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~-------------------~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h 68 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGI-------------------WIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68 (279)
T ss_pred hceeccccCccCCcceEEEE-------------------EcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCC
Confidence 45666778888887776553 222333 57888875442 2334667888989999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++. ....++++||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||++
T Consensus 69 ~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili 142 (279)
T cd05111 69 AYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILL 142 (279)
T ss_pred CCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEE
Confidence 99999999875 4557889999999999998843 2356899999999999999999999998 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++...............++..|++||.+.++.++.++||||||++|
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 201 (279)
T cd05111 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201 (279)
T ss_pred cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHH
Confidence 99999999999999876443332223334567889999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=237.07 Aligned_cols=189 Identities=27% Similarity=0.427 Sum_probs=154.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc---------cHHHHHHHHHHHH
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ---------GLQEFKNEVTLIA 309 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~---------~~~~~~~E~~~l~ 309 (452)
||.....++.|++|.++. .....+++.+|+|.+...... ..+.+.+|+.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~-------------------a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 61 (267)
T cd06628 1 KWIKGALIGSGSFGSVYL-------------------GMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61 (267)
T ss_pred CccccceeecCCCeEEEE-------------------EEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHH
Confidence 455556666666655554 344567889999988654322 2256889999999
Q ss_pred cCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 310 KLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 310 ~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++||||+++++++......+++|||+++++|..++. ....+++..+..++.|++.+|++||+.+ ++|+||||+
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~ 135 (267)
T cd06628 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGA 135 (267)
T ss_pred hcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHH
Confidence 9999999999999999999999999999999999883 3456899999999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcc----ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNE----ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||.++........ .......|+..|+|||.+.+..++.++|+||||+++
T Consensus 136 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il 202 (267)
T cd06628 136 NILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLV 202 (267)
T ss_pred HEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHH
Confidence 999999999999999998876532111 111234678999999999888899999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=234.22 Aligned_cols=188 Identities=24% Similarity=0.372 Sum_probs=154.4
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-----cccHHHHHHHHHHHHcCCCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-----GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~ 314 (452)
|++.+.++.|++|.++ ......+++++|+|.+.... ....+.+.+|+.++++++||
T Consensus 4 ~~~~~~lg~g~~~~vy-------------------~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 64 (263)
T cd06625 4 WRRGKLLGQGAFGRVY-------------------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64 (263)
T ss_pred ccccceecCCCceEEE-------------------EEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCC
Confidence 5556666666665554 44455678999999886542 12345688999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++..+...++||||+++++|.+++. ....+++..++.++.|++.||.+||+.+ |+|+||||+||+++
T Consensus 65 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~ 138 (263)
T cd06625 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRD 138 (263)
T ss_pred CeeeeEEEEccCCeEEEEEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 99999999999999999999999999998884 3356889999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCcccc-ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEAN-TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++.......... .....|+..|+|||++.+..++.++||||||++|
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 197 (263)
T cd06625 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTV 197 (263)
T ss_pred CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHH
Confidence 999999999999876543221111 1234678899999999988899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=254.00 Aligned_cols=189 Identities=24% Similarity=0.375 Sum_probs=153.9
Q ss_pred ccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeec----CCcccHHHHHHHHHHH
Q 012989 233 YPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSR----SSGQGLQEFKNEVTLI 308 (452)
Q Consensus 233 ~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~~E~~~l 308 (452)
...+++||+. .+|.|.+-+||++ -+..+|.+||=-.++. +++...++|..|+.+|
T Consensus 37 p~gRy~k~~e--vLGrGafKtVYka-------------------~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lL 95 (632)
T KOG0584|consen 37 PTGRYLKFDE--VLGRGAFKTVYKA-------------------FDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLL 95 (632)
T ss_pred CCCceeehhh--hcccccceeeeec-------------------cccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHH
Confidence 3455666664 5677777777766 3445676665332221 2455668999999999
Q ss_pred HcCCCCCccceeeeEecCCe--EEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 309 AKLQHKNLVRLLGCCLDGNE--LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 309 ~~l~h~~iv~l~~~~~~~~~--~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
+.|+||||++++++|.+... +-+|+|++..|+|..|+ ++.+..+...++.|++||++||.|||++. .|||||||
T Consensus 96 KsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~---kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDL 171 (632)
T KOG0584|consen 96 KSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYR---KKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDL 171 (632)
T ss_pred ccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHH---HHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCcccccc
Confidence 99999999999999997654 88999999999999999 45566899999999999999999999986 69999999
Q ss_pred CCCCeEECCC-CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 387 KTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 387 kp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
|.+||+|+.+ |.|||+|+|+|..... ......+|||.|||||++. ..|+...||||||..
T Consensus 172 KCDNIFinG~~G~VKIGDLGLAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMC 232 (632)
T KOG0584|consen 172 KCDNIFVNGNLGEVKIGDLGLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMC 232 (632)
T ss_pred ccceEEEcCCcCceeecchhHHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHH
Confidence 9999999854 8899999999987542 2234479999999999996 789999999999963
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=235.38 Aligned_cols=188 Identities=28% Similarity=0.428 Sum_probs=155.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++.+.+|.|++|.|+.+ ...++..||+|.+.... ...+.+.+|+.+++.++|+||++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~--------------------~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 65 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMG--------------------YYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVR 65 (261)
T ss_pred HeEEeeecCCcCCceEEEE--------------------EecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeee
Confidence 5666667777777666543 23456789999886543 34578999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+...+..+++|||+++++|.+++... ....+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.
T Consensus 66 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~ 141 (261)
T cd05072 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLM 141 (261)
T ss_pred EEEEEcCCCCcEEEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCc
Confidence 999999999999999999999999988542 3456889999999999999999999998 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||++......... ......++..|+|||.+.++.++.++||||||+++
T Consensus 142 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 194 (261)
T cd05072 142 CKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 194 (261)
T ss_pred EEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHH
Confidence 999999999876443221 12223457789999999888899999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=234.45 Aligned_cols=188 Identities=26% Similarity=0.393 Sum_probs=157.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+....++.|++|.++.+ ....+++.+++|.+........+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~ 64 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKA-------------------RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64 (262)
T ss_pred ceEEEEEecCCCceEEEEe-------------------EecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhc
Confidence 5666666777776655543 455578899999998766666788999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+...+..+++|||+++++|.+++.. ....+++.+++.++.|++.+|.|||+++ |+|+||||+||+++.++.
T Consensus 65 ~~~~~~~~~~~~l~~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~ 139 (262)
T cd06613 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGD 139 (262)
T ss_pred eEEEEEeCCEEEEEEeCCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCC
Confidence 99999999999999999999999998843 2256899999999999999999999998 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccC---CCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG---VFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwSlG~il 452 (452)
+||+|||++..+..... ......++..|+|||.+.+. .++.++|+||||++|
T Consensus 140 ~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l 194 (262)
T cd06613 140 VKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITA 194 (262)
T ss_pred EEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHH
Confidence 99999999876543221 12234678899999999766 889999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=234.86 Aligned_cols=167 Identities=23% Similarity=0.387 Sum_probs=137.9
Q ss_pred cCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHH
Q 012989 280 ADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKR 358 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~ 358 (452)
.++..||+|++.... ....+.+.+|+.++++++||||+++++.+. ....++||||+++++|.+++.. ....+++..
T Consensus 20 ~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~ 96 (257)
T cd05115 20 KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG--KKDEITVSN 96 (257)
T ss_pred CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHh--CCCCCCHHH
Confidence 346679999987653 333467899999999999999999999875 4578999999999999998843 245689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccc-ccccccccccccccccccC
Q 012989 359 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVVGTYGYMAPEYAMEG 437 (452)
Q Consensus 359 ~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~ 437 (452)
++.++.||+.+|.|||+++ ++||||||+||+++.++.+||+|||++..+........ .....++..|+|||.+.+.
T Consensus 97 ~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05115 97 VVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173 (257)
T ss_pred HHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC
Confidence 9999999999999999999 99999999999999999999999999976543322111 1112235789999999888
Q ss_pred CCceeeeeeeeeeeC
Q 012989 438 VFSVNRMFLVSEFFF 452 (452)
Q Consensus 438 ~~s~~~DvwSlG~il 452 (452)
.++.++||||||++|
T Consensus 174 ~~~~~~Di~slG~~l 188 (257)
T cd05115 174 KFSSRSDVWSYGITM 188 (257)
T ss_pred CCCchhhHHHHHHHH
Confidence 899999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=247.06 Aligned_cols=198 Identities=24% Similarity=0.339 Sum_probs=157.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
-||++.+.+|.|++|.|+.+..... ....+++.||||+++... ......+.+|+.++.++ +|||
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 72 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGI--------------DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 72 (343)
T ss_pred hHhcccccccCCccceEEEEeeccC--------------CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCcc
Confidence 3788999999999999887642110 123467899999997543 33346788999999999 6899
Q ss_pred ccceeeeEecC-CeEEEEEEecCCCChhhhhccCCC--------------------------------------------
Q 012989 316 LVRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDSTK-------------------------------------------- 350 (452)
Q Consensus 316 iv~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~~-------------------------------------------- 350 (452)
|+++++.+... ...++||||+++++|.+++.....
T Consensus 73 iv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (343)
T cd05103 73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGF 152 (343)
T ss_pred HhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccc
Confidence 99999987654 568999999999999988753210
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccc
Q 012989 351 --------------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 351 --------------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 410 (452)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 153 VEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred cCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 124788889999999999999999999 999999999999999999999999998765
Q ss_pred cCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 411 SGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 411 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.............++..|+|||.+.+..++.++||||||++|
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 271 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHH
Confidence 433222222223456789999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=232.26 Aligned_cols=180 Identities=29% Similarity=0.445 Sum_probs=151.0
Q ss_pred CccEEEEEEecC---CeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 270 SKEICVQGILAD---GKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 270 ~~~v~~~~~~~~---~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
++.|+....... +..|++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++++|.+++
T Consensus 8 ~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 87 (262)
T cd00192 8 FGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYL 87 (262)
T ss_pred ceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHH
Confidence 344444444444 889999999766433 3678999999999999999999999999999999999999999999998
Q ss_pred ccCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccc
Q 012989 346 FDSTK------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 419 (452)
Q Consensus 346 ~~~~~------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 419 (452)
..... ...+++.+++.++.|++.||++||+++ ++|+||||+||+++.++.+||+|||.+............
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 164 (262)
T cd00192 88 RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164 (262)
T ss_pred hhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccc
Confidence 54321 367999999999999999999999999 999999999999999999999999999876544322223
Q ss_pred cccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 420 NRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 420 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
....++..|+|||.+....++.++||||+|+++
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 197 (262)
T cd00192 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLL 197 (262)
T ss_pred cCCCcCccccCHHHhccCCcchhhccHHHHHHH
Confidence 345678899999999888899999999999974
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=238.04 Aligned_cols=190 Identities=24% Similarity=0.374 Sum_probs=153.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCe----eeEEEEeecC-CcccHHHHHHHHHHHHcCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGK----EIAVKRLSRS-SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~----~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~ 312 (452)
.+|+....+|.|++|.||.+. ...+++ .||+|.+... .....+.+.+|+.+++.++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~-------------------~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~ 67 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGI-------------------WIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67 (279)
T ss_pred hheeeeeecCCCCCceEEEEE-------------------EecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC
Confidence 356777888888888777553 223333 5899998754 3334567889999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++.+... ..+++||++++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 68 ~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil 141 (279)
T cd05109 68 SPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVL 141 (279)
T ss_pred CCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 99999999988754 57899999999999988843 2346899999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++...............+++.|+|||...+..++.++|||||||+|
T Consensus 142 ~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05109 142 VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV 201 (279)
T ss_pred EcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHH
Confidence 999999999999999876533322222222346789999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=237.06 Aligned_cols=190 Identities=21% Similarity=0.338 Sum_probs=156.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++...++.|.+|.|+. .....+++.||||.+... .......+.+|+++++.++|||
T Consensus 3 ~~~i~~~l~~g~~~~v~~-------------------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 63 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYR-------------------ATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63 (267)
T ss_pred ceeeeeeeccCCCeeEEE-------------------EEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcc
Confidence 566666777777765554 455568899999987643 2333456889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|+++++.+...+..+++|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++
T Consensus 64 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~ 140 (267)
T cd08228 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEc
Confidence 9999999999999999999999999988774322 2345899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.++|+|||++..+..... ......|++.|+|||.+.+..++.++|+||||+++
T Consensus 141 ~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 196 (267)
T cd08228 141 ATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196 (267)
T ss_pred CCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 999999999999876543321 12234678899999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=234.17 Aligned_cols=187 Identities=22% Similarity=0.349 Sum_probs=152.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|+..+.+|.|++|.|+.+ ...++..+|+|.+... ......+.+|+.++++++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~--------------------~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 63 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLG--------------------KWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQ 63 (256)
T ss_pred HcEEeeEecCCcCceEEEE--------------------EeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCcee
Confidence 3555666777777666543 3345668999987643 334567899999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++..+...++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.
T Consensus 64 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~ 138 (256)
T cd05114 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGV 138 (256)
T ss_pred EEEEEccCCCEEEEEEcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCe
Confidence 999999999999999999999999888432 235899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||.++........ ......++..|+|||.+.+..++.++|+||||++|
T Consensus 139 ~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l 191 (256)
T cd05114 139 VKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLM 191 (256)
T ss_pred EEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHH
Confidence 999999998765332221 11223456789999999888899999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=234.79 Aligned_cols=187 Identities=23% Similarity=0.384 Sum_probs=152.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+....+|.|++|.++.+ ...++..+|||.+.... ...+.+.+|+.++++++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~--------------------~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 63 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYG--------------------KWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQ 63 (256)
T ss_pred HeEEeeEecCcccceEEEE--------------------EecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeee
Confidence 4566667777777766543 22345569999887543 33567899999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++......++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.
T Consensus 64 ~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~ 138 (256)
T cd05113 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGC 138 (256)
T ss_pred EEEEEccCCCcEEEEEcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCC
Confidence 999999999999999999999999988432 236899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||.++........ ......++..|++||.+.+..++.++||||||++|
T Consensus 139 ~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l 191 (256)
T cd05113 139 VKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM 191 (256)
T ss_pred EEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHH
Confidence 999999998765433211 11223456789999999888899999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=242.14 Aligned_cols=202 Identities=27% Similarity=0.368 Sum_probs=159.7
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h 313 (452)
+..||.+...+|.|++|.|+.+...... +........+|+|.+... .......+.+|+.+++++ +|
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~------------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h 77 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGID------------KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccC------------CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCC
Confidence 4468888899999999988866321100 001124567899988754 233456788999999999 69
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
|||+++++++...+..+++|||+++++|.+++.... ....+++.++..++.||+.||.|||++|
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--- 154 (314)
T cd05099 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--- 154 (314)
T ss_pred CCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 999999999999999999999999999999885422 1245899999999999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+|||++.++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++
T Consensus 155 i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 226 (314)
T cd05099 155 CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226 (314)
T ss_pred eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHH
Confidence 999999999999999999999999999865432221111122345679999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=238.09 Aligned_cols=187 Identities=24% Similarity=0.341 Sum_probs=155.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|+....++.|++|.++.+ ....+++.||+|++.... ....+.+.+|+.++++++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~-------------------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i 62 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKC-------------------RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62 (286)
T ss_pred ceeeeeeecccCCeEEEEE-------------------EECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCE
Confidence 5777777777777666543 445578999999886542 2234568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+......++||||+++++|..++. ....+++..++.++.||+.+|+|||+.+ ++|+||||+||+++.+
T Consensus 63 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~ 136 (286)
T cd07847 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQ 136 (286)
T ss_pred eeeeeEEeeCCEEEEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCC
Confidence 999999999999999999999998888763 3346899999999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++
T Consensus 137 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~ 191 (286)
T cd07847 137 GQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVF 191 (286)
T ss_pred CcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHH
Confidence 9999999999987644321 1223457889999999865 5578999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=241.97 Aligned_cols=191 Identities=22% Similarity=0.288 Sum_probs=159.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc---ccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG---QGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+....++.|++|.+|.+ ....+++.+|||.+..... ...+.+.+|+++++.++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 62 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLV-------------------RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62 (316)
T ss_pred ceEEeeeecCCccEEEEEE-------------------EEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCC
Confidence 5777788888888766644 4455789999999976532 24567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+......++||||+.+++|.+++.. .....+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~ 138 (316)
T cd05574 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHE 138 (316)
T ss_pred chhheeeeecCCEEEEEEEecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcC
Confidence 99999999999999999999999999998843 23457999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcc---------------------------ccccccccccccccccccccCCCceeeeeeee
Q 012989 396 EMNPKISDFGMARIFSGNQNE---------------------------ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVS 448 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 448 (452)
++.++|+|||++......... .......||..|+|||++.+..++.++|||||
T Consensus 139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 218 (316)
T cd05574 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218 (316)
T ss_pred CCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence 999999999998754322111 11223478999999999998889999999999
Q ss_pred eeeC
Q 012989 449 EFFF 452 (452)
Q Consensus 449 G~il 452 (452)
|+++
T Consensus 219 G~ll 222 (316)
T cd05574 219 GILL 222 (316)
T ss_pred HHHH
Confidence 9874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=238.47 Aligned_cols=188 Identities=24% Similarity=0.378 Sum_probs=155.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|++...+|.|++|.|+ ......+++.+++|.+........+.+.+|+.+++.++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy-------------------~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 73 (292)
T cd06644 13 VWEIIGELGDGAFGKVY-------------------KAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73 (292)
T ss_pred hhhhhheecCCCCeEEE-------------------EEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEee
Confidence 45666666666665554 44566678999999998776667788999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+..+...++||||+++++|..++.. ....+++..++.++.||+.+|.|||+++ ++||||||+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~ 148 (292)
T cd06644 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGD 148 (292)
T ss_pred eEEEEEeCCeEEEEEecCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCC
Confidence 99999999999999999999999887633 2346899999999999999999999998 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+||+|||++....... .......+++.|+|||++. ...++.++|+||||+++
T Consensus 149 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 149 IKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred EEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 9999999987543221 1123346789999999984 34578899999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=236.44 Aligned_cols=197 Identities=28% Similarity=0.413 Sum_probs=159.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+....+|.|++|.|+.+.... .....++..+|+|.+........+.+.+|+++++.++|+||++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~--------------~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 71 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHN--------------LLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71 (280)
T ss_pred hceeccccCCccCCeEEEeEEec--------------CCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCce
Confidence 55566778888888777552110 0112356789999988766666778999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
+++++...+..+++|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dl 148 (280)
T cd05092 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDL 148 (280)
T ss_pred EEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 99999999999999999999999988854321 135899999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|||+++++.+||+|||++................+++.|+|||.+.+..++.++|||||||+|
T Consensus 149 kp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 149 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred cHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 999999999999999999998765433222222233457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=234.20 Aligned_cols=177 Identities=23% Similarity=0.365 Sum_probs=148.8
Q ss_pred CCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccC
Q 012989 269 SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS 348 (452)
Q Consensus 269 ~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 348 (452)
.++.++......++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++||||+++++|..++..
T Consensus 17 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~- 95 (282)
T cd06643 17 AFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE- 95 (282)
T ss_pred CCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh-
Confidence 3344445566667899999999776666677899999999999999999999999999999999999999999887743
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccc
Q 012989 349 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGY 428 (452)
Q Consensus 349 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 428 (452)
....+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||++....... .......|++.|
T Consensus 96 -~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y 169 (282)
T cd06643 96 -LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYW 169 (282)
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccc
Confidence 2356899999999999999999999999 9999999999999999999999999987643321 122335689999
Q ss_pred ccccccc-----cCCCceeeeeeeeeeeC
Q 012989 429 MAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 429 ~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+|||++. +..++.++|+|||||++
T Consensus 170 ~aPE~~~~~~~~~~~~~~~~Dv~slGvil 198 (282)
T cd06643 170 MAPEVVMCETSKDRPYDYKADVWSLGITL 198 (282)
T ss_pred cCHhhccccCCCCCCCCccchhhhHHHHH
Confidence 9999973 45578899999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=266.07 Aligned_cols=197 Identities=21% Similarity=0.302 Sum_probs=157.6
Q ss_pred cccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcC
Q 012989 234 PSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 234 ~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l 311 (452)
+...-+|++...+|.|++|.||.+ .+..+++.+|+|.+... .......+..|+.++++|
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLA-------------------kdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L 69 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLV-------------------KHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEE-------------------EECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc
Confidence 444568899999999998777654 45567889999998754 233456789999999999
Q ss_pred CCCCccceeeeEec--CCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeEec
Q 012989 312 QHKNLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSR----LRVIHR 384 (452)
Q Consensus 312 ~h~~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~----~~ivH~ 384 (452)
+||||++++++|.. ...+||||||+++++|.+++... .....+++..++.|+.||+.||.|||+.+. .+||||
T Consensus 70 ~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR 149 (1021)
T PTZ00266 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR 149 (1021)
T ss_pred CCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec
Confidence 99999999998864 45799999999999999888542 223569999999999999999999998431 239999
Q ss_pred CCCCCCeEECC-----------------CCCeeEccccccccccCCCcccccccccccccccccccccc--CCCceeeee
Q 012989 385 DLKTSNVLLDH-----------------EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME--GVFSVNRMF 445 (452)
Q Consensus 385 Dlkp~NIll~~-----------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv 445 (452)
||||+||||+. .+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||
T Consensus 150 DLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDV 226 (1021)
T PTZ00266 150 DLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDM 226 (1021)
T ss_pred cCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHH
Confidence 99999999964 2348999999998654322 1234578999999999854 458999999
Q ss_pred eeeeeeC
Q 012989 446 LVSEFFF 452 (452)
Q Consensus 446 wSlG~il 452 (452)
|||||||
T Consensus 227 WSLG~IL 233 (1021)
T PTZ00266 227 WALGCII 233 (1021)
T ss_pred HHHHHHH
Confidence 9999985
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=235.97 Aligned_cols=188 Identities=28% Similarity=0.431 Sum_probs=157.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|+....+|.|++|.|+.+ .. .+++.+++|.+........+.+.+|+.+++.++||||++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~-------------------~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 66 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEG-------------------LW-KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66 (261)
T ss_pred HHHHhhhhccCCCccEEEe-------------------Ee-cCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhh
Confidence 4566666677777666544 22 338899999998776656778999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++......++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~ 142 (261)
T cd05148 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLV 142 (261)
T ss_pred eeeeEecCCCeEEEEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCce
Confidence 999999999999999999999999998553 3456899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||.+.......... ....++..|++||.+.+..++.++||||||+++
T Consensus 143 ~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l 194 (261)
T cd05148 143 CKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILL 194 (261)
T ss_pred EEEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHH
Confidence 9999999997654332211 123457789999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=233.40 Aligned_cols=189 Identities=25% Similarity=0.359 Sum_probs=155.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|++.+.++.|++|.++ ......+++.||+|++.... ....+.+.+|++++++++|+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~-------------------~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 61 (257)
T cd08223 1 AYCFVRVVGKGSYGEVS-------------------LVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61 (257)
T ss_pred CceEEEEecCCCCeEEE-------------------EEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCe
Confidence 36677777777765555 44556678899999987542 3345678899999999999999
Q ss_pred cceeeeEec-CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 317 VRLLGCCLD-GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 317 v~l~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
+++++.+.. +...+++|||+++++|.+++... ....+++.+++.++.|++.+|++||+.+ ++|+||||+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~ 137 (257)
T cd08223 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTR 137 (257)
T ss_pred eeeeeeecCCCCEEEEEecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEec
Confidence 999998874 44689999999999999888542 3456899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++|+|||++........ ......|++.|+|||++.+..++.++|+||||+++
T Consensus 138 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 192 (257)
T cd08223 138 TNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCV 192 (257)
T ss_pred CCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHH
Confidence 99999999999986643322 22345679999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=239.72 Aligned_cols=190 Identities=28% Similarity=0.420 Sum_probs=152.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCe--eeEEEEeecC-CcccHHHHHHHHHHHHcC-CC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGK--EIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~--~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h 313 (452)
..|++...+|.|++|.|+.+ ....++. .+++|.+... .......+.+|+.++.++ +|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a-------------------~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h 67 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKA-------------------RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67 (303)
T ss_pred hhceeeeeecCCCCceEEEE-------------------EEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCC
Confidence 35677777888888777655 3333454 4678777543 333456788999999999 89
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
|||+++++++..++.+++||||+++++|.+++.... ....+++.+++.++.||+.||+|||++|
T Consensus 68 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--- 144 (303)
T cd05088 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--- 144 (303)
T ss_pred CCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 999999999999999999999999999999885432 1235899999999999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||||||+|||++.++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||++|
T Consensus 145 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 145 FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 999999999999999999999999998642211 111112346779999999888899999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=270.78 Aligned_cols=190 Identities=27% Similarity=0.382 Sum_probs=159.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.+||.-..|+|+|.||.||. +....+|+..|+|.++.. .....+.+.+|..++..|+||
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYt-------------------avN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHp 1294 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYT-------------------AVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHP 1294 (1509)
T ss_pred eeeeccccccCCcceeeeEE-------------------eecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCc
Confidence 45666666666666666554 466789999999988754 344566788999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|+|+++++=.+.+..+|.||||++|+|.+++ ..++-.++.....+..|++.|+.|||++| ||||||||.||+++
T Consensus 1295 NlV~YyGVEvHRekv~IFMEyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld 1368 (1509)
T KOG4645|consen 1295 NLVRYYGVEVHREKVYIFMEYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLD 1368 (1509)
T ss_pred cccccCceeecHHHHHHHHHHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeee
Confidence 9999999999999999999999999999998 44555778888889999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCcc--cccccccccccccccccccc---CCCceeeeeeeeeee
Q 012989 395 HEMNPKISDFGMARIFSGNQNE--ANTNRVVGTYGYMAPEYAME---GVFSVNRMFLVSEFF 451 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~i 451 (452)
.+|.+|++|||.|..+.+.... .......||+.|||||++.+ ..-..++||||+||+
T Consensus 1369 ~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCV 1430 (1509)
T KOG4645|consen 1369 FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCV 1430 (1509)
T ss_pred cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccce
Confidence 9999999999999887655311 12345689999999999964 335678999999997
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=232.77 Aligned_cols=176 Identities=24% Similarity=0.374 Sum_probs=146.6
Q ss_pred ccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK 350 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~ 350 (452)
+.|+......+++.||+|.+... ......+.+|+++++.++||||+++++.+..+...+++|||+++++|.+++... .
T Consensus 20 ~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~ 97 (263)
T cd05052 20 GEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-N 97 (263)
T ss_pred ceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC-C
Confidence 33444455667899999998654 344567899999999999999999999999999999999999999999988442 3
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccc
Q 012989 351 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMA 430 (452)
Q Consensus 351 ~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 430 (452)
...+++..++.++.|++++|+|||+.+ ++||||||+||+++.++.+||+|||++......... ......++..|+|
T Consensus 98 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~a 173 (263)
T cd05052 98 RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 173 (263)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCC
Confidence 346899999999999999999999998 999999999999999999999999998765433211 1112234678999
Q ss_pred ccccccCCCceeeeeeeeeeeC
Q 012989 431 PEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 431 PE~~~~~~~s~~~DvwSlG~il 452 (452)
||.+.+..++.++|||||||+|
T Consensus 174 PE~~~~~~~~~~~Dv~slG~il 195 (263)
T cd05052 174 PESLAYNKFSIKSDVWAFGVLL 195 (263)
T ss_pred HHHhccCCCCchhHHHHHHHHH
Confidence 9999888999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=237.73 Aligned_cols=176 Identities=28% Similarity=0.381 Sum_probs=144.1
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS 348 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 348 (452)
+.|+......+++.||||++.... ....+.+.+|+.+++.++||||+++++.+..+...++||||++ ++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~ 92 (285)
T cd07861 14 GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSL 92 (285)
T ss_pred eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcC
Confidence 344444556688999999986542 2334678899999999999999999999999999999999997 4777777543
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccc
Q 012989 349 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGY 428 (452)
Q Consensus 349 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 428 (452)
.....+++..++.++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||++....... .......+++.|
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y 167 (285)
T cd07861 93 PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWY 167 (285)
T ss_pred CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccc
Confidence 44467999999999999999999999999 9999999999999999999999999987653321 112234568999
Q ss_pred ccccccccC-CCceeeeeeeeeeeC
Q 012989 429 MAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 429 ~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+|||.+.+. .++.++||||||+++
T Consensus 168 ~aPE~~~~~~~~~~~~Dv~slG~il 192 (285)
T cd07861 168 RAPEVLLGSPRYSTPVDIWSIGTIF 192 (285)
T ss_pred cChHHhcCCCCcCcHHHHHHHHHHH
Confidence 999988654 478999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=248.73 Aligned_cols=188 Identities=21% Similarity=0.330 Sum_probs=162.7
Q ss_pred CCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEe
Q 012989 259 FSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335 (452)
Q Consensus 259 ~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~ 335 (452)
+...+.++.|.+|+|++.....+...+|+|.+.+.+ .......+.|-.||..-.++-||+||..|++++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 344566789999999999999999999999998763 33445678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCc
Q 012989 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415 (452)
Q Consensus 336 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 415 (452)
++||++-.+| .+.+-|++..++.++.+|.-|+++.|+.| +|||||||+|||||.+|++||.||||+.-|.....
T Consensus 711 IPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 711 IPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred cCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999998887 56677999999999999999999999999 99999999999999999999999999965421100
Q ss_pred --------c--------------------------------ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 416 --------E--------------------------------ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 416 --------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ ......+||+.|+|||++....++..+|+||.|+||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0 001235899999999999999999999999999986
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=235.05 Aligned_cols=169 Identities=23% Similarity=0.308 Sum_probs=136.2
Q ss_pred CCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCC--CCCCCHH
Q 012989 281 DGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK--GAQLDWK 357 (452)
Q Consensus 281 ~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--~~~l~~~ 357 (452)
....+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++++|.+++..... ...+++.
T Consensus 21 ~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05042 21 SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD 100 (269)
T ss_pred CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHH
Confidence 45678889876443 33345688999999999999999999999999999999999999999998855322 2345678
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccc--
Q 012989 358 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-- 435 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-- 435 (452)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++................+++.|+|||++.
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05042 101 VLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhc
Confidence 88999999999999999999 9999999999999999999999999986543222111122334577899999874
Q ss_pred -----cCCCceeeeeeeeeeeC
Q 012989 436 -----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 436 -----~~~~s~~~DvwSlG~il 452 (452)
...++.++|||||||+|
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 178 GQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred cccccccccchhhHHHHHHHHH
Confidence 34578899999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=234.89 Aligned_cols=189 Identities=24% Similarity=0.339 Sum_probs=152.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-----cccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-----GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~h 313 (452)
.|++...++.|++|.++. .....+++.||||.+.... ....+.+.+|+.++++++|
T Consensus 3 ~~~~~~~l~~g~~g~v~~-------------------~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 63 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYL-------------------CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63 (265)
T ss_pred cceEeeEEecCCceEEEE-------------------EEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCC
Confidence 355666777777765553 3455678999999886431 1234578899999999999
Q ss_pred CCccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 314 KNLVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 314 ~~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
|||+++++.+... ..++++|||+++++|.+++. ....+++..++.++.|++.+|++||+.+ ++|+||||+||
T Consensus 64 ~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~ni 137 (265)
T cd06652 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANI 137 (265)
T ss_pred CCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHE
Confidence 9999999988764 46889999999999998884 3345889999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||++......... .......|+..|+|||.+.+..++.++|+||||+++
T Consensus 138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 199 (265)
T cd06652 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199 (265)
T ss_pred EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHH
Confidence 9999999999999998765432111 112234688999999999888899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=250.43 Aligned_cols=197 Identities=23% Similarity=0.360 Sum_probs=155.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCC-CCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQ-HKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i 316 (452)
+|.+.+.+|.|++|.|+.+..... .....++.||||+++... ....+.+.+|+.+|.++. ||||
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~--------------~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGL--------------SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCC--------------CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCe
Confidence 455566777777777765532100 012346789999997552 333457889999999997 9999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-----------------------------------------------
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST----------------------------------------------- 349 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----------------------------------------------- 349 (452)
+++++.+......++||||+++++|.++++...
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 999999999999999999999999998885421
Q ss_pred ------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 350 ------------------------------------------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 350 ------------------------------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
....+++..++.|+.||+.||+|||+.+ |
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---i 260 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---C 260 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---c
Confidence 1124678889999999999999999998 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||||||+|||++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||++|
T Consensus 261 vHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil 331 (401)
T cd05107 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILL 331 (401)
T ss_pred CcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHH
Confidence 99999999999999999999999999865433222222334568899999999888899999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=230.26 Aligned_cols=178 Identities=23% Similarity=0.273 Sum_probs=155.6
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|.+|+|.+++...+++.+|||++++. .+.....-+.|-++|+.-+||.+..+...|+.++++|+||||..||.|..
T Consensus 178 kGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~ 257 (516)
T KOG0690|consen 178 KGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFF 257 (516)
T ss_pred CCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEee
Confidence 334455557777889999999999876 34445567789999999999999999999999999999999999999977
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
.+ .+.+.|++...+.+..+|+.||.|||+++ ||.||||.+|.|+|.+|++||.|||+++.- -........++
T Consensus 258 HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFC 329 (516)
T KOG0690|consen 258 HL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFC 329 (516)
T ss_pred eh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--ccccceecccc
Confidence 77 45677999999999999999999999999 999999999999999999999999999752 23344566789
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||.|.|||++....|....|+|.+|+++
T Consensus 330 GTPEYLAPEVleDnDYgraVDWWG~GVVM 358 (516)
T KOG0690|consen 330 GTPEYLAPEVLEDNDYGRAVDWWGVGVVM 358 (516)
T ss_pred CChhhcCchhhccccccceeehhhhhHHH
Confidence 99999999999999999999999999874
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=238.37 Aligned_cols=188 Identities=23% Similarity=0.353 Sum_probs=156.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++...++.|++|.|+ ......+++.+|+|.+........+.+.+|++++++++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~-------------------~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 66 (280)
T cd06611 6 IWEIIGELGDGAFGKVY-------------------KAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66 (280)
T ss_pred HHHHHHHhcCCCCceEE-------------------EEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeE
Confidence 56666666777766555 33445578999999998776666778999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+..+...++||||+++++|..++.. ....+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~ 141 (280)
T cd06611 67 LYEAYFYENKLWILIEFCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGD 141 (280)
T ss_pred EEEEEecCCeEEEEeeccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCC
Confidence 99999999999999999999999998843 2346999999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
++|+|||++........ ......|++.|+|||.+. ...++.++|+||||+++
T Consensus 142 ~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il 198 (280)
T cd06611 142 VKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITL 198 (280)
T ss_pred EEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHH
Confidence 99999999876433221 123356899999999874 34578899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=236.75 Aligned_cols=198 Identities=26% Similarity=0.379 Sum_probs=154.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..|++...+|.|++|.||.+..... .....+..||+|.+.... ......+.+|+.+++.++|+||
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~--------------~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 71 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGR--------------DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecC--------------CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCE
Confidence 4567777788888877765532100 000156789999886543 3334568999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK----GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
+++++++......++||||+++++|.+++..... ...+++..++.++.||+.+|+|||+++ ++|+||||+||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil 148 (277)
T cd05036 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCL 148 (277)
T ss_pred eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEE
Confidence 9999999999999999999999999998854321 235899999999999999999999998 999999999999
Q ss_pred ECCCC---CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEM---NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++ .+||+|||+++................+..|+|||++.+..++.++|||||||+|
T Consensus 149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 211 (277)
T cd05036 149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211 (277)
T ss_pred EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHH
Confidence 98765 5999999999876332221112222345689999999988999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=240.84 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=158.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
.+|.+.+.+|+|++|.|+.+....... ....+...+|+|.+... .......+.+|+.+++.+ +|||
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDK------------EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCC------------cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCC
Confidence 478888999999999888663211000 01123467999998754 234456788999999999 7999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
|+++++.+...+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+++ ++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~ 162 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI 162 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999999854321 235899999999999999999999998 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||||+||+++.++.+||+|||.++...............+++.|+|||.+.+..++.++|||||||+|
T Consensus 163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 232 (307)
T cd05098 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 232 (307)
T ss_pred cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999998765432211111122345789999999888899999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=239.41 Aligned_cols=176 Identities=26% Similarity=0.421 Sum_probs=150.6
Q ss_pred CCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 268 TSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 268 ~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
+.++.++......+++.||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++++|..++.
T Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~- 110 (297)
T cd06659 32 GSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS- 110 (297)
T ss_pred CCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-
Confidence 3344555556667899999999976655556778999999999999999999999999999999999999999988772
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
...+++..++.++.|++.+|.+||+.+ ++|+||||+||+++.++.+||+|||++..+..... ......|+..
T Consensus 111 ---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~ 182 (297)
T cd06659 111 ---QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPY 182 (297)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCcc
Confidence 245899999999999999999999999 99999999999999999999999999876543321 2233568999
Q ss_pred cccccccccCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||++.+..++.++||||||++|
T Consensus 183 y~aPE~~~~~~~~~~~Dv~slG~il 207 (297)
T cd06659 183 WMAPEVISRTPYGTEVDIWSLGIMV 207 (297)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHH
Confidence 9999999888899999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=242.68 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=158.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
.||++...+|.|++|.|+.+...... +........||+|.+... .....+.+.+|+.+++++ +|||
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGID------------KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccC------------CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCC
Confidence 47888889999999888765321100 000123457899988754 233456789999999999 8999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
|+++++.+..++..+++|||+++++|.+++.... ....+++.+++.++.||+.||.|||+++ |+
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---iv 156 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CI 156 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 9999999999999999999999999999885421 2345888999999999999999999999 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||++|
T Consensus 157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 226 (334)
T cd05100 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 226 (334)
T ss_pred ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHH
Confidence 9999999999999999999999999765433222112222345689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=236.32 Aligned_cols=186 Identities=24% Similarity=0.366 Sum_probs=157.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
||+....++.|++|.++ ......+++.||+|.+.... ......+.+|+.+++.++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~-------------------~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 62 (274)
T cd06609 2 LFTLLECIGKGSFGEVY-------------------KAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62 (274)
T ss_pred hhhhhhhhcCCCCeEEE-------------------EEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCee
Confidence 56666666666665555 44555689999999987653 34456788999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+..+...++|+||+++++|.+++.. ..+++..++.++.|++.+|.+||+++ ++|+||+|+||+++.++
T Consensus 63 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~ 135 (274)
T cd06609 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEG 135 (274)
T ss_pred eeeEEEEECCeEEEEEEeeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCC
Confidence 999999999999999999999999998842 27899999999999999999999998 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++|+|||+++....... ......|++.|+|||.+.+..++.++||||||++|
T Consensus 136 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il 188 (274)
T cd06609 136 DVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188 (274)
T ss_pred CEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 999999999987654321 22334678899999999888899999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=231.51 Aligned_cols=177 Identities=28% Similarity=0.373 Sum_probs=150.9
Q ss_pred CccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 270 SKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
.+.++......+++.|++|.+... .....+.+.+|+++++.++||||+++++.+..++..++||||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 92 (256)
T cd08529 13 FGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM 92 (256)
T ss_pred CeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHH
Confidence 344445566678999999998754 344567789999999999999999999999999999999999999999998854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
. ....+++..++.++.||+.+|.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..... ......|++.
T Consensus 93 ~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 166 (256)
T cd08529 93 Q-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPY 166 (256)
T ss_pred h-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCcc
Confidence 3 3456899999999999999999999998 99999999999999999999999999886654322 1233467899
Q ss_pred cccccccccCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||+..+..++.++|+||||+++
T Consensus 167 y~aPE~~~~~~~~~~~Di~slG~il 191 (256)
T cd08529 167 YLSPELCEDKPYNEKSDVWALGVVL 191 (256)
T ss_pred ccCHHHhcCCCCCCccchHHHHHHH
Confidence 9999999988899999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=236.03 Aligned_cols=176 Identities=26% Similarity=0.415 Sum_probs=146.6
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC------cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
+.++......+++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.++
T Consensus 14 ~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~ 93 (268)
T cd06630 14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL 93 (268)
T ss_pred eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHH
Confidence 333344556788999999987542 12346789999999999999999999999999999999999999999998
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC-CeeEccccccccccCCCccc--cccc
Q 012989 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEA--NTNR 421 (452)
Q Consensus 345 l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~--~~~~ 421 (452)
+.. ...+++..++.++.||+.||.+||+++ ++|+||||+||+++.++ .+||+|||.+..+....... ....
T Consensus 94 l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 167 (268)
T cd06630 94 LSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167 (268)
T ss_pred HHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccc
Confidence 843 456899999999999999999999999 99999999999998876 59999999987765432111 1223
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..|+..|+|||.+.+..++.++|+||+|+++
T Consensus 168 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 198 (268)
T cd06630 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198 (268)
T ss_pred cccccceeCHhHhccCCCCcccchHHHHHHH
Confidence 4678999999999888899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=240.57 Aligned_cols=199 Identities=26% Similarity=0.357 Sum_probs=159.1
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h 313 (452)
...+|+..+.+|.|++|.|+.+.... .....++..||+|.++... ....+.+.+|+.+++++ +|
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~--------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h 98 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYG--------------LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEec--------------CCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCC
Confidence 34567777788888888776542100 0112346689999987553 33456789999999999 79
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++.+...+..+++|||+++++|.+++... ....+++.+++.++.|++.+|+|||+++ |+|+||||+|||+
T Consensus 99 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~ 174 (302)
T cd05055 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLL 174 (302)
T ss_pred CCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEE
Confidence 99999999999999999999999999999988532 2234899999999999999999999998 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||+|
T Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil 233 (302)
T cd05055 175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 233 (302)
T ss_pred cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHH
Confidence 99999999999999865443221122223457889999999988999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=239.09 Aligned_cols=174 Identities=26% Similarity=0.421 Sum_probs=149.2
Q ss_pred CccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
++.|+......+++.||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++.
T Consensus 35 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--- 111 (292)
T cd06658 35 TGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT--- 111 (292)
T ss_pred CeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh---
Confidence 34444555566789999999876655566778999999999999999999999999999999999999999998873
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 429 (452)
...+++.+++.++.||+.+|+|||+++ |+||||||+||+++.++.+||+|||++........ ......|+..|+
T Consensus 112 -~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~ 185 (292)
T cd06658 112 -HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWM 185 (292)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCcccc
Confidence 235899999999999999999999998 99999999999999999999999999876543221 223456899999
Q ss_pred cccccccCCCceeeeeeeeeeeC
Q 012989 430 APEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||.+.+..++.++|+||||++|
T Consensus 186 aPE~~~~~~~~~~~Dv~slGvil 208 (292)
T cd06658 186 APEVISRLPYGTEVDIWSLGIMV 208 (292)
T ss_pred CHHHHccCCCCchhhHHHHHHHH
Confidence 99999888899999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=236.68 Aligned_cols=197 Identities=17% Similarity=0.246 Sum_probs=150.9
Q ss_pred eecCccccccCCCCCCCCCCCC-----CCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccce
Q 012989 245 FYNDTSIGTLLPAVFSPPSPGS-----VTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRL 319 (452)
Q Consensus 245 f~g~g~~g~v~~a~~~~~~~~~-----~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l 319 (452)
.+|+|++|.||.+......... ..................|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 3789999999977532111000 00011111222233456789999876655555678899999999999999999
Q ss_pred eeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC--
Q 012989 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-- 397 (452)
Q Consensus 320 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-- 397 (452)
++++..+...++||||+++++|+.++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988843 2456899999999999999999999998 99999999999997654
Q ss_pred -----CeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 398 -----NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 -----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l 211 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence 3799999987643221 12346888999998865 5689999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=239.99 Aligned_cols=187 Identities=26% Similarity=0.387 Sum_probs=152.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
||+....++.|++|.++.+ ....+|+.+|+|.+.... ......+.+|+.++++++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~-------------------~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i 61 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKA-------------------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61 (284)
T ss_pred CceeEEEecccCCeEEEEE-------------------EECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCe
Confidence 5777777888877666544 455678999999987542 2223567889999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+.+....++|+||+++ +|..++.. ....+++..++.++.||++||.|||+.+ |+|+||||+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~ 135 (284)
T cd07839 62 VRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKN 135 (284)
T ss_pred eeHHHHhccCCceEEEEecCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCC
Confidence 9999999999999999999975 66665532 2356899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+..... ......+++.|+|||++.+.. ++.++|||||||++
T Consensus 136 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 190 (284)
T cd07839 136 GELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 190 (284)
T ss_pred CcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHH
Confidence 9999999999986543221 122345689999999987644 78999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=236.71 Aligned_cols=188 Identities=27% Similarity=0.410 Sum_probs=156.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|++.+.++.|++|.++.+ ....+++.|++|++.... ....+.+.+|+.++++++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~-------------------~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i 61 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKA-------------------KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61 (286)
T ss_pred CceEEeecccCCCcEEEEE-------------------EECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCC
Confidence 4677777777777665543 455678999999987653 3345678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...++||||+ +++|.+++... ...+++.+++.++.||+.+|+|||+++ ++|+||||+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 62 VKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISAD 135 (286)
T ss_pred cceeeEEecCCeeEEEeccc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCC
Confidence 99999999999999999999 99999887432 356999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+.++|+|||++........ .......|+..|+|||.+.+. .++.++||||+|+++
T Consensus 136 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 191 (286)
T cd07832 136 GVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIF 191 (286)
T ss_pred CcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHH
Confidence 9999999999887654322 112234689999999998654 468999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=239.26 Aligned_cols=196 Identities=27% Similarity=0.363 Sum_probs=155.9
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
|++...+|.|++|.||.+..... ........+++|.+.... ....+.+.+|+.+++.++||||++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~--------------~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 67 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRL--------------KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67 (290)
T ss_pred ccccccccCcCCcceEEEEEecC--------------CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEee
Confidence 56667788888888876532100 001234678999886553 334567899999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDST---------------------KGAQLDWKRRISIINGIARGLLYLHEDS 377 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g 377 (452)
+++.+..++..+++|||+.+++|.+++.... ....+++..++.++.|++.+|+|||+++
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 147 (290)
T cd05045 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147 (290)
T ss_pred EEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999998874321 1245889999999999999999999998
Q ss_pred CCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++|
T Consensus 148 ---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 219 (290)
T cd05045 148 ---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 219 (290)
T ss_pred ---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHH
Confidence 999999999999999999999999999765433222222233457789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=264.12 Aligned_cols=182 Identities=24% Similarity=0.275 Sum_probs=155.5
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
.++.|.+|+|.+.+...+++.||+|++.+- ......-|..|-.+|..-+.+-|+.++..|++..++|+||||++||+
T Consensus 82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD 161 (1317)
T KOG0612|consen 82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD 161 (1317)
T ss_pred HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence 344555577778888889999999999762 23344668999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
|-.++ .+...+++..++.++..|+.||.-||+.| +|||||||+|||||..|++||+|||.+-....+ ......
T Consensus 162 lltLl---Sk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G~V~s~ 234 (1317)
T KOG0612|consen 162 LLTLL---SKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GTVRSS 234 (1317)
T ss_pred HHHHH---hhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC-CcEEec
Confidence 99988 33447999999999999999999999999 999999999999999999999999998766532 223344
Q ss_pred ccccccccccccccc----c-CCCceeeeeeeeeeeC
Q 012989 421 RVVGTYGYMAPEYAM----E-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~----~-~~~s~~~DvwSlG~il 452 (452)
..+|||.|.|||++. + +.|+..+|+||+||++
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~ 271 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFM 271 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHH
Confidence 569999999999994 3 6699999999999874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=239.32 Aligned_cols=189 Identities=19% Similarity=0.285 Sum_probs=154.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|+..+.++.|++|.++ ......+++.|++|.+.... ....+.+.+|+++++.++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~-------------------~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~ 62 (305)
T cd05609 2 DFETIKLISNGAYGAVY-------------------LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62 (305)
T ss_pred CceEeeEeecCCCeeEE-------------------EEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC
Confidence 35666777777776555 34556678999999987653 233457889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..+++.++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~ 136 (305)
T cd05609 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITS 136 (305)
T ss_pred eeeeEEEEecCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECC
Confidence 9999999999999999999999999999983 3356899999999999999999999998 999999999999999
Q ss_pred CCCeeEccccccccccCCCc-------------cccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQN-------------EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++....... ........|+..|+|||.+.+..++.++|+||||++|
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl 206 (305)
T cd05609 137 MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206 (305)
T ss_pred CCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHH
Confidence 99999999999864211100 0011124578899999999888899999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=245.18 Aligned_cols=184 Identities=29% Similarity=0.411 Sum_probs=159.9
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.+++|.+|+|-.+.... +..||+|.++... ...+.+|.+|+++|.+|+||||+.|++++..++.+++|+||+++|+|.
T Consensus 545 kiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLn 623 (807)
T KOG1094|consen 545 KIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLN 623 (807)
T ss_pred hhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHH
Confidence 45678889888877655 7999999998774 444588999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
+++....... +.......|+.||+.||+||.+.+ +|||||.+.|+|++.+.++||+|||+++.+-.........+.
T Consensus 624 qFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~ 699 (807)
T KOG1094|consen 624 QFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRA 699 (807)
T ss_pred HHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecce
Confidence 9996653332 456667789999999999999998 999999999999999999999999999966555555555666
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+-+..|||||.++.++++.++|+|+||+.|
T Consensus 700 vlpiRwmawEsillgkFttaSDvWafgvTl 729 (807)
T KOG1094|consen 700 VLPIRWMAWESILLGKFTTASDVWAFGVTL 729 (807)
T ss_pred eeeeeehhHHHHHhccccchhhhhhhHHHH
Confidence 778999999999999999999999999853
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=255.30 Aligned_cols=184 Identities=17% Similarity=0.233 Sum_probs=147.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCC---
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH--- 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h--- 313 (452)
..||++...+|.|++|.||.+ .+..+++.||||+++... .....+..|+.+++.++|
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a-------------------~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~ 187 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEA-------------------WDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADP 187 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEE-------------------EEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCc
Confidence 358999999999999887755 445578899999986432 223456678888877754
Q ss_pred ---CCccceeeeEecC-CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCC
Q 012989 314 ---KNLVRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKT 388 (452)
Q Consensus 314 ---~~iv~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp 388 (452)
.+++++++++... .++++|||++ +++|.+++. +...+++..++.|+.||+.||+|||+ .| ||||||||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP 260 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKP 260 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCH
Confidence 4588888888764 5789999988 667777663 34569999999999999999999997 48 99999999
Q ss_pred CCeEECCCC----------------CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEM----------------NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~----------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++ .+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||+|
T Consensus 261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred HHEEEecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence 999998765 49999999875422 122346889999999999999999999999999985
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=233.38 Aligned_cols=187 Identities=22% Similarity=0.361 Sum_probs=151.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+..+.++.|++|.|+.+ ...++..+|+|.+.... .....+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~--------------------~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~ 63 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLG--------------------KWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQ 63 (256)
T ss_pred HcchhhhhccCCCceEEEe--------------------EecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEE
Confidence 4566666777777666543 22356789999886442 23457889999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+...+..++||||+++++|.+++... ...+++..++.++.||+.+|.|||+.+ ++||||||+||+++.++.
T Consensus 64 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~ 138 (256)
T cd05059 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNV 138 (256)
T ss_pred EEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCc
Confidence 999999999999999999999999988432 236899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||+++......... .....++..|+|||.+.+..++.++|+||||++|
T Consensus 139 ~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il 191 (256)
T cd05059 139 VKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLM 191 (256)
T ss_pred EEECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHH
Confidence 9999999987654322111 1112335679999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=232.63 Aligned_cols=186 Identities=27% Similarity=0.388 Sum_probs=156.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-----cccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-----GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~h 313 (452)
||+..+.++.|++|.++.+ ....+++.|++|.+.... ....+.+.+|+.+++.++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h 61 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEG-------------------LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61 (258)
T ss_pred CccccceeeecCCceEEEE-------------------EEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC
Confidence 5666677777777666543 344578999999986543 2345678999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
+||+++++.+..+...+++|||+++++|.+++. +...+++..++.++.||+.+|.+||+.+ ++|+||||+||++
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~ 135 (258)
T cd06632 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILV 135 (258)
T ss_pred CCchheeeeEecCCeEEEEEEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 999999999999999999999999999999884 3346899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
+.++.+||+|||++....... ......|+..|++||.+.... ++.++|+||||+++
T Consensus 136 ~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l 192 (258)
T cd06632 136 DTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV 192 (258)
T ss_pred CCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHH
Confidence 999999999999987654332 123456789999999987766 89999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=235.39 Aligned_cols=177 Identities=23% Similarity=0.362 Sum_probs=148.1
Q ss_pred ccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 271 KEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
+.|+......+++.++||.+... .....+++.+|+.+++.++||||+++++.+..++..+++|||+++++|.+++..
T Consensus 16 g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 95 (267)
T cd08229 16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 95 (267)
T ss_pred eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHH
Confidence 33444455668999999988653 233446788999999999999999999999999999999999999999988753
Q ss_pred C-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccc
Q 012989 348 S-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 348 ~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
. .....+++..++.++.||+.+|.|||+++ ++|+||||+||+++.++.++|+|||++..+...... .....|+.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~ 170 (267)
T cd08229 96 FKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTP 170 (267)
T ss_pred hhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCc
Confidence 2 23456899999999999999999999999 999999999999999999999999998765433221 22346789
Q ss_pred ccccccccccCCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.|+|||.+.+..++.++|+||||+++
T Consensus 171 ~~~ape~~~~~~~~~~~Dv~slG~il 196 (267)
T cd08229 171 YYMSPERIHENGYNFKSDIWSLGCLL 196 (267)
T ss_pred CccCHHHhcCCCccchhhHHHHHHHH
Confidence 99999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=240.55 Aligned_cols=191 Identities=28% Similarity=0.384 Sum_probs=153.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEec--CCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILA--DGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~--~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
||++...++.|++|.++.+ .... +++.||||.+.... ....+.+.+|+.++++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~-------------------~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 61 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKA-------------------KRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61 (316)
T ss_pred CceEEEEeccCCcEEEEEE-------------------EecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC
Confidence 5777788888888777755 3333 68999999998632 3445678899999999999
Q ss_pred CCccceeeeEecC--CeEEEEEEecCCCChhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 314 KNLVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDST--KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 314 ~~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|||+++++.+... ...++||||+++ +|..++.... ....+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 62 ~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~ 137 (316)
T cd07842 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPA 137 (316)
T ss_pred CCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHH
Confidence 9999999999988 889999999976 5555443221 2236899999999999999999999999 999999999
Q ss_pred CeEECC----CCCeeEccccccccccCCCc-ccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDH----EMNPKISDFGMARIFSGNQN-EANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~----~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||+++. ++.+||+|||++........ ........+++.|+|||.+.+ ..++.++||||||++|
T Consensus 138 Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 206 (316)
T cd07842 138 NILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIF 206 (316)
T ss_pred HEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999 89999999999987644332 122234567899999998866 4578999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=232.36 Aligned_cols=190 Identities=21% Similarity=0.358 Sum_probs=158.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|+....++.|++|.++.+ ....+++.||+|.++.. .....+.+.+|++++++++|+|
T Consensus 3 ~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~ 63 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKA-------------------ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63 (267)
T ss_pred ceeeeeeeccCCceEEEEE-------------------EEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC
Confidence 5677777777777666544 44457899999988643 2333567899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|+++++.+...+..++||||+++++|..++... .....+++.+++.++.||+.+|.|||+.| |+|+||||+||+++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~ 140 (267)
T cd08224 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEEC
Confidence 999999999999999999999999999887542 23456899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.++|+|||++..+...... .....|++.|+|||.+.+..++.++|+||||+++
T Consensus 141 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il 196 (267)
T cd08224 141 ATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196 (267)
T ss_pred CCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHH
Confidence 9999999999998765433211 2234678999999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=238.22 Aligned_cols=188 Identities=24% Similarity=0.330 Sum_probs=153.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|+....+|.|++|.|+.+ ....+++.||+|.+.... ......+.+|+.+++.++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI 66 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKG-------------------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66 (301)
T ss_pred cceEEeeEeccCcCEEEEEE-------------------EEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCc
Confidence 46777778888888776654 445578899999987543 3334567899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...++||||+++ +|..++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+||+++.+
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~ 140 (301)
T cd07873 67 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINER 140 (301)
T ss_pred ceEEEEEecCCeEEEEEecccc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCC
Confidence 9999999999999999999975 78777743 2346899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ ......+++.|+|||++.+ ..++.++||||||++|
T Consensus 141 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l 195 (301)
T cd07873 141 GELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 195 (301)
T ss_pred CcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHH
Confidence 9999999999875432221 1223456899999998865 4578899999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-29 Score=237.37 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=157.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+|+....+|.|++|.|+.+..... ....++..||+|.+.... ......+.+|+.++++++||||
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~--------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i 70 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGL--------------LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70 (288)
T ss_pred HhceecccccccccccEEEEEEccc--------------CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCch
Confidence 3677778888888888876532100 011356789999987543 3345678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------------KGAQLDWKRRISIINGIARGLLYLHEDS 377 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g 377 (452)
+++++++..+...+++|||+++++|.+++.... ....+++..++.++.||+.+|.|||+++
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~ 150 (288)
T cd05050 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK 150 (288)
T ss_pred heEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999885321 1135788999999999999999999998
Q ss_pred CCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||||||+||+++.++.+||+|||++.................+..|+|||.+.+..++.++|||||||++
T Consensus 151 ---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 222 (288)
T cd05050 151 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222 (288)
T ss_pred ---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHH
Confidence 999999999999999999999999998765433221112222346789999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=233.67 Aligned_cols=190 Identities=24% Similarity=0.390 Sum_probs=154.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecC----CeeeEEEEeecCC-cccHHHHHHHHHHHHcCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILAD----GKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~----~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~ 312 (452)
.+|++.+.+|.|++|.++.+. ...+ ...+|+|.+.... ......+.+|+.++++++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~-------------------~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~ 67 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGV-------------------WIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67 (279)
T ss_pred HHcEEcceecCCCCccEEEEE-------------------EecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC
Confidence 366777788888888777552 1222 3468999887653 334567889999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++.. ...++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ ++|+||||+||+
T Consensus 68 h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil 141 (279)
T cd05057 68 HPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVL 141 (279)
T ss_pred CCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEE
Confidence 9999999999887 789999999999999998843 2345899999999999999999999998 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||.++...............++..|+|||.+....++.++|+||||+++
T Consensus 142 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05057 142 VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201 (279)
T ss_pred EcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHH
Confidence 999999999999999876533322222222336789999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=239.39 Aligned_cols=186 Identities=27% Similarity=0.356 Sum_probs=143.8
Q ss_pred eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeE
Q 012989 244 QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCC 323 (452)
Q Consensus 244 ~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 323 (452)
..+|.|++|.||.+.. ....+++.||+|.+.... ....+.+|+.++++++||||+++++++
T Consensus 7 ~~lG~G~~g~Vy~~~~-----------------~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~ 67 (317)
T cd07867 7 CKVGRGTYGHVYKAKR-----------------KDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVF 67 (317)
T ss_pred eEeccCCCeeEEEEEe-----------------cCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 3567777777765521 122356889999986543 235678999999999999999999988
Q ss_pred ec--CCeEEEEEEecCCCChhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE--
Q 012989 324 LD--GNELLLIYEYMPNKSLDLFLFDS------TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-- 393 (452)
Q Consensus 324 ~~--~~~~~lv~E~~~~~~L~~~l~~~------~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll-- 393 (452)
.. +...++||||+++ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 68 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~ 143 (317)
T cd07867 68 LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMG 143 (317)
T ss_pred eccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEcc
Confidence 54 5678999999876 565555321 12345899999999999999999999999 9999999999999
Q ss_pred --CCCCCeeEccccccccccCCCcc-cccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 394 --DHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 --~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 144 ~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 206 (317)
T cd07867 144 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred CCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence 56678999999999876543221 12234578999999999876 4579999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=231.07 Aligned_cols=192 Identities=26% Similarity=0.398 Sum_probs=160.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|++.+.++.|++|.++.+ ....++..+++|++.... ....+.+.+|+++++.++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 62 (267)
T cd06610 2 DYELIEVIGVGATAVVYAA-------------------ICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62 (267)
T ss_pred cceeeeeecCCCCeEEEEE-------------------EEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEE
Confidence 4667777777777766644 334578899999987542 33567799999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+..++..++|||++++++|.+++........+++..+..++.||+.+|.+||+.+ ++|+||||+||++++++
T Consensus 63 ~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~ 139 (267)
T cd06610 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDG 139 (267)
T ss_pred EEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCC
Confidence 999999999999999999999999999854333356899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccc--cccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
.+||+|||++..+....... ......|+..|++||++... .++.++|+||||+++
T Consensus 140 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~ 197 (267)
T cd06610 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197 (267)
T ss_pred CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHH
Confidence 99999999988765443321 22345689999999998776 789999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=236.14 Aligned_cols=188 Identities=21% Similarity=0.329 Sum_probs=153.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|++...++.|++|.++ ......+++.||+|.+... .......+.+|+.++++++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~-------------------~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~ 62 (286)
T cd06622 2 EIEVLDELGKGNYGSVY-------------------KVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62 (286)
T ss_pred hhhhhhhhcccCCeEEE-------------------EEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHH
Confidence 45555666666665554 4455567899999988754 333456789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~ 396 (452)
++++.+..++..++||||+++++|..++........+++..+..++.||+.+|.|||+ .+ |+|+||||+||+++.+
T Consensus 63 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~ 139 (286)
T cd06622 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGN 139 (286)
T ss_pred hhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCC
Confidence 9999999999999999999999999888543334579999999999999999999996 47 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccC------CCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlG~il 452 (452)
+.+||+|||++..+.... .....|++.|+|||.+.+. .++.++|+|||||+|
T Consensus 140 ~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 197 (286)
T cd06622 140 GQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197 (286)
T ss_pred CCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHH
Confidence 999999999987653322 1223578899999998543 358899999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=233.92 Aligned_cols=190 Identities=24% Similarity=0.351 Sum_probs=155.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc----------ccHHHHHHHHHH
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG----------QGLQEFKNEVTL 307 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~----------~~~~~~~~E~~~ 307 (452)
++|...+.+|.|++|.|+.+ ....+++.+|||.++.... ...+.+.+|+.+
T Consensus 1 ~~~~~~~~lg~g~~~~vy~~-------------------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 61 (272)
T cd06629 1 FKWVKGELIGKGTYGRVYLA-------------------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61 (272)
T ss_pred CceeecceecccCceEEEEE-------------------eecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHH
Confidence 35667777777777666644 4455789999998864211 113467889999
Q ss_pred HHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 308 IAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 308 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
++.++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.||+.+|.+||+++ ++|+|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~ 135 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLK 135 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCC
Confidence 9999999999999999999999999999999999998843 356899999999999999999999998 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCC--CceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV--FSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il 452 (452)
|+||+++.++.+||+|||+++...............|+..|+|||.+.... ++.++|+||||+++
T Consensus 136 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 136 ADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred hhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence 999999999999999999987654332222233346789999999987654 89999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=231.46 Aligned_cols=169 Identities=26% Similarity=0.317 Sum_probs=137.7
Q ss_pred CCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC--CCCCCCHH
Q 012989 281 DGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST--KGAQLDWK 357 (452)
Q Consensus 281 ~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~l~~~ 357 (452)
++..+|+|.+.... ......+.+|+.++++++||||+++++.+......++||||+++++|.+++.... .....++.
T Consensus 21 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05087 21 TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100 (269)
T ss_pred CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHH
Confidence 45679999887553 2334578899999999999999999999999999999999999999999885422 22346778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC
Q 012989 358 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 437 (452)
.++.++.|++.||+|||+.+ ++|+||||+||+++.++++||+|||+++...............|+..|+|||++.+.
T Consensus 101 ~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05087 101 TLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence 88899999999999999999 999999999999999999999999998754333222222345678899999988532
Q ss_pred -------CCceeeeeeeeeeeC
Q 012989 438 -------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 438 -------~~s~~~DvwSlG~il 452 (452)
.++.++|+||||+++
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 178 HGNLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred cccccccCCCccchhHHHHHHH
Confidence 358899999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=236.49 Aligned_cols=189 Identities=27% Similarity=0.410 Sum_probs=150.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCC--eeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADG--KEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~--~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
+|++...+|.|++|.|+.+. ...++ ..+++|.++.. .....+.+.+|+.+++++ +||
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~-------------------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp 63 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAM-------------------IKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63 (297)
T ss_pred cceeeeeecCCCcceEEEEE-------------------ecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCC
Confidence 56777788888888777542 22233 34788887643 334456789999999999 799
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
||+++++.+......+++|||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---i 140 (297)
T cd05089 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---F 140 (297)
T ss_pred chhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999999885421 1235889999999999999999999998 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||||||+|||++.++.+||+|||++....... .......+..|+|||.+.+..++.++|||||||+|
T Consensus 141 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il 208 (297)
T cd05089 141 IHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLL 208 (297)
T ss_pred ccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHH
Confidence 999999999999999999999999986422111 11111225679999999888899999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=233.30 Aligned_cols=194 Identities=23% Similarity=0.386 Sum_probs=156.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+|+..+++|.|++|.||.+.... ...+...+|+|.+... .....+.+.+|++++++++||||
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~----------------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 68 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKM----------------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEec----------------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCe
Confidence 367778889999998887653210 1112347999998755 33445678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++.+++...+..++||||+++++|..++.. ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.+
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~ 143 (268)
T cd05063 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSN 143 (268)
T ss_pred eEEEEEEccCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCC
Confidence 9999999999999999999999999998843 2356899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccc-cccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANT-NRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++............ .....+..|+|||++.+..++.++|||||||+|
T Consensus 144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il 200 (268)
T cd05063 144 LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200 (268)
T ss_pred CcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHH
Confidence 99999999998765433221111 111234579999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=232.43 Aligned_cols=186 Identities=25% Similarity=0.352 Sum_probs=157.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++...++.|++|.++ ......+++.||+|.+.+.. ....+.+.+|++++++++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~-------------------~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 61 (258)
T cd05578 1 HFELLRVIGKGAFGKVC-------------------IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61 (258)
T ss_pred CceEEEEeccCCCceEE-------------------EEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCC
Confidence 36666777777776555 44555678999999997542 244678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..+...++||||+++++|..++.. ...+++..+..++.||+++|.|||+.+ ++|+||||+||+++.
T Consensus 62 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~ 135 (258)
T cd05578 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDE 135 (258)
T ss_pred hHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcC
Confidence 99999999999999999999999999998833 357899999999999999999999998 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++
T Consensus 136 ~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 189 (258)
T cd05578 136 QGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTA 189 (258)
T ss_pred CCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHH
Confidence 9999999999987654332 12234678899999999888899999999999874
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=234.50 Aligned_cols=186 Identities=24% Similarity=0.382 Sum_probs=156.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+.+..++.|++|.++ ......+++.+++|++........+.+.+|+.+++.++||||++
T Consensus 20 ~~~~~~~lg~g~~g~v~-------------------~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~ 80 (285)
T cd06648 20 YLDNFVKIGEGSTGIVC-------------------IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80 (285)
T ss_pred hhhcceEeccCCCeEEE-------------------EEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChhe
Confidence 45556667777665555 33455678999999987665555677899999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+...++.++++||+++++|.+++.. ..+++.++..++.|++.+|++||+++ ++||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 153 (285)
T cd06648 81 MYSSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGR 153 (285)
T ss_pred EEEEEEcCCeEEEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCc
Confidence 99999999999999999999999998843 45899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++|+|||.+........ ......|++.|+|||.+.+..++.++|+||||+++
T Consensus 154 ~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l 205 (285)
T cd06648 154 VKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205 (285)
T ss_pred EEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHH
Confidence 99999998875543221 12234689999999999888899999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=228.24 Aligned_cols=181 Identities=24% Similarity=0.355 Sum_probs=148.4
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
+.+..+.|+...... ++.|++|++...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.++
T Consensus 4 g~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 82 (251)
T cd05041 4 GKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTF 82 (251)
T ss_pred ccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHH
Confidence 344455555555555 999999998765433 456799999999999999999999999999999999999999999998
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccc
Q 012989 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVG 424 (452)
Q Consensus 345 l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 424 (452)
+... ...+++..++.++.|++.+|.+||+++ ++||||||+||+++.++.+||+|||++................+
T Consensus 83 l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 83 LRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 8432 346889999999999999999999999 99999999999999999999999999876542221111122234
Q ss_pred ccccccccccccCCCceeeeeeeeeeeC
Q 012989 425 TYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 425 t~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+..|+|||.+.++.++.++|+||||+++
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~ 185 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILL 185 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHH
Confidence 6679999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=232.28 Aligned_cols=198 Identities=23% Similarity=0.356 Sum_probs=158.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..+|++.+.++.|++|.|+.+..... ....+..|++|++... .....+.+.+|+.++++++|||
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~---------------~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~n 69 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDE---------------KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecC---------------CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCC
Confidence 45788889999999988875532100 0013678999988654 3344567889999999999999
Q ss_pred ccceeeeEec-CCeEEEEEEecCCCChhhhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLD-GNELLLIYEYMPNKSLDLFLFDSTKG-----AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++.. +...++++||+++++|..++...... ..+++..++.++.||+.||+|||+.+ ++|+||||+
T Consensus 70 i~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~ 146 (280)
T cd05043 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAAR 146 (280)
T ss_pred CCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHh
Confidence 9999998765 56789999999999999988543222 56899999999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++
T Consensus 147 nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 209 (280)
T cd05043 147 NCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209 (280)
T ss_pred hEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence 999999999999999999866443322222233457789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=231.49 Aligned_cols=183 Identities=30% Similarity=0.443 Sum_probs=154.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|+....++.|++|.|+.+. ..++.||||.+..... ..+++.+|+.+++.++|+||++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~---------------------~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~ 64 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGD---------------------YRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQ 64 (256)
T ss_pred hccceeeeecCCCceEEEEE---------------------ecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceee
Confidence 46666777778777766442 2478899999976544 5678999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+...+..++||||+++++|.+++... ....+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.
T Consensus 65 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~ 140 (256)
T cd05039 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLV 140 (256)
T ss_pred eEEEEcCCCCeEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCC
Confidence 999999999999999999999999988542 2236899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||.++....... ...++..|+|||.+..+.++.++|+||||+++
T Consensus 141 ~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il 189 (256)
T cd05039 141 AKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILL 189 (256)
T ss_pred EEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHH
Confidence 99999999986532221 12346679999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=230.14 Aligned_cols=189 Identities=26% Similarity=0.407 Sum_probs=159.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i 316 (452)
||+....++.|++|.++.+ ....+++.|++|.+..... ...+.+.+|+.+++.++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i 61 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTA-------------------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61 (264)
T ss_pred CceeeeEeecCCCcEEEEE-------------------EECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCCh
Confidence 6777888888888666543 4455789999999876644 356789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+...+..++|+||+++++|.+++. ....+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~ 135 (264)
T cd06626 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHN 135 (264)
T ss_pred hheeeeEecCCEEEEEEecCCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence 999999999999999999999999999884 3445889999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccc--ccccccccccccccccccCC---CceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEAN--TNRVVGTYGYMAPEYAMEGV---FSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlG~il 452 (452)
+.+||+|||++........... .....++..|+|||++.+.. ++.++||||||+++
T Consensus 136 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il 196 (264)
T cd06626 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196 (264)
T ss_pred CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHH
Confidence 9999999999887654332211 12346788999999997766 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=232.66 Aligned_cols=188 Identities=27% Similarity=0.383 Sum_probs=154.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC------cccHHHHHHHHHHHHcCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS------GQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~~E~~~l~~l~ 312 (452)
+|.....+|.|++|.|+.+ ...+++.+|+|.+.... ......+.+|++++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~--------------------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 60 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCG--------------------LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60 (265)
T ss_pred CccccceEeccCCeEEEEE--------------------EEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC
Confidence 3566667777777666543 23578899999887542 122356889999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|+||+++++++......+++|||+++++|.+++. +...+++..+..++.|++.+|+|||+.+ |+|+||||+||+
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil 134 (265)
T cd06631 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVM 134 (265)
T ss_pred CCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEE
Confidence 9999999999999999999999999999999984 3346899999999999999999999998 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCc----cccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQN----EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||++........ ........|+..|+|||.+.+..++.++|+||||+++
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~ 198 (265)
T cd06631 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTV 198 (265)
T ss_pred ECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHH
Confidence 99999999999999876432111 1112234689999999999988899999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=231.13 Aligned_cols=188 Identities=24% Similarity=0.385 Sum_probs=151.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-||++.+.++.|++|.|+.+ . ..+...||+|++.... ...+.+.+|+.+++.++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~-------------------~-~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~ 64 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMG-------------------T-WNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64 (262)
T ss_pred HHeeEeeecCCCCCCcEEEE-------------------E-ecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcc
Confidence 36777777888887766644 2 2334569999987543 3346789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+. ....++||||+++++|.+++... ....+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++
T Consensus 65 ~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~ 139 (262)
T cd05071 65 QLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENL 139 (262)
T ss_pred eEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCC
Confidence 9998875 45689999999999999988532 2345799999999999999999999998 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||.++.+...... ......++..|+|||...+..++.++||||||+++
T Consensus 140 ~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l 193 (262)
T cd05071 140 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193 (262)
T ss_pred cEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHH
Confidence 9999999999765433221 11223457789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=235.46 Aligned_cols=188 Identities=24% Similarity=0.367 Sum_probs=157.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
||++...++.|++|.++.+ ....+++.||+|+++.. .....+.+.+|++++++++|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~-------------------~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 62 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKC-------------------RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62 (288)
T ss_pred ceeEEEEecccCCeeEEEE-------------------EeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCe
Confidence 6888888888888766644 44557889999988754 23345778999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..++..++||||++++.+..+. .+...+++.+++.++.||+.+|.|||+.+ ++|+||||+||+++.+
T Consensus 63 ~~~~~~~~~~~~~~iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~ 136 (288)
T cd07833 63 VNLKEAFRRKGRLYLVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSES 136 (288)
T ss_pred eehhheEEECCEEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC
Confidence 99999999999999999999987777655 23355899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+.+||+|||++.......... .....++..|+|||++.+. .++.++|+||||++|
T Consensus 137 ~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l 192 (288)
T cd07833 137 GVLKLCDFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM 192 (288)
T ss_pred CCEEEEeeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHH
Confidence 999999999988765443212 2235678999999999887 789999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=236.36 Aligned_cols=187 Identities=26% Similarity=0.373 Sum_probs=153.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-----cHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-----GLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-----~~~~~~~E~~~l~~l~h 313 (452)
||+..+.++.|++|.++.+ ....+++.||||++...... ....+.+|+++++.++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~-------------------~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h 61 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKA-------------------RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61 (298)
T ss_pred CceeeeeeeeccccEEEEE-------------------EECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC
Confidence 4666677777777666544 44557899999999765322 34557789999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
+||+++++++...+..++||||+ +++|..++.... ..+++..++.++.||++||.|||+++ |+|+||||+||++
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill 135 (298)
T cd07841 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLI 135 (298)
T ss_pred CCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEE
Confidence 99999999999999999999999 889999884322 36999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++....... ......+++.|+|||.+.+ ..++.++|+|||||++
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 193 (298)
T cd07841 136 ASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIF 193 (298)
T ss_pred cCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999987654322 1222356888999998854 4578999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=230.81 Aligned_cols=189 Identities=24% Similarity=0.369 Sum_probs=153.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-----CcccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-----SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~~E~~~l~~l~h 313 (452)
.|++.+.++.|++|.++.+ ....+++.||+|.+... .......+.+|+.++++++|
T Consensus 3 ~~~~~~~lg~g~~g~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h 63 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLC-------------------YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63 (264)
T ss_pred ceeeeeeEccCCCeEEEEE-------------------EEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCC
Confidence 4666667777777665543 45567899999987532 12344678899999999999
Q ss_pred CCccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 314 KNLVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 314 ~~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||+++++.+... ..++++|||+++++|.+++. ....+++..++.++.||+.+|.|||+.+ ++|+||||+||
T Consensus 64 ~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni 137 (264)
T cd06653 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANI 137 (264)
T ss_pred CCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHE
Confidence 9999999998764 46889999999999998883 3345889999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCc-cccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQN-EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++.++.++|+|||+++....... ........|+..|+|||.+.+..++.++|+||||++|
T Consensus 138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 199 (264)
T cd06653 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199 (264)
T ss_pred EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHH
Confidence 999999999999999986543211 1112235689999999999888899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=231.71 Aligned_cols=179 Identities=28% Similarity=0.390 Sum_probs=150.5
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.+.++.|+......+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||||+++++|.+
T Consensus 3 ~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 82 (277)
T cd05577 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKY 82 (277)
T ss_pred CCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHH
Confidence 3445666666777789999999987542 2234567889999999999999999999999999999999999999998
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
++.... ...+++.+++.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||.+....... ......
T Consensus 83 ~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 155 (277)
T cd05577 83 HIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRA 155 (277)
T ss_pred HHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccccc
Confidence 885432 246899999999999999999999999 9999999999999999999999999987654321 122345
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++..|+|||.+.+..++.++|+||||+++
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il 184 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTL 184 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHH
Confidence 78899999999888899999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=238.14 Aligned_cols=178 Identities=15% Similarity=0.215 Sum_probs=145.0
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS 348 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 348 (452)
+.|+......+++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 93 (327)
T cd08227 14 MTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH 93 (327)
T ss_pred EEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh
Confidence 455566777899999999997542 233456788999999999999999999999999999999999999999988432
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc-----cccccc
Q 012989 349 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-----NTNRVV 423 (452)
Q Consensus 349 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~ 423 (452)
....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+++.||+............ ......
T Consensus 94 -~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (327)
T cd08227 94 -FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSV 169 (327)
T ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccccccccccccc
Confidence 2345899999999999999999999999 9999999999999999999999998654332111100 112235
Q ss_pred ccccccccccccc--CCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
++..|+|||++.+ ..++.++|||||||++
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~il 200 (327)
T cd08227 170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 200 (327)
T ss_pred ceecccChHHhhcccCCCCchhhHHHHHHHH
Confidence 6788999999975 4589999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=230.23 Aligned_cols=189 Identities=20% Similarity=0.269 Sum_probs=149.3
Q ss_pred ecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEec
Q 012989 246 YNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD 325 (452)
Q Consensus 246 ~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 325 (452)
+|.|++|.||.+......... ...........|++|.+..........+.+|+.+++.++||||+++++++..
T Consensus 3 lg~G~~~~vy~~~~~~~~~~~-------~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 3 LGRGTRTQIYAGILNYKDDDE-------DDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred cccCCcceEeeeecccCCCcc-------ccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 577888888876432111000 0001123456789998876655556678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC-------
Q 012989 326 GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN------- 398 (452)
Q Consensus 326 ~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~------- 398 (452)
+...++||||+++++|+.++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCce
Confidence 9999999999999999888743 3356899999999999999999999998 999999999999987664
Q ss_pred eeEccccccccccCCCccccccccccccccccccccc-cCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
+|++|||++...... ....++..|+|||.+. +..++.++||||||++|
T Consensus 151 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 199 (262)
T cd05077 151 IKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTL 199 (262)
T ss_pred eEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHH
Confidence 899999998654321 2235788999999886 56789999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=228.94 Aligned_cols=189 Identities=17% Similarity=0.201 Sum_probs=153.3
Q ss_pred cccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-
Q 012989 234 PSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ- 312 (452)
Q Consensus 234 ~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~- 312 (452)
+.-.-||++...+|+|.+|.|. .+-+...+..||||+++.- ..-.+..+-|+++|+++.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~-------------------ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~ 144 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVV-------------------ECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINE 144 (415)
T ss_pred cccccceehhhhhcCCcccceE-------------------EEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHh
Confidence 4445688888878877776655 4455566899999998643 333456778999999993
Q ss_pred C-C----CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 313 H-K----NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 313 h-~----~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
+ | -++++.++|...++.|||+|.+ |.++.+++.. ..-.+++...++.+..||++++++||+.+ ++|-|||
T Consensus 145 ~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLK 219 (415)
T KOG0671|consen 145 SDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLK 219 (415)
T ss_pred cCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCC
Confidence 2 2 3788899999999999999998 7788888854 34467999999999999999999999998 9999999
Q ss_pred CCCeEECC--------------------CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeee
Q 012989 388 TSNVLLDH--------------------EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLV 447 (452)
Q Consensus 388 p~NIll~~--------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS 447 (452)
|+|||+.+ +..+||+|||.|..... .....+.|..|.|||++++-.||.++||||
T Consensus 220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWS 294 (415)
T KOG0671|consen 220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWS 294 (415)
T ss_pred hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCcee
Confidence 99999831 23489999999986322 224567799999999999999999999999
Q ss_pred eeeeC
Q 012989 448 SEFFF 452 (452)
Q Consensus 448 lG~il 452 (452)
+||||
T Consensus 295 iGCIL 299 (415)
T KOG0671|consen 295 IGCIL 299 (415)
T ss_pred eeeEE
Confidence 99997
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=228.81 Aligned_cols=167 Identities=26% Similarity=0.374 Sum_probs=138.9
Q ss_pred ecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCH
Q 012989 279 LADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDW 356 (452)
Q Consensus 279 ~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~ 356 (452)
..+++.+|+|+++... ....+.+.+|+.+++.++||||+++++.+. .+..++||||+++++|.+++. ....+++
T Consensus 19 ~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 94 (257)
T cd05116 19 KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ---KNKHVTE 94 (257)
T ss_pred CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH---hcCCCCH
Confidence 4567899999987543 234567899999999999999999999875 456789999999999999883 3356899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc-cccccccccccccccccc
Q 012989 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAM 435 (452)
Q Consensus 357 ~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 435 (452)
..+..++.|++.+|++||+++ |+||||||+||+++.++.+||+|||+++......... ......+++.|+|||.+.
T Consensus 95 ~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 95 KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence 999999999999999999999 9999999999999999999999999998764432211 111223467899999998
Q ss_pred cCCCceeeeeeeeeeeC
Q 012989 436 EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 436 ~~~~s~~~DvwSlG~il 452 (452)
...++.++|+||||++|
T Consensus 172 ~~~~~~~~Di~slG~~l 188 (257)
T cd05116 172 YYKFSSKSDVWSFGVLM 188 (257)
T ss_pred cCCcCchhHHHHHHHHH
Confidence 88899999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=234.52 Aligned_cols=188 Identities=25% Similarity=0.350 Sum_probs=151.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|+....+|.|.+|.|+.+ ....+++.||||.+.... ......+.+|+++++.++|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~-------------------~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 65 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKG-------------------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65 (291)
T ss_pred cceeEEEEEeecCCeEEEEE-------------------EEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcce
Confidence 35777777888877766644 445578999999987543 2223457789999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++||||+++ +|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~ 139 (291)
T cd07844 66 VTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISER 139 (291)
T ss_pred eeEEEEEecCCeEEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCC
Confidence 9999999999999999999985 888877432 346899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... ......++..|+|||++.+ ..++.++||||+|++|
T Consensus 140 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il 194 (291)
T cd07844 140 GELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIF 194 (291)
T ss_pred CCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHH
Confidence 9999999999875432111 1122346889999999865 4588999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=228.69 Aligned_cols=188 Identities=25% Similarity=0.390 Sum_probs=156.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|+....+|.|++|.++. .....+++.+|||.+... +....+.+.+|+++++.++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~-------------------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i 61 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHL-------------------CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61 (256)
T ss_pred CceEEEEecccCceEEEE-------------------EEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCch
Confidence 577777777777766554 345567899999998754 23345678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..++..++||||+++++|.+++... ....+++..++.++.|++.+|++||+++ ++|+||||+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~ 137 (256)
T cd08220 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKH 137 (256)
T ss_pred hheeeeEecCCEEEEEEecCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 99999999999999999999999999988542 2445899999999999999999999999 9999999999999865
Q ss_pred C-CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 M-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ .+||+|||.+........ .....|+..|+|||.+.+..++.++||||||+++
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 191 (256)
T cd08220 138 KMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191 (256)
T ss_pred CCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHH
Confidence 4 589999999987644322 2234678999999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=229.17 Aligned_cols=189 Identities=21% Similarity=0.370 Sum_probs=157.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
||+....+|.|++|.++ ......+++.||+|.+... .....+.+.+|+.++++++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~-------------------~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 61 (256)
T cd08218 1 KYVKVKKIGEGSFGKAI-------------------LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61 (256)
T ss_pred CceEEEEeccCCceEEE-------------------EEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCe
Confidence 56777777777776554 4455668899999998753 23345678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+...++.++||||+++++|.+.+... ....+++.+++.++.|++.+|.+||+++ ++|+||+|+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~ 137 (256)
T cd08218 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKD 137 (256)
T ss_pred eeeEeeecCCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC
Confidence 99999999999999999999999998887432 2345889999999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++|+|||++..+..... ......|++.|+|||.+.+..++.++|+||||+++
T Consensus 138 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~ 191 (256)
T cd08218 138 GTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVL 191 (256)
T ss_pred CCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHH
Confidence 9999999999976543321 12234678899999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=236.02 Aligned_cols=192 Identities=32% Similarity=0.504 Sum_probs=152.8
Q ss_pred ceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcccee
Q 012989 242 LYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLL 320 (452)
Q Consensus 242 ~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~ 320 (452)
....+|.|.+|.|+.+.... .....+..|+||.++.. .....+.+.+|++.+++++||||++++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~---------------~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~ 67 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ---------------KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLY 67 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES---------------TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EE
T ss_pred EeeEEccCCCcEEEEEEEEc---------------ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccc
Confidence 45667888888877653210 11235788999999654 334478899999999999999999999
Q ss_pred eeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCee
Q 012989 321 GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400 (452)
Q Consensus 321 ~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~k 400 (452)
+++...+..++||||+++++|.+++... ....+++.+++.|+.||++||.|||+++ ++|++|+|+||+++.++.+|
T Consensus 68 g~~~~~~~~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~K 143 (259)
T PF07714_consen 68 GFCIENEPLFLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVK 143 (259)
T ss_dssp EEEESSSSEEEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEE
T ss_pred cccccccccccccccccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 9999888899999999999999999653 2456899999999999999999999998 99999999999999999999
Q ss_pred EccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 401 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||++................+...|+|||.+.+..++.++||||||+++
T Consensus 144 l~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l 195 (259)
T PF07714_consen 144 LSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLL 195 (259)
T ss_dssp EESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999876332222222233467899999999988899999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=229.60 Aligned_cols=182 Identities=26% Similarity=0.389 Sum_probs=150.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++...++.|++|.++.+. ..++.+|+|.+.... ..+.+.+|+.++++++|+|+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~---------------------~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~ 63 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGD---------------------YRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQ 63 (256)
T ss_pred hCeeeeeecccCCCeEEEEE---------------------EcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeee
Confidence 56777778888887766442 247789999886442 3467899999999999999999
Q ss_pred eeeeEe-cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 319 LLGCCL-DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 319 l~~~~~-~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
+++.+. .++..+++|||+++++|.+++... ....+++..++.++.||+.+|+|||+++ ++||||||+||+++.++
T Consensus 64 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~ 139 (256)
T cd05082 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDN 139 (256)
T ss_pred EEEEEEcCCCceEEEEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCC
Confidence 998754 556799999999999999988542 2345889999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++
T Consensus 140 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~ 189 (256)
T cd05082 140 VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 189 (256)
T ss_pred cEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHH
Confidence 99999999987543322 122346789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=228.46 Aligned_cols=166 Identities=27% Similarity=0.369 Sum_probs=142.0
Q ss_pred CeeeEEEEeecCCc-ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHH
Q 012989 282 GKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360 (452)
Q Consensus 282 ~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~ 360 (452)
...||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++++|.+++..... ..+++..++
T Consensus 23 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~ 100 (257)
T cd05040 23 VIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLC 100 (257)
T ss_pred ceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHH
Confidence 34699999987655 556789999999999999999999999988 889999999999999998854322 568999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc-cccccccccccccccccccCCC
Q 012989 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVF 439 (452)
Q Consensus 361 ~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 439 (452)
.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+....... ......++..|+|||.+.+..+
T Consensus 101 ~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 101 DYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred HHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCc
Confidence 99999999999999999 9999999999999999999999999998765432211 1122456788999999988899
Q ss_pred ceeeeeeeeeeeC
Q 012989 440 SVNRMFLVSEFFF 452 (452)
Q Consensus 440 s~~~DvwSlG~il 452 (452)
+.++||||||++|
T Consensus 178 ~~~~Di~slG~~l 190 (257)
T cd05040 178 SHASDVWMFGVTL 190 (257)
T ss_pred CchhhhHHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=233.36 Aligned_cols=197 Identities=23% Similarity=0.312 Sum_probs=159.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|+....+|.|++|.|+.+..... ....+.+.|++|.+...... ..+.+.+|++++++++|+||
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~--------------~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 70 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI--------------EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC--------------CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcce
Confidence 4677778888898888876642111 01234577999988655433 45679999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKG------AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
+++++++...+..++||||+++++|.+++...... ..+++..++.++.||+.+|+|||+.+ |+||||||+|
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~N 147 (275)
T cd05046 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARN 147 (275)
T ss_pred eeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccce
Confidence 99999999999999999999999999988543311 26899999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++
T Consensus 148 ili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 208 (275)
T cd05046 148 CLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208 (275)
T ss_pred EEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHH
Confidence 999999999999999986543221 1222334567889999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=228.78 Aligned_cols=167 Identities=20% Similarity=0.306 Sum_probs=134.6
Q ss_pred eeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHH
Q 012989 283 KEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRI 360 (452)
Q Consensus 283 ~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~ 360 (452)
..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++|.+++.... ....+++..++
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (268)
T cd05086 23 ARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ 102 (268)
T ss_pred ceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHH
Confidence 456677765442 3445789999999999999999999999999999999999999999999885432 23456777889
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc----
Q 012989 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME---- 436 (452)
Q Consensus 361 ~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---- 436 (452)
.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++................|+..|+|||++..
T Consensus 103 ~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (268)
T cd05086 103 RMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179 (268)
T ss_pred HHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCc
Confidence 99999999999999998 99999999999999999999999999764322211122234567899999998742
Q ss_pred ---CCCceeeeeeeeeeeC
Q 012989 437 ---GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 437 ---~~~s~~~DvwSlG~il 452 (452)
..++.++||||||+++
T Consensus 180 ~~~~~~~~~~DiwslG~~l 198 (268)
T cd05086 180 LITAEQTKPSNVWALGVTL 198 (268)
T ss_pred cccCCCCCcchhHHHHHHH
Confidence 3457899999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=232.21 Aligned_cols=188 Identities=26% Similarity=0.414 Sum_probs=151.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 317 (452)
+|+..+.++.|++|.|+ ......+++.||+|++.... .....+.+|+.+++++ +||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy-------------------~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~ 66 (272)
T cd06637 7 IFELVELVGNGTYGQVY-------------------KGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 66 (272)
T ss_pred hhhHHHheeecCCeEEE-------------------EEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCee
Confidence 45555566666665444 44556688999999987553 3456788999999998 799999
Q ss_pred ceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 318 RLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 318 ~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
++++.+... ..++++|||+++++|.+++... ....+++..+..++.|++.+|.|||+++ |+|+||||+||
T Consensus 67 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~ni 142 (272)
T cd06637 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV 142 (272)
T ss_pred eEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHE
Confidence 999998753 4689999999999999988542 3456899999999999999999999998 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||++....... .......|++.|+|||++. +..++.++|||||||+|
T Consensus 143 li~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l 206 (272)
T cd06637 143 LLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 206 (272)
T ss_pred EECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHH
Confidence 99999999999999987653322 1223457899999999985 34688899999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=228.46 Aligned_cols=177 Identities=22% Similarity=0.302 Sum_probs=151.5
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.+..+.++......+++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++.+..+...+++|||+++++|.+
T Consensus 3 ~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 82 (262)
T cd05572 3 VGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82 (262)
T ss_pred CCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHH
Confidence 3445566666777789999999987542 2345679999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
++. +...+++..+..++.||+.+|+|||+++ ++|+||||+||+++.++.+||+|||++....... ......
T Consensus 83 ~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 83 ILR---DRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 883 3345899999999999999999999999 9999999999999999999999999998764432 122346
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.|++||.+.+..++.++|+||+|++|
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il 182 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILL 182 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHH
Confidence 78999999999888899999999999875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=230.01 Aligned_cols=187 Identities=26% Similarity=0.431 Sum_probs=151.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++...++.|++|.|+.+ ...++..+|+|.+..... ..+.+.+|+.++++++|+|+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~--------------------~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~ 65 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMG--------------------TWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQ 65 (260)
T ss_pred HhhhhheeccccCceEEEE--------------------EecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEE
Confidence 6677777777777666543 334567799999875432 3567999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+. ....+++|||+++++|.+++... ....+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.
T Consensus 66 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~ 140 (260)
T cd05070 66 LYAVVS-EEPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLV 140 (260)
T ss_pred EEeEEC-CCCcEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCce
Confidence 999875 45689999999999999988542 3345899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||++..+....... .....++..|+|||.+.+..++.++|+||||++|
T Consensus 141 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 193 (260)
T cd05070 141 CKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193 (260)
T ss_pred EEeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHH
Confidence 9999999997654332111 1122346789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=230.51 Aligned_cols=166 Identities=24% Similarity=0.403 Sum_probs=135.9
Q ss_pred eeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceeeeEecC------CeEEEEEEecCCCChhhhhccC---CCCC
Q 012989 284 EIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDS---TKGA 352 (452)
Q Consensus 284 ~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~---~~~~ 352 (452)
.+|+|.++.. .....+.+.+|+.+++.++||||+++++.+... ...+++|||+++++|..++... ....
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 6899988754 344467789999999999999999999876432 2578999999999998876322 1234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccc
Q 012989 353 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432 (452)
Q Consensus 353 ~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 432 (452)
.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.............+++.|++||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence 5899999999999999999999998 9999999999999999999999999998764332211122234577899999
Q ss_pred ccccCCCceeeeeeeeeeeC
Q 012989 433 YAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 433 ~~~~~~~s~~~DvwSlG~il 452 (452)
.+.+..++.++||||||+++
T Consensus 185 ~~~~~~~~~~~Di~slG~il 204 (272)
T cd05075 185 SLADRVYTTKSDVWSFGVTM 204 (272)
T ss_pred HccCCCcChHHHHHHHHHHH
Confidence 99988999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=226.30 Aligned_cols=178 Identities=25% Similarity=0.355 Sum_probs=145.1
Q ss_pred CCCccEEEEEEecCCeeeEEEEeecCCc-ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhc
Q 012989 268 TSSKEICVQGILADGKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLF 346 (452)
Q Consensus 268 ~~~~~v~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~ 346 (452)
++++.|+.. ...++..+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||+++++|.+++.
T Consensus 6 g~~g~vy~~-~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 84 (250)
T cd05085 6 GNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR 84 (250)
T ss_pred CCCceEEEE-EecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHH
Confidence 344444433 356788999999876532 334568899999999999999999999999999999999999999998884
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccc
Q 012989 347 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 347 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
. ....+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++......... ......++.
T Consensus 85 ~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~ 158 (250)
T cd05085 85 K--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPI 158 (250)
T ss_pred h--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcc
Confidence 3 2345889999999999999999999999 999999999999999999999999998754322211 111223467
Q ss_pred ccccccccccCCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.|+|||++.++.++.++||||||+++
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll 184 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILL 184 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHH
Confidence 89999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=230.04 Aligned_cols=189 Identities=26% Similarity=0.420 Sum_probs=154.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++...++.|++|.|+.+ . ..+++.+|||.+.... ...+.+.+|+.++++++|+||+
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~-------------------~-~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~ 64 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMG-------------------T-WNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64 (261)
T ss_pred hheeeeeeeccCcceEEEEE-------------------E-EcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEe
Confidence 35666666777777665543 2 3456789999987543 3457799999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+......++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++
T Consensus 65 ~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~ 140 (261)
T cd05034 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENL 140 (261)
T ss_pred eeeeeeecCCceEEEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCC
Confidence 9999999989999999999999999988542 3346899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||++..+...... ......++..|+|||.+.+..++.++|+||||+++
T Consensus 141 ~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il 194 (261)
T cd05034 141 VCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILL 194 (261)
T ss_pred CEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHH
Confidence 9999999998776432211 11122346789999999988899999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=234.20 Aligned_cols=188 Identities=26% Similarity=0.404 Sum_probs=159.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..||+..+.++.|++|.++.+ ....+++.|++|.+........+.+.+|+.+++.++||||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~-------------------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i 78 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTA-------------------IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78 (293)
T ss_pred hhhceeeeEecCCCCeEEEEE-------------------EEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCe
Confidence 357888888888887766644 3345788899999876555556788999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+...+..++|+||+++++|.+++.. ..+++.++..++.|++.+|.|||+++ ++|+||||+||+++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~ 151 (293)
T cd06647 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD 151 (293)
T ss_pred eehhheeeeCCcEEEEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCC
Confidence 9999999999999999999999999998832 35789999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++..+..... ......|++.|++||.+.+..++.++|+||||+++
T Consensus 152 ~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll 205 (293)
T cd06647 152 GSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205 (293)
T ss_pred CCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHH
Confidence 9999999998876543322 12234678999999999888899999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=234.75 Aligned_cols=185 Identities=23% Similarity=0.334 Sum_probs=154.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|++...+|.|++|.++ ......+++.||+|++.... ....+.+.+|+++++.++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~-------------------~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 66 (284)
T cd06620 6 DLETISDLGAGNGGSVS-------------------KVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIV 66 (284)
T ss_pred HHHHHHHcCCCCCeEEE-------------------EEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcc
Confidence 45555556666665555 44556678999999887553 33457789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~ 396 (452)
++++.+.....+++||||+++++|..++. ..+.+++..+..++.|++.+|.|||+ ++ ++|+||||+||+++.+
T Consensus 67 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~ 140 (284)
T cd06620 67 SFYGAFLNENNICMCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSR 140 (284)
T ss_pred eEeeeEecCCEEEEEEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCC
Confidence 99999999999999999999999998883 34568999999999999999999997 56 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++|+|||++....... .....|+..|+|||++.+..++.++|+|||||++
T Consensus 141 ~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 192 (284)
T cd06620 141 GQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISI 192 (284)
T ss_pred CcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHH
Confidence 999999999986543221 2235689999999999888999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=228.13 Aligned_cols=176 Identities=25% Similarity=0.365 Sum_probs=144.0
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC-----cccHHHHHHHHHHHHcCCCCCccceeeeEec--CCeEEEEEEecCCCChhh
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS-----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~ 343 (452)
+.++......+++.|++|++.... ....+.+.+|+.+++.++||||+++++.+.. ....+++|||+++++|.+
T Consensus 16 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~ 95 (266)
T cd06651 16 GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD 95 (266)
T ss_pred EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHH
Confidence 334444556678999999886432 1234568899999999999999999998875 357899999999999998
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCc-ccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN-EANTNRV 422 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~ 422 (452)
++. ....+++..++.++.|++.+|++||+.+ |+|+||||+||+++.++.+||+|||+++....... .......
T Consensus 96 ~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 169 (266)
T cd06651 96 QLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169 (266)
T ss_pred HHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccC
Confidence 884 3345899999999999999999999998 99999999999999999999999999876533211 1112234
Q ss_pred ccccccccccccccCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++..|+|||.+.+..++.++|||||||++
T Consensus 170 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~ 199 (266)
T cd06651 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTV 199 (266)
T ss_pred CccccccCHHHhCCCCCCchhhhHHHHHHH
Confidence 578999999999888899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=233.65 Aligned_cols=188 Identities=24% Similarity=0.298 Sum_probs=150.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|.+.+.+|.|++|.|+.+ ....+++.||||.+.... ......+.+|+.+++.++|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~-------------------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 65 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKG-------------------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65 (291)
T ss_pred ceeEEEEEEEecCCEEEEEE-------------------EEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCE
Confidence 35777777888877666543 455678899999987553 2333467889999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...++||||+. ++|...+.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~ 139 (291)
T cd07870 66 VLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYL 139 (291)
T ss_pred eEEEEEEecCCeEEEEEeccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCC
Confidence 999999999999999999996 466555532 2345788899999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++...... .......+++.|+|||.+.+. .++.++||||||++|
T Consensus 140 ~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 194 (291)
T cd07870 140 GELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIF 194 (291)
T ss_pred CcEEEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHH
Confidence 999999999987543221 112234568999999998754 578899999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=227.74 Aligned_cols=188 Identities=27% Similarity=0.423 Sum_probs=154.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.+|++.+.+|.|++|.|+.+. ..+++.||+|.+.... ...+.+.+|+.++++++|+||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~--------------------~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~ 64 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGY--------------------YNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64 (260)
T ss_pred HHceeeeeeccCccceEEeee--------------------cCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCee
Confidence 356777788888887776552 3467889999987543 3456789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+. .+..+++|||+++++|.+++... ....+++.+++.++.|++.+|+|||+.+ ++|+||||+||+++.++
T Consensus 65 ~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~ 139 (260)
T cd05067 65 RLYAVVT-QEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETL 139 (260)
T ss_pred eEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCC
Confidence 9998864 55789999999999999887442 3456899999999999999999999998 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++|+|||++......... ......++..|+|||.+....++.++||||||+++
T Consensus 140 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l 193 (260)
T cd05067 140 CCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 193 (260)
T ss_pred CEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHH
Confidence 9999999998765432211 12223457789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=255.96 Aligned_cols=206 Identities=17% Similarity=0.290 Sum_probs=148.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCe----eeEEEEeecCCcccHHHHHHHHHHHHcCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGK----EIAVKRLSRSSGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~----~vAiK~~~~~~~~~~~~~~~E~~~l~~l~ 312 (452)
.-+|++...+|.|++|.||.+............ ..+ .....+. .++.|.+.. .......+.+|+.+|++++
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEAR-RGV---NSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLN 221 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhh-hcc---ccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCC
Confidence 357999999999999999865321110000000 000 0000111 112222221 2234566889999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST--KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
||||+++++++...+..++|+|++.+ +|..++.... ........+++.|+.||+.||+|||+++ ||||||||+|
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~N 297 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLEN 297 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 99999999999999999999999865 5555543221 1223446678899999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred EEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 99999999999999999876543221 22345789999999999999999999999999985
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=230.87 Aligned_cols=193 Identities=20% Similarity=0.293 Sum_probs=154.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..+|.+...++.|++|.|+.+.... ...+...|+||...... ....+.+.+|+.+++.++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------------~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~ 68 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMS----------------PENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEec----------------CCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCc
Confidence 4467777888888888777553110 01234578999887654 445678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++.. ...++||||+++++|.+++.. ....+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.
T Consensus 69 i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~ 142 (270)
T cd05056 69 IVKLIGVITE-NPVWIVMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSS 142 (270)
T ss_pred hhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEec
Confidence 9999998875 457899999999999999843 2345899999999999999999999998 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++
T Consensus 143 ~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 198 (270)
T cd05056 143 PDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198 (270)
T ss_pred CCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHH
Confidence 9999999999987654432211 1122345689999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=262.06 Aligned_cols=181 Identities=26% Similarity=0.394 Sum_probs=142.0
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceeeeEecC-------------------
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG------------------- 326 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------------------- 326 (452)
.|++|.|+..+..-||+.||||+|... +......+.+|+.+|++|+|||||+++..|.+.
T Consensus 489 kGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQ 568 (1351)
T KOG1035|consen 489 KGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQ 568 (1351)
T ss_pred CCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcc
Confidence 334444445566679999999999866 444566789999999999999999998733100
Q ss_pred --------------------------------------------------------------------------------
Q 012989 327 -------------------------------------------------------------------------------- 326 (452)
Q Consensus 327 -------------------------------------------------------------------------------- 326 (452)
T Consensus 569 s~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~es 648 (1351)
T KOG1035|consen 569 SASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSES 648 (1351)
T ss_pred cCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhh
Confidence
Q ss_pred --------------------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 327 --------------------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 327 --------------------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
..+||-||||+..+|.++++...... .....|++++||++||.|+|++| ||||||
T Consensus 649 s~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~g---iIHRDL 723 (1351)
T KOG1035|consen 649 SESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQG---IIHRDL 723 (1351)
T ss_pred hhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCc---eeeccC
Confidence 12488999999988888884432211 47789999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEcccccccccc----------------CCCccccccccccccccccccccccC---CCceeeeeee
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFS----------------GNQNEANTNRVVGTYGYMAPEYAMEG---VFSVNRMFLV 447 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwS 447 (452)
||.||+++++..|||+|||++.... ........+..+||.-|+|||++.+. .|+.|+|+||
T Consensus 724 KP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYS 803 (1351)
T KOG1035|consen 724 KPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYS 803 (1351)
T ss_pred CcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHH
Confidence 9999999999999999999998721 00111234567999999999999543 5999999999
Q ss_pred eeeeC
Q 012989 448 SEFFF 452 (452)
Q Consensus 448 lG~il 452 (452)
+|+||
T Consensus 804 LGIVl 808 (1351)
T KOG1035|consen 804 LGIVL 808 (1351)
T ss_pred HHHHH
Confidence 99986
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=227.90 Aligned_cols=157 Identities=22% Similarity=0.380 Sum_probs=133.8
Q ss_pred eeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHH
Q 012989 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISI 362 (452)
Q Consensus 283 ~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i 362 (452)
..+++|.+...... ...+.+|+.+++.++||||+++++.+.. ...++||||+++++|.+++... ...+++..+..+
T Consensus 31 ~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 106 (259)
T cd05037 31 VSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE--KNNVSLHWKLDV 106 (259)
T ss_pred eeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh--ccCCCHHHHHHH
Confidence 45788877654333 6789999999999999999999999888 7789999999999999988542 226899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC-------CeeEccccccccccCCCccccccccccccccccccccc
Q 012989 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-------NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435 (452)
Q Consensus 363 ~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 435 (452)
+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..... .....++..|+|||++.
T Consensus 107 ~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~ 177 (259)
T cd05037 107 AKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIR 177 (259)
T ss_pred HHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhc
Confidence 999999999999998 99999999999999887 799999999876433 12234677899999997
Q ss_pred cC--CCceeeeeeeeeeeC
Q 012989 436 EG--VFSVNRMFLVSEFFF 452 (452)
Q Consensus 436 ~~--~~s~~~DvwSlG~il 452 (452)
+. .++.++||||||+++
T Consensus 178 ~~~~~~~~~~Di~slG~~~ 196 (259)
T cd05037 178 NGQASLTIAADKWSFGTTL 196 (259)
T ss_pred CCCCCcchhhHHHHHHHHH
Confidence 76 789999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=228.19 Aligned_cols=180 Identities=28% Similarity=0.402 Sum_probs=143.3
Q ss_pred CCCCccEEEEEEecCCe--eeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 267 VTSSKEICVQGILADGK--EIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~--~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.+.++.|+......++. .+++|.+... .....+.+.+|+++++++ +||||+++++.+...+..+++|||+++++|.
T Consensus 5 ~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (270)
T cd05047 5 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 84 (270)
T ss_pred CCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHH
Confidence 34444555545545554 4688888643 334456789999999999 7999999999999999999999999999999
Q ss_pred hhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 343 LFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 343 ~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 85 ~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~ 161 (270)
T cd05047 85 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRG 161 (270)
T ss_pred HHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccc
Confidence 9885422 1235889999999999999999999998 99999999999999999999999999863
Q ss_pred ccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 410 FSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 410 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..... .......+..|+|||.+.+..++.++||||||++|
T Consensus 162 ~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il 201 (270)
T cd05047 162 QEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 201 (270)
T ss_pred cchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHH
Confidence 22111 11112235679999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=247.36 Aligned_cols=182 Identities=26% Similarity=0.463 Sum_probs=154.3
Q ss_pred CCCCCCccEEEEEEec---CCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 265 GSVTSSKEICVQGILA---DGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 265 ~~~~~~~~v~~~~~~~---~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
.+.|.+|+|+..+... ....||||.++.. .++.+.+|+.|+.||-+++||||++|.++........||.|||++|+
T Consensus 637 IGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGs 716 (996)
T KOG0196|consen 637 IGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGS 716 (996)
T ss_pred EecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCc
Confidence 3566666666544333 3467999999876 45556789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
|+.+|+. ..++|++.+...+++.|+.|++||-+.+ +|||||...|||++.+-.+|++|||+++.+.++. .....
T Consensus 717 LDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~yt 790 (996)
T KOG0196|consen 717 LDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYT 790 (996)
T ss_pred HHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC-Ccccc
Confidence 9999965 3456999999999999999999999999 9999999999999999999999999999776554 22222
Q ss_pred cccc--ccccccccccccCCCceeeeeeeeeeeC
Q 012989 421 RVVG--TYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~g--t~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..-| +..|.|||.+..++++.++||||||+++
T Consensus 791 t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVm 824 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 824 (996)
T ss_pred ccCCccceeecChhHhhhcccCchhhccccceEE
Confidence 2222 5789999999999999999999999985
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=235.74 Aligned_cols=189 Identities=26% Similarity=0.439 Sum_probs=149.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCe----eeEEEEeecCC-cccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGK----EIAVKRLSRSS-GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~----~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h 313 (452)
.|+....+|.|++|.||.+ ....+++ .+|+|.+.... ......+.+|+.+++.++|
T Consensus 8 ~~~~~~~lg~G~~g~vy~~-------------------~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h 68 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKG-------------------IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68 (303)
T ss_pred hceeccccccCCCccEEEE-------------------EEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC
Confidence 3455556777777666644 3333443 57999886543 2334468899999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++.+... ..++++||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+|+||||+||++
T Consensus 69 ~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill 142 (303)
T cd05110 69 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLV 142 (303)
T ss_pred CCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeee
Confidence 9999999988754 46799999999999988843 2345899999999999999999999998 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+.............++..|++||.+.+..++.++||||||++|
T Consensus 143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l 201 (303)
T cd05110 143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201 (303)
T ss_pred cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHH
Confidence 99999999999999876543332223334457789999999988999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=223.96 Aligned_cols=177 Identities=21% Similarity=0.211 Sum_probs=147.5
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCccceeeeEec----CCeEEEEEEecCC
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLD----GNELLLIYEYMPN 338 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----~~~~~lv~E~~~~ 338 (452)
.++.|..|.|..+.+..+++.+|+|++... +...+|+++--.. .|||||.++++|+. ...+.+|||.++|
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 456778899999999999999999988533 4566788765444 69999999999874 3468899999999
Q ss_pred CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC---CCeeEccccccccccCCCc
Q 012989 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE---MNPKISDFGMARIFSGNQN 415 (452)
Q Consensus 339 ~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~ 415 (452)
|.|...+.+. ....|++.++-.|++||..|+.|||+.+ |.||||||+|+|.+.+ ..+||+|||+|+.-..
T Consensus 144 GeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--- 216 (400)
T KOG0604|consen 144 GELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--- 216 (400)
T ss_pred hHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC---
Confidence 9998888542 3456999999999999999999999999 9999999999999754 4599999999986432
Q ss_pred cccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 416 EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 416 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.......+-|+.|+|||++....|+..+|+||+|+|+
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVim 253 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHH
Confidence 2223345679999999999988999999999999974
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=239.57 Aligned_cols=169 Identities=22% Similarity=0.283 Sum_probs=141.4
Q ss_pred EEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCC
Q 012989 277 GILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQ 353 (452)
Q Consensus 277 ~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~ 353 (452)
....+.+.+|+|++... +.+...-+.+|+.+|.+| .|.+|++|+++-..++.+|||||+= ..+|..++.. +...
T Consensus 380 V~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k--~~~~ 456 (677)
T KOG0596|consen 380 VLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKK--KKSI 456 (677)
T ss_pred eecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHh--ccCC
Confidence 34456778888877543 556677899999999999 5999999999999999999999974 5689888843 2333
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccc
Q 012989 354 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEY 433 (452)
Q Consensus 354 l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 433 (452)
.+.-.++.+..||+.++.++|++| |||.||||.|+|+- +|.+||||||.|..+..+.........+||+.||+||.
T Consensus 457 ~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEA 532 (677)
T KOG0596|consen 457 DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEA 532 (677)
T ss_pred CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHH
Confidence 343388899999999999999999 99999999999984 57899999999999888877777778899999999999
Q ss_pred cccCC-----------CceeeeeeeeeeeC
Q 012989 434 AMEGV-----------FSVNRMFLVSEFFF 452 (452)
Q Consensus 434 ~~~~~-----------~s~~~DvwSlG~il 452 (452)
+.... .+.++||||+||||
T Consensus 533 l~~~~s~~~~~~~k~Ki~r~SDvWSLGCIL 562 (677)
T KOG0596|consen 533 LTDMSSSRENGKSKIKISRKSDVWSLGCIL 562 (677)
T ss_pred HhhccccccCCCcceeecCccchhhhhhHH
Confidence 84221 57889999999996
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=229.97 Aligned_cols=194 Identities=27% Similarity=0.435 Sum_probs=156.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv 317 (452)
.|+..+.+|.|++|.|+.+..... ...+++.+|||.+...... ..+.+.+|+++++.++||||+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~---------------~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~ 69 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPL---------------GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCC---------------CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChh
Confidence 455567778888877776532110 1235789999999766443 467899999999999999999
Q ss_pred ceeeeEec--CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 318 RLLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 318 ~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
++++++.. ....+++|||+++++|.+++... ...+++..++.++.||+.+|+|||+.+ ++|+||||+||+++.
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~ 144 (284)
T cd05038 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVES 144 (284)
T ss_pred eEEeeeecCCCCceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcC
Confidence 99999887 56799999999999999998432 235899999999999999999999998 999999999999999
Q ss_pred CCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++.......... ......++..|++||.+.+..++.++||||||+++
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 202 (284)
T cd05038 145 EDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202 (284)
T ss_pred CCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhh
Confidence 9999999999998765332211 11123446679999999888999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=230.49 Aligned_cols=173 Identities=27% Similarity=0.385 Sum_probs=146.7
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
+.|+......+++.||+|.+.... ....+.+.+|+.++++++||||+++++.+..+...++||||+++++|.+++.
T Consensus 18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--- 94 (277)
T cd06642 18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--- 94 (277)
T ss_pred eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh---
Confidence 344444555678899999987543 3445678999999999999999999999999999999999999999988873
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 429 (452)
...+++..++.++.||+.+|.|||+++ ++|+||+|+||+++.++.+||+|||++..+..... ......|+..|+
T Consensus 95 -~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 168 (277)
T cd06642 95 -PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWM 168 (277)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCccccc
Confidence 246899999999999999999999998 99999999999999999999999999876543321 122346789999
Q ss_pred cccccccCCCceeeeeeeeeeeC
Q 012989 430 APEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||.+.+..++.++|+||||+++
T Consensus 169 aPE~~~~~~~~~~~Dv~slG~il 191 (277)
T cd06642 169 APEVIKQSAYDFKADIWSLGITA 191 (277)
T ss_pred CHHHhCcCCCchhhhHHHHHHHH
Confidence 99999888899999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=239.14 Aligned_cols=185 Identities=26% Similarity=0.333 Sum_probs=151.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||+....++.|++|.|+.+ ....+++.||||.+.+. .......+.+|+.+++.++||
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 75 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAA-------------------YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75 (353)
T ss_pred hcceEEEEEeccCCCEEEEEE-------------------EECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCC
Confidence 457887788888887666544 55668999999998653 233445678899999999999
Q ss_pred CccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++++... .+.++||||+.+ +|.+.+.. .+++..+..++.||+.||+|||++| |+||||||
T Consensus 76 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp 146 (353)
T cd07850 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 146 (353)
T ss_pred CCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCH
Confidence 999999988644 357999999965 67666621 2889999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+++.++.+||+|||+++....... .....|++.|+|||.+.+..++.++|||||||+|
T Consensus 147 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 207 (353)
T cd07850 147 SNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (353)
T ss_pred HHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHH
Confidence 999999999999999999986543221 2234678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=234.25 Aligned_cols=187 Identities=25% Similarity=0.357 Sum_probs=153.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|+....++.|++|.|+. .....+++.||+|++..... ...+.+.+|+++++.++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~-------------------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 62 (286)
T cd07846 2 KYENLGLVGEGSYGMVMK-------------------CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62 (286)
T ss_pred ceeEeeeeccCCCeEEEE-------------------EEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcch
Confidence 466666677777765554 34455789999998865422 235678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...++||||+++++|..+.. ....+++.+++.++.||+.+|.|||+.+ ++|+||+|+||+++.+
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~ 136 (286)
T cd07846 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQS 136 (286)
T ss_pred hhHHHhcccCCeEEEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCC
Confidence 999999999999999999999999988763 2345899999999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ ......++..|+|||++.+ ..++.++||||||+++
T Consensus 137 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 191 (286)
T cd07846 137 GVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLV 191 (286)
T ss_pred CcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHH
Confidence 9999999999876544321 2233467899999999865 4578899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=227.43 Aligned_cols=176 Identities=28% Similarity=0.402 Sum_probs=145.7
Q ss_pred CccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
++.|+......+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++...
T Consensus 21 ~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 99 (268)
T cd06624 21 YGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK- 99 (268)
T ss_pred ceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh-
Confidence 3444444556678899999988776666778999999999999999999999999999999999999999999988542
Q ss_pred CCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-CCCeeEccccccccccCCCcccccccccccc
Q 012989 350 KGAQL--DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 350 ~~~~l--~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
...+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++........ ......|++
T Consensus 100 -~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~ 173 (268)
T cd06624 100 -WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTL 173 (268)
T ss_pred -cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCc
Confidence 2334 88889999999999999999998 999999999999976 67899999999876543221 122345789
Q ss_pred ccccccccccCC--CceeeeeeeeeeeC
Q 012989 427 GYMAPEYAMEGV--FSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~~~--~s~~~DvwSlG~il 452 (452)
.|+|||.+.+.. ++.++|+||||++|
T Consensus 174 ~~~aPE~~~~~~~~~~~~~Dv~slGvvl 201 (268)
T cd06624 174 QYMAPEVIDKGPRGYGAPADIWSLGCTI 201 (268)
T ss_pred cccChhhhccccccCCchhhhHHHHHHH
Confidence 999999986543 78899999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=225.12 Aligned_cols=166 Identities=31% Similarity=0.486 Sum_probs=141.5
Q ss_pred CeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHH
Q 012989 282 GKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~ 360 (452)
+..||+|.+...... ..+.+.+|+.+++.++|+||+++++.+...+..+++||++++++|.+++.... ...+++..++
T Consensus 28 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~ 106 (258)
T smart00219 28 EVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR-PKELSLSDLL 106 (258)
T ss_pred CceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh-hccCCHHHHH
Confidence 488999999765433 56789999999999999999999999999999999999999999999884321 1228999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCc
Q 012989 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440 (452)
Q Consensus 361 ~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 440 (452)
.++.||+.+|.+||+.+ ++|+||||+||+++.++.++|+|||++............ ...+++.|+|||.+.+..++
T Consensus 107 ~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~ 182 (258)
T smart00219 107 SFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFT 182 (258)
T ss_pred HHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCC
Confidence 99999999999999998 999999999999999999999999999876544222211 22367899999999888899
Q ss_pred eeeeeeeeeeeC
Q 012989 441 VNRMFLVSEFFF 452 (452)
Q Consensus 441 ~~~DvwSlG~il 452 (452)
.++|+||+|+++
T Consensus 183 ~~~Di~slG~i~ 194 (258)
T smart00219 183 SKSDVWSFGVLL 194 (258)
T ss_pred cchhHHHHHHHH
Confidence 999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=225.66 Aligned_cols=182 Identities=29% Similarity=0.410 Sum_probs=150.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-.|++...+|.|++|.++.+. .+++.||+|.+.... ..+.+.+|+.+++.++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~---------------------~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~ 62 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE---------------------YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLV 62 (254)
T ss_pred HHceeeeeeccCCCCceEecc---------------------cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcC
Confidence 357778888999988777542 357889999986542 346789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+... ..+++|||+++++|.+++... ....+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++
T Consensus 63 ~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~ 137 (254)
T cd05083 63 RLLGVILHN-GLYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137 (254)
T ss_pred eEEEEEcCC-CcEEEEECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCC
Confidence 999998754 479999999999999988543 2345899999999999999999999998 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||++....... .....+..|+|||.+.++.++.++|+||||+++
T Consensus 138 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l 187 (254)
T cd05083 138 VAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLL 187 (254)
T ss_pred cEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHH
Confidence 99999999987543221 122336789999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=229.22 Aligned_cols=176 Identities=26% Similarity=0.281 Sum_probs=141.6
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHc---CCCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAK---LQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~---l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
.|.++.|+......+++.+|+|.+.+.. ......+.+|..+++. .+||||+.+++.+..++..++||||+++++
T Consensus 4 ~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 83 (279)
T cd05633 4 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGD 83 (279)
T ss_pred cCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCC
Confidence 3445556666667789999999886542 1222334455544444 479999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
|..++. ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....... ..
T Consensus 84 L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 153 (279)
T cd05633 84 LHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (279)
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence 998884 3456999999999999999999999999 9999999999999999999999999987554322 12
Q ss_pred ccccccccccccccc-cCCCceeeeeeeeeeeC
Q 012989 421 RVVGTYGYMAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
...|++.|+|||.+. +..++.++|+||+||+|
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 186 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCML 186 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHH
Confidence 346899999999986 45689999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=226.92 Aligned_cols=188 Identities=24% Similarity=0.384 Sum_probs=151.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-||++...+|.|++|.++.+. ...+..+|+|.+.... ...+.+.+|+.+++.++|+|++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~--------------------~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~ 64 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGT--------------------WNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLV 64 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEE--------------------EcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCee
Confidence 367777888888887766442 2344569999876543 3456789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++. ....+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++
T Consensus 65 ~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~ 139 (260)
T cd05069 65 PLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNL 139 (260)
T ss_pred eEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCC
Confidence 9998875 45688999999999999988542 3345899999999999999999999998 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||++......... ......++..|+|||...+..++.++|+||||++|
T Consensus 140 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l 193 (260)
T cd05069 140 VCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193 (260)
T ss_pred eEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHH
Confidence 9999999999765432211 11223457789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=225.83 Aligned_cols=174 Identities=24% Similarity=0.360 Sum_probs=148.7
Q ss_pred CccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
.+.++......+++.+++|.+..... .+.+.+|++++++++||||+++++.+..+...++++||+++++|.+++..
T Consensus 16 ~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~-- 91 (256)
T cd06612 16 YGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI-- 91 (256)
T ss_pred CeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh--
Confidence 34444445556689999999875533 67899999999999999999999999999999999999999999998843
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 429 (452)
....+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++........ ......|+..|+
T Consensus 92 ~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 166 (256)
T cd06612 92 TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWM 166 (256)
T ss_pred CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCcccc
Confidence 2456899999999999999999999998 99999999999999999999999999887644321 122345788999
Q ss_pred cccccccCCCceeeeeeeeeeeC
Q 012989 430 APEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||++.+..++.++||||||+|+
T Consensus 167 ~PE~~~~~~~~~~~Di~s~G~il 189 (256)
T cd06612 167 APEVIQEIGYNNKADIWSLGITA 189 (256)
T ss_pred CHHHHhcCCCCchhhHHHHHHHH
Confidence 99999888899999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=228.74 Aligned_cols=177 Identities=25% Similarity=0.366 Sum_probs=149.7
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
.+.++.++......+++.||||.+.... ....+.+.+|+.++++++||||+++++.+..+...++||||+++++|.+++
T Consensus 14 ~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i 93 (277)
T cd06640 14 KGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL 93 (277)
T ss_pred cCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence 3344455555566678999999987542 445677899999999999999999999999999999999999999999888
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 425 (452)
. ...+++..+..++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++
T Consensus 94 ~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~ 164 (277)
T cd06640 94 R----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGT 164 (277)
T ss_pred h----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCc
Confidence 3 245889999999999999999999998 99999999999999999999999999976543321 12234678
Q ss_pred cccccccccccCCCceeeeeeeeeeeC
Q 012989 426 YGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 426 ~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..|+|||.+.+..++.++|+||||++|
T Consensus 165 ~~y~apE~~~~~~~~~~~Dv~slG~il 191 (277)
T cd06640 165 PFWMAPEVIQQSAYDSKADIWSLGITA 191 (277)
T ss_pred ccccCHhHhccCCCccHHHHHHHHHHH
Confidence 899999999888899999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=229.67 Aligned_cols=193 Identities=24% Similarity=0.330 Sum_probs=154.5
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h 313 (452)
....+|++...++.|++|.|+.+ ....+++.+|+|++.... .....+.+|+.+++.+ +|
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~-------------------~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h 74 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKV-------------------LNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDH 74 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEE-------------------EECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcC
Confidence 35567787777888877666543 455678899999876432 2345688899999999 69
Q ss_pred CCccceeeeEe-----cCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 314 KNLVRLLGCCL-----DGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 314 ~~iv~l~~~~~-----~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
|||+++++.+. .+...++||||+++++|.+++... .....+++..++.++.|++.+|.|||+.+ ++|||||
T Consensus 75 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk 151 (286)
T cd06638 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVK 151 (286)
T ss_pred CCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCC
Confidence 99999999874 345799999999999998877432 23456899999999999999999999998 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
|+||+++.++.+||+|||+++....... ......|++.|+|||++. +..++.++|||||||++
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~ 219 (286)
T cd06638 152 GNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219 (286)
T ss_pred HHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence 9999999999999999999876543221 222346899999999874 34578999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=228.70 Aligned_cols=196 Identities=27% Similarity=0.343 Sum_probs=160.4
Q ss_pred cccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-------cccHHHHHHHHH
Q 012989 234 PSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-------GQGLQEFKNEVT 306 (452)
Q Consensus 234 ~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~~E~~ 306 (452)
+.-+-||-+...+|.|+|..||++ .++...+.||+|+-.... ..-.+...+|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKA-------------------FDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyr 519 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKA-------------------FDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYR 519 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHh-------------------cccchhheeeEeeehhccchhhHhhhhHHHHHHHHHh
Confidence 344668888888888888777766 456788999999754221 111345678999
Q ss_pred HHHcCCCCCccceeeeEecC-CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 012989 307 LIAKLQHKNLVRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385 (452)
Q Consensus 307 ~l~~l~h~~iv~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~D 385 (452)
|-+.|.||.||++|++|..+ +.+|-|+||++|.+|+.++ +..+.+++.+++.|+-||+.||.||.+.. .+|||-|
T Consensus 520 IHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYD 595 (775)
T KOG1151|consen 520 IHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYD 595 (775)
T ss_pred hhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeec
Confidence 99999999999999999854 6789999999999999999 56677999999999999999999999985 7899999
Q ss_pred CCCCCeEECC---CCCeeEccccccccccCCCccc-----ccccccccccccccccccc----CCCceeeeeeeeeeeC
Q 012989 386 LKTSNVLLDH---EMNPKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPEYAME----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 386 lkp~NIll~~---~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwSlG~il 452 (452)
|||.|||+.. -|.+||.|||++++..++.... .+....||.+|.+||.+.- ...+.|.||||+|+||
T Consensus 596 LKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 596 LKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred cCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 9999999954 4679999999999987664432 2345689999999998853 3479999999999996
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=230.14 Aligned_cols=175 Identities=26% Similarity=0.422 Sum_probs=148.9
Q ss_pred CCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccC
Q 012989 269 SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS 348 (452)
Q Consensus 269 ~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 348 (452)
.++.++......+++.||||++..........+.+|+.+++.++|+||+++++.+..+++.++||||+++++|.+++.
T Consensus 32 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-- 109 (292)
T cd06657 32 STGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-- 109 (292)
T ss_pred CCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh--
Confidence 334444555667899999999876555556779999999999999999999999999999999999999999988773
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccc
Q 012989 349 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGY 428 (452)
Q Consensus 349 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 428 (452)
...+++..++.++.|++.+|+|||+.| ++|+||||+||+++.++.++|+|||++........ ......|++.|
T Consensus 110 --~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y 182 (292)
T cd06657 110 --HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYW 182 (292)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccc
Confidence 235899999999999999999999998 99999999999999999999999999876543221 12335678999
Q ss_pred ccccccccCCCceeeeeeeeeeeC
Q 012989 429 MAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 429 ~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||.+.+..++.++|+||+|+++
T Consensus 183 ~~pE~~~~~~~~~~~Dv~slGvil 206 (292)
T cd06657 183 MAPELISRLPYGPEVDIWSLGIMV 206 (292)
T ss_pred cCHHHhcCCCCCchhhHHHHHHHH
Confidence 999999888899999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=225.68 Aligned_cols=188 Identities=24% Similarity=0.389 Sum_probs=153.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++.+.++.|++|.|+.+ ...++..+|+|.+... ....+.+.+|+.++++++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~--------------------~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 64 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMA--------------------TYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLV 64 (260)
T ss_pred cceeEEeEecCccceEEEEE--------------------EecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcc
Confidence 46777778888888766644 2345667999988654 23456789999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++.+.. ...+++|||+++++|.+++... ....+++..++.++.||+.+|.|||+.+ ++|+||||+||+++.++
T Consensus 65 ~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~ 139 (260)
T cd05073 65 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASL 139 (260)
T ss_pred eEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCC
Confidence 99999887 7789999999999999988542 3456889999999999999999999998 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||.+..+...... ......++..|+|||++....++.++|+||||+++
T Consensus 140 ~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 193 (260)
T cd05073 140 VCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 193 (260)
T ss_pred cEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHH
Confidence 9999999998765433221 12223456789999999888899999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=228.97 Aligned_cols=168 Identities=30% Similarity=0.438 Sum_probs=140.9
Q ss_pred CeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC----CCCCCCH
Q 012989 282 GKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST----KGAQLDW 356 (452)
Q Consensus 282 ~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~~~l~~ 356 (452)
++.+|||.+.... ......+.+|+.+++.++||||+++++++..+...++||||+++++|.+++.... ....+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred ceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 4689999886542 3445678999999999999999999999999999999999999999998885422 2245789
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC-----CeeEccccccccccCCCccccccccccccccccc
Q 012989 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-----NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAP 431 (452)
Q Consensus 357 ~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 431 (452)
.+++.++.||+.+|.|||+.+ ++|+||||+||+++.++ .+||+|||+++...............++..|+||
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence 999999999999999999998 99999999999999887 8999999998765433322222233457889999
Q ss_pred cccccCCCceeeeeeeeeeeC
Q 012989 432 EYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 432 E~~~~~~~s~~~DvwSlG~il 452 (452)
|.+.++.++.++||||||+++
T Consensus 183 E~~~~~~~~~~~Dv~slG~il 203 (269)
T cd05044 183 ESLLDGKFTTQSDVWSFGVLM 203 (269)
T ss_pred HHHccCCcccchhHHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=227.06 Aligned_cols=176 Identities=26% Similarity=0.287 Sum_probs=142.2
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCc---ccHHHHHHHHHH---HHcCCCCCccceeeeEecCCeEEEEEEecCCCC
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSG---QGLQEFKNEVTL---IAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~E~~~---l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~ 340 (452)
.+.++.|+......+++.||||.+.+... .....+..|..+ ++...||+|+++++.+...+..++||||++|++
T Consensus 4 ~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~ 83 (278)
T cd05606 4 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 83 (278)
T ss_pred cCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCc
Confidence 44456666666777899999999876421 112234444443 444579999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
|..++. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+.... ..
T Consensus 84 L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~ 153 (278)
T cd05606 84 LHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (278)
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence 998883 3456999999999999999999999999 9999999999999999999999999987654322 22
Q ss_pred ccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 421 RVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
...|+..|+|||.+.++ .++.++||||+|++|
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l 186 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 186 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHH
Confidence 34689999999998754 589999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=227.71 Aligned_cols=177 Identities=26% Similarity=0.365 Sum_probs=150.9
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
.+.++.++......+++.+++|.+.... ....+.+.+|+++++.++||||+++++.+..+...++++||+++++|.+++
T Consensus 11 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 90 (265)
T cd06605 11 AGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL 90 (265)
T ss_pred CCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHH
Confidence 3344555566677789999999987653 344567899999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVG 424 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 424 (452)
.... ..+++..+..++.|++++|++||+ .+ ++|+||||+||+++.++.+||+|||.+......... ...+
T Consensus 91 ~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~ 161 (265)
T cd06605 91 KEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVG 161 (265)
T ss_pred HHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccC
Confidence 4422 678999999999999999999999 88 999999999999999999999999998765432211 1567
Q ss_pred ccccccccccccCCCceeeeeeeeeeeC
Q 012989 425 TYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 425 t~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+..|+|||.+.+..++.++|+||||+++
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l 189 (265)
T cd06605 162 TSSYMAPERIQGNDYSVKSDIWSLGLSL 189 (265)
T ss_pred ChhccCHHHHcCCCCCchhhHHHHHHHH
Confidence 8999999999888999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=227.58 Aligned_cols=194 Identities=22% Similarity=0.355 Sum_probs=150.6
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
|++.+.++.|++|.|+.+.. +....+++.||||++... .....+++.+|+.+++.++||||+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~----------------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 64 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQL----------------KSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64 (273)
T ss_pred CcchhcccCCCCCCEEeeEe----------------eccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcc
Confidence 34455667777777665521 112345789999998754 334456788999999999999999
Q ss_pred ceeeeEecCC------eEEEEEEecCCCChhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 318 RLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDST---KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 318 ~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
++++++.... ..++++||+.+++|..++.... ....+++..++.++.||+.+|+|||+.+ |+||||||
T Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp 141 (273)
T cd05074 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAA 141 (273)
T ss_pred eEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecccch
Confidence 9999886532 2478899999999987764321 2235789999999999999999999998 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+++.++.+||+|||+++...............+++.|++||.+.+..++.++|||||||+|
T Consensus 142 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il 205 (273)
T cd05074 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTM 205 (273)
T ss_pred hhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHH
Confidence 9999999999999999998865433222222233456789999999888899999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=226.87 Aligned_cols=179 Identities=25% Similarity=0.375 Sum_probs=151.2
Q ss_pred CCCccEEEEEEecCCeeeEEEEeecCCc---ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 268 TSSKEICVQGILADGKEIAVKRLSRSSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 268 ~~~~~v~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
+..+.++......+++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...+++|||+++++|.++
T Consensus 4 g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 83 (265)
T cd05579 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASL 83 (265)
T ss_pred CCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHH
Confidence 4455666666677799999999876533 4566789999999999999999999999999999999999999999998
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCc------ccc
Q 012989 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN------EAN 418 (452)
Q Consensus 345 l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~ 418 (452)
+.. ...+++..++.++.||+.+|.+||+.+ ++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 84 l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 84 LEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 843 336899999999999999999999998 99999999999999999999999999876433321 112
Q ss_pred ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 419 TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 419 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.....++..|++||.......+.++|+||||+++
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence 2334678899999999888899999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=226.54 Aligned_cols=186 Identities=25% Similarity=0.365 Sum_probs=157.2
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc-ccHHHHHHHHHHHHcCCCCCccc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
|+..+.++.|++|.++ ......+++.|+||++..... ...+.+.+|+..++.++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~-------------------~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 63 (264)
T cd06623 3 LERVKVLGQGSSGVVY-------------------KVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63 (264)
T ss_pred ceeeeeeeecCCeEEE-------------------EEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeee
Confidence 5555666666665444 445666899999999876643 44678999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
+++.+......++||||+++++|.+++.. ...+++..++.++.|++++|.+||+ .+ ++|+||+|+||+++.++
T Consensus 64 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~ 137 (264)
T cd06623 64 CYGAFYKEGEISIVLEYMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKG 137 (264)
T ss_pred EEEEEccCCeEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCC
Confidence 99999999999999999999999999843 3668999999999999999999999 98 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++
T Consensus 138 ~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 190 (264)
T cd06623 138 EVKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190 (264)
T ss_pred CEEEccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHH
Confidence 99999999988764433221 234678999999999888999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=228.93 Aligned_cols=174 Identities=26% Similarity=0.420 Sum_probs=146.6
Q ss_pred CccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCC---CCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 270 SKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
.+.++......+++.||+|.+... .....+.+.+|+.+++.++ |||++++++.+..+...++||||+++++|.+++
T Consensus 14 ~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (277)
T cd06917 14 YGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM 93 (277)
T ss_pred CceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHH
Confidence 344445556678999999998755 3445567889999999996 999999999999999999999999999999887
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 425 (452)
.. ..+++..++.++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++..+..... ......|+
T Consensus 94 ~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~ 164 (277)
T cd06917 94 KA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGT 164 (277)
T ss_pred Hc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCC
Confidence 32 36899999999999999999999999 99999999999999999999999999987654432 12334689
Q ss_pred ccccccccccc-CCCceeeeeeeeeeeC
Q 012989 426 YGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 426 ~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
..|+|||.+.+ ..++.++|+||||++|
T Consensus 165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l 192 (277)
T cd06917 165 PYWMAPEVITEGKYYDTKADIWSLGITI 192 (277)
T ss_pred cceeCHHHhccCCccccchhHHHHHHHH
Confidence 99999998865 4478999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=229.48 Aligned_cols=188 Identities=25% Similarity=0.387 Sum_probs=151.6
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
|+...-++.|++|.++ ......+++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 2 y~~~~~l~~g~~~~v~-------------------~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 62 (284)
T cd07836 2 FKQLEKLGEGTYATVY-------------------KGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVR 62 (284)
T ss_pred ceEeeeeccCCceEEE-------------------EEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEee
Confidence 5555566666665544 44555679999999987653 233566788999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+...+..++||||+++ +|.+++........+++..+..++.||+.+|.|||+.+ ++|+||||+||+++.++.
T Consensus 63 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~ 138 (284)
T cd07836 63 LHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGE 138 (284)
T ss_pred eeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCc
Confidence 99999999999999999986 77777654333456899999999999999999999998 999999999999999999
Q ss_pred eeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+||+|||++........ ......++..|++||.+.+ ..++.++|+||||+++
T Consensus 139 ~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l 191 (284)
T cd07836 139 LKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIM 191 (284)
T ss_pred EEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHH
Confidence 99999999876543211 1223456889999998865 4578899999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=233.69 Aligned_cols=179 Identities=24% Similarity=0.311 Sum_probs=153.1
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.|++|+|.+.....+.+.+|||+++++ ...+.+--+.|-++|... +-|.+++++..|++-+.+|+||||+.||+|
T Consensus 358 GKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDL 437 (683)
T KOG0696|consen 358 GKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDL 437 (683)
T ss_pred ccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchh
Confidence 3444555666667778899999999876 344455567788888877 578999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
--.+ ++-+.+.+..+..++.+|+-||-+||++| ||.||||.+|||++.+|++||.|||+++.-. -....+..
T Consensus 438 Myhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkT 509 (683)
T KOG0696|consen 438 MYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKT 509 (683)
T ss_pred hhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc--cCCcceee
Confidence 7766 55677999999999999999999999999 9999999999999999999999999997422 23445667
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++|||.|+|||++...+|+...|+||||++|
T Consensus 510 FCGTPdYiAPEIi~YqPYgksvDWWa~GVLL 540 (683)
T KOG0696|consen 510 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 540 (683)
T ss_pred ecCCCcccccceEEecccccchhHHHHHHHH
Confidence 8999999999999999999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=230.61 Aligned_cols=190 Identities=22% Similarity=0.296 Sum_probs=154.4
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC----cccHHHHHHHHHHHHcC-CCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS----GQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~ 314 (452)
|++...++.|++|.++.+... ....+|+.||+|.+.... ....+++.+|+.+++++ +|+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~----------------~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 65 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKV----------------SGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65 (290)
T ss_pred ceeeeeeccCCcceEEEEEec----------------cCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCC
Confidence 667778888888777654210 112478899999987532 22346788999999999 699
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..+...++||||+++++|.+++. ....+++..+..++.||+.+|.|||+.+ ++||||||+|||++
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~ 139 (290)
T cd05613 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLD 139 (290)
T ss_pred ChhceeeEeecCCeEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEC
Confidence 99999999999999999999999999999884 3456889999999999999999999998 99999999999999
Q ss_pred CCCCeeEccccccccccCCCcccccccccccccccccccccc--CCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++..+..... .......|+..|+|||.+.+ ..++.++||||||++|
T Consensus 140 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l 198 (290)
T cd05613 140 SNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198 (290)
T ss_pred CCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHH
Confidence 999999999999876543321 12234568999999999865 3468899999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=223.32 Aligned_cols=164 Identities=31% Similarity=0.453 Sum_probs=137.0
Q ss_pred CeeeEEEEeecCCc-ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHH
Q 012989 282 GKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360 (452)
Q Consensus 282 ~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~ 360 (452)
+..+|+|.+..... ...+.+.+|+.+++.+.||||+++++++. .+..++||||+++++|.+++.. ...+++..++
T Consensus 23 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~ 98 (257)
T cd05060 23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK---RREIPVSDLK 98 (257)
T ss_pred cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh---CCCCCHHHHH
Confidence 47899999876533 34567899999999999999999999876 4568999999999999999843 3468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccc-ccccccccccccccccccCCC
Q 012989 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN-TNRVVGTYGYMAPEYAMEGVF 439 (452)
Q Consensus 361 ~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 439 (452)
.++.|++.+|++||+.+ ++|+||||+|||++.++.+||+|||+++.......... .....++..|+|||.+.+..+
T Consensus 99 ~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 99 ELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred HHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCC
Confidence 99999999999999998 99999999999999999999999999986643332211 111223567999999988899
Q ss_pred ceeeeeeeeeeeC
Q 012989 440 SVNRMFLVSEFFF 452 (452)
Q Consensus 440 s~~~DvwSlG~il 452 (452)
+.++||||||++|
T Consensus 176 ~~~~Di~slG~~l 188 (257)
T cd05060 176 SSKSDVWSYGVTL 188 (257)
T ss_pred CccchHHHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=235.88 Aligned_cols=184 Identities=22% Similarity=0.308 Sum_probs=156.5
Q ss_pred CCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--------cccHHHHHHHHHHHHcCC---CCCccceeeeEecCC
Q 012989 259 FSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--------GQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGN 327 (452)
Q Consensus 259 ~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~ 327 (452)
+....+.+.|.+|.|+.+.+.++..+|+||.|.+.. +...-.+-.||+||..|+ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 445566788999999999999999999999987652 111223557999999997 999999999999999
Q ss_pred eEEEEEEec-CCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccc
Q 012989 328 ELLLIYEYM-PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGM 406 (452)
Q Consensus 328 ~~~lv~E~~-~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 406 (452)
.+||+||-. +|-+|.+++ .....+++.++..|++|++.|+++||+.| |||||||-+|+.++.+|-+||+|||.
T Consensus 643 ~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 999999975 456677777 45667999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccccccccCCCcee-eeeeeeeeeC
Q 012989 407 ARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVN-RMFLVSEFFF 452 (452)
Q Consensus 407 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwSlG~il 452 (452)
+....... ...++||..|+|||++.+.+|-.| -|||++|++|
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgill 759 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILL 759 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhhee
Confidence 87653332 345789999999999999888544 9999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=226.05 Aligned_cols=180 Identities=24% Similarity=0.341 Sum_probs=146.8
Q ss_pred CCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceeeeEecCC-----eEEEEEEecC
Q 012989 265 GSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN-----ELLLIYEYMP 337 (452)
Q Consensus 265 ~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~lv~E~~~ 337 (452)
.+-|.+|.||-..+-.+|+.||+|++..- +-...+++.+|+++|..++|.|++..++..+-.+ ++|++.|++.
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ 140 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ 140 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH
Confidence 34444455555556678999999998643 2334567889999999999999999999887553 5788999984
Q ss_pred CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc
Q 012989 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA 417 (452)
Q Consensus 338 ~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 417 (452)
.+|+.++ .....++...++-++.||++||+|||+.+ |+||||||.|.|++.+-.+||+|||+++....+....
T Consensus 141 -SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 141 -SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred -hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 4888888 45567999999999999999999999999 9999999999999999999999999998765443322
Q ss_pred ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 418 NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 418 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
.+..+-|..|.|||++++ ..|+...||||.||||
T Consensus 214 -MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF 248 (449)
T KOG0664|consen 214 -MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF 248 (449)
T ss_pred -hHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence 233455999999999987 5599999999999985
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=227.57 Aligned_cols=185 Identities=19% Similarity=0.277 Sum_probs=147.5
Q ss_pred eecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEe
Q 012989 245 FYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL 324 (452)
Q Consensus 245 f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 324 (452)
.+|.|++|.||.+....... .......++++|.+........+.+.+|+.+++.++||||+++++.+.
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~------------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 69 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGD------------YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV 69 (258)
T ss_pred CCCcccchhheeeeeccccc------------ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE
Confidence 35777887777653211000 001234568999887665555678899999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC------
Q 012989 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN------ 398 (452)
Q Consensus 325 ~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~------ 398 (452)
.+...++||||+++++|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 70 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~ 144 (258)
T cd05078 70 CGDESIMVQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNP 144 (258)
T ss_pred eCCCcEEEEecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCC
Confidence 999999999999999999998432 336899999999999999999999999 999999999999987765
Q ss_pred --eeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 399 --PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+|++|||++...... ....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 145 ~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 145 PFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred ceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 699999988654321 22457889999999976 4579999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=222.50 Aligned_cols=174 Identities=28% Similarity=0.427 Sum_probs=149.9
Q ss_pred ccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK 350 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~ 350 (452)
+.++......+++.+++|++........+.+.+|++++++++|+||+++++.+..+...++++||+++++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-- 91 (253)
T cd05122 14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST-- 91 (253)
T ss_pred eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc--
Confidence 334344555578999999998765556678999999999999999999999999999999999999999999988432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccc
Q 012989 351 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMA 430 (452)
Q Consensus 351 ~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 430 (452)
...+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....|+..|+|
T Consensus 92 ~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ 165 (253)
T cd05122 92 NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMA 165 (253)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccC
Confidence 256899999999999999999999998 99999999999999999999999999877654332 234567899999
Q ss_pred ccccccCCCceeeeeeeeeeeC
Q 012989 431 PEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 431 PE~~~~~~~s~~~DvwSlG~il 452 (452)
||.+.+..++.++|+||||++|
T Consensus 166 PE~~~~~~~~~~~Dv~slG~il 187 (253)
T cd05122 166 PEVINGKPYDYKADIWSLGITA 187 (253)
T ss_pred HHHHcCCCCCccccHHHHHHHH
Confidence 9999888899999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=231.13 Aligned_cols=179 Identities=17% Similarity=0.205 Sum_probs=148.6
Q ss_pred CccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 270 SKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
++.+++.....+++.||||++... .....+.+.+|+.+++.++|+||+++++.+..++..+++|||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~ 92 (314)
T cd08216 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKT 92 (314)
T ss_pred CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHH
Confidence 345566666778999999998765 344567899999999999999999999999999999999999999999998854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCc-----ccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN-----EANTNRV 422 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~ 422 (452)
. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+........ .......
T Consensus 93 ~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 93 H-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred h-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 3 2345899999999999999999999999 99999999999999999999999998865532211 1112234
Q ss_pred cccccccccccccc--CCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
.++..|+|||++.. ..++.++|+|||||++
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il 200 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHH
Confidence 56788999999865 3588999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=223.19 Aligned_cols=190 Identities=23% Similarity=0.381 Sum_probs=160.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|++.+.++.|++|.++.+ ....+++.+++|++..... ...+.+.+|+++++.++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 61 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLV-------------------RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61 (258)
T ss_pred CceEEeeeccCCCeEEEEE-------------------EEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCCh
Confidence 4677777777777666544 4555789999999976532 456778999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
+++++.+......++|+|++++++|.+++.... ....+++.++..++.|++.+|.+||+.+ ++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~ 138 (258)
T cd08215 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTS 138 (258)
T ss_pred hheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcC
Confidence 999999999999999999999999998885422 2467999999999999999999999998 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++|+|||.+....... .......|++.|+|||...+..++.++|+||+|+++
T Consensus 139 ~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~ 193 (258)
T cd08215 139 NGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVL 193 (258)
T ss_pred CCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHH
Confidence 9999999999998765433 122334688999999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=224.51 Aligned_cols=187 Identities=22% Similarity=0.390 Sum_probs=151.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|+....++.|++|.++.+ ...+++.+|+|.+... ......+.+|++++++++|||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~--------------------~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 63 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLG--------------------YWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQ 63 (256)
T ss_pred HeEEEeeecCcccceEEEE--------------------EEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeee
Confidence 4555666777777665533 2234678999988644 233467899999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++.+......++||||+++++|.+++.. ....+++..++.++.|++.+|++||+.+ ++|+||||+||+++.++.
T Consensus 64 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~ 138 (256)
T cd05112 64 LYGVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQV 138 (256)
T ss_pred EEEEEccCCceEEEEEcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCe
Confidence 99999999999999999999999988843 2345889999999999999999999998 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||++......... ......++..|+|||.+.++.++.++||||||++|
T Consensus 139 ~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l 191 (256)
T cd05112 139 VKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLM 191 (256)
T ss_pred EEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHH
Confidence 999999998765432211 11123346789999999888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=240.50 Aligned_cols=178 Identities=25% Similarity=0.395 Sum_probs=152.0
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCccceeeeEec-----CCeEEEEEEecCCCC
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLD-----GNELLLIYEYMPNKS 340 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-----~~~~~lv~E~~~~~~ 340 (452)
.|.++.|+.....++++..|+|++....+ ..++++.|.++++.+ .|||++.++++|.. ++++|||||||.||+
T Consensus 29 ~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGS 107 (953)
T KOG0587|consen 29 NGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGS 107 (953)
T ss_pred eccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCcc
Confidence 34456666677888999999999876643 346788999999998 69999999999873 568999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
..++++... +..+.|..+.-|++.++.||.+||.+. ++|||||-.|||++.++.+||.|||.+...... ....+
T Consensus 108 VTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRn 181 (953)
T KOG0587|consen 108 VTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRN 181 (953)
T ss_pred HHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc--ccccc
Confidence 999986654 788999999999999999999999998 999999999999999999999999998776433 33345
Q ss_pred ccccccccccccccc-----cCCCceeeeeeeeeee
Q 012989 421 RVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFF 451 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~i 451 (452)
..+|||.|||||++. ...|+..+|+||||++
T Consensus 182 T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGIT 217 (953)
T KOG0587|consen 182 TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGIT 217 (953)
T ss_pred CcCCCcccccceeeecccCCCCCcccccchhhccce
Confidence 679999999999984 3558889999999985
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=223.76 Aligned_cols=167 Identities=26% Similarity=0.375 Sum_probs=136.3
Q ss_pred CCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceeeeEe-cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHH
Q 012989 281 DGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL-DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKR 358 (452)
Q Consensus 281 ~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~ 358 (452)
+...+|||.+... .....+.+.+|+.+++.++||||+++++.+. .++..+++|||+.+++|.+++... ...+++..
T Consensus 22 ~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~ 99 (262)
T cd05058 22 QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE--THNPTVKD 99 (262)
T ss_pred ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc--CCCCCHHH
Confidence 4567999998643 3344567889999999999999999999765 455689999999999999988432 33467888
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcc--cccccccccccccccccccc
Q 012989 359 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVVGTYGYMAPEYAME 436 (452)
Q Consensus 359 ~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 436 (452)
+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++........ .......++..|+|||.+.+
T Consensus 100 ~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 100 LIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence 8999999999999999998 999999999999999999999999998765332111 11122345778999999988
Q ss_pred CCCceeeeeeeeeeeC
Q 012989 437 GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 437 ~~~s~~~DvwSlG~il 452 (452)
..++.++||||||+++
T Consensus 177 ~~~~~~~Di~slG~~l 192 (262)
T cd05058 177 QKFTTKSDVWSFGVLL 192 (262)
T ss_pred CccchHHHHHHHHHHH
Confidence 8999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=222.76 Aligned_cols=187 Identities=28% Similarity=0.390 Sum_probs=158.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|++...++.|.+|.++. .....+++.|++|.+..... ...+.+.+|++++++++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~-------------------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 61 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYK-------------------GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61 (254)
T ss_pred CceeeeEEcccCCeEEEE-------------------EEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCc
Confidence 466677777777765554 34556788999999976643 456789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...+++||++++++|.+++. ....+++..++.++.|++.+|.+||+.| |+|+||||+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 62 VKYIGSIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKD 135 (254)
T ss_pred cEEEEEEEeCCEEEEEEecCCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCC
Confidence 999999999999999999999999999883 3367999999999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||.+......... .....++..|+|||...+..++.++|+||+|+++
T Consensus 136 ~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l 189 (254)
T cd06627 136 GVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189 (254)
T ss_pred CCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHH
Confidence 99999999999876543321 2334678999999999887889999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=223.09 Aligned_cols=169 Identities=16% Similarity=0.105 Sum_probs=143.2
Q ss_pred CCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 268 TSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 268 ~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
|..+.|+...+..+++.+|+|++.... .+.+|...+....||||+++++.+......++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 556778888889999999999997653 234455566667899999999999999999999999999999888843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||.+....... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 345899999999999999999999999 9999999999999999999999999876543321 22345778
Q ss_pred cccccccccCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||.+.+..++.++|+||+|+++
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il 172 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAIL 172 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHH
Confidence 9999999888899999999999874
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=233.13 Aligned_cols=184 Identities=29% Similarity=0.490 Sum_probs=154.4
Q ss_pred cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC--CCCCccc
Q 012989 241 ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL--QHKNLVR 318 (452)
Q Consensus 241 ~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~ 318 (452)
++.+.+++|.+|.|+++.. +++.||||++... ..+.|.+|-+|++.. +|+||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL---------------------~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~ 268 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL---------------------DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQ 268 (534)
T ss_pred hhHHHhhcCccceeehhhc---------------------cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHH
Confidence 4455678888888887753 5699999999644 457788999998875 8999999
Q ss_pred eeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEecCCCC
Q 012989 319 LLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDS------RLRVIHRDLKT 388 (452)
Q Consensus 319 l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g------~~~ivH~Dlkp 388 (452)
+++.-.... +++||+||.+.|+|.+++ +...++|.+..+|+.-+++||+|||+.- ..+|+|||||.
T Consensus 269 Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkS 344 (534)
T KOG3653|consen 269 FIGAEKRGTADRMEYWLVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKS 344 (534)
T ss_pred hhchhccCCccccceeEEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccc
Confidence 998877555 899999999999999999 3456899999999999999999999753 24699999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCC-C----c-eeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-F----S-VNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~----s-~~~DvwSlG~il 452 (452)
.|||+.++++..|+|||+|.++............+||.+|||||++.+.. + + .+.||||+|.||
T Consensus 345 kNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 345 KNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred cceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 99999999999999999999988777666666689999999999996533 1 1 249999999875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=227.73 Aligned_cols=188 Identities=26% Similarity=0.397 Sum_probs=151.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 317 (452)
+|+....++.|++|.++ ......+++.+|+|++.... .....+..|+.+++++ +|+||+
T Consensus 17 ~~~~~~~lg~g~~~~v~-------------------~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~ 76 (282)
T cd06636 17 IFELVEVVGNGTYGQVY-------------------KGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIA 76 (282)
T ss_pred hhhhheeeccCCCeEEE-------------------EEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEE
Confidence 56666666666665555 44556688999999986543 3346688999999998 699999
Q ss_pred ceeeeEec------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 318 RLLGCCLD------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 318 ~l~~~~~~------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
++++.+.. ....+++|||+++++|.+++... ....+++..++.++.||+.+|.|||+.+ |+|+||||+||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~ni 152 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNV 152 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 99999853 46789999999999999888542 3345889999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+++.++.++|+|||++........ ......|++.|+|||.+. +..++.++|+|||||++
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l 216 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216 (282)
T ss_pred EECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence 999999999999999876532211 223456899999999875 35688899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=235.34 Aligned_cols=188 Identities=26% Similarity=0.400 Sum_probs=152.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...++.|++|.|+.+ ....+++.||||++.... .....++.+|+.++++++||||
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 65 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSA-------------------THKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65 (336)
T ss_pred cceEEEEEEEecCCeEEEEE-------------------EEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCc
Confidence 47888888999988777654 445678999999986532 3345668899999999999999
Q ss_pred cceeeeEecC-----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 317 VRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 317 v~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+++++++... .+.++||||+++ +|..++ ....+++..++.++.||+.||.+||+.+ |+||||||+||
T Consensus 66 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Ni 137 (336)
T cd07849 66 IGILDIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137 (336)
T ss_pred CchhheeecccccccceEEEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHE
Confidence 9999887644 358999999975 676665 2346999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccc-ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||++.......... ......||+.|+|||.+.+ ..++.++||||||+++
T Consensus 138 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil 200 (336)
T cd07849 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL 200 (336)
T ss_pred EECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence 99999999999999987654332211 1223568999999998754 5689999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=225.49 Aligned_cols=190 Identities=25% Similarity=0.392 Sum_probs=155.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|++...++.|++|.++.+ ....+++.+|+|.+... .....+++.+|+.+++.++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 61 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKV-------------------RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61 (265)
T ss_pred CceeeeeeccCCCeEEEEe-------------------eecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCcc
Confidence 3666667777777666543 55567899999998754 33445678899999999999999
Q ss_pred cceeeeEec--CCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecCCCC
Q 012989 317 VRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLH-----EDSRLRVIHRDLKT 388 (452)
Q Consensus 317 v~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH-----~~g~~~ivH~Dlkp 388 (452)
+++++.+.. +...+++|||+++++|.+++... .....+++..++.++.||+.+|.+|| +.+ ++|+||||
T Consensus 62 ~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p 138 (265)
T cd08217 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKP 138 (265)
T ss_pred ceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCH
Confidence 999998764 45689999999999999888542 23467899999999999999999999 777 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+++.++.+||+|||++......... .....|++.|+|||.+.+..++.++|+||||+++
T Consensus 139 ~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il 200 (265)
T cd08217 139 ANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200 (265)
T ss_pred HHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHH
Confidence 9999999999999999999876543321 2234679999999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=225.80 Aligned_cols=191 Identities=26% Similarity=0.383 Sum_probs=154.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
.-||++...++.|++|.++.+ ....+++.+++|++..... ..+.+.+|+.+++++ +|+|
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~-------------------~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~ 64 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKA-------------------RHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPN 64 (275)
T ss_pred hhheeheeeecCCCCeEEEEE-------------------EECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCC
Confidence 357888888888877666543 4455788999999876543 346789999999999 7999
Q ss_pred ccceeeeEecCC------eEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 316 LVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 316 iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
|+++++.+.... .+++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|
T Consensus 65 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p 141 (275)
T cd06608 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKG 141 (275)
T ss_pred hheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCH
Confidence 999999997644 4899999999999988875422 2467899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-----CCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il 452 (452)
+||+++.++.+||+|||++........ ......|+..|+|||++.. ..++.++||||||+||
T Consensus 142 ~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 208 (275)
T cd06608 142 QNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208 (275)
T ss_pred HHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHH
Confidence 999999999999999999876543221 2233468999999998743 4478899999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=227.01 Aligned_cols=188 Identities=24% Similarity=0.325 Sum_probs=147.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHH-HHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTL-IAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~-l~~l~h~~i 316 (452)
.|+....+|.|++|.|+ ......+|+.||||+++... ......+..|+.+ ++.++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~-------------------~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i 62 (283)
T cd06617 2 DLEVIEELGRGAYGVVD-------------------KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62 (283)
T ss_pred CceEEEEecccCCeEEE-------------------EEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCe
Confidence 35556666777766555 44566789999999987652 2233455566665 566789999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NIll~ 394 (452)
+++++.+..++..+++|||++ ++|..++... .....+++..++.++.||+.||+|||++ + ++||||||+||+++
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~ 138 (283)
T cd06617 63 VTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLIN 138 (283)
T ss_pred eeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEEC
Confidence 999999999999999999997 4777666432 2345799999999999999999999987 7 99999999999999
Q ss_pred CCCCeeEccccccccccCCCcccccccccccccccccccccc----CCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++..+.... ......|+..|+|||.+.+ ..++.++|+|||||+|
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l 197 (283)
T cd06617 139 RNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197 (283)
T ss_pred CCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHH
Confidence 99999999999987654321 1223467899999998854 4578999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=222.98 Aligned_cols=189 Identities=28% Similarity=0.371 Sum_probs=158.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|...+.++.|++|.++.+ ....+++.|++|++..... ...+.+.+|+.++++++||||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 61 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLA-------------------LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61 (260)
T ss_pred CceeeeEeeecCceEEEEE-------------------EECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCE
Confidence 3555666777766655543 4455789999999876542 456789999999999999999
Q ss_pred cceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
+++++.+... ...++++|++++++|.+++.. ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++
T Consensus 62 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~ 135 (260)
T cd06606 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVD 135 (260)
T ss_pred eeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEc
Confidence 9999999988 889999999999999998843 337999999999999999999999998 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||.+................++..|+|||.+.+..++.++||||||++|
T Consensus 136 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 193 (260)
T cd06606 136 SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTV 193 (260)
T ss_pred CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHH
Confidence 9999999999999876654432122335678999999999888899999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-28 Score=207.56 Aligned_cols=182 Identities=24% Similarity=0.304 Sum_probs=149.5
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
..+.|.+|.+...++..+|...|+|.+... +.+...++++|+.+..+- ..|.+|.+++........|+.||.+. .+|
T Consensus 53 elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSl 131 (282)
T KOG0984|consen 53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSL 131 (282)
T ss_pred hhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhH
Confidence 345566677777888999999999999765 445556788888877665 78999999999999999999999995 478
Q ss_pred hhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccc
Q 012989 342 DLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420 (452)
Q Consensus 342 ~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 420 (452)
+.+.++. .++..+++..+-+|+..+++||.|||++- .+||||+||+||||+.+|++|++|||.+..+.+. ...+
T Consensus 132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---iAkt 206 (282)
T KOG0984|consen 132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---IAKT 206 (282)
T ss_pred HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh---hHHH
Confidence 7766442 35677999999999999999999999863 5999999999999999999999999998766433 2233
Q ss_pred ccccccccccccccc----cCCCceeeeeeeeeee
Q 012989 421 RVVGTYGYMAPEYAM----EGVFSVNRMFLVSEFF 451 (452)
Q Consensus 421 ~~~gt~~y~aPE~~~----~~~~s~~~DvwSlG~i 451 (452)
...|...|||||.+. ...|+.|+||||||+.
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGIt 241 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGIT 241 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhh
Confidence 356889999999983 3479999999999985
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=229.92 Aligned_cols=190 Identities=22% Similarity=0.369 Sum_probs=149.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|+....++.|++|.|+.+ ....+++.||||.+.... ......+.+|+.++++++|||
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 72 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKA-------------------RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72 (310)
T ss_pred hheEEEEEeecCCCEEEEEE-------------------EECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCC
Confidence 36777777787777666544 455678999999886542 223345678999999999999
Q ss_pred ccceeeeEecCC--------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 316 LVRLLGCCLDGN--------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 316 iv~l~~~~~~~~--------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
|+++++++.... ..++||||+.+ +|...+.. ....+++.+++.++.||++||+|||+++ ++|+|||
T Consensus 73 iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~ 146 (310)
T cd07865 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146 (310)
T ss_pred ccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 999999887543 46999999965 67666632 3346899999999999999999999998 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCcc--ccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|+||+++.++.+||+|||++..+...... .......++..|+|||.+.+. .++.++|+||||++|
T Consensus 147 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 214 (310)
T cd07865 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM 214 (310)
T ss_pred HHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHH
Confidence 99999999999999999999876443221 112234678899999988654 478899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=225.09 Aligned_cols=175 Identities=27% Similarity=0.368 Sum_probs=147.1
Q ss_pred CCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 269 SSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 269 ~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
.++.|+......+++.||||.+.... ......+.+|+.++++++||||+++++.+..+...++||||+++++|..++.
T Consensus 16 ~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~- 94 (277)
T cd06641 16 SFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE- 94 (277)
T ss_pred CCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-
Confidence 33444444556678999999886542 3345678899999999999999999999999999999999999999998883
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
...+++..+..++.|++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++..+..... ......|+..
T Consensus 95 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 166 (277)
T cd06641 95 ---PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPF 166 (277)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCcc
Confidence 245899999999999999999999998 99999999999999999999999999876543221 1223467889
Q ss_pred cccccccccCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||.+.+..++.++|+||||+++
T Consensus 167 y~~PE~~~~~~~~~~~Dv~slG~~l 191 (277)
T cd06641 167 WMAPEVIKQSAYDSKADIWSLGITA 191 (277)
T ss_pred ccChhhhccCCCCchhhHHHHHHHH
Confidence 9999999888899999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=226.42 Aligned_cols=191 Identities=26% Similarity=0.323 Sum_probs=151.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
..+|+....++.|++|.++ ......+++.+|+|.+.... .....+.+|+.+++++ +|||
T Consensus 21 ~~~y~~~~~l~~g~~~~vy-------------------~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~n 80 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVY-------------------KVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPN 80 (291)
T ss_pred CCCeEEEEEeecCCCeEEE-------------------EEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCC
Confidence 3456666666666665554 44555688999999986542 2346678899999999 8999
Q ss_pred ccceeeeEecC-----CeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
++++++.+... ...++||||+++++|.+++... .....+++..++.++.|++.+|++||+.+ ++|+||||+
T Consensus 81 i~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~ 157 (291)
T cd06639 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGN 157 (291)
T ss_pred eEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH
Confidence 99999998754 3689999999999998887432 23456899999999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-----CCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-----VFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||++......... .....|+..|+|||.+... .++.++|||||||++
T Consensus 158 nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~ 223 (291)
T cd06639 158 NILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223 (291)
T ss_pred HEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence 999999999999999998765432221 2234678999999987543 368999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=228.26 Aligned_cols=189 Identities=26% Similarity=0.343 Sum_probs=150.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCC-CCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQ-HKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~ 315 (452)
+|+....++.|.+|.|+.+ ....+++.||||++.... ......+.+|+.+++.++ |||
T Consensus 2 ~y~~~~~lg~g~~g~vy~~-------------------~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 62 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKA-------------------RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62 (295)
T ss_pred CceEeeEecccCCeEEEEE-------------------EECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCC
Confidence 5777777777777666644 455678999999876542 223467888999999994 699
Q ss_pred ccceeeeEecCCe-----EEEEEEecCCCChhhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 316 LVRLLGCCLDGNE-----LLLIYEYMPNKSLDLFLFDSTK--GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 316 iv~l~~~~~~~~~-----~~lv~E~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
|+++++.+...+. .++||||+++ +|..++..... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 63 i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~ 138 (295)
T cd07837 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKP 138 (295)
T ss_pred ccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence 9999999887665 8999999986 77777643222 356899999999999999999999999 99999999
Q ss_pred CCeEECC-CCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 389 SNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+||+++. ++.+||+|||+++.+...... .....+++.|+|||.+.+ ..++.++|+||||++|
T Consensus 139 ~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 202 (295)
T cd07837 139 QNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIF 202 (295)
T ss_pred HHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHH
Confidence 9999998 889999999998765432211 122356889999998865 4579999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=228.60 Aligned_cols=189 Identities=29% Similarity=0.408 Sum_probs=158.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCC-CC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQ-HK 314 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~ 314 (452)
+|+....+|.|++|.++.+ ....+++.||+|++.+. .....+.+.+|+.++++++ ||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~ 62 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLA-------------------KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62 (280)
T ss_pred CceEeeeecCCCceEEEEE-------------------EEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCC
Confidence 5677777788877666644 44558999999998753 2233467889999999998 99
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..++..++|||++++++|.+++. +...+++..++.++.|++.+|.+||+.+ ++|+||||+||+++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~ 136 (280)
T cd05581 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLD 136 (280)
T ss_pred CchhHHHHhcCCceEEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEEC
Confidence 99999999999999999999999999999884 3447999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCcc------------------ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNE------------------ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.++|+|||++......... .......|+..|+|||......++.++|+||||+++
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 212 (280)
T cd05581 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212 (280)
T ss_pred CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHH
Confidence 9999999999998866543321 222345678999999999888899999999999874
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=228.94 Aligned_cols=184 Identities=28% Similarity=0.391 Sum_probs=148.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
.+|+....++.|++|.++ ......+++.||+|++.... ....+++.+|+.+++.++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy-------------------~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ 75 (307)
T cd06607 15 KLFTDLREIGHGSFGAVY-------------------FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75 (307)
T ss_pred hhhhhheeecCCCCeEEE-------------------EEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCC
Confidence 356666666666665554 44455678999999986442 23345788999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..++..++||||+++ ++.+++.. ....+++..+..++.||+.+|.|||+.+ |+|+||+|+||+++
T Consensus 76 niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~ 149 (307)
T cd06607 76 NTIEYKGCYLREHTAWLVMEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLT 149 (307)
T ss_pred CEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEC
Confidence 999999999999999999999975 55555522 2346899999999999999999999998 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++...... ....|++.|+|||++. .+.++.++||||||+++
T Consensus 150 ~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 150 EPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred CCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 9999999999998754322 2346788999999874 46689999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=233.70 Aligned_cols=189 Identities=23% Similarity=0.355 Sum_probs=151.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.+|++.+.++.|++|.|+ ......+++.||+|++.... ......+.+|+.++++++|||
T Consensus 5 ~~y~~~~~lg~g~~g~v~-------------------~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 65 (334)
T cd07855 5 SRYKPIENIGSGAYGVVC-------------------SAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65 (334)
T ss_pred hceeeeeeeecCCCeEEE-------------------EEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCC
Confidence 466777777777776555 33555679999999987642 234567888999999999999
Q ss_pred ccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 316 LVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 316 iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
|+++++++.. ....++||||+. ++|..++. ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 66 iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Ni 138 (334)
T cd07855 66 IIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNL 138 (334)
T ss_pred ccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHE
Confidence 9999998763 356899999996 57888773 3455999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccc--ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||++.......... ......|+..|+|||.+.+ ..++.++||||||+++
T Consensus 139 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l 202 (334)
T cd07855 139 LVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202 (334)
T ss_pred EEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHH
Confidence 99999999999999987654332211 1123578999999999865 4589999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=222.02 Aligned_cols=175 Identities=22% Similarity=0.267 Sum_probs=143.3
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCc---ccHHHHHHHHHHH-HcCCCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSG---QGLQEFKNEVTLI-AKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+.+.++.|+......+++.||||.+.+... .....+..|..++ ..++|+|++++++.+..++.+++||||+++++|
T Consensus 5 ~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 84 (260)
T cd05611 5 SKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84 (260)
T ss_pred CcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCH
Confidence 344555666666777899999999865421 1223345555544 445899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
..++. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.... ...
T Consensus 85 ~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~ 152 (260)
T cd05611 85 ASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK 152 (260)
T ss_pred HHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence 99883 3356899999999999999999999998 99999999999999999999999999875432 223
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..|++.|++||.+.+..++.++||||||++|
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il 183 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVI 183 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHH
Confidence 4578899999999888889999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=224.61 Aligned_cols=178 Identities=28% Similarity=0.422 Sum_probs=150.1
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhc
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLF 346 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~ 346 (452)
.+.++.++......+++.+++|++..... ..+.+.+|+++++.++|+||+++++.+......++|+||+++++|.+++.
T Consensus 29 ~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 107 (286)
T cd06614 29 EGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT 107 (286)
T ss_pred CCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHH
Confidence 33444555555556789999999976644 56778999999999999999999999999999999999999999999985
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccc
Q 012989 347 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 347 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
... ..+++..++.++.|++.+|.+||+.| ++|+||||+||+++.++.+||+|||++........ ......++.
T Consensus 108 ~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~ 180 (286)
T cd06614 108 QNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTP 180 (286)
T ss_pred Hhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCc
Confidence 422 37999999999999999999999998 99999999999999999999999999875543221 122345788
Q ss_pred ccccccccccCCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.|++||.+.+..++.++|+||||++|
T Consensus 181 ~y~~PE~~~~~~~~~~~Dv~slGvil 206 (286)
T cd06614 181 YWMAPEVIKRKDYGPKVDIWSLGIMC 206 (286)
T ss_pred ccCCHhHhcCCCCCCccccHHHHHHH
Confidence 99999999888899999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-28 Score=214.86 Aligned_cols=181 Identities=22% Similarity=0.333 Sum_probs=149.5
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
..+.|..|.|+......+|..+|||.+.+. +..+.++++..+.++.+- ..|+||+.+++|..+...++-||.+.. .+
T Consensus 99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ 177 (391)
T KOG0983|consen 99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CA 177 (391)
T ss_pred hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HH
Confidence 345666778888888899999999999876 455667788888777665 489999999999999999999999843 56
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
+.+++. -.+++++..+-++...+++||.||.++. +|+|||+||+|||+|..|++||+|||.+..+.+... ..+
T Consensus 178 ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htr 250 (391)
T KOG0983|consen 178 EKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTR 250 (391)
T ss_pred HHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---ccc
Confidence 666643 2356999999999999999999998765 499999999999999999999999999987655443 344
Q ss_pred cccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
..|.+.|||||.+- ...|+.++||||||+.|
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITl 284 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITL 284 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccch
Confidence 57899999999983 45699999999999864
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=223.57 Aligned_cols=188 Identities=27% Similarity=0.396 Sum_probs=157.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|++...++.|++|.++ ......+++.+++|.+... .......+.+|+.+++.++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~-------------------~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 61 (256)
T cd08530 1 DFKVLKKLGKGSYGSVY-------------------KVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61 (256)
T ss_pred CceEeeeecCCCceeEE-------------------EEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCc
Confidence 46667777777765555 3345668899999998754 23345678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
+++++.+......++||||+++++|..++.... ....+++..++.++.|++.||.+||+.| ++|+||||+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~ 138 (256)
T cd08530 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVA 138 (256)
T ss_pred hhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEec
Confidence 999999999999999999999999998875422 2356899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++....... .....|++.|++||.+.+..++.++|+||||+++
T Consensus 139 ~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~ 191 (256)
T cd08530 139 NDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLL 191 (256)
T ss_pred CCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHH
Confidence 9999999999998765431 2224578899999999998999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=229.07 Aligned_cols=188 Identities=26% Similarity=0.367 Sum_probs=150.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|+....+|.|.+|.|+.+ ....+++.||+|++..... .....+.+|+.++++++|+|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 67 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRA-------------------RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67 (309)
T ss_pred cceeEeeeeeecCCEEEEEE-------------------EECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCC
Confidence 46777777777777666544 4556789999999875422 22345678999999999999
Q ss_pred ccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 316 LVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 316 iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|+++++++... +..++||||+++ +|.+++.. ....+++.+++.++.||+.+|.|||+.+ ++||||||+||++
T Consensus 68 i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~ 141 (309)
T cd07845 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLL 141 (309)
T ss_pred CcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999998765 568999999975 77776633 2356899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||+|++|
T Consensus 142 ~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il 199 (309)
T cd07845 142 TDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCIL 199 (309)
T ss_pred CCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHH
Confidence 9999999999999987654321 1122345788999999865 4578999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=222.61 Aligned_cols=189 Identities=24% Similarity=0.397 Sum_probs=155.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
||+....++.|++|.++.+ ....++..+|+|.+... .....+.+.+|+.+++.++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i 61 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLA-------------------KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61 (257)
T ss_pred CceEEEEecCCCcceEEEE-------------------EEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCCh
Confidence 4666667777777655543 45567889999998754 22345678899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++.+..+...++|+||+++++|.+++... ....+++..++.++.|++++|.|||+.+ ++|+||||+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~ 137 (257)
T cd08225 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKN 137 (257)
T ss_pred hhhhheeccCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCC
Confidence 99999999999999999999999999988542 2335799999999999999999999998 9999999999999988
Q ss_pred CC-eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MN-PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~-~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+. +||+|||.+........ ......|++.|+|||.+.+..++.++|+||||+++
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il 192 (257)
T cd08225 138 GMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVL 192 (257)
T ss_pred CCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHH
Confidence 65 69999999876643322 12234578999999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=232.26 Aligned_cols=188 Identities=24% Similarity=0.373 Sum_probs=153.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
..||++...+|.|++|.++.+ .+..+++.||||.+... .......+.+|+.+++.++|+
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 64 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSA-------------------KNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64 (337)
T ss_pred ccceeEEEEeccCCCeEEEEE-------------------EecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCC
Confidence 347888888888888766644 45568999999998753 233455678899999999999
Q ss_pred CccceeeeEecC-----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 315 NLVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 315 ~iv~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
||+++++++... ...++||||+. ++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||||+
T Consensus 65 ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~ 137 (337)
T cd07858 65 NVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPS 137 (337)
T ss_pred CccchHHheecccccccCcEEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 999999988654 35899999996 57877773 3456999999999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||+++...... .......++..|+|||.+.+ ..++.++|+||||++|
T Consensus 138 Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 199 (337)
T cd07858 138 NLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIF 199 (337)
T ss_pred HEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHH
Confidence 9999999999999999998654332 11223467899999998864 4689999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-29 Score=238.46 Aligned_cols=180 Identities=21% Similarity=0.252 Sum_probs=161.7
Q ss_pred CCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCC
Q 012989 263 SPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339 (452)
Q Consensus 263 ~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~ 339 (452)
..++.|++|.|.+.....+...+|+|++++. +....+++..|-.||...+.|.||++|..|.+..+.|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 3456788888888777777777999999875 3455677889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccc
Q 012989 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 419 (452)
Q Consensus 340 ~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 419 (452)
.|+.++ ...+.|+...++.++.-+++|++|||++| ||.|||||+|.|++.+|-+||.|||+|+.+... ..+
T Consensus 506 ElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KT 576 (732)
T KOG0614|consen 506 ELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKT 576 (732)
T ss_pred hhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC---Cce
Confidence 999999 45677999999999999999999999999 999999999999999999999999999988644 346
Q ss_pred cccccccccccccccccCCCceeeeeeeeeee
Q 012989 420 NRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 420 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
..++|||.|+|||++++...+...|.||||++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIl 608 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGIL 608 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHH
Confidence 77899999999999999999999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=231.87 Aligned_cols=188 Identities=28% Similarity=0.398 Sum_probs=155.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
||++...++.|++|.++.+ ....+++.||||++.... ....+.+.+|+.+++.++|+||
T Consensus 1 ~y~i~~~ig~g~~~~v~~~-------------------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 61 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSA-------------------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61 (330)
T ss_pred CceeeeeecCCCCeEEEEE-------------------EeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcch
Confidence 6777778888887766644 444568999999987653 3445678999999999999999
Q ss_pred cceeeeEecCC-----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 317 VRLLGCCLDGN-----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 317 v~l~~~~~~~~-----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+++++++.... ..+++|||+++ +|.+++. ....+++..++.++.||+.||++||+.| |+|+||||+||
T Consensus 62 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~ni 134 (330)
T cd07834 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNI 134 (330)
T ss_pred hhhhhhhcccCcccccceEEEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 99999988775 79999999975 7877773 3347999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCcc-ccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|++.++.++|+|||++......... .......+++.|+|||.+.+. .++.++|+||||+++
T Consensus 135 li~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il 197 (330)
T cd07834 135 LVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF 197 (330)
T ss_pred EEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHH
Confidence 9999999999999999876544311 112334678999999999877 789999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=225.88 Aligned_cols=190 Identities=24% Similarity=0.322 Sum_probs=154.7
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC----cccHHHHHHHHHHHHcC-CCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS----GQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~ 314 (452)
|++.+.++.|++|.+|.+.. .....+++.||||.+.+.. ....+.+.+|+.+++++ +||
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~----------------~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~ 65 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRK----------------VGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65 (288)
T ss_pred ceEEEEeccCCCceEEEEEE----------------eccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCc
Confidence 67778888888887775421 1123467899999987532 22345688999999999 599
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+..+...++||||+++++|..++. ....+++..++.++.|++++|.|||+.+ ++|+||||+||+++
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~ 139 (288)
T cd05583 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLD 139 (288)
T ss_pred chhhhheeeecCCEEEEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC
Confidence 99999999999999999999999999988883 3356899999999999999999999998 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCC--CceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV--FSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il 452 (452)
.++.++|+|||+++.+...... ......|+..|++||.+.+.. .+.++|+||||++|
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il 198 (288)
T cd05583 140 SEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198 (288)
T ss_pred CCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHH
Confidence 9999999999998765433221 122346789999999987654 78899999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=224.29 Aligned_cols=176 Identities=26% Similarity=0.365 Sum_probs=143.5
Q ss_pred CccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
.+.++......+++.||||++.... ......+.+|++++++++||||+++++++..++..++||||+. ++|..++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~ 91 (284)
T cd07860 13 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA 91 (284)
T ss_pred ceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHh
Confidence 3444455566789999999987542 2234578899999999999999999999999999999999996 578777743
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ......+++.
T Consensus 92 ~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 165 (284)
T cd07860 92 S-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 165 (284)
T ss_pred C-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cccccccccc
Confidence 2 3456899999999999999999999998 99999999999999999999999999876543221 1223356889
Q ss_pred cccccccccCC-CceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
|+|||.+.+.. ++.++||||||++|
T Consensus 166 y~aPE~~~~~~~~~~~~Dv~slG~il 191 (284)
T cd07860 166 YRAPEILLGCKYYSTAVDIWSLGCIF 191 (284)
T ss_pred ccCCeEEecCCCCCcHHHHHHHHHHH
Confidence 99999886644 58899999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=224.34 Aligned_cols=187 Identities=24% Similarity=0.349 Sum_probs=149.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.|+....++.|++|.|+. .....+++.++||.++... ......+.+|+.++++++||||
T Consensus 6 ~y~~~~~lg~g~~~~v~~-------------------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 66 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYR-------------------ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI 66 (293)
T ss_pred hhhhhhhhcCCCCeEEEE-------------------EEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCE
Confidence 455556666666655554 3455678899999997543 2223456789999999999999
Q ss_pred cceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
+++++++... ...++||||+++ +|.+++.. ....+++.+++.++.||+.||+|||+.+ ++|+||||+||+++
T Consensus 67 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~ 140 (293)
T cd07843 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLN 140 (293)
T ss_pred EEEEEEEEecCCCcEEEEehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEEC
Confidence 9999998877 889999999975 88777743 2236899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++..+..... ......+++.|+|||.+.+. .++.++|+||||+++
T Consensus 141 ~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 197 (293)
T cd07843 141 NRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIF 197 (293)
T ss_pred CCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHH
Confidence 999999999999887654321 12234578899999998654 468999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=231.31 Aligned_cols=188 Identities=26% Similarity=0.398 Sum_probs=150.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcC-CCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.+|+....++.|++|.++.+ ....+++.+|||++... .......+.+|+.+++++ +||
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ 67 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKA-------------------IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEE-------------------EEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCC
Confidence 46777777777777666543 34457889999988643 233445678899999999 999
Q ss_pred CccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 315 NLVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 315 ~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||+++++++... ...++||||+++ +|..++.. ..+++..++.++.||+.+|.|||+.+ |+|+||||+||+
T Consensus 68 ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nil 139 (337)
T cd07852 68 NIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNIL 139 (337)
T ss_pred CccceeeeeccCCCceEEEEeccccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 999999988653 468999999975 88877732 26889999999999999999999998 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCcc---cccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNE---ANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||++..+...... .......|+..|+|||.+.+ ..++.++|+||||+++
T Consensus 140 l~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l 203 (337)
T cd07852 140 LNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203 (337)
T ss_pred EcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHH
Confidence 999999999999999866443321 22334578999999998754 5578999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=224.07 Aligned_cols=188 Identities=23% Similarity=0.326 Sum_probs=152.8
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|+....+|.|++|.++ ......+++.+|+|.+.... .....++.+|+++++.++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~-------------------~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 62 (287)
T cd06621 2 KIVELSRLGEGAGGSVT-------------------KCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62 (287)
T ss_pred ceEEEEEeccCCceEEE-------------------EEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCee
Confidence 45556666666665554 44555678999999987553 23456789999999999999999
Q ss_pred ceeeeEecC--CeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 318 RLLGCCLDG--NELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 318 ~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
++++.+... ..+++||||+++++|.+++... .....+++..+..++.||+.+|.|||+.+ ++|+||+|+||+++
T Consensus 63 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~ 139 (287)
T cd06621 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLT 139 (287)
T ss_pred eeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEe
Confidence 999988653 4789999999999998876432 23456899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.++|+|||++........ ....++..|++||.+.+..++.++||||||+++
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 193 (287)
T cd06621 140 RKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTL 193 (287)
T ss_pred cCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 999999999999875432221 234568899999999988999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=224.64 Aligned_cols=188 Identities=26% Similarity=0.359 Sum_probs=148.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|+....++.|.+|.++. .....+++.||||++.... ....+.+.+|+++++.++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~-------------------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 63 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYK-------------------ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63 (294)
T ss_pred ceEEEEEecCCCCEEEEE-------------------EEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCE
Confidence 566667777777765553 3455678999999986542 2334568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH- 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~- 395 (452)
+++++.+..+...++||||+++ +|...+.. .....+++..++.++.||+.||+|||+++ ++|+||||+||+++.
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~ 138 (294)
T PLN00009 64 VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRR 138 (294)
T ss_pred eeEEEEEecCCeEEEEEecccc-cHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECC
Confidence 9999999999999999999965 66666532 22334688899999999999999999998 999999999999985
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||+|+++
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~ 194 (294)
T PLN00009 139 TNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIF 194 (294)
T ss_pred CCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 45699999999976543211 1123456889999998865 4578999999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=220.55 Aligned_cols=168 Identities=20% Similarity=0.250 Sum_probs=137.6
Q ss_pred CCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhhhc
Q 012989 268 TSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLF 346 (452)
Q Consensus 268 ~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~ 346 (452)
+.++.|+......+++.+|+|.+....... .|+.....+ +||||+++++.+..++..++||||+++++|.+++.
T Consensus 27 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~ 101 (267)
T PHA03390 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK 101 (267)
T ss_pred CCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHH
Confidence 334555555667789999999987542221 123222222 79999999999999999999999999999999884
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC-CeeEccccccccccCCCccccccccccc
Q 012989 347 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSGNQNEANTNRVVGT 425 (452)
Q Consensus 347 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt 425 (452)
. ...+++.+++.++.||++||.+||+.+ ++||||||+||+++.++ .++|+|||+++..... ....|+
T Consensus 102 ~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~ 169 (267)
T PHA03390 102 K---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGT 169 (267)
T ss_pred h---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCC
Confidence 3 347999999999999999999999999 99999999999999998 9999999998765322 123578
Q ss_pred cccccccccccCCCceeeeeeeeeeeC
Q 012989 426 YGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 426 ~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..|+|||++.+..++.++||||||+++
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il 196 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLT 196 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHH
Confidence 999999999988999999999999874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=227.10 Aligned_cols=190 Identities=24% Similarity=0.398 Sum_probs=150.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc--cHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ--GLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|++...++.|++|.++.+ ....+++.+|||++...... ....+.+|+++++.++|||
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~-------------------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 68 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKA-------------------RQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68 (311)
T ss_pred ccEEEEEEeccCCCEEEEEE-------------------EECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCC
Confidence 48888888888888766644 45567899999998754322 2346788999999999999
Q ss_pred ccceeeeEecC--------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 316 LVRLLGCCLDG--------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 316 iv~l~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
|+++++.+... ...++||||+.+ +|...+.. ....+++..++.++.||+++|.|||+++ |+|+|||
T Consensus 69 i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~ 142 (311)
T cd07866 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIK 142 (311)
T ss_pred ccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 99999987543 347999999976 55555532 3456999999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccc---------ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEA---------NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|+||+++.++.+||+|||+++......... ......|++.|+|||.+.+ ..++.++||||||++|
T Consensus 143 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 217 (311)
T cd07866 143 AANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217 (311)
T ss_pred HHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHH
Confidence 999999999999999999997654332211 1122366888999998865 4579999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=223.07 Aligned_cols=173 Identities=24% Similarity=0.337 Sum_probs=138.1
Q ss_pred CccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCC-CCCccceeeeEecC--CeEEEEEEecCCCChhhhh
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDG--NELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l 345 (452)
.+.++......+++.||+|++.... ........+|+.+++++. |+||+++++.+.++ +..++||||+++ +|.+.+
T Consensus 12 ~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l 90 (282)
T cd07831 12 FSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI 90 (282)
T ss_pred cceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHH
Confidence 3444455566789999999987642 222234457899999885 99999999999987 889999999976 666666
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 425 (452)
.. ....+++.+++.++.||+.||+|||+.+ ++||||||+||+++. +.+||+|||+++....... .....++
T Consensus 91 ~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~ 161 (282)
T cd07831 91 KG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYIST 161 (282)
T ss_pred Hh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCC
Confidence 32 2356899999999999999999999999 999999999999999 9999999999986543322 1234578
Q ss_pred cccccccccc-cCCCceeeeeeeeeeeC
Q 012989 426 YGYMAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 426 ~~y~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
..|+|||.+. ++.++.++|||||||+|
T Consensus 162 ~~y~aPE~~~~~~~~~~~~Di~slGv~l 189 (282)
T cd07831 162 RWYRAPECLLTDGYYGPKMDIWAVGCVF 189 (282)
T ss_pred cccCChhHhhcCCCCCcchhHHHHHHHH
Confidence 9999999764 45578999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=230.42 Aligned_cols=190 Identities=23% Similarity=0.301 Sum_probs=150.2
Q ss_pred Cccccc-eeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCccc--------------HHHH
Q 012989 237 NFRYEL-YQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQG--------------LQEF 301 (452)
Q Consensus 237 ~~ry~~-~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~--------------~~~~ 301 (452)
..||.. ..++|.|++|.||.+ .+..+++.||||++....... ...+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKA-------------------YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67 (335)
T ss_pred ccchhhhhhcccCCCceeEEEE-------------------EECCCCCeEEEEEeeccccccccccchhhhcccccchhH
Confidence 346653 456777777666544 455678999999986542211 1247
Q ss_pred HHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 302 ~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
.+|+++++.++|+||+++++++...+..++||||+++ +|.+++. ....+++..+..++.||+.||++||+.+ |
T Consensus 68 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i 140 (335)
T PTZ00024 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---F 140 (335)
T ss_pred HHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecccc-CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 7899999999999999999999999999999999975 7877773 3456899999999999999999999999 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCC------------ccccccccccccccccccccccC-CCceeeeeeee
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ------------NEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVS 448 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSl 448 (452)
+|+||||+||+++.++.+||+|||++....... .........+++.|+|||.+.+. .++.++|+|||
T Consensus 141 ~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 999999999999999999999999987654111 01111223568899999998764 46899999999
Q ss_pred eeeC
Q 012989 449 EFFF 452 (452)
Q Consensus 449 G~il 452 (452)
||++
T Consensus 221 G~~l 224 (335)
T PTZ00024 221 GCIF 224 (335)
T ss_pred HHHH
Confidence 9874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=229.57 Aligned_cols=188 Identities=29% Similarity=0.376 Sum_probs=149.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecC--CeeeEEEEeecC--CcccHHHHHHHHHHHHcC-CC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILAD--GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~--~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l-~h 313 (452)
+|++...++.|++|.|+.+. ...+ +..||||++... .....+.+.+|+.+++++ +|
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~-------------------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h 61 (332)
T cd07857 1 RYELIKELGQGAYGIVCSAR-------------------NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61 (332)
T ss_pred CceEEEEccccCCeEEEEEE-------------------eCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCC
Confidence 57778888888887776553 3334 788999998653 222356788999999999 59
Q ss_pred CCccceeeeEecC----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 314 KNLVRLLGCCLDG----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 314 ~~iv~l~~~~~~~----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|||+++++..... ...+++||++. ++|..++ .....+++..++.++.||+.||+|||+.| |+||||||+
T Consensus 62 ~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l---~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~ 134 (332)
T cd07857 62 KNITCLYDMDIVFPGNFNELYLYEELME-ADLHQII---RSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPG 134 (332)
T ss_pred CChheeeeeeeeccccCCcEEEEEeccc-CCHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 9999999875432 45789999986 5787777 34456999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcc--cccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++|+||+|+++
T Consensus 135 Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l 200 (332)
T cd07857 135 NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL 200 (332)
T ss_pred HeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999999999866533221 11234578999999998765 4689999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=223.65 Aligned_cols=176 Identities=28% Similarity=0.380 Sum_probs=143.2
Q ss_pred CccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
.+.++......+|+.||||++.... ......+.+|+++++.++|||++++++.+..++..+++|||++ ++|.+++..
T Consensus 12 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~ 90 (283)
T cd07835 12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDS 90 (283)
T ss_pred CeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhh
Confidence 3444455566689999999987543 2234568899999999999999999999999999999999995 588887743
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
. ....+++..++.++.|++++|+|||+++ ++|+||+|+||+++.++.+||+|||++........ ......++..
T Consensus 91 ~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 164 (283)
T cd07835 91 S-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLW 164 (283)
T ss_pred C-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccCccccccC
Confidence 2 2246899999999999999999999998 99999999999999999999999999876533221 1122356889
Q ss_pred cccccccccC-CCceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|+|||.+.+. .++.++|+||||++|
T Consensus 165 ~~aPE~~~~~~~~~~~~Di~slG~~l 190 (283)
T cd07835 165 YRAPEILLGSRQYSTPVDIWSIGCIF 190 (283)
T ss_pred CCCCceeecCcccCcHHHHHHHHHHH
Confidence 9999988654 578999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=217.83 Aligned_cols=181 Identities=22% Similarity=0.296 Sum_probs=158.6
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCC
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNK 339 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~ 339 (452)
..+.+++.+|...+..++.+.+|+|++++. ...+......|-.+..+- +||.+|.++..|++.+.+++|.||.+||
T Consensus 257 vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~gg 336 (593)
T KOG0695|consen 257 VIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGG 336 (593)
T ss_pred eecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCc
Confidence 345667788888888999999999999875 445566678888888877 7999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccc
Q 012989 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT 419 (452)
Q Consensus 340 ~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 419 (452)
+|-..+ ++.+.++++.++.+..+|..||.|||++| ||.||||.+|+|+|..|++||.|+|+++.- -.+...+
T Consensus 337 dlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~--l~~gd~t 408 (593)
T KOG0695|consen 337 DLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--LGPGDTT 408 (593)
T ss_pred ceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC--CCCCccc
Confidence 986555 56677999999999999999999999999 999999999999999999999999999752 2334456
Q ss_pred cccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 420 NRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 420 ~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..++|||.|.|||++++..|....|+|++|+++
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlm 441 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLM 441 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHH
Confidence 678999999999999999999999999999874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=225.82 Aligned_cols=192 Identities=22% Similarity=0.366 Sum_probs=152.0
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~ 312 (452)
.+.-+|++...++.|++|.|+.+ ....+++.||||+++... ......+.+|+.+++.++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~-------------------~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~ 64 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKA-------------------RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN 64 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEE-------------------EECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC
Confidence 34457777777888877666644 444578899999987543 233456788999999999
Q ss_pred CCCccceeeeEecCC----------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGN----------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 313 h~~iv~l~~~~~~~~----------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
||||+++++++.... .+++||||+++ ++...+.. ....+++..++.++.||+.||.|||+.+ |+
T Consensus 65 h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~ 138 (302)
T cd07864 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FL 138 (302)
T ss_pred CCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999987654 79999999987 56555532 2346899999999999999999999999 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|+||||+||+++.++.+||+|||++..+....... .....++..|+|||.+.+ ..++.++|||||||++
T Consensus 139 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~ 208 (302)
T cd07864 139 HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208 (302)
T ss_pred cCCCCHHHEEECCCCcEEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHH
Confidence 99999999999999999999999998765433211 122345788999998864 4578999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=224.14 Aligned_cols=195 Identities=14% Similarity=0.155 Sum_probs=142.8
Q ss_pred EccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecC---CeeeEEEEeecCCcccH----------
Q 012989 232 RYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILAD---GKEIAVKRLSRSSGQGL---------- 298 (452)
Q Consensus 232 ~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~---~~~vAiK~~~~~~~~~~---------- 298 (452)
..+.-..+|++.+.+|.|++|.||.+.. ..+ +..+|+|..........
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~-------------------~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~ 66 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQC-------------------ASDHCINNQAVAKIENLENETIVMETLVYNNIY 66 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEE-------------------cCCcccccceEEEeccccCCchhhHHHHHHhhh
Confidence 3344456899999999999999886632 222 45667775433321110
Q ss_pred -HHHHHHHHHHHcCCCCCccceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012989 299 -QEFKNEVTLIAKLQHKNLVRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYL 373 (452)
Q Consensus 299 -~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~L 373 (452)
.....+...+..++|++++++++...... ..++++|++.. ++.+.+. .....++..++.|+.|++.||+||
T Consensus 67 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~l 142 (294)
T PHA02882 67 DIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYI 142 (294)
T ss_pred hHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHH
Confidence 11223334556678999999998766543 45788887744 5555552 223467888999999999999999
Q ss_pred hcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcc-----ccccccccccccccccccccCCCceeeeeeee
Q 012989 374 HEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-----ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVS 448 (452)
Q Consensus 374 H~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 448 (452)
|+.+ |+||||||+|||++.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||
T Consensus 143 H~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSl 219 (294)
T PHA02882 143 HEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL 219 (294)
T ss_pred HhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHH
Confidence 9998 999999999999999999999999999876432211 11223468999999999999999999999999
Q ss_pred eeeC
Q 012989 449 EFFF 452 (452)
Q Consensus 449 G~il 452 (452)
||+|
T Consensus 220 G~~l 223 (294)
T PHA02882 220 GYCM 223 (294)
T ss_pred HHHH
Confidence 9975
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=230.42 Aligned_cols=184 Identities=25% Similarity=0.352 Sum_probs=150.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++...+|.|.+|.|+.+ ....+++.||||++... .....+.+.+|+.+++.++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 74 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSA-------------------LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74 (343)
T ss_pred ccceEEEEEeeecCCeEEEEE-------------------EECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCC
Confidence 447777778888888766543 45668899999998653 222345688999999999999
Q ss_pred CccceeeeEecCC------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++.+.... .+++|||++ +++|..++. ...+++..++.++.||+.||+|||+.| |+||||||
T Consensus 75 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp 146 (343)
T cd07880 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKP 146 (343)
T ss_pred CccceeeeecCCccccccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 9999999987653 469999998 678887773 346899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+||+++.++.+||+|||++...... .....+++.|++||.+.+ ..++.++|+||||++|
T Consensus 147 ~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll 206 (343)
T cd07880 147 GNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206 (343)
T ss_pred HHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999998764322 123456889999999875 4588999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=222.60 Aligned_cols=175 Identities=23% Similarity=0.369 Sum_probs=143.6
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecC--CeEEEEEEecCCCChhhhhc
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG--NELLLIYEYMPNKSLDLFLF 346 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~ 346 (452)
+.++......+++.+|+|++.... ......+.+|+.+++.++|||++++++.+... ...++||||+++ +|..++.
T Consensus 13 ~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (287)
T cd07840 13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD 91 (287)
T ss_pred eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHh
Confidence 444444556678999999998663 33456788999999999999999999999988 899999999975 7877773
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccc
Q 012989 347 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 347 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
. ....+++..++.++.||++||++||+.+ ++|+||||+||++++++.+||+|||++......... ......++.
T Consensus 92 ~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~ 165 (287)
T cd07840 92 S--PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITL 165 (287)
T ss_pred c--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-ccccccccc
Confidence 3 2256899999999999999999999998 999999999999999999999999999876544321 122335688
Q ss_pred cccccccccc-CCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
.|+|||.+.+ ..++.++||||||+++
T Consensus 166 ~y~~PE~~~~~~~~~~~~Dv~slG~~l 192 (287)
T cd07840 166 WYRPPELLLGATRYGPEVDMWSVGCIL 192 (287)
T ss_pred ccCCceeeEccccCChHHHHHHHHHHH
Confidence 8999998764 4579999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=226.82 Aligned_cols=180 Identities=19% Similarity=0.234 Sum_probs=145.5
Q ss_pred CCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhc
Q 012989 269 SSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLF 346 (452)
Q Consensus 269 ~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~ 346 (452)
.++.|+...+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++.
T Consensus 12 ~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~ 91 (328)
T cd08226 12 NLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLK 91 (328)
T ss_pred CceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHH
Confidence 45667777788899999999987542 3345678999999999999999999999999999999999999999998885
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc-----cccc
Q 012989 347 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-----NTNR 421 (452)
Q Consensus 347 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~ 421 (452)
.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|+.||+.+.......... ....
T Consensus 92 ~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (328)
T cd08226 92 TY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167 (328)
T ss_pred hh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccc
Confidence 42 2345899999999999999999999998 9999999999999999999999998654322111110 0111
Q ss_pred ccccccccccccccc--CCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
..++..|+|||++.+ ..++.++|||||||+|
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l 200 (328)
T cd08226 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200 (328)
T ss_pred ccCccCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence 234677999999876 3478999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=231.00 Aligned_cols=188 Identities=26% Similarity=0.366 Sum_probs=151.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.||+....+|.|++|.|+.+ ....+++.||+|++........+.+.+|++++++++||||+
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~-------------------~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~ 65 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSA-------------------VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65 (342)
T ss_pred cceEEEEEecCCCCEEEEEE-------------------EECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcch
Confidence 58888888888888766644 45567899999999877666667899999999999999999
Q ss_pred ceeeeEecC--------------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 012989 318 RLLGCCLDG--------------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383 (452)
Q Consensus 318 ~l~~~~~~~--------------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH 383 (452)
++++.+... ...++||||+++ +|.+++. ...+++..++.++.||++||.|||+.| |+|
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH 137 (342)
T cd07854 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLH 137 (342)
T ss_pred hhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999876644 357999999974 7877662 245899999999999999999999999 999
Q ss_pred cCCCCCCeEECC-CCCeeEccccccccccCCCccc-ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|||||+||+++. ++.+||+|||.++......... ......|+..|+|||.+.. ..++.++|||||||+|
T Consensus 138 ~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (342)
T cd07854 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 209 (342)
T ss_pred CCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence 999999999985 4568999999987653321111 1122357889999998754 5678899999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=229.63 Aligned_cols=183 Identities=27% Similarity=0.351 Sum_probs=148.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||+....++.|++|.++. .....+++.||+|++.... ....+.+.+|+.++++++|||
T Consensus 17 ~~y~~~~~lg~G~~g~v~~-------------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~ 77 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCA-------------------AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77 (345)
T ss_pred CceEEEEEeeecCCeEEEE-------------------EEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCc
Confidence 4777777888888876654 3455689999999987542 223466888999999999999
Q ss_pred ccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++... ...++++|++ +++|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 78 iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~ 149 (345)
T cd07877 78 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS 149 (345)
T ss_pred ccceeeeeeecccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChH
Confidence 99999988643 3478888887 778887773 235899999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++
T Consensus 150 NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il 208 (345)
T cd07877 150 NLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 208 (345)
T ss_pred HEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHH
Confidence 999999999999999998754321 223467899999998865 5688999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=233.27 Aligned_cols=182 Identities=24% Similarity=0.360 Sum_probs=153.6
Q ss_pred CCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 265 GSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 265 ~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
++.|.+|+|+...-.+-.-.||||.++. +....++|+.|..+|+.++|||+|+|+++|.....+|||.|||..|+|.++
T Consensus 275 LGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdY 353 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDY 353 (1157)
T ss_pred cCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHH
Confidence 3455556655433334456799999864 467789999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccc
Q 012989 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVG 424 (452)
Q Consensus 345 l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 424 (452)
+++- ....++.-..+.++.||.+|++||..++ +|||||-..|.|+.++..+|++|||+++....+..-......+
T Consensus 354 LRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKF- 428 (1157)
T KOG4278|consen 354 LREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKF- 428 (1157)
T ss_pred HHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccC-
Confidence 9763 3455777888899999999999999999 9999999999999999999999999999876654433322222
Q ss_pred ccccccccccccCCCceeeeeeeeeeeC
Q 012989 425 TYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 425 t~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.|.|||-+....++.|+|||+||++|
T Consensus 429 PIKWTAPEsLAyNtFSiKSDVWAFGVLL 456 (1157)
T KOG4278|consen 429 PIKWTAPESLAYNTFSIKSDVWAFGVLL 456 (1157)
T ss_pred cccccCcccccccccccchhhHHHHHHH
Confidence 7889999999999999999999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=216.24 Aligned_cols=178 Identities=26% Similarity=0.348 Sum_probs=151.3
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCc---ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.|..+.++......+++.+++|.+.+... .....+.+|+.++++++||||+++++.+..+...++|||++++++|.+
T Consensus 3 ~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 82 (250)
T cd05123 3 KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFS 82 (250)
T ss_pred CCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHH
Confidence 34456666666667899999999876532 245678999999999999999999999999999999999999999998
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
++. ....+++..++.++.|++++|.+||+.+ ++|+||||+||+++.++.++|+|||++....... .......
T Consensus 83 ~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 83 HLS---KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 883 3346899999999999999999999998 9999999999999999999999999987754332 1223456
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++..|++||...+..++.++|+||||+++
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~ 183 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLL 183 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHH
Confidence 78899999999888899999999999874
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=222.92 Aligned_cols=175 Identities=29% Similarity=0.407 Sum_probs=143.2
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
+.+.++.++......++..+|+|++.... ....+.+.+|++++++++|||++++++++..+...++||||+++ +|.
T Consensus 34 g~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~ 112 (317)
T cd06635 34 GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SAS 112 (317)
T ss_pred ccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHH
Confidence 34444555555666788999999987542 23345788999999999999999999999999999999999976 665
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
+.+.. ....+++.++..++.||+.+|.|||+.+ |+|+||||+||+++.++.+||+|||++...... ...
T Consensus 113 ~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~ 181 (317)
T cd06635 113 DLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSF 181 (317)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc------ccc
Confidence 55532 2456899999999999999999999999 999999999999999999999999998654321 234
Q ss_pred ccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
.|++.|+|||.+. .+.++.++||||||+++
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil 214 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHH
Confidence 5788999999873 46789999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=222.22 Aligned_cols=184 Identities=25% Similarity=0.347 Sum_probs=148.6
Q ss_pred cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC--CCCCccc
Q 012989 241 ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL--QHKNLVR 318 (452)
Q Consensus 241 ~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~ 318 (452)
.+.+-+|+|.+|.|..+. ..|+.||||++... +...+.+|.+|++.+ +|+||+.
T Consensus 214 ~L~e~IGkGRyGEVwrG~---------------------wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGR---------------------WRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred EEEEEecCccccceeecc---------------------ccCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhh
Confidence 345566777777666654 46899999999644 335678899999875 9999999
Q ss_pred eeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCC
Q 012989 319 LLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-----DSRLRVIHRDLKTS 389 (452)
Q Consensus 319 l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-----~g~~~ivH~Dlkp~ 389 (452)
+++.-..+. ++|||.||.+.|+|.+++. ...++....++++..++.||++||- +|...|.|||||..
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 998876543 6999999999999999993 3569999999999999999999993 34455999999999
Q ss_pred CeEECCCCCeeEccccccccccCCC--cccccccccccccccccccccc----CCC-cee-eeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQ--NEANTNRVVGTYGYMAPEYAME----GVF-SVN-RMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~----~~~-s~~-~DvwSlG~il 452 (452)
|||+..++.+-|+|+|+|..+.... .....+..+||..|||||++-. ..+ +.| +||||||+||
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 9999999999999999998876553 2334567799999999999832 222 444 9999999875
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=218.10 Aligned_cols=188 Identities=22% Similarity=0.376 Sum_probs=150.2
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEec-CCeeeEEEEeecC----------CcccHHHHHHHHHHH
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILA-DGKEIAVKRLSRS----------SGQGLQEFKNEVTLI 308 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~-~~~~vAiK~~~~~----------~~~~~~~~~~E~~~l 308 (452)
|++...+|.|++|.++.+ .... .++.+|+|.+... ......++.+|+.++
T Consensus 2 y~~~~~ig~G~~~~v~~~-------------------~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 62 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKV-------------------RKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62 (269)
T ss_pred chhhhhhcCCCCceEEEE-------------------EEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHH
Confidence 455555666666555543 3333 5788999987532 122345577888888
Q ss_pred Hc-CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecC
Q 012989 309 AK-LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRD 385 (452)
Q Consensus 309 ~~-l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~D 385 (452)
.+ ++||||+++++.+..++..+++|||+++++|.+++... .....+++..++.++.|++.+|.+||+ .+ ++|+|
T Consensus 63 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~d 139 (269)
T cd08528 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRD 139 (269)
T ss_pred hhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecC
Confidence 75 79999999999999999999999999999998877432 234568999999999999999999996 66 99999
Q ss_pred CCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 386 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||+||+++.++.+||+|||.+....... ......|+..|++||.+.++.++.++|+||||+++
T Consensus 140 l~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll 203 (269)
T cd08528 140 LTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCIL 203 (269)
T ss_pred CCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHH
Confidence 99999999999999999999998654332 22345679999999999988899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-27 Score=222.37 Aligned_cols=173 Identities=25% Similarity=0.363 Sum_probs=143.5
Q ss_pred cEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 272 EICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 272 ~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
.++......+++.+++|.+..... .....+.+|+.+++.++|+||+++++.+..+...++||||+++ +|..++..
T Consensus 14 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~-- 90 (283)
T cd05118 14 VVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD-- 90 (283)
T ss_pred eEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh--
Confidence 333444556789999999876532 2456788999999999999999999999999999999999976 77766633
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 429 (452)
....+++..++.++.||+.+|.+||+.+ |+|+||||+||+++.++.+||+|||.+....... .......++..|+
T Consensus 91 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~ 165 (283)
T cd05118 91 RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYR 165 (283)
T ss_pred hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCccccc
Confidence 2357899999999999999999999999 9999999999999999999999999987765433 1112245788999
Q ss_pred cccccccC-CCceeeeeeeeeeeC
Q 012989 430 APEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|||.+.+. .++.++|+||||++|
T Consensus 166 ~PE~~~~~~~~~~~~Di~slG~~l 189 (283)
T cd05118 166 APELLLGDKGYSTPVDIWSVGCIF 189 (283)
T ss_pred CcHHHhcCCCCCchhHHHHHHHHH
Confidence 99998776 789999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-28 Score=216.04 Aligned_cols=189 Identities=23% Similarity=0.411 Sum_probs=152.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.|+-...+|+|.+|.|+.++. .++++.||+|++-.++ ..-....++|+.+|+.|+|+|+
T Consensus 18 ~yek~~kigqGtfgeVFkAr~-------------------~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv 78 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARS-------------------KNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhh-------------------cCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhH
Confidence 567777888899988887753 4578889999765432 2223456789999999999999
Q ss_pred cceeeeEecC--------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 317 VRLLGCCLDG--------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 317 v~l~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
+.+++.+... ..+|+||++++. +|.-++. .....++..++.+++.+++.||.|+|+.. |+|||+||
T Consensus 79 ~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKa 152 (376)
T KOG0669|consen 79 VNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKA 152 (376)
T ss_pred HHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccH
Confidence 9999887632 358999999976 6666663 23456999999999999999999999998 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccc--ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
.|+||+.+|.+||+|||+++.+...+... .....+-|.+|.+||.+++ ..|+++.|||.-|||+
T Consensus 153 aNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 153 ANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM 219 (376)
T ss_pred hhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence 99999999999999999998876554332 2223455999999999876 5689999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-27 Score=224.33 Aligned_cols=192 Identities=23% Similarity=0.240 Sum_probs=160.9
Q ss_pred ccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC
Q 012989 233 YPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 233 ~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~ 312 (452)
+.--.-||+++.+.|.|-|++|..+.. ...|..||||+|... ....+.=+.|++||++|+
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D-------------------~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~ 486 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARD-------------------QARGQEVAIKIIRNN-EVMHKTGLKELEILKKLN 486 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccc-------------------cCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhh
Confidence 444567999999999999988887743 445779999999654 223344578999999995
Q ss_pred ------CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 313 ------HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 313 ------h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
.-|+++++..|...+|+|||+|-+ ..+|.+.+..-..+-.|....+..++.||+.||..|-+.| |+|.||
T Consensus 487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDI 562 (752)
T KOG0670|consen 487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADI 562 (752)
T ss_pred ccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeeccc
Confidence 248999999999999999999988 5589998877777778999999999999999999999999 999999
Q ss_pred CCCCeEECCCCC-eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMN-PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|||+++..+ +||+|||.|.....+.. +...-+.+|.|||+++|-+|+...|+||.||.|
T Consensus 563 KPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 563 KPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTL 625 (752)
T ss_pred CccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceee
Confidence 999999987654 89999999987654432 122337789999999999999999999999975
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=220.49 Aligned_cols=170 Identities=30% Similarity=0.419 Sum_probs=139.8
Q ss_pred ccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 271 KEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
+.++......+++.|+||++.... ....+.+.+|+++++.++|||++++++.+..+...++||||+.+ ++.+++.
T Consensus 35 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~- 112 (313)
T cd06633 35 GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLE- 112 (313)
T ss_pred eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHH-
Confidence 444444555678999999987542 23345688999999999999999999999999999999999975 5655553
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
.....+++.+++.++.||+.+|.|||+.| ++|+||||+||+++.++.+||+|||++.... ......|+..
T Consensus 113 -~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~ 182 (313)
T cd06633 113 -VHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPY 182 (313)
T ss_pred -hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC------CCCCcccccc
Confidence 23456899999999999999999999999 9999999999999999999999999886422 1223568899
Q ss_pred cccccccc---cCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
|+|||++. .+.++.++||||||++|
T Consensus 183 y~aPE~~~~~~~~~~~~~sDv~slGvil 210 (313)
T cd06633 183 WMAPEVILAMDEGQYDGKVDVWSLGITC 210 (313)
T ss_pred ccChhhccccCCCCCCchhhHHHHHHHH
Confidence 99999984 46689999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=224.50 Aligned_cols=184 Identities=27% Similarity=0.394 Sum_probs=150.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
..||+....++.|.+|.|+.+ ....+++.||||++.+. .....+.+.+|+.+++.++||
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp 69 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSA-------------------RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69 (328)
T ss_pred ccceEEEEeecccCCeEEEEE-------------------EECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCC
Confidence 457888888888888766544 45568999999988643 233456788999999999999
Q ss_pred CccceeeeEec-CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 315 NLVRLLGCCLD-GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 315 ~iv~l~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
||+++++++.. ....+++|||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+|+||||+||++
T Consensus 70 niv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili 141 (328)
T cd07856 70 NIISLSDIFISPLEDIYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILI 141 (328)
T ss_pred CeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeE
Confidence 99999999876 55789999998 558887773 345888999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 142 ~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 196 (328)
T cd07856 142 NENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIF 196 (328)
T ss_pred CCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHH
Confidence 99999999999998754221 123456889999998765 5689999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=222.40 Aligned_cols=170 Identities=30% Similarity=0.434 Sum_probs=139.9
Q ss_pred ccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 271 KEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
+.++......+++.+|||.+... .....+++.+|+++++.++|+|++++++++......++||||+.+ ++.+.+..
T Consensus 29 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 107 (308)
T cd06634 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEV 107 (308)
T ss_pred EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-CHHHHHHH
Confidence 34444455667899999998643 233445688999999999999999999999999999999999975 66665532
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
....+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++...... ....|++.
T Consensus 108 --~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~ 176 (308)
T cd06634 108 --HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPY 176 (308)
T ss_pred --cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCcc
Confidence 2345899999999999999999999998 999999999999999999999999998764322 23457889
Q ss_pred cccccccc---cCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
|+|||.+. ...++.++|||||||++
T Consensus 177 y~aPE~~~~~~~~~~~~~~Di~slG~il 204 (308)
T cd06634 177 WMAPEVILAMDEGQYDGKVDVWSLGITC 204 (308)
T ss_pred ccCHHHHhhcccCCCCcccchHHHHHHH
Confidence 99999974 35688999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-27 Score=213.14 Aligned_cols=184 Identities=24% Similarity=0.298 Sum_probs=147.5
Q ss_pred eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc-ccHHHHHHHHHHHHcC-CCCCccceee
Q 012989 244 QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG-QGLQEFKNEVTLIAKL-QHKNLVRLLG 321 (452)
Q Consensus 244 ~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~l~~ 321 (452)
.-+|.|.+|+|.+- .+.+.|+..|||+|..... .+.++++.|.+...+- +.||||++++
T Consensus 70 g~iG~G~fG~V~KM-------------------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKM-------------------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred HHhcCCcchhhhhh-------------------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 34677777777654 4456899999999986643 5567788888876655 6899999999
Q ss_pred eEecCCeEEEEEEecCCCChhhhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 322 CCLDGNELLLIYEYMPNKSLDLFLFD--STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 322 ~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
....++..|+-||+++ .+|+.+.+. ..+...+++..+-.|.--.+.||.||-+.- .|||||+||+|||++..|.+
T Consensus 131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 9999999999999994 477655422 124567899988899999999999998753 59999999999999999999
Q ss_pred eEccccccccccCCCccccccccccccccccccccc--cCCCceeeeeeeeeeeC
Q 012989 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM--EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 400 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwSlG~il 452 (452)
||+|||.+..+.+ ....+...|...|||||.+. +..|+.+|||||||+.|
T Consensus 208 KLCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL 259 (361)
T KOG1006|consen 208 KLCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITL 259 (361)
T ss_pred eeecccchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceE
Confidence 9999999876533 23345568999999999983 44599999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=217.09 Aligned_cols=173 Identities=28% Similarity=0.428 Sum_probs=139.3
Q ss_pred cEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcC---CCCCccceeeeEecCCe-----EEEEEEecCCCCh
Q 012989 272 EICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKL---QHKNLVRLLGCCLDGNE-----LLLIYEYMPNKSL 341 (452)
Q Consensus 272 ~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~-----~~lv~E~~~~~~L 341 (452)
.++......+++.||||++..... .....+.+|+.+++++ +||||+++++.+...+. .+++||++.+ +|
T Consensus 14 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l 92 (287)
T cd07838 14 TVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DL 92 (287)
T ss_pred EEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CH
Confidence 333444455789999999975422 2234566788877766 59999999999998776 9999999975 78
Q ss_pred hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 342 ~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
.+++... ....+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.+||+|||++..+..... ...
T Consensus 93 ~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~ 165 (287)
T cd07838 93 ATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTS 165 (287)
T ss_pred HHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---ccc
Confidence 7776432 2235899999999999999999999998 99999999999999999999999999877643322 123
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..++..|+|||.+.+..++.++|+|||||++
T Consensus 166 ~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred ccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 3578899999999988999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=226.18 Aligned_cols=182 Identities=27% Similarity=0.395 Sum_probs=148.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.+|+....+|.|++|.|+.+ ....+++.||||++.+. .......+.+|+.+++.++|||
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 75 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSA-------------------IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75 (342)
T ss_pred cceEEEEEeeecCCeEEEEE-------------------EeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCC
Confidence 47888888888888776644 34457899999998754 2233456889999999999999
Q ss_pred ccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++... ..+++||||+.. +|..+. ...+++..+..++.|++.||+|||+++ |+||||||+
T Consensus 76 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~ 146 (342)
T cd07879 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPG 146 (342)
T ss_pred ccchhheecccccCCCCceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 99999998754 346999999864 665544 235899999999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++|
T Consensus 147 NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil 205 (342)
T cd07879 147 NLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205 (342)
T ss_pred HEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence 999999999999999998754221 223467889999999876 4689999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=218.29 Aligned_cols=179 Identities=23% Similarity=0.289 Sum_probs=142.6
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
.|.++.|+......+++.+|||++.... ......+.+|+.++.++. |+||+++++.+..+...+++|||++. ++.++
T Consensus 14 ~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l 92 (288)
T cd06616 14 RGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKF 92 (288)
T ss_pred CCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHH
Confidence 3344555555667789999999987543 334567889999999996 99999999999999999999999864 55443
Q ss_pred hcc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccc
Q 012989 345 LFD--STKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 345 l~~--~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+..... ...
T Consensus 93 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~ 166 (288)
T cd06616 93 YKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTR 166 (288)
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---ccc
Confidence 311 12335699999999999999999999974 7 99999999999999999999999999876543221 123
Q ss_pred cccccccccccccccC---CCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEG---VFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~---~~s~~~DvwSlG~il 452 (452)
..|++.|+|||++.+. .++.++||||||+++
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il 200 (288)
T cd06616 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200 (288)
T ss_pred ccCccCccCHHHhccccccCCcchhhhhHHHHHH
Confidence 3578999999998765 689999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=217.02 Aligned_cols=174 Identities=27% Similarity=0.351 Sum_probs=140.7
Q ss_pred ccEEEEEEecCCeeeEEEEeecCCc-ccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS 348 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 348 (452)
+.++......+++.|+||++..... .......+|+..+++++ |+||+++++.+..++..++||||+ +++|.+.+...
T Consensus 13 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~ 91 (283)
T cd07830 13 GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR 91 (283)
T ss_pred eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc
Confidence 3333444555788999999875532 22334567999999998 999999999999999999999999 67887777432
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccc
Q 012989 349 TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGY 428 (452)
Q Consensus 349 ~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 428 (452)
. ...+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++........ .....|+..|
T Consensus 92 ~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~ 164 (283)
T cd07830 92 K-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWY 164 (283)
T ss_pred c-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccc
Confidence 2 346899999999999999999999999 99999999999999999999999999876543222 2234678899
Q ss_pred ccccccc-cCCCceeeeeeeeeeeC
Q 012989 429 MAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 429 ~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
+|||++. ...++.++|+||||+++
T Consensus 165 ~aPE~~~~~~~~~~~~Di~s~G~~l 189 (283)
T cd07830 165 RAPEILLRSTSYSSPVDIWALGCIM 189 (283)
T ss_pred cCceeeecCcCcCCccchhhHHHHH
Confidence 9999874 45579999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=216.10 Aligned_cols=189 Identities=25% Similarity=0.356 Sum_probs=150.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-----CcccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-----SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~~E~~~l~~l~h 313 (452)
||.+...+|.|++|.++.+. ....+..+++|.++.. ......++..|+.+++.++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 61 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVK-------------------DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61 (260)
T ss_pred CceeeeeecCCCCceEEEEE-------------------ecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC
Confidence 67888888888888777542 2333444555554431 22334467789999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|||+++++.+......++||||+++++|..++... .....+++.+++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nil 138 (260)
T cd08222 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIF 138 (260)
T ss_pred CcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheE
Confidence 99999999999999999999999999998887542 23457999999999999999999999998 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++. +.+||+|||+++....... ......|++.|+|||.+.+..++.++|+||||+++
T Consensus 139 i~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~ 195 (260)
T cd08222 139 LKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCIL 195 (260)
T ss_pred eec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHH
Confidence 975 5699999999876543322 12234578899999999888899999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=216.27 Aligned_cols=175 Identities=27% Similarity=0.375 Sum_probs=145.4
Q ss_pred CccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhcc
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD 347 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~ 347 (452)
.+.++......+++.+|+|.+.... ....+.+..|+.++++++|+||+++++.+...+..++|||++++ +|.+++..
T Consensus 12 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~ 90 (282)
T cd07829 12 YGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK 90 (282)
T ss_pred cceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHh
Confidence 3444445566679999999988653 33456788999999999999999999999999999999999975 89888843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
. ...+++..++.++.|++.+|++||+++ |+|+||+|+||+++.++.+||+|||.++....... ......++..
T Consensus 91 ~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~ 163 (282)
T cd07829 91 R--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLW 163 (282)
T ss_pred h--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcC
Confidence 2 246999999999999999999999999 99999999999999999999999999887643322 1222345788
Q ss_pred cccccccccC-CCceeeeeeeeeeeC
Q 012989 428 YMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|+|||.+.+. .++.++||||||+++
T Consensus 164 ~~aPE~~~~~~~~~~~~Dv~slG~~l 189 (282)
T cd07829 164 YRAPEILLGSKHYSTAVDIWSVGCIF 189 (282)
T ss_pred cCChHHhcCCcCCCccccHHHHHHHH
Confidence 9999998766 789999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=224.90 Aligned_cols=183 Identities=26% Similarity=0.370 Sum_probs=150.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.+|+....++.|++|.++.+ ....+++.||||++... .....+.+.+|+.++++++|||
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 75 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSA-------------------FDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75 (343)
T ss_pred CceEEEEEeccCCceEEEEE-------------------EECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCC
Confidence 46777788888887766644 44557899999998653 2233466788999999999999
Q ss_pred ccceeeeEecCCe------EEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDGNE------LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~~~------~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++.+...+. .++|+||+ +++|.+++. ...+++..++.++.||+.+|.|||+.| |+|+||||+
T Consensus 76 iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~ 147 (343)
T cd07851 76 VIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPS 147 (343)
T ss_pred HHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999998876654 89999998 568888773 246999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++
T Consensus 148 Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l 206 (343)
T cd07851 148 NIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred HeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHH
Confidence 999999999999999998765332 223457889999998865 4678999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=216.50 Aligned_cols=187 Identities=23% Similarity=0.327 Sum_probs=145.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
..|+....++.|.+|.++ ......+++.||||.++... ......+..|+.++.+. .|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~-------------------~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 75 (296)
T cd06618 15 NDLENLGEIGSGTCGQVY-------------------KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPY 75 (296)
T ss_pred chheeeeEeeccCCeEEE-------------------EEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCc
Confidence 345556666666665554 33445568999999997543 23345567788777666 4999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~ 394 (452)
|+++++++......+++|||+++ +|..++.. ....+++..+..++.||+.+|.|||+ .+ |+||||+|+||+++
T Consensus 76 i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~ 149 (296)
T cd06618 76 IVKCYGYFITDSDVFICMELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLD 149 (296)
T ss_pred hHhhheeeecCCeEEEEeeccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEc
Confidence 99999999999999999999855 66666533 23478999999999999999999997 57 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccC----CCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG----VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++..+...... ....++..|+|||.+.+. .++.++|+||||++|
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 208 (296)
T cd06618 150 ASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISL 208 (296)
T ss_pred CCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHH
Confidence 9999999999998765432221 223578899999998654 388999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-26 Score=182.75 Aligned_cols=102 Identities=44% Similarity=0.828 Sum_probs=78.9
Q ss_pred ccCCC---CCcc-CCCChhHHHHHHHHHHHhhcccCCCCCCcccCeeeeccCCCCCeEEEEEeccCCCCccchHHHHHHH
Q 012989 30 YHNCP---STNF-TPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTAGHEPNKVYGLFLCRGDLGTENCQSCVNFA 105 (452)
Q Consensus 30 ~~~C~---~~~~-~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~~~f~~~~~g~~~~~vyg~~~C~~D~~~~~C~~Cl~~a 105 (452)
++.|+ .++| +++++|++||+.||+.|++.++..+ ..+|++++.|.++++|||++||++|+++++|..||+.|
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~----~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a 76 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS----SKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADA 76 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-----TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc----ccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHH
Confidence 46788 3667 6788899999999999999987542 15899999899999999999999999999999999999
Q ss_pred HHHHhhhCCCCceEEEEccceEEEEcCCCc
Q 012989 106 TSETAQLCPFGKEYIIGYEECLLRYSNISF 135 (452)
Q Consensus 106 ~~~~~~~C~~~~~a~~~~~~C~lry~~~~f 135 (452)
+..+++.|+.+++|+||++.|+||||+++|
T Consensus 77 ~~~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 77 VANISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HCCHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-26 Score=202.14 Aligned_cols=181 Identities=20% Similarity=0.355 Sum_probs=149.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i 316 (452)
-.|++..-.|.|..+.|+.+ ....+++.++||++++- ..+.+.+|+.||+.|. ||||
T Consensus 38 ddYeivrk~GRGKYSEVFeg-------------------~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NI 95 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEG-------------------INITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNI 95 (338)
T ss_pred chHHHHHHHcCccHhhHhcc-------------------cccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCe
Confidence 46777777777777666655 34567899999999754 3467899999999996 9999
Q ss_pred cceeeeEecCC--eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDGN--ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
+++++...++. .+.||+||+.+.+...+. ..++...+..++.||++||.|+|+.| |+|||+||.|+|||
T Consensus 96 i~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmId 166 (338)
T KOG0668|consen 96 IKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMID 166 (338)
T ss_pred eehhhhhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeec
Confidence 99999988754 588999999987776554 34788889999999999999999999 99999999999999
Q ss_pred CCC-CeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 395 HEM-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.. .++|+|+|+|..+..... .+..+.+..|--||++.. ..|+..-|+|||||+|
T Consensus 167 h~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 167 HELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 223 (338)
T ss_pred hhhceeeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHH
Confidence 764 599999999998865433 344566888999999864 5689999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=208.99 Aligned_cols=168 Identities=27% Similarity=0.358 Sum_probs=141.0
Q ss_pred EEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceeeeEecCC------eEEEEEEecCCCChhhh
Q 012989 273 ICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN------ELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 273 v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~ 344 (452)
++-.-+.-.+++||||++... +....++..+|..++..++|+||++++.+|.-.. ..|+|||++.. +|...
T Consensus 32 v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~v 110 (369)
T KOG0665|consen 32 VVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQV 110 (369)
T ss_pred EEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHH
Confidence 444455567899999988654 3444567788999999999999999999987543 58999999955 78777
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccc
Q 012989 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVG 424 (452)
Q Consensus 345 l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 424 (452)
+. -.++..++..|+.|++.|++|||+.| |+||||||+||++..+..+||.|||+++.-... ...+..+.
T Consensus 111 i~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVv 179 (369)
T KOG0665|consen 111 IL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVV 179 (369)
T ss_pred HH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhh
Confidence 73 34788999999999999999999999 999999999999999999999999999853322 23445677
Q ss_pred ccccccccccccCCCceeeeeeeeeeeC
Q 012989 425 TYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 425 t~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|..|.|||++.+..+..+.||||+|||+
T Consensus 180 tRyyrapevil~~~~ke~vdiwSvGci~ 207 (369)
T KOG0665|consen 180 TRYYRAPEVILGMGYKENVDIWSVGCIM 207 (369)
T ss_pred eeeccCchheeccCCcccchhhhhhhHH
Confidence 9999999999988899999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=232.48 Aligned_cols=186 Identities=21% Similarity=0.291 Sum_probs=153.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|.+...+|.|.+|.||.+ ....+++.||||++.... ......+..|+.+++.++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a-------------------~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp 64 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLG-------------------RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64 (669)
T ss_pred CCEEEEEEEecCCCeEEEEE-------------------EECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCC
Confidence 36777888888888776644 455678999999987542 23346788999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++.+....+++|||||+++++|..++. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++
T Consensus 65 ~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~---~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~ 138 (669)
T cd05610 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLIS 138 (669)
T ss_pred CcCeEEEEEEECCEEEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEc
Confidence 99999999999999999999999999999884 3346899999999999999999999998 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCC-Cceeeeeeeeee
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEF 450 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~ 450 (452)
.++.+||+|||+++...... .......+|+.|++||...... -...+++||+|+
T Consensus 139 ~~g~vkL~DFGls~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~ 193 (669)
T cd05610 139 NEGHIKLTDFGLSKVTLNRE--LNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGF 193 (669)
T ss_pred CCCCEEEEeCCCCccccCCc--ccccccccCccccCccccccCCCCceeeeeeecCc
Confidence 99999999999998754332 2223457899999999764333 355688899885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-26 Score=225.74 Aligned_cols=173 Identities=21% Similarity=0.247 Sum_probs=144.0
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
..+.+.++.+.+..+..+++..++|++.+.. ....+|+.++... +||||+++++.+.++.+.|+|||.+.|+-+.
T Consensus 329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 329 ELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 3456677888899999999999999997662 2234577666665 7999999999999999999999999998886
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE-CCCCCeeEccccccccccCCCccccccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-DHEMNPKISDFGMARIFSGNQNEANTNR 421 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll-~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 421 (452)
+.++. .. ....++..|++||+.++.|||++| +|||||||+|||+ +..++++|+|||.++..... ...
T Consensus 405 ~ri~~---~~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~t 472 (612)
T KOG0603|consen 405 RRIRS---KP-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDT 472 (612)
T ss_pred HHHHh---cc-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcc
Confidence 66632 22 233788889999999999999999 9999999999999 68999999999999875443 122
Q ss_pred cccccccccccccccCCCceeeeeeeeeeeC
Q 012989 422 VVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 422 ~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+-|..|.|||++....|++.+|+||||++|
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlL 503 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLL 503 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHH
Confidence 3448999999999999999999999999986
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-26 Score=225.03 Aligned_cols=191 Identities=28% Similarity=0.392 Sum_probs=159.5
Q ss_pred cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccce
Q 012989 241 ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRL 319 (452)
Q Consensus 241 ~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l 319 (452)
..++.+|+|.||+|..+....+ ..+.-.||||.+...... ....|++|+.+|.+|+|+|+++|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~p----------------sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQP----------------SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCC----------------CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEE
Confidence 3466789999998887654321 113356899999876444 67889999999999999999999
Q ss_pred eeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 320 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
|++..+ ...-+|||+++.|+|.+.+++ .....|.....-.++.||+.||.||..++ +|||||-..|+|+-....+
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtV 251 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTV 251 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheeccccee
Confidence 999887 667899999999999999977 45667889999999999999999999998 9999999999999999999
Q ss_pred eEccccccccccCCCcccccc-ccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 400 KISDFGMARIFSGNQNEANTN-RVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 400 kl~DFG~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|||+.+.+...+...... ..--...|.|||.+....|+.++|||+|||.|
T Consensus 252 KI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTi 305 (1039)
T KOG0199|consen 252 KICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTI 305 (1039)
T ss_pred eeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhH
Confidence 999999999887665443211 11126789999999999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=220.63 Aligned_cols=188 Identities=20% Similarity=0.382 Sum_probs=155.4
Q ss_pred ceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcccee
Q 012989 242 LYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLL 320 (452)
Q Consensus 242 ~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~ 320 (452)
....+|.|.||.||.+.+..+. ....--||||..+.+ .....+.|+.|..+|+.++||||++++
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~---------------kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPE---------------KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred HHHhhcCCcccceeeeEecccc---------------cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 3456777777777766554331 112344899998874 556678899999999999999999999
Q ss_pred eeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCee
Q 012989 321 GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400 (452)
Q Consensus 321 ~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~k 400 (452)
+++.+. ..|||||+++-|.|..++.. +...++......++.||..+|.|||+.. .|||||-..|||+....-+|
T Consensus 458 Gv~~e~-P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 458 GVCVEQ-PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred eeeecc-ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceee
Confidence 998775 57999999999999999943 4567999999999999999999999998 99999999999999999999
Q ss_pred EccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 401 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
|+|||+++-+.+....... +-.-+..|||||.+.-..++.++|||=||+.
T Consensus 532 LaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVC 581 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVC 581 (974)
T ss_pred ecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHH
Confidence 9999999987665433322 2223788999999999999999999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=244.91 Aligned_cols=172 Identities=23% Similarity=0.373 Sum_probs=142.3
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
..+.|.+|.|+......+++.||||++...... ..+|++++++++||||+++++++..+...++||||+++++|.+
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~ 772 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHH
Confidence 456677788877777789999999998644321 2356889999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 423 (452)
+++ .+++.++..|+.|+++||+|||.....+|+||||||+||+++.++..++. ||........ ....
T Consensus 773 ~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~ 839 (968)
T PLN00113 773 VLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCF 839 (968)
T ss_pred HHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCcc
Confidence 983 38899999999999999999995433349999999999999999888775 6655432211 1236
Q ss_pred cccccccccccccCCCceeeeeeeeeeeC
Q 012989 424 GTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 424 gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+.|+|||++.+..++.++|||||||+|
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl 868 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLIL 868 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHH
Confidence 78999999999999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=202.35 Aligned_cols=173 Identities=28% Similarity=0.402 Sum_probs=149.4
Q ss_pred ccEEEEEEecCCeeeEEEEeecCCccc-HHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
|.++......+++.+++|++....... .+.+.+|++.+++++|+||+++++.+......+++||++++++|..++..
T Consensus 3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~-- 80 (244)
T smart00220 3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK-- 80 (244)
T ss_pred eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh--
Confidence 455555666678999999997665444 68899999999999999999999999999999999999999999998843
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 429 (452)
...+++..++.++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 81 -~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 -RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 223899999999999999999999998 9999999999999999999999999998765432 223456788999
Q ss_pred cccccccCCCceeeeeeeeeeeC
Q 012989 430 APEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||...+..++.++|+||||+++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l 176 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVIL 176 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHH
Confidence 99999888899999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=221.18 Aligned_cols=211 Identities=18% Similarity=0.175 Sum_probs=146.0
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHH-------------
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEF------------- 301 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~------------- 301 (452)
...-.|++.+.+|+|+||.||.+.......... ..........+++.||||++........++|
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v---~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~ 218 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGV---TQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET 218 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchh---hhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence 346678889999999999999774322111100 0000112334567899999875533333333
Q ss_pred -HHHHHHHHcCCCCCc-----cceeeeEec--------CCeEEEEEEecCCCChhhhhccCC------------------
Q 012989 302 -KNEVTLIAKLQHKNL-----VRLLGCCLD--------GNELLLIYEYMPNKSLDLFLFDST------------------ 349 (452)
Q Consensus 302 -~~E~~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~E~~~~~~L~~~l~~~~------------------ 349 (452)
..|+.++.+++|.++ +++++++.. .+..+|||||+++++|.++++...
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 346667777766544 566666543 356899999999999988885321
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccc
Q 012989 350 ---KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 350 ---~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
....+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp 374 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDP 374 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCc
Confidence 1123567889999999999999999998 999999999999999999999999999765332211 111123478
Q ss_pred ccccccccccCCC----------------------ceeeeeeeeeeeC
Q 012989 427 GYMAPEYAMEGVF----------------------SVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~~~~----------------------s~~~DvwSlG~il 452 (452)
.|+|||.+..... ..+.|+||+||||
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil 422 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL 422 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence 9999998854321 1247999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=221.10 Aligned_cols=186 Identities=27% Similarity=0.376 Sum_probs=163.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+||.....|.|++|.||+++ +...++..|+|.++........-+.+|+.+++.-+|||||
T Consensus 15 ddyellqrvgsgTygdvyKaR-------------------d~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~niv 75 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKAR-------------------DKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIV 75 (829)
T ss_pred cchhheeeecCCcccchhhhc-------------------ccccCchhhheeeeccCCccccccccceeeeecCCCcChH
Confidence 467888888888888888774 5568999999999988777788889999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
.+++.+......|+.|||+.||+|.+..+ --.++++.++....++.+++|+|||+.| =+|||||-.||+++..|
T Consensus 76 ay~gsylr~dklwicMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~g 149 (829)
T KOG0576|consen 76 AYFGSYLRRDKLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEG 149 (829)
T ss_pred HHHhhhhhhcCcEEEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccC
Confidence 99999999999999999999999988763 3467999999999999999999999999 89999999999999999
Q ss_pred CeeEccccccccccCCCcccccccccccccccccccc---ccCCCceeeeeeeeee
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA---MEGVFSVNRMFLVSEF 450 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlG~ 450 (452)
.+|+.|||.+..+.. ...+...+.||+.|||||+. +.+.|..++|||+.|+
T Consensus 150 DvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gi 203 (829)
T KOG0576|consen 150 DVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGI 203 (829)
T ss_pred ceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhccccccccccccccc
Confidence 999999999876542 23345568999999999987 5678999999999995
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=220.77 Aligned_cols=179 Identities=28% Similarity=0.391 Sum_probs=143.3
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~ 344 (452)
+.|..|.+.+.+.. +|+.||||++-.. ......+|+..|+.= +|||||++++.-.++...||..|.|. .+|.++
T Consensus 518 G~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dl 592 (903)
T KOG1027|consen 518 GYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDL 592 (903)
T ss_pred ccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHH
Confidence 45556777776654 5789999998644 234567899999887 69999999999999999999999994 599999
Q ss_pred hccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC---C--CCeeEccccccccccCCCcccc
Q 012989 345 LFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH---E--MNPKISDFGMARIFSGNQNEAN 418 (452)
Q Consensus 345 l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~--~~~kl~DFG~a~~~~~~~~~~~ 418 (452)
+... ...........+.++.|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++.+..++....
T Consensus 593 ie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 593 IESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred HhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 8542 11111122456788999999999999988 999999999999976 3 4599999999999876654432
Q ss_pred -ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 419 -TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 419 -~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.....||-+|+|||++.....+.+.||||+||||
T Consensus 670 r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvf 704 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVF 704 (903)
T ss_pred cccCCCCcccccCHHHHhccccCcccchhhcCceE
Confidence 3445799999999999988888899999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=224.89 Aligned_cols=189 Identities=17% Similarity=0.211 Sum_probs=129.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecC----CeeeEEEEeecCCcccHHHHHHHHHHHHcCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILAD----GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~----~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~ 312 (452)
.-+|+..+.+|.|++|.||.+. ...+ +..||||++...... +...+| .++...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~-------------------~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~ 187 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKAS-------------------LVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRAC 187 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEE-------------------EcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhc
Confidence 4578888999999998888663 2334 789999987643221 112221 112222
Q ss_pred CCCccceeee------EecCCeEEEEEEecCCCChhhhhccCCC-----------------CCCCCHHHHHHHHHHHHHH
Q 012989 313 HKNLVRLLGC------CLDGNELLLIYEYMPNKSLDLFLFDSTK-----------------GAQLDWKRRISIINGIARG 369 (452)
Q Consensus 313 h~~iv~l~~~------~~~~~~~~lv~E~~~~~~L~~~l~~~~~-----------------~~~l~~~~~~~i~~ql~~a 369 (452)
+.++..+... ...+.+.+|||||+++++|.+++..... ........+..++.||+.|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~a 267 (566)
T PLN03225 188 PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFA 267 (566)
T ss_pred hhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHH
Confidence 2233322222 2355679999999999999888753211 0112234567899999999
Q ss_pred HHHHhcCCCCCeEecCCCCCCeEECC-CCCeeEccccccccccCCCccccccccccccccccccccccC-----------
Q 012989 370 LLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG----------- 437 (452)
Q Consensus 370 L~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------- 437 (452)
|+|||+++ |+||||||+|||++. ++.+||+|||+++.+..... .......||+.|+|||.+...
T Consensus 268 L~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~ 343 (566)
T PLN03225 268 LDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 343 (566)
T ss_pred HHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccc
Confidence 99999998 999999999999986 57899999999986543322 223346789999999976322
Q ss_pred -----------CCceeeeeeeeeeeC
Q 012989 438 -----------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 438 -----------~~s~~~DvwSlG~il 452 (452)
.+..++|||||||||
T Consensus 344 ~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 344 ATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred cccccchhccccCCCCcccHHHHHHH
Confidence 234456999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=193.90 Aligned_cols=176 Identities=28% Similarity=0.371 Sum_probs=147.9
Q ss_pred CccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccC
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS 348 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 348 (452)
.+.++......+++.+++|.+...... ..+.+.+|++.++.++|+|++++++.+......++++|++++++|.+++..
T Consensus 12 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~- 90 (225)
T smart00221 12 FGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK- 90 (225)
T ss_pred CeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh-
Confidence 344444455556899999999876544 677899999999999999999999999999999999999999999998843
Q ss_pred CCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccc
Q 012989 349 TKGAQ-LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG 427 (452)
Q Consensus 349 ~~~~~-l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 427 (452)
... +++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+..+...... ......++..
T Consensus 91 --~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~ 164 (225)
T smart00221 91 --KGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPF 164 (225)
T ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCC
Confidence 223 889999999999999999999998 999999999999999999999999999876544311 2233567889
Q ss_pred ccccccc-ccCCCceeeeeeeeeeeC
Q 012989 428 YMAPEYA-MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 428 y~aPE~~-~~~~~s~~~DvwSlG~il 452 (452)
|++||.. ....++.++|+||||+++
T Consensus 165 ~~~pe~~~~~~~~~~~~Dv~~lG~~~ 190 (225)
T smart00221 165 YLAPEVLLGGKGYGEAVDIWSLGVIL 190 (225)
T ss_pred cCCHhHhcCCCCCCchhhHHHHHHHH
Confidence 9999998 677788899999999864
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=219.70 Aligned_cols=188 Identities=25% Similarity=0.344 Sum_probs=158.4
Q ss_pred eeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceee
Q 012989 243 YQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLG 321 (452)
Q Consensus 243 ~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~ 321 (452)
...+|.|.||+||++.+.| ....=+-+||||++... ..+..+++++|+-+|.+|+|||+++|++
T Consensus 701 ~kvLGsgAfGtV~kGiw~P---------------ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLg 765 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIP---------------EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLG 765 (1177)
T ss_pred hceeccccceeEEeeeEec---------------CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhh
Confidence 4567888888888765433 21223568999988655 4556788999999999999999999999
Q ss_pred eEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeE
Q 012989 322 CCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401 (452)
Q Consensus 322 ~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl 401 (452)
++.... .-||++|++.|+|.++++.. ...+..+..+.|..||++||.|||++. +|||||-..|||+..-.++||
T Consensus 766 vc~~s~-~qlvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 766 VCMLST-LQLVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred hcccch-HHHHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEE
Confidence 998776 78899999999999999663 456888999999999999999999988 999999999999999999999
Q ss_pred ccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 402 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
.|||+++....+........-.-.+.|||-|.++...|+.++|||||||.
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVt 889 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVT 889 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhh
Confidence 99999998876665554443344788999999999999999999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-24 Score=221.40 Aligned_cols=167 Identities=30% Similarity=0.431 Sum_probs=141.4
Q ss_pred CeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-----CC---
Q 012989 282 GKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-----KG--- 351 (452)
Q Consensus 282 ~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-----~~--- 351 (452)
...||||.++.. .....+.+..|+++|+.+ +|+||+.+++.+..+...++|+||++.|+|..+++..+ ..
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 578999998755 345677899999999999 69999999999999999999999999999999996544 00
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccc--c
Q 012989 352 -----AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV--G 424 (452)
Q Consensus 352 -----~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~--g 424 (452)
..++..+.+.++.||+.|++||++.. +|||||-..|||+..+..+||+|||+++........... .-. =
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~L 483 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTL 483 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEec-CCCCcc
Confidence 23899999999999999999999998 999999999999999999999999999865443322211 111 2
Q ss_pred ccccccccccccCCCceeeeeeeeeeeC
Q 012989 425 TYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 425 t~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+..|||||.+....|+.|+||||||++|
T Consensus 484 P~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 484 PVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred ceeecCHHHhccCcccccchhhHHHHHH
Confidence 5569999999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=185.91 Aligned_cols=179 Identities=30% Similarity=0.496 Sum_probs=149.2
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
.+..+.++......+++++++|++...... ..+.+.+|+..++.++|++|+++++.+......+++||++++++|..++
T Consensus 3 ~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~ 82 (215)
T cd00180 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82 (215)
T ss_pred cCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHH
Confidence 344455555566667999999998765432 3567999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-CCCeeEccccccccccCCCcccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVVG 424 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 424 (452)
... ...+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 83 ~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 83 KEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred Hhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 432 146899999999999999999999998 999999999999999 89999999999986644321 1223456
Q ss_pred ccccccccccccC-CCceeeeeeeeeeeC
Q 012989 425 TYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 425 t~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
...|++||..... .++.++|+|++|+++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~ 184 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHH
Confidence 8899999999777 789999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=201.62 Aligned_cols=163 Identities=18% Similarity=0.189 Sum_probs=123.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEec-CCeeeEEEEeecC-----CcccHHHHHHHHHHHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILA-DGKEIAVKRLSRS-----SGQGLQEFKNEVTLIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~-~~~~vAiK~~~~~-----~~~~~~~~~~E~~~l~~ 310 (452)
..+|++...+|.|++|.||.+ .... +++.+|||++... .....+.+.+|+++|++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a-------------------~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~ 77 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERG-------------------YFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKT 77 (365)
T ss_pred cCCceEccEEeecCcEEEEEE-------------------EEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHh
Confidence 346777778888888777755 3333 5777899987533 12235668999999999
Q ss_pred CCCCCccc-eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CC
Q 012989 311 LQHKNLVR-LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL-KT 388 (452)
Q Consensus 311 l~h~~iv~-l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl-kp 388 (452)
++|+|+++ +++. ...+|||||++|++|.... .. . ...++.|++++|.|||++| |+|||| ||
T Consensus 78 L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP 140 (365)
T PRK09188 78 VRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKP 140 (365)
T ss_pred ccCCCCCcEEEEc----CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCc
Confidence 99999985 4432 4579999999999996321 11 1 1467899999999999999 999999 99
Q ss_pred CCeEECCCCCeeEccccccccccCCCcccc------ccccccccccccccccc
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEAN------TNRVVGTYGYMAPEYAM 435 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~ 435 (452)
+|||++.++.+||+|||+++.+........ .....+++.|++||++.
T Consensus 141 ~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 141 QNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999999999999999999997754432111 13457788999999984
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=201.09 Aligned_cols=137 Identities=20% Similarity=0.293 Sum_probs=108.1
Q ss_pred cccCC-CCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-----C---CCccceeee
Q 012989 252 GTLLP-AVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-----H---KNLVRLLGC 322 (452)
Q Consensus 252 g~v~~-a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~l~~~ 322 (452)
|.++. ++|...+.++.|++.+||++-+..+.+.||+|+.+... .-.+..+.||++|++++ | ..||+|++.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 44444 45555555666666778888999999999999986542 23456788999999983 3 379999999
Q ss_pred Eec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 323 CLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 323 ~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|.. +.|+|||+|++ |.+|..+|.. ..-+.++...++.|++||+.||.|||+.. +|||-||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 985 45899999999 5566666644 34466999999999999999999999864 59999999999999
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=181.30 Aligned_cols=187 Identities=18% Similarity=0.251 Sum_probs=152.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCC-CCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH-KNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv 317 (452)
.|.+..-+|.|+||.+| ......+|++||||.-.... ....+.-|..++..|++ ..|+
T Consensus 16 ky~lvrkiGsGSFGdIy-------------------~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP 74 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIY-------------------LGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIP 74 (341)
T ss_pred ceEEEEeecCCchhhee-------------------eeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCc
Confidence 45555566666665555 55667899999999865442 33568889999999975 6888
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC-
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE- 396 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~- 396 (452)
.+..++.+.++-.+|||++ |.+|++++.. -.+.++..+++-++-|++.-++|+|.++ .|||||||+|+|+.-+
T Consensus 75 ~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 75 HIRHYGTEKDYNVLVMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGR 148 (341)
T ss_pred hhhhhccccccceeeeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeecccc
Confidence 8888888999999999998 8899998743 3456999999999999999999999999 9999999999999643
Q ss_pred --CCeeEccccccccccCCCcccc-----ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 --MNPKISDFGMARIFSGNQNEAN-----TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 --~~~kl~DFG~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..+.|+|||+++.+.+...... .....||..|++-....+...+.++|+-|+|.+|
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 4599999999999876654432 2345899999999999998999999999999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-23 Score=194.24 Aligned_cols=189 Identities=20% Similarity=0.350 Sum_probs=153.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
..-|.....+|.|+|++|+.+.... .....+.||+|.+...+. ..++.+|+++|..+ .+.|
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~----------------~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~n 96 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIE----------------QDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDN 96 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhh----------------hccccceEeeeecccccC--chHHHHHHHHHHHhccchh
Confidence 4456777889999999999875322 123578899999876543 36799999999999 5899
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++.+.+..+++..+||||++.....++.+ .++..++..+++.++.||.++|+.| ||||||||+|+|.+.
T Consensus 97 i~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 97 IIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNR 167 (418)
T ss_pred hhcchhhhccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCcccccccc
Confidence 9999999999999999999999988888773 3778999999999999999999999 999999999999985
Q ss_pred C-CCeeEccccccccccCCC--------------c----------------------------ccccccccccccccccc
Q 012989 396 E-MNPKISDFGMARIFSGNQ--------------N----------------------------EANTNRVVGTYGYMAPE 432 (452)
Q Consensus 396 ~-~~~kl~DFG~a~~~~~~~--------------~----------------------------~~~~~~~~gt~~y~aPE 432 (452)
. +.-.|+|||++..+.... . ....-...||++|.|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 5 668999999997221100 0 00011247999999999
Q ss_pred cccc-CCCceeeeeeeeeeeC
Q 012989 433 YAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 433 ~~~~-~~~s~~~DvwSlG~il 452 (452)
++.. ...+.++||||-|+||
T Consensus 248 vL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred HHhhccCcCCccceeecccee
Confidence 9864 5579999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-23 Score=188.29 Aligned_cols=188 Identities=21% Similarity=0.282 Sum_probs=159.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 316 (452)
..|.+.+.+|.|+||..+.+ ..+-++++||||....++ ...++..|.+.++.| ..++|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G-------------------~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GI 86 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLG-------------------KNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGI 86 (449)
T ss_pred ccceeccccccCcceeeecc-------------------cccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCC
Confidence 46777778888888776644 455689999999876554 447899999999999 57999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+.++.+...+.+-.||||++ |.+|++++. --++.|+..++..++.|++.-++++|++. +|.|||||+|+||..-
T Consensus 87 P~vYYFGqeG~~NiLVidLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp 160 (449)
T KOG1165|consen 87 PQVYYFGQEGKYNILVIDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRP 160 (449)
T ss_pred Cceeeeccccchhhhhhhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCC
Confidence 99999999999999999998 889999772 24567999999999999999999999999 9999999999999754
Q ss_pred CC-----eeEccccccccccCCCcccc-----ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MN-----PKISDFGMARIFSGNQNEAN-----TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~-----~kl~DFG~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++ +.|+|||+|+.+.+++.... .....||..||+-.-.++...|.++|+-|||-+|
T Consensus 161 ~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvF 226 (449)
T KOG1165|consen 161 GTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVF 226 (449)
T ss_pred CCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhh
Confidence 43 89999999999987765432 3456899999999999999999999999999775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=194.33 Aligned_cols=190 Identities=19% Similarity=0.248 Sum_probs=153.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecC-CeeeEEEEeecCCcccHHHHHHHHHHHHcCCC----
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILAD-GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH---- 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~-~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h---- 313 (452)
+|.+.+-+|+|++|.|+.+. +..+ .+.+|+|............+..|..++..++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~-------------------~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~ 79 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVS-------------------DKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGP 79 (322)
T ss_pred ceEEeeeccccCCceEEEEE-------------------ecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCC
Confidence 89999999999998887553 2233 46789998776544433478899999999973
Q ss_pred CCccceeeeE-ecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 314 KNLVRLLGCC-LDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 ~~iv~l~~~~-~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
++++.+++.+ ..+...++||+.+ |.+|.++..... .+.++..++..|+.|++.+|++||+.| ++||||||+|++
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~ 154 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFV 154 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHee
Confidence 6899999999 5778899999988 889999775433 578999999999999999999999999 999999999999
Q ss_pred ECCC-----CCeeEccccccc--cccCCCcc----c-c-ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHE-----MNPKISDFGMAR--IFSGNQNE----A-N-TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~-----~~~kl~DFG~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+... ..++|+|||+++ .+...... . . ...+.||..|++++...+...++++|+||++.++
T Consensus 155 ~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l 227 (322)
T KOG1164|consen 155 VGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYML 227 (322)
T ss_pred ecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHH
Confidence 9865 359999999999 43222211 1 1 2235699999999999999999999999988654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-22 Score=177.19 Aligned_cols=177 Identities=17% Similarity=0.253 Sum_probs=139.6
Q ss_pred CCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCccceeee-EecCCeEEEEEEecCCCC
Q 012989 263 SPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGC-CLDGNELLLIYEYMPNKS 340 (452)
Q Consensus 263 ~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~-~~~~~~~~lv~E~~~~~~ 340 (452)
..+++|.+|.+.++++..++..+++|.+.+.. ....+|.+|..---.| .|.||+.-|++ |++.+.+++++||++.|+
T Consensus 30 k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gd 108 (378)
T KOG1345|consen 30 KQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGD 108 (378)
T ss_pred HHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccch
Confidence 34566777888888999999999999987653 2346788888776666 48899988875 778889999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC-C-CCCeeEccccccccccCCCcccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-H-EMNPKISDFGMARIFSGNQNEAN 418 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~-~~~~kl~DFG~a~~~~~~~~~~~ 418 (452)
|..-+ ....+.+.-.+.++.|+++||+|+|+++ +||||||.+||||- . .-++||+|||+.+..+..-
T Consensus 109 L~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV---- 177 (378)
T KOG1345|consen 109 LRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV---- 177 (378)
T ss_pred hhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCcee----
Confidence 98766 2345888889999999999999999999 99999999999983 2 2469999999987643221
Q ss_pred ccccccccccccccccc---cCC--CceeeeeeeeeeeC
Q 012989 419 TNRVVGTYGYMAPEYAM---EGV--FSVNRMFLVSEFFF 452 (452)
Q Consensus 419 ~~~~~gt~~y~aPE~~~---~~~--~s~~~DvwSlG~il 452 (452)
...--+..|.+||+.. ++. ..+.+|+|.||+||
T Consensus 178 -~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 178 -KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred -hhhhhhcccCCcHHHhhccccceEecccccchheeeee
Confidence 2222367899999763 233 46779999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=175.23 Aligned_cols=165 Identities=11% Similarity=0.211 Sum_probs=122.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccH---HH------HHHHHHHH
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGL---QE------FKNEVTLI 308 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~---~~------~~~E~~~l 308 (452)
-||...+.++.|++|.|+ .... ++..+|||.+........ +. +.+|+..+
T Consensus 31 ~~y~~~~~l~~~~f~~v~-------------------l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l 89 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVS-------------------LIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQT 89 (232)
T ss_pred CceEEEEEecCCCceEEE-------------------EEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHH
Confidence 456666666666665554 3222 466899999975532222 22 67899999
Q ss_pred HcCCCCCccceeeeEecC--------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 309 AKLQHKNLVRLLGCCLDG--------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 309 ~~l~h~~iv~l~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
.+++|++|+.+.+++... ...+|||||++|.+|.++. .+++ ....+++.+|..+|+.|
T Consensus 90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g--- 155 (232)
T PRK10359 90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG--- 155 (232)
T ss_pred HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---
Confidence 999999999999886643 3589999999999997763 1232 24569999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||||||+||++++++ ++|+|||.......... ...+.+...+..+.|+||||+.|
T Consensus 156 i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~ 212 (232)
T PRK10359 156 MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYL 212 (232)
T ss_pred CccCCCChHHEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEee
Confidence 99999999999999988 99999998865422111 01144566677899999999975
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-21 Score=155.28 Aligned_cols=91 Identities=40% Similarity=0.693 Sum_probs=75.3
Q ss_pred ChhhhHHHHHHHHHHHHHHhhcc-CCceeeeeecccCCccEEEEEEeecCCChhhhhHHHHhccccCcccCCCccccEEE
Q 012989 154 PGRLFDQLVWNLMNEAVNQALST-TKMFTTVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPLDGCCSIKIGGRVR 232 (452)
Q Consensus 154 ~~~~f~~~~~~l~~~l~~~a~~~-~~~~~~~~~~~~~~~~vyglaQC~~Dls~~~C~~Cl~~~~~~~~~~~~~~~g~~i~ 232 (452)
++..|++++++||..|+..|+.+ +.+|++++. ..+.++||||+||++||++++|+.||+.++.+++.+|+.+.|++|+
T Consensus 15 ~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~ 93 (106)
T PF01657_consen 15 DNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVW 93 (106)
T ss_dssp TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEE
T ss_pred CCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEE
Confidence 45569999999999999998865 578999886 4578899999999999999999999999999999999999999999
Q ss_pred ccccCccccceee
Q 012989 233 YPSCNFRYELYQF 245 (452)
Q Consensus 233 ~~~c~~ry~~~~f 245 (452)
+++|++|||.++|
T Consensus 94 ~~~C~lRY~~~~F 106 (106)
T PF01657_consen 94 YDSCFLRYENYPF 106 (106)
T ss_dssp ESSEEEEEESS--
T ss_pred CCCEEEEEECCCC
Confidence 9999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-22 Score=214.12 Aligned_cols=137 Identities=15% Similarity=0.156 Sum_probs=103.8
Q ss_pred cCCC-CCccceeeeEe-------cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 310 KLQH-KNLVRLLGCCL-------DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 310 ~l~h-~~iv~l~~~~~-------~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
.++| +||++++++|. ....++++||++ +.+|.+++.. ....+++.+++.|++||++||.|||++| |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4445 57888888772 334577888987 5599999843 2456999999999999999999999999 9
Q ss_pred EecCCCCCCeEECC-------------------CCCeeEccccccccccCCCc--------------ccccccccccccc
Q 012989 382 IHRDLKTSNVLLDH-------------------EMNPKISDFGMARIFSGNQN--------------EANTNRVVGTYGY 428 (452)
Q Consensus 382 vH~Dlkp~NIll~~-------------------~~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y 428 (452)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566777777654221000 0001124689999
Q ss_pred ccccccccCCCceeeeeeeeeeeC
Q 012989 429 MAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 429 ~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||++.+..++.++|||||||||
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL 205 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLL 205 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHH
Confidence 999999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-20 Score=165.57 Aligned_cols=135 Identities=16% Similarity=0.127 Sum_probs=98.6
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCcc--c-------H-----------------HHHHHHHHHHHcCCCCCcccee
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSGQ--G-------L-----------------QEFKNEVTLIAKLQHKNLVRLL 320 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~~iv~l~ 320 (452)
.|+.+.|+..... +|++||||+++..... . . .....|++++.++.++++....
T Consensus 7 ~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~ 85 (190)
T cd05147 7 TGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPE 85 (190)
T ss_pred cccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCc
Confidence 3334444444443 8999999999754211 1 1 1234599999999887764433
Q ss_pred eeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 321 GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYL-HEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 321 ~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~L-H~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
.... . ..+|||||++|+++..... ....+++.++..++.|++.+|.++ |+.| |+||||||+|||++ ++.+
T Consensus 86 ~~~~-~-~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 86 PILL-K-SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred EEEe-c-CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 3222 2 2389999999977754431 235689999999999999999999 7888 99999999999998 4789
Q ss_pred eEcccccccccc
Q 012989 400 KISDFGMARIFS 411 (452)
Q Consensus 400 kl~DFG~a~~~~ 411 (452)
+|+|||++....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-21 Score=179.96 Aligned_cols=197 Identities=18% Similarity=0.278 Sum_probs=156.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
|+.......+|.||.++.+..... ....+.+.|-+|.++.. ++-....++.|..++..+.|||+.
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eE--------------dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREE--------------DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred heechhhhhcCchhheeeeeeccc--------------CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 345556667777777776543210 11234566778877654 555567789999999999999999
Q ss_pred ceeeeEecC-CeEEEEEEecCCCChhhhhc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 318 RLLGCCLDG-NELLLIYEYMPNKSLDLFLF-----DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 318 ~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~-----~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
++.++..+. ...++++.+..-++|..++. +....+.++..+...++.|++.|++|||+++ +||.||-..|.
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNC 427 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNC 427 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcc
Confidence 999987654 56888899999999999997 5555667888899999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|++.-.+||+|=.+++.+-+.+.+.-....-.+..||+||.+.+..|+..+|+||||++|
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 9999999999999999876655444322222337899999999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=159.45 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=101.3
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCcc---------------------c-----HHHHHHHHHHHHcCCCCCcccee
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSGQ---------------------G-----LQEFKNEVTLIAKLQHKNLVRLL 320 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~~iv~l~ 320 (452)
.|+.+.|+..... +|+.||||++...... . ...+..|...+.++.|+++....
T Consensus 7 ~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 85 (190)
T cd05145 7 TGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPE 85 (190)
T ss_pred cCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCce
Confidence 3444455454444 8999999998765211 0 12346789999999999875444
Q ss_pred eeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCCCe
Q 012989 321 GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 321 ~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
.+... ..+|||||++|+++..... ....++..++..++.|++.+|.++|+ .| |+||||||+|||++ ++.+
T Consensus 86 ~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 86 PILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred EEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCE
Confidence 43333 2489999999875543321 22457888999999999999999999 88 99999999999998 8899
Q ss_pred eEccccccccccC
Q 012989 400 KISDFGMARIFSG 412 (452)
Q Consensus 400 kl~DFG~a~~~~~ 412 (452)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-19 Score=172.10 Aligned_cols=187 Identities=29% Similarity=0.443 Sum_probs=149.9
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc---cHHHHHHHHHHHHcCCCC-C
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ---GLQEFKNEVTLIAKLQHK-N 315 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~h~-~ 315 (452)
|+....++.|.++.++.+. .. ..+++|.+...... ....+.+|+.+++.+.|+ +
T Consensus 2 ~~~~~~l~~g~~~~v~~~~-------------------~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 59 (384)
T COG0515 2 YRILRKLGEGSFGEVYLAR-------------------DR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59 (384)
T ss_pred ceeEEeecCCCCeEEEEEE-------------------ec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcc
Confidence 5555666666665555442 22 78899998766332 367799999999999988 7
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
++++++.+......++++|++.++++.+++........++......++.|++.++.++|+.+ ++||||||+||+++.
T Consensus 60 i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~ 136 (384)
T COG0515 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDR 136 (384)
T ss_pred eeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecC
Confidence 99999999888888999999999999966632211136899999999999999999999999 999999999999999
Q ss_pred CC-CeeEccccccccccCCCccc----ccccccccccccccccccc---CCCceeeeeeeeeee
Q 012989 396 EM-NPKISDFGMARIFSGNQNEA----NTNRVVGTYGYMAPEYAME---GVFSVNRMFLVSEFF 451 (452)
Q Consensus 396 ~~-~~kl~DFG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~i 451 (452)
.+ .++++|||.++.+....... ......||..|++||.+.+ ...+...|+||+|++
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~ 200 (384)
T COG0515 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200 (384)
T ss_pred CCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHH
Confidence 98 69999999998655443221 2355689999999999987 578999999999954
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=156.45 Aligned_cols=139 Identities=17% Similarity=0.260 Sum_probs=104.3
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-----CCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-----QHK 314 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~ 314 (452)
......+|.|+++.||. +..++.. +||++........+.+.+|+.+++.+ .||
T Consensus 4 L~~~~~LG~G~~~~Vy~---------------------hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~ 61 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA---------------------HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWS 61 (210)
T ss_pred cCCcceecCCCceEEEE---------------------CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCc
Confidence 34455677777766653 1224444 69988765455567899999999999 579
Q ss_pred CccceeeeEecCC---e-EEEEEEe--cCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCC
Q 012989 315 NLVRLLGCCLDGN---E-LLLIYEY--MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGL-LYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 315 ~iv~l~~~~~~~~---~-~~lv~E~--~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL-~~LH~~g~~~ivH~Dlk 387 (452)
||++++++++++. . +.+|||| .++++|.+++.. ..+++. ..++.|++.++ +|||+++ |+|||||
T Consensus 62 nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlK 132 (210)
T PRK10345 62 GIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELK 132 (210)
T ss_pred ccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCC
Confidence 9999999999874 4 4478999 557999999933 236555 35678888888 9999999 9999999
Q ss_pred CCCeEECCC----CCeeEcc-cccccc
Q 012989 388 TSNVLLDHE----MNPKISD-FGMARI 409 (452)
Q Consensus 388 p~NIll~~~----~~~kl~D-FG~a~~ 409 (452)
|+|||++.. ..++|+| ||....
T Consensus 133 p~NILl~~~~~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 133 PQNILCQRISESEVIPVVCDNIGESTF 159 (210)
T ss_pred HHHEEEeccCCCCCcEEEEECCCCcce
Confidence 999999743 3799999 554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-18 Score=178.36 Aligned_cols=180 Identities=22% Similarity=0.299 Sum_probs=140.3
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeec----C-Ccc-cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCC
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSR----S-SGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~----~-~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~ 339 (452)
+.+.++.+.........+..+.|.... . ... ....+..|..+-..|.|+|++..+....+.....-+|||+++
T Consensus 327 g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~- 405 (601)
T KOG0590|consen 327 GSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY- 405 (601)
T ss_pred eecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-
Confidence 445555455555555555555554321 1 111 112256677777888999998888887777666666999999
Q ss_pred ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcc--c
Q 012989 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--A 417 (452)
Q Consensus 340 ~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~ 417 (452)
+|..++. ....+...++-.+++||+.|++|+|+.| |.||||||+|++++.++.+||+|||.+..+...... .
T Consensus 406 Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 406 DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 9988873 3356888999999999999999999999 999999999999999999999999999887665544 4
Q ss_pred cccccccccccccccccccCCCcee-eeeeeeeeeC
Q 012989 418 NTNRVVGTYGYMAPEYAMEGVFSVN-RMFLVSEFFF 452 (452)
Q Consensus 418 ~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwSlG~il 452 (452)
.....+|+..|+|||.+.+..|++. .||||.|+|+
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~ 515 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIY 515 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceE
Confidence 5566799999999999999999877 9999999985
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=151.74 Aligned_cols=147 Identities=15% Similarity=0.149 Sum_probs=107.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEE-EecCCeeeEEEEeecCCcc-------------------
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQG-ILADGKEIAVKRLSRSSGQ------------------- 296 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~-~~~~~~~vAiK~~~~~~~~------------------- 296 (452)
..-|++.+.++.|++|.|+.+ . +..+|+.||||++......
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a-------------------~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHA-------------------LDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKI 87 (237)
T ss_pred CchHHhCCeeccCcceeEEEE-------------------EecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCC
Confidence 334566666777777665544 3 3468999999998754210
Q ss_pred -----cHHHHHHHHHHHHcCCCC--CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 012989 297 -----GLQEFKNEVTLIAKLQHK--NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARG 369 (452)
Q Consensus 297 -----~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~a 369 (452)
....+..|+.+++++.+. .++++++. ...++||||++|.+|..... ....+...++..++.||+.+
T Consensus 88 ~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~ 160 (237)
T smart00090 88 NPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEE 160 (237)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHH
Confidence 012356899999999753 34444442 23589999999988866541 22346667788999999999
Q ss_pred HHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccC
Q 012989 370 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 412 (452)
Q Consensus 370 L~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 412 (452)
|.+||++| +|+||||||+||+++ ++.++|+|||.+.....
T Consensus 161 l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 161 MRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred HHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999886 499999999999999 88999999999886543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=141.48 Aligned_cols=137 Identities=19% Similarity=0.183 Sum_probs=100.9
Q ss_pred CCeeeEEEEeecCCcc----cHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCC
Q 012989 281 DGKEIAVKRLSRSSGQ----GLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLD 355 (452)
Q Consensus 281 ~~~~vAiK~~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~ 355 (452)
.+++++.+.+...... ....+.+|+++|++|+ |+++++++++ +..+++|||+.|.+|...+ ..
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~---~~----- 91 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRP---PR----- 91 (218)
T ss_pred CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhh---hh-----
Confidence 6788887777544221 1225889999999995 5889999886 4469999999999886533 11
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeEECCCCCeeEccccccccccCCCcc----c--c-----ccccc
Q 012989 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDL-KTSNVLLDHEMNPKISDFGMARIFSGNQNE----A--N-----TNRVV 423 (452)
Q Consensus 356 ~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~a~~~~~~~~~----~--~-----~~~~~ 423 (452)
....++.|++.+|+++|++| |+|||| ||+|||++.++.++|+|||++........- . . .....
T Consensus 92 --~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~ 166 (218)
T PRK12274 92 --GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRM 166 (218)
T ss_pred --hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHh
Confidence 12357889999999999999 999999 799999999999999999999865433210 0 0 01123
Q ss_pred ccccccccccc
Q 012989 424 GTYGYMAPEYA 434 (452)
Q Consensus 424 gt~~y~aPE~~ 434 (452)
.++.|+.|+..
T Consensus 167 y~~~~l~~~~~ 177 (218)
T PRK12274 167 YCPAALTPVER 177 (218)
T ss_pred cCCCCCCHHHH
Confidence 57788888754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-17 Score=146.86 Aligned_cols=94 Identities=21% Similarity=0.158 Sum_probs=80.8
Q ss_pred CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccc
Q 012989 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 418 (452)
Q Consensus 339 ~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 418 (452)
|+|.+++.. .+..+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 578888843 2456999999999999999999999875 999999999999999 99987654321
Q ss_pred ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 419 TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 419 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..||+.|+|||++.+..++.++|||||||+|
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il 94 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITL 94 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHH
Confidence 2579999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.3e-16 Score=140.96 Aligned_cols=129 Identities=19% Similarity=0.301 Sum_probs=102.7
Q ss_pred CCCccEEEEEEecCCeeeEEEEeecCCcc--------cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCC
Q 012989 268 TSSKEICVQGILADGKEIAVKRLSRSSGQ--------GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339 (452)
Q Consensus 268 ~~~~~v~~~~~~~~~~~vAiK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~ 339 (452)
|..+.|+.... ++..+++|+....... ...++.+|+.++..++|++++....++......+++|||++|+
T Consensus 7 G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~ 84 (211)
T PRK14879 7 GAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGE 84 (211)
T ss_pred CceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCc
Confidence 33444443332 6788999986543211 1245788999999999999887777777778889999999999
Q ss_pred ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 340 ~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+|.+++... .. +...++.+++.+|.++|+.+ ++|+|++|+|||++ ++.++|+|||.+..
T Consensus 85 ~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 85 PLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999887321 12 78899999999999999999 99999999999999 78899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-16 Score=142.71 Aligned_cols=117 Identities=21% Similarity=0.299 Sum_probs=93.3
Q ss_pred cCCeeeEEEEeecCCc--------ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCC
Q 012989 280 ADGKEIAVKRLSRSSG--------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKG 351 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~ 351 (452)
.++..+++|....... ....++.+|+++++.++|+++....-++...+..++||||++|++|.+.+...
T Consensus 15 ~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~--- 91 (199)
T TIGR03724 15 FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEG--- 91 (199)
T ss_pred cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhc---
Confidence 4678899998654321 11356778999999999887655555555666789999999999998876321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccc
Q 012989 352 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 352 ~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 410 (452)
. ..++.|++.+|.+||+.+ ++|+|+||+||+++ ++.++++|||+++..
T Consensus 92 ~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 92 N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 1 078999999999999999 99999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.5e-18 Score=167.13 Aligned_cols=158 Identities=25% Similarity=0.259 Sum_probs=133.3
Q ss_pred cCCeeeEEEEeecCCc--ccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCH
Q 012989 280 ADGKEIAVKRLSRSSG--QGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDW 356 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~ 356 (452)
..+.-+|+|.+++... ........|..++...+ ||.+++++..++.+...++++++..|+.|...+ .+...+++
T Consensus 20 da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l---~~~~~f~~ 96 (612)
T KOG0603|consen 20 DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL---SKEVMFDE 96 (612)
T ss_pred cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc---ccCCchHH
Confidence 3567788888776521 12225667888999996 999999999999999999999999999887666 45566888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc
Q 012989 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436 (452)
Q Consensus 357 ~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 436 (452)
.....+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-..+. .+||..|||||++.
T Consensus 97 ~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~- 166 (612)
T KOG0603|consen 97 LDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN- 166 (612)
T ss_pred HHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh-
Confidence 889999999999999999999 99999999999999999999999999987544332 28999999999997
Q ss_pred CCCceeeeeeeeeee
Q 012989 437 GVFSVNRMFLVSEFF 451 (452)
Q Consensus 437 ~~~s~~~DvwSlG~i 451 (452)
......|.||||++
T Consensus 167 -gh~~a~D~ws~gvl 180 (612)
T KOG0603|consen 167 -GHLSAADWWSFGVL 180 (612)
T ss_pred -ccCCcccchhhhhh
Confidence 45778999999986
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-16 Score=169.32 Aligned_cols=175 Identities=18% Similarity=0.134 Sum_probs=134.4
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC---CCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
+.|+++.|++..... |+.||||+-+..+..+..- =.+++.+|+ -+-|..+...+...+.-+||+||.+.|+|-
T Consensus 707 G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtll 782 (974)
T KOG1166|consen 707 GEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLL 782 (974)
T ss_pred ccccceEEEEeecCC-CcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHH
Confidence 344455555555555 9999999987765543211 112333333 345677777777788889999999999999
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC-------CCeeEccccccccccCCCc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-------MNPKISDFGMARIFSGNQN 415 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-------~~~kl~DFG~a~~~~~~~~ 415 (452)
+++ ...+..++..+..++.|++..+++||..+ |||+||||+|.||... ..++|||||.+-....-..
T Consensus 783 d~~---N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~ 856 (974)
T KOG1166|consen 783 DLI---NTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPD 856 (974)
T ss_pred Hhh---ccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCC
Confidence 999 36677999999999999999999999999 9999999999999532 3499999999865543344
Q ss_pred cccccccccccccccccccccCCCceeeeeeeeee
Q 012989 416 EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEF 450 (452)
Q Consensus 416 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 450 (452)
.......++|-.+-.+|+..|.+|++..|.|.++-
T Consensus 857 ~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa 891 (974)
T KOG1166|consen 857 GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAA 891 (974)
T ss_pred CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHH
Confidence 44556678899999999999999999999987653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.1e-16 Score=161.02 Aligned_cols=98 Identities=20% Similarity=0.331 Sum_probs=87.3
Q ss_pred HHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 012989 298 LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDS 377 (452)
Q Consensus 298 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g 377 (452)
.+++.+|+++++.++|++++....+.......++||||++|++|.+++. ....++.|++++|.+||+.+
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g 448 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG 448 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC
Confidence 3568899999999999999888777777778899999999999988772 45678999999999999999
Q ss_pred CCCeEecCCCCCCeEECCCCCeeEccccccccc
Q 012989 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 410 (452)
++||||||+|||+ .++.++|+|||+++..
T Consensus 449 ---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 449 ---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999 6788999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-15 Score=134.57 Aligned_cols=131 Identities=16% Similarity=0.200 Sum_probs=96.2
Q ss_pred CCCCCCccEEEEEEecCCeeeEEEEeecCCcc----------------------cHHHHHHHHHHHHcCCCC--Ccccee
Q 012989 265 GSVTSSKEICVQGILADGKEIAVKRLSRSSGQ----------------------GLQEFKNEVTLIAKLQHK--NLVRLL 320 (452)
Q Consensus 265 ~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~--~iv~l~ 320 (452)
.+.+..+.|+.. ...+|+.||||++...... .......|+.++..+.|+ .+++.+
T Consensus 23 i~~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~ 101 (198)
T cd05144 23 IGVGKESDVYLA-LDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPI 101 (198)
T ss_pred cccCcceEEEEE-EcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCcee
Confidence 334444444433 3357999999987643210 112367789999999777 445444
Q ss_pred eeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCee
Q 012989 321 GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400 (452)
Q Consensus 321 ~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~k 400 (452)
+ ....++||||++|++|..+.. ......++.+++.++.++|+.+ |+|+||||+||+++.++.++
T Consensus 102 ~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 102 D----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred e----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEE
Confidence 3 245589999999998876541 0345678899999999999998 99999999999999999999
Q ss_pred EccccccccccC
Q 012989 401 ISDFGMARIFSG 412 (452)
Q Consensus 401 l~DFG~a~~~~~ 412 (452)
|+|||++.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=134.68 Aligned_cols=120 Identities=22% Similarity=0.284 Sum_probs=92.1
Q ss_pred CCeeeEEEEeecCC-------------cccHHHHHHHHHHHHcCCCCCc--cceeeeEecCC----eEEEEEEecCC-CC
Q 012989 281 DGKEIAVKRLSRSS-------------GQGLQEFKNEVTLIAKLQHKNL--VRLLGCCLDGN----ELLLIYEYMPN-KS 340 (452)
Q Consensus 281 ~~~~vAiK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~----~~~lv~E~~~~-~~ 340 (452)
++..++||.+.... .....++.+|++++..|+|++| +..++...... ..++|||+++| .+
T Consensus 54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~ 133 (239)
T PRK01723 54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARD 133 (239)
T ss_pred CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCC
Confidence 47788998875421 1233568889999999998875 66666644322 23599999997 68
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccccc
Q 012989 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 411 (452)
Q Consensus 341 L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 411 (452)
|.+++.. ..++.. .+.||+.+|.+||++| |+|+||||+|||++.++.++|+|||.+....
T Consensus 134 L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 134 LVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred HHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence 8887732 235543 3578999999999999 9999999999999999999999999987643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-16 Score=155.35 Aligned_cols=119 Identities=25% Similarity=0.382 Sum_probs=105.5
Q ss_pred eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccc
Q 012989 328 ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 407 (452)
Q Consensus 328 ~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 407 (452)
+++|.|+++.-.+|.+++.........++...+.++.|+..+++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 589999999999999999766677778899999999999999999 66 999999999999999999999999998
Q ss_pred ccccCCC----ccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 408 RIFSGNQ----NEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 408 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
....... .........||..||+||.+.+..|+.|+||||||+||
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil 452 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLIL 452 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHH
Confidence 7665444 22344567899999999999999999999999999986
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=5e-14 Score=120.81 Aligned_cols=116 Identities=21% Similarity=0.236 Sum_probs=97.6
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCC--CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHH
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH--KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRR 359 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~ 359 (452)
+..+++|....... ...+.+|+.+++.++| .++++++.....++..+++|||+++..+..+ +....
T Consensus 21 ~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~ 88 (155)
T cd05120 21 DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEK 88 (155)
T ss_pred CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHH
Confidence 37899998865533 4678999999999976 5899999988888899999999998766532 55677
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 360 ISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 360 ~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
..++.+++++|..+|.....+++|+|+||+||+++..+.++++|||.++.
T Consensus 89 ~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 89 EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 78899999999999986334499999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-14 Score=126.41 Aligned_cols=132 Identities=18% Similarity=0.218 Sum_probs=88.0
Q ss_pred CCCCccEEEEEEecCCeeeEEEEeecCCcc--cHHH----------------------HHHHHHHHHcCCCCC--cccee
Q 012989 267 VTSSKEICVQGILADGKEIAVKRLSRSSGQ--GLQE----------------------FKNEVTLIAKLQHKN--LVRLL 320 (452)
Q Consensus 267 ~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~~--iv~l~ 320 (452)
.+.++.|+.... .++++||||++...... .... ...|...+..+.+.. +++.+
T Consensus 7 ~G~~g~Vy~a~~-~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~ 85 (187)
T cd05119 7 TGKEADVYLALD-GDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPI 85 (187)
T ss_pred cccceeEEEEEC-CCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceE
Confidence 333444444433 37899999988754211 1111 135666666664432 44444
Q ss_pred eeEecCCeEEEEEEecCCCChhhh-hccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCCC
Q 012989 321 GCCLDGNELLLIYEYMPNKSLDLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 321 ~~~~~~~~~~lv~E~~~~~~L~~~-l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+. ...++||||++++.+... +.. .... .++..++.|++.++.++|+ .+ |+|+||||+||+++ ++.
T Consensus 86 ~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 86 DL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred ec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCc
Confidence 43 246899999999543211 110 0011 6678899999999999999 88 99999999999999 899
Q ss_pred eeEccccccccccC
Q 012989 399 PKISDFGMARIFSG 412 (452)
Q Consensus 399 ~kl~DFG~a~~~~~ 412 (452)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.9e-15 Score=156.92 Aligned_cols=164 Identities=18% Similarity=0.208 Sum_probs=121.5
Q ss_pred CCeeeEEEEeecCC-cccHHHHHHHHHH--HHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHH
Q 012989 281 DGKEIAVKRLSRSS-GQGLQEFKNEVTL--IAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWK 357 (452)
Q Consensus 281 ~~~~vAiK~~~~~~-~~~~~~~~~E~~~--l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~ 357 (452)
+|. |+||++.+.. .-....+.++++- ....+|||.+++..+.+.+...|||-+|... +|.+.+ ..+..+...
T Consensus 46 eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRl---STRPFL~~i 120 (1431)
T KOG1240|consen 46 EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRL---STRPFLVLI 120 (1431)
T ss_pred Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhh---ccchHHHHH
Confidence 444 8999987664 3333444443333 4455899999999998888889999999865 777766 445567888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccccc-CCCcccccccccc----cccccccc
Q 012989 358 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS-GNQNEANTNRVVG----TYGYMAPE 432 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~-~~~~~~~~~~~~g----t~~y~aPE 432 (452)
+-+.|+.||+.||..+|+.| |+|+|||.+||||+....+.|+||..-+..- ..+......-++- -..|.|||
T Consensus 121 EKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPE 197 (1431)
T KOG1240|consen 121 EKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPE 197 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChH
Confidence 88999999999999999999 9999999999999999999999998765421 1111111112222 34799999
Q ss_pred cccc----------CC-CceeeeeeeeeeeC
Q 012989 433 YAME----------GV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 433 ~~~~----------~~-~s~~~DvwSlG~il 452 (452)
.+.. .. .+++-||||+||++
T Consensus 198 RFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 198 RFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred hhhccccccccCCcccccChhhhhhhhhHHH
Confidence 8843 11 67889999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-14 Score=151.01 Aligned_cols=167 Identities=26% Similarity=0.297 Sum_probs=135.5
Q ss_pred CeeeEEEEeecCC--cccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHH
Q 012989 282 GKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKR 358 (452)
Q Consensus 282 ~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~ 358 (452)
...+|.|.+.... ....++...|..+-+.+. |+|++++++.....+..++++|+..|+++...+.. ......+...
T Consensus 46 ~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~ 124 (601)
T KOG0590|consen 46 ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSS 124 (601)
T ss_pred cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc-CCccCCCCcc
Confidence 4456666665442 333445566887777776 99999999999999999999999999999877631 1222566777
Q ss_pred HHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCeEECCCC-CeeEccccccccccC-CCcccccccccc-cccccccccc
Q 012989 359 RISIINGIARGLLYLH-EDSRLRVIHRDLKTSNVLLDHEM-NPKISDFGMARIFSG-NQNEANTNRVVG-TYGYMAPEYA 434 (452)
Q Consensus 359 ~~~i~~ql~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~ 434 (452)
...++.|+..++.|+| +.+ +.|+||||+|.+++..+ ..|+.|||++..+.. ..........+| ++.|+|||..
T Consensus 125 ~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 125 ASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred hhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence 8889999999999999 888 99999999999999999 999999999998877 445555566788 9999999999
Q ss_pred ccC-CCceeeeeeeeeeeC
Q 012989 435 MEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 435 ~~~-~~s~~~DvwSlG~il 452 (452)
.+. ...+..|+||.|++|
T Consensus 202 ~~~~~~~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 202 SGKAYRGPSVDVWSLGIVL 220 (601)
T ss_pred cchhhcCCCcccccccccc
Confidence 874 457779999999975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.4e-14 Score=131.34 Aligned_cols=231 Identities=21% Similarity=0.234 Sum_probs=142.8
Q ss_pred HhccccCcccCCCccccEEEccccCccccceeeecCccccccCCCCCCCCC--CCCCC------CC-------ccE-EEE
Q 012989 213 RLAISPLDGCCSIKIGGRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPS--PGSVT------SS-------KEI-CVQ 276 (452)
Q Consensus 213 ~~~~~~~~~~~~~~~g~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~--~~~~~------~~-------~~v-~~~ 276 (452)
+.+.+...+.++..+.-|+...-..-.||+.+|+|+|=...||.+...... ..+.+ ++ ++. ...
T Consensus 132 r~~~~~ks~~whDei~~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~ 211 (598)
T KOG4158|consen 132 RYNEDLKSTEWHDEIPNRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVS 211 (598)
T ss_pred HHHHhhhccCCCCcCcchhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCccc
Confidence 445555666666666666666556667999999999999899987754311 11100 11 111 011
Q ss_pred EEecCCeeeEEEEeecC-CcccHHHHH----HHH--------------HHHHcC--------CCCCccceeeeEec----
Q 012989 277 GILADGKEIAVKRLSRS-SGQGLQEFK----NEV--------------TLIAKL--------QHKNLVRLLGCCLD---- 325 (452)
Q Consensus 277 ~~~~~~~~vAiK~~~~~-~~~~~~~~~----~E~--------------~~l~~l--------~h~~iv~l~~~~~~---- 325 (452)
.-.....+.|||.+-.- .......++ +|. ...+.+ +|||||++...|.+
T Consensus 212 ~p~~~aFPLAiKmMfN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~ 291 (598)
T KOG4158|consen 212 KPAQKAFPLAIKMMFNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKV 291 (598)
T ss_pred CccccccchHHHHhcccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhcc
Confidence 11223346788865322 112222222 121 011111 59999999887753
Q ss_pred -----------------------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 326 -----------------------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 326 -----------------------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
+...|+||..++. +|..++.. ...+.....-|+.|+++|+.|||++| |.
T Consensus 292 lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~laQlLEav~hL~~hg---vA 363 (598)
T KOG4158|consen 292 LPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILAQLLEAVTHLHKHG---VA 363 (598)
T ss_pred CCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHHHHHHHHHHHHHcc---ch
Confidence 2347999998844 88888832 33566777889999999999999999 99
Q ss_pred ecCCCCCCeEEC--CC--CCeeEccccccccccC--CC-cccc-cccccccccccccccccc--CC----Cceeeeeeee
Q 012989 383 HRDLKTSNVLLD--HE--MNPKISDFGMARIFSG--NQ-NEAN-TNRVVGTYGYMAPEYAME--GV----FSVNRMFLVS 448 (452)
Q Consensus 383 H~Dlkp~NIll~--~~--~~~kl~DFG~a~~~~~--~~-~~~~-~~~~~gt~~y~aPE~~~~--~~----~s~~~DvwSl 448 (452)
|||+|.+|||+. ++ ..+.|+|||++-.-.. -. +... .-..-|...-||||+... ++ --.|+|.|+.
T Consensus 364 hRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~ 443 (598)
T KOG4158|consen 364 HRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAA 443 (598)
T ss_pred hhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhh
Confidence 999999999983 33 3489999998632111 00 0000 112356778899999843 22 2347999998
Q ss_pred eee
Q 012989 449 EFF 451 (452)
Q Consensus 449 G~i 451 (452)
|-|
T Consensus 444 Gal 446 (598)
T KOG4158|consen 444 GAL 446 (598)
T ss_pred hhh
Confidence 854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.2e-14 Score=132.76 Aligned_cols=170 Identities=18% Similarity=0.178 Sum_probs=104.6
Q ss_pred EEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC----------CCccceeeeEe---------cC---C-
Q 012989 274 CVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH----------KNLVRLLGCCL---------DG---N- 327 (452)
Q Consensus 274 ~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~~iv~l~~~~~---------~~---~- 327 (452)
+...+..+++++|+|+.... .....+.+++|......+.+ -.++.-++... .. .
T Consensus 29 ~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~ 108 (288)
T PF14531_consen 29 FEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSI 108 (288)
T ss_dssp EEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEE
T ss_pred EEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCcc
Confidence 34466778999999987644 23356777777766665432 12222222222 11 1
Q ss_pred ----eEEEEEEecCCCChhhhhcc---C-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 328 ----ELLLIYEYMPNKSLDLFLFD---S-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 328 ----~~~lv~E~~~~~~L~~~l~~---~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
..+++|+-+ .++|..++.. . .....+.......+..|+++.+++||..| ++|+||||+|++++.+|.+
T Consensus 109 ~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v 184 (288)
T PF14531_consen 109 YWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGV 184 (288)
T ss_dssp EEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-E
T ss_pred ceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCE
Confidence 236788877 4477666521 1 11223344455667799999999999999 9999999999999999999
Q ss_pred eEccccccccccCCCcccccccccccccccccccccc--------CCCceeeeeeeeeeeC
Q 012989 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME--------GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 400 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwSlG~il 452 (452)
+|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++
T Consensus 185 ~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 185 FLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred EEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 99999987654332211 223678999998743 2478899999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.4e-14 Score=147.98 Aligned_cols=83 Identities=27% Similarity=0.417 Sum_probs=70.1
Q ss_pred HHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCC------------c-cccccccccccccccccc
Q 012989 367 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ------------N-EANTNRVVGTYGYMAPEY 433 (452)
Q Consensus 367 ~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~------------~-~~~~~~~~gt~~y~aPE~ 433 (452)
+.+++|||+.| |+|||+||+|.+|+.-|++|+.|||+++...... . .......+||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 77899999999 9999999999999999999999999987542111 0 111234589999999999
Q ss_pred cccCCCceeeeeeeeeeeC
Q 012989 434 AMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 434 ~~~~~~s~~~DvwSlG~il 452 (452)
+....|....|+|+||+||
T Consensus 230 ilrqgygkpvdwwamGiIl 248 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIIL 248 (1205)
T ss_pred hhhhccCCCccHHHHHHHH
Confidence 9999999999999999985
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.9e-14 Score=126.99 Aligned_cols=175 Identities=22% Similarity=0.328 Sum_probs=129.7
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhh
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
.+..+|+.|. -...|..++.|+++.. +......|.+|.-.|+-+.||||.++++.+..+.++.++..|++.++|..
T Consensus 199 ~e~hsgelwr--grwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 199 AESHSGELWR--GRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred ccCCCccccc--ccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 3444555543 2345667777887644 34445678999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec-CCCCCCeEECCCCCeeEccccccccccCCCcccccccc
Q 012989 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR-DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422 (452)
Q Consensus 344 ~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~-Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 422 (452)
.+++. .+-..+..++.+++.++++|+.|||+.. +++-| -|....++||++.+.+|.- +-.+. . ......
T Consensus 277 vlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kf-s-----fqe~gr 346 (448)
T KOG0195|consen 277 VLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-S-----FQEVGR 346 (448)
T ss_pred HHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-cccee-e-----eecccc
Confidence 99764 3455788899999999999999999875 34443 5888999999998877641 11111 0 001112
Q ss_pred ccccccccccccccCCCc---eeeeeeeeeeeC
Q 012989 423 VGTYGYMAPEYAMEGVFS---VNRMFLVSEFFF 452 (452)
Q Consensus 423 ~gt~~y~aPE~~~~~~~s---~~~DvwSlG~il 452 (452)
.-.|.||+||.+...+-+ ..+|+|||.++|
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaill 379 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILL 379 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHH
Confidence 237899999999765533 359999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.6e-13 Score=133.66 Aligned_cols=140 Identities=27% Similarity=0.477 Sum_probs=113.9
Q ss_pred HHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCC
Q 012989 308 IAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV-IHRDL 386 (452)
Q Consensus 308 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i-vH~Dl 386 (452)
|+.+.|.|+.++++.+..+...++|.+|+..|+|.+.+.. ....+++-....++++|+.||+|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578999999999999999999999999999999999954 4556889999999999999999999875 4 99999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC---C----CceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG---V----FSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~s~~~DvwSlG~il 452 (452)
+..|.++|....+||.|||+.................-..-|.|||++.+. . .+.+.|+||||+|+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 999999999999999999998765321111111111225679999999653 1 46779999999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.1e-12 Score=129.24 Aligned_cols=79 Identities=25% Similarity=0.306 Sum_probs=61.2
Q ss_pred CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccc
Q 012989 326 GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIAR-GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404 (452)
Q Consensus 326 ~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~-aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DF 404 (452)
....+|||||++|.+|.++..... ...+ ...++.+++. .+..+|+.| ++|+|+||.||+++.++.++|+||
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDf 301 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDF 301 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeC
Confidence 345799999999999988763211 1122 3446666665 478899998 999999999999999999999999
Q ss_pred cccccccC
Q 012989 405 GMARIFSG 412 (452)
Q Consensus 405 G~a~~~~~ 412 (452)
|++..+..
T Consensus 302 G~~~~l~~ 309 (437)
T TIGR01982 302 GIVGRLSE 309 (437)
T ss_pred CCeeECCH
Confidence 99987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-11 Score=108.89 Aligned_cols=97 Identities=15% Similarity=0.173 Sum_probs=75.1
Q ss_pred HHHHHHHcCCC--CCccceeeeEecCCeEEEEEEecCCCChhh-hhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCC
Q 012989 303 NEVTLIAKLQH--KNLVRLLGCCLDGNELLLIYEYMPNKSLDL-FLFDSTKGAQLDWKRRISIINGIARGLLYL-HEDSR 378 (452)
Q Consensus 303 ~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~L-H~~g~ 378 (452)
+|.+.|+++.. -++++++++ ...+|||||+.+..+.. .+ +...++..+...+..|++.+|..+ |+.|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g- 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN- 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence 89999999953 467777764 45689999997754421 12 112355566778889999999998 8888
Q ss_pred CCeEecCCCCCCeEECCCCCeeEcccccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 411 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 411 (452)
|||+||+|.|||++ ++.++|+|||.+....
T Consensus 146 --lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 --LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred --eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999996 4689999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.2e-11 Score=108.92 Aligned_cols=114 Identities=22% Similarity=0.144 Sum_probs=83.3
Q ss_pred CCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC-ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHH
Q 012989 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN-LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRR 359 (452)
Q Consensus 281 ~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~ 359 (452)
.++.+++|....... ....+..|+.+++.+.+.+ +++++.... ...++||||++|.++.... . ..
T Consensus 20 ~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~--------~---~~ 85 (170)
T cd05151 20 ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED--------F---SD 85 (170)
T ss_pred CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc--------c---cC
Confidence 478899998754422 2235678999999986544 445555433 3357999999998775420 1 11
Q ss_pred HHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 360 ISIINGIARGLLYLHEDS--RLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 360 ~~i~~ql~~aL~~LH~~g--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
..++.+++++|..||+.+ +..++|+|+||+||+++ ++.++++||+.+..
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 345689999999999987 22359999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-11 Score=125.28 Aligned_cols=77 Identities=16% Similarity=0.199 Sum_probs=55.0
Q ss_pred CCeEEEEEEecCCCChhhhhccCCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC----C
Q 012989 326 GNELLLIYEYMPNKSLDLFLFDSTKG---AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----N 398 (452)
Q Consensus 326 ~~~~~lv~E~~~~~~L~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~ 398 (452)
....+|||||++|+.+.++......+ ..+....+..++.|++ ..| ++|+|+||.||+++.++ .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCe
Confidence 34567999999999997643111111 1244444444555544 577 99999999999999988 8
Q ss_pred eeEccccccccccC
Q 012989 399 PKISDFGMARIFSG 412 (452)
Q Consensus 399 ~kl~DFG~a~~~~~ 412 (452)
++++|||++..+..
T Consensus 303 i~llDFGivg~l~~ 316 (537)
T PRK04750 303 YIALDFGIVGSLNK 316 (537)
T ss_pred EEEEecceEEECCH
Confidence 99999999977643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.6e-11 Score=118.98 Aligned_cols=177 Identities=20% Similarity=0.187 Sum_probs=133.5
Q ss_pred CCCccEEEEEE--ecCCeeeEEEEeec--CCcccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 268 TSSKEICVQGI--LADGKEIAVKRLSR--SSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 268 ~~~~~v~~~~~--~~~~~~vAiK~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
|..+.++...- ..++..+|+|+-+. ..+....+=.+|+.--+.+ .|++.++.+..++..+..++-+|++. .+|.
T Consensus 127 g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~ 205 (524)
T KOG0601|consen 127 GSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQ 205 (524)
T ss_pred CCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhH
Confidence 33444444343 56788899997332 2223333334566666666 59999999999999999999999985 6776
Q ss_pred hhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCeEECCC-CCeeEccccccccccCCCccc
Q 012989 343 LFLFDSTKGAQLDWKRRISIINGIAR----GLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEA 417 (452)
Q Consensus 343 ~~l~~~~~~~~l~~~~~~~i~~ql~~----aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~ 417 (452)
.+.+ .....++...++.+..+... ||.++|... ++|-|+||+||++..+ ...+++|||+...+....-..
T Consensus 206 ~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~ 280 (524)
T KOG0601|consen 206 SYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSS 280 (524)
T ss_pred Hhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCcccc
Confidence 6663 23445788899999999999 999999999 9999999999999999 889999999998877654222
Q ss_pred c---ccccccccccccccccccCCCceeeeeeeeeee
Q 012989 418 N---TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 418 ~---~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
. ..+..|...|++||... +.++..+|++|+|-+
T Consensus 281 ~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev 316 (524)
T KOG0601|consen 281 VFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEV 316 (524)
T ss_pred ceeeeecCCCCceEeChhhhc-cccchHhhhcchhhh
Confidence 1 12235678899999874 567889999999965
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-09 Score=98.60 Aligned_cols=127 Identities=19% Similarity=0.302 Sum_probs=96.2
Q ss_pred ecCCeeeEEEEeecCCc-ccHHHHHHHHHHHHcCCC--CCccceeeeEecCC---eEEEEEEecCCCChhhhhccCCCCC
Q 012989 279 LADGKEIAVKRLSRSSG-QGLQEFKNEVTLIAKLQH--KNLVRLLGCCLDGN---ELLLIYEYMPNKSLDLFLFDSTKGA 352 (452)
Q Consensus 279 ~~~~~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~---~~~lv~E~~~~~~L~~~l~~~~~~~ 352 (452)
..+|+.+++|....... .....+..|.++++.+++ ..+++++.+..... ..++|||+++|.++...+. ..
T Consensus 19 ~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~----~~ 94 (223)
T cd05154 19 AGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL----RP 94 (223)
T ss_pred ecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC----CC
Confidence 34468999998754422 235678999999999975 34677777766543 6789999999998876552 13
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------------CC
Q 012989 353 QLDWKRRISIINGIARGLLYLHEDS-----------------------------------------------------RL 379 (452)
Q Consensus 353 ~l~~~~~~~i~~ql~~aL~~LH~~g-----------------------------------------------------~~ 379 (452)
.++......++.++++.|..||+.. ..
T Consensus 95 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (223)
T cd05154 95 ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRP 174 (223)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCc
Confidence 4777788888889999998888531 24
Q ss_pred CeEecCCCCCCeEECC--CCCeeEcccccccc
Q 012989 380 RVIHRDLKTSNVLLDH--EMNPKISDFGMARI 409 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~ 409 (452)
.++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 5799999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.7e-10 Score=97.71 Aligned_cols=123 Identities=24% Similarity=0.313 Sum_probs=79.9
Q ss_pred EEEecCCeeeEEEEeecCC--------------c-------c-----cHHHHHHHHHHHHcCCCC--CccceeeeEecCC
Q 012989 276 QGILADGKEIAVKRLSRSS--------------G-------Q-----GLQEFKNEVTLIAKLQHK--NLVRLLGCCLDGN 327 (452)
Q Consensus 276 ~~~~~~~~~vAiK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~~ 327 (452)
.....+|..+|||+..... . . ......+|.+.|.++... ++++++++.
T Consensus 4 ~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~---- 79 (188)
T PF01163_consen 4 HAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN---- 79 (188)
T ss_dssp EEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----
T ss_pred EEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----
Confidence 3455678899999765320 0 0 123467899999999765 567777553
Q ss_pred eEEEEEEecC--CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCeEECCCCCeeEccc
Q 012989 328 ELLLIYEYMP--NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLY-LHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404 (452)
Q Consensus 328 ~~~lv~E~~~--~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~-LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DF 404 (452)
...|||||++ |..+..+. +. .++......++.+++..+.. +|+.| |+|+||.+.||+++.+ .+.||||
T Consensus 80 ~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp TTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--G
T ss_pred CCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 65554433 11 11134456777888885555 57888 9999999999999887 9999999
Q ss_pred ccccccc
Q 012989 405 GMARIFS 411 (452)
Q Consensus 405 G~a~~~~ 411 (452)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.5e-10 Score=95.12 Aligned_cols=98 Identities=23% Similarity=0.364 Sum_probs=78.5
Q ss_pred HHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 012989 298 LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDS 377 (452)
Q Consensus 298 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g 377 (452)
.++-.+|+.++.+++--.|..-.=+..+.....|+|||++|..|.+.+... ...+++.+-.-+.-||+.|
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g 112 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG 112 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC
Confidence 345678999999986555554444556666778999999999998888332 2567788888888999999
Q ss_pred CCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
|+|+||.++||++.... +.++|||++..
T Consensus 113 ---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 ---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999997665 99999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=100.80 Aligned_cols=127 Identities=18% Similarity=0.157 Sum_probs=92.9
Q ss_pred ecCCeeeEEEEeecCCcc-----------cHHHHHHHHHHHHcCCCCC--ccceeeeEec-----CCeEEEEEEecCCC-
Q 012989 279 LADGKEIAVKRLSRSSGQ-----------GLQEFKNEVTLIAKLQHKN--LVRLLGCCLD-----GNELLLIYEYMPNK- 339 (452)
Q Consensus 279 ~~~~~~vAiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~-----~~~~~lv~E~~~~~- 339 (452)
..+|+.+.||......-. ....+.+|...+.++...+ +++++.+.+. ....+||||++++.
T Consensus 42 ~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~ 121 (268)
T PRK15123 42 ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTI 121 (268)
T ss_pred EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCc
Confidence 456788999976433210 1113778999998885433 3444555543 23578999999986
Q ss_pred ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-------CCCeeEcccccccc
Q 012989 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-------EMNPKISDFGMARI 409 (452)
Q Consensus 340 ~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-------~~~~kl~DFG~a~~ 409 (452)
+|.+++.... ....+......++.+++..+..||+.| |+|+|+++.|||++. +..+.||||+.++.
T Consensus 122 sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 122 SLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 7888873221 234566778899999999999999999 999999999999975 46799999998864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.6e-09 Score=91.16 Aligned_cols=127 Identities=21% Similarity=0.293 Sum_probs=90.0
Q ss_pred ecCCeeeEEEEeecC--------CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCC-CChhhhhccCC
Q 012989 279 LADGKEIAVKRLSRS--------SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN-KSLDLFLFDST 349 (452)
Q Consensus 279 ~~~~~~vAiK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~-~~L~~~l~~~~ 349 (452)
...|+...||.=..+ ..-...+.++|+++|.++.--.|.--.=++.+...-.|+|||++| .++.+++...-
T Consensus 27 ~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~ 106 (229)
T KOG3087|consen 27 SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTM 106 (229)
T ss_pred ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHc
Confidence 346777777742211 112345678899999998654554444455566666799999988 56677664432
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC---eeEcccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN---PKISDFGMARI 409 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~ 409 (452)
... ........++++|-+.+.-||..+ |+|+||..+||++.+++. +.++|||++..
T Consensus 107 ~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 107 EDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 222 233333688999999999999999 999999999999977655 68999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-09 Score=110.73 Aligned_cols=160 Identities=19% Similarity=0.201 Sum_probs=118.6
Q ss_pred EecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHH
Q 012989 278 ILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWK 357 (452)
Q Consensus 278 ~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~ 357 (452)
...++.+|.|...+..+....+..++.++.|+.++||+|+++++.++.....|||+|.+. .|..++.. +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence 345788999999887766445668889999999999999999999999999999999874 45655522 3456
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC
Q 012989 358 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 437 (452)
.+...+.||+.||.+||..+ .++|++|.-+.|+++..|..||++|-++............ ..--..|..|+.+-..
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~--~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS--LYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc--chhhhcccChhhcCcc
Confidence 66777899999999998554 3999999999999999999999999887654322211111 1112235566654221
Q ss_pred CCceeeeeeeeeee
Q 012989 438 VFSVNRMFLVSEFF 451 (452)
Q Consensus 438 ~~s~~~DvwSlG~i 451 (452)
. -..|.|-|||+
T Consensus 181 ~--~s~D~~~Lg~l 192 (690)
T KOG1243|consen 181 E--WSIDSWGLGCL 192 (690)
T ss_pred c--cchhhhhHHHH
Confidence 1 34688888875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.7e-09 Score=100.58 Aligned_cols=141 Identities=23% Similarity=0.240 Sum_probs=106.9
Q ss_pred HHHcCCCCCccceeeeEecC-----CeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 307 LIAKLQHKNLVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 307 ~l~~l~h~~iv~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
-|-++-|.|||+++.+|.+. .+..++.||++.+++..++++.+ ....+......+|+.||+.||.|||+.. .+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 34455799999999998754 45889999999999999997644 3456888888999999999999999985 68
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccC---CCccccccccccccccccccccccCCCceeeeeeeee
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSG---NQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSE 449 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG 449 (452)
|+|+.+..+.|++.+++-+|+.- +....+.. ...........|-++|.+||.=.--..+.++|||+||
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 99999999999999999888742 11111100 0011122334567889999987666678889999998
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.1e-08 Score=89.34 Aligned_cols=124 Identities=24% Similarity=0.256 Sum_probs=92.1
Q ss_pred CCeeeEEEEeecC-C------cccHHHHHHHHHHHHcCCCC--CccceeeeEecC----CeEEEEEEecCC-CChhhhhc
Q 012989 281 DGKEIAVKRLSRS-S------GQGLQEFKNEVTLIAKLQHK--NLVRLLGCCLDG----NELLLIYEYMPN-KSLDLFLF 346 (452)
Q Consensus 281 ~~~~vAiK~~~~~-~------~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~----~~~~lv~E~~~~-~~L~~~l~ 346 (452)
.++.+-+|..... . .....+..+|...+..|... .+++.+++.+.. ...+||+|++++ .+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4556666643322 1 12345678888888888533 345566666543 246899999988 47888884
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC---CeeEccccccccc
Q 012989 347 DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISDFGMARIF 410 (452)
Q Consensus 347 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~ 410 (452)
.. ...+......++.+++..+.-||+.| |+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 111 ~~---~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QW---EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hh---cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 32 22667778899999999999999999 99999999999999887 7999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.2e-09 Score=105.04 Aligned_cols=160 Identities=19% Similarity=0.115 Sum_probs=119.6
Q ss_pred cCCeeeEEEEeecCCcccHHH--HHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCH
Q 012989 280 ADGKEIAVKRLSRSSGQGLQE--FKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDW 356 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~~~~~~--~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~ 356 (452)
.++..+++|.+.+.......+ -..|+.+...+ .|.+++.+...|...++.++--||++++++...+ .....+++
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~ 365 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS---VTSQMLDE 365 (524)
T ss_pred CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh---HHHHhcCc
Confidence 567788999876653222222 34567666666 5899999999998888888999999999887665 23345788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC-CCeeEccccccccccCCCccccccccccccccc--cccc
Q 012989 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYM--APEY 433 (452)
Q Consensus 357 ~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~--aPE~ 433 (452)
...+.+..|++.++.++|+.. ++|+|+||+||++.++ +..++.|||....+.-.. ....+.-++. +|+.
T Consensus 366 ~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~ 437 (524)
T KOG0601|consen 366 DPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEIL 437 (524)
T ss_pred chhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec-----ccccccccccccchhh
Confidence 889999999999999999998 9999999999999886 788999999886421111 1112233344 4555
Q ss_pred cccCCCceeeeeeeeee
Q 012989 434 AMEGVFSVNRMFLVSEF 450 (452)
Q Consensus 434 ~~~~~~s~~~DvwSlG~ 450 (452)
.....+-.+.|++|||.
T Consensus 438 ~e~~~~~~~~~~~sl~~ 454 (524)
T KOG0601|consen 438 LEDYPHLSKADIFSLGL 454 (524)
T ss_pred ccccccccccccccccc
Confidence 55667788999999984
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.4e-08 Score=96.04 Aligned_cols=139 Identities=22% Similarity=0.318 Sum_probs=108.7
Q ss_pred EEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEec----CCeEEEEEEecCC-CChhhhhcc
Q 012989 273 ICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD----GNELLLIYEYMPN-KSLDLFLFD 347 (452)
Q Consensus 273 v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~E~~~~-~~L~~~l~~ 347 (452)
.+..-...||..|.+|++.............-+++++++.|+|||++.++|.. +..+++|++|.++ ++|.++.+.
T Consensus 292 tyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~ 371 (655)
T KOG3741|consen 292 TYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFA 371 (655)
T ss_pred eEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHcc
Confidence 34455667899999999954433333334456788999999999999999883 4579999999987 556554433
Q ss_pred C------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCC
Q 012989 348 S------------TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 414 (452)
Q Consensus 348 ~------------~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 414 (452)
. ..+...++..+|.++.||..||.++|+.| +.-+-|.|.+|+++.+.+++|..-|....+..+.
T Consensus 372 ~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 372 NPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred CCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 2 23446789999999999999999999999 9899999999999999999998888776654443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.3e-07 Score=83.49 Aligned_cols=131 Identities=18% Similarity=0.225 Sum_probs=90.7
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecCC-----------------c-----ccHHHHHHHHHHHHcCCCC--Cccce
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRSS-----------------G-----QGLQEFKNEVTLIAKLQHK--NLVRL 319 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-----------------~-----~~~~~~~~E~~~l~~l~h~--~iv~l 319 (452)
..+.|.-+.|+. ....+|.++|||.=.... . -.+...++|.++|++|... .|++.
T Consensus 98 ~IGvGKEsdVY~-~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 98 KIGVGKESDVYV-AIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred ccccCccceEEE-EECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 445555555554 344578999999432110 0 0123457899999999755 67777
Q ss_pred eeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 320 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
+++ +...+|||+++|-.|...- ++....-.++..|+.-+..+-+.| |||+|+.+=||+++++|.+
T Consensus 177 ~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 177 IAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred ccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCE
Confidence 664 5568999999996664422 234445556666666666666777 9999999999999999999
Q ss_pred eEccccccccc
Q 012989 400 KISDFGMARIF 410 (452)
Q Consensus 400 kl~DFG~a~~~ 410 (452)
.++||-.+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999877643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.5e-07 Score=80.58 Aligned_cols=121 Identities=19% Similarity=0.242 Sum_probs=77.9
Q ss_pred EEEEEecCCeeeEEEEeecCCcccHHHH---------HHHHHHHHcCCCC---Cccceeee-----EecCCeEEEEEEec
Q 012989 274 CVQGILADGKEIAVKRLSRSSGQGLQEF---------KNEVTLIAKLQHK---NLVRLLGC-----CLDGNELLLIYEYM 336 (452)
Q Consensus 274 ~~~~~~~~~~~vAiK~~~~~~~~~~~~~---------~~E~~~l~~l~h~---~iv~l~~~-----~~~~~~~~lv~E~~ 336 (452)
++....-+|+.+.+|..........+.| .+++..+..++.. .+..++-+ +......+|+|||+
T Consensus 46 ~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYI 125 (229)
T PF06176_consen 46 YVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYI 125 (229)
T ss_pred EEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEe
Confidence 3556667888999997655432222222 2333334444322 22222222 22334578999999
Q ss_pred CCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 337 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+|..|.+.. .+++ .+...+.+.+..||+.| ++|+|++|.|++++.+ .++++||+..+.
T Consensus 126 eG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 126 EGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred cCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence 998876543 1232 24466778899999999 9999999999999855 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-06 Score=77.64 Aligned_cols=125 Identities=18% Similarity=0.178 Sum_probs=90.8
Q ss_pred CCeeeEEEEeecC------CcccHHHHHHHHHHHHcCCCC--CccceeeeEec----CCeEEEEEEecCC-CChhhhhcc
Q 012989 281 DGKEIAVKRLSRS------SGQGLQEFKNEVTLIAKLQHK--NLVRLLGCCLD----GNELLLIYEYMPN-KSLDLFLFD 347 (452)
Q Consensus 281 ~~~~vAiK~~~~~------~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~----~~~~~lv~E~~~~-~~L~~~l~~ 347 (452)
+|..+=+|+-... .+.....|.+|+..|++|... .++++...-.. .-+-+||+|-++| .+|.+++.+
T Consensus 40 ~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~ 119 (216)
T PRK09902 40 NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQ 119 (216)
T ss_pred CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhc
Confidence 4446777765421 144667899999999999532 25555522211 1247899997754 688877733
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC--eeEcccccccc
Q 012989 348 STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN--PKISDFGMARI 409 (452)
Q Consensus 348 ~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~ 409 (452)
. ...+.+......++.+++..+.-||+.| +.|+|+.+.||+++.++. ++++||--++.
T Consensus 120 ~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 120 H-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred C-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 2 2234677778899999999999999999 999999999999987777 99999976653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.1e-08 Score=106.23 Aligned_cols=146 Identities=21% Similarity=0.244 Sum_probs=109.4
Q ss_pred HHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 301 ~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
...+-.++-...+|.++.....+......+|+++|+.+++|...++. ....+..-....+..+..++++||...
T Consensus 851 ~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~--- 924 (1205)
T KOG0606|consen 851 IRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL--- 924 (1205)
T ss_pred cCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---
Confidence 33344444344556666655556667789999999999999887743 234666667778888999999999987
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCC---------------------Ccc--------ccccccccccccccc
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN---------------------QNE--------ANTNRVVGTYGYMAP 431 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---------------------~~~--------~~~~~~~gt~~y~aP 431 (452)
++|+|++|.|+++..+++.++.|||........ ... .......||+.|.+|
T Consensus 925 r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen 925 RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence 899999999999999999999999843322110 000 012235789999999
Q ss_pred cccccCCCceeeeeeeeeeeC
Q 012989 432 EYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 432 E~~~~~~~s~~~DvwSlG~il 452 (452)
|..++......+|+|+.|++|
T Consensus 1005 e~~lg~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 1005 EILLGRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred cccccccCCCcchhhhhhhhh
Confidence 999999999999999999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.7e-06 Score=78.60 Aligned_cols=136 Identities=15% Similarity=0.127 Sum_probs=80.6
Q ss_pred CccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhc--
Q 012989 270 SKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLF-- 346 (452)
Q Consensus 270 ~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~-- 346 (452)
.....++... ++..+.+|+..... ...+.+|+++++.+. +--++++++.....+..++|||+++|.++.....
T Consensus 11 ~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~ 86 (244)
T cd05150 11 SGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEEL 86 (244)
T ss_pred CcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhccc
Confidence 3333344433 34678888865432 345778999998884 4457788888777777899999999988764321
Q ss_pred -----------------cCCC-CCCCCHH--HHHHH-----------------------HHHHHHHHHHHh-cCCCCCeE
Q 012989 347 -----------------DSTK-GAQLDWK--RRISI-----------------------INGIARGLLYLH-EDSRLRVI 382 (452)
Q Consensus 347 -----------------~~~~-~~~l~~~--~~~~i-----------------------~~ql~~aL~~LH-~~g~~~iv 382 (452)
.... ..++... ..... ..++...|.... ...+..++
T Consensus 87 ~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 166 (244)
T cd05150 87 EPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVT 166 (244)
T ss_pred CHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEE
Confidence 0000 0011100 00000 111111111111 11123489
Q ss_pred ecCCCCCCeEECCCCCeeEcccccccc
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
|+|+.|.|||+++++.+.|+||+.+..
T Consensus 167 HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 167 HGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCCCCccEEEeCCcEEEEEEcccccc
Confidence 999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.9e-06 Score=75.35 Aligned_cols=118 Identities=19% Similarity=0.166 Sum_probs=73.5
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCC--CccceeeeEecCCeEEEEEEecCCCC-hhhhhccCCCCCCCCHHH
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK--NLVRLLGCCLDGNELLLIYEYMPNKS-LDLFLFDSTKGAQLDWKR 358 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~~~~~lv~E~~~~~~-L~~~l~~~~~~~~l~~~~ 358 (452)
+..+++|...... ......+|.++++.+..- .+++.+++....+...+|||+++|.. +...+.. +...
T Consensus 22 ~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~-------~~~~ 92 (226)
T TIGR02172 22 TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISD-------NPSR 92 (226)
T ss_pred CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcC-------CHHH
Confidence 5567788765432 335678999999998643 35778888888888899999999963 2211100 0011
Q ss_pred HHHHHHHHHHHHH---------------------------------------HHhc-CCCCCeEecCCCCCCeEECCCCC
Q 012989 359 RISIINGIARGLL---------------------------------------YLHE-DSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 359 ~~~i~~ql~~aL~---------------------------------------~LH~-~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
...++.++++.+. +|.+ ..+..++|+|+.|.||+++.++
T Consensus 93 ~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~- 171 (226)
T TIGR02172 93 LEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG- 171 (226)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-
Confidence 1111111111111 1111 1123478999999999999888
Q ss_pred eeEcccccccc
Q 012989 399 PKISDFGMARI 409 (452)
Q Consensus 399 ~kl~DFG~a~~ 409 (452)
+.|+||+.+..
T Consensus 172 ~~iIDwe~a~~ 182 (226)
T TIGR02172 172 TYWIDLGDFGY 182 (226)
T ss_pred cEEEechhcCc
Confidence 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5e-06 Score=85.03 Aligned_cols=81 Identities=19% Similarity=0.211 Sum_probs=56.0
Q ss_pred cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccc
Q 012989 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404 (452)
Q Consensus 325 ~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DF 404 (452)
-.....|+|||++|-.+.+...... ..++...+.....++ -+..+-..| ++|.|.+|.||+++.++++.+.||
T Consensus 237 ~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~--f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 237 YTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRA--FLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred ccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHH--HHHHHHhcC---ccccCCCccceEEecCCcEEEEcC
Confidence 3456789999999998888753222 334533332222221 122333456 999999999999999999999999
Q ss_pred cccccccC
Q 012989 405 GMARIFSG 412 (452)
Q Consensus 405 G~a~~~~~ 412 (452)
|+...+..
T Consensus 310 Gi~g~l~~ 317 (517)
T COG0661 310 GIVGRLDP 317 (517)
T ss_pred cceecCCH
Confidence 99876653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.2e-06 Score=74.13 Aligned_cols=105 Identities=22% Similarity=0.203 Sum_probs=82.4
Q ss_pred HHHHHHHHcCCC-CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 302 KNEVTLIAKLQH-KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 302 ~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
.+|..+++.+++ +++++++|++-. ++|.|+.+.+++.............+|..+.+|+.++++.+++|+..-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 699999999833 678999987655422111122334789999999999999999999854344
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccc
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 410 (452)
+...|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-05 Score=72.10 Aligned_cols=102 Identities=19% Similarity=0.287 Sum_probs=73.0
Q ss_pred cHHHHHHHHHHHHcCC------CCCccceeeeEecCCeEEEEEEecCC------CChhhhhccCCCCCCCCHHHHHHHHH
Q 012989 297 GLQEFKNEVTLIAKLQ------HKNLVRLLGCCLDGNELLLIYEYMPN------KSLDLFLFDSTKGAQLDWKRRISIIN 364 (452)
Q Consensus 297 ~~~~~~~E~~~l~~l~------h~~iv~l~~~~~~~~~~~lv~E~~~~------~~L~~~l~~~~~~~~l~~~~~~~i~~ 364 (452)
...+..+|+.-...+. +.+|.+++++.+++.-..+|+|.+.. .+|.+++ ....++. .....+
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L- 127 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQAL- 127 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHH-
Confidence 3466777887777776 78999999999999999999998643 4566666 2334555 333333
Q ss_pred HHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC----CeeEcc-cccccc
Q 012989 365 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM----NPKISD-FGMARI 409 (452)
Q Consensus 365 ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~~kl~D-FG~a~~ 409 (452)
-+-.++|-+++ |+.+|++|+||++.... .+.|+| ||....
T Consensus 128 --~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 128 --DEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred --HHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEeCCCCccc
Confidence 44445666666 99999999999996443 488888 675543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3e-05 Score=70.74 Aligned_cols=133 Identities=17% Similarity=0.240 Sum_probs=84.8
Q ss_pred CCCccEEEEEEecCCeeeEEEEeecCCc-------------------ccHH-----HHHHHHHHHHcCC--CCCccceee
Q 012989 268 TSSKEICVQGILADGKEIAVKRLSRSSG-------------------QGLQ-----EFKNEVTLIAKLQ--HKNLVRLLG 321 (452)
Q Consensus 268 ~~~~~v~~~~~~~~~~~vAiK~~~~~~~-------------------~~~~-----~~~~E~~~l~~l~--h~~iv~l~~ 321 (452)
|.-.+|++. ...++..+|+|+...... .... ...+|..-|.++. +-.+++-+.
T Consensus 59 GKEA~Vy~a-~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~ 137 (268)
T COG1718 59 GKEANVYLA-ETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIA 137 (268)
T ss_pred CcceEEEee-ccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCcee
Confidence 333444433 336789999998864310 0111 1245666666663 333444444
Q ss_pred eEecCCeEEEEEEecCCCCh-hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCCCe
Q 012989 322 CCLDGNELLLIYEYMPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 322 ~~~~~~~~~lv~E~~~~~~L-~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
+. .-.|||||+....+ .-.+ +.-++...++..+..++++.+.-|-. .+ +||+||..=|||+. ++.+
T Consensus 138 ~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 138 FR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeE
Confidence 33 34699999966421 1111 11223344677888899999988877 66 99999999999998 8899
Q ss_pred eEccccccccccCC
Q 012989 400 KISDFGMARIFSGN 413 (452)
Q Consensus 400 kl~DFG~a~~~~~~ 413 (452)
.|||||.+.....+
T Consensus 206 ~iID~~QaV~~~hp 219 (268)
T COG1718 206 YIIDVSQAVTIDHP 219 (268)
T ss_pred EEEECccccccCCC
Confidence 99999998765433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.3e-06 Score=88.59 Aligned_cols=139 Identities=20% Similarity=0.181 Sum_probs=103.4
Q ss_pred HHHHHHHHHHHcCCCCC-ccceeeeEecCCeEEEEEEecCCC-ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 012989 299 QEFKNEVTLIAKLQHKN-LVRLLGCCLDGNELLLIYEYMPNK-SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED 376 (452)
Q Consensus 299 ~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~E~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~ 376 (452)
....-++++|.+++||| .+..++-++.+.+.+++|+++.++ +-.... ......+..-+...+.+.-.++|+++|+.
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhcccccccccc
Confidence 45667899999999999 777777777888999999999876 221111 01122244445556667777889999986
Q ss_pred CCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeee
Q 012989 377 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEF 450 (452)
Q Consensus 377 g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 450 (452)
. =+|+| ||+..+ +..|..||+....+.... ..+...+|+.|+|||+.....+..+-|+||++.
T Consensus 356 ~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~ 418 (829)
T KOG0576|consen 356 Y---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAV 418 (829)
T ss_pred c---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCc
Confidence 4 48888 777655 678999999887654432 344567899999999999999999999999884
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.8e-07 Score=96.32 Aligned_cols=71 Identities=11% Similarity=0.143 Sum_probs=56.1
Q ss_pred EecCCCCC-CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTS-NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~-NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.|++.+|. |++++.....++.|||.++..............+||+.|+|||++.+..++.++|||||||+|
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il 570 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCL 570 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHH
Confidence 45566666 677777777899999998876544433344556899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.2e-05 Score=71.04 Aligned_cols=59 Identities=14% Similarity=0.189 Sum_probs=38.1
Q ss_pred eeeEEEEeecCCcccHHHHHHHHHHHHcCCCC---CccceeeeEecC---CeEEEEEEecCCCChhh
Q 012989 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK---NLVRLLGCCLDG---NELLLIYEYMPNKSLDL 343 (452)
Q Consensus 283 ~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~~~---~~~~lv~E~~~~~~L~~ 343 (452)
..+.+|.... ......+.+|.++++.|... .++++++..... ...+++||+++|.++..
T Consensus 19 ~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~~ 83 (235)
T cd05155 19 DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETATA 83 (235)
T ss_pred CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCCc
Confidence 3567776443 22345789999999988532 355555544332 24589999999987743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.01 E-value=9.7e-05 Score=81.15 Aligned_cols=59 Identities=17% Similarity=0.363 Sum_probs=41.8
Q ss_pred eeeEEEEeecCC-cccHHHHHHHHHHHHcCC-CCCc--cceeeeEecC---CeEEEEEEecCCCCh
Q 012989 283 KEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQ-HKNL--VRLLGCCLDG---NELLLIYEYMPNKSL 341 (452)
Q Consensus 283 ~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i--v~l~~~~~~~---~~~~lv~E~~~~~~L 341 (452)
..+++|+..... ......+.+|+++|+.+. |+++ ++++.++.+. +..|+|||+++|..+
T Consensus 66 ~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 66 KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 467778764432 223457889999999995 6654 7777776654 467899999998754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=6e-05 Score=69.39 Aligned_cols=125 Identities=21% Similarity=0.218 Sum_probs=68.4
Q ss_pred eeeEEEEeecCCcccHHHHHHHHHHHHcCCCC--CccceeeeEec---CCeEEEEEEecCCCChhh--------------
Q 012989 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK--NLVRLLGCCLD---GNELLLIYEYMPNKSLDL-------------- 343 (452)
Q Consensus 283 ~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~---~~~~~lv~E~~~~~~L~~-------------- 343 (452)
..+++|..... .....+.+|..+++.+... .+++++..... ....+++||+++|..+..
T Consensus 21 ~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~ 98 (239)
T PF01636_consen 21 GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQL 98 (239)
T ss_dssp SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHH
T ss_pred cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccc
Confidence 58999986543 3456788999999988533 35677764432 335799999999988776
Q ss_pred --hhc---cC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc----CCCCCeEecCCCCCCe
Q 012989 344 --FLF---DS-TKGAQLDWKR---------RISI------------INGIAR-GLLYLHE----DSRLRVIHRDLKTSNV 391 (452)
Q Consensus 344 --~l~---~~-~~~~~l~~~~---------~~~i------------~~ql~~-aL~~LH~----~g~~~ivH~Dlkp~NI 391 (452)
.+. .. .....+.... .... ...+.. .++.+++ ..+..++|+|+.|+||
T Consensus 99 ~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Ni 178 (239)
T PF01636_consen 99 GRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNI 178 (239)
T ss_dssp HHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGE
T ss_pred hhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccc
Confidence 110 00 0111111100 0000 111222 2333332 1334599999999999
Q ss_pred EEC-CCCCeeEcccccccc
Q 012989 392 LLD-HEMNPKISDFGMARI 409 (452)
Q Consensus 392 ll~-~~~~~kl~DFG~a~~ 409 (452)
|++ .++.+-|+||+.+..
T Consensus 179 l~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 179 LVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEESSTTEEEE--GTT-EE
T ss_pred eeeeccceeEEEecccceE
Confidence 999 555567999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=1e-05 Score=82.95 Aligned_cols=87 Identities=16% Similarity=0.334 Sum_probs=67.2
Q ss_pred HHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc------c-cccccccccccccccccc
Q 012989 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA------N-TNRVVGTYGYMAPEYAME 436 (452)
Q Consensus 364 ~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~------~-~~~~~gt~~y~aPE~~~~ 436 (452)
.+.+.||.++|..- .+||+.|.|++|.++.++..||..|+.+....++..-+ . ..-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999865 59999999999999999999999999876544321111 0 011123568999999998
Q ss_pred CCCceeeeeeeeeeeC
Q 012989 437 GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 437 ~~~s~~~DvwSlG~il 452 (452)
...+.++|++|+|++.
T Consensus 184 ~~~~~~sd~fSlG~li 199 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLI 199 (700)
T ss_pred ccccccccceeeeeEE
Confidence 8889999999999963
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=68.36 Aligned_cols=125 Identities=18% Similarity=0.131 Sum_probs=69.8
Q ss_pred cCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc-cceeeeEecCCeEEEEEEecCCCChhhh--------------
Q 012989 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLDGNELLLIYEYMPNKSLDLF-------------- 344 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~E~~~~~~L~~~-------------- 344 (452)
.+++.+++|..............+|..+++.+....+ ++++.... -++||||++|..+...
T Consensus 17 ~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~ 92 (256)
T TIGR02721 17 HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAAL 92 (256)
T ss_pred eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHH
Confidence 5677888887544322211235789999999864333 44454432 3689999999776431
Q ss_pred ---hccCC-CCCCCCHH-HHHHHHHHH---------HHHHHHHhcC-----CCCCeEecCCCCCCeEECCCCCeeEcccc
Q 012989 345 ---LFDST-KGAQLDWK-RRISIINGI---------ARGLLYLHED-----SRLRVIHRDLKTSNVLLDHEMNPKISDFG 405 (452)
Q Consensus 345 ---l~~~~-~~~~l~~~-~~~~i~~ql---------~~aL~~LH~~-----g~~~ivH~Dlkp~NIll~~~~~~kl~DFG 405 (452)
++... ...+++.. .+..+..++ ...++.+.+. -+..++|+|+.|.||+++.++ ++|+||.
T Consensus 93 l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE 171 (256)
T TIGR02721 93 LHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWE 171 (256)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEecc
Confidence 01100 11122221 111221111 1112222111 123489999999999999877 7899998
Q ss_pred cccc
Q 012989 406 MARI 409 (452)
Q Consensus 406 ~a~~ 409 (452)
.+..
T Consensus 172 ~a~~ 175 (256)
T TIGR02721 172 YASD 175 (256)
T ss_pred ccCc
Confidence 7753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00011 Score=75.06 Aligned_cols=79 Identities=13% Similarity=0.152 Sum_probs=54.7
Q ss_pred CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC----CCCeeEc
Q 012989 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH----EMNPKIS 402 (452)
Q Consensus 327 ~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~----~~~~kl~ 402 (452)
....|+|||++|..+.+...- ....++...+..-+-+...-+ |-..| ++|+|-+|.||+++. ++.+.+.
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~q--If~~G---ffHaDPHPGNilv~~~~~~~~~ivll 347 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQ--IFKTG---FFHADPHPGNILVRPNPEGDEEIVLL 347 (538)
T ss_pred cceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHH--HHhcC---CccCCCCCCcEEEecCCCCCccEEEE
Confidence 457899999999888766432 233466555444443333222 33446 999999999999984 5679999
Q ss_pred cccccccccC
Q 012989 403 DFGMARIFSG 412 (452)
Q Consensus 403 DFG~a~~~~~ 412 (452)
|||+...+..
T Consensus 348 DhGl~~~is~ 357 (538)
T KOG1235|consen 348 DHGLYAVISH 357 (538)
T ss_pred cccccccccH
Confidence 9999876543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00048 Score=63.78 Aligned_cols=31 Identities=23% Similarity=0.398 Sum_probs=27.0
Q ss_pred CCeEecCCCCCCeEECC-CCCeeEcccccccc
Q 012989 379 LRVIHRDLKTSNVLLDH-EMNPKISDFGMARI 409 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~ 409 (452)
..++|+|++|.|||++. ++.+.|+||-.+..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 45999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=8.4e-05 Score=72.29 Aligned_cols=118 Identities=14% Similarity=0.156 Sum_probs=88.0
Q ss_pred EEEEEEecCCCCh-hhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccc
Q 012989 329 LLLIYEYMPNKSL-DLFLFDS---TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404 (452)
Q Consensus 329 ~~lv~E~~~~~~L-~~~l~~~---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DF 404 (452)
+-++|+.++|.-- ..+.... +.-..+.|...+..++.|+.+...||++| .+-+|++++|+|+.+++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 7788998887532 2222111 12345789999999999999999999999 999999999999999999999985
Q ss_pred cccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 405 GMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 405 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
..-... .........+|...|.+||.-. +-.-+...|.|.||+++
T Consensus 162 Dsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLi 211 (637)
T COG4248 162 DSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLI 211 (637)
T ss_pred cceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHH
Confidence 543322 2222334458899999999764 34457779999988764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0012 Score=63.50 Aligned_cols=56 Identities=11% Similarity=-0.002 Sum_probs=40.2
Q ss_pred eeEEEEeecCCcccHHHHHHHHHHHHcCCC---CCccceeeeEec---CCeEEEEEEecCCCCh
Q 012989 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQH---KNLVRLLGCCLD---GNELLLIYEYMPNKSL 341 (452)
Q Consensus 284 ~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~l~~~~~~---~~~~~lv~E~~~~~~L 341 (452)
.+.+|..+. ......+..|...|+.|.. -.++++++.+.. .+..+||||+++|.++
T Consensus 39 ~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 39 NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 466676432 1123578999999999953 368888887754 3668999999998765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00059 Score=67.12 Aligned_cols=123 Identities=20% Similarity=0.320 Sum_probs=71.3
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC-ccceeeeEecCCeEEEEEEecCCCChhhh----------------
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN-LVRLLGCCLDGNELLLIYEYMPNKSLDLF---------------- 344 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~E~~~~~~L~~~---------------- 344 (452)
++.|.+|+.......... -.+|..+++.+...+ -+++++.+... .|.||+++.+|...
T Consensus 65 ~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~ 139 (344)
T PLN02236 65 GRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLR 139 (344)
T ss_pred CCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHH
Confidence 467888877554333323 367999999985433 34666666433 58999988777421
Q ss_pred -hccCC-CC--CCCCHHHHHHHHHHH-----------------HHHHHHH----hc-CCCCCeEecCCCCCCeEECC-CC
Q 012989 345 -LFDST-KG--AQLDWKRRISIINGI-----------------ARGLLYL----HE-DSRLRVIHRDLKTSNVLLDH-EM 397 (452)
Q Consensus 345 -l~~~~-~~--~~l~~~~~~~i~~ql-----------------~~aL~~L----H~-~g~~~ivH~Dlkp~NIll~~-~~ 397 (452)
++... .. ....+.++..+..++ ...+..| .. ..+..++|+|+++.|||+++ ++
T Consensus 140 ~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~ 219 (344)
T PLN02236 140 EFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR 219 (344)
T ss_pred HHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC
Confidence 01100 00 111233333333222 1111122 21 22345899999999999986 46
Q ss_pred CeeEcccccccc
Q 012989 398 NPKISDFGMARI 409 (452)
Q Consensus 398 ~~kl~DFG~a~~ 409 (452)
.++|+||..+..
T Consensus 220 ~~~lID~Eya~~ 231 (344)
T PLN02236 220 AITIIDYEYASY 231 (344)
T ss_pred cEEEEeehhccc
Confidence 799999988753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00081 Score=64.68 Aligned_cols=125 Identities=20% Similarity=0.224 Sum_probs=72.0
Q ss_pred CCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC--ccceeee------EecCCeEEEEEEecCCCChhhh----h---
Q 012989 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN--LVRLLGC------CLDGNELLLIYEYMPNKSLDLF----L--- 345 (452)
Q Consensus 281 ~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~------~~~~~~~~lv~E~~~~~~L~~~----l--- 345 (452)
++..+++|+... .....+..|+.+++.|.+.+ +++++.. ....+..++|+|+++|..+... .
T Consensus 36 ~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~l 112 (296)
T cd05153 36 DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQI 112 (296)
T ss_pred CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHH
Confidence 445788898754 23456778898888885332 4454432 2234567899999999776430 0
Q ss_pred -------ccCCCC--------CCCCHHHHH----------HHHHHHHHHHHHHhc----CCCCCeEecCCCCCCeEECCC
Q 012989 346 -------FDSTKG--------AQLDWKRRI----------SIINGIARGLLYLHE----DSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 346 -------~~~~~~--------~~l~~~~~~----------~i~~ql~~aL~~LH~----~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+..... ....+.... .....+...+.++.+ .-+..++|+|+.|.||+++.+
T Consensus 113 g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~ 192 (296)
T cd05153 113 GEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGD 192 (296)
T ss_pred HHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCC
Confidence 000000 001111100 011112333444443 112349999999999999987
Q ss_pred CCeeEccccccc
Q 012989 397 MNPKISDFGMAR 408 (452)
Q Consensus 397 ~~~kl~DFG~a~ 408 (452)
+.+.|+||+.+.
T Consensus 193 ~~~~iIDfe~a~ 204 (296)
T cd05153 193 ELSGVIDFYFAC 204 (296)
T ss_pred ceEEEeehhhhc
Confidence 777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0022 Score=61.68 Aligned_cols=119 Identities=18% Similarity=0.267 Sum_probs=75.4
Q ss_pred CeeeEEEEeec--CCcccHHHHHHHHHHHHcCCC--CCccceeeeEecCC--eEEEEEEecCCCChhhhhccCCCCCCCC
Q 012989 282 GKEIAVKRLSR--SSGQGLQEFKNEVTLIAKLQH--KNLVRLLGCCLDGN--ELLLIYEYMPNKSLDLFLFDSTKGAQLD 355 (452)
Q Consensus 282 ~~~vAiK~~~~--~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~l~ 355 (452)
+++++++ ... ..........+|..+++.+.- --++..++.+..+. ..|.||+|.+|..+...... .+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~------~~ 120 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP------ES 120 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc------cc
Confidence 7778887 332 122334556778888888743 23344455555544 67999999999644332211 01
Q ss_pred HHHHHHHH-HHHHHHHHHHhcC-------------------------------------------------------CCC
Q 012989 356 WKRRISII-NGIARGLLYLHED-------------------------------------------------------SRL 379 (452)
Q Consensus 356 ~~~~~~i~-~ql~~aL~~LH~~-------------------------------------------------------g~~ 379 (452)
.. ..++ ..+.+.|..||+- ++.
T Consensus 121 ~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 121 LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 01 1222 2555555555541 124
Q ss_pred CeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 380 RVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
.++|+|+.+.||+++..+.+=|+||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 699999999999999998899999999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0034 Score=61.07 Aligned_cols=30 Identities=37% Similarity=0.399 Sum_probs=25.6
Q ss_pred CCeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
.+++|+|++|+||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 349999999999999866556899999875
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00092 Score=58.00 Aligned_cols=128 Identities=16% Similarity=0.177 Sum_probs=84.6
Q ss_pred ceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc-cee
Q 012989 242 LYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV-RLL 320 (452)
Q Consensus 242 ~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~ 320 (452)
+..+++.|..+.||... ..|..+|+|+=..+ .....+..|+++|..++-.++- +++
T Consensus 26 v~~~L~KG~~s~Vyl~~---------------------~~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy 82 (201)
T COG2112 26 VEKELAKGTTSVVYLGE---------------------WRGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVY 82 (201)
T ss_pred hhhhhhcccccEEEEee---------------------ccCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEE
Confidence 45577777777776543 24668999975443 3457899999999999876654 445
Q ss_pred eeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC-CCCeEECCCCCe
Q 012989 321 GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK-TSNVLLDHEMNP 399 (452)
Q Consensus 321 ~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk-p~NIll~~~~~~ 399 (452)
.+... ++.|||+.|..|...... .+...+ ..+++.---|-..| |-|..|. |..+++..++.+
T Consensus 83 ~yg~~----~i~me~i~G~~L~~~~~~------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~ 145 (201)
T COG2112 83 FYGED----FIRMEYIDGRPLGKLEIG------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDV 145 (201)
T ss_pred Eechh----hhhhhhhcCcchhhhhhc------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcE
Confidence 44333 455999999888664411 122222 33444444455566 9999887 455555566699
Q ss_pred eEcccccccc
Q 012989 400 KISDFGMARI 409 (452)
Q Consensus 400 kl~DFG~a~~ 409 (452)
.||||..|+.
T Consensus 146 ~iIDFd~At~ 155 (201)
T COG2112 146 YIIDFDSATF 155 (201)
T ss_pred EEEEccchhh
Confidence 9999999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0034 Score=60.72 Aligned_cols=125 Identities=18% Similarity=0.200 Sum_probs=69.0
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC--ccceeeeE------ecCCeEEEEEEecCCCChhhh---------
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN--LVRLLGCC------LDGNELLLIYEYMPNKSLDLF--------- 344 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~------~~~~~~~lv~E~~~~~~L~~~--------- 344 (452)
+..+.+|+..... ....+..|.++++.|...+ +++++... ...+..+++|||++|..+...
T Consensus 45 ~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G 122 (307)
T TIGR00938 45 VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVG 122 (307)
T ss_pred CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHH
Confidence 3467788765421 2345667788888874322 34443321 124567899999998654211
Q ss_pred -----hccCCCC------C--CC-CHHHHH------------HHHHHHHHHHHHHhc----CCCCCeEecCCCCCCeEEC
Q 012989 345 -----LFDSTKG------A--QL-DWKRRI------------SIINGIARGLLYLHE----DSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 345 -----l~~~~~~------~--~l-~~~~~~------------~i~~ql~~aL~~LH~----~g~~~ivH~Dlkp~NIll~ 394 (452)
++..... . .+ .|.... .....+...++++.. .-+..++|+|+++.||+++
T Consensus 123 ~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~ 202 (307)
T TIGR00938 123 EVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFD 202 (307)
T ss_pred HHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEE
Confidence 0000000 0 00 011100 001122334555532 1134599999999999999
Q ss_pred CCCCeeEccccccc
Q 012989 395 HEMNPKISDFGMAR 408 (452)
Q Consensus 395 ~~~~~kl~DFG~a~ 408 (452)
.++.+.|+||+.+.
T Consensus 203 ~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 203 GDSVKGVIDFYFAC 216 (307)
T ss_pred CCceEEEeeccccc
Confidence 88777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0044 Score=61.79 Aligned_cols=63 Identities=13% Similarity=0.076 Sum_probs=41.9
Q ss_pred EEEEecCC-eeeEEEEeecC------C-cccHHHHHHHHHHHHcCC---CCCccceeeeEecCCeEEEEEEecCCC
Q 012989 275 VQGILADG-KEIAVKRLSRS------S-GQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYEYMPNK 339 (452)
Q Consensus 275 ~~~~~~~~-~~vAiK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~E~~~~~ 339 (452)
+.....+| +.|.||.-... . +-..++...|.+.|+.+. ..++++++.+. ....++|||++++.
T Consensus 43 yrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVME~L~~~ 116 (401)
T PRK09550 43 FRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVMEDLSDH 116 (401)
T ss_pred EEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEEecCCCc
Confidence 44444555 58999985422 1 224567788888888873 34677787763 35578999999863
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0043 Score=59.03 Aligned_cols=30 Identities=23% Similarity=0.552 Sum_probs=25.4
Q ss_pred CeEecCCCCCCeEECCCCC-eeEcccccccc
Q 012989 380 RVIHRDLKTSNVLLDHEMN-PKISDFGMARI 409 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~~~~-~kl~DFG~a~~ 409 (452)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0038 Score=60.22 Aligned_cols=123 Identities=24% Similarity=0.315 Sum_probs=71.8
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC-ccceeeeEecCCeEEEEEEecCCCChhhh-h--------------
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN-LVRLLGCCLDGNELLLIYEYMPNKSLDLF-L-------------- 345 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~E~~~~~~L~~~-l-------------- 345 (452)
++.+++|+..... .......+|.++++.+...+ .++++..+.. .+|+||++|..+... +
T Consensus 29 ~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~ 103 (302)
T cd05156 29 PRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTLTTEELRDPDISAEIARRMA 103 (302)
T ss_pred CCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcCCHhHcCCcHHHHHHHHHHH
Confidence 5788999865432 23345678998998885333 4555655542 368999999776431 1
Q ss_pred --ccCCCCC------CCC--HHHHHH--------------------------HHHHHHHHHHHHhc------CCCCCeEe
Q 012989 346 --FDSTKGA------QLD--WKRRIS--------------------------IINGIARGLLYLHE------DSRLRVIH 383 (452)
Q Consensus 346 --~~~~~~~------~l~--~~~~~~--------------------------i~~ql~~aL~~LH~------~g~~~ivH 383 (452)
+...... ..+ +..+.. +..++..-++++.. ..+..++|
T Consensus 104 ~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH 183 (302)
T cd05156 104 KLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEAKYLRFLLESTSEESGSPVVFCH 183 (302)
T ss_pred HhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHHHHHHHHHhhccCCCCCCceEEe
Confidence 0100000 011 101100 11222233334432 13456899
Q ss_pred cCCCCCCeEECCC----CCeeEcccccccc
Q 012989 384 RDLKTSNVLLDHE----MNPKISDFGMARI 409 (452)
Q Consensus 384 ~Dlkp~NIll~~~----~~~kl~DFG~a~~ 409 (452)
+|+.|.|||++.+ +.++|+||..+..
T Consensus 184 ~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 184 NDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred cCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 9999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0024 Score=57.12 Aligned_cols=125 Identities=23% Similarity=0.328 Sum_probs=82.5
Q ss_pred ccccceeeecCccc-cccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeec---CCc------------------
Q 012989 238 FRYELYQFYNDTSI-GTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSR---SSG------------------ 295 (452)
Q Consensus 238 ~ry~~~~f~g~g~~-g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~---~~~------------------ 295 (452)
-.++..+|+|.|.- |.|+++ .-+|+.+|||.... ..+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv---------------------~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKV---------------------EIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPA 95 (207)
T ss_pred CcEeeeeecCCCCceeEEEEE---------------------EECCeEEEEEEeeccccCCCccccccccccccccchhh
Confidence 45566667777766 555533 33678999998321 110
Q ss_pred ccHHHHHHHHHHHHcCC---CCCc--cceeeeEecC------------------CeEEEEEEecCCCChhhhhccCCCCC
Q 012989 296 QGLQEFKNEVTLIAKLQ---HKNL--VRLLGCCLDG------------------NELLLIYEYMPNKSLDLFLFDSTKGA 352 (452)
Q Consensus 296 ~~~~~~~~E~~~l~~l~---h~~i--v~l~~~~~~~------------------~~~~lv~E~~~~~~L~~~l~~~~~~~ 352 (452)
.-...|..|.+...+|+ +.++ |+.+++..-. ....||.||.+...
T Consensus 96 ~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------ 163 (207)
T PF13095_consen 96 HYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------ 163 (207)
T ss_pred hhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------
Confidence 11234778888887774 4566 8888887422 12467778765532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccc
Q 012989 353 QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 407 (452)
Q Consensus 353 ~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 407 (452)
.+.. .=+.+|++-|..+|+.| |+-+|+|+.|.. .-||+|||.+
T Consensus 164 ~~~~----~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 164 PLQI----RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccch----hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 1222 33567788889999999 999999999987 3589999864
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.011 Score=57.45 Aligned_cols=131 Identities=24% Similarity=0.317 Sum_probs=75.5
Q ss_pred EEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC------ccceee----eEecCCeEEEEEEecCCCChhh-
Q 012989 275 VQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN------LVRLLG----CCLDGNELLLIYEYMPNKSLDL- 343 (452)
Q Consensus 275 ~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~l~~----~~~~~~~~~lv~E~~~~~~L~~- 343 (452)
|.....+|+. ++|+.... ....++..|+..++.|.-.. ++.+=+ ....+.+.+-++||++|..+..
T Consensus 42 f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~ 118 (331)
T COG2334 42 FRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERD 118 (331)
T ss_pred EEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCC
Confidence 4444455555 88887654 44567888899998883211 222111 1112237888999999988873
Q ss_pred hhc------------------cCC-----CCCCCCHH----H---------HHHHHHHHHHHHHHHhcC-------CCCC
Q 012989 344 FLF------------------DST-----KGAQLDWK----R---------RISIINGIARGLLYLHED-------SRLR 380 (452)
Q Consensus 344 ~l~------------------~~~-----~~~~l~~~----~---------~~~i~~ql~~aL~~LH~~-------g~~~ 380 (452)
... ... ......|. . -.....++...+..+.+. ++..
T Consensus 119 ~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~ 198 (331)
T COG2334 119 DNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQ 198 (331)
T ss_pred CcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccce
Confidence 110 000 00112222 0 011333444445544432 1122
Q ss_pred eEecCCCCCCeEECCCCC-eeEccccccc
Q 012989 381 VIHRDLKTSNVLLDHEMN-PKISDFGMAR 408 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~-~kl~DFG~a~ 408 (452)
+||+|+.|+||+++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999885 8999999775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0093 Score=56.94 Aligned_cols=57 Identities=19% Similarity=0.263 Sum_probs=38.0
Q ss_pred cCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC---CCCccceeeeEecCCeEEEEEEecCCC
Q 012989 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYEYMPNK 339 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~E~~~~~ 339 (452)
.+++.+-||.-. ......|..|.+-|+.|. .-.+++++.+...++..+|||||++.+
T Consensus 38 ~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 678889999865 233467889999998883 346889999998888889999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.013 Score=56.86 Aligned_cols=136 Identities=19% Similarity=0.196 Sum_probs=89.7
Q ss_pred CCCCCccEEEEEEecCCeeeEEEEeecC------------------------Cccc--HHHHHHHHHHHHcCCCCCccce
Q 012989 266 SVTSSKEICVQGILADGKEIAVKRLSRS------------------------SGQG--LQEFKNEVTLIAKLQHKNLVRL 319 (452)
Q Consensus 266 ~~~~~~~v~~~~~~~~~~~vAiK~~~~~------------------------~~~~--~~~~~~E~~~l~~l~h~~iv~l 319 (452)
+.|.-.+|+. ....+|..+|||+.+-. ++.. .-...+|++-|.+|+...|+--
T Consensus 153 STGKEANVYH-at~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~P 231 (520)
T KOG2270|consen 153 STGKEANVYH-ATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCP 231 (520)
T ss_pred ccCccceeEe-eecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 4555566665 55678889999987521 0110 1123567777888766554422
Q ss_pred eeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 320 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
.-.... ...|||+++.....-.-. -+.-.++...+..+-.|++.-+.-|-+.. ++||.||.-=|+|+ .+|.+
T Consensus 232 ePIlLk--~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 232 EPILLK--NHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred Cceeee--cceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCEE
Confidence 211111 246899999653332111 23445778888888899999998887654 49999999999998 67889
Q ss_pred eEccccccccc
Q 012989 400 KISDFGMARIF 410 (452)
Q Consensus 400 kl~DFG~a~~~ 410 (452)
.|||-+.+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99999887543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0049 Score=56.11 Aligned_cols=123 Identities=18% Similarity=0.242 Sum_probs=61.6
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC-ccceeeeEecCCeEEEEEEecCCCChhhh-hcc------------
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN-LVRLLGCCLDGNELLLIYEYMPNKSLDLF-LFD------------ 347 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~E~~~~~~L~~~-l~~------------ 347 (452)
++.|.+|+.... ......-..|..+++.+...+ -+++++.+... +|.||+++..|+.- +.+
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 467888877555 344556678999999886444 45666665443 57799988665321 100
Q ss_pred ----C----CCCCCCCHHHHHHH----------------------HHHHHHHHHHHhc----C-CCCCeEecCCCCCCeE
Q 012989 348 ----S----TKGAQLDWKRRISI----------------------INGIARGLLYLHE----D-SRLRVIHRDLKTSNVL 392 (452)
Q Consensus 348 ----~----~~~~~l~~~~~~~i----------------------~~ql~~aL~~LH~----~-g~~~ivH~Dlkp~NIl 392 (452)
. .....--+..+..+ +.++-.-+..+.+ . .+..+.|.|+.|.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0 00000011222222 1112222222221 1 1235789999999999
Q ss_pred E-CCCCCeeEcccccccc
Q 012989 393 L-DHEMNPKISDFGMARI 409 (452)
Q Consensus 393 l-~~~~~~kl~DFG~a~~ 409 (452)
+ +.++.++||||-.+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.047 Score=53.31 Aligned_cols=66 Identities=14% Similarity=0.067 Sum_probs=40.1
Q ss_pred EEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC--cccee---e--eEecCCeEEEEEEecCCCCh
Q 012989 275 VQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN--LVRLL---G--CCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 275 ~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~---~--~~~~~~~~~lv~E~~~~~~L 341 (452)
|.....++..+++|+.... ......+..|++.+..|.... ++... + ....++..+.++++++|...
T Consensus 42 y~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 42 YQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred EEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 4444556778999987432 234567788888888874221 22211 1 12234567889999988654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.031 Score=54.66 Aligned_cols=122 Identities=17% Similarity=0.278 Sum_probs=68.2
Q ss_pred eeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc-cceeeeEecCCeEEEEEEecCCCChhhh-------h---------
Q 012989 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLDGNELLLIYEYMPNKSLDLF-------L--------- 345 (452)
Q Consensus 283 ~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~E~~~~~~L~~~-------l--------- 345 (452)
..|.+|+....... .-.-.+|..+++.+...++ +++++++..+ +|.||+++..|..- +
T Consensus 43 ~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~ 117 (330)
T PLN02421 43 VSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINARTLTPSDMRKPKVAAEIAKELRR 117 (330)
T ss_pred ceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCCCChHHCCCHHHHHHHHHHHHH
Confidence 47888876544322 2233678999998865444 5566665322 58999988766321 0
Q ss_pred -ccCC-CC-C-CCCHHHHHHHHHHH-------------------------HHHHHHHh-c-CCCCCeEecCCCCCCeEEC
Q 012989 346 -FDST-KG-A-QLDWKRRISIINGI-------------------------ARGLLYLH-E-DSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 346 -~~~~-~~-~-~l~~~~~~~i~~ql-------------------------~~aL~~LH-~-~g~~~ivH~Dlkp~NIll~ 394 (452)
+... .. . .--+..+..+..++ +..+..+. . ..+..+.|.|+.+.|||++
T Consensus 118 lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~ 197 (330)
T PLN02421 118 LHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLN 197 (330)
T ss_pred HhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEe
Confidence 1100 00 1 11233333332222 11111121 1 1133478999999999997
Q ss_pred C-CCCeeEcccccccc
Q 012989 395 H-EMNPKISDFGMARI 409 (452)
Q Consensus 395 ~-~~~~kl~DFG~a~~ 409 (452)
+ ++.++++||..+..
T Consensus 198 ~~~~~l~lID~EYag~ 213 (330)
T PLN02421 198 EDEGKLYFIDFEYGSY 213 (330)
T ss_pred CCCCcEEEEcccccCC
Confidence 5 47899999987753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.05 Score=52.55 Aligned_cols=29 Identities=24% Similarity=0.338 Sum_probs=25.1
Q ss_pred CCeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.015 Score=56.29 Aligned_cols=74 Identities=22% Similarity=0.294 Sum_probs=58.8
Q ss_pred cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccc
Q 012989 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404 (452)
Q Consensus 325 ~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DF 404 (452)
+..+.|++|++- |+++.... .-.++++..|+.+-+..+.-+... .+.-||++.-+||||+ +|++.||||
T Consensus 297 e~~y~yl~~kdh-gt~is~ik-------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIK-------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred CceEEEEEEecC-Cceeeeee-------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEe
Confidence 345678888876 55554322 245788999999988888888765 3689999999999999 999999999
Q ss_pred ccccc
Q 012989 405 GMARI 409 (452)
Q Consensus 405 G~a~~ 409 (452)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99984
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.058 Score=60.73 Aligned_cols=30 Identities=37% Similarity=0.525 Sum_probs=25.3
Q ss_pred CCeEecCCCCCCeEECCCC--Cee-Eccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEM--NPK-ISDFGMAR 408 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~--~~k-l~DFG~a~ 408 (452)
..+||+|+++.|||++.++ ++. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3499999999999999875 555 99999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.0003 Score=78.27 Aligned_cols=149 Identities=11% Similarity=-0.048 Sum_probs=105.7
Q ss_pred HHHHHHHHHHcCCCCCccceeeeEec--CCeEEEEEEecCCCChhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcC
Q 012989 300 EFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTK-GAQLDWKRRISIINGIARGLLYLHED 376 (452)
Q Consensus 300 ~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~ 376 (452)
....|...++..+|+++.....-... ..+-+.+++++.+|.+.+.+-+..+ ...++..-+.....+.+....-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34455555666788888776655543 3457889999999999888855433 33445444554455547777776654
Q ss_pred C--CCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeee
Q 012989 377 S--RLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEF 450 (452)
Q Consensus 377 g--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 450 (452)
. +.--+|+++|+-|.+|..+.++|+.++|+.+...+. ........+++.|+.|++...-.++.++|+|+.++
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 3 334789999999999999999999999999832221 12233456788999999998888999999998554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.0052 Score=67.29 Aligned_cols=145 Identities=21% Similarity=0.151 Sum_probs=99.7
Q ss_pred HHHHHHHHHHHHcCCCCCccceeeeEecCCe----EEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012989 298 LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE----LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYL 373 (452)
Q Consensus 298 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~L 373 (452)
......|+..+.+++|+|++.++.+...... ..+..|++..-++...+ ..-...+....+.+..++++||.++
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHH
Confidence 3445567778888899999999888665432 22344677777776666 3445688899999999999999999
Q ss_pred hcCCCCCeEecCCCCC---CeEECCCCCeeEc--cccccccccCCCccccccccccccccccccccccCCCc--eeeeee
Q 012989 374 HEDSRLRVIHRDLKTS---NVLLDHEMNPKIS--DFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS--VNRMFL 446 (452)
Q Consensus 374 H~~g~~~ivH~Dlkp~---NIll~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~~~Dvw 446 (452)
|+.. ..|.-+..+ +--.+..+.+.+. ||+..+.+.+...... ..-+..+.+||.......+ ...|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence 9986 555544444 4444556666666 8988877654433221 2235667888888665544 447999
Q ss_pred eeeee
Q 012989 447 VSEFF 451 (452)
Q Consensus 447 SlG~i 451 (452)
.+|.+
T Consensus 377 ~lgll 381 (1351)
T KOG1035|consen 377 CLGLL 381 (1351)
T ss_pred HHHHH
Confidence 98864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.088 Score=50.95 Aligned_cols=31 Identities=23% Similarity=0.290 Sum_probs=27.7
Q ss_pred CCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
.+++|+|+.++|||++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4599999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.19 Score=45.83 Aligned_cols=69 Identities=22% Similarity=0.268 Sum_probs=48.2
Q ss_pred ccEEEEEEecC-CeeeEEEEeecCCcccHHHHHHHHHHHHcCC---CCCccceeeeEecCCeEEEEEEecCCCChh
Q 012989 271 KEICVQGILAD-GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 271 ~~v~~~~~~~~-~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
|.+--.-.+.+ ..++-+|.=. ......|..|+.-|+.+. .-.+++++.+.....+.|+||||++-+.++
T Consensus 27 G~inea~~v~dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceeEeecCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 33433333444 3567777632 233467888888887774 356888999999999999999999887765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.014 Score=55.76 Aligned_cols=94 Identities=14% Similarity=0.179 Sum_probs=66.8
Q ss_pred HHHHHHHHHcCCC-C-CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 012989 301 FKNEVTLIAKLQH-K-NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSR 378 (452)
Q Consensus 301 ~~~E~~~l~~l~h-~-~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~ 378 (452)
..+|...|+.|.. . -+++.++ .+..++|||++.|-.|.... ...+.+ .+...+..-+--|-.+|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~---~ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPP---TLYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeee------ecCChH---HHHHHHHHHHHHHHHcC-
Confidence 4578889988853 2 2444444 35678999999998775533 112222 34445555566677888
Q ss_pred CCeEecCCCCCCeEECCCCCeeEccccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 410 (452)
+||+|..-=||+++.++.+++|||-.....
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999865443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.082 Score=52.74 Aligned_cols=56 Identities=9% Similarity=0.013 Sum_probs=35.8
Q ss_pred CCeeeEEEEeecC----C---cccHHHHHHHHHHHHcCC---CCCccceeeeEecCCeEEEEEEecCC
Q 012989 281 DGKEIAVKRLSRS----S---GQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYEYMPN 338 (452)
Q Consensus 281 ~~~~vAiK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~E~~~~ 338 (452)
++..+.||+-... . +-...+-..|.+.|+.+. ..++++++.+.. +..+++||++++
T Consensus 54 ~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 54 SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeecCC
Confidence 4557889975521 1 113344555677776663 347888888777 446788999977
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.14 Score=46.36 Aligned_cols=102 Identities=16% Similarity=0.173 Sum_probs=65.5
Q ss_pred eEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHH
Q 012989 285 IAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363 (452)
Q Consensus 285 vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~ 363 (452)
..+|++..-.-. ...-+.++.++++++. .|+++..= ....+-++.|.|-.... .. ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHHH
Confidence 344555432212 2345678888888764 46666622 34457899998843211 11 1222
Q ss_pred HHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEcccccc
Q 012989 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMA 407 (452)
Q Consensus 364 ~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 407 (452)
..=+..|.-.|+.. ...+|+|-.|+|||-|..|.+||.|-+..
T Consensus 148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 22357788889542 35999999999999999999999998753
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.23 Score=48.76 Aligned_cols=28 Identities=21% Similarity=0.431 Sum_probs=23.7
Q ss_pred CeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 380 RVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
.++|+|+.+.||+++++ .++++|+-.+.
T Consensus 193 ~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 48999999999999765 47899997664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.52 Score=47.03 Aligned_cols=37 Identities=14% Similarity=0.205 Sum_probs=27.7
Q ss_pred HHHHHHHHcCCCC-CccceeeeEecCCeEEEEEEecCCCChh
Q 012989 302 KNEVTLIAKLQHK-NLVRLLGCCLDGNELLLIYEYMPNKSLD 342 (452)
Q Consensus 302 ~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~E~~~~~~L~ 342 (452)
.+|+++++.+... .-+++++.+.. ++|.||++|..|.
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence 5689999999654 44666776643 5999999998774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 452 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-27 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 6e-93
Identities = 68/169 (40%), Positives = 96/169 (56%), Gaps = 9/169 (5%)
Query: 277 GILADGKEIAVKRLS----RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
G + + +AVK+L+ ++ + Q+F E+ ++AK QH+NLV LLG DG++L L+
Sbjct: 50 GYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
Y YMPN SL L L W R I G A G+ +LHE+ IHRD+K++N+L
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165
Query: 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
LD KISDFG+AR T+R+VGT YMAPE + G +
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITP 213
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 267 bits (686), Expect = 5e-87
Identities = 71/173 (41%), Positives = 97/173 (56%), Gaps = 10/173 (5%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G LADG +AVKRL QG + +F+ EV +I+ H+NL+RL G C+ E LL+Y Y
Sbjct: 49 GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 336 MPNKSLDLFLFDSTKG-AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
M N S+ L + + LDW +R I G ARGL YLH+ ++IHRD+K +N+LLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-------VFS 440
E + DFG+A++ T V GT G++APEY G VF
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFG 220
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-79
Identities = 69/173 (39%), Positives = 108/173 (62%), Gaps = 13/173 (7%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G+L DG ++A+KR + S QG++EF+ E+ ++ +H +LV L+G C + NE++LIY+YM
Sbjct: 58 GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 337 PNKSLDLFLFDSTKGAQ-LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
N +L L+ S + W++R+ I G ARGL YLH + +IHRD+K+ N+LLD
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174
Query: 396 EMNPKISDFGMARIF-SGNQNEANTNRVVGTYGYMAPEYAMEG-------VFS 440
PKI+DFG+++ +Q +T V GT GY+ PEY ++G V+S
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYS 226
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 4e-66
Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 16/177 (9%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN----ELLLIYEYM 336
+ +AVK Q + + EV + ++H+N+++ +G G +L LI +
Sbjct: 46 LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-------SRLRVIHRDLKTS 389
SL FL K + W I +ARGL YLHED + + HRD+K+
Sbjct: 105 EKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160
Query: 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFL 446
NVLL + + I+DFG+A F ++ +T+ VGT YMAPE + FL
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-55
Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 22/175 (12%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN-----ELLLIYEY 335
D + +AVK S ++ Q K + + ++H N+ R + E LL+ EY
Sbjct: 35 DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED------SRLRVIHRDLKTS 389
PN SL +L T DW + + + RGL YLH + + + HRDL +
Sbjct: 94 YPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 390 NVLLDHEMNPKISDFGMARIFSGN------QNEANTNRVVGTYGYMAPEYAMEGV 438
NVL+ ++ ISDFG++ +GN + + VGT YMAPE V
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV 204
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-51
Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 5/153 (3%)
Query: 282 GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G ++AVK L + + EF EV ++ +L+H N+V +G L ++ EY+
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
SL L S QLD +RR+S+ +A+G+ YLH ++HR+LK+ N+L+D +
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG++R+ + ++ GT +MAPE
Sbjct: 179 KVCDFGLSRLKA--STFLSSKSAAGTPEWMAPE 209
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 17/171 (9%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
G+ + +K L R + + F EV ++ L+H N+++ +G L I EY+ +L
Sbjct: 35 GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
+ +Q W +R+S IA G+ YLH + +IHRDL + N L+ N +
Sbjct: 95 RGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVV 149
Query: 402 SDFGMARIFSGNQNEANTNR------------VVGTYGYMAPEYAMEGVFS 440
+DFG+AR+ + + R VVG +MAPE +
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-46
Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 13/155 (8%)
Query: 282 GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMP 337
G +I VK L S + ++F E + H N++ +LG C LI +MP
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
SL L + +D + + +ARG+ +LH L + L + +V++D +M
Sbjct: 93 YGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDM 150
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+IS + F + + ++APE
Sbjct: 151 TARISMADVKFSFQ-------SPGRMYAPAWVAPE 178
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
K++A+K++ S + F E+ ++++ H N+V+L G CL N + L+ EY SL
Sbjct: 31 AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSL 86
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN-PK 400
L + +S ++G+ YLH +IHRDLK N+LL K
Sbjct: 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
I DFG A + + G+ +MAPE
Sbjct: 147 ICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 8e-46
Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 282 GKEIAVKRL----SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
G E+AVK Q ++ + E L A L+H N++ L G CL L L+ E+
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L+ L G ++ ++ IARG+ YLH+++ + +IHRDLK+SN+L+ ++
Sbjct: 90 GGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145
Query: 398 NP--------KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI+DFG+AR + + G Y +MAPE
Sbjct: 146 ENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 284 EIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
++AVK L+ + + Q LQ FKNEV ++ K +H N++ +G L ++ ++ SL
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSL 106
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
L + + K+ I I ARG+ YLH +IHRDLK++N+ L + KI
Sbjct: 107 YHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKI 161
Query: 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DFG+A S ++ G+ +MAPE
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 22/165 (13%)
Query: 280 ADGKEIAVKRLSRSSGQG-------LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
D +A+K L +G QEF+ EV +++ L H N+V+L G N ++
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMV 99
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
E++P L L D K + W ++ ++ IA G+ Y+ + ++HRDL++ N+
Sbjct: 100 MEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIF 156
Query: 393 LD-----HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L + K++DFG+++ + + ++G + +MAPE
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPE 196
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 284 EIAVKRL--SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
E+A++ + R + L+ FK EV + +H+N+V +G C+ L +I ++L
Sbjct: 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 342 DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401
+ D LD + I I +G+ YLH ++H+DLK+ NV D I
Sbjct: 117 YSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVI 170
Query: 402 SDFGMARIFSGNQNEANTNR---VVGTYGYMAPE 432
+DFG+ I Q ++ G ++APE
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 20/164 (12%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNE--VTLIAKLQHKNLVRLLGCCLDGN----ELLLIYEY 335
G+++AVK + E + ++H+N++ + + G +L LI +Y
Sbjct: 60 GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR-----VIHRDLKTSN 390
N SL +L K LD K + + GL +LH + + HRDLK+ N
Sbjct: 117 HENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVVGTYGYMAPE 432
+L+ I+D G+A F + NE + N VGT YM PE
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 32/190 (16%)
Query: 268 TSSKEICVQGILA------------DGKEIAVKRLSRSSGQGLQEFKNE--VTLIAKLQH 313
T +++I + + G+ +AVK S + + + E + L+H
Sbjct: 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRH 61
Query: 314 KNLVRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARG 369
+N++ + + +L LI Y SL +L + LD + I+ IA G
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASG 117
Query: 370 LLYLHEDSRLR-----VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANT--NRV 422
L +LH + + HRDLK+ N+L+ I+D G+A + S + N+ + N
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 423 VGTYGYMAPE 432
VGT YMAPE
Sbjct: 178 VGTKRYMAPE 187
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNE--VTLIAKLQHKNLVRLLGCCLDGN----ELLLIYE 334
G+E+AVK S + + + E + L+H+N++ + N +L L+ +
Sbjct: 64 RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-----SRLRVIHRDLKTS 389
Y + SL +L + + I + A GL +LH + + + HRDLK+
Sbjct: 121 YHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 390 NVLLDHEMNPKISDFGMARIFSGNQNEANT--NRVVGTYGYMAPE 432
N+L+ I+D G+A + + N VGT YMAPE
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 30/188 (15%)
Query: 275 VQGILADGKEI--AVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
+ ++ AVK L + ++F+ E L+ LQH+++V+ G C DG+ L+++
Sbjct: 36 CYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 95
Query: 333 YEYMPNKSLDLFL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRL 379
+EYM + L+ FL +L + + I + IA G++YL +
Sbjct: 96 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQ 152
Query: 380 RVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEY 433
+HRDL T N L+ + KI DFGM+R ++S + + R +M PE
Sbjct: 153 HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR------WMPPES 206
Query: 434 AMEGVFSV 441
M F+
Sbjct: 207 IMYRKFTT 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 27/186 (14%)
Query: 275 VQGILADGKEI--AVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
+L + ++ AVK L +S Q+F+ E L+ LQH+++VR G C +G LL++
Sbjct: 62 CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121
Query: 333 YEYMPNKSLDLFL------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380
+EYM + L+ FL + L + +++ + +A G++YL + L
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLH 178
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG-----YMAPEYAM 435
+HRDL T N L+ + KI DFGM+R + + R VG +M PE +
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPESIL 233
Query: 436 EGVFSV 441
F+
Sbjct: 234 YRKFTT 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMPNK 339
G+ +AVK+L S+ + L++F+ E+ ++ LQH N+V+ G C L LI EY+P
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
SL +L ++D + + + I +G+ YL R IHRDL T N+L+++E
Sbjct: 99 SLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRV 153
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFS 440
KI DFG+ ++ ++ V G + APE E FS
Sbjct: 154 KIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFS 195
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 54/168 (32%), Positives = 86/168 (51%), Gaps = 16/168 (9%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMPN 338
G+ +AVK+L S+ + L++F+ E+ ++ LQH N+V+ G C L LI EY+P
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL +L ++D + + + I +G+ YL R IHRDL T N+L+++E
Sbjct: 129 GSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 183
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFSV 441
KI DFG+ ++ ++ V G + APE E FSV
Sbjct: 184 VKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSV 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMPNK 339
G +AVK+L S ++F+ E+ ++ L +V+ G L L+ EY+P+
Sbjct: 52 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L FL A+LD R + + I +G+ YL R +HRDL N+L++ E +
Sbjct: 112 CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHV 166
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFS 440
KI+DFG+A++ +++ VV G + APE + +FS
Sbjct: 167 KIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFS 208
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 31/189 (16%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
+ G + A+K L ++ G +EF++E L A+LQH N+V LLG L +
Sbjct: 30 LFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 89
Query: 332 IYEYMPNKSLDLFL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSR 378
I+ Y + L FL D T + L+ + ++ IA G+ YL S
Sbjct: 90 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SS 146
Query: 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPE 432
V+H+DL T NVL+ ++N KISD G+ R +++ + + N R +MAPE
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR------WMAPE 200
Query: 433 YAMEGVFSV 441
M G FS+
Sbjct: 201 AIMYGKFSI 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 19/163 (11%)
Query: 286 AVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMPNKSLD 342
AVK L +G Q +K E+ ++ L H+++++ GCC D L L+ EY+P SL
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 343 LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKIS 402
+L + + + I G+ YLH IHRDL NVLLD++ KI
Sbjct: 124 DYL----PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIG 176
Query: 403 DFGMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFS 440
DFG+A+ V G + APE E F
Sbjct: 177 DFGLAKAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFY 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 38/155 (24%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 280 ADGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
DG++ +K +SR S + +E + EV ++A ++H N+V+ + L ++ +Y
Sbjct: 47 EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L + ++ KG + + I L ++H+ +++HRD+K+ N+ L +
Sbjct: 107 GGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDG 162
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++ DFG+AR+ + A +GT Y++PE
Sbjct: 163 TVQLGDFGIARVLNSTVELARA--CIGTPYYLSPE 195
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 48/169 (28%), Positives = 84/169 (49%), Gaps = 17/169 (10%)
Query: 281 DGKEIAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMP 337
G+++AVK L S G + + K E+ ++ L H+N+V+ G C + GN + LI E++P
Sbjct: 49 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
+ SL +L +++ K+++ I +G+ YL + +HRDL NVL++ E
Sbjct: 109 SGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEH 163
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFSV 441
KI DFG+ + ++ V + APE M+ F +
Sbjct: 164 QVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYI 208
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 25/183 (13%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
+G++ D E A+K + +S + EF NE +++ + ++VRLLG G L+
Sbjct: 46 AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105
Query: 332 IYEYMPNKSLDLFL-------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
I E M L +L ++ A + I + IA G+ YL+ + +HR
Sbjct: 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHR 162
Query: 385 DLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEYAMEGV 438
DL N ++ + KI DFGM R I+ + R +M+PE +GV
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR------WMSPESLKDGV 216
Query: 439 FSV 441
F+
Sbjct: 217 FTT 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
L++ IA+K + + Q E+ L L+HKN+V+ LG + + + E +P
Sbjct: 44 LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIING-IARGLLYLHEDSRLRVIHRDLKTSNVLLD-HE 396
SL L S G D ++ I I GL YLH++ +++HRD+K NVL++ +
Sbjct: 104 GSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYS 159
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KISDFG ++ +G T GT YMAPE
Sbjct: 160 GVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 7/167 (4%)
Query: 276 QGIL-ADGKEIAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIY 333
G L AD +AVK +F E ++ + H N+VRL+G C + ++
Sbjct: 132 SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 334 EYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
E + FL T+GA+L K + ++ A G+ YL IHRDL N L+
Sbjct: 192 ELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLV 246
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ KISDFGM+R + A+ + APE G +S
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 39/197 (19%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
G+L AVK L +S +F+ E L+A+ + N+V+LLG C G + L
Sbjct: 68 APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127
Query: 332 IYEYMPNKSLDLFL---------------------FDSTKGAQLDWKRRISIINGIARGL 370
++EYM L+ FL S L ++ I +A G+
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187
Query: 371 LYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVG 424
YL S + +HRDL T N L+ M KI+DFG++R I+S + +A+ N R
Sbjct: 188 AYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR--- 241
Query: 425 TYGYMAPEYAMEGVFSV 441
+M PE ++
Sbjct: 242 ---WMPPESIFYNRYTT 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 286 AVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345
AVK L + ++EF E ++ +++H NLV+LLG C +I E+M +L +L
Sbjct: 42 AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Query: 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG 405
+ ++ + + I+ + YL + IHRDL N L+ K++DFG
Sbjct: 101 REC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 406 MARIFSGNQNEANTN-----RVVGTYGYMAPEYAMEGVFSV 441
++R+ +G+ A+ + + APE FS+
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSI 191
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 30/177 (16%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
AVK L ++ + L + +E+ ++ + +HKN++ LLG C L +I EY +L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 344 FL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
+L + Q+ +K +S +ARG+ YL + + IHRDL N
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 233
Query: 391 VLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEYAMEGVFSV 441
VL+ KI+DFG+AR I + + + TN + +MAPE + V++
Sbjct: 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 284
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 17/170 (10%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G ++A+K + + EF E ++ L H+ LV+L G C + +I EY
Sbjct: 42 YGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M N L +L + ++ + + + + YL + +HRDL N L++
Sbjct: 101 MANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVND 155
Query: 396 EMNPKISDFGMARIFSGNQNEANTN-----RVVGTYGYMAPEYAMEGVFS 440
+ K+SDFG++R ++ ++ R + PE M FS
Sbjct: 156 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 199
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 54/183 (29%), Positives = 74/183 (40%), Gaps = 25/183 (13%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
V G+ D + AVK L S Q +F E +I+K H+N+VR +G L +
Sbjct: 51 VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 110
Query: 332 IYEYMPNKSLDLFL----FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
+ E M L FL ++ + L + + IA G YL IHRD+
Sbjct: 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIA 167
Query: 388 TSNVLLD---HEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGY-----MAPEYAMEGV 438
N LL KI DFGMAR I+ + G M PE MEG+
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASY------YRKGGCAMLPVKWMPPEAFMEGI 221
Query: 439 FSV 441
F+
Sbjct: 222 FTS 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 13/168 (7%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G + ++A+K + R ++F E ++ KL H LV+L G CL+ + L+ E+
Sbjct: 26 LGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M + L +L T+ + + + + G+ YL VIHRDL N L+
Sbjct: 85 MEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGE 139
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFS 440
K+SDFGM R +Q ++T GT + +PE +S
Sbjct: 140 NQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 183
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
+ AVK L +S L++ +E ++ ++ H ++++L G C LLL
Sbjct: 44 AFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103
Query: 332 IYEYMPNKSLDLFL---------------------FDSTKGAQLDWKRRISIINGIARGL 370
I EY SL FL D L IS I++G+
Sbjct: 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGM 163
Query: 371 LYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVG 424
YL + ++++HRDL N+L+ KISDFG++R ++ + + +
Sbjct: 164 QYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK--- 217
Query: 425 TYGYMAPEYAMEGVFSV 441
+MA E + +++
Sbjct: 218 ---WMAIESLFDHIYTT 231
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 54/183 (29%), Positives = 73/183 (39%), Gaps = 25/183 (13%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
V G+ D + AVK L S Q +F E +I+K H+N+VR +G L +
Sbjct: 92 VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151
Query: 332 IYEYMPNKSLDLFL----FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
+ E M L FL ++ + L + + IA G YL IHRD+
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIA 208
Query: 388 TSNVLLD---HEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYGY-----MAPEYAMEGV 438
N LL KI DFGMAR I+ G M PE MEG+
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGY------YRKGGCAMLPVKWMPPEAFMEGI 262
Query: 439 FSV 441
F+
Sbjct: 263 FTS 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 279 LADGKEIAVKRL---SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
L DG +A+K++ + + E+ L+ +L H N+++ ++ NEL ++ E
Sbjct: 54 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113
Query: 336 MPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
L + + + + + L ++H RV+HRD+K +NV +
Sbjct: 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFIT 170
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ D G+ R FS A++ +VGT YM+PE
Sbjct: 171 ATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 30/177 (16%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
AVK L ++ + L + +E+ ++ + +HKN++ LLG C L +I EY +L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 344 FL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
+L + Q+ +K +S +ARG+ YL + + IHRDL N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 187
Query: 391 VLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEYAMEGVFSV 441
VL+ KI+DFG+AR I + + + TN + +MAPE + V++
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 238
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 17/162 (10%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
A+K L + + + ++F +E +++ + H N++RL G G +++ EYM N SLD F
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
L T Q + + ++ G+ G+ YL S L +HRDL NVL+D + K+SDF
Sbjct: 141 L--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 405 GMARIFSGNQNEANTNRVVGTYG------YMAPEYAMEGVFS 440
G++R+ + + A T T G + APE FS
Sbjct: 196 GLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEAIAFRTFS 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 13/168 (7%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G ++AVK + + EF E + KL H LV+ G C + ++ EY
Sbjct: 26 LGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ N L +L + G L+ + + + + G+ +L + IHRDL N L+D
Sbjct: 85 ISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDR 139
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFS 440
++ K+SDFGM R +Q ++ GT + APE +S
Sbjct: 140 DLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYS 183
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 6/155 (3%)
Query: 286 AVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345
AVK L + ++EF E ++ +++H NLV+LLG C +I E+M +L +L
Sbjct: 249 AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFG 405
++ + + I+ + YL + IHR+L N L+ K++DFG
Sbjct: 308 -RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 406 MARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
++R+ +G+ A+ + APE FS
Sbjct: 364 LSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFS 397
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-30
Identities = 45/187 (24%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 275 VQGILADGKE----IAVKRLSR--SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN- 327
++G L +AVK + SS + ++EF +E + H N++RLLG C++ +
Sbjct: 51 MEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110
Query: 328 ----ELLLIYEYMPNKSLDLFLFDS---TKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380
+ ++I +M L +L S T + + + + IA G+ YL S
Sbjct: 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRN 167
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEYA 434
+HRDL N +L +M ++DFG+++ I+SG+ + ++A E
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESL 221
Query: 435 MEGVFSV 441
+ V++
Sbjct: 222 ADRVYTS 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 30/188 (15%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELL 330
G+ + + AVK L S + + +E+ +++ L QH+N+V LLG C G +L
Sbjct: 67 AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 331 LIYEYMPNKSLDLFL-----------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRL 379
+I EY L FL + + + + + +A+G+ +L +
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASK 183
Query: 380 RVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEY 433
IHRD+ NVLL + KI DFG+AR I + + N + +MAPE
Sbjct: 184 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPES 237
Query: 434 AMEGVFSV 441
+ V++V
Sbjct: 238 IFDCVYTV 245
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 15/164 (9%)
Query: 281 DGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE----LLLIYE 334
E+A + + + Q FK E ++ LQH N+VR + ++L+ E
Sbjct: 50 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
M + +L +L + + K S I +GL +LH + +IHRDLK N+ +
Sbjct: 110 LMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFIT 165
Query: 395 HEM-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
+ KI D G+A + + V+GT +MAPE E
Sbjct: 166 GPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEEK 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
A+K L +S + +E +E ++A + + ++ RLLG CL + + LI + MP L +
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 106
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
+ + + ++ IA+G+ YL R++HRDL NVL+ + KI+DF
Sbjct: 107 V--REHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 405 GMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFS 440
G+A++ + E + G +MA E + +++
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYT 197
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 15/166 (9%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD----GNELLLIYE 334
L DG A+KR+ Q +E + E + H N++RL+ CL +E L+
Sbjct: 51 LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 335 YMPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
+ +L + KG L + + ++ GI RGL +H HRDLK +N+LL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILL 167
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVV-------GTYGYMAPE 432
E P + D G + + + T Y APE
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 34/190 (17%)
Query: 277 GILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLI 332
G++ + AVK L + + +E+ +++ L H N+V LLG C G L+I
Sbjct: 46 GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105
Query: 333 YEYMPNKSLDLFL---------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDS 377
EY L FL LD + +S +A+G+ +L +
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---A 162
Query: 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAP 431
IHRDL N+LL H KI DFG+AR I + + N + +MAP
Sbjct: 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK------WMAP 216
Query: 432 EYAMEGVFSV 441
E V++
Sbjct: 217 ESIFNCVYTF 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
A+K L + + ++F E +++ + H N++RL G ++++ EYM N SLD F
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
L AQ + + ++ GIA G+ YL S + +HRDL N+L++ + K+SDF
Sbjct: 137 L--RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDF 191
Query: 405 GMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFS 440
G+ R+ + A T R G + +PE F+
Sbjct: 192 GLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFT 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
A+K L + + + +F E ++ + H N++RL G +++I EYM N +LD F
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
L K + + + ++ GIA G+ YL + + +HRDL N+L++ + K+SDF
Sbjct: 137 L--REKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 405 GMARIFSGNQNEANTNRVVGTYG------YMAPEYAMEGVFS 440
G++R+ + T T G + APE F+
Sbjct: 192 GLSRVLEDDPEATYT-----TSGGKIPIRWTAPEAISYRKFT 228
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 21/178 (11%)
Query: 275 VQGILADGKE----IAVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE- 328
G L D AVK L+R + + +F E ++ H N++ LLG CL
Sbjct: 42 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L++ YM + L F+ + K I +A+G+ YL + +HRDL
Sbjct: 102 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAA 156
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG------YMAPEYAMEGVFS 440
N +LD + K++DFG+AR + V G +MA E F+
Sbjct: 157 RNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 40/176 (22%), Positives = 68/176 (38%), Gaps = 26/176 (14%)
Query: 280 ADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE---------- 328
D A+KR+ ++ EV +AKL+H +VR L+ N
Sbjct: 28 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 329 --LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
L + + ++L ++ + + + I IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDL 144
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV----------VGTYGYMAPE 432
K SN+ + K+ DFG+ ++ E VGT YM+PE
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 27/168 (16%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--------------- 325
DGK +KR+ ++ ++ + EV +AKL H N+V GC
Sbjct: 35 DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 326 -GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
L + E+ +L+ ++ + +G +LD + + I +G+ Y+H ++I+R
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINR 146
Query: 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DLK SN+ L KI DFG+ N+ R GT YM+PE
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRTRSKGTLRYMSPE 191
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 42/175 (24%), Positives = 76/175 (43%), Gaps = 26/175 (14%)
Query: 284 EIAVKRL--SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG------NELLLIYEY 335
++AVK L + ++EF E + + H ++ +L+G L ++I +
Sbjct: 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 336 MPNKSLDLFLFDS---TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
M + L FL S L + + + IA G+ YL S IHRDL N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCM 169
Query: 393 LDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEYAMEGVFSV 441
L +M ++DFG++R I+SG+ + ++A E + +++V
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK------WLALESLADNLYTV 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 30/177 (16%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
AVK L S ++ + L + +E+ ++ + +HKN++ LLG C L +I EY +L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 344 FL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
+L QL K +S +ARG+ YL + + IHRDL N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 221
Query: 391 VLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMAPEYAMEGVFSV 441
VL+ + KI+DFG+AR I + + TN + +MAPE + +++
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTH 272
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G ++AVK L + F E L+ +LQH+ LVRL + +I EY
Sbjct: 31 MGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M N SL FL + G +L + + + IA G+ ++ IHRDL+ +N+L+
Sbjct: 89 MENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSD 144
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFS 440
++ KI+DFG+AR+ N+ A G + APE G F+
Sbjct: 145 TLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTFT 188
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNE-L 329
GI AVK L ++ + +E+ ++ + H N+V LLG C L
Sbjct: 48 AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107
Query: 330 LLIYEYMPNKSLDLFL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHED 376
++I E+ +L +L + L + I +A+G+ +L
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--- 164
Query: 377 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVGTYGYMA 430
+ + IHRDL N+LL + KI DFG+AR I+ + + +MA
Sbjct: 165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK------WMA 218
Query: 431 PEYAMEGVFSV 441
PE + V+++
Sbjct: 219 PETIFDRVYTI 229
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 31/176 (17%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
A+KR+ +S ++F E+ ++ KL H N++ LLG C L L EY P+ +L
Sbjct: 56 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 344 FL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
FL ++ + L ++ + +ARG+ YL S+ + IHRDL N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 172
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFSV 441
+L+ KI+DFG++R Q V T G +MA E V++
Sbjct: 173 ILVGENYVAKIADFGLSR----GQEVY----VKKTMGRLPVRWMAIESLNYSVYTT 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
++AVK + + ++ F E ++ LQH LV+L + +I E+
Sbjct: 206 MATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M SL FL +G++ + I IA G+ ++ + IHRDL+ +N+L+
Sbjct: 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSA 319
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFSV 441
+ KI+DFG+AR+ N+ A G + APE G F++
Sbjct: 320 SLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTI 364
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 46/163 (28%), Positives = 63/163 (38%), Gaps = 14/163 (8%)
Query: 284 EIAVKRL---SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+AVK L S + + +F EV + L H+NL+RL G L + ++ E P S
Sbjct: 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGS 106
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
L L +A G+ YL R IHRDL N+LL K
Sbjct: 107 LLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVK 161
Query: 401 ISDFGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFS 440
I DFG+ R N + + + APE FS
Sbjct: 162 IGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFS 202
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 28/245 (11%)
Query: 215 AISPLDGCCSIKIGGRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEI- 273
+I L K G Y + + + + V PS V ++ I
Sbjct: 39 SIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIG 98
Query: 274 -----CV-QGIL--ADGKEI--AVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 322
CV G L DGK+I AVK L+R + + +F E ++ H N++ LLG
Sbjct: 99 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158
Query: 323 CLDGNE-LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381
CL L++ YM + L F+ + K I +A+G+ +L + +
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---ASKKF 213
Query: 382 IHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVGTYG-----YMAPEYAM 435
+HRDL N +LD + K++DFG+AR ++ + + T +MA E
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMALESLQ 269
Query: 436 EGVFS 440
F+
Sbjct: 270 TQKFT 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 280 ADGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEY 335
+DGK + K + Q +EV L+ +L+H N+VR +D L ++ EY
Sbjct: 29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 336 MPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNVL 392
L + + + LD + + ++ + L H D V+HRDLK +NV
Sbjct: 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
LD + N K+ DFG+ARI + + + A T VGT YM+PE
Sbjct: 149 LDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPE 186
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 20/163 (12%)
Query: 286 AVKRL--SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
AVK L + E E ++ +L + +VR++G C +L+ E L+
Sbjct: 48 AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNK 106
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
+L + + K I +++ ++ G+ YL +HRDL NVLL + KISD
Sbjct: 107 YL---QQNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISD 160
Query: 404 FGMARIFSGNQNEANTNRVVGTYG------YMAPEYAMEGVFS 440
FG+++ ++N + APE FS
Sbjct: 161 FGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFS 198
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 46/179 (25%), Positives = 71/179 (39%), Gaps = 21/179 (11%)
Query: 275 VQGILADGKE----IAVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE- 328
G D + A+K LSR + Q ++ F E L+ L H N++ L+G L
Sbjct: 38 YHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
++ YM + L F+ K IS +ARG+ YL + + +HRDL
Sbjct: 98 PHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAA 152
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG------YMAPEYAMEGVFSV 441
N +LD K++DFG+AR + V + A E F+
Sbjct: 153 RNCMLDESFTVKVADFGLARDI----LDREYYSVQQHRHARLPVKWTALESLQTYRFTT 207
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
A+K L +S + +E +E ++A + + ++ RLLG CL + + LI + MP L +
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 106
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
+ + + + ++ IA+G+ YL R++HRDL NVL+ + KI+DF
Sbjct: 107 VRE--HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 405 GMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFS 440
G+A++ + E + G +MA E + +++
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYT 197
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL-DGNELLLIYEYMPNKS 340
G ++AVK + + Q F E +++ +L+H NLV+LLG + + L ++ EYM S
Sbjct: 216 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
L +L S + L + + + YL +HRDL NVL+ + K
Sbjct: 274 LVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAK 329
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGY--MAPEYAMEGVFS 440
+SDFG+ + EA++ + G APE E FS
Sbjct: 330 VSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE-LLLIYEYMP 337
G ++AVK + + Q F E +++ +L+H NLV+LLG ++ L ++ EYM
Sbjct: 41 DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
SL +L S + L + + + YL +HRDL NVL+ +
Sbjct: 99 KGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 154
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGY--MAPEYAMEGVFS 440
K+SDFG+ + EA++ + G APE E FS
Sbjct: 155 VAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 286 AVKRLSRSSG-QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
+K + SG Q Q + + I L H ++VRLLG C G+ L L+ +Y+P SL
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDH 104
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
+ L + ++ IA+G+ YL ++HR+L NVLL +++DF
Sbjct: 105 V--RQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADF 159
Query: 405 GMARIFSGNQNEANTNRVVGTYG-----YMAPEYAMEGVFS 440
G+A + + + + +MA E G ++
Sbjct: 160 GVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYT 195
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 21/175 (12%)
Query: 276 QGIL-ADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
QG+ K+I A+K L + +E E ++ +L + +VRL+G C L+L
Sbjct: 28 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 86
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
+ E L FL K ++ +++ ++ G+ YL +HRDL NV
Sbjct: 87 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNV 141
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYG------YMAPEYAMEGVFS 440
LL + KISDFG+++ + + + APE FS
Sbjct: 142 LLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFRKFS 191
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 30/171 (17%)
Query: 284 EIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
E+ +K L ++ + F ++++KL HK+LV G C+ G+E +L+ E++ SLD
Sbjct: 42 EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP---- 399
+L ++ ++ + +A + +L +IH ++ N+LL E +
Sbjct: 102 YL--KKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGN 156
Query: 400 ----KISDFGMARIFSGNQNEANTNRVVGTYGY-----MAPEYAMEG-VFS 440
K+SD G++ + PE +
Sbjct: 157 PPFIKLSDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLN 196
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 39/197 (19%)
Query: 275 VQGILADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELL 330
GI G I AVK L ++ + +E+ ++ +L H+N+V LLG C +
Sbjct: 66 AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125
Query: 331 LIYEYMPNKSLDLFL--------------------FDSTKGAQLDWKRRISIINGIARGL 370
LI+EY L +L + L ++ + +A+G+
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 371 LYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTN-----RVVG 424
+L +HRDL NVL+ H KI DFG+AR I S + N +
Sbjct: 186 EFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK--- 239
Query: 425 TYGYMAPEYAMEGVFSV 441
+MAPE EG++++
Sbjct: 240 ---WMAPESLFEGIYTI 253
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 29/176 (16%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
D + A+K++ + + L +EV L+A L H+ +VR L+ + + KS
Sbjct: 30 DSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 341 LDLF----------LFD--STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
LF L+D ++ + I L Y+H +IHRDLK
Sbjct: 89 -TLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKP 144
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANT------------NRVVGTYGYMAPE 432
N+ +D N KI DFG+A+ + + +GT Y+A E
Sbjct: 145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G +A+K L + + F E ++ KL+H+ LV+L + + ++ EY
Sbjct: 202 MGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M SL FL G L + + + IA G+ Y+ R+ +HRDL+ +N+L+
Sbjct: 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGE 315
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ K++DFG+AR+ N+ A + APE A+ G F+
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 359
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 17/156 (10%)
Query: 282 GKEIAVKRLSRSSGQGLQEFK-NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
G + AVK++ L+ F+ E+ A L +V L G +G + + E + S
Sbjct: 83 GFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP- 399
L + + L R + + GL YLH R++H D+K NVLL + +
Sbjct: 137 LGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 400 KISDFGMARIFSGNQNEANTNR---VVGTYGYMAPE 432
+ DFG A + + + GT +MAPE
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 281 DGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL--VRLLGCCLDGNELLLIYEYM 336
+ A+K ++ Q L ++NE+ + KLQ + +RL + + ++ E
Sbjct: 51 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG 110
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
++DL + K +D R S + + +H+ ++H DLK +N L+ +
Sbjct: 111 ---NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-D 162
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG+A + + VGT YM PE
Sbjct: 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 276 QGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
G +A+K L + + F E ++ KL+H+ LV+L + + ++ EY
Sbjct: 285 MGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M SL FL G L + + + IA G+ Y+ R+ +HRDL+ +N+L+
Sbjct: 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGE 398
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ K++DFG+AR+ N+ A + APE A+ G F+
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 442
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 44/152 (28%), Positives = 85/152 (55%), Gaps = 11/152 (7%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
G+E+A+++++ + NE+ ++ + ++ N+V L L G+EL ++ EY+ SL
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 342 DLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
D +D + +I+ + + L +LH + +VIHRD+K+ N+LL + + K
Sbjct: 105 T----DVVTETCMD-EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK 156
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++DFG + Q++ +T +VGT +MAPE
Sbjct: 157 LTDFGFCAQITPEQSKRST--MVGTPYWMAPE 186
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 281 DGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL--VRLLGCCLDGNELLLIYEYM 336
+ A+K ++ Q L ++NE+ + KLQ + +RL + + ++ E
Sbjct: 32 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
++DL + K +D R S + + +H+ ++H DLK +N L+ +
Sbjct: 91 --GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-D 143
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG+A + + VGT YM PE
Sbjct: 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 41/154 (26%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G A K + S + L+++ E+ ++A H +V+LLG +L ++ E+ P
Sbjct: 42 ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101
Query: 340 SLDLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
++D + + +G I ++ + L +LH R+IHRDLK NVL+ E +
Sbjct: 102 AVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGD 155
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+++DFG++ + ++ +GT +MAPE
Sbjct: 156 IRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPE 187
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
G+++AVK + Q + NEV ++ QH N+V + L G EL ++ E++ +L
Sbjct: 70 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 342 DLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
D +L+ + +I+ + + + L YLH VIHRD+K+ ++LL + K
Sbjct: 130 T----DIVSQVRLN-EEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVK 181
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+SDFG S + + + +VGT +MAPE
Sbjct: 182 LSDFGFCAQISKDVPKRKS--LVGTPYWMAPE 211
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 15/172 (8%)
Query: 276 QGIL-ADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLL 331
QG+ K+I A+K L + +E E ++ +L + +VRL+G C L+L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 412
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
+ E L FL K ++ +++ ++ G+ YL +HR+L NV
Sbjct: 413 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT---YGYMAPEYAMEGVFS 440
LL + KISDFG+++ + + + APE FS
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFS 517
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 39/158 (24%), Positives = 65/158 (41%), Gaps = 12/158 (7%)
Query: 286 AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF 344
A+K + +S ++F E + + H ++V+L+G N + +I E L F
Sbjct: 47 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF 105
Query: 345 LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDF 404
L + LD I ++ L YL R +HRD+ NVL+ K+ DF
Sbjct: 106 L--QVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 405 GMARIFSGNQNEANTNRVVGTY--GYMAPEYAMEGVFS 440
G++R ++ G +MAPE F+
Sbjct: 161 GLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 195
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 276 QGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL--VRLLGCCLDGNELLL 331
Q + + A+K ++ Q L ++NE+ + KLQ + +RL + + +
Sbjct: 74 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
+ E ++DL + K +D R S + + +H+ ++H DLK +N
Sbjct: 134 VMEC---GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANF 186
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L+ + K+ DFG+A + + VG YM PE
Sbjct: 187 LIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 35/169 (20%), Positives = 65/169 (38%), Gaps = 22/169 (13%)
Query: 281 DGKEI--AVKRLSR-SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
G++I AVK + + ++F +E ++ L H ++V+L+G +I E P
Sbjct: 37 KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELYP 95
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L +L L + I + + YL + +HRD+ N+L+
Sbjct: 96 YGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPE 150
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYG------YMAPEYAMEGVFS 440
K+ DFG++R + +M+PE F+
Sbjct: 151 CVKLGDFGLSRYIEDEDYYKAS-------VTRLPIKWMSPESINFRRFT 192
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNK 339
D +++AVKR+ EV L+ + +H N++R D + E
Sbjct: 47 DNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT 103
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-----D 394
+ K I+++ GL +LH L ++HRDLK N+L+
Sbjct: 104 LQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAH 157
Query: 395 HEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPE 432
++ ISDFG+ + + ++ + + V GT G++APE
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 39/155 (25%), Positives = 53/155 (34%), Gaps = 12/155 (7%)
Query: 281 DGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMP 337
DG+ AVK + EV K+ QH VRL +G L L E
Sbjct: 81 DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG 140
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L GA L + + L +LH ++H D+K +N+ L
Sbjct: 141 P---SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRG 194
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG+ G YMAPE
Sbjct: 195 RCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 12/170 (7%)
Query: 276 QGIL--ADGKEI--AVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELL 330
QGI + + A+K + +S ++F E + + H ++V+L+G + N +
Sbjct: 408 QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
+I E L FL + LD I ++ L YL R +HRD+ N
Sbjct: 467 IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARN 521
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
VL+ K+ DFG++R + + + +MAPE F+
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFT 570
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 282 GKEIAVKRLS---RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ +A+K++S + S + Q+ EV + KL+H N ++ GC L + L+ EY
Sbjct: 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138
Query: 339 KSLDLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
+ DL L + I+ + +G +GL YLH +IHRD+K N+LL
Sbjct: 139 SASDLLEVHKKP---LQ-EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPG 191
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG + AN+ VGT +MAPE
Sbjct: 192 LVKLGDFG----SASIMAPANS--FVGTPYWMAPE 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 13/171 (7%)
Query: 269 SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE 328
S + G+ +A+K++ LQE E++++ + ++V+ G +
Sbjct: 41 SYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98
Query: 329 LLLIYEYMPNKSL-DLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDL 386
L ++ EY S+ D+ + L + I+ I +GL YLH R IHRD+
Sbjct: 99 LWIVMEYCGAGSVSDII---RLRNKTLT-EDEIATILQSTLKGLEYLHFM---RKIHRDI 151
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
K N+LL+ E + K++DFG+A + + NT V+GT +MAPE E
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEI 200
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 7e-25
Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 9/130 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL-FLFDSTKGAQLDWKRRISI 362
E++L+ +L H N+V+LL N+L L++E++ DL D++ + S
Sbjct: 52 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSY 108
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV 422
+ + +GL + H RV+HRDLK N+L++ E K++DFG+AR F G T+ V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 423 VGTYGYMAPE 432
V T Y APE
Sbjct: 165 V-TLWYRAPE 173
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 279 LADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
K +A+K + + +++ + E+T++++ + + G L +L +I EY+
Sbjct: 44 NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
S D + LD + +I+ I I +GL YLH + + IHRD+K +NVLL
Sbjct: 104 GGSAL----DLLEPGPLD-ETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH 155
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
K++DFG+A + Q + NT VGT +MAPE +
Sbjct: 156 GEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E+ L+ +L+HKN+VRL +L L++E+ DL + + LD + S +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ +GL + H V+HRDLK N+L++ K+++FG+AR F G + VV
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
Query: 424 GTYGYMAPE 432
T Y P+
Sbjct: 164 -TLWYRPPD 171
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 28/174 (16%)
Query: 281 DGKEIAVKRLSRSSGQGLQEF-----------------KNEVTLIAKLQHKNLVRLLGCC 323
D K A+K+ +S + ++F KNE+ +I ++++ + G
Sbjct: 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112
Query: 324 LDGNELLLIYEYMPNKSL-----DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSR 378
+ +E+ +IYEYM N S+ F+ D + + II + Y+H +
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NE 170
Query: 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ HRD+K SN+L+D K+SDFG + + GTY +M PE
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPE 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 282 GKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGC--CLDGNELLLIYEYMPN 338
G A+K + S + E ++ KL HKN+V+L +LI E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----D 394
SL L + + L + ++ + G+ +L E ++HR++K N++ D
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGED 150
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ K++DFG AR ++ + + GT Y+ P+
Sbjct: 151 GQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEYLHPD 185
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 282 GKEIAVKRLSRSSGQGLQEF-KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
G +A K + ++ E+ ++ + +V G E+ + E+M S
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
LD L K ++ + + + +GL YL E +++HRD+K SN+L++ K
Sbjct: 118 LDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 172
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ DFG++ + AN+ VGT YM+PE
Sbjct: 173 LCDFGVSGQLIDSM--ANSF--VGTRSYMSPE 200
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 17/158 (10%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
K + V + + S G ++ K E ++ L+H ++V LL L +++E+M
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD-- 112
Query: 343 LFLFDS--TKGAQLDW---KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L + + I L Y H+ +IHRD+K VLL +
Sbjct: 113 --LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKE 167
Query: 398 NP---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N K+ FG+A + A VGT +MAPE
Sbjct: 168 NSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPE 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 40/129 (31%), Positives = 67/129 (51%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E++L+ +L H N+V L+ L L++E+M DL L + +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYL 125
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ RG+ + H+ R++HRDLK N+L++ + K++DFG+AR F G + T+ VV
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 424 GTYGYMAPE 432
T Y AP+
Sbjct: 182 -TLWYRAPD 189
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 20/159 (12%)
Query: 282 GKEIAVKRLSRSS--GQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
G E+A+K + + + G+ + +NEV + +L+H +++ L D N + L+ E N
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 339 KSLDLFLFD--STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
+ + ++ I G+LYLH ++HRDL SN+LL
Sbjct: 96 GEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRN 148
Query: 397 MNPKISDFGMARIFSGNQNEANTNR---VVGTYGYMAPE 432
MN KI+DFG+A Q + + + GT Y++PE
Sbjct: 149 MNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPE 182
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E++++ +L+H N+V+L L+L++E++ DL L+ S +
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFL 106
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ G+ Y H+ RV+HRDLK N+L++ E KI+DFG+AR F G T+ +V
Sbjct: 107 LQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 424 GTYGYMAPE 432
T Y AP+
Sbjct: 163 -TLWYRAPD 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
EV+L+ L+H N+V L L L++EY+ DL + G ++ +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFL 106
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ RGL Y H +V+HRDLK N+L++ K++DFG+AR + N VV
Sbjct: 107 FQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
Query: 424 GTYGYMAPE 432
T Y P+
Sbjct: 163 -TLWYRPPD 170
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 42/134 (31%), Positives = 71/134 (52%), Gaps = 13/134 (9%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL-FLFDSTKGAQLDWKRRISI 362
E++L+ +L+H+N+VRL N+L L++E+M DL DS +++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNL 109
Query: 363 INGIA----RGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 418
+ +GL + HE+ +++HRDLK N+L++ K+ DFG+AR F G
Sbjct: 110 VKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 419 TNRVVGTYGYMAPE 432
++ VV T Y AP+
Sbjct: 166 SSEVV-TLWYRAPD 178
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 282 GKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGC--CLDGNELLLIYEYMPN 338
G A+K + S + E ++ KL HKN+V+L +LI E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----D 394
SL L + + L + ++ + G+ +L E ++HR++K N++ D
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGED 150
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ K++DFG AR ++ + + GT Y+ P+
Sbjct: 151 GQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEYLHPD 185
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-23
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 282 GKEIAVKRLS-RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+++A+KR++ + E E+ +++ H N+V + +EL L+ + + S
Sbjct: 40 KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 341 L-DLFLFDSTKGAQLDWK---RRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ D+ KG I+ I + GL YLH++ IHRD+K N+LL
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGE 156
Query: 396 EMNPKISDFGM-ARIFSGNQNEANTNR--VVGTYGYMAPE 432
+ + +I+DFG+ A + +G N R VGT +MAPE
Sbjct: 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 9e-23
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E+ ++ +L+H NLV LL L L++EY + + SI
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSIT 108
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+ + + H + IHRD+K N+L+ K+ DFG AR+ ++ + V
Sbjct: 109 WQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
Query: 424 GTYGYMAPE 432
T Y +PE
Sbjct: 165 -TRWYRSPE 172
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 282 GKEIAVKRLSRSSG-QGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G+ +AVKR+ + + ++ ++ ++ + +V+ G + + E M +
Sbjct: 47 GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-ST 105
Query: 340 SLDLFLFDSTKGAQLDWKRRIS------IINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
S D F K I I + L +L E+ L++IHRD+K SN+LL
Sbjct: 106 SFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILL 159
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
D N K+ DFG++ + + G YMAPE
Sbjct: 160 DRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPE 195
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 32/160 (20%), Positives = 60/160 (37%), Gaps = 15/160 (9%)
Query: 282 GKEIAVKR--LSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G+ + V+R L S + + + E+ + H N+V + NEL ++ +M
Sbjct: 52 GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 111
Query: 340 SL-DLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
S DL G I+ I G+ + L Y+H +HR +K S++L+ +
Sbjct: 112 SAKDLICTHFMDGMNELA---IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDG 165
Query: 398 NPKISDFGMARIFSGNQNEANT-----NRVVGTYGYMAPE 432
+S + V +++PE
Sbjct: 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 41/172 (23%), Positives = 66/172 (38%), Gaps = 19/172 (11%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCL-------DGNELL 330
+ G+E A+KRL + + + EV + KL H N+V+ G
Sbjct: 50 VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L+ + L FL L + I R + ++H + +IHRDLK N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVEN 168
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNR----------VVGTYGYMAPE 432
+LL ++ K+ DFG A S + + + + T Y PE
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 44/171 (25%), Positives = 65/171 (38%), Gaps = 25/171 (14%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G+ +AVKR+ E+ L+ + H N++R L + E
Sbjct: 38 QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN 94
Query: 340 SLDLFL---FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
DL IS++ IA G+ +LH L++IHRDLK N+L+
Sbjct: 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTS 151
Query: 397 MNP-------------KISDFGMARIFSGNQN--EANTNRVVGTYGYMAPE 432
ISDFG+ + Q+ N N GT G+ APE
Sbjct: 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 15/157 (9%)
Query: 282 GKEIAVKRLSRSSG-----QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G+ +AVKR+ + + L + + + V G ++ + E M
Sbjct: 32 GQIMAVKRIRATVNSQEQKRLLMDLD---ISMRTVDCPFTVTFYGALFREGDVWICMELM 88
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ SLD F Q + + I I + L +LH S+L VIHRD+K SNVL++
Sbjct: 89 -DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINA 145
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG++ ++ + G YMAPE
Sbjct: 146 LGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPE 179
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 29/163 (17%)
Query: 282 GKEIAVKRLSRSS--GQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ A K + +S +E E+++ L H+++V G D + + ++ E
Sbjct: 40 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99
Query: 339 KSLDLFLFDSTKGAQLDWKRRIS------IINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
+SL + K ++ ++ + I G YLH R RVIHRDLK N+
Sbjct: 100 RSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLF 147
Query: 393 LDHEMNPKISDFGMARIFSGNQNEANTNR---VVGTYGYMAPE 432
L+ ++ KI DFG+A + E + R + GT Y+APE
Sbjct: 148 LNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPE 185
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 39/177 (22%), Positives = 61/177 (34%), Gaps = 32/177 (18%)
Query: 279 LADGKEIAVKR--LSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEY 335
DG A+KR + Q EV A L QH ++VR + + +L+ EY
Sbjct: 33 RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92
Query: 336 MPNKSL-DLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
SL D + + ++ + RGL Y+H ++H D+K SN+ +
Sbjct: 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFIS 149
Query: 395 HEMNP-------------------KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
P KI D G S + G ++A E
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS------SPQVEEGDSRFLANE 200
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 43/129 (33%), Positives = 70/129 (54%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E+ L+ +L H N++ LL + + L++++M DL + L + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYM 118
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
+GL YLH+ ++HRDLK +N+LLD K++DFG+A+ F G+ N A T++VV
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
Query: 424 GTYGYMAPE 432
T Y APE
Sbjct: 175 -TRWYRAPE 182
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 36/155 (23%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
A G+ K ++ KNE++++ +L H L+ L D E++LI E++
Sbjct: 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL--S 131
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
+LF + + ++ I+ + GL ++HE ++H D+K N++ + +
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKAS 188
Query: 400 --KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI DFG+A + ++ T + APE
Sbjct: 189 SVKIIDFGLATKLNPDE---IVKVTTATAEFAAPE 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 29/163 (17%)
Query: 282 GKEIAVKRLSRSS--GQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ A K + +S +E E+++ L H+++V G D + + ++ E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 339 KSLDLFLFDSTKGAQLDWKRRIS------IINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
+SL + K ++ ++ + I G YLH R RVIHRDLK N+
Sbjct: 126 RSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLF 173
Query: 393 LDHEMNPKISDFGMARIFSGNQNEANTNR---VVGTYGYMAPE 432
L+ ++ KI DFG+A + E + R + GT Y+APE
Sbjct: 174 LNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPE 211
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 37/129 (28%), Positives = 58/129 (44%), Gaps = 8/129 (6%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISII 363
E+ L+ +L+H+NLV LL C L++E++ + LD++ +
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYL 130
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVV 423
I G+ + H +IHRD+K N+L+ K+ DFG AR E + V
Sbjct: 131 FQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
Query: 424 GTYGYMAPE 432
T Y APE
Sbjct: 187 -TRWYRAPE 194
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
A G ++A K + + +E KNE++++ +L H NL++L N+++L+ EY+
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 340 SLDLFLFDS--TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
LFD + L I + I G+ ++H+ + ++H DLK N+L +
Sbjct: 172 E----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRD 224
Query: 398 NP--KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI DFG+AR + + GT ++APE
Sbjct: 225 AKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPE 258
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 18/160 (11%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDG------NELLLIYE 334
G+ A+K + +G +E K E+ ++ K H+N+ G + ++L L+ E
Sbjct: 49 GQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107
Query: 335 YMPNKSL-DLFLFDSTKGAQLDWKRRISII-NGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
+ S+ DL +TKG L + I+ I I RGL +LH+ +VIHRD+K NVL
Sbjct: 108 FCGAGSVTDLI--KNTKGNTLK-EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVL 161
Query: 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L K+ DFG++ NT +GT +MAPE
Sbjct: 162 LTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 199
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-22
Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 10/155 (6%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
A G A K + + + E+ ++ L+H LV L D NE+++IYE+M
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM--S 237
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
+LF + + ++ + + + +GL ++HE +H DLK N++ + +
Sbjct: 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSN 294
Query: 400 --KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG+ Q + GT + APE
Sbjct: 295 ELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPE 326
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 27/176 (15%)
Query: 281 DGKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLL--GCCLDGNELLLIY---E 334
+G+ + +K L S Q E +A++ H ++V++ D + + Y E
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
Y+ +SL G +L I+ + I L YLH + +++ DLK N++L
Sbjct: 165 YVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLT 216
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG------VFSVNRM 444
E K+ D G + + GT G+ APE G +++V R
Sbjct: 217 EE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTGPTVATDIYTVGRT 265
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 282 GKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLL------GCCLDGNELLLIYE 334
G+++A+K+ + +E + E+ ++ KL H N+V + LL E
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
Y L +L L ++++ I+ L YLHE R+IHRDLK N++L
Sbjct: 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQ 155
Query: 395 ---HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ KI D G A+ + VGT Y+APE
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGEL-CTE--FVGTLQYLAPE 193
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 47/167 (28%), Positives = 86/167 (51%), Gaps = 23/167 (13%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMPN 338
D K+ A+K++ +G + + E+ L+ +L+H N++ L L + + L+++Y
Sbjct: 47 DDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-- 102
Query: 339 KSLDLF-LFDSTKGAQLDWKRRI-------SIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
DL+ + + ++ + K S++ I G+ YLH + V+HRDLK +N
Sbjct: 103 -EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPAN 158
Query: 391 VLLDHEMNP----KISDFGMARIFSG-NQNEANTNRVVGTYGYMAPE 432
+L+ E KI+D G AR+F+ + A+ + VV T+ Y APE
Sbjct: 159 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 33/157 (21%), Positives = 67/157 (42%), Gaps = 15/157 (9%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
+ K K + G K E++++ +H+N++ L EL++I+E++
Sbjct: 28 SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86
Query: 340 SLDLFLFD--STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
+F+ +T +L+ + +S ++ + L +LH + H D++ N++
Sbjct: 87 D----IFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRR 139
Query: 398 NP--KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ KI +FG AR N + Y APE
Sbjct: 140 SSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPE 173
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 42/135 (31%), Positives = 62/135 (45%), Gaps = 16/135 (11%)
Query: 304 EVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF-LFDSTKGAQLDWKRRISI 362
EV+L+ +LQH+N++ L + L LI+EY DL D + + S
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPD--VSMRVIKSF 137
Query: 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-----KISDFGMARIFSGNQNEA 417
+ + G+ + H R +HRDLK N+LL KI DFG+AR F G
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 418 NTNRVVGTYGYMAPE 432
T+ ++ T Y PE
Sbjct: 194 FTHEII-TLWYRPPE 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 304 EVTLIAKLQHKNLVRLLGCC--------LDGNELLLIYEYMPNKSLDLFLFDSTKGAQLD 355
E+ ++ L+H+N+V L+ C + L++++ DL S +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFT 122
Query: 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415
++ + GL Y+H + +++HRD+K +NVL+ + K++DFG+AR FS +N
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 416 EAN---TNRVVGTYGYMAPE 432
TNRVV T Y PE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 32/152 (21%), Positives = 55/152 (36%), Gaps = 13/152 (8%)
Query: 291 SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK 350
SS + ++ + KN V L L + + ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 351 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410
+ + I IA + +LH ++HRDLK SN+ + K+ DFG+
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 411 SGNQNEANTN----------RVVGTYGYMAPE 432
++ E VGT YM+PE
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 41/180 (22%), Positives = 69/180 (38%), Gaps = 41/180 (22%)
Query: 274 CVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLI 332
C+ L +E AVK + + G EV ++ + Q H+N++ L+ + + L+
Sbjct: 32 CIN--LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLR 380
+E M S+ I ++ +A L +LH
Sbjct: 90 FEKMRGGSI----LS-----------HIHKRRHFNELEASVVVQDVASALDFLHN---KG 131
Query: 381 VIHRDLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNR-----VVGTYGYMAPE 432
+ HRDLK N+L +H KI DF + N + + + G+ YMAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 28/162 (17%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
A K++ + + + FK E+ ++ L H N++RL D ++ L+ E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE- 92
Query: 342 DLFLFD--------STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
LF+ A I+ + + Y H+ L V HRDLK N L
Sbjct: 93 ---LFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHK---LNVAHRDLKPENFLF 139
Query: 394 ---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ K+ DFG+A F + VGT Y++P+
Sbjct: 140 LTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 4e-21
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 38/168 (22%)
Query: 282 GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G E A K ++ S + Q+ + E + KLQH N+VRL + + L+++ +
Sbjct: 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90
Query: 340 SLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRDLK 387
LF+ I I I + Y H ++HR+LK
Sbjct: 91 E----LFE-----------DIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLK 132
Query: 388 TSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL + K++DFG+A + ++ + GT GY++PE
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPE 177
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 30/166 (18%)
Query: 280 ADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+E AVK ++++ + EV L+ KL H N+++L D + ++ E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 338 NKSLDLFLFD--------STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
LFD S A II + G+ Y+H+ ++HRDLK
Sbjct: 105 GGE----LFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK---HNIVHRDLKPE 150
Query: 390 NVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL + + + KI DFG++ F N +GT Y+APE
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPE 193
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 19/162 (11%)
Query: 280 ADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ G E +K +++ Q +++ + E+ ++ L H N++++ D + + ++ E
Sbjct: 45 SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 339 KSLDLFLFD-----STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
L + +G L ++ + L Y H V+H+DLK N+L
Sbjct: 105 GE----LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILF 157
Query: 394 ---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI DFG+A +F ++ ++ GT YMAPE
Sbjct: 158 QDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPE 196
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 17/156 (10%)
Query: 282 GKEIAVKRLSRS----SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+A+K L ++ +G Q + EV + + L+H N++RL G D + LI EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92
Query: 338 NKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
++ + K ++ D +R + I +A L Y H RVIHRD+K N+LL
Sbjct: 93 LGTV----YRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSA 145
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI+DFG +S + + + GT Y+ PE
Sbjct: 146 GELKIADFG----WSVHAPSSRRTDLCGTLDYLPPE 177
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 18/157 (11%)
Query: 282 GKEIAVKRLSRSSG-----QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G IAVK++ RS + L + ++ +V+ G + ++ + E M
Sbjct: 50 GHVIAVKQMRRSGNKEENKRILMDLD---VVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
+ ++++ I + L YL E VIHRD+K SN+LLD
Sbjct: 107 -GTCAEKLKKRMQGPIPERILGKMTV--AIVKALYYLKEK--HGVIHRDVKPSNILLDER 161
Query: 397 MNPKISDFGMARIFSGN-QNEANTNRVVGTYGYMAPE 432
K+ DFG SG ++ +R G YMAPE
Sbjct: 162 GQIKLCDFG----ISGRLVDDKAKDRSAGCAAYMAPE 194
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 282 GKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+ +AVK + E K E+ + L H+N+V+ G +GN L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 341 LDLFLFDSTKGAQLDWKRRIS----------IINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L FD +++ + ++ G+ YLH + + HRD+K N
Sbjct: 92 L----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGITHRDIKPEN 135
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+LLD N KISDFG+A +F N E N++ GT Y+APE
Sbjct: 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 43/173 (24%)
Query: 282 GKEIAVKRLSRSSGQGL---------QEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLL 331
KE AVK + + G + EV ++ K+ H N+++L L
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRL 379
+++ M L FD + I+ + + LH+ L
Sbjct: 102 VFDLMKKGEL----FD-----------YLTEKVTLSEKETRKIMRALLEVICALHK---L 143
Query: 380 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++HRDLK N+LLD +MN K++DFG + + V GT Y+APE
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 38/168 (22%)
Query: 282 GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G E A K ++ S + Q+ + E + KLQH N+VRL + + L+++ +
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 340 SLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRDLK 387
LF+ I I I + Y H ++HR+LK
Sbjct: 114 E----LFE-----------DIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLK 155
Query: 388 TSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL + K++DFG+A + ++ + GT GY++PE
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPE 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 282 GKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+ +AVK + E K E+ + L H+N+V+ G +GN L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 341 LDLFLFDSTKGAQLDWKRRIS----------IINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L FD +++ + ++ G+ YLH + + HRD+K N
Sbjct: 92 L----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGITHRDIKPEN 135
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+LLD N KISDFG+A +F N E N++ GT Y+APE
Sbjct: 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 30/166 (18%)
Query: 280 ADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
E A+K + ++ S + EV ++ L H N+++L D L+ E
Sbjct: 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 338 NKSLDLFLFD--------STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
LFD + A II + G+ YLH+ ++HRDLK
Sbjct: 120 GGE----LFDEIIHRMKFNEVDAA-------VIIKQVLSGVTYLHK---HNIVHRDLKPE 165
Query: 390 NVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL + + KI DFG++ +F + +GT Y+APE
Sbjct: 166 NLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE 208
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 282 GKEIAVK--RLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
++A+K + + + F+ EV ++L H+N+V ++ + + L+ EY+
Sbjct: 36 NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
+L ++ L I+ N I G+ + H +R++HRD+K N+L+D
Sbjct: 96 PTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKT 149
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA 434
KI DFG+A+ S TN V+GT Y +PE A
Sbjct: 150 LKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQA 184
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 42/172 (24%)
Query: 282 GKEIAVKRLSRSSGQGLQE--------FKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLI 332
G E AVK + ++ + E + E ++ ++ H +++ L+ + + L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLR 380
++ M L FD + SI+ + + +LH
Sbjct: 179 FDLMRKGEL----FD-----------YLTEKVALSEKETRSIMRSLLEAVSFLHA---NN 220
Query: 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++HRDLK N+LLD M ++SDFG + + + GT GY+APE
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPE 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 38/170 (22%)
Query: 280 ADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+E AVK ++++ + EV L+ KL H N+++L D + ++ E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 338 NKSLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRD 385
LFD I II + G+ Y+H+ ++HRD
Sbjct: 105 GGE----LFD-----------EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRD 146
Query: 386 LKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
LK N+LL + + + KI DFG++ F N +GT Y+APE
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPE 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 283 KEIAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
K I ++ + G +E + EV+++ ++ H N++ L + +++LI E +
Sbjct: 43 KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE- 101
Query: 342 DLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP- 399
LFD + L + S I I G+ YLH ++ H DLK N++L + P
Sbjct: 102 ---LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155
Query: 400 ---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG+A + GT ++APE
Sbjct: 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE 188
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 16/156 (10%)
Query: 283 KEIAVKRLS-RSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
K I ++ G +E + EV+++ ++ H N++ L + +++LI E +
Sbjct: 43 KFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE- 101
Query: 342 DLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP- 399
LFD + L + S I I G+ YLH ++ H DLK N++L + P
Sbjct: 102 ---LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155
Query: 400 ---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K+ DFG+A + GT ++APE
Sbjct: 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE 188
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 31/167 (18%)
Query: 280 ADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G+E AVK +S+ + EV L+ +L H N+++L D L+ E
Sbjct: 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108
Query: 337 PNKSLDLFLFD--------STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
LFD S A II + G+ Y+H+ +++HRDLK
Sbjct: 109 TGGE----LFDEIISRKRFSEVDAA-------RIIRQVLSGITYMHK---NKIVHRDLKP 154
Query: 389 SNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL + N +I DFG++ F ++ +GT Y+APE
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPE 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 45/138 (32%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 304 EVTLIAKLQ---HKNLVRLLGCC-----LDGNELLLIYEYMPNKSLDL-FLFDSTKGAQL 354
EV ++ L+ H N+VRL C +L L++E++ DL D +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGV 117
Query: 355 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 414
+ ++ + RGL +LH RV+HRDLK N+L+ K++DFG+ARI+S
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 415 NEANTNRVVGTYGYMAPE 432
T+ VV T Y APE
Sbjct: 175 AL--TSVVV-TLWYRAPE 189
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 37/168 (22%)
Query: 282 GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G+E A ++ S + Q+ + E + L+H N+VRL + LI++ +
Sbjct: 36 GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95
Query: 340 SLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRDLK 387
LF+ I I I +L+ H+ + V+HR+LK
Sbjct: 96 E----LFE-----------DIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLK 137
Query: 388 TSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL ++ K++DFG+A G Q GT GY++PE
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPE 183
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 45/176 (25%), Positives = 69/176 (39%), Gaps = 43/176 (24%)
Query: 274 CVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLI 332
C+ A E AVK + +S E+ ++ + QH N++ L DG + ++
Sbjct: 41 CIH--KATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLR 380
E M L D +I +++ I + + YLH
Sbjct: 95 TELMKGGEL----LD-----------KILRQKFFSEREASAVLFTITKTVEYLHA---QG 136
Query: 381 VIHRDLKTSNVLL-DHEMNP---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
V+HRDLK SN+L D NP +I DFG A+ T T ++APE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPE 190
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 282 GKEIAVKRLSRS--SGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+A+K L +S +G++ + E+ + + L+H N++R+ D + L+ E+ P
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 339 KSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L + K + D +R + + +A L Y H +VIHRD+K N+L+ ++
Sbjct: 99 GEL----YKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKG 151
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI+DFG +S + + GT Y+ PE
Sbjct: 152 ELKIADFG----WSVHAPSLRRRTMCGTLDYLPPE 182
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 304 EVTLIAKLQ---HKNLVRLLGCCLDGNE-----LLLIYEYMPNKSLDL-FLFDSTKGAQL 354
EV L+ +L+ H N+VRL+ C + L++E++ DL D L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGL 117
Query: 355 DWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQ 414
+ ++ RGL +LH + ++HRDLK N+L+ K++DFG+ARI+S
Sbjct: 118 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 415 NEANTNRVVGTYGYMAPE 432
T VV T Y APE
Sbjct: 175 A--LTPVVV-TLWYRAPE 189
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 10/156 (6%)
Query: 282 GKEIAVKRLSR--SSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ +A+K +S SS + + E +LQ ++V + +L + +
Sbjct: 59 ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
L L + L R ++I+ I L H HRD+K N+L+ +
Sbjct: 119 VDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDF 172
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA 434
+ DFG+A + + VGT YMAPE
Sbjct: 173 AYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERF 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 15/159 (9%)
Query: 282 GKEIAVKRLSRSS----GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEY 335
AVK L + G K E+ L+ +L+HKN+++L+ + + + ++ EY
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRI--SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
++ K + +I+G+ YLH ++H+D+K N+LL
Sbjct: 90 CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH---SQGIVHKDIKPGNLLL 142
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KIS G+A + G+ + PE
Sbjct: 143 TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 37/166 (22%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
GK A+K + +S +NE+ ++ K++H+N+V L L+ + +
Sbjct: 34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE- 92
Query: 342 DLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRDLKTS 389
LFD RI +I + + YLHE ++HRDLK
Sbjct: 93 ---LFD-----------RILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPE 135
Query: 390 NVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+L + I+DFG++++ + GT GY+APE
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPE 177
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 38/167 (22%)
Query: 283 KEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
K I +RLS S +E + EV ++ +++H N++ L + +++LI E + L
Sbjct: 36 KFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL 95
Query: 342 DLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRDLKTS 389
FD + + I G+ YLH R+ H DLK
Sbjct: 96 ----FD-----------FLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPE 137
Query: 390 NVLLDHEMNP----KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N++L + P K+ DFG+A + GT ++APE
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPE 181
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 283 KEIAVKRL-SRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
K I +R S G ++ + EV+++ ++QH N++ L + +++LI E +
Sbjct: 42 KFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE- 100
Query: 342 DLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP- 399
LFD + L + + I G+ YLH L++ H DLK N++L P
Sbjct: 101 ---LFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPK 154
Query: 400 ---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
KI DFG+A + GT ++APE
Sbjct: 155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPE 187
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 39/193 (20%), Positives = 64/193 (33%), Gaps = 48/193 (24%)
Query: 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLD 342
K + ++ + + + ++ K EV L+ KL H N+ RL D + L+ E
Sbjct: 57 KIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGG--H 114
Query: 343 LFLFDSTKGAQLDWKRRI---------------------------------------SII 363
L + K + +I+
Sbjct: 115 LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174
Query: 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLL--DHEMNPKISDFGMARIFSGNQNEANT-- 419
I L YLH + HRD+K N L + K+ DFG+++ F N
Sbjct: 175 RQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 420 NRVVGTYGYMAPE 432
GT ++APE
Sbjct: 232 TTKAGTPYFVAPE 244
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 46/174 (26%), Positives = 75/174 (43%), Gaps = 35/174 (20%)
Query: 275 VQGILADGKEIAVKRLSRSSGQGLQEFKN-EVTLIAKLQHKNLVRLLGC------CLDGN 327
Q L + E+A+K++ + + FKN E+ ++ ++H N+V L D
Sbjct: 57 FQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 328 ELLLIYEYMPNKSLDL--FLFDSTKGAQLDWKRRISIING------IARGLLYLHEDSRL 379
L L+ EY+P + K Q + ++ + R L Y+H +
Sbjct: 112 FLNLVLEYVP---ETVYRASRHYAKLKQ-----TMPMLLIKLYMYQLLRSLAYIH---SI 160
Query: 380 RVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ HRD+K N+LLD K+ DFG A+I E N + + Y Y APE
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPE 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 24/164 (14%)
Query: 281 DGKEIAVKRLSRS--------SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
KE+ VK + + L + E+ ++++++H N++++L + L+
Sbjct: 48 KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWK--RRI--SIINGIARGLLYLHEDSRLRVIHRDLKT 388
E + LDLF F +LD I +++ + YL +IHRD+K
Sbjct: 108 MEKHGS-GLDLFAFIDRHP-RLDEPLASYIFRQLVSAVG----YLR---LKDIIHRDIKD 158
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+++ + K+ DFG A + GT Y APE
Sbjct: 159 ENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPE 199
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 25/164 (15%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEF---KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
A +E A+K L + + E ++++L H V+L D +L Y
Sbjct: 53 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 112
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIAR--------GLLYLHEDSRLRVIHRDLKT 388
N +L + R L YLH +IHRDLK
Sbjct: 113 KNG--ELL-------KYIRKIGSFD--ETCTRFYTAEIVSALEYLHG---KGIIHRDLKP 158
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL+ +M+ +I+DFG A++ S +A N VGT Y++PE
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 13/140 (9%)
Query: 301 FKNEVTLIAKLQHKNLVRLL--GCCLDGNELLLIY---EYMPNKSLDLFLFDSTKGAQLD 355
F+ E A L H +V + G + L Y EY+ +L + +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMT 114
Query: 356 WKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415
KR I +I + L + H + +IHRD+K +N+++ K+ DFG+AR + + N
Sbjct: 115 PKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 416 E-ANTNRVVGTYGYMAPEYA 434
T V+GT Y++PE A
Sbjct: 172 SVTQTAAVIGTAQYLSPEQA 191
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 39/169 (23%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPN 338
+ AVK +S+ + E+T + + H N+V+L D L+ E +
Sbjct: 34 KSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90
Query: 339 KSLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRDL 386
L F+ RI I+ + + ++H+ + V+HRDL
Sbjct: 91 GEL----FE-----------RIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDL 132
Query: 387 KTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K N+L + + KI DFG AR+ + T T Y APE
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPE 179
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 16/183 (8%), Positives = 33/183 (18%), Gaps = 40/183 (21%)
Query: 282 GKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCC--------------- 323
++ A+K + S L+ A+L ++
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 324 -----------LDGNELLLIYEYMP---NKSLDLFLFDSTKGAQLDWKRRISIINGIARG 369
LL+ F + + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 370 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYM 429
L ++H N+ + + + D Y
Sbjct: 207 AANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYA 258
Query: 430 APE 432
E
Sbjct: 259 PRE 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 27/187 (14%), Positives = 53/187 (28%), Gaps = 42/187 (22%)
Query: 280 ADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQ------------------------ 312
G+ V + +++ K EV + L+
Sbjct: 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 313 -HKNLVRLLGCCLDGN--ELLLIYEYMPNKSLDLF--LFD-STKGAQLDWKRRISIINGI 366
K ++R+ D +Y M + L S+ L R+ + +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215
Query: 367 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426
R L LH ++H L+ +++LD ++ F +
Sbjct: 216 IRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSR 266
Query: 427 GYMAPEY 433
G+ PE
Sbjct: 267 GFEPPEL 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 22/165 (13%), Positives = 50/165 (30%), Gaps = 16/165 (9%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+ ++ +K ++ + + ++ L N +L+ E +
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 341 LD--LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
L + L+ +T + IS + + +H+ +IH D+K N +L +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFL 210
Query: 399 P-----------KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ D G + T G+ E
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 37/175 (21%)
Query: 280 ADGKEIAVKRLSRS-------------SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG 326
E A+K + +S + +E NE++L+ L H N+++L D
Sbjct: 59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS------IINGIARGLLYLHEDSRLR 380
L+ E+ LF+ Q+ + + I+ I G+ YLH+
Sbjct: 119 KYFYLVTEFYEGGE----LFE-----QIINRHKFDECDAANIMKQILSGICYLHK---HN 166
Query: 381 VIHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
++HRD+K N+LL + +N KI DFG++ FS + +GT Y+APE
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE 218
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 27/186 (14%), Positives = 55/186 (29%), Gaps = 37/186 (19%)
Query: 280 ADGKEIAVKRLS---RSSGQGLQEFKNEVTLIAKLQ----------------------HK 314
G+ V R +++ K EV + L+
Sbjct: 101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 315 NLVRLLGCCLDGNELLLIYEY--MPNKSLDLFLF------DSTKGAQLDWKRRISIINGI 366
+++ LD ++ ++ + P +L F S+ L R+ + +
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220
Query: 367 ARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTY 426
R L LH ++H L+ +++LD ++ F G + R
Sbjct: 221 IRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPP 276
Query: 427 GYMAPE 432
A
Sbjct: 277 ETTAER 282
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN-EVTLIAKLQHKNLVRLLGC------CLDGNELLLIYE 334
G+ +A+K++ + + FKN E+ ++ KL H N+VRL D L L+ +
Sbjct: 79 GELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 335 YMPNKSLDL--FLFDSTKGAQLDWKRRISIING------IARGLLYLHEDSRLRVIHRDL 386
Y+P + ++ Q + +I + R L Y+H + HRD+
Sbjct: 134 YVP---ETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDI 182
Query: 387 KTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K N+LLD + K+ DFG A+ + E N + + Y Y APE
Sbjct: 183 KPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRAPE 226
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 38/166 (22%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSL 341
K A+K L ++ + + + E+ ++ +L H N+++L E+ L+ E +
Sbjct: 78 QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE- 134
Query: 342 DLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRVIHRDLKTS 389
LFD RI + I + YLHE ++HRDLK
Sbjct: 135 ---LFD-----------RIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPE 177
Query: 390 NVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+L + KI+DFG+++I V GT GY APE
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPE 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 19/137 (13%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNE--LLLIYEYMPNKSLDLFLFDSTKGAQLDWK-- 357
E+ ++ KL H N+V+L+ D NE L +++E + + + L
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQA 139
Query: 358 RRI--SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415
R +I GI YLH ++IHRD+K SN+L+ + + KI+DFG++ F G+
Sbjct: 140 RFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 416 EANTNRVVGTYGYMAPE 432
+ VGT +MAPE
Sbjct: 193 LLSN--TVGTPAFMAPE 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 282 GKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
G+E+A+K + ++ + LQ+ EV ++ L H N+V+L L LI EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 340 SLDLFLFDSTKGAQLDWK--RRI--SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
++F + G ++ K R I++ + Y H + R++HRDLK N+LLD
Sbjct: 100 --EVFDYLVAHG-RMKEKEARSKFRQIVSAVQ----YCH---QKRIVHRDLKAENLLLDA 149
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+MN KI+DFG + F+ + G Y APE
Sbjct: 150 DMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPE 183
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 45/174 (25%)
Query: 282 GKEIAVKRLSRSSGQGLQE--------FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIY 333
K++A+K +S+ + E+ ++ KL H ++++ D + ++
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 334 EYMPNKSLDLFLFDSTKGAQLDWKRRI------------SIINGIARGLLYLHEDSRLRV 381
E M L FD ++ + + YLHE +
Sbjct: 94 ELMEGGEL----FD-----------KVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGI 135
Query: 382 IHRDLKTSNVLL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
IHRDLK NVLL + + KI+DFG ++I G + T + GT Y+APE
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTYLAPE 186
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 39/171 (22%)
Query: 282 GKEIAVKRLSRSSGQGLQE--------FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIY 333
K++A++ +S+ + E+ ++ KL H ++++ D + ++
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 334 EYMPNKSLDLFLFDSTKGAQLDW---KRRIS------IINGIARGLLYLHEDSRLRVIHR 384
E M +LF D +R+ + + YLHE +IHR
Sbjct: 219 ELMEGG--ELF----------DKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHR 263
Query: 385 DLKTSNVLLDHEMNP---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DLK NVLL + KI+DFG ++I + GT Y+APE
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPE 311
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 19/162 (11%)
Query: 280 ADGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLDGNELLLIYEYM 336
+ G+E A K + R E +E+ ++ + ++ L + +E++LI EY
Sbjct: 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111
Query: 337 PNKSLDLFLFD---STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
+ F + I +I I G+ YLH+ ++H DLK N+LL
Sbjct: 112 AGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILL 164
Query: 394 ---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+ KI DFGM+R ++GT Y+APE
Sbjct: 165 SSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPE 203
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 31/168 (18%)
Query: 282 GKEIAVKRLSRSSGQGLQE--FKN----EVTLIAKLQHKNLVRLLGCCL-----DGNE-- 328
G +A+K++ +Q+ F+N + +A L H N+V+L D +
Sbjct: 48 GMSVAIKKV-------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100
Query: 329 LLLIYEYMP---NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385
L ++ EY+P ++ + + + + R + LH S + V HRD
Sbjct: 101 LNVVMEYVPDTLHRCCRNY---YRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRD 156
Query: 386 LKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+K NVL++ K+ DFG A+ S +E N + Y Y APE
Sbjct: 157 IKPHNVLVNEADGTLKLCDFGSAKKLS--PSEPNVAYICSRY-YRAPE 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 42/168 (25%), Positives = 68/168 (40%), Gaps = 26/168 (15%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKN------EVTLIAKLQHK--NLVRLLGCCLDGNELL 330
++D +A+K + + E N EV L+ K+ ++RLL + +
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWK--RRIS--IINGIARGLLYLHEDSRLRVIHRDL 386
LI E P DLF F + +GA L + R ++ + + H V+HRD+
Sbjct: 125 LILER-PEPVQDLFDFITERGA-LQEELARSFFWQVLEAVR----HCH---NCGVLHRDI 175
Query: 387 KTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEY 433
K N+L+D K+ DFG + GT Y PE+
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 42/170 (24%), Positives = 66/170 (38%), Gaps = 28/170 (16%)
Query: 279 LADGKEIAVKRLSRS------SGQGLQEFKNEVTLIAKL----QHKNLVRLLGCCLDGNE 328
L D ++A+K + R+ EV L+ K+ H ++RLL
Sbjct: 53 LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG 112
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWK--RRI--SIINGIARGLLYLHEDSRLRVIHR 384
+L+ E P + DLF + + KG L R ++ I + H V+HR
Sbjct: 113 FMLVLER-PLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQ----HCH---SRGVVHR 163
Query: 385 DLKTSNVLLDHEMNP-KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEY 433
D+K N+L+D K+ DFG + GT Y PE+
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEW 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 27/164 (16%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNE----LLLIYE 334
G++ A+K L S + + EV + ++V +L + + LL+I E
Sbjct: 52 RTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106
Query: 335 YMPNKSLDLFLFD--STKGAQLDWKRRIS-IINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
M L F +G Q +R + I+ I + +LH + HRD+K N+
Sbjct: 107 CMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENL 159
Query: 392 LL---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L + + K++DFG A+ + N T Y+APE
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPE 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 34/178 (19%), Positives = 74/178 (41%), Gaps = 30/178 (16%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL-----GCCLDGN 327
+ +A+K++ R F++ E+ ++ +L H ++V++L +
Sbjct: 78 KRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 328 ELLLIYEYMPNKSLDLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
EL ++ E D LF + + +++ + G+ Y+H S ++HRDL
Sbjct: 131 ELYVVLEIAD---SDFKKLFRTPVYLTELHIK--TLLYNLLVGVKYVH--SA-GILHRDL 182
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRM 444
K +N L++ + + K+ DFG+AR +N + + M ++
Sbjct: 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 40/134 (29%), Positives = 57/134 (42%), Gaps = 10/134 (7%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL---FDSTKGAQLDWKR 358
E ++AK+ + +V L +L L+ M D+ R
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPGFQEPR 290
Query: 359 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 418
I I GL +LH+ +I+RDLK NVLLD + N +ISD G+A Q +
Sbjct: 291 AIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 419 TNRVVGTYGYMAPE 432
GT G+MAPE
Sbjct: 348 G--YAGTPGFMAPE 359
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 28/165 (16%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDG----NELLLIYE 334
++ A+K L + + EV L + ++VR++ + LL++ E
Sbjct: 85 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 335 YMPNKSLDLFLFD--STKGAQLDWKRRIS-IINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
+ L F +G Q +R S I+ I + YLH + + HRD+K N+
Sbjct: 140 CLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 192
Query: 392 LLDHEMNP----KISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
L + P K++DFG A+ + + N T T Y+APE
Sbjct: 193 LYTSK-RPNAILKLTDFGFAKETTSH-NSLTT--PCYTPYYVAPE 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 51/173 (29%)
Query: 282 GKEIAVKRLSRS--SGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+++A+K +SR + + E++ + L+H ++++L Y+ +
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-------------YDVITT 80
Query: 339 KSLDLF---------LFDSTKGAQLDWKRRIS----------IINGIARGLLYLHEDSRL 379
+ D+ LFD + K+R++ II I Y H R
Sbjct: 81 PT-DIVMVIEYAGGELFD-----YIVEKKRMTEDEGRRFFQQIICAIE----YCH---RH 127
Query: 380 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
+++HRDLK N+LLD +N KI+DFG++ I + T+ G+ Y APE
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPE 177
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 34/164 (20%)
Query: 282 GKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+ +AVK + R G + E + E+ L+H N+VR L L +I EY
Sbjct: 45 KELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102
Query: 341 LDLFLFDSTKGAQLDWKRRIS----------IINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L ++ ++ R S +++G++ Y H +++ HRDLK N
Sbjct: 103 L----YE-----RICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQICHRDLKLEN 146
Query: 391 VLLDH--EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
LLD KI DFG ++ + ++ + VGT Y+APE
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYIAPE 187
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 25/168 (14%)
Query: 281 DGKEIAVKRLSRSSGQGLQE--FKN---------EVTLIAKLQHKNLVRLLGCCL----- 324
+G +A+KR+ + G + E+ L+ H N++ L +
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104
Query: 325 DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384
++L L+ E M DL + + + + I GL LHE V+HR
Sbjct: 105 AMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHR 158
Query: 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
DL N+LL + I DF +AR + + T+ V Y APE
Sbjct: 159 DLHPGNILLADNNDITICDFNLAREDT--ADANKTHYVT-HRWYRAPE 203
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 282 GKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
G ++AVK L+R S + + K E+ + +H ++++L + ++ EY+
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 339 KSLDLFLFDSTKGA-QLDWKRRI--SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+LF + G + RR+ I++ + Y H R V+HRDLK NVLLD
Sbjct: 96 G--ELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RHMVVHRDLKPENVLLDA 146
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
MN KI+DFG++ + S T G+ Y APE
Sbjct: 147 HMNAKIADFGLSNMMSDG-EFLRT--SCGSPNYAAPE 180
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 32/164 (19%)
Query: 282 GKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
G ++AVK L+R S + + + E+ + +H ++++L +++ ++ EY+
Sbjct: 41 GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100
Query: 339 KSLDLFLFDSTKGAQLDWKRRIS----------IINGIARGLLYLHEDSRLRVIHRDLKT 388
L FD + R+ I++G+ Y H R V+HRDLK
Sbjct: 101 GEL----FD-----YICKNGRLDEKESRRLFQQILSGVD----YCH---RHMVVHRDLKP 144
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
NVLLD MN KI+DFG++ + S T+ G+ Y APE
Sbjct: 145 ENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS--CGSPNYAAPE 185
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 29/67 (43%), Positives = 41/67 (61%), Gaps = 7/67 (10%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I GL ++H V++RDLK +N+LLD + +ISD G+A FS + + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 426 YGYMAPE 432
+GYMAPE
Sbjct: 354 HGYMAPE 360
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 33/167 (19%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLLGCCL-----DGN 327
+A+K++S F++ E+ ++ + +H+N++ +
Sbjct: 52 KVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 328 ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
++ ++ + M + L+ K L + I RGL Y+H + V+HRDLK
Sbjct: 104 DVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLK 155
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEAN--TNRVVGTYGYMAPE 432
SN+LL+ + KI DFG+AR+ + + T V T Y APE
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPE 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 9/132 (6%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKG-AQLDWKRRI 360
NE ++ K+ + +V L + L L+ M DL G A R +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG--DLKFHIYHMGQAGFPEARAV 289
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420
I GL LH R+++RDLK N+LLD + +ISD G+A Q
Sbjct: 290 FYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIK 343
Query: 421 RVVGTYGYMAPE 432
VGT GYMAPE
Sbjct: 344 GRVGTVGYMAPE 355
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 34/166 (20%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL------GCCLDG 326
+ +A+K+LSR F+N E+ L+ + HKN++ LL +
Sbjct: 50 ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
++ ++ E M +L +LD +R ++ + G+ +LH +IHRDL
Sbjct: 103 QDVYIVMELMDA---NL---CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 153
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K SN+++ + KI DFG+AR + T VV T Y APE
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-TRYYRAPE 196
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 35/166 (21%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL------GCCLDG 326
G ++A+K+L R F++ E+ L+ ++H+N++ LL D
Sbjct: 50 GAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
+ L+ +M L K +L R ++ + +GL Y+H +IHRDL
Sbjct: 103 TDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDL 154
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K N+ ++ + KI DFG+AR V T Y APE
Sbjct: 155 KPGNLAVNEDCELKILDFGLARQADSEMTGY-----VVTRWYRAPE 195
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 36/166 (21%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL------GCCLDG 326
G+++A+K+LSR F++ E+ L+ +QH+N++ LL +
Sbjct: 49 GEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
+ L+ +M DL G + ++ ++ + +GL Y+H V+HRDL
Sbjct: 102 YDFYLVMPFMQT---DL---QKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDL 152
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K N+ ++ + KI DFG+AR T VV T Y APE
Sbjct: 153 KPGNLAVNEDCELKILDFGLARHADAEM----TGYVV-TRWYRAPE 193
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 25/139 (17%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361
E+ ++ L+H LV L D ++ ++ + + DL L
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG--DLRY-------HLQQNVHFK 113
Query: 362 IINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 413
+ L YL R+IHRD+K N+LLD + I+DF +A +
Sbjct: 114 --EETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168
Query: 414 QNEANTNRVVGTYGYMAPE 432
+ T + GT YMAPE
Sbjct: 169 -TQITT--MAGTKPYMAPE 184
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 34/166 (20%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL------GCCLDG 326
+ +A+K+LSR F+N E+ L+ + HKN++ LL +
Sbjct: 87 DRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
++ L+ E M +L +LD +R ++ + G+ +LH +IHRDL
Sbjct: 140 QDVYLVMELMDA---NL---CQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 190
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K SN+++ + KI DFG+AR + T VV T Y APE
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-TRYYRAPE 233
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 41/177 (23%), Positives = 76/177 (42%), Gaps = 44/177 (24%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL------------ 320
K +A+K++ + E+ +I +L H N+V++
Sbjct: 36 DKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86
Query: 321 --GCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSR 378
G + N + ++ EYM + L + + L + + + RGL Y+H +
Sbjct: 87 DVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN- 140
Query: 379 LRVIHRDLKTSNVLLDHE-MNPKISDFGMARIFSGNQNEAN--TNRVVGTYGYMAPE 432
V+HRDLK +N+ ++ E + KI DFG+ARI + + + +V T Y +P
Sbjct: 141 --VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPR 194
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 39/199 (19%), Positives = 72/199 (36%), Gaps = 67/199 (33%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN-EVTLIAKLQHKNLVRLLGC------------------ 322
GK A+K++ + +KN E+ ++ L H N+++L+
Sbjct: 32 GKRFALKKVLQD-----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86
Query: 323 --------------------CLDGNELLLIYEYMPNKSLDL--FLFDSTKGAQLDWKRRI 360
L +I EY+P L L + + I
Sbjct: 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DTLHKVLKSFIRSGR-----SI 138
Query: 361 SIING------IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP-KISDFGMARIFSGN 413
+ + R + ++H L + HRD+K N+L++ + N K+ DFG A+
Sbjct: 139 PMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--I 193
Query: 414 QNEANTNRVVGTYGYMAPE 432
+E + + + Y APE
Sbjct: 194 PSEPSVAYICSRF-YRAPE 211
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 35/166 (21%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL------GCCLDG 326
G +AVK+LSR F++ E+ L+ ++H+N++ LL +
Sbjct: 54 GLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 327 NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
N++ L+ M L + K +L +I I RGL Y+H +IHRDL
Sbjct: 107 NDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDL 158
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
K SN+ ++ + KI DFG+AR + T V T Y APE
Sbjct: 159 KPSNLAVNEDCELKILDFGLARHTADEM----TGYVA-TRWYRAPE 199
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 38/171 (22%), Positives = 77/171 (45%), Gaps = 30/171 (17%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLLGCCL-----DGN 327
K +A+K+++R F++ E+T++ +L+ ++RL + +
Sbjct: 51 EKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103
Query: 328 ELLLIYEYMPNKSLDLF-LFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
EL ++ E + DL LF + L + +I+ + G ++HE +IHRDL
Sbjct: 104 ELYIVLEIADS---DLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDL 155
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
K +N LL+ + + K+ DFG+AR + ++ N + ++
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 37/165 (22%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNE--LLLIYEYMP 337
+ +++ VK L ++ K E+ ++ L+ N++ L D L++E++
Sbjct: 60 NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116
Query: 338 NKSLDLFLFDSTKGAQLDWKRRI---------SIINGIARGLLYLHEDSRLRVIHRDLKT 388
N D+K+ + I + L Y H S ++HRD+K
Sbjct: 117 N---------------TDFKQLYQTLTDYDIRFYMYEILKALDYCH--SM-GIMHRDVKP 158
Query: 389 SNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
NV++DHE ++ D+G+A + Q RV Y + PE
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRY-FKGPE 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 8e-13
Identities = 39/139 (28%), Positives = 65/139 (46%), Gaps = 27/139 (19%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361
+E +++ + H ++R+ G D ++ +I +Y+ +LF + L +R
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG--ELF-------SLLRKSQRFP 104
Query: 362 IINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 413
N +A+ L YLH +I+RDLK N+LLD + KI+DFG A+
Sbjct: 105 --NPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK----- 154
Query: 414 QNEANTNRVVGTYGYMAPE 432
T + GT Y+APE
Sbjct: 155 YVPDVTYTLCGTPDYIAPE 173
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 38/173 (21%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQHKNLVRLL-----GCCLDGN 327
G+ +A+K++ F E+ ++ +H+N++ + + N
Sbjct: 36 GEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87
Query: 328 ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
E+ +I E M DL ST+ L I R + LH + VIHRDLK
Sbjct: 88 EVYIIQELMQT---DLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLK 139
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRV--------VGTYGYMAPE 432
SN+L++ + K+ DFG+ARI + + + V T Y APE
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 37/140 (26%), Positives = 55/140 (39%), Gaps = 24/140 (17%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360
F E ++A +V+L D L ++ EYMP DL L +
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG--DLV--------NLMSNYDV 165
Query: 361 SIINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSG 412
AR L +H + IHRD+K N+LLD + K++DFG +
Sbjct: 166 P--EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 413 NQNEANTNRVVGTYGYMAPE 432
+ VGT Y++PE
Sbjct: 221 EGMV-RCDTAVGTPDYISPE 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 33/132 (25%), Positives = 57/132 (43%), Gaps = 6/132 (4%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRI 360
F+ E ++ + + +L D N L L+ EY DL S G ++ +
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG--DLLTLLSKFGERIPAEMAR 165
Query: 361 SIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTN 420
+ I + +H L +HRD+K N+LLD + +++DFG + +
Sbjct: 166 FYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSL 221
Query: 421 RVVGTYGYMAPE 432
VGT Y++PE
Sbjct: 222 VAVGTPDYLSPE 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 37/139 (26%), Positives = 61/139 (43%), Gaps = 27/139 (19%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361
NE ++ + LV+L D + L ++ EY+ ++F + L R S
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG--EMF-------SHLRRIGRFS 139
Query: 362 IINGIAR--------GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGN 413
AR YLH L +I+RDLK N+L+D + +++DFG A+
Sbjct: 140 --EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 414 QNEANTNRVVGTYGYMAPE 432
+ + T + GT +APE
Sbjct: 190 RVKGRTWTLCGTPEALAPE 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 30/142 (21%), Positives = 57/142 (40%), Gaps = 26/142 (18%)
Query: 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP--------NKSLDLFLFDSTK-- 350
F+ E ++ K + L D N L L+ +Y +K D + +
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180
Query: 351 GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410
A+ + + +H+ L +HRD+K N+L+D + +++DFG
Sbjct: 181 LAE------------MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225
Query: 411 SGNQNEANTNRVVGTYGYMAPE 432
+ ++ VGT Y++PE
Sbjct: 226 MED-GTVQSSVAVGTPDYISPE 246
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 24/67 (35%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L +LH+ L +I+RD+K N+LLD + ++DFG+++ F ++ E GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
Query: 426 YGYMAPE 432
YMAP+
Sbjct: 224 IEYMAPD 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 27/67 (40%), Positives = 42/67 (62%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
+A L +LH L +I+RDLK N+LLD E + K++DFG+++ ++ +A + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 426 YGYMAPE 432
YMAPE
Sbjct: 190 VEYMAPE 196
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 17/130 (13%), Positives = 40/130 (30%), Gaps = 11/130 (8%)
Query: 282 GKEIAVKRLSRSSG---QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+++A+ + LQE + ++++ + R+L L++ E++
Sbjct: 56 DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL I + +A H R V S V + + +
Sbjct: 116 GSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGD 167
Query: 399 PKISDFGMAR 408
++
Sbjct: 168 VVLAYPATMP 177
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 24/67 (35%), Positives = 40/67 (59%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I+ L +LH+ +I+RDLK N++L+H+ + K++DFG+ + + +T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 426 YGYMAPE 432
YMAPE
Sbjct: 185 IEYMAPE 191
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 39/137 (28%), Positives = 58/137 (42%), Gaps = 19/137 (13%)
Query: 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRIS 361
E ++ +H L L + L + EY +LF L +R S
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFF-------HLSRERVFS 246
Query: 362 I------INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415
I L YLH S V++RDLK N++LD + + KI+DFG+ + G ++
Sbjct: 247 EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKD 302
Query: 416 EANTNRVVGTYGYMAPE 432
A GT Y+APE
Sbjct: 303 GATMKTFCGTPEYLAPE 319
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 28/67 (41%), Positives = 39/67 (58%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I+ L YLHE +I+RDLK NVLLD E + K++D+GM + + +T GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 174 PNYIAPE 180
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L++LH+ +I+RDLK NVLLDHE + K++DFGM + N T GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 188 PDYIAPE 194
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 38/163 (23%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 282 GKEIAVKRLSRSSGQGLQEFKN---------EVTLIAKLQ-HKNLVRLLGCCL--DGNEL 329
G+ +AVK++ + F+N E+ ++ +L H+N+V LL + ++
Sbjct: 34 GEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86
Query: 330 LLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
L+++YM + L + L+ + ++ + + + YLH S ++HRD+K S
Sbjct: 87 YLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH--SG-GLLHRDMKPS 138
Query: 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPE 432
N+LL+ E + K++DFG++R F + N + +
Sbjct: 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
IA L YLH L +++RDLK N+LLD + + ++DFG+ + + + +T GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 203 PEYLAPE 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I L YLH V++RD+K N++LD + + KI+DFG+ + + T GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 169 PEYLAPE 175
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 28/67 (41%), Positives = 39/67 (58%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I+ L YLHE +I+RDLK NVLLD E + K++D+GM + + +T GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 217 PNYIAPE 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 27/67 (40%), Positives = 38/67 (56%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
I GL +LH +++RDLK N+LLD + + KI+DFGM + + NT GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 182 PDYIAPE 188
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 28/67 (41%), Positives = 37/67 (55%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
IA GL +L +I+RDLK NV+LD E + KI+DFGM + + T GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 185 PDYIAPE 191
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 28/67 (41%), Positives = 37/67 (55%), Gaps = 5/67 (7%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425
IA GL +L +I+RDLK NV+LD E + KI+DFGM + + T GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGT 505
Query: 426 YGYMAPE 432
Y+APE
Sbjct: 506 PDYIAPE 512
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 5/77 (6%)
Query: 366 IARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMAR-IFSGNQNEANTNRVVG 424
+A+G+ +L + + IHRDL N+LL + KI DFG+AR I+ + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257
Query: 425 TYGYMAPEYAMEGVFSV 441
+MAPE + V+++
Sbjct: 258 PLKWMAPETIFDRVYTI 274
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 29/140 (20%), Positives = 53/140 (37%), Gaps = 13/140 (9%)
Query: 280 ADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKL-QHKNLVRLLGCCLD-GNELLLIYEYM 336
A + +AVK L + + +E+ ++ + H N+V LLG C G L++I E+
Sbjct: 50 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 109
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
+L +L +R + +G + + I DLK +
Sbjct: 110 KFGNLSTYL----------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS 159
Query: 397 MNPKISDFGMARIFSGNQNE 416
+ S F + S + E
Sbjct: 160 QSSASSGFVEEKSLSDVEEE 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 45/150 (30%)
Query: 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDG----NELLLIYE 334
++ A+K L + + EV L + Q ++VR++ + LL++ E
Sbjct: 41 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRI--------------SIINGIARGLLYLHEDSRLR 380
+ L F RI I+ I + YLH +
Sbjct: 96 CLDGGEL----FS-----------RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 137
Query: 381 VIHRDLKTSNVLLDHE---MNPKISDFGMA 407
+ HRD+K N+L + K++DFG A
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 1e-06
Identities = 22/128 (17%), Positives = 40/128 (31%), Gaps = 10/128 (7%)
Query: 324 LDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383
++L ++ E+ +DL + SI++ + L LR H
Sbjct: 132 FKDDQLFIVLEFE-FGGIDLEQMRTKL---SSLATAKSILHQLTASLAVAEA--SLRFEH 185
Query: 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNR 443
RDL NVLL K+ + + V Y +G+
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSS----TIPSCGLQVSIIDYTLSRLERDGIVVFCD 241
Query: 444 MFLVSEFF 451
+ + + F
Sbjct: 242 VSMDEDLF 249
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 50/370 (13%), Positives = 103/370 (27%), Gaps = 108/370 (29%)
Query: 102 VNFATSETAQLC----------PFGKEYIIGYEECLLRYSNISFFSAVDTSFRLSQWNAE 151
++F T E Q F + + + + S S + + +A
Sbjct: 7 MDFETGEH-QYQYKDILSVFEDAFVDNFDCKDVQDMPK----SILSKEEIDHIIMSKDAV 61
Query: 152 NSPGRLFDQLVWNLMNEAVNQALSTTKMF--TTVKKNYTASQTLYSLVQCTPDLSRDDCS 209
+ RLF W L+++ + F ++ NY + L S
Sbjct: 62 SGTLRLF----WTLLSKQEEMV----QKFVEEVLRINY---KFLMS-------------- 96
Query: 210 RCLRLAISPLDGCCSIKIGGRVRYPSCN---FRYELYQFYNDTSIGTLLPAVFSP---PS 263
I R PS + + + YND VF+
Sbjct: 97 ----------------PIKTEQRQPSMMTRMYIEQRDRLYND-------NQVFAKYNVSR 133
Query: 264 PGSVT----------SSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH 313
+K + + G+L GK + S + ++ +
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV-QCKMDFKIFWLN---- 188
Query: 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISI-INGIARGLLY 372
L C +L + + + L+ D ++ D I + I+ I L
Sbjct: 189 ------LKNCNSPETVLEMLQKL------LYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 373 LHEDSRLRVIHRDLKTSNVLLDHEMNPKISD-FGM-ARIFSGNQNEANTNRVVGTYGYMA 430
L + + + ++L + N K + F + +I + + T+ +
Sbjct: 237 L-------LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 431 PEYAMEGVFS 440
+
Sbjct: 290 SLDHHSMTLT 299
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 23/83 (27%), Positives = 38/83 (45%), Gaps = 17/83 (20%)
Query: 360 ISIINGIAR----GLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP------KISDFGMARI 409
+ + I++ GL Y+H R +IH D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 410 FSGNQNEANTNRVVGTYGYMAPE 432
+ + + T Y +PE
Sbjct: 188 YDEHYTN-----SIQTREYRSPE 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH------KNLVRLLGCCLDGNELLLI 332
+ + +A+K + ++ L + + EV L+ + +V L + N L L+
Sbjct: 76 RVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134
Query: 333 YEYMPNKSLDLFLF---DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389
+E + S +L+ + +G L+ R+ + + LL+L L +IH DLK
Sbjct: 135 FEML---SYNLYDLLRNTNFRGVSLNLTRKFAQ--QMCTALLFLA-TPELSIIHCDLKPE 188
Query: 390 NVLLDHEMNP--KISDFGMARIFSGNQNEANTNRVVGTY----GYMAPE 432
N+LL + KI DFG + G + + Y Y +PE
Sbjct: 189 NILLCNPKRSAIKIVDFGSS-CQLGQR--------IYQYIQSRFYRSPE 228
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 452 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.98 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.98 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.98 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.98 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.98 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.98 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.98 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.98 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.98 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.98 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.98 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.98 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.98 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.89 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.28 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.72 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.92 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.47 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.73 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 87.15 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=349.89 Aligned_cols=189 Identities=27% Similarity=0.387 Sum_probs=169.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|++.+.+|.|++|.|+.+ .+..+++.||||++.+. .....+.+.+|+++|++|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a-------------------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~Hpn 93 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLA-------------------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93 (311)
T ss_dssp GEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTT
T ss_pred ccEEEEEEecccCeEEEEE-------------------EECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCC
Confidence 5889999999999877755 56678999999999764 2345678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
||++++++++++.+||||||++||+|.+++. +.+.+++.+++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 94 Iv~l~~~~~~~~~~yivmEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~ 167 (311)
T 4aw0_A 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNE 167 (311)
T ss_dssp BCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred CCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcC
Confidence 9999999999999999999999999999984 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++++||+|||+|+.+............+||+.|||||++.+..|+.++||||+||||
T Consensus 168 ~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvil 224 (311)
T 4aw0_A 168 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 224 (311)
T ss_dssp TSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred CCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHH
Confidence 999999999999987655545555667999999999999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=350.07 Aligned_cols=187 Identities=25% Similarity=0.372 Sum_probs=167.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.+|+....+|.|++|.|+.+ .+..+|+.||||++........+.+.+|+.+|++++|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a-------------------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV 134 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIA-------------------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 134 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBC
T ss_pred HhcEEeEEeecCcCeEEEEE-------------------EECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 46888889999999887755 45668999999999877666667899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++.+++.+||||||++||+|.+++.. ..+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++
T Consensus 135 ~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g 207 (346)
T 4fih_A 135 EMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 207 (346)
T ss_dssp CEEEEEEETTEEEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTC
T ss_pred cEEEEEEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCC
Confidence 999999999999999999999999998843 45999999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||+|||+++.+..... .....+||+.|||||++.+..|+.++|||||||||
T Consensus 208 ~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvil 260 (346)
T 4fih_A 208 RVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 260 (346)
T ss_dssp CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHH
Confidence 999999999987654322 23457899999999999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=350.29 Aligned_cols=191 Identities=21% Similarity=0.354 Sum_probs=161.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++.+.+|.|++|.|+.+ .+..+|+.||||++.+. .....+.+.+|+.+|++|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hp 83 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILV-------------------KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83 (350)
T ss_dssp CCCEEEEEEC------CEEEE-------------------EETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCT
T ss_pred ccceEEeEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCC
Confidence 358999999999999877755 55678999999999765 344567899999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|||++++++++++.+||||||++||+|.+++.. .+...+++.+++.|+.||+.||+|||++| ||||||||+|||++
T Consensus 84 nIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~ 159 (350)
T 4b9d_A 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLT 159 (350)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEEC
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEEC
Confidence 999999999999999999999999999999854 23456899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++++||+|||+++.+.... ......+||+.|||||++.+..|+.++|||||||||
T Consensus 160 ~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvil 215 (350)
T 4b9d_A 160 KDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVL 215 (350)
T ss_dssp TTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHH
Confidence 99999999999998764321 123346899999999999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.58 Aligned_cols=187 Identities=25% Similarity=0.372 Sum_probs=167.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|+....+|.|++|.|+.+ .+..+|+.||||++........+.+.+|+.+|+.++|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a-------------------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV 211 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIA-------------------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 211 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBC
T ss_pred HhcEeeeEeccCcCcEEEEE-------------------EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCC
Confidence 46899999999999877755 55678999999999877666677899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++.+++.+||||||++||+|.+++.. ..+++.++..|+.||+.||+|||++| ||||||||+||||+.++
T Consensus 212 ~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g 284 (423)
T 4fie_A 212 EMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 284 (423)
T ss_dssp CEEEEEEETTEEEEEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTC
T ss_pred ceEEEEEECCEEEEEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCC
Confidence 999999999999999999999999998843 45999999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||+|||+++.+..... .....+||+.|||||++.+..|+.++|||||||||
T Consensus 285 ~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvil 337 (423)
T 4fie_A 285 RVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 337 (423)
T ss_dssp CEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHH
Confidence 999999999987654322 23457899999999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=338.76 Aligned_cols=197 Identities=26% Similarity=0.423 Sum_probs=165.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|.+.+.+|.|+||.||.+..... ....+++.||||+++..+....++|.+|+++|++|+|||||+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~--------------~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNL--------------CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSC--------------C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred HeEEeeEEeeCCCcEEEEEEECCc--------------ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCcc
Confidence 466778899999999987643210 112468899999998777777788999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDS----------TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~----------~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
+++++.+++.++|||||+++|+|.++++.. .....+++.+++.|+.||+.||+|||+++ ||||||||
T Consensus 80 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp 156 (299)
T 4asz_A 80 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLAT 156 (299)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCH
Confidence 999999999999999999999999999643 23457999999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++++||+|||+++...............||+.|||||++.++.|+.++|||||||+|
T Consensus 157 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 157 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220 (299)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 9999999999999999999876544433334445799999999999999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=334.44 Aligned_cols=192 Identities=23% Similarity=0.353 Sum_probs=153.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.|+..+.+|.|++|.|+.+ .+..+++.||||+++... ....+++.+|+.+|++|+|||||
T Consensus 6 dy~~~~~lG~G~fg~V~~a-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV 66 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEA-------------------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66 (299)
T ss_dssp HEEEEEEEEECC--EEEEE-------------------EETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred hCEEeeEEecCCCeEEEEE-------------------EECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4778888999999887755 455689999999997653 34457799999999999999999
Q ss_pred ceeeeEecCC------------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 012989 318 RLLGCCLDGN------------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385 (452)
Q Consensus 318 ~l~~~~~~~~------------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~D 385 (452)
++++++...+ ++||||||+++++|.+++.........++..++.|+.||++||+|||+++ |||||
T Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRD 143 (299)
T 4g31_A 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRD 143 (299)
T ss_dssp CEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred eEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---Ccccc
Confidence 9999987543 47999999999999999965444445677889999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeeEccccccccccCCCccc----------cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEA----------NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 386 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||+|||++.++.+||+|||+|+.+....... .....+||+.|||||++.+..|+.++|||||||||
T Consensus 144 lKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvil 220 (299)
T 4g31_A 144 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLIL 220 (299)
T ss_dssp CCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHH
Confidence 99999999999999999999998775433211 12345899999999999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=328.58 Aligned_cols=186 Identities=21% Similarity=0.398 Sum_probs=148.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|++.+.+|+|++|.|+.+ .+..+|+.||||++.+. .....+++.+|+.++++++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp 73 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLA-------------------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73 (275)
T ss_dssp -CCEEEEEEEC---CCEEEE-------------------ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCT
T ss_pred eCeEEEEEEecCcCeEEEEE-------------------EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCC
Confidence 37999999999999888765 34568999999999765 233456799999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|||++++++++++.+||||||+ +|+|.+++. +...+++.+++.++.||+.||+|||++| |+||||||+|||++
T Consensus 74 nIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~ 146 (275)
T 3hyh_A 74 HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLD 146 (275)
T ss_dssp TBCCEEEEEECSSEEEEEEECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEEC
T ss_pred CCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEEC
Confidence 9999999999999999999999 568888774 3456999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
.++++||+|||+|+...... .....+||+.|||||++.+..+ +.++||||+||+|
T Consensus 147 ~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvil 202 (275)
T 3hyh_A 147 EHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202 (275)
T ss_dssp TTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHH
T ss_pred CCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHH
Confidence 99999999999998754332 2334689999999999988876 5789999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.67 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=158.3
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.+.+.+.+|+|+||.||.+..... ....+++.||||+++..+....++|.+|+++|++|+|||||+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~--------------~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNL--------------LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSS--------------CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred HeEEEEEEccCCCcEEEEEEECCc--------------ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 345566799999999987643210 012468899999998777777888999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDST------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
+++++.+++.++|||||+++|+|.++++... ...++++.+++.|+.||+.||+|||+++ ||||||
T Consensus 108 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDL 184 (329)
T 4aoj_A 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDL 184 (329)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccc
Confidence 9999999999999999999999999986532 2346999999999999999999999998 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|||++.++++||+|||+++...............||+.|||||++.+..++.++|||||||+|
T Consensus 185 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl 250 (329)
T 4aoj_A 185 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250 (329)
T ss_dssp CGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHH
Confidence 999999999999999999999876554444444556899999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.49 Aligned_cols=191 Identities=23% Similarity=0.261 Sum_probs=157.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|++.+.+|.|++|.|+.+... ....+++.||||++++.. .....++.+|+.+|++++|||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~----------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn 87 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKI----------------SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEEC----------------SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTT
T ss_pred cccEEEEEEecCCCeEEEEEEEc----------------cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCC
Confidence 37999999999999988865311 012357899999997642 233457889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
||++++++++++.+||||||++||+|.+++. +.+.+++.+++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 88 Iv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~ 161 (304)
T 3ubd_A 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDE 161 (304)
T ss_dssp EECEEEEEEETTEEEEEECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECT
T ss_pred CCeEEEEEEECCEEEEEEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcC
Confidence 9999999999999999999999999999984 3457999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++++||+|||+|+...... ......+||+.|||||++.+..|+.++||||+||+|
T Consensus 162 ~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvil 216 (304)
T 3ubd_A 162 EGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216 (304)
T ss_dssp TSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHH
T ss_pred CCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHH
Confidence 9999999999998654332 223456899999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.63 Aligned_cols=184 Identities=23% Similarity=0.238 Sum_probs=156.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|+..+.+|.|++|.||.+ .+..+|+.||||+++.... ..+|+.+++.|+|||||+
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a-------------------~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~ 114 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRM-------------------KDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVP 114 (336)
T ss_dssp EEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCC
T ss_pred heEeCcEeccCCCeEEEEE-------------------EECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCc
Confidence 5777778999999877755 5567899999999976532 246999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC-
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM- 397 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~- 397 (452)
+++++.+++.+||||||++|++|.+++.. .+.+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++
T Consensus 115 l~~~~~~~~~~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~ 188 (336)
T 4g3f_A 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGS 188 (336)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSC
T ss_pred EEEEEEECCEEEEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCC
Confidence 99999999999999999999999999943 456999999999999999999999999 99999999999999987
Q ss_pred CeeEccccccccccCCCcc---ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNE---ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||+|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||||
T Consensus 189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvil 246 (336)
T 4g3f_A 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246 (336)
T ss_dssp CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHH
Confidence 5999999999876543221 123346899999999999999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=327.03 Aligned_cols=187 Identities=26% Similarity=0.322 Sum_probs=156.9
Q ss_pred ccc-cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRY-ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry-~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.|| +....+|.|++|.||.+ .+..+++.||||++... .....++|.+|+.+|++|+||
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hp 85 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKG-------------------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCT
T ss_pred CceEEeeeEEecCcCcEEEEE-------------------EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCC
Confidence 344 45556899999888755 45568999999999754 344567899999999999999
Q ss_pred CccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 315 NLVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 315 ~iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|||+++++++. +..+||||||++||+|.+++. +...+++..++.|+.||+.||+|||+++ .+||||||||+|
T Consensus 86 nIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~N 161 (290)
T 3fpq_A 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDN 161 (290)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGG
T ss_pred CCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhh
Confidence 99999999875 356899999999999999994 3456999999999999999999999875 359999999999
Q ss_pred eEECC-CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDH-EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++. ++.+||+|||+|+.... ......+||+.|||||++.+ .|+.++|||||||+|
T Consensus 162 ILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvil 219 (290)
T 3fpq_A 162 IFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM 219 (290)
T ss_dssp EEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred eeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHH
Confidence 99984 78999999999986432 22345689999999998864 699999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.20 Aligned_cols=196 Identities=27% Similarity=0.387 Sum_probs=163.0
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
++..+.+|.|+||.||.+.... .....+++.||||+++.. .....++|.+|+.++++++|||||+
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~--------------~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~ 93 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFG--------------PAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC---------------------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCC
T ss_pred CeEeeEeccCCCcEEEEEEEcC--------------CccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3445679999999998764311 012346789999999755 3445678999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~D 385 (452)
+++++..++.++|||||+++|+|.+++..... ...+++.+++.|+.||+.||+|||+++ |||||
T Consensus 94 l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRD 170 (308)
T 4gt4_A 94 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKD 170 (308)
T ss_dssp EEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred cceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCC
Confidence 99999999999999999999999999854321 246999999999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 386 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||+|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||+|
T Consensus 171 LK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl 237 (308)
T 4gt4_A 171 LATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 237 (308)
T ss_dssp CSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHH
Confidence 9999999999999999999999876554444444556899999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.65 Aligned_cols=186 Identities=26% Similarity=0.409 Sum_probs=150.8
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.+++.+.+|.|+||.||.+.. ...||||+++.. +....+.|.+|+.++++++||||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~----------------------~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI 94 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKW----------------------HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI 94 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEES----------------------SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred HeEEeeEEeeCCCcEEEEEEE----------------------CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCE
Confidence 445566789999988886632 235899998754 34456789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|++++++.. +.++|||||+++|+|.++++. ....+++.+++.|+.||+.||+|||+++ ||||||||+|||++.+
T Consensus 95 V~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~ 168 (307)
T 3omv_A 95 LLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEG 168 (307)
T ss_dssp CCEEEEECS-SSCEEEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETT
T ss_pred eeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCC
Confidence 999998754 568999999999999999853 3456999999999999999999999998 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc---CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME---GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il 452 (452)
+++||+|||+|+..............+||+.|||||++.+ +.|+.++|||||||+|
T Consensus 169 ~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl 227 (307)
T 3omv_A 169 LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL 227 (307)
T ss_dssp EEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred CcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence 9999999999987654444444456789999999999863 4689999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.24 Aligned_cols=198 Identities=24% Similarity=0.337 Sum_probs=165.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCC-CC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQH-KN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h-~~ 315 (452)
-+|++.+.+|.|+||.||.+..... .....++.||||++.... ....+.|.+|+++|.+++| ||
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~--------------~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGI--------------DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETS--------------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCC--------------CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence 4788889999999999987642110 011245789999997653 3445679999999999965 89
Q ss_pred ccceeeeEecC-CeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 316 LVRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 316 iv~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
||++++++... +.++|||||+++|+|.++++... ....+++.+++.|+.||+.||+|||+++ |
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 99999998764 57899999999999999996532 1345899999999999999999999999 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||||+|||++.++.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||+|
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999999999999999999999999877555444444556899999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=324.37 Aligned_cols=189 Identities=23% Similarity=0.363 Sum_probs=159.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++.+.+|.|++|.|+.+ .+..+|+.||||++++. .....+++.+|+++|+.|+|||
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a-------------------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn 114 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSA-------------------RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 114 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCeEEEEEEecccCeEEEEE-------------------EECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCC
Confidence 48999999999999887755 45668999999999754 2334567889999999999999
Q ss_pred ccceeeeEec------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLD------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
||++++++.. ..++||||||++ ++|.+++ ...+.+++.+++.|++||+.||+|||++| ||||||||+
T Consensus 115 Iv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i---~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~ 187 (398)
T 4b99_A 115 IIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQII---HSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPS 187 (398)
T ss_dssp BCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHH---TSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred cceEeeeeecccccccCCEEEEEEeCCC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCcc
Confidence 9999998764 357899999996 5688888 34567999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCC--ccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQ--NEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||+++.+.... ........+||+.|||||++.+. .++.++||||+||||
T Consensus 188 NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il 253 (398)
T 4b99_A 188 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253 (398)
T ss_dssp GEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred ccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHH
Confidence 9999999999999999998765432 22234457999999999998875 469999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=316.46 Aligned_cols=188 Identities=24% Similarity=0.290 Sum_probs=149.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|.+.+.+|.|+||.||.+. .+|+.||||+++..... ...++.|+..+.+++|||||+
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~---------------------~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~ 61 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGK---------------------WRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILG 61 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEE---------------------ETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCC
T ss_pred EEEEEEEEeeCCCeEEEEEE---------------------ECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCc
Confidence 57778889999999888652 26899999999654321 222345666667889999999
Q ss_pred eeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCC
Q 012989 319 LLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDS-----RLRVIHRDLKTS 389 (452)
Q Consensus 319 l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g-----~~~ivH~Dlkp~ 389 (452)
+++++..++ +++|||||+++|+|.++++. ..+++..++.|+.|++.||+|||++. ..+||||||||+
T Consensus 62 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~ 137 (303)
T 3hmm_A 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp EEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGG
T ss_pred EEEEEEecCCCceEEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcc
Confidence 999998653 68999999999999999943 45899999999999999999999871 123999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccc--cccccccccccccccccccC------CCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEG------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlG~il 452 (452)
|||++.++++||+|||+++......... .....+||+.|||||++.+. .++.++|||||||+|
T Consensus 138 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl 208 (303)
T 3hmm_A 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred cEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHH
Confidence 9999999999999999998765443222 23346899999999998654 478899999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=314.78 Aligned_cols=190 Identities=18% Similarity=0.264 Sum_probs=158.3
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
-.-+|++.+.+|.|++|.|+.+.. +....+++.||||++.+.. ...++.+|+++|+.+ +||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~----------------~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~ 80 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATA----------------QLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQD 80 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEE----------------EBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBT
T ss_pred ccCcEEEEEEEecccCcEEEEEEE----------------cccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCC
Confidence 345899999999999999886631 0112357899999986543 346788999999998 699
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++.+++++||||||+++++|.+++ +.+++.+++.+++||+.||+|||++| |+||||||+|||++
T Consensus 81 nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 81 NVMGVKYCFRKNDHVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYN 151 (361)
T ss_dssp TBCCCSEEEEETTEEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred CCceEEEEEEECCEEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEe
Confidence 9999999999999999999999999999988 24899999999999999999999999 99999999999998
Q ss_pred CC-CCeeEccccccccccCCCcc--------------------------ccccccccccccccccccccC-CCceeeeee
Q 012989 395 HE-MNPKISDFGMARIFSGNQNE--------------------------ANTNRVVGTYGYMAPEYAMEG-VFSVNRMFL 446 (452)
Q Consensus 395 ~~-~~~kl~DFG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvw 446 (452)
.+ +++||+|||+|+........ ......+||+.|||||++.+. .++.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 77 78999999999865433211 112335799999999999875 489999999
Q ss_pred eeeeeC
Q 012989 447 VSEFFF 452 (452)
Q Consensus 447 SlG~il 452 (452)
|+||||
T Consensus 232 SlG~il 237 (361)
T 4f9c_A 232 SAGVIF 237 (361)
T ss_dssp HHHHHH
T ss_pred hhHHHH
Confidence 999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.53 Aligned_cols=187 Identities=25% Similarity=0.297 Sum_probs=158.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHH---HHHHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNE---VTLIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E---~~~l~~ 310 (452)
.-.|++...+|.|++|.|+.+ .+..+|+.||||++.+.. ......+.+| +.+++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la-------------------~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~ 248 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGC-------------------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS
T ss_pred hHHeEEEEEEecccCeEEEEE-------------------EECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh
Confidence 346888888999999777644 566789999999997541 2223334444 566677
Q ss_pred CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 311 l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
++|||||+++++|++.+.+||||||++||+|..++. +.+.+++..++.|+.||+.||+|||++| ||||||||+|
T Consensus 249 ~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeN 322 (689)
T 3v5w_A 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 322 (689)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGG
T ss_pred CCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHH
Confidence 899999999999999999999999999999999994 3456999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||++.+|++||+|||+|+.+.... ....+||+.|||||++.+ ..|+.++||||+||||
T Consensus 323 ILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvil 381 (689)
T 3v5w_A 323 ILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381 (689)
T ss_dssp EEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHH
T ss_pred eEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999999998765432 345689999999999964 5799999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.66 Aligned_cols=189 Identities=22% Similarity=0.332 Sum_probs=167.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++.+.+|.|+||.|+.+ .+..+|+.||||++........+.+.+|+.+|+.|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~-------------------~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnI 216 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRV-------------------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTB
T ss_pred ccccEEEEEEeeccCeEEEEE-------------------EECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCC
Confidence 358999999999999877754 5567899999999987766667889999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|+++++|.++..+||||||++||+|.+++.. +...+++.+++.|++||+.||+|||+++ |+||||||+|||++.+
T Consensus 217 v~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~ 291 (573)
T 3uto_A 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK 291 (573)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS
T ss_pred CeEEEEEEECCEEEEEEeecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCC
Confidence 9999999999999999999999999988843 3456999999999999999999999999 9999999999999865
Q ss_pred --CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 --MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 --~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+.... .....+||+.|||||++.+..|+.++||||+||||
T Consensus 292 ~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvil 346 (573)
T 3uto_A 292 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346 (573)
T ss_dssp SCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHH
T ss_pred CCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHH
Confidence 789999999998875432 23446899999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.14 Aligned_cols=188 Identities=24% Similarity=0.396 Sum_probs=166.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..||+....+|.|++|.|+.+ .+..+++.||||++........+.+.+|+.+++.++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~i 79 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTA-------------------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEE-------------------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB
T ss_pred hhceeeeeeeccCCCeEEEEE-------------------EECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCC
Confidence 468999999999999887755 3456789999999987766667889999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++||||+++++|.+++.. ..+++.+++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~ 152 (297)
T 3fxz_A 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD 152 (297)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CeEeEEEEECCEEEEEEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCC
Confidence 9999999999999999999999999998843 35899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||++|
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 206 (297)
T 3fxz_A 153 GSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206 (297)
T ss_dssp CCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHH
T ss_pred CCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHH
Confidence 9999999999987654332 23345799999999999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=287.06 Aligned_cols=188 Identities=21% Similarity=0.287 Sum_probs=163.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|+....+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|+.+++.++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 65 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILV-------------------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCT
T ss_pred HHeEEEEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCC
Confidence 47888889999999777644 45568999999999764 234567789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++...+..++||||++|++|..++. ....+++..++.++.||+.||+|||++| |+||||||+|||++
T Consensus 66 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 139 (337)
T 1o6l_A 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLD 139 (337)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred cCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEEC
Confidence 99999999999999999999999999998884 3456999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+|
T Consensus 140 ~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 195 (337)
T 1o6l_A 140 KDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHH
T ss_pred CCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHH
Confidence 99999999999998643221 223456899999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=282.09 Aligned_cols=192 Identities=24% Similarity=0.411 Sum_probs=165.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|+..+.+|.|++|.|+.+ .+..+++.||+|++........+.+.+|+.++++++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~-------------------~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~i 69 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKV-------------------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEE-------------------EETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred hhHeeccceecCCCCEEEEEE-------------------EECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCc
Confidence 347888889999999877754 4556799999999977777777889999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 70 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~ 144 (310)
T 3s95_A 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVREN 144 (310)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTT
T ss_pred ccEEEEEecCCeeEEEEEecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCC
Confidence 9999999999999999999999999999854 2456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccc------------cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEA------------NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++......... ......||+.|+|||++.+..++.++||||||++|
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 212 (310)
T 3s95_A 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212 (310)
T ss_dssp SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHH
Confidence 999999999998764433221 11145799999999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=286.41 Aligned_cols=187 Identities=26% Similarity=0.399 Sum_probs=163.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|++...+|.|++|.|+.+ .+..+|+.||||++... +....+++.+|+++++.++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 75 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLA-------------------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCEEEEEEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCC
Confidence 47899999999999777644 55568999999999765 3445677899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++...+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 76 Iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~ 149 (328)
T 3fe3_A 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDA 149 (328)
T ss_dssp BCCEEEEEECSSEEEEEECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred EeeEEEEEEECCEEEEEEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcC
Confidence 99999999999999999999999999998843 356999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCc-eeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS-VNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwSlG~il 452 (452)
++++||+|||+++.+.... .....+||+.|+|||++.+..++ .++||||+||+|
T Consensus 150 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 204 (328)
T 3fe3_A 150 DMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204 (328)
T ss_dssp TSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHH
T ss_pred CCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHH
Confidence 9999999999998764332 23446799999999999888775 789999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=283.13 Aligned_cols=193 Identities=23% Similarity=0.339 Sum_probs=161.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.++++++||||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni 66 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEA-------------------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEE-------------------EETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTB
T ss_pred hcCceeeEecCCCCeEEEEE-------------------EEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCE
Confidence 47888999999999877755 445589999999997543 3456789999999999999999
Q ss_pred cceeeeEecCC---------------------------------------------------------eEEEEEEecCCC
Q 012989 317 VRLLGCCLDGN---------------------------------------------------------ELLLIYEYMPNK 339 (452)
Q Consensus 317 v~l~~~~~~~~---------------------------------------------------------~~~lv~E~~~~~ 339 (452)
+++++++.... ..++||||++++
T Consensus 67 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 146 (332)
T 3qd2_B 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKE 146 (332)
T ss_dssp CCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSS
T ss_pred eeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCC
Confidence 99999986543 389999999999
Q ss_pred ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcc---
Q 012989 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE--- 416 (452)
Q Consensus 340 ~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--- 416 (452)
+|.+++.........++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 147 ~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 223 (332)
T 3qd2_B 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223 (332)
T ss_dssp CHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC------
T ss_pred CHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc
Confidence 99999976555566788889999999999999999999 999999999999999999999999999876544221
Q ss_pred -------ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 417 -------ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 417 -------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.......||+.|+|||++.+..++.++||||||++|
T Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 266 (332)
T 3qd2_B 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266 (332)
T ss_dssp --------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHH
T ss_pred cccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHH
Confidence 122345799999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=281.90 Aligned_cols=196 Identities=24% Similarity=0.352 Sum_probs=162.3
Q ss_pred EEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHH
Q 012989 231 VRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTL 307 (452)
Q Consensus 231 i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~ 307 (452)
+.+..-.-||++...+|.|++|.|+.+ .+..+++.||||++.... ....+.+.+|+.+
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~ 64 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLA-------------------EDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEE-------------------EETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHH
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEE-------------------EECCCCCeEEEEEeccCccccHHHHHHHHHHHHH
Confidence 334445678999999999999877754 455678999999986542 3345678999999
Q ss_pred HHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 308 IAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 308 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+|||||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlk 138 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIK 138 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 9999999999999999999999999999999999999843 356999999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||++.++++||+|||+++.+..... .......||+.|+|||++.+..++.++||||||++|
T Consensus 139 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 202 (294)
T 4eqm_A 139 PQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVL 202 (294)
T ss_dssp GGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHH
T ss_pred HHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHH
Confidence 9999999999999999999987643321 223345789999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=283.92 Aligned_cols=191 Identities=27% Similarity=0.358 Sum_probs=163.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++.... ....+.+.+|+.+++.++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn 66 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLA-------------------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTT
T ss_pred hhhceeeeEEecCCCEEEEEE-------------------EECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCC
Confidence 458999999999999877754 445689999999987553 233466889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++..++..++||||+++++|.+++ .....+++.+++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 67 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~ 140 (323)
T 3tki_A 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDE 140 (323)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTEEGGGGS---BTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred CCeEEEEEecCCeEEEEEEcCCCCcHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeC
Confidence 999999999999999999999999999988 34456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+.............||+.|+|||++.+..+ +.++||||||++|
T Consensus 141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 198 (323)
T 3tki_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198 (323)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHH
T ss_pred CCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHH
Confidence 99999999999987654444444455689999999999987775 8889999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=284.74 Aligned_cols=188 Identities=22% Similarity=0.311 Sum_probs=164.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc------ccHHHHHHHHHHHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG------QGLQEFKNEVTLIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~~E~~~l~~ 310 (452)
.-+|++...+|.|++|.|+.+ ....+|+.||||++.+... ...+.+.+|+.++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~-------------------~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~ 71 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKC-------------------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTT
T ss_pred hhceEEeeEEeeCcCEEEEEE-------------------EECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHh
Confidence 457899999999999877754 4556899999999986532 135789999999999
Q ss_pred CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 311 l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
++||||+++++++......++||||+++++|.+++ .....+++.+++.++.||+.||.|||++| |+||||||+|
T Consensus 72 l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~N 145 (361)
T 2yab_A 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPEN 145 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH---TTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99999999999999999999999999999999998 34567999999999999999999999999 9999999999
Q ss_pred eEECCCC----CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEM----NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.++ .+||+|||+++.+.... .....+||+.|+|||++.+..++.++|||||||||
T Consensus 146 Ill~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp EEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 9998877 79999999998765432 23345799999999999998999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=289.23 Aligned_cols=190 Identities=26% Similarity=0.383 Sum_probs=159.4
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL- 311 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l- 311 (452)
..-+|++...+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|..+++.+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~ 81 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLA-------------------RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT
T ss_pred chhheEEEEEEeeCCCEEEEEE-------------------EEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc
Confidence 3457899999999999877754 45567999999999764 334556788999999998
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++...+..++||||++|++|..++.. ...+++.+++.++.||+.||+|||++| |+||||||+||
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NI 155 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNV 155 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGE
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHE
Confidence 799999999999999999999999999999988843 356999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++++||+|||+++..... .......+||+.|+|||++.+..++.++|||||||+|
T Consensus 156 Ll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 214 (353)
T 3txo_A 156 LLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214 (353)
T ss_dssp EECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHH
T ss_pred EECCCCCEEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHH
Confidence 9999999999999999753322 2223456899999999999988999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=281.55 Aligned_cols=185 Identities=22% Similarity=0.350 Sum_probs=162.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|+.+++.++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 66 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLI-------------------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBT
T ss_pred HHcEEEEEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCC
Confidence 47888889999998777644 45568999999999754 224467788999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++.+....++||||+++++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++
T Consensus 67 ~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 140 (318)
T 1fot_A 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLD 140 (318)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEEC
T ss_pred CCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEc
Confidence 999999999999999999999999999999843 456999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++++||+|||+++..... ....+||+.|+|||++.+..++.++|||||||+|
T Consensus 141 ~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 193 (318)
T 1fot_A 141 KNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193 (318)
T ss_dssp TTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHH
T ss_pred CCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHH
Confidence 9999999999999865332 2345799999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=290.14 Aligned_cols=189 Identities=23% Similarity=0.316 Sum_probs=162.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcC-C
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKL-Q 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~ 312 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++++.. ....+.+.+|..+++++ +
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~-------------------~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~ 111 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLV-------------------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTT
T ss_pred hhHcEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCC
Confidence 457899999999999877754 455688999999998652 33345688999999887 8
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++.+.+.+++||||+++++|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 112 hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NIL 185 (396)
T 4dc2_A 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVL 185 (396)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEE
T ss_pred CCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEE
Confidence 99999999999999999999999999999988843 356999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++++||+|||+++..... .......+||+.|+|||++.+..++.++|||||||+|
T Consensus 186 l~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvll 243 (396)
T 4dc2_A 186 LDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 243 (396)
T ss_dssp ECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred ECCCCCEEEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHH
Confidence 999999999999999853322 2234456899999999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=280.13 Aligned_cols=193 Identities=34% Similarity=0.625 Sum_probs=165.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|+....+|.|++|.|+.+. ..+++.||||++........+.+.+|+.+++.++||||
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~--------------------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 97 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGV--------------------LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL 97 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEE--------------------CTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTB
T ss_pred HhccCccceeecCCCeeEEEEE--------------------ECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCE
Confidence 4577777778888877766442 34688999999887766777889999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
+++++++...+..++||||+++++|.+++.... ....+++.+++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 98 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~ 174 (321)
T 2qkw_B 98 VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174 (321)
T ss_dssp CCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECT
T ss_pred eeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECC
Confidence 999999999999999999999999999885432 2236999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 175 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 231 (321)
T 2qkw_B 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231 (321)
T ss_dssp TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHH
T ss_pred CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHH
Confidence 999999999999875543333333445789999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=285.50 Aligned_cols=188 Identities=21% Similarity=0.309 Sum_probs=163.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|+.+++.++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~-------------------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h 74 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIV-------------------QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC
T ss_pred hHHeEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC
Confidence 457888999999999877644 45567899999999754 23456778999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++......++||||++|++|..++. ....+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 75 p~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll 148 (384)
T 4fr4_A 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILL 148 (384)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEE
Confidence 999999999999999999999999999999884 3456999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++.+.... .....+||+.|+|||++. +..++.++|||||||+|
T Consensus 149 ~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il 207 (384)
T 4fr4_A 149 DEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207 (384)
T ss_dssp CTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHH
T ss_pred CCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHH
Confidence 999999999999998764332 234568999999999986 34589999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=284.50 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=166.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.-+|++.+.+|.|++|.||.+....... ....++..||||+++.. .....+.+.+|+.+++.+ +||
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp 147 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK------------DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCST------------TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCT
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccC------------cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCC
Confidence 3588899999999999988663211000 01135678999999765 334467799999999999 899
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------------GAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
||+++++++..++.+++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |
T Consensus 148 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 224 (370)
T 2psq_A 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---C 224 (370)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 999999999999999999999999999999865321 245899999999999999999999999 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||||||+|||++.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||+|
T Consensus 225 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 295 (370)
T 2psq_A 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295 (370)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred eccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHH
Confidence 99999999999999999999999999876554433333445678999999999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=283.10 Aligned_cols=189 Identities=23% Similarity=0.321 Sum_probs=163.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-C
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-Q 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~ 312 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|..+++++ +
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~ 68 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLV-------------------RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTT
T ss_pred hhheEEEEEEEecCCeEEEEE-------------------EECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCC
Confidence 457888899999999777654 45567999999999865 233456688999999988 8
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++......++||||+++++|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 69 hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIl 142 (345)
T 3a8x_A 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVL 142 (345)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEE
T ss_pred CCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEE
Confidence 99999999999999999999999999999988843 356999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+|
T Consensus 143 l~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 200 (345)
T 3a8x_A 143 LDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 200 (345)
T ss_dssp ECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred ECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHH
Confidence 9999999999999998543221 223456899999999999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.12 Aligned_cols=186 Identities=21% Similarity=0.268 Sum_probs=163.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|+....+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|+.+++.++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h 100 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLV-------------------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC
T ss_pred HHHCEEEEEeecCcCcEEEEE-------------------EECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC
Confidence 458999999999999877654 45568999999999754 23456778999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++.+....++||||+++++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll 174 (350)
T 1rdq_E 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLI 174 (350)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEE
Confidence 9999999999999999999999999999998843 346999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++..... ....+||+.|+|||++.+..++.++|||||||+|
T Consensus 175 ~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 228 (350)
T 1rdq_E 175 DQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228 (350)
T ss_dssp CTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhH
Confidence 99999999999999875432 2345799999999999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=283.51 Aligned_cols=189 Identities=23% Similarity=0.336 Sum_probs=163.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcC-C
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKL-Q 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~ 312 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++++.. ....+.+..|..+++.+ +
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~ 76 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLA-------------------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEE-------------------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT
T ss_pred hHHeEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCC
Confidence 457888899999999777654 455689999999997642 34556788999999887 9
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++.+.+..++||||++|++|.+++.. ...+++.+++.++.||+.||+|||++| |+||||||+|||
T Consensus 77 hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIl 150 (345)
T 1xjd_A 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNIL 150 (345)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEE
T ss_pred CCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEE
Confidence 99999999999999999999999999999998843 356999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+|
T Consensus 151 l~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 208 (345)
T 1xjd_A 151 LDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 208 (345)
T ss_dssp ECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred ECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHH
Confidence 9999999999999998643222 223456899999999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=277.71 Aligned_cols=188 Identities=21% Similarity=0.295 Sum_probs=163.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc------ccHHHHHHHHHHHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG------QGLQEFKNEVTLIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~~E~~~l~~ 310 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++..... ...+.+.+|+.+++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 70 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKC-------------------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEE-------------------EETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHH
T ss_pred ccceEeceEEeeCCCeEEEEE-------------------EECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHh
Confidence 457899999999999877754 4556799999999976532 246789999999999
Q ss_pred CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 311 l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
++||||+++++++......++||||+++++|.+++. ....+++.+++.++.||+.||.|||+++ |+||||||+|
T Consensus 71 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~N 144 (326)
T 2y0a_A 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPEN 144 (326)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHH
Confidence 999999999999999999999999999999999983 4467999999999999999999999999 9999999999
Q ss_pred eEECCCC----CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEM----NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++||||||++|
T Consensus 145 Ill~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 207 (326)
T 2y0a_A 145 IMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207 (326)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHH
Confidence 9999887 799999999987643322 2345789999999999989999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=274.82 Aligned_cols=188 Identities=25% Similarity=0.353 Sum_probs=158.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|.|+.+ .+..+++.||||++.... ....+.+.+|+.++++++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 62 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKA-------------------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTT
T ss_pred CCceeeeEecCCCCeEEEEE-------------------EECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCC
Confidence 37899999999999877755 455678999999997653 334577889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++..++..++||||++++.+..+. .....+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~ 136 (292)
T 3o0g_A 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINR 136 (292)
T ss_dssp BCCEEEEEEETTEEEEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred EeeEEeEEEeCCEEEEEEecCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 999999999999999999999875444443 23456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||+|
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 192 (292)
T 3o0g_A 137 NGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192 (292)
T ss_dssp TSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred CCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHH
Confidence 9999999999998764332 2233457899999999997766 79999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=277.81 Aligned_cols=187 Identities=26% Similarity=0.392 Sum_probs=164.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
..|+....+|.|++|.|+.+ ....+|+.||||++........+.+.+|+.+++.++||||+
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a-------------------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv 105 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLA-------------------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV 105 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBC
T ss_pred hhhhccEEeccCCCeEEEEE-------------------EECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcc
Confidence 45777778999999877754 44457999999999877777778899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++...+..++||||+++++|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 106 EMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDG 178 (321)
T ss_dssp CEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTC
T ss_pred eEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCC
Confidence 99999999999999999999999999883 346999999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++....... ......||+.|+|||++.+..++.++||||||++|
T Consensus 179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il 231 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231 (321)
T ss_dssp CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHH
Confidence 999999999987654322 23346799999999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=282.67 Aligned_cols=188 Identities=22% Similarity=0.322 Sum_probs=162.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++... .....+.+.+|+.+++.++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hp 88 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRC-------------------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCT
T ss_pred ccCeEEeeEEecCCCeEEEEE-------------------EECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCC
Confidence 357999999999999877754 44567899999999765 334456789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++...+..++||||+++++|.+.+. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 89 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~ 162 (362)
T 2bdw_A 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLA 162 (362)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEES
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEe
Confidence 99999999999999999999999999988883 4456999999999999999999999999 99999999999998
Q ss_pred CCC---CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEM---NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||||
T Consensus 163 ~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 220 (362)
T 2bdw_A 163 SKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220 (362)
T ss_dssp CSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 654 59999999998765332 22346799999999999998999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.50 Aligned_cols=191 Identities=19% Similarity=0.264 Sum_probs=162.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.+.. ......+.+|+.++..++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~-------------------~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h 133 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVV-------------------KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT
T ss_pred hhheEEEEEEEeCCCEEEEEE-------------------EEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC
Confidence 357888999999999877654 445678999999997531 2223448899999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++.+++..+|||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 134 p~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl 208 (437)
T 4aw2_A 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILM 208 (437)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeE
Confidence 9999999999999999999999999999999853 2456999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++....... ......+||+.|+|||++. .+.++.++|||||||+|
T Consensus 209 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil 271 (437)
T 4aw2_A 209 DMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271 (437)
T ss_dssp CTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHH
T ss_pred cCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHH
Confidence 9999999999999987644322 2233468999999999997 56789999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=291.23 Aligned_cols=189 Identities=23% Similarity=0.271 Sum_probs=161.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.+. .....+.+.+|+.+++.++|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~-------------------~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h 128 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLV-------------------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC
T ss_pred ccccEEEEEEEcCCCEEEEEE-------------------EECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC
Confidence 347888999999999877754 45567899999999753 12233558899999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++.++...+|||||++|++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 129 p~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl 201 (410)
T 3v8s_A 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLL 201 (410)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeE
Confidence 9999999999999999999999999999998843 35899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCC----CceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV----FSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||+|
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvil 263 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHH
T ss_pred CCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHH
Confidence 9999999999999987644321 2233568999999999997655 88999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=282.66 Aligned_cols=192 Identities=23% Similarity=0.321 Sum_probs=162.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-----CcccHHHHHHHHHHHHcC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-----SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~~E~~~l~~l 311 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++... .....+.+.+|+.+++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 83 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRC-------------------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC
T ss_pred ccceEEeeEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC
Confidence 357999999999999877754 45568999999998643 122467899999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
+||||+++++++..++..++||||+++++|.+.+... .....+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 84 ~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~N 160 (351)
T 3c0i_A 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHC 160 (351)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHH
Confidence 9999999999999999999999999999998776432 23446899999999999999999999999 9999999999
Q ss_pred eEECCCCC---eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMN---PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||||
T Consensus 161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (351)
T 3c0i_A 161 VLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223 (351)
T ss_dssp EEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHH
Confidence 99987655 99999999987654322 23345799999999999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=289.44 Aligned_cols=190 Identities=22% Similarity=0.304 Sum_probs=162.4
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h 313 (452)
-.-+|++...+|.|++|.|+.+ .+..+++.+|+|++.... ....+.+.+|+.+++.++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~-------------------~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h 69 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRC-------------------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEE-------------------EETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB
T ss_pred ccCCeEEEEEeccCCCeEEEEE-------------------EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC
Confidence 3458999999999999877754 455689999999997653 3345678999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++.+++..++||||+++++|.+.+.. ...+++..+..++.||+.||.|||++| |+||||||+|||+
T Consensus 70 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll 143 (444)
T 3soa_A 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLL 143 (444)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEE
T ss_pred cCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEE
Confidence 9999999999999999999999999999888843 456999999999999999999999999 9999999999999
Q ss_pred C---CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 D---HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ .++.+||+|||+++....... ......||+.|+|||++.+..++.++||||+||||
T Consensus 144 ~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 144 ASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203 (444)
T ss_dssp SBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred eccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHH
Confidence 8 457899999999987654322 22346799999999999998999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=282.81 Aligned_cols=189 Identities=23% Similarity=0.302 Sum_probs=163.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-C
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-Q 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~ 312 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.+. .....+.+..|..+++.+ +
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~ 79 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLS-------------------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEE-------------------EETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTC
T ss_pred hHHcEEEEEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCC
Confidence 357888899999999877654 44557899999999764 234567788999999988 8
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||+|+++++++...+..|+||||++|++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||
T Consensus 80 hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIl 153 (353)
T 2i0e_A 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVM 153 (353)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEE
T ss_pred CCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEE
Confidence 99999999999999999999999999999998843 346999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+|
T Consensus 154 l~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 211 (353)
T 2i0e_A 154 LDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211 (353)
T ss_dssp ECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHH
T ss_pred EcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHH
Confidence 9999999999999998643221 223456899999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=276.59 Aligned_cols=188 Identities=19% Similarity=0.270 Sum_probs=163.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++.+.+|.|++|.|+.+ .+..+++.||+|.+... ....+.+.+|+.+++.++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~-------------------~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnI 63 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRC-------------------VETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTB
T ss_pred hhceEeeeEEecCCCeEEEEE-------------------EECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCC
Confidence 458999999999999877754 45568999999998754 3345678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH- 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~- 395 (452)
+++++++...+..++||||+++++|.+++.. ....+++.+++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~ 138 (321)
T 1tki_A 64 LHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTR 138 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS
T ss_pred CeEeEEEecCCEEEEEEEeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccC
Confidence 9999999999999999999999999998833 3346999999999999999999999999 999999999999987
Q ss_pred -CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 -EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+.... ......||+.|+|||++.+..++.++||||||++|
T Consensus 139 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 193 (321)
T 1tki_A 139 RSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193 (321)
T ss_dssp SCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHH
T ss_pred CCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHH
Confidence 7899999999998765432 23345789999999999988899999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=270.89 Aligned_cols=187 Identities=26% Similarity=0.338 Sum_probs=155.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc----------------------
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG---------------------- 295 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---------------------- 295 (452)
-+|++...+|.|++|.|+.+ .+..+++.||||++.....
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 73 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLA-------------------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEE-------------------EETTTTEEEEEEEEECC------------------------
T ss_pred cceEEEeEEeecCCEEEEEE-------------------EECCCCcEEEEEEeehhhhhhhccccccccccccccccccc
Confidence 48999999999999877755 4556899999999875421
Q ss_pred ----ccHHHHHHHHHHHHcCCCCCccceeeeEec--CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 012989 296 ----QGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARG 369 (452)
Q Consensus 296 ----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~a 369 (452)
...+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++ ....+++.+++.++.||+.|
T Consensus 74 ~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~ 149 (298)
T 2zv2_A 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKG 149 (298)
T ss_dssp -------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHH
Confidence 123568899999999999999999999986 56899999999999998765 34569999999999999999
Q ss_pred HHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCC---Cceeeeee
Q 012989 370 LLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV---FSVNRMFL 446 (452)
Q Consensus 370 L~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Dvw 446 (452)
|+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++|||
T Consensus 150 l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~ 224 (298)
T 2zv2_A 150 IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224 (298)
T ss_dssp HHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHH
T ss_pred HHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhH
Confidence 99999999 99999999999999999999999999987654322 123457899999999997655 47789999
Q ss_pred eeeeeC
Q 012989 447 VSEFFF 452 (452)
Q Consensus 447 SlG~il 452 (452)
|||++|
T Consensus 225 slG~~l 230 (298)
T 2zv2_A 225 AMGVTL 230 (298)
T ss_dssp HHHHHH
T ss_pred hHHHHH
Confidence 999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=275.15 Aligned_cols=192 Identities=21% Similarity=0.327 Sum_probs=164.1
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ 314 (452)
-.-||++.+.+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|++++++++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 67 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRG-------------------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCT
T ss_pred CCCCEEEEEEecCCCCeEEEEE-------------------EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCC
Confidence 4568999999999999887755 445578999999997543 34467788999999999999
Q ss_pred CccceeeeEecCC--eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 315 NLVRLLGCCLDGN--ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 315 ~iv~l~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||+++++++.... ..++||||+++++|.+++........+++.+++.++.||+.||+|||+++ |+||||||+|||
T Consensus 68 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 144 (319)
T 4euu_A 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIM 144 (319)
T ss_dssp TBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEE
Confidence 9999999998765 78999999999999999966555555999999999999999999999999 999999999999
Q ss_pred E----CCCCCeeEccccccccccCCCccccccccccccccccccccc--------cCCCceeeeeeeeeeeC
Q 012989 393 L----DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM--------EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l----~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DvwSlG~il 452 (452)
+ +.++.+||+|||+++....... .....||+.|+|||++. +..++.++|||||||+|
T Consensus 145 l~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 145 RVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp EEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred EeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 9 7778899999999987654332 23457899999999986 57889999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=288.45 Aligned_cols=191 Identities=19% Similarity=0.276 Sum_probs=162.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|+....+|.|++|.|+.+ ....+++.||||++.+.. ....+.+.+|..++..++|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~-------------------~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h 120 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVV-------------------KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT
T ss_pred hhhEEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC
Confidence 347888999999999877654 455689999999997532 2234558899999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++.+.+..||||||++|++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 121 p~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl 195 (412)
T 2vd5_A 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILL 195 (412)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeee
Confidence 99999999999999999999999999999998532 346999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccc-------cCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-------EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++....... ......+||+.|+|||++. ...++.++|||||||+|
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvil 260 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHH
T ss_pred cCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHH
Confidence 9999999999999987654322 1223468999999999997 35789999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=282.68 Aligned_cols=197 Identities=13% Similarity=0.079 Sum_probs=164.5
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC---
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ--- 312 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~--- 312 (452)
...+|++...+|.|++|.||.+.... .....+++.||||++... ....+..|+.+++.++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--------------~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGD--------------LNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSM 125 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC---------------------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGG
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecC--------------CcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhh
Confidence 35689999999999999988763211 023457899999998654 3456788888888886
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST--KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|+||+++++.+..++..+|||||+++++|.+++.... ....+++.+++.|+.||+.||+|||+++ |+||||||+|
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~N 202 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDN 202 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGG
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHH
Confidence 8999999999999999999999999999999985421 3466999999999999999999999999 9999999999
Q ss_pred eEECC-----------CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDH-----------EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~-----------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++. ++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||+|
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 275 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHH
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHH
Confidence 99998 899999999999765533333344556899999999999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=278.09 Aligned_cols=192 Identities=24% Similarity=0.311 Sum_probs=153.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC----cccHHHHHHHHHHHHcCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS----GQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~~E~~~l~~l~ 312 (452)
.-+|++...+|.|++|.|+.+... ....+++.||||++++.. ......+.+|+.+++.++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 79 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKV----------------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEC----------------SSTTTTCEEEEEEECCC--------------HHHHHHHCC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEe----------------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC
Confidence 458999999999999888855311 012478999999997642 234556889999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 80 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nil 153 (327)
T 3a62_A 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIM 153 (327)
T ss_dssp CTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEE
T ss_pred CCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeE
Confidence 99999999999999999999999999999988843 356899999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||++|
T Consensus 154 l~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 211 (327)
T 3a62_A 154 LNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALM 211 (327)
T ss_dssp ECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHH
T ss_pred ECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHH
Confidence 9999999999999987543222 123345789999999999998999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=276.50 Aligned_cols=192 Identities=28% Similarity=0.449 Sum_probs=154.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ 314 (452)
..+|++.+.+|.|++|.|+.+. .+++.||||++.... ....+.+.+|+.++++++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~---------------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp 94 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAE---------------------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE---------------------ETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCT
T ss_pred hhHceeeeEeecCCCeEEEEEE---------------------ECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC
Confidence 4578889999999998887552 368899999987653 34456789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++......++||||+++++|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||++
T Consensus 95 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~ 173 (309)
T 3p86_A 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVD 173 (309)
T ss_dssp TBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEEC
T ss_pred CEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEe
Confidence 999999999999999999999999999999854333334999999999999999999999875 3499999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||++|
T Consensus 174 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 229 (309)
T 3p86_A 174 KKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229 (309)
T ss_dssp TTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred CCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHH
Confidence 99999999999997543321 123345789999999999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.78 Aligned_cols=190 Identities=20% Similarity=0.277 Sum_probs=164.6
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..-+|++.+.+|.|++|.|+.+ ....+++.||+|++..........+.+|+.+++.++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~-------------------~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn 109 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRC-------------------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTT
T ss_pred cccceEEEEEEecCCCEEEEEE-------------------EECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcC
Confidence 3457999999999999877754 445678999999998776656678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++......++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 110 Iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~ 184 (387)
T 1kob_A 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCET 184 (387)
T ss_dssp BCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESS
T ss_pred CCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEec
Confidence 99999999999999999999999999988843 3346999999999999999999999999 999999999999974
Q ss_pred --CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 --EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 --~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 185 ~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 240 (387)
T 1kob_A 185 KKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240 (387)
T ss_dssp TTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHH
T ss_pred CCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHH
Confidence 46799999999987644322 2334789999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=290.72 Aligned_cols=189 Identities=22% Similarity=0.347 Sum_probs=146.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|.|+.+ .+..+++.||||++... .....+++.+|+.+|+.++|||
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~n 113 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEA-------------------YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113 (458)
T ss_dssp TTEEECCC-------CEEEE-------------------EECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCeEEeeEeeecCCeEEEEE-------------------EECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCC
Confidence 57888888888888777654 45668999999999754 3345677999999999999999
Q ss_pred ccceeeeEec-----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 316 LVRLLGCCLD-----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 316 iv~l~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|+++++++.. ....|+|||+++ ++|..++. ....+++..++.|+.||+.||+|||+++ |+||||||+|
T Consensus 114 iv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~N 186 (458)
T 3rp9_A 114 VVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPAN 186 (458)
T ss_dssp BCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred CCceEEEEecCCcccCceEEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhh
Confidence 9999999853 357999999985 58888873 3456999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCcc-------------------------cccccccccccccccccc-ccCCCceeee
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNE-------------------------ANTNRVVGTYGYMAPEYA-MEGVFSVNRM 444 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~D 444 (452)
||++.++.+||+|||+++........ ......+||+.|+|||++ .+..++.++|
T Consensus 187 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~D 266 (458)
T 3rp9_A 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266 (458)
T ss_dssp EEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHH
T ss_pred EEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhH
Confidence 99999999999999999876533211 123345889999999986 4667999999
Q ss_pred eeeeeeeC
Q 012989 445 FLVSEFFF 452 (452)
Q Consensus 445 vwSlG~il 452 (452)
||||||||
T Consensus 267 iwSlG~il 274 (458)
T 3rp9_A 267 VWSIGCIF 274 (458)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=282.97 Aligned_cols=189 Identities=23% Similarity=0.280 Sum_probs=153.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHH-HHcCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTL-IAKLQ 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~-l~~l~ 312 (452)
.-+|+....+|.|++|.|+.+ ....+++.||||++.+.. ......+.+|..+ ++.++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~ 97 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLA-------------------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEE-------------------EETTTCCEEEEEEEEGGGBC-------------CCBCCCC
T ss_pred hhheEEEEEEeeCCCeEEEEE-------------------EEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC
Confidence 357899999999999777654 455678999999997653 2334556777776 46789
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++.+...+..|+||||++|++|..++.. ...+++..++.++.||+.||+|||++| |+||||||+|||
T Consensus 98 hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIl 171 (373)
T 2r5t_A 98 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENIL 171 (373)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred CCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEE
Confidence 99999999999999999999999999999988843 456899999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+|
T Consensus 172 l~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 229 (373)
T 2r5t_A 172 LDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVL 229 (373)
T ss_dssp ECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred ECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHH
Confidence 9999999999999998643222 223456899999999999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=278.77 Aligned_cols=188 Identities=21% Similarity=0.356 Sum_probs=160.5
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~ 312 (452)
..-+|++.+.+|.|++|.|+.+ .+..+++.||||++.+. .....+.+.+|+.+++.++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~ 67 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLA-------------------THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC
T ss_pred ccCCEEEEEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC
Confidence 3458999999999999877654 45568999999998754 2233467899999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++..+...++||||+ +++|.+++.. ...+++.+++.++.||+.||.|||++| |+||||||+|||
T Consensus 68 hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIl 140 (336)
T 3h4j_B 68 HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLL 140 (336)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEE
T ss_pred CCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEE
Confidence 999999999999999999999999 5677777733 356999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
++.++.+||+|||++....... .....+||+.|+|||++.+..+ +.++||||||++|
T Consensus 141 l~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 198 (336)
T 3h4j_B 141 LDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198 (336)
T ss_dssp ECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHH
T ss_pred EcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHH
Confidence 9999999999999998764432 2334579999999999988776 7899999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.55 Aligned_cols=192 Identities=26% Similarity=0.379 Sum_probs=165.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|+....+|.|++|.|+.+ ....+|+.||||++.+.. ....+.+.+|+.++++++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a-------------------~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h 244 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFAC-------------------QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC
T ss_pred hhheEEEEEEeeCCCeEEEEE-------------------EECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC
Confidence 457888888999999777654 445689999999997542 3445778999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|||+++++++......++||||++|++|..++.... ....+++..++.++.||+.||+|||++| |+||||||+|||
T Consensus 245 p~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NIL 321 (543)
T 3c4z_A 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVL 321 (543)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEE
Confidence 999999999999999999999999999998885432 2456999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++++||+|||+++.+..... .....+||+.|+|||++.+..++.++|||||||||
T Consensus 322 l~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvil 379 (543)
T 3c4z_A 322 LDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379 (543)
T ss_dssp ECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred EeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHH
Confidence 99999999999999987654322 22345899999999999999999999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=276.09 Aligned_cols=196 Identities=24% Similarity=0.386 Sum_probs=161.5
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-.-||++...+|.|++|.|+.+.... ....+..||||++... .....+.+.+|+.+++.++||
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~----------------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 110 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRV----------------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECC----------------TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCT
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEec----------------CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC
Confidence 34689999999999998887653211 0124556999999765 344567799999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++..++..++||||+++++|.+++.. ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 185 (325)
T 3kul_A 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVD 185 (325)
T ss_dssp TBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEC
Confidence 999999999999999999999999999999843 3356999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++.+....... ......+|+.|+|||++.+..++.++||||||++|
T Consensus 186 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 244 (325)
T 3kul_A 186 SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244 (325)
T ss_dssp TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHH
Confidence 99999999999998765432221 22233567889999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=282.67 Aligned_cols=199 Identities=27% Similarity=0.340 Sum_probs=164.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++...+|.|++|.|+.+.... .....+++.||||++... .......+.+|+.++++++|||
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~--------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn 135 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSG--------------MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-------------------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTT
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEcc--------------CCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCC
Confidence 3578889999999999988664211 013356889999999754 3445567899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST----KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
|+++++++......++||||+++++|.+++.... ....+++.+++.++.||+.||+|||++| |+||||||+||
T Consensus 136 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 212 (367)
T 3l9p_A 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNC 212 (367)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhE
Confidence 9999999999999999999999999999986532 2346999999999999999999999999 99999999999
Q ss_pred EECCCC---CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEM---NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++ .+||+|||+++.+.............||+.|+|||++.+..++.++|||||||+|
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 999655 4999999999865433333334445789999999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=275.32 Aligned_cols=188 Identities=18% Similarity=0.195 Sum_probs=161.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 316 (452)
-+|++...+|.|++|.|+.+ .+..+++.||||++..... .+.+.+|+.+++.+ +||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i 67 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLG-------------------KNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGI 67 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEE-------------------EETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTS
T ss_pred CCeEEEEEeeccCCceEEEE-------------------EECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCC
Confidence 47888889999998777654 4556899999999875532 24688999999999 99999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++......++||||+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~ 141 (330)
T 2izr_A 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRP 141 (330)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCG
T ss_pred CEEEEEEecCCccEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccC
Confidence 99999999999999999999 89999988542 457999999999999999999999999 9999999999999988
Q ss_pred CC-----eeEccccccccccCCCccc-----cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MN-----PKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~-----~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+. +||+|||+++.+....... ......||+.|+|||++.+..++.++||||||++|
T Consensus 142 ~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 207 (330)
T 2izr_A 142 GNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMF 207 (330)
T ss_dssp GGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHH
Confidence 87 9999999998765443221 12456899999999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=280.47 Aligned_cols=194 Identities=16% Similarity=0.209 Sum_probs=163.5
Q ss_pred cCccccceeeecCc--cccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcC
Q 012989 236 CNFRYELYQFYNDT--SIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 236 c~~ry~~~~f~g~g--~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l 311 (452)
-.-||++...+|.| ++|.|+.+ ....+++.||||++.... ....+.+.+|+.+++.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l 83 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLA-------------------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEE-------------------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC
T ss_pred CCCcEEEEecccCCcCCceEEEEE-------------------EEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC
Confidence 34689999999999 87766644 555689999999997653 34456788999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++..++..++||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 84 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NI 159 (389)
T 3gni_B 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHI 159 (389)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred CCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999998543 2356999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCc-----ccccccccccccccccccccc--CCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQN-----EANTNRVVGTYGYMAPEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||.+........ ........||+.|+|||++.+ ..++.++|||||||||
T Consensus 160 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 227 (389)
T 3gni_B 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227 (389)
T ss_dssp EECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHH
T ss_pred EEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHH
Confidence 999999999999998865432211 111223478999999999987 6799999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=279.43 Aligned_cols=191 Identities=25% Similarity=0.351 Sum_probs=154.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++.... ......+.+|+.++++++|
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h 71 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLA-------------------RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCC
T ss_pred cCcEEEEEEEccCCCEEEEEE-------------------EECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCC
Confidence 458999999999999777654 455689999999997653 2334678999999999999
Q ss_pred CCccceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 314 KNLVRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 314 ~~iv~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|||+++++++.... ..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+
T Consensus 72 p~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~ 145 (311)
T 3ork_A 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145 (311)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred CCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHH
Confidence 99999999988654 35999999999999999843 346999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||++|
T Consensus 146 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 209 (311)
T 3ork_A 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209 (311)
T ss_dssp GEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHH
Confidence 999999999999999999876543222 223345789999999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=280.19 Aligned_cols=188 Identities=23% Similarity=0.343 Sum_probs=156.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
.+++..+.+|.|++|.|+.+ ....+++.||||++........+.+.+|+.++++++||||+
T Consensus 89 ~~~~~~~~lG~G~~g~Vy~a-------------------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 149 (373)
T 2x4f_A 89 YTVSKTEILGGGRFGQVHKC-------------------EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149 (373)
T ss_dssp EEEEEEEECC-----CEEEE-------------------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred eeeecceEEecCcCEEEEEE-------------------EEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCC
Confidence 34444667888888777654 45568999999999877666678899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE--CC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--DH 395 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll--~~ 395 (452)
++++++...+..+|||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.
T Consensus 150 ~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 224 (373)
T 2x4f_A 150 QLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRD 224 (373)
T ss_dssp CEEEEEECSSEEEEEEECCTTCEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETT
T ss_pred eEEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCC
Confidence 999999999999999999999999887743 2345899999999999999999999999 9999999999999 56
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||||
T Consensus 225 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 278 (373)
T 2x4f_A 225 AKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278 (373)
T ss_dssp TTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHH
T ss_pred CCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHH
Confidence 77899999999987654322 2334789999999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=271.87 Aligned_cols=191 Identities=24% Similarity=0.348 Sum_probs=158.2
Q ss_pred cccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcC
Q 012989 234 PSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 234 ~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l 311 (452)
....-||++...+|.|++|.|+.+. ..+++.||||++.... ....+.+.+|+.+++++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~--------------------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l 76 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAK--------------------DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEE--------------------ETTSCEEEEEEEC------CHHHHHHHHHHHHHHC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEE--------------------ECCCCEEEEEEEecccccchhhHHHHHHHHHHHHc
Confidence 3456799999999999998887552 2468899999987542 33356788999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++..+...++||||+++ +|.+.+.. ....+++.+++.++.||+.||.|||++| |+||||||+||
T Consensus 77 ~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NI 150 (311)
T 3niz_A 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNL 150 (311)
T ss_dssp CCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred CCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhE
Confidence 999999999999999999999999986 66666633 3456999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 151 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 210 (311)
T 3niz_A 151 LINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIF 210 (311)
T ss_dssp EECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred EECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHH
Confidence 999999999999999987643322 2233578999999999876 5689999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.96 Aligned_cols=190 Identities=25% Similarity=0.371 Sum_probs=163.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|+....+|.|++|.|+.+ ....+|+.||||++.+. .......+.+|+.+|+.++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a-------------------~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h 243 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCAC-------------------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC
T ss_pred ccceEEEEEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC
Confidence 356888888888888776644 45568999999999754 23345678899999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++.+.+..++||||++|++|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 244 p~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILl 319 (576)
T 2acx_A 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILL 319 (576)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEE
Confidence 99999999999999999999999999999888543 2345999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++.+..... ....+||+.|+|||++.+..++.++|||||||||
T Consensus 320 d~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvil 375 (576)
T 2acx_A 320 DDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375 (576)
T ss_dssp CTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHH
T ss_pred eCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHH
Confidence 9999999999999987643322 2345899999999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=277.56 Aligned_cols=187 Identities=28% Similarity=0.432 Sum_probs=158.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|++...+|.|++|.||.+. ..++.||||++.... ........|+.++++++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~---------------------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpni 80 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQ---------------------LLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENI 80 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEE---------------------ETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTB
T ss_pred hhhchhhheecccCceEEEEEE---------------------ECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCc
Confidence 4589999999999999888652 247899999996543 333456679999999999999
Q ss_pred cceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCeE
Q 012989 317 VRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED----------SRLRVI 382 (452)
Q Consensus 317 v~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~----------g~~~iv 382 (452)
+++++++.... .+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+. + |+
T Consensus 81 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---iv 153 (322)
T 3soc_A 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---IS 153 (322)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EE
T ss_pred hhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EE
Confidence 99999998743 47999999999999999843 3499999999999999999999998 8 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-----CCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il 452 (452)
||||||+|||++.++.+||+|||+++.+.............||+.|+|||++.+ ..++.++|||||||+|
T Consensus 154 H~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 228 (322)
T 3soc_A 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228 (322)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred eCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHH
Confidence 999999999999999999999999988765544444445689999999999976 4567889999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=281.02 Aligned_cols=199 Identities=24% Similarity=0.345 Sum_probs=164.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.-+|++...+|.|++|.||.+..... ....+++.||||++... .....+.+.+|+++++++ +||
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp 86 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGI--------------DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS--------------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred ccceeeceeecCCCCceEEEEEeccc--------------cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCc
Confidence 45899999999999998886631100 02346789999999765 334456799999999999 789
Q ss_pred CccceeeeEecCC-eEEEEEEecCCCChhhhhccCCC-------------------------------------------
Q 012989 315 NLVRLLGCCLDGN-ELLLIYEYMPNKSLDLFLFDSTK------------------------------------------- 350 (452)
Q Consensus 315 ~iv~l~~~~~~~~-~~~lv~E~~~~~~L~~~l~~~~~------------------------------------------- 350 (452)
||+++++++...+ ..++||||+++++|.+++.....
T Consensus 87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 9999999998755 49999999999999999865322
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccc
Q 012989 351 --------------------GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 351 --------------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 410 (452)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 122899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 411 SGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 411 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.............||+.|+|||++.+..++.++||||||++|
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 285 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHH
Confidence 544443344456789999999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=277.12 Aligned_cols=199 Identities=25% Similarity=0.374 Sum_probs=164.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++.+.+|.|++|.||.+..... ....+++.||||++... .....+.+.+|+.++++++|||
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 111 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGL--------------LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETS--------------STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCc--------------CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCC
Confidence 45888999999999988886632100 00135689999999765 3344567999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK---------------------GAQLDWKRRISIINGIARGLLYLH 374 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~ql~~aL~~LH 374 (452)
|+++++++..++..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 191 (343)
T 1luf_A 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 191 (343)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999865321 256999999999999999999999
Q ss_pred cCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 375 EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 375 ~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 192 ~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 266 (343)
T 1luf_A 192 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266 (343)
T ss_dssp HTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHH
Confidence 999 999999999999999999999999999876543332333445679999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=291.18 Aligned_cols=189 Identities=22% Similarity=0.274 Sum_probs=153.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++.+. .......+.+|+.+++.++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 207 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILV-------------------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEHHHHC-------------CCCCCSC
T ss_pred hHHcEEeEEEeeCcCEEEEEE-------------------EEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC
Confidence 357999999999999877754 45568999999999754 33445678899999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIl 392 (452)
|||+++++++...+..++||||+++++|..++.. ...+++..++.++.||+.||+|||+ +| |+||||||+|||
T Consensus 208 ~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIl 281 (446)
T 4ejn_A 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLM 281 (446)
T ss_dssp TTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEE
T ss_pred CeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEE
Confidence 9999999999999999999999999999888843 4569999999999999999999998 88 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+|
T Consensus 282 l~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 339 (446)
T 4ejn_A 282 LDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339 (446)
T ss_dssp ECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHH
T ss_pred ECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHH
Confidence 9999999999999997643222 223446899999999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.36 Aligned_cols=191 Identities=23% Similarity=0.356 Sum_probs=158.0
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h 313 (452)
..-||++...+|.|++|.|+.+ .+..+++.||||++... .....+++.+|+.+|+.++|
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a-------------------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h 84 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLA-------------------YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEE-------------------EETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCC
T ss_pred ecCCEEEEEEEeecCCEEEEEE-------------------EECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCC
Confidence 4568999999999999877755 45568999999999754 33456789999999999999
Q ss_pred CCccceeeeEecC-----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 314 KNLVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 314 ~~iv~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
|||+++++++... ...|+||||+++ +|.+++. ....+++..++.++.||+.||+|||++| |+||||||
T Consensus 85 ~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp 157 (432)
T 3n9x_A 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKP 157 (432)
T ss_dssp TTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCH
Confidence 9999999999866 579999999865 8988883 3456999999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCcc--------------------cccccccccccccccccc-ccCCCceeeeeee
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNE--------------------ANTNRVVGTYGYMAPEYA-MEGVFSVNRMFLV 447 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwS 447 (452)
+|||++.++.+||+|||+++........ ......+||+.|+|||++ ....++.++||||
T Consensus 158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS 237 (432)
T 3n9x_A 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237 (432)
T ss_dssp GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence 9999999999999999999876543221 123456899999999986 5666999999999
Q ss_pred eeeeC
Q 012989 448 SEFFF 452 (452)
Q Consensus 448 lG~il 452 (452)
|||||
T Consensus 238 lG~il 242 (432)
T 3n9x_A 238 TGCIF 242 (432)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=285.58 Aligned_cols=187 Identities=26% Similarity=0.401 Sum_probs=162.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|++...+|.|++|.|+.+ .+..+|+.||||++.+.. ....+.+.+|+.+++.++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a-------------------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp 76 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVG-------------------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCT
T ss_pred cCEEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCC
Confidence 47899999999999877654 455689999999997542 23456789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++...+..++||||+++++|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~ 150 (476)
T 2y94_A 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLD 150 (476)
T ss_dssp TBCCEEEEEECSSEEEEEEECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEC
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEe
Confidence 99999999999999999999999999999983 4566999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
.++++||+|||+++...... .....+||+.|+|||++.+..+ +.++|||||||+|
T Consensus 151 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil 206 (476)
T 2y94_A 151 AHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206 (476)
T ss_dssp TTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHH
T ss_pred cCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHH
Confidence 99999999999998765432 2334579999999999988766 7899999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=263.74 Aligned_cols=190 Identities=27% Similarity=0.359 Sum_probs=163.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|.|++|.|+.+ ....+++.||||++... .....+.+.+|+.+++.++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 67 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLA-------------------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTB
T ss_pred cceEEEEEeecCCCcEEEEE-------------------EECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCc
Confidence 47888899999998777654 44557899999999754 33445789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++||||+++++|.+++. ....+++.+++.++.||+.||.|||+++ |+|+||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~ 141 (276)
T 2yex_A 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDER 141 (276)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred eeeeeEEEcCCEEEEEEEecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccC
Confidence 999999999999999999999999999883 3456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
+.+||+|||++..+.............||+.|+|||++.+..+ +.++||||||++|
T Consensus 142 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 198 (276)
T 2yex_A 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198 (276)
T ss_dssp CCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHH
T ss_pred CCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHH
Confidence 9999999999987654433333445678999999999987665 7889999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=273.38 Aligned_cols=197 Identities=27% Similarity=0.447 Sum_probs=161.4
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
...+|++...+|.|++|.|+.+.+.. ....+++.||||++........+.+.+|+.++++++|||
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 72 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDP---------------LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECT---------------TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEec---------------ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999888664211 123478999999998777667788999999999999999
Q ss_pred ccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 316 LVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 316 iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|+++++++... ...++||||+++++|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 73 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~ 147 (295)
T 3ugc_A 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILV 147 (295)
T ss_dssp BCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEE
Confidence 99999998654 5689999999999999998543 335999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++........ .......||..|+|||++.+..++.++||||||++|
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (295)
T 3ugc_A 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207 (295)
T ss_dssp EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence 99999999999999876543322 122234578889999999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=278.37 Aligned_cols=201 Identities=26% Similarity=0.355 Sum_probs=167.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.-||++.+.+|.|++|.|+.+....... ....++..||||++... .....+.+.+|+++++++ +||
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp 135 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDK------------DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSST------------TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccc------------cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCc
Confidence 3589999999999999988664211000 01124568999999765 344457799999999999 999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------------GAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
||+++++++..++..++||||+++++|.+++..... ...+++.+++.|+.||+.||.|||+++ |
T Consensus 136 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 212 (382)
T 3tt0_A 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---C 212 (382)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 999999999999999999999999999999865321 246999999999999999999999999 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il 283 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHH
Confidence 99999999999999999999999999876554433334445678999999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=283.74 Aligned_cols=191 Identities=25% Similarity=0.350 Sum_probs=161.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.++++++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni 174 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSG-------------------RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTB
T ss_pred HHeEEeeEeccCCCCeEEEE-------------------EEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCE
Confidence 47888889999999887755 334578999999987552 3334568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 175 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~ 249 (377)
T 3cbl_A 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEK 249 (377)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEEEEEEecCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCC
Confidence 9999999999999999999999999998853 2345899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++...............+|+.|+|||++.++.++.++||||||++|
T Consensus 250 ~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 305 (377)
T 3cbl_A 250 NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305 (377)
T ss_dssp CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHH
Confidence 99999999999865433222222223457889999999989999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=264.60 Aligned_cols=187 Identities=22% Similarity=0.298 Sum_probs=162.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-||++...+|.|++|.|+.+ ....++..||+|++........+.+.+|++++++++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i 68 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIA-------------------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTB
T ss_pred hhhEEeeeEEeecCCEEEEEE-------------------EeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCE
Confidence 458999999999999877754 4456788999999987766677889999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--- 393 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll--- 393 (452)
+++++++..+...++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+||++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 142 (277)
T 3f3z_A 69 IRLYETFEDNTDIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTD 142 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSS
T ss_pred eeEEEEEecCCeEEEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecC
Confidence 9999999999999999999999999888743 355899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||++..+.... ......||+.|+|||++.+ .++.++||||||++|
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l 197 (277)
T 3f3z_A 143 SPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197 (277)
T ss_dssp STTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHH
T ss_pred CCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHH
Confidence 788899999999998765432 2234578999999998865 489999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-33 Score=271.36 Aligned_cols=199 Identities=26% Similarity=0.340 Sum_probs=165.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..+|++.+.+|.|++|.|+.+..... ....+++.||||++... .....+.+.+|+.+++.++|||
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 87 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHL--------------KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETG--------------GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTT
T ss_pred hhheeeeeeecccCCeeEEEEEEecc--------------CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCc
Confidence 46888899999999988886531100 00235689999999765 3445677899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK---------------------GAQLDWKRRISIINGIARGLLYLH 374 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~ql~~aL~~LH 374 (452)
|+++++++...+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999865332 234899999999999999999999
Q ss_pred cCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 375 EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 375 ~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++ |+||||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++|
T Consensus 168 ~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 168 EMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242 (314)
T ss_dssp HTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHH
Confidence 999 999999999999999999999999999876554433333445678899999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-33 Score=279.70 Aligned_cols=189 Identities=24% Similarity=0.395 Sum_probs=149.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCC-C
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQ-H 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~-h 313 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++... .....+++.+|+.+++.+. |
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h 68 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKS-------------------IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68 (388)
T ss_dssp HTTEEEEEC-------CEEEE-------------------EETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCceEEEEEeeeCCCeEEEEE-------------------EECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCC
Confidence 458899999999998777654 45568999999998654 3445667889999999997 9
Q ss_pred CCccceeeeEecCC--eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 314 KNLVRLLGCCLDGN--ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 314 ~~iv~l~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
|||+++++++...+ .+++||||+++ +|..++.. ..+++..+..++.||+.||+|||++| |+||||||+||
T Consensus 69 ~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NI 140 (388)
T 3oz6_A 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNI 140 (388)
T ss_dssp TTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred CCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHe
Confidence 99999999998544 79999999975 88888743 46899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCc-------------------ccccccccccccccccccccc-CCCceeeeeeeeeee
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQN-------------------EANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFF 451 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~i 451 (452)
|++.++.+||+|||+++.+..... .......+||+.|+|||++.+ ..++.++||||||||
T Consensus 141 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i 220 (388)
T 3oz6_A 141 LLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220 (388)
T ss_dssp EECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred EEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHH
Confidence 999999999999999987643211 112234589999999999976 678999999999998
Q ss_pred C
Q 012989 452 F 452 (452)
Q Consensus 452 l 452 (452)
|
T Consensus 221 l 221 (388)
T 3oz6_A 221 L 221 (388)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=270.12 Aligned_cols=188 Identities=22% Similarity=0.311 Sum_probs=163.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc------ccHHHHHHHHHHHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG------QGLQEFKNEVTLIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~~E~~~l~~ 310 (452)
.-+|++.+.+|.|++|.|+.+ .+..+++.||||++..... ...+.+.+|+.++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 71 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKC-------------------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHH
T ss_pred hccEEEeeEeeecCCEEEEEE-------------------EECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHh
Confidence 357899999999999877754 4456799999999976532 136789999999999
Q ss_pred CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 311 l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
++||||+++++++......++||||+++++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~N 145 (321)
T 2a2a_A 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPEN 145 (321)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHH
Confidence 999999999999999999999999999999999984 3456899999999999999999999999 9999999999
Q ss_pred eEECCCC----CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEM----NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++||||||++|
T Consensus 146 Il~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (321)
T ss_dssp EEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHH
Confidence 9999888 799999999987654322 2345789999999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-33 Score=276.35 Aligned_cols=188 Identities=23% Similarity=0.284 Sum_probs=153.0
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..-||++...+|.|++|.|+.+ .+..+++.||||++.... ...+.+.+|+.+++.++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpn 77 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLM-------------------RDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPN 77 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEE-------------------EETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTT
T ss_pred CCCcEEEEEEeccCCCEEEEEE-------------------EECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCC
Confidence 3568999999999999877654 455689999999997653 23467889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 78 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~ 151 (361)
T 3uc3_A 78 IVRFKEVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDG 151 (361)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECS
T ss_pred CCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 99999999999999999999999999988843 346999999999999999999999999 999999999999987
Q ss_pred CCC--eeEccccccccccCCCccccccccccccccccccccccCCCcee-eeeeeeeeeC
Q 012989 396 EMN--PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVN-RMFLVSEFFF 452 (452)
Q Consensus 396 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwSlG~il 452 (452)
++. +||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||+|
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (361)
T 3uc3_A 152 SPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208 (361)
T ss_dssp SSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHH
T ss_pred CCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHH
Confidence 765 999999998753222 12234578999999999988887666 9999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-33 Score=275.57 Aligned_cols=186 Identities=22% Similarity=0.309 Sum_probs=146.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.... ..+.+.+|+.++++++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~-------------------~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~ni 110 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRC-------------------KQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNI 110 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEC------------CHHHHHCCCTTB
T ss_pred cCcEEEeeEEeeCCCEEEEEE-------------------EECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCC
Confidence 357999999999999887755 444578899999997653 34668899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH- 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~- 395 (452)
+++++++..+...++||||+++++|.+++. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~ 184 (349)
T 2w4o_A 111 IKLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATP 184 (349)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSS
T ss_pred cceeeeEecCCeEEEEEEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecC
Confidence 999999999999999999999999999883 3456999999999999999999999999 999999999999975
Q ss_pred --CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 --EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 --~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 185 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 240 (349)
T 2w4o_A 185 APDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240 (349)
T ss_dssp STTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHH
Confidence 8899999999998654322 22345789999999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-33 Score=286.32 Aligned_cols=185 Identities=26% Similarity=0.327 Sum_probs=152.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++.+. .....+++.+|+.+++.++||
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a-------------------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp 121 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAA-------------------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEE-------------------EETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred cCCeEEEEEeecCCCeEEEEE-------------------EECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCC
Confidence 358999999999999777654 45668999999999764 344567789999999999999
Q ss_pred CccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++++... .+.+|||||++++ |...+. ..+++.+++.++.||+.||+|||++| |+||||||
T Consensus 122 nIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp 192 (464)
T 3ttj_A 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 192 (464)
T ss_dssp TBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred CCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCh
Confidence 999999999754 4679999999875 544441 24899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++++||+|||+++..... ......+||+.|+|||++.+..++.++|||||||||
T Consensus 193 ~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 253 (464)
T 3ttj_A 193 SNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253 (464)
T ss_dssp GGEEECTTSCEEECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred HhEEEeCCCCEEEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHH
Confidence 9999999999999999999875432 223446899999999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=274.81 Aligned_cols=198 Identities=25% Similarity=0.380 Sum_probs=162.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
-+|++...+|.|++|.|+.+..... ....+++.||||++... .....+.+.+|+.+++++ +|||
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 110 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGI--------------SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESC--------------SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTT
T ss_pred HHceeeeeecCCCCceeEEeeeecc--------------ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCC
Confidence 5788888999999988886532100 01235678999999754 334457899999999999 8999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhc
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK--------------------GAQLDWKRRISIINGIARGLLYLHE 375 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--------------------~~~l~~~~~~~i~~ql~~aL~~LH~ 375 (452)
|+++++++...+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+
T Consensus 111 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 190 (344)
T 1rjb_A 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190 (344)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999865322 1348999999999999999999999
Q ss_pred CCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 376 DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 376 ~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+| |+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||++|
T Consensus 191 ~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 191 KS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264 (344)
T ss_dssp TT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHH
Confidence 99 999999999999999999999999999876554433334445678999999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-33 Score=273.30 Aligned_cols=171 Identities=22% Similarity=0.235 Sum_probs=130.1
Q ss_pred ccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC
Q 012989 271 KEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
|.|+...+..+++.||||++.+. ....+.+|+.+++.++ ||||+++++++.++...++||||+++++|.+++..
T Consensus 25 g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 99 (325)
T 3kn6_A 25 SICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-- 99 (325)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--
T ss_pred eEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh--
Confidence 44444566678999999999654 3467889999999997 99999999999999999999999999999998843
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC---CeeEccccccccccCCCcccccccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM---NPKISDFGMARIFSGNQNEANTNRVVGTY 426 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 426 (452)
...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....... ......||+
T Consensus 100 -~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~ 173 (325)
T 3kn6_A 100 -KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTL 173 (325)
T ss_dssp -CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------------
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCc
Confidence 456999999999999999999999999 99999999999998766 799999999986543322 233457899
Q ss_pred ccccccccccCCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.|+|||++.+..++.++||||||++|
T Consensus 174 ~y~aPE~~~~~~~~~~~DiwslG~il 199 (325)
T 3kn6_A 174 HYAAPELLNQNGYDESCDLWSLGVIL 199 (325)
T ss_dssp ----------CCCCHHHHHHHHHHHH
T ss_pred CccCHHHhcCCCCCCccchHHHHHHH
Confidence 99999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=274.42 Aligned_cols=188 Identities=21% Similarity=0.304 Sum_probs=160.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--------ccHHHHHHHHHHH
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--------QGLQEFKNEVTLI 308 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~~E~~~l 308 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++..... ...+.+.+|+.++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTA-------------------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEE-------------------EETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHH
T ss_pred ccceEEEeEEEecCCEEEEEE-------------------EECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHH
Confidence 358899999999999877755 4556899999999976521 1334577899999
Q ss_pred HcCCCCCccceeeeEecCCeEEEEEEecCCC-ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 309 AKLQHKNLVRLLGCCLDGNELLLIYEYMPNK-SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 309 ~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
++++||||+++++++...+..++|||++.++ +|..++. ....+++..++.|+.||+.||.|||+++ |+|||||
T Consensus 84 ~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlk 157 (335)
T 3dls_A 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIK 157 (335)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccC
Confidence 9999999999999999999999999998766 8988883 3456999999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
|+|||++.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++||||||++|
T Consensus 158 p~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (335)
T 3dls_A 158 DENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220 (335)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHH
T ss_pred HHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHH
Confidence 9999999999999999999987654322 234578999999999988777 8899999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-33 Score=270.11 Aligned_cols=190 Identities=25% Similarity=0.363 Sum_probs=147.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.++++++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 65 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKG-------------------LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65 (317)
T ss_dssp --------------CEEEEE-------------------ECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTB
T ss_pred cceeEeeEECCCCCEEEEEE-------------------EECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCc
Confidence 46777888888888777654 445578999999997653 3345778999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS---TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
+++++++..++..++||||+++ +|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~ 141 (317)
T 2pmi_A 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLI 141 (317)
T ss_dssp CCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred ceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEE
Confidence 9999999999999999999985 888777432 12346899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+..... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 142 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 199 (317)
T 2pmi_A 142 NKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199 (317)
T ss_dssp CTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred cCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999987643321 2234578999999999976 4689999999999975
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-33 Score=263.74 Aligned_cols=189 Identities=23% Similarity=0.372 Sum_probs=161.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|+....+|.|++|.|+.+. ..+++.||||++.... ...+.+.+|+.++++++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~--------------------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i 67 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGY--------------------WLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKL 67 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE--------------------ETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTB
T ss_pred hhhceeeheecCCCccEEEEEE--------------------ecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCE
Confidence 3578889999999998887542 3367889999997653 345779999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..+...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~ 142 (269)
T 4hcu_A 68 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN 142 (269)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGG
T ss_pred eeEEEEEecCCceEEEEEeCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCC
Confidence 9999999999999999999999999998843 3456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... .......||+.|+|||++.+..++.++||||||++|
T Consensus 143 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 197 (269)
T 4hcu_A 143 QVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 197 (269)
T ss_dssp GCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHH
Confidence 9999999999986543321 222334568889999999989999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=272.90 Aligned_cols=192 Identities=36% Similarity=0.587 Sum_probs=161.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|+....+|.|++|.|+.+. ..+++.||||++.... ......+.+|+.+++.++|||
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~--------------------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 88 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGR--------------------LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEEC--------------------CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred hhccccceeEecCCCcEEEEEE--------------------ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence 3477777888888887777553 3468899999987653 223346899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCCeEecCCCCCCe
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHED---SRLRVIHRDLKTSNV 391 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~---g~~~ivH~Dlkp~NI 391 (452)
|+++++++......++||||+++++|.+++.... ....+++..++.++.||+.||.|||++ + |+||||||+||
T Consensus 89 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Ni 165 (326)
T 3uim_A 89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANI 165 (326)
T ss_dssp BCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGE
T ss_pred ccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhE
Confidence 9999999999999999999999999999986543 344599999999999999999999999 8 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||++|
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 225 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHH
T ss_pred EECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHH
Confidence 9999999999999999876543322 23345689999999999988999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-33 Score=277.87 Aligned_cols=195 Identities=23% Similarity=0.395 Sum_probs=153.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..+|++...+|.|++|.||.+.... ...++..||||+++.. .....+.+.+|+.++++++|||
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n 107 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKL----------------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBC----------------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTT
T ss_pred HhhceeeeEEeeCCCeEEEEEEEec----------------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCC
Confidence 3588999999999999998774321 0135778999999765 3445567999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++......++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 182 (373)
T 2qol_A 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINS 182 (373)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred CCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcC
Confidence 99999999999999999999999999999853 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||++|
T Consensus 183 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il 240 (373)
T 2qol_A 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240 (373)
T ss_dssp TCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHH
Confidence 9999999999998765432211 12223457889999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-33 Score=267.47 Aligned_cols=187 Identities=25% Similarity=0.355 Sum_probs=155.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|.|+.+ .. .+++.||||++.... ....+.+.+|+.++++++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~-------------------~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 61 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKA-------------------QN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEE-------------------EE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTT
T ss_pred ccchhhhhcccCCCEEEEEE-------------------Ec-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCC
Confidence 37899999999999888755 22 568999999987543 233577889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++..++..++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINR 135 (288)
T ss_dssp BCCEEEEEECSSCEEEEEECCSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred EeeeeeEEccCCeEEEEEEecCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcC
Confidence 99999999999999999999986 78777743 2356999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 191 (288)
T 1ob3_A 136 EGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191 (288)
T ss_dssp TSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred CCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHH
Confidence 99999999999987643221 2233578999999999976 4589999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=273.93 Aligned_cols=195 Identities=24% Similarity=0.256 Sum_probs=158.6
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-----CcccHHHHHHHHHHHHc
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-----SGQGLQEFKNEVTLIAK 310 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~~E~~~l~~ 310 (452)
-.-||++...+|.|++|.|+.+ ....+++.||||++... .....+.+.+|+.++++
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 84 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVA-------------------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHH
T ss_pred hhhheeecceeeecCCeEEEEE-------------------EECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHh
Confidence 3468999999999999877755 44567899999998754 34556789999999999
Q ss_pred CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------------------------------CCCC
Q 012989 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------------------------------KGAQ 353 (452)
Q Consensus 311 l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------------------------------~~~~ 353 (452)
++||||+++++++...+..++||||+++++|.+++.... ....
T Consensus 85 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (345)
T 3hko_A 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164 (345)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHH
T ss_pred CCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999998884210 0123
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC--CeeEccccccccccCCCccc--cccccccccccc
Q 012989 354 LDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM--NPKISDFGMARIFSGNQNEA--NTNRVVGTYGYM 429 (452)
Q Consensus 354 l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~ 429 (452)
+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+....... ......||+.|+
T Consensus 165 ~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 165 QREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence 467889999999999999999999 99999999999998776 89999999998764332221 234457899999
Q ss_pred ccccccc--CCCceeeeeeeeeeeC
Q 012989 430 APEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 430 aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
|||++.+ ..++.++||||||++|
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred CchhhccCCCCCCcHHHHHHHHHHH
Confidence 9999865 6789999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=269.28 Aligned_cols=197 Identities=22% Similarity=0.286 Sum_probs=169.8
Q ss_pred cEEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHH
Q 012989 229 GRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEV 305 (452)
Q Consensus 229 ~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~ 305 (452)
..+..+....||++.+.+|.|++|.||.+ .+..+++.||+|++... .....+.+.+|+
T Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~ 92 (335)
T 2owb_A 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEI-------------------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 92 (335)
T ss_dssp SEEEETTTTEEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHH
T ss_pred ceecCcccCCceEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEechhhhcCHHHHHHHHHHH
Confidence 34556677789999999999999877754 44567899999998754 234467789999
Q ss_pred HHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 012989 306 TLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385 (452)
Q Consensus 306 ~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~D 385 (452)
.+++.++||||+++++++...+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+|||
T Consensus 93 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~d 166 (335)
T 2owb_A 93 SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRD 166 (335)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecC
Confidence 999999999999999999999999999999999999988843 356999999999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 386 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||++|
T Consensus 167 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 231 (335)
T 2owb_A 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231 (335)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHH
T ss_pred CCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHH
Confidence 999999999999999999999987643322 22345789999999999988899999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=273.34 Aligned_cols=191 Identities=23% Similarity=0.400 Sum_probs=154.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCe----eeEEEEeecC-CcccHHHHHHHHHHHHcC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGK----EIAVKRLSRS-SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~----~vAiK~~~~~-~~~~~~~~~~E~~~l~~l 311 (452)
..+|+....+|.|++|.||.+. ...+++ +||+|.+... .....+.+.+|+.+++++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~-------------------~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l 74 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGL-------------------WIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEE-------------------ECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC
T ss_pred HHHcccceEEeeCCCeEEEEEE-------------------EcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC
Confidence 4589999999999999888663 223343 4688887544 345567899999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++..+. .++|+|++++++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+||
T Consensus 75 ~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NI 148 (327)
T 3poz_A 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNV 148 (327)
T ss_dssp CBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheE
Confidence 9999999999998765 7889999999999998854 2456999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++++||+|||+++.+.............||+.|+|||++.+..++.++||||||++|
T Consensus 149 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3poz_A 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp EEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHH
Confidence 9999999999999999887655444444445678899999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-33 Score=295.21 Aligned_cols=188 Identities=23% Similarity=0.315 Sum_probs=159.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC-CC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l-~h 313 (452)
-+|++...+|.|++|.|+ ......+++.||||++++. .....+.+..|..++..+ +|
T Consensus 341 ~~f~~~~~LG~G~fG~V~-------------------~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~ 401 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVM-------------------LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401 (674)
T ss_dssp TTEEEEEESSBTTTBCEE-------------------EEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCC
T ss_pred cceEEEEEEccCCCEEEE-------------------EEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCC
Confidence 356666666667666555 4456678999999999754 234457788999999988 79
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|+|+++++++.+.+.+||||||+++++|..++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+|||+
T Consensus 402 ~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl 475 (674)
T 3pfq_A 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVML 475 (674)
T ss_dssp TTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEE
T ss_pred CeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEE
Confidence 9999999999999999999999999999998843 356999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||||
T Consensus 476 ~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvil 532 (674)
T 3pfq_A 476 DSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532 (674)
T ss_dssp CSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHH
T ss_pred cCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHH
Confidence 999999999999998643222 224456899999999999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=263.50 Aligned_cols=196 Identities=22% Similarity=0.289 Sum_probs=168.4
Q ss_pred EEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHH
Q 012989 230 RVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVT 306 (452)
Q Consensus 230 ~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~ 306 (452)
.+..+....||+....+|.|++|.|+.+ .+..+++.||+|++... .....+.+.+|+.
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~ 67 (294)
T 2rku_A 7 VLVDPRSRRRYVRGRFLGKGGFAKCFEI-------------------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67 (294)
T ss_dssp EEEETTTTEEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHH
T ss_pred eeeCCCcccceEEEEEEeecCCEEEEEE-------------------EECCCCceEEEEEechhhccCHHHHHHHHHHHH
Confidence 3445667789999999999999877754 44557889999998765 2334567899999
Q ss_pred HHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 307 LIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 307 ~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
+++.++||||+++++++...+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||
T Consensus 68 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 141 (294)
T 2rku_A 68 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDL 141 (294)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 99999999999999999999999999999999999988743 356999999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||++|
T Consensus 142 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 205 (294)
T 2rku_A 142 KLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205 (294)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHH
T ss_pred ChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHH
Confidence 99999999999999999999987643222 22345789999999999988899999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-33 Score=272.17 Aligned_cols=193 Identities=21% Similarity=0.364 Sum_probs=146.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCC---eeeEEEEeecC--CcccHHHHHHHHHHHHcCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADG---KEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~---~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~ 312 (452)
-+|++.+.+|.|++|.|+.+.. ..++ ..||||++... .....+.+.+|+.++++++
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~-------------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~ 83 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQL-------------------KQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC--------------------------CEEEEEEC------CHHHHHHHHHHHHHTTCC
T ss_pred hHeEEeceecccCCeEEEEEEE-------------------cccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC
Confidence 4799999999999998886632 2223 37999998765 3445678999999999999
Q ss_pred CCCccceeeeEecCCeE------EEEEEecCCCChhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 012989 313 HKNLVRLLGCCLDGNEL------LLIYEYMPNKSLDLFLFDST---KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~------~lv~E~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH 383 (452)
||||+++++++...... ++||||+++++|.+++.... ....+++.+++.++.||+.||.|||++| |+|
T Consensus 84 h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH 160 (323)
T 3qup_A 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIH 160 (323)
T ss_dssp CTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred CCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---ccc
Confidence 99999999999877654 99999999999998885432 2236999999999999999999999999 999
Q ss_pred cCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++|
T Consensus 161 ~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 229 (323)
T 3qup_A 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229 (323)
T ss_dssp SCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHH
Confidence 999999999999999999999999876554433333344668899999999999999999999999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-33 Score=269.74 Aligned_cols=199 Identities=27% Similarity=0.357 Sum_probs=166.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ 314 (452)
..+|+..+.+|.|++|.|+.+..... ....+++.||||++.... ....+.+.+|+.+++++ +||
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ 87 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGL--------------IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS--------------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred hhhhhHHHhhCccCCcceEEEEEeec--------------cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCC
Confidence 35889999999999998886531000 012467899999997653 33457799999999999 999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK---------------GAQLDWKRRISIINGIARGLLYLHEDSRL 379 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~ 379 (452)
||+++++++..++..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++
T Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 165 (313)
T 1t46_A 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-- 165 (313)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999999999999999999999999999999865322 225899999999999999999999999
Q ss_pred CeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 380 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 166 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 237 (313)
T 1t46_A 166 -CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (313)
T ss_dssp -CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred -eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHH
Confidence 999999999999999999999999999877655433333445678899999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-33 Score=263.02 Aligned_cols=188 Identities=22% Similarity=0.324 Sum_probs=161.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||+|++... .....+.+.+|+.++++++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 65 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRC-------------------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCT
T ss_pred hhhhhhhhhhcCcCCeEEEEE-------------------EEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999877754 44567899999999755 334457788999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++..+...++||||+++++|.+.+.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 66 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~ 139 (284)
T 3kk8_A 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLA 139 (284)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEES
T ss_pred CcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEe
Confidence 999999999999999999999999999887743 356999999999999999999999999 99999999999998
Q ss_pred CCCC---eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMN---PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++. +||+|||++........ .....||+.|+|||++.+..++.++||||||++|
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 197 (284)
T 3kk8_A 140 SKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197 (284)
T ss_dssp SSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred cCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHH
Confidence 7665 99999999976643322 2345789999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-33 Score=267.59 Aligned_cols=188 Identities=23% Similarity=0.303 Sum_probs=155.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.++++++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 63 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKC-------------------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTT
T ss_pred ccceEeeEEeecCCeEEEEE-------------------EeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCC
Confidence 47899999999999877754 445678999999986553 223566889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++...+..++||||+++++|..++. ....+++..++.++.||+.||.|||++| |+||||||+||+++.
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~ 137 (311)
T 4agu_A 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITK 137 (311)
T ss_dssp BCCEEEEEEETTEEEEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred ccchhheeecCCeEEEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcC
Confidence 9999999999999999999999999988873 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||++|
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 193 (311)
T 4agu_A 138 HSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVF 193 (311)
T ss_dssp TSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHH
T ss_pred CCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHH
Confidence 99999999999987653322 2234578999999999976 6689999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-33 Score=262.35 Aligned_cols=189 Identities=25% Similarity=0.427 Sum_probs=142.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.++++++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 71 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRA-------------------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCT
T ss_pred ccceeeeeecCCCceEEEEE-------------------EEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCC
Confidence 47889999999999877754 445688999999997542 23357799999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~ 146 (278)
T 3cok_A 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLT 146 (278)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEEC
T ss_pred CeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999998843 3356999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||++|
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 202 (278)
T 3cok_A 147 RNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMF 202 (278)
T ss_dssp TTCCEEECCCTTCEECC------------------------------CTHHHHHHHHH
T ss_pred CCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHH
Confidence 999999999999987543222 12235789999999999988999999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-33 Score=272.12 Aligned_cols=191 Identities=24% Similarity=0.372 Sum_probs=157.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCee----eEEEEeecC-CcccHHHHHHHHHHHHcC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKE----IAVKRLSRS-SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~----vAiK~~~~~-~~~~~~~~~~E~~~l~~l 311 (452)
.-+|+....+|.|++|.||.+. ...+++. ||+|.+... .....+.+.+|+.+++.+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~-------------------~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l 72 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGV-------------------WIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEE-------------------ECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC
T ss_pred HhHceeeeeeeecCCceEEEEE-------------------EcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC
Confidence 4589999999999998888653 2334444 777777544 233445678899999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++. +...++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 73 ~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Ni 146 (325)
T 3kex_A 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNV 146 (325)
T ss_dssp CCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTE
T ss_pred CCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheE
Confidence 9999999999886 45689999999999999988532 346899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++++||+|||+++.+.............||+.|+|||++.+..++.++||||||++|
T Consensus 147 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (325)
T 3kex_A 147 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207 (325)
T ss_dssp EESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHH
Confidence 9999999999999999987655444444556788899999999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=269.53 Aligned_cols=191 Identities=22% Similarity=0.362 Sum_probs=157.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++...+|.|++|.|+.+ ....+++.||||++.... ......+.+|+.+++.++||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 76 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKA-------------------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEE-------------------EETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCT
T ss_pred ccceeEEEEEecCCCcEEEEE-------------------EECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCC
Confidence 358999999999999877755 455689999999986553 33356788999999999999
Q ss_pred CccceeeeEec--------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 315 NLVRLLGCCLD--------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 315 ~iv~l~~~~~~--------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
||+++++++.. .+..++||||+++ +|...+. .....+++.+++.++.||+.||.|||++| |+||||
T Consensus 77 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 150 (351)
T 3mi9_A 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDM 150 (351)
T ss_dssp TBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred CcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCC
Confidence 99999999987 4468999999986 5555553 23356999999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCc--ccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQN--EANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||+|||++.++.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 151 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 219 (351)
T 3mi9_A 151 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219 (351)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHH
Confidence 99999999999999999999987653322 122344578999999999876 5589999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-33 Score=267.34 Aligned_cols=186 Identities=23% Similarity=0.225 Sum_probs=151.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcC-CCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l-~h~ 314 (452)
-+|+....+|.|++|.|+.+ ....+++.||||++.... .........|+..+..+ +||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~ 117 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKV-------------------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEE-------------------EETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred hheeeeheeccCCCeEEEEE-------------------EECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCC
Confidence 57888889999999877754 445689999999986542 23334455666666555 899
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++..++..++||||+ +++|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++
T Consensus 118 ~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLG 191 (311)
T ss_dssp TBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred cEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEC
Confidence 9999999999999999999999 5688777743 2456999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++++||+|||+++....... .....||+.|+|||++.+ .++.++||||||++|
T Consensus 192 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 245 (311)
T 3p1a_A 192 PRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTI 245 (311)
T ss_dssp GGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHH
T ss_pred CCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHH
Confidence 999999999999887643322 234568999999998875 789999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-33 Score=269.65 Aligned_cols=201 Identities=25% Similarity=0.372 Sum_probs=164.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.-+|++.+.+|.|++|.|+.+....... ....+++.||||++... .....+.+.+|+.+++++ +||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp 101 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDK------------DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCST------------TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccc------------cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCC
Confidence 4689999999999999988764321100 01135788999999765 334567789999999999 899
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK-------------GAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
||+++++++...+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |
T Consensus 102 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 178 (334)
T 2pvf_A 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---C 178 (334)
T ss_dssp TBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 999999999999999999999999999999865321 235899999999999999999999999 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++|
T Consensus 179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 249 (334)
T 2pvf_A 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249 (334)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHH
Confidence 99999999999999999999999999876554333333445678899999999988999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=265.03 Aligned_cols=189 Identities=28% Similarity=0.414 Sum_probs=156.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-----cccHHHHHHHHHHHHcC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-----GQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l 311 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++.... ......+.+|+.+++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l 68 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKA-------------------RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEE-------------------ECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHH
T ss_pred ccceEEEEEEecCCCeEEEEE-------------------EECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHH
Confidence 458999999999999877755 344678999999987432 22235677888888777
Q ss_pred C---CCCccceeeeEecCC-----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 012989 312 Q---HKNLVRLLGCCLDGN-----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383 (452)
Q Consensus 312 ~---h~~iv~l~~~~~~~~-----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH 383 (452)
+ ||||+++++++.... ..++|||++++ +|.+++... ....+++.+++.++.||+.||+|||+++ |+|
T Consensus 69 ~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH 143 (308)
T 3g33_A 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVH 143 (308)
T ss_dssp HHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 4 999999999998755 58999999975 898888542 2344999999999999999999999999 999
Q ss_pred cCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 209 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHH
Confidence 9999999999999999999999998764332 23446789999999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-33 Score=266.97 Aligned_cols=196 Identities=24% Similarity=0.418 Sum_probs=162.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..+|+..+.+|.|++|.|+.+.+.. ....+++.||||++... .....+.+.+|+.+++.++|||
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 84 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDP---------------EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT---------------TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTT
T ss_pred hhhhhhhhccCCCCceEEEEEEEcc---------------ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCC
Confidence 3568899999999998887653211 02357899999999754 3445678999999999999999
Q ss_pred ccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 316 LVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 316 iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|+++++++... ...++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+||++
T Consensus 85 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~ 159 (302)
T 4e5w_A 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLV 159 (302)
T ss_dssp BCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred eeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEE
Confidence 99999999876 678999999999999998843 2345999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+...... .......||..|+|||++.+..++.++||||||++|
T Consensus 160 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 219 (302)
T 4e5w_A 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219 (302)
T ss_dssp EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHH
Confidence 99999999999999876544322 223345678899999999999999999999999974
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-33 Score=270.62 Aligned_cols=199 Identities=23% Similarity=0.335 Sum_probs=164.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++.+.+|.|++|.|+.+.... .....+++.||||++.... ......+.+|+.+++.++|||
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 89 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKG--------------VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEE--------------EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTT
T ss_pred hhheeeeeEeccCCceEEEeeeecC--------------ccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCC
Confidence 4589999999999999888653100 0111357889999997553 344567899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
|+++++++...+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp 166 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAA 166 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSG
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCcc
Confidence 9999999999999999999999999999885421 1246799999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHH
Confidence 9999999999999999999876544333333445678999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-33 Score=273.51 Aligned_cols=188 Identities=21% Similarity=0.324 Sum_probs=153.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCC-
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQH- 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h- 313 (452)
..+|++...+|.|++|.||.+. ..+++.||||++... .....+.+.+|+.+++.++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~--------------------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 67 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVL--------------------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEE--------------------CTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT
T ss_pred cCEEEEEEEEecCCCeEEEEEE--------------------eCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc
Confidence 4589999999999998887552 246889999998755 33445778999999999976
Q ss_pred -CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 314 -KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 -~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|||+++++++..+...++||| +.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||
T Consensus 68 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIl 140 (343)
T 3dbq_A 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFL 140 (343)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred CCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEE
Confidence 999999999999999999999 467799998843 456999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCcccccccccccccccccccccc-----------CCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-----------GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlG~il 452 (452)
++ ++.+||+|||+++.+.............||+.|+|||++.+ ..++.++|||||||+|
T Consensus 141 l~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il 210 (343)
T 3dbq_A 141 IV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210 (343)
T ss_dssp EE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred EE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence 97 67899999999987755444333445689999999999865 6789999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=263.30 Aligned_cols=189 Identities=19% Similarity=0.265 Sum_probs=161.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
.-+|++.+.+|.|++|.|+.+ .+..+++.||||++..... .+.+.+|+.+++.+ +|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~ 67 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEG-------------------TNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEE-------------------EETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTT
T ss_pred ccceEEEEEEeecCCEEEEEE-------------------EECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCC
Confidence 457999999999999877754 4456899999999875432 34588999999999 7999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
++++++++......++||||+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 68 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 141 (298)
T 1csn_A 68 IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGR 141 (298)
T ss_dssp CCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECC
T ss_pred CCeEEeecCCCceeEEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecc
Confidence 999999999999999999999 99999998542 346999999999999999999999999 999999999999987
Q ss_pred CCC-----eeEccccccccccCCCcc-----ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMN-----PKISDFGMARIFSGNQNE-----ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~-----~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++. +||+|||+++........ .......||+.|+|||++.+..++.++||||||++|
T Consensus 142 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (298)
T 1csn_A 142 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 208 (298)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHH
Confidence 776 999999999876554322 123456799999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-33 Score=266.09 Aligned_cols=187 Identities=21% Similarity=0.324 Sum_probs=158.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++........+.+.+|+.+++.++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i 68 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLV-------------------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTB
T ss_pred hccceeeeeccCCCCceEEEE-------------------EECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCe
Confidence 357889999999999777644 4456799999999987655556778999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL--- 393 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll--- 393 (452)
+++++++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~ 142 (304)
T 2jam_A 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTP 142 (304)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSS
T ss_pred eehhhhcccCCEEEEEEEcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecC
Confidence 9999999999999999999999999888843 346899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++..... ......||+.|+|||++.+..++.++||||||++|
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 197 (304)
T 2jam_A 143 EENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197 (304)
T ss_dssp STTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHH
T ss_pred CCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHH
Confidence 78889999999998754322 22335689999999999999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-33 Score=261.16 Aligned_cols=189 Identities=24% Similarity=0.348 Sum_probs=161.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+ ...++..||+|++.... ...+.+.+|+.++++++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~--------------------~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i 65 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLG--------------------KWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKL 65 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEE--------------------EETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTB
T ss_pred hhheeeeeeeccCCCceEEEE--------------------EecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCE
Confidence 458889999999999887654 33567789999997653 345779999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++......++||||+++++|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~ 140 (268)
T 3sxs_A 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRD 140 (268)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTT
T ss_pred eeEEEEEccCCceEEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCC
Confidence 99999999999999999999999999988542 345999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||++|
T Consensus 141 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 195 (268)
T 3sxs_A 141 LCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195 (268)
T ss_dssp CCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHH
T ss_pred CCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHH
Confidence 99999999999876544322 22234567889999999988999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-33 Score=278.03 Aligned_cols=192 Identities=21% Similarity=0.325 Sum_probs=163.1
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+.||++.+.+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|++++++++||
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp 67 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRG-------------------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCT
T ss_pred CCCceEEEEEEEcCCCeEEEEE-------------------EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCC
Confidence 3568999999999999887755 445678999999997543 34467788999999999999
Q ss_pred CccceeeeEecCC--eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 315 NLVRLLGCCLDGN--ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 315 ~iv~l~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||+++++++.... ..++||||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 68 nIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 144 (396)
T 4eut_A 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIM 144 (396)
T ss_dssp TBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEE
Confidence 9999999998755 78999999999999999965444455999999999999999999999999 999999999999
Q ss_pred E----CCCCCeeEccccccccccCCCcccccccccccccccccccccc--------CCCceeeeeeeeeeeC
Q 012989 393 L----DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME--------GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l----~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwSlG~il 452 (452)
+ +.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 145 l~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 145 RVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp EEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred EeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 9 777789999999998764432 2234578999999999865 5688999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-33 Score=265.63 Aligned_cols=187 Identities=20% Similarity=0.300 Sum_probs=161.1
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCC-------eeeEEEEeecCCcccHHHHHHHHHHH
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADG-------KEIAVKRLSRSSGQGLQEFKNEVTLI 308 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~-------~~vAiK~~~~~~~~~~~~~~~E~~~l 308 (452)
-.-+|++...+|.|++|.|+.+. ...++ ..||+|++........+.+.+|+.++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~-------------------~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l 66 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGV-------------------RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEE-------------------EEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHH
T ss_pred chhHeeeeeeeccCCCceEEEEE-------------------EecccccccccchhhhhhhcccccHHHHHHHHHHHHHH
Confidence 35689999999999998888653 22233 67999999877667778899999999
Q ss_pred HcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 309 AKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 309 ~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
++++||||+++++++..++..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 141 (289)
T 4fvq_A 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCA 141 (289)
T ss_dssp HTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred HhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCc
Confidence 9999999999999999999999999999999999998542 334899999999999999999999999 99999999
Q ss_pred CCeEECCCCC--------eeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMN--------PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~--------~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+|||++.++. +||+|||++..... .....||+.|+|||++.+ ..++.++||||||++|
T Consensus 142 ~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp GGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred ceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 9999998887 99999999875422 123467999999999987 7789999999999974
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=264.76 Aligned_cols=188 Identities=36% Similarity=0.516 Sum_probs=157.1
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC----CcccHHHHHHHHHHHHcCCCCC
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS----SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
|.....+|.|++|.||.+. .+++.||||++... .....+.+.+|+.++++++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~---------------------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGY---------------------VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp TTTCCEEEECSSEEEEEEE---------------------SSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred cccCCccccCCCeEEEEEE---------------------ECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 3344566777776665442 26889999998753 2334677999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++...+..++||||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 99999999999999999999999999998865445567999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...............||+.|+|||++.+ .++.++||||||++|
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il 224 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVL 224 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHH
Confidence 99999999999987654433333445678999999998864 589999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=282.36 Aligned_cols=188 Identities=24% Similarity=0.398 Sum_probs=159.8
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h 313 (452)
..-||++...+|.|++|.|+.+ .+..+++.||||++.+. .......+.+|+.++++++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h 80 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKC-------------------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEE-------------------EETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC
T ss_pred hhcceEEeEEEeecCCEEEEEE-------------------EECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC
Confidence 3468999999999999877754 44568999999998754 23456789999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++.....+++||||+++++|.+.+.. ...+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 81 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~ 154 (486)
T 3mwu_A 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILL 154 (486)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEE
Confidence 9999999999999999999999999999887743 356999999999999999999999999 9999999999999
Q ss_pred C---CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 D---HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ .++.+||+|||+++.+.... ......||+.|+|||++.+ .++.++||||+||||
T Consensus 155 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 212 (486)
T 3mwu_A 155 ESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212 (486)
T ss_dssp SSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHH
T ss_pred ecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHH
Confidence 5 45679999999998764432 2334578999999999875 599999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=274.88 Aligned_cols=185 Identities=21% Similarity=0.244 Sum_probs=147.4
Q ss_pred Cccccce-eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHc-CCCC
Q 012989 237 NFRYELY-QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAK-LQHK 314 (452)
Q Consensus 237 ~~ry~~~-~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~-l~h~ 314 (452)
.-+|++. ..+|.|++|.|+.+ .+..+++.||||++... ..+.+|+.++.+ .+||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~-------------------~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp 115 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQI-------------------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 115 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTST
T ss_pred cccceeccceeeeccCeEEEEE-------------------EECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCC
Confidence 3456654 67888888776644 55668999999998643 567789988754 5899
Q ss_pred CccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 315 NLVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 315 ~iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
||+++++++.. ...++|||||+++++|.+++... ....+++.+++.|+.||+.||.|||+++ |+||||||+|
T Consensus 116 ~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 191 (400)
T 1nxk_A 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 191 (400)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcce
Confidence 99999999875 56799999999999999998542 2346999999999999999999999999 9999999999
Q ss_pred eEECC---CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDH---EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++. ++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||||
T Consensus 192 ill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 253 (400)
T 1nxk_A 192 LLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253 (400)
T ss_dssp EEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHH
T ss_pred EEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHH
Confidence 99997 7889999999998654322 23346789999999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=268.04 Aligned_cols=196 Identities=24% Similarity=0.359 Sum_probs=160.2
Q ss_pred EEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--ccHHHHHHHHHH
Q 012989 230 RVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--QGLQEFKNEVTL 307 (452)
Q Consensus 230 ~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~~E~~~ 307 (452)
.-++....-||++...+|.|++|.|+.+ ....+++.||||++..... ...+.+.+|+.+
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~ 77 (331)
T 4aaa_A 17 ENLYFQSMEKYENLGLVGEGSYGMVMKC-------------------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKL 77 (331)
T ss_dssp --CCCBCGGGEEEEEEGGGGTTSSEEEE-------------------EETTTCCEEEEEEEESCSSCHHHHHHHHHHHHH
T ss_pred chhhhhhhhhheeeeEEeecCCEEEEEE-------------------EECCCCceEEEEEEecCCCchHHHHHHHHHHHH
Confidence 3345566779999999999999887755 4456789999999865532 334568899999
Q ss_pred HHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 308 IAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 308 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
+++++||||+++++++......++||||+++++|..++. ....+++..++.++.||+.||.|||++| |+|||||
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlk 151 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIK 151 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcC
Confidence 999999999999999999999999999999999988763 3456999999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+. .++.++||||||++|
T Consensus 152 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 215 (331)
T 4aaa_A 152 PENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV 215 (331)
T ss_dssp GGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred hheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHH
Confidence 9999999999999999999976543322 22345789999999999765 689999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=265.44 Aligned_cols=191 Identities=21% Similarity=0.315 Sum_probs=153.3
Q ss_pred Cccccce-eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELY-QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~-~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.-+|++. +.+|.|++|.|+ ...+..+++.||||++........+.+.+|+.++.++ +||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~-------------------~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~ 71 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQ-------------------TCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEE-------------------EEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCT
T ss_pred ceeEEecCceecCCceEEEE-------------------EEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCC
Confidence 3456653 566666666555 4455568999999999877666678899999999985 799
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++..++..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 72 NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCE 145 (316)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEES
T ss_pred CeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEc
Confidence 999999999999999999999999999998843 356899999999999999999999999 99999999999999
Q ss_pred CCCC---eeEccccccccccCCCc-----ccccccccccccccccccccc-----CCCceeeeeeeeeeeC
Q 012989 395 HEMN---PKISDFGMARIFSGNQN-----EANTNRVVGTYGYMAPEYAME-----GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~---~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwSlG~il 452 (452)
.++. +||+|||++........ ........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 8776 99999999876542211 111223468999999999865 5688999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-33 Score=271.31 Aligned_cols=185 Identities=23% Similarity=0.275 Sum_probs=156.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++.+.... ..+|++++.++ +|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~ 77 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRC-------------------IHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPN 77 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTT
T ss_pred cccEEEEEEEeeCCCEEEEEE-------------------EECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCC
Confidence 357888899999999777644 45568999999999765432 35688888888 7999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++.++...++||||+++++|.+.+. ....+++.+++.++.||+.||+|||++| |+||||||+|||+..
T Consensus 78 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 78 IITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVD 151 (342)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESS
T ss_pred cCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEec
Confidence 9999999999999999999999999998884 3456999999999999999999999999 999999999999854
Q ss_pred C-C---CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 E-M---NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~-~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ + .+||+|||+++.+..... .....+||+.|+|||++.+..++.++|||||||+|
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 210 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHH
Confidence 3 3 499999999987654322 22345789999999999888899999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=271.35 Aligned_cols=188 Identities=25% Similarity=0.346 Sum_probs=150.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++.... ....+.+.+|+.++++++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 93 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKA-------------------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEE-------------------EETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCT
T ss_pred hhhEEEEEEEEecCCeEEEEE-------------------EECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCC
Confidence 458999999999999877754 455689999999997553 22345678999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++..+...++||||+++ +|.+++. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++
T Consensus 94 ~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~ 166 (329)
T 3gbz_A 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLS 166 (329)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CcceEEEEEecCCEEEEEEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEe
Confidence 999999999999999999999985 8888884 3446999999999999999999999999 99999999999995
Q ss_pred -----CCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 395 -----HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 -----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++.+..... ......||+.|+|||++.+. .++.++|||||||+|
T Consensus 167 ~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 167 VSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228 (329)
T ss_dssp C-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred cCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 445599999999987643322 22345789999999999774 489999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=261.58 Aligned_cols=188 Identities=25% Similarity=0.355 Sum_probs=164.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|+....+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.+++.++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 81 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKG-------------------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHhhhhcccCCeEEEEE-------------------EECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCC
Confidence 356888899999999877754 445678999999997653 445678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++......++||||+++++|.+++. ...+++..++.++.||+.||.|||++| |+|+||||+||+++.
T Consensus 82 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~ 154 (303)
T 3a7i_A 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSE 154 (303)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred EeEEEEEEecCCeEEEEEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECC
Confidence 9999999999999999999999999999883 356999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||++|
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 209 (303)
T 3a7i_A 155 HGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 209 (303)
T ss_dssp TSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHH
Confidence 99999999999987654322 22345789999999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=262.16 Aligned_cols=189 Identities=25% Similarity=0.335 Sum_probs=160.1
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l 311 (452)
...-+|++...+|.|++|.|+.+ ....+++.||||++... .......+.+|+.+++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l 66 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLA-------------------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC
T ss_pred eecccEEEeeEEecCCCeEEEEE-------------------EEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC
Confidence 34568999999999999877754 45567889999998654 223356789999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Ni 140 (279)
T 3fdn_A 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 140 (279)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGE
T ss_pred CCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhE
Confidence 999999999999999999999999999999988843 356999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||++....... .....||+.|+|||++.+..++.++||||||++|
T Consensus 141 li~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 197 (279)
T 3fdn_A 141 LLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197 (279)
T ss_dssp EECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred EEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHH
Confidence 99999999999999986543322 2345789999999999999999999999999974
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=262.10 Aligned_cols=189 Identities=21% Similarity=0.346 Sum_probs=158.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|+..+.+|.|++|.|+.+ ...+++.||||++.... ...+.+.+|++++++++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~--------------------~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i 81 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYG--------------------KWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 81 (283)
T ss_dssp GGGEEEEEECC---CEEEEEE--------------------EETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTB
T ss_pred HHHHHhHhhcCCCCCceEEEE--------------------EEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCE
Confidence 347888889999999877644 33467889999997653 345779999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++......++||||+++++|.+++... ...+++.+++.++.||+.+|.|||+++ |+||||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~ 156 (283)
T 3gen_A 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQ 156 (283)
T ss_dssp CCEEEEECSSSSEEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTT
T ss_pred eeEEEEEecCCCeEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCC
Confidence 99999999999999999999999999998542 346999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++
T Consensus 157 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 211 (283)
T 3gen_A 157 GVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211 (283)
T ss_dssp SCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred CCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHH
Confidence 9999999999986543321 122234568889999999988999999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-33 Score=275.24 Aligned_cols=187 Identities=20% Similarity=0.319 Sum_probs=153.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCC--C
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQ--H 313 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~--h 313 (452)
.+|++...+|.|++|.||.+. ..+++.||||++... .....+.+.+|+.++++++ |
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~--------------------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~ 115 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVL--------------------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEE--------------------CTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTC
T ss_pred CceEEEEEEccCCCeEEEEEE--------------------cCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCC
Confidence 469999999999998887552 235889999999765 3345677999999999996 5
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++..++.+++||| +.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 116 ~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll 188 (390)
T 2zmd_A 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI 188 (390)
T ss_dssp TTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEE
T ss_pred CeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEE
Confidence 999999999999999999999 567899998843 346899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCcccccccccccccccccccccc-----------CCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-----------GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlG~il 452 (452)
+ ++.+||+|||+++.+............+||+.|+|||++.+ ..++.++|||||||||
T Consensus 189 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil 257 (390)
T 2zmd_A 189 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257 (390)
T ss_dssp S-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHH
T ss_pred E-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHH
Confidence 5 58899999999987654443333445689999999999865 4689999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=259.99 Aligned_cols=187 Identities=22% Similarity=0.341 Sum_probs=158.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC------cccHHHHHHHHHHHHcC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS------GQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~~E~~~l~~l 311 (452)
-+|++.+.+|.|++|.|+.+ ....+++.||+|++.... ....+.+.+|+.+++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 65 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKC-------------------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC
T ss_pred hhhhhHHhhcccCceEEEEE-------------------EEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC
Confidence 37888899999999877754 445578999999987642 12467899999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++..+...++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 66 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Ni 139 (283)
T 3bhy_A 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENI 139 (283)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred CCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHE
Confidence 999999999999999999999999999999998843 356999999999999999999999999 99999999999
Q ss_pred EECCCC----CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEM----NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++||||||++|
T Consensus 140 l~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 201 (283)
T 3bhy_A 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201 (283)
T ss_dssp EESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHH
Confidence 998877 799999999987643322 2335689999999999989999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=261.72 Aligned_cols=190 Identities=19% Similarity=0.345 Sum_probs=157.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++.+.+|.|++|.|+.+ ....+++.+|+|++.... ....+.+.+|++++++++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 81 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLV-------------------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTT
T ss_pred hhheeecceeccCCCeEEEEE-------------------EEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCch
Confidence 458889999999999877754 455678999999997653 445688999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE-
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL- 393 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll- 393 (452)
|+++++++......++||||+++++|.+.+... .....+++..++.++.||+.||+|||+++ |+||||||+||++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~ 158 (285)
T 3is5_A 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQ 158 (285)
T ss_dssp BCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEES
T ss_pred HHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEe
Confidence 999999999999999999999999998877432 23466999999999999999999999999 9999999999999
Q ss_pred --CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 --DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+..... .....||+.|+|||++. +.++.++||||||++|
T Consensus 159 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il 215 (285)
T 3is5_A 159 DTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215 (285)
T ss_dssp SSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHH
T ss_pred cCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHH
Confidence 4567899999999987644322 23457899999999875 5789999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-33 Score=271.06 Aligned_cols=184 Identities=29% Similarity=0.401 Sum_probs=157.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
.+|+....+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.++++++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 114 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFA-------------------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCT
T ss_pred hheeeeeEEccCCCEEEEEE-------------------EEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCC
Confidence 56888899999999877754 455689999999997543 23346789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++..++..++||||++| +|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 115 niv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 188 (348)
T 1u5q_A 115 NTIQYRGCYLREHTAWLVMEYCLG-SASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLS 188 (348)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred CEeeEEEEEEECCeEEEEEecCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEC
Confidence 999999999999999999999975 66666532 2456999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++..... ....||+.|+|||++. ++.++.++|||||||+|
T Consensus 189 ~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il 243 (348)
T 1u5q_A 189 EPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243 (348)
T ss_dssp TTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHH
Confidence 9999999999999765322 2357899999999984 57789999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=266.02 Aligned_cols=194 Identities=26% Similarity=0.391 Sum_probs=161.0
Q ss_pred Cccc-cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRY-ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry-~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ 314 (452)
..|| ++...+|.|++|.|+.+.+. .....+++.||||++.... ....+.+.+|+.++++++||
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~---------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 93 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYD---------------PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEC---------------SCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEc---------------cCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCc
Confidence 4566 88999999999998644221 1233478999999998653 34467799999999999999
Q ss_pred CccceeeeEec--CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 315 NLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 315 ~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||+++++++.. ...+++||||+++++|.+++.. ..+++.+++.++.||+.+|.|||+.+ |+||||||+||+
T Consensus 94 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil 166 (318)
T 3lxp_A 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVL 166 (318)
T ss_dssp TBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred chhhEEEEEecCCCceEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEE
Confidence 99999999987 4678999999999999999843 34999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||++|
T Consensus 167 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 227 (318)
T 3lxp_A 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227 (318)
T ss_dssp ECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred EcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHH
Confidence 999999999999999876544322 123344678899999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=265.02 Aligned_cols=195 Identities=21% Similarity=0.283 Sum_probs=150.7
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h 313 (452)
-..-||++.+.+|.|++|.|+.+.... ....+..||||++... .....+.+.+|+.++++++|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h 75 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMS----------------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC----------------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEec----------------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC
Confidence 345699999999999999888663211 1124667999998754 34446779999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 76 ~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 149 (281)
T 1mp8_A 76 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLV 149 (281)
T ss_dssp TTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CccceEEEEEc-cCccEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEE
Confidence 99999999974 5678999999999999999853 2346999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||++|
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (281)
T 1mp8_A 150 SSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207 (281)
T ss_dssp EETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred CCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHH
Confidence 99999999999999876543221 22234568899999999989999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=269.00 Aligned_cols=186 Identities=24% Similarity=0.287 Sum_probs=159.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC----
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ---- 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---- 312 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++... ....+.+..|+.+++.++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~ 93 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLC-------------------QHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDI 93 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCST
T ss_pred cCEEEEEEEEcccCCeEEEEE-------------------EECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCC
Confidence 358999999999999877754 45567899999998643 344566788999999996
Q ss_pred -CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 313 -HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 313 -h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
||||+++++++...+..++|||++ +++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 168 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENI 168 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccE
Confidence 999999999999999999999999 88999988543 3345999999999999999999999999 99999999999
Q ss_pred EECC-------------------------CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeee
Q 012989 392 LLDH-------------------------EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFL 446 (452)
Q Consensus 392 ll~~-------------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw 446 (452)
|++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++|||
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchH
Confidence 9975 788999999999864332 2345789999999999999999999999
Q ss_pred eeeeeC
Q 012989 447 VSEFFF 452 (452)
Q Consensus 447 SlG~il 452 (452)
||||+|
T Consensus 244 slG~il 249 (360)
T 3llt_A 244 SFGCVL 249 (360)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=264.63 Aligned_cols=190 Identities=21% Similarity=0.229 Sum_probs=152.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++.+.+|.|++|.||.+ ....+++.||||++.... ....+.+.+|+.++++++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 93 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEA-------------------EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEE-------------------EETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC
T ss_pred eccEEEEEEEcCCCCeeEEEE-------------------EEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC
Confidence 468999999999999877754 445578999999997652 2234778999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++..++..++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~ 167 (309)
T 2h34_A 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILV 167 (309)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEE
Confidence 9999999999999999999999999999998843 346999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||++|
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 225 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVL 225 (309)
T ss_dssp CTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHH
T ss_pred cCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHH
Confidence 9999999999999976544322 222345789999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=262.05 Aligned_cols=188 Identities=22% Similarity=0.266 Sum_probs=158.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcC-CC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l-~h 313 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++... .......+.+|+..+..+ +|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h 70 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKC-------------------VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSC
T ss_pred cchhhhhhhhcCCCceEEEEE-------------------EEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCC
Confidence 458899999999999877754 44557999999999864 233456788999999999 99
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|||+++++++..++..++||||+++++|.+++.... ....+++.+++.++.||+.||.|||+++ |+||||||+|||
T Consensus 71 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl 147 (289)
T 1x8b_A 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIF 147 (289)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEE
Confidence 999999999999999999999999999999885422 1256899999999999999999999999 999999999999
Q ss_pred ECCC-------------------CCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 393 LDHE-------------------MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~-------------------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
++.+ ..+||+|||++....... ...||+.|+|||++.+. .++.++||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (289)
T 1x8b_A 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTV 221 (289)
T ss_dssp EC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHH
T ss_pred EcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHH
Confidence 9844 479999999998754322 23589999999999765 667899999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=282.11 Aligned_cols=189 Identities=22% Similarity=0.349 Sum_probs=159.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++...+|.|++|.|+. .....++..||||+++... ...+.+.+|+.+|++++||||++
T Consensus 221 ~~~~~~~lG~G~fg~Vy~-------------------~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~ 280 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYE-------------------GVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQ 280 (495)
T ss_dssp GEEEEEESGGGTTSSEEE-------------------EEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCC
T ss_pred HceeeeEecCCCCeEEEE-------------------EEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEee
Confidence 455566677777766654 3455678999999997553 35678999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++......+|||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 281 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~ 356 (495)
T 1opk_A 281 LLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHL 356 (495)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEEEecCCcEEEEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCc
Confidence 999999999999999999999999999643 3356899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++|
T Consensus 357 ~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l 409 (495)
T 1opk_A 357 VKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409 (495)
T ss_dssp EEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred EEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHH
Confidence 99999999987644322 122234567899999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=272.77 Aligned_cols=184 Identities=24% Similarity=0.350 Sum_probs=151.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|+....+|.|++|.|+.+ .+..+|+.||||++... .....+++.+|+.+++.++||
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp 84 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSA-------------------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84 (367)
T ss_dssp BSSEEEEEEC------CEEEE-------------------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBT
T ss_pred cceEEEeEEeeecCCeEEEEE-------------------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCc
Confidence 357888888888888777654 45568999999998654 333456789999999999999
Q ss_pred CccceeeeEecCC------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++++.... .+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||
T Consensus 85 nIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp 156 (367)
T 1cm8_A 85 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKP 156 (367)
T ss_dssp TBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCH
Confidence 9999999998663 469999999 7899998843 45899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||||
T Consensus 157 ~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 157 GNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred HHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 9999999999999999999875432 234578999999999877 6799999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=264.07 Aligned_cols=186 Identities=27% Similarity=0.341 Sum_probs=154.0
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHc--CCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAK--LQH 313 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~--l~h 313 (452)
..-+|++.+.+|.|++|.|+.+. .+++.||||++... ....+..|.+++.. ++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~---------------------~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h 61 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGS---------------------WQGENVAVKIFSSR---DEKSWFRETELYNTVMLRH 61 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEE---------------------ETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCC
T ss_pred ccCcEEEEEeeccCCCcEEEEEE---------------------ECCEEEEEEEeccc---cchhhHHHHHHHHHhhccC
Confidence 34589999999999998887552 26899999998654 34556677777776 799
Q ss_pred CCccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCe
Q 012989 314 KNLVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLH--------EDSRLRV 381 (452)
Q Consensus 314 ~~iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~g~~~i 381 (452)
|||+++++++.. ....++||||+++++|.+++. ...+++..++.++.||+.||+||| +++ |
T Consensus 62 ~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---i 134 (301)
T 3q4u_A 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---I 134 (301)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---E
T ss_pred cCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---e
Confidence 999999998654 356899999999999999983 346999999999999999999999 888 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccc--cccccccccccccccccccC------CCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEG------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlG~il 452 (452)
+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il 213 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence 999999999999999999999999998765443221 12335789999999999876 567899999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=282.35 Aligned_cols=187 Identities=25% Similarity=0.381 Sum_probs=161.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-||++...+|.|++|.|+.+ ....+++.||||++.+.. ....+.+.+|+.++++++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h 85 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILC-------------------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC
T ss_pred cCceEEeeEEecCCCEEEEEE-------------------EECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC
Confidence 458999999999999877754 455689999999997542 3456789999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++......++||||+.+++|.+.+. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 86 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLL 159 (484)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEE
Confidence 999999999999999999999999999988884 3456999999999999999999999999 9999999999999
Q ss_pred ---CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 ---DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+.... ......||+.|+|||++.+ .++.++||||+||||
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 217 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 217 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHH
T ss_pred ecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHH
Confidence 567889999999998765432 2234578999999999865 689999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=262.08 Aligned_cols=192 Identities=22% Similarity=0.337 Sum_probs=164.6
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-..+|++...+|.|++|.|+.+ ....+++.||||++... ....+.+.+|+.++++++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~ 70 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEG-------------------VWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPN 70 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEE-------------------EEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTT
T ss_pred cccceeEEeecCCCCceeEEEe-------------------EecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCC
Confidence 3457888888999998777654 45567899999998754 345678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++..+...++||||+++++|.+++... ....+++..++.++.||+.+|.|||+++ |+||||||+||+++.
T Consensus 71 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~ 146 (288)
T 3kfa_A 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGE 146 (288)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECG
T ss_pred EeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcC
Confidence 999999999999999999999999999998543 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||++|
T Consensus 147 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 202 (288)
T 3kfa_A 147 NHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202 (288)
T ss_dssp GGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHH
Confidence 99999999999987654332 223334678899999999999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-33 Score=271.18 Aligned_cols=199 Identities=25% Similarity=0.373 Sum_probs=163.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.-+|+....+|.|++|.|+.+..... +.....+.||+|.+.... ....+.+.+|+.+++.+ +||
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ 110 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGL--------------GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTC--------------SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHceeeeEeccCCCcceEEEEecCC--------------CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCC
Confidence 35788888899999988876532110 001234579999997653 34457799999999999 899
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-----------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-----------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH 383 (452)
||+++++++...+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+|
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 187 (333)
T 2i1m_A 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIH 187 (333)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred CeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---ccc
Confidence 99999999999999999999999999999885421 1346899999999999999999999999 999
Q ss_pred cCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 188 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 256 (333)
T 2i1m_A 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256 (333)
T ss_dssp SCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHH
Confidence 999999999999999999999999876544433333445678899999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=275.84 Aligned_cols=186 Identities=22% Similarity=0.295 Sum_probs=148.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--------cccHHHHHHHHHHHH
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--------GQGLQEFKNEVTLIA 309 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--------~~~~~~~~~E~~~l~ 309 (452)
-+|++.+.+|.|++|.|+.+ .+..+++.||||++.+.. ......+.+|+.+|+
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 195 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLA-------------------FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHH
T ss_pred ccEEEEeEEeeCCCeEEEEE-------------------EECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHH
Confidence 47888889999999877654 455688999999987542 112234789999999
Q ss_pred cCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 310 KLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 310 ~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++||||+++++++.. +..++||||+++++|.+++ .....+++.+++.++.||+.||+|||+++ |+||||||+
T Consensus 196 ~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~ 268 (419)
T 3i6u_A 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPE 268 (419)
T ss_dssp HCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGT---SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred hCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChH
Confidence 9999999999999764 4579999999999998888 34567999999999999999999999999 999999999
Q ss_pred CeEECCCC---CeeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEM---NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
|||++.++ .+||+|||+++...... ......||+.|+|||++. ...++.++|||||||+|
T Consensus 269 NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il 334 (419)
T 3i6u_A 269 NVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334 (419)
T ss_dssp GEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHH
T ss_pred hEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHH
Confidence 99997654 49999999998764322 233467999999999985 36789999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=280.76 Aligned_cols=187 Identities=23% Similarity=0.336 Sum_probs=156.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++.+.. ......+.+|+.+++.++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp 96 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLC-------------------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96 (494)
T ss_dssp HHHEEEEEEEECC---EEEEE-------------------EETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCT
T ss_pred hcCeEEeeEEecCCCEEEEEE-------------------EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCC
Confidence 348999999999999877754 455678999999997652 34467899999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++......++||||+++++|.+.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 97 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 170 (494)
T 3lij_A 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLE 170 (494)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEe
Confidence 999999999999999999999999999887743 356999999999999999999999999 99999999999997
Q ss_pred CC---CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HE---MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.. +.+||+|||+++.+.... ......||+.|+|||++. +.++.++||||+||+|
T Consensus 171 ~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il 227 (494)
T 3lij_A 171 SKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVIL 227 (494)
T ss_dssp CSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHH
T ss_pred CCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHH
Confidence 64 459999999998765432 233457999999999875 5799999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=264.88 Aligned_cols=197 Identities=20% Similarity=0.347 Sum_probs=151.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|++...+|.|++|.|+.+.. .....+++.||||++... .....+.+.+|+.++++++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~----------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 96 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNL----------------KQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEE----------------ECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCT
T ss_pred HHHeeeccceeecCCeEEEEEEE----------------eccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCC
Confidence 45889999999999988886531 111224678999998755 334456799999999999999
Q ss_pred CccceeeeEecCC-----eEEEEEEecCCCChhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 315 NLVRLLGCCLDGN-----ELLLIYEYMPNKSLDLFLFDS---TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 315 ~iv~l~~~~~~~~-----~~~lv~E~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
||+++++++.... ..++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~di 173 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDL 173 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCC
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999998754 359999999999999888432 23456999999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+||+++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||++|
T Consensus 174 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 239 (313)
T 3brb_A 174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239 (313)
T ss_dssp SGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHH
T ss_pred CcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHH
Confidence 999999999999999999999876544332333345678899999999999999999999999974
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=259.89 Aligned_cols=187 Identities=30% Similarity=0.463 Sum_probs=149.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC----cccHHHHHHHHHHHHcCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS----GQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~~E~~~l~~l~ 312 (452)
.-+|+..+.+|.|++|.|+.+. ..++.||||++.... ....+.+.+|+.+++.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~---------------------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 64 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAF---------------------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEE---------------------ETTEEEEEEEC----------CHHHHHHHHHHHHHCC
T ss_pred hhheeeeeeeccCCCeEEEEEE---------------------EcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC
Confidence 3588999999999998887552 258899999987542 233577899999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++..++..++||||+++++|.+++. ...+++..++.++.||+.||.|||+++..+|+||||||+|||
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil 140 (271)
T 3dtc_A 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140 (271)
T ss_dssp CTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred CCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence 9999999999999999999999999999999883 356999999999999999999999987445889999999999
Q ss_pred ECC--------CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDH--------EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~--------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++. ++.+||+|||+++.+.... .....||+.|+|||.+.+..++.++||||||+++
T Consensus 141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 204 (271)
T 3dtc_A 141 ILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLL 204 (271)
T ss_dssp ESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred EecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHH
Confidence 986 6779999999998654332 2234689999999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=260.46 Aligned_cols=186 Identities=23% Similarity=0.340 Sum_probs=161.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++... .....+.+.+|+.+++.++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 74 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLA-------------------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCT
T ss_pred hhceeeheecCCCCeEEEEE-------------------EEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCC
Confidence 57888899999998877654 44567899999998654 223356789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 75 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~ 148 (284)
T 2vgo_A 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMG 148 (284)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEEC
T ss_pred CEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEc
Confidence 999999999999999999999999999988843 346899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++....... .....||+.|+|||++.+..++.++||||||++|
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 202 (284)
T 2vgo_A 149 YKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202 (284)
T ss_dssp TTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHH
T ss_pred CCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHH
Confidence 99999999999987654322 2345789999999999999999999999999974
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=263.61 Aligned_cols=201 Identities=24% Similarity=0.287 Sum_probs=165.2
Q ss_pred EEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHH
Q 012989 231 VRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIA 309 (452)
Q Consensus 231 i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~ 309 (452)
+..+.-..+|+..+.+|.|++|.|+.+.. .....++..||+|++... .....+.+.+|+.+++
T Consensus 14 ~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~----------------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~ 77 (298)
T 3pls_A 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEY----------------IDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMR 77 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEE----------------ECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHH
T ss_pred eEccccceEEccCceeccCCCceEEEEEE----------------ecCCCceeeeeeeeccccccHHHHHHHHHHHHHHH
Confidence 34455667888889999999998886531 111223457999998754 3345677899999999
Q ss_pred cCCCCCccceeeeEecCCeE-EEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 310 KLQHKNLVRLLGCCLDGNEL-LLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 310 ~l~h~~iv~l~~~~~~~~~~-~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
.++||||+++++++...+.. ++||||+.+++|.+++.. ....+++.+++.++.||+.||+|||++| |+||||||
T Consensus 78 ~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp 152 (298)
T 3pls_A 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAA 152 (298)
T ss_dssp TCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred hCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCc
Confidence 99999999999999876654 999999999999999854 3456899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCc--cccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQN--EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++.+..... ........+|+.|+|||.+.+..++.++||||||+++
T Consensus 153 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 218 (298)
T 3pls_A 153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218 (298)
T ss_dssp GGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHH
Confidence 999999999999999999986644321 1223345678999999999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=263.24 Aligned_cols=190 Identities=29% Similarity=0.402 Sum_probs=147.5
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~ 312 (452)
--.-+|++...+|.|++|.||.+. +...||||+++.. .....+.+.+|+.++++++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~----------------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGK----------------------WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEE----------------------SSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred cCccceeeeeEecCCCCeEEEEEE----------------------EcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCC
Confidence 345689999999999999888653 2345999998755 3444577999999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||++++++. .....++||||+++++|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||
T Consensus 79 h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil 152 (289)
T 3og7_A 79 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIF 152 (289)
T ss_dssp CTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 99999999954 55678999999999999988843 3456999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++...............||+.|+|||++. +..++.++||||||++|
T Consensus 153 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp EETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred ECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 9999999999999998665433333344567899999999986 66789999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-33 Score=267.23 Aligned_cols=199 Identities=24% Similarity=0.344 Sum_probs=164.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ 314 (452)
.-+|++.+.+|.|++|.||.+..... ....+++.||||++.... ....+.+.+|+.+++++ +||
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp 91 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGI--------------DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS--------------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecC--------------CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCC
Confidence 46899999999999998886631100 012467899999997653 33456789999999999 799
Q ss_pred CccceeeeEecCC-eEEEEEEecCCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 315 NLVRLLGCCLDGN-ELLLIYEYMPNKSLDLFLFDSTK-------------GAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 315 ~iv~l~~~~~~~~-~~~lv~E~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
||+++++++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 168 (316)
T 2xir_A 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--- 168 (316)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 9999999988754 59999999999999999854322 223899999999999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 999999999999999999999999999876554433334455789999999999999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=263.04 Aligned_cols=198 Identities=22% Similarity=0.320 Sum_probs=160.6
Q ss_pred cccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCC
Q 012989 234 PSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 234 ~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~ 312 (452)
+.-..+|+..+.+|.|++|.|+.+... ........+|+|.+... .....+.+.+|+.++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~ 84 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLL----------------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC---------------------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC
T ss_pred CccceehhhcceeeecCCceEEEEEEe----------------cCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC
Confidence 345678999999999999998866321 11223456899998764 3345677999999999999
Q ss_pred CCCccceeeeEe-cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 313 HKNLVRLLGCCL-DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 313 h~~iv~l~~~~~-~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
||||+++++++. .++..++||||+++++|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 85 h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Ni 159 (298)
T 3f66_A 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNC 159 (298)
T ss_dssp CTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheE
Confidence 999999999854 55688999999999999999853 3456899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCcc--ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNE--ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||++|
T Consensus 160 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 222 (298)
T 3f66_A 160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222 (298)
T ss_dssp EECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999999876543321 123344678899999999999999999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=261.64 Aligned_cols=187 Identities=25% Similarity=0.446 Sum_probs=159.7
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
...+|+..+.+|.|++|.|+.+ ....+++.||||++.... +.+.+|++++++++|||
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~ 65 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKA-------------------KHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVN 65 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEE-------------------EETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTT
T ss_pred hccccceeeeeccCCceEEEEE-------------------EEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCC
Confidence 4468999999999999877755 444578999999997653 35678999999999999
Q ss_pred ccceeeeEec----------------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 012989 316 LVRLLGCCLD----------------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRL 379 (452)
Q Consensus 316 iv~l~~~~~~----------------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~ 379 (452)
|+++++++.. ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++
T Consensus 66 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 142 (284)
T 2a19_B 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK-- 142 (284)
T ss_dssp BCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 9999998864 44589999999999999998542 2356999999999999999999999999
Q ss_pred CeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 380 RVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|+||||+||+++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||++|
T Consensus 143 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (284)
T 2a19_B 143 -LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211 (284)
T ss_dssp -EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHH
T ss_pred -eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHH
Confidence 99999999999999999999999999987654322 2334689999999999998999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=272.08 Aligned_cols=188 Identities=22% Similarity=0.293 Sum_probs=162.0
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-.-+|++...+|.|++|.|+.+ ....+++.||+|++... .....+.+.+|+.+++.++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~ 91 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKV-------------------SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCT
T ss_pred ccccceeeeeecCCCCeEEEEE-------------------EECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCC
Confidence 3458999999999999877755 44567899999999765 344457799999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEE
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NIll 393 (452)
||+++++++..++..++||||+++++|.+++.. ...+++..++.++.||+.+|.|||+. + |+||||||+|||+
T Consensus 92 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~ 165 (360)
T 3eqc_A 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILV 165 (360)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEE
T ss_pred CEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEE
Confidence 999999999999999999999999999999843 34689999999999999999999985 8 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||++...... ......||+.|+|||++.+..++.++||||||++|
T Consensus 166 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 166 NSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 220 (360)
T ss_dssp CTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHH
T ss_pred CCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHH
Confidence 99999999999998765322 22345789999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=267.78 Aligned_cols=196 Identities=24% Similarity=0.372 Sum_probs=165.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|+....+|.|++|.|+.+.+.. ....+++.||||++........+.+.+|++++++++||||
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 86 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDP---------------LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECT---------------TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred hhhhhhhhhccCCCCeEEEEEEecc---------------CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCce
Confidence 4689999999999999888653211 0235789999999987776677789999999999999999
Q ss_pred cceeeeEe--cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCL--DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~--~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
+++++++. .....++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~ 161 (327)
T 3lxl_A 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVE 161 (327)
T ss_dssp CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEEC
Confidence 99999887 456799999999999999988532 235999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||++|
T Consensus 162 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220 (327)
T ss_dssp ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence 99999999999998765433221 23334678899999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=266.59 Aligned_cols=199 Identities=27% Similarity=0.341 Sum_probs=159.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++...+|.|++|.||.+.... .....+++.||||++... ......++.+|+.++++++|||
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 94 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSG--------------MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC----------------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcC--------------CCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCC
Confidence 4589999999999999888664211 013456889999999754 3445667899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK----GAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
|+++++++......++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 95 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NI 171 (327)
T 2yfx_A 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNC 171 (327)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHE
Confidence 99999999999999999999999999999865432 245899999999999999999999999 99999999999
Q ss_pred EECCC---CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHE---MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.+ ..+||+|||+++...............||+.|+|||++.+..++.++||||||++|
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHH
Confidence 99844 45999999999866544333333445779999999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=259.93 Aligned_cols=186 Identities=26% Similarity=0.369 Sum_probs=154.8
Q ss_pred eeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeee
Q 012989 243 YQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGC 322 (452)
Q Consensus 243 ~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 322 (452)
...+|.|++|.|+.+ .+..+++.||||.+........+.+.+|+.+++.++||||++++++
T Consensus 27 ~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 87 (295)
T 2clq_A 27 RVVLGKGTYGIVYAG-------------------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87 (295)
T ss_dssp BCEEEECSSSEEEEE-------------------EETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cEEEeecCcEEEEEE-------------------EECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeE
Confidence 336777777666644 5556889999999987766667889999999999999999999999
Q ss_pred EecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-CCCeeE
Q 012989 323 CLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-EMNPKI 401 (452)
Q Consensus 323 ~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kl 401 (452)
+...+..++||||+++++|.+++........+++..++.++.||+.||.|||+++ |+|+||||+||+++. ++.+||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl 164 (295)
T 2clq_A 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKI 164 (295)
T ss_dssp EEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEE
T ss_pred EEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEE
Confidence 9999999999999999999999866444456789999999999999999999999 999999999999987 899999
Q ss_pred ccccccccccCCCccccccccccccccccccccccCC--CceeeeeeeeeeeC
Q 012989 402 SDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV--FSVNRMFLVSEFFF 452 (452)
Q Consensus 402 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il 452 (452)
+|||+++....... ......||+.|+|||++.+.. ++.++||||||++|
T Consensus 165 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 215 (295)
T 2clq_A 165 SDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215 (295)
T ss_dssp CCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHH
T ss_pred eecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHH
Confidence 99999987643321 223457899999999997644 78999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=269.14 Aligned_cols=190 Identities=25% Similarity=0.378 Sum_probs=153.3
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-----cHHHHHHHHHHHHc
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-----GLQEFKNEVTLIAK 310 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-----~~~~~~~E~~~l~~ 310 (452)
-.-||++...+|.|++|.||.+ ....+++.||||++...... ..+.+.+|+.+++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 68 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKA-------------------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68 (346)
T ss_dssp -----CEEEEEEEETTEEEEEE-------------------ECSSCCSEEEEEEC------------CTHHHHHHHHHHH
T ss_pred HhcccEEEeEEeecCCEEEEEE-------------------EECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhh
Confidence 3468999999999999888755 33457899999998754221 13468899999999
Q ss_pred CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 311 l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
++||||+++++++......++||||+++ +|..++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|
T Consensus 69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 142 (346)
T 1ua2_A 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNN 142 (346)
T ss_dssp CCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHH
Confidence 9999999999999999999999999987 78777733 3456899999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
||++.++.+||+|||+++.+..... ......||+.|+|||++.+. .++.++|||||||+|
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 203 (346)
T 1ua2_A 143 LLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 203 (346)
T ss_dssp EEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHH
T ss_pred EEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHH
Confidence 9999999999999999987643322 22345789999999998654 589999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=267.48 Aligned_cols=191 Identities=23% Similarity=0.403 Sum_probs=152.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCee----eEEEEeecC-CcccHHHHHHHHHHHHcC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKE----IAVKRLSRS-SGQGLQEFKNEVTLIAKL 311 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~----vAiK~~~~~-~~~~~~~~~~E~~~l~~l 311 (452)
.-+|++...+|.|++|.||.+. ...+++. ||+|.+... .....+.+.+|+.+++.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~-------------------~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l 74 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGL-------------------WIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE-------------------ECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC
T ss_pred HhHceEEEEeeeCCCeEEEEEE-------------------EcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC
Confidence 4689999999999998887653 3344554 477766543 445678899999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+||||+++++++..+. .++|+|++++++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+||
T Consensus 75 ~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NI 148 (327)
T 3lzb_A 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNV 148 (327)
T ss_dssp CBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHE
Confidence 9999999999998765 7889999999999998854 2456999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||++|
T Consensus 149 l~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3lzb_A 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp EEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHH
Confidence 9999999999999999877554443334445678899999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=269.96 Aligned_cols=183 Identities=28% Similarity=0.366 Sum_probs=141.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|.|+.+ .+..+|+.||||++... .....+++.+|+.+++.++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 89 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAA-------------------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89 (367)
T ss_dssp TTEEEEEECC----CCEEEE-------------------EETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred CceEEeeEEeecCCeEEEEE-------------------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCC
Confidence 58899999999998877754 45568999999999754 3344577889999999999999
Q ss_pred ccceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++... ...++|||++ +++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+
T Consensus 90 Iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~ 161 (367)
T 2fst_X 90 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS 161 (367)
T ss_dssp BCCCSEEECSCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred CCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHh
Confidence 99999998754 5689999998 678888773 256999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||||
T Consensus 162 NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (367)
T 2fst_X 162 NLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220 (367)
T ss_dssp GEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred hEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence 999999999999999999865322 234578999999999876 6789999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=268.96 Aligned_cols=204 Identities=16% Similarity=0.163 Sum_probs=159.8
Q ss_pred cEEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCccc-----------
Q 012989 229 GRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQG----------- 297 (452)
Q Consensus 229 ~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~----------- 297 (452)
|.+....-.-+|++...+|.|++|.||.+..... .....++.||||++.......
T Consensus 26 g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--------------~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~ 91 (364)
T 3op5_A 26 GEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSS--------------ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAA 91 (364)
T ss_dssp TCEEECTTCCEEEEEEECCCC-CCEEEEEEECCS--------------SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHC
T ss_pred CcEeeccCCCeEEEEEEEecCCCeEEEEeeecCc--------------cccccccceEEEEeeccchhHHHHHHHHHhhh
Confidence 3455556667999999999999999987642110 011246889999987654211
Q ss_pred HHHHHHHHHHHHcCCCCCccceeeeEecC----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012989 298 LQEFKNEVTLIAKLQHKNLVRLLGCCLDG----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYL 373 (452)
Q Consensus 298 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~L 373 (452)
...+..|+..++.++||||+++++++... ...+|||||+ +++|.+++.. ....+++.+++.|+.||+.||+||
T Consensus 92 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~l 168 (364)
T 3op5_A 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYI 168 (364)
T ss_dssp CHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 11234456667778899999999998764 5689999999 9999999854 345699999999999999999999
Q ss_pred hcCCCCCeEecCCCCCCeEEC--CCCCeeEccccccccccCCCccc-----cccccccccccccccccccCCCceeeeee
Q 012989 374 HEDSRLRVIHRDLKTSNVLLD--HEMNPKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPEYAMEGVFSVNRMFL 446 (452)
Q Consensus 374 H~~g~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw 446 (452)
|+++ |+||||||+|||++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||
T Consensus 169 H~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 245 (364)
T 3op5_A 169 HEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLE 245 (364)
T ss_dssp HHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHH
T ss_pred HHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHH
Confidence 9999 99999999999999 88999999999998765432211 11334699999999999999999999999
Q ss_pred eeeeeC
Q 012989 447 VSEFFF 452 (452)
Q Consensus 447 SlG~il 452 (452)
||||+|
T Consensus 246 slG~~l 251 (364)
T 3op5_A 246 ILGYCM 251 (364)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=275.74 Aligned_cols=183 Identities=26% Similarity=0.381 Sum_probs=155.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++.+.+|.|++|.|+.+. ..++.||||+++... ..+.+.+|+.++++++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~---------------------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv 249 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGD---------------------YRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLV 249 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------------------ETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBC
T ss_pred HHeEEEeeecCcCCeeEEEEE---------------------ecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEE
Confidence 467788889999998887542 247899999997653 457899999999999999999
Q ss_pred ceeeeEecCC-eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 318 RLLGCCLDGN-ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 318 ~l~~~~~~~~-~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
++++++.... ..++||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 250 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~ 325 (450)
T 1k9a_A 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSED 325 (450)
T ss_dssp CEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCC
Confidence 9999987655 799999999999999999643 2334799999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++...... ....+|+.|+|||++.+..++.++||||||++|
T Consensus 326 ~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l 376 (450)
T 1k9a_A 326 NVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 376 (450)
T ss_dssp SCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHH
T ss_pred CCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHH
Confidence 999999999998543221 123568899999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=267.07 Aligned_cols=201 Identities=15% Similarity=0.160 Sum_probs=157.4
Q ss_pred cEEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-----------c
Q 012989 229 GRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-----------G 297 (452)
Q Consensus 229 ~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-----------~ 297 (452)
+.+....-.-+|++.+.+|.|++|.||.+.... ...++..+|||++...... .
T Consensus 28 g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~ 91 (345)
T 2v62_A 28 GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTN----------------KPEKDARHVVKVEYQENGPLFSELKFYQRVA 91 (345)
T ss_dssp TCEEECTTSCEEEEEEEC------CEEEEEESS----------------SCGGGCCEEEEEEECC-CHHHHHHHHHHHHC
T ss_pred CCeeccccCceEEEEeeEeecCCeEEEEEEecC----------------CCCccceEEEEeeecCCcchHHHHHHHHHHh
Confidence 344455556799999999999998888663211 0126788999998765321 1
Q ss_pred HHHHHHHHHHHHcCCCCCccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012989 298 LQEFKNEVTLIAKLQHKNLVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYL 373 (452)
Q Consensus 298 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~L 373 (452)
...+.+|+.+++.++||||+++++++.. ....++||||+ +++|.+++.. ...+++.+++.++.||+.||+||
T Consensus 92 ~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~L 167 (345)
T 2v62_A 92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYI 167 (345)
T ss_dssp CHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH
Confidence 2346678899999999999999999987 78899999999 9999999843 33799999999999999999999
Q ss_pred hcCCCCCeEecCCCCCCeEECCCC--CeeEccccccccccCCCcc-----ccccccccccccccccccccCCCceeeeee
Q 012989 374 HEDSRLRVIHRDLKTSNVLLDHEM--NPKISDFGMARIFSGNQNE-----ANTNRVVGTYGYMAPEYAMEGVFSVNRMFL 446 (452)
Q Consensus 374 H~~g~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dvw 446 (452)
|+++ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||
T Consensus 168 H~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 244 (345)
T 2v62_A 168 HENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVE 244 (345)
T ss_dssp HHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHH
T ss_pred HhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHH
Confidence 9999 99999999999999887 9999999999876433211 112345789999999999999999999999
Q ss_pred eeeeeC
Q 012989 447 VSEFFF 452 (452)
Q Consensus 447 SlG~il 452 (452)
|||++|
T Consensus 245 slG~il 250 (345)
T 2v62_A 245 ILGYCM 250 (345)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=258.79 Aligned_cols=192 Identities=22% Similarity=0.361 Sum_probs=158.8
Q ss_pred cccccee-eecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQ-FYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~-f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|.+.. .+|.|++|.|+.+.. ....+++.||||++... .....+.+.+|+.++++++|||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~-----------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 71 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVY-----------------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 71 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEE-----------------C---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHhhhhhccccccCceeEEEeEe-----------------ccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCC
Confidence 4666666 899999988876532 12346788999999765 3445677999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++ ..+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 72 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~ 145 (287)
T 1u59_A 72 IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVN 145 (287)
T ss_dssp BCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEE
T ss_pred EeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcC
Confidence 99999999 45568999999999999998843 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||++|
T Consensus 146 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 203 (287)
T 1u59_A 146 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203 (287)
T ss_dssp TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 999999999999876543322 122334568999999999988999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=278.27 Aligned_cols=189 Identities=25% Similarity=0.367 Sum_probs=158.9
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc-------------ccHHHH
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG-------------QGLQEF 301 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~-------------~~~~~~ 301 (452)
...-+|++...+|.|++|.|+.+ ....+++.||||++.+... ...+.+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLC-------------------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEE-------------------EETTTCCEEEEEEEEC----------------CTHHHH
T ss_pred CcccceEEEeEecccCCeEEEEE-------------------EECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHH
Confidence 34568999999999999877754 4556789999999975421 335678
Q ss_pred HHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 302 KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 302 ~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
.+|+.++++++||||+++++++......++||||+++++|.+.+.. ...+++..++.++.||+.||.|||+++ |
T Consensus 94 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 167 (504)
T 3q5i_A 94 YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---I 167 (504)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 9999999999999999999999999999999999999999888843 356999999999999999999999999 9
Q ss_pred EecCCCCCCeEECCCC---CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEM---NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||||||+|||++.++ .+||+|||+++.+.... ......||+.|+|||++. +.++.++||||+||||
T Consensus 168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il 237 (504)
T 3q5i_A 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIM 237 (504)
T ss_dssp ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHH
T ss_pred EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHH
Confidence 9999999999998876 69999999998765432 233457899999999986 5689999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=260.53 Aligned_cols=188 Identities=25% Similarity=0.374 Sum_probs=158.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.... ..+.+.+|+.+++.++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i 86 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKA-------------------IHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHV 86 (314)
T ss_dssp --CEEEEEECC----CEEEEE-------------------EETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTB
T ss_pred hhhhhhheeeccCCCeEEEEE-------------------EECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCC
Confidence 457888888998888777654 445578999999997653 34778999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.| |+|+||||+||+++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~ 161 (314)
T 3com_A 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTE 161 (314)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred ccEEEEEEeCCEEEEEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCC
Confidence 9999999999999999999999999998842 3456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||++|
T Consensus 162 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (314)
T 3com_A 162 GHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITA 215 (314)
T ss_dssp CCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHH
T ss_pred CCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHH
Confidence 9999999999987644322 22345789999999999998999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=262.15 Aligned_cols=190 Identities=23% Similarity=0.305 Sum_probs=157.9
Q ss_pred Cccccce-eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcC-C
Q 012989 237 NFRYELY-QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKL-Q 312 (452)
Q Consensus 237 ~~ry~~~-~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l-~ 312 (452)
.-||.+. +.+|.|++|.|+.+ ....+++.||||++... .......+.+|+.+++.+ +
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~ 87 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQC-------------------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT
T ss_pred hhEEeeccceeCCCCCeEEEEE-------------------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC
Confidence 3466666 77888888777644 45567999999998764 334467899999999999 5
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++......++||||+++++|.+++.. .....+++.+++.++.||+.||+|||++| |+||||||+|||
T Consensus 88 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl 163 (327)
T 3lm5_A 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNIL 163 (327)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEE
Confidence 69999999999999999999999999999998843 23466999999999999999999999999 999999999999
Q ss_pred ECC---CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDH---EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||++|
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHH
Confidence 998 78999999999987643322 2345789999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=267.47 Aligned_cols=187 Identities=22% Similarity=0.375 Sum_probs=159.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc--------ccHHHHHHHHHHHH
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG--------QGLQEFKNEVTLIA 309 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~~E~~~l~ 309 (452)
-+|++...+|.|++|.|+.+ ....+|+.||||++..... ...+.+.+|+.+++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a-------------------~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 154 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRC-------------------VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhcccceEEecCCCEEEEEE-------------------EECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHH
Confidence 47888899999999877755 3445799999999875531 12456789999999
Q ss_pred cC-CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 310 KL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 310 ~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
++ +||||+++++++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.| |+|+||||
T Consensus 155 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp 228 (365)
T 2y7j_A 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKP 228 (365)
T ss_dssp HHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred HhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 99 799999999999999999999999999999998843 356999999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc------CCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME------GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||++|
T Consensus 229 ~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 295 (365)
T 2y7j_A 229 ENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295 (365)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred HHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence 99999999999999999998765432 2234678999999999863 3588999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-33 Score=270.69 Aligned_cols=179 Identities=16% Similarity=0.132 Sum_probs=146.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--------cccHHHHHHHHHHH
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--------GQGLQEFKNEVTLI 308 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--------~~~~~~~~~E~~~l 308 (452)
.-+|++...+|.|++|.|+.+. .+++.||||++.... ....+.+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~---------------------~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l 77 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTI---------------------ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEE---------------------ETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHH
T ss_pred cccchheeeecccCceEEEEEE---------------------eCCceEEEEEEecCCccccccccchhHHHHHHHHHHH
Confidence 3589999999999998887652 268999999998652 23347889999999
Q ss_pred HcCC---------CCCccceee-----------------eEec-------------CCeEEEEEEecCCCChhhhhccCC
Q 012989 309 AKLQ---------HKNLVRLLG-----------------CCLD-------------GNELLLIYEYMPNKSLDLFLFDST 349 (452)
Q Consensus 309 ~~l~---------h~~iv~l~~-----------------~~~~-------------~~~~~lv~E~~~~~~L~~~l~~~~ 349 (452)
+.++ ||||+++.+ ++.. ....+|||||++++++.+.+.
T Consensus 78 ~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--- 154 (336)
T 2vuw_A 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--- 154 (336)
T ss_dssp HHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---
T ss_pred HHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---
Confidence 9886 555555544 4443 678999999999986655552
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCeEECCCC--------------------CeeEccccccc
Q 012989 350 KGAQLDWKRRISIINGIARGLLYLH-EDSRLRVIHRDLKTSNVLLDHEM--------------------NPKISDFGMAR 408 (452)
Q Consensus 350 ~~~~l~~~~~~~i~~ql~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFG~a~ 408 (452)
...+++.+++.|+.||+.||+||| +++ |+||||||+|||++.++ .+||+|||+++
T Consensus 155 -~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~ 230 (336)
T 2vuw_A 155 -TKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSR 230 (336)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCB
T ss_pred -hcCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccE
Confidence 256899999999999999999999 899 99999999999999887 89999999998
Q ss_pred cccCCCccccccccccccccccccccccCCCceeeeeeeeeee
Q 012989 409 IFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFF 451 (452)
Q Consensus 409 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~i 451 (452)
..... ..+||+.|+|||++.+.. +.++||||+++.
T Consensus 231 ~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~ 265 (336)
T 2vuw_A 231 LERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKK 265 (336)
T ss_dssp EEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHH
T ss_pred ecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCC
Confidence 76432 347899999999998766 899999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-33 Score=273.03 Aligned_cols=192 Identities=21% Similarity=0.281 Sum_probs=159.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC----cccHHHHHHHHHHHHcC-C
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS----GQGLQEFKNEVTLIAKL-Q 312 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~~E~~~l~~l-~ 312 (452)
-+|++...+|.|++|.||.+.... ...+++.||||++++.. ....+.+.+|+.+++.+ +
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 117 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKIS----------------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS----------------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT
T ss_pred cceEEEEEeccCCCEEEEEEEEcc----------------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccC
Confidence 589999999999999888653210 12478999999986532 23345678899999999 7
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++......++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||
T Consensus 118 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 191 (355)
T 1vzo_A 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENIL 191 (355)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred CCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 99999999999999999999999999999998843 346999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCcccccccccccccccccccccc--CCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME--GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++.+..... .......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 192 l~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il 252 (355)
T 1vzo_A 192 LDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252 (355)
T ss_dssp ECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHH
T ss_pred ECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence 99999999999999987643322 22334679999999999975 3478899999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=268.62 Aligned_cols=185 Identities=25% Similarity=0.320 Sum_probs=148.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++... .....+.+.+|+.+++.++||
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp 84 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAA-------------------YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCT
T ss_pred hhheeEeeeeEecCCEEEEEE-------------------EECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCC
Confidence 358999999999999877654 45567899999999764 334456788999999999999
Q ss_pred CccceeeeEecCC------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||+++++++.... ..++||||+++ +|.+.+. ..+++..++.++.||+.||.|||++| |+||||||
T Consensus 85 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp 155 (371)
T 2xrw_A 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 155 (371)
T ss_dssp TBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred CccceEEeeccccccccccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCH
Confidence 9999999998665 78999999976 6766662 34899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 156 ~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 216 (371)
T 2xrw_A 156 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216 (371)
T ss_dssp GGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred HHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHH
Confidence 99999999999999999998654321 22345789999999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=266.01 Aligned_cols=197 Identities=22% Similarity=0.365 Sum_probs=155.6
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ 314 (452)
...+|+..+.+|.|++|.||.+.... .....+..||||++... .......+.+|+.++++++||
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 106 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKT---------------SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC------------------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCT
T ss_pred ChHHhhcccEEecCCCeEEEEEEEec---------------CCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCC
Confidence 34588888999999999888663210 01122456999999765 334456789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++...+..++||||+++++|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 107 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~ 181 (333)
T 1mqb_A 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVN 181 (333)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred CCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEEC
Confidence 999999999999999999999999999999854 3456999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||++|
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 240 (333)
T 1mqb_A 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240 (333)
T ss_dssp TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHH
Confidence 99999999999998765432211 12233567899999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=267.65 Aligned_cols=189 Identities=23% Similarity=0.350 Sum_probs=158.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++.... ....+.+.+|++++++++|||
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n 86 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSA-------------------YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccEEEEEEeecCCCeEEEEE-------------------EECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCC
Confidence 348999999999999877755 455688999999997543 334577899999999999999
Q ss_pred ccceeeeEecC-----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 316 LVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 316 iv~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|+++++++... ...++|||++++ +|.+++.. ..+++.+++.++.||+.||.|||++| |+||||||+|
T Consensus 87 iv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 158 (364)
T 3qyz_A 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSN 158 (364)
T ss_dssp BCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CccceeEEecCCccccceEEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHh
Confidence 99999999765 468999999975 88887733 45999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCccc-ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||++.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 159 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 222 (364)
T 3qyz_A 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222 (364)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHH
T ss_pred EEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHH
Confidence 999999999999999998765433222 1344589999999998754 5589999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=262.72 Aligned_cols=192 Identities=28% Similarity=0.405 Sum_probs=157.2
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeee--EEEEeecC-CcccHHHHHHHHHHHHcC-
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEI--AVKRLSRS-SGQGLQEFKNEVTLIAKL- 311 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~v--AiK~~~~~-~~~~~~~~~~E~~~l~~l- 311 (452)
-.-+|++.+.+|.|++|.|+.+ ....+++.+ |||.+... .....+.+.+|+.+++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~ 83 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKA-------------------RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 83 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEE-------------------EEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC
T ss_pred cHHHccceeeeecCCCceEEEE-------------------EEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc
Confidence 3468888899999999877755 445567655 99998754 344556789999999999
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSR 378 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~ 378 (452)
+||||+++++++...+..++||||+++++|.+++.... ....+++.+++.++.||+.||.|||+++
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 162 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 162 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 89999999999999999999999999999999985432 2346999999999999999999999999
Q ss_pred CCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+|||++.++.+||+|||+++..... .......+|+.|+|||++.+..++.++||||||++|
T Consensus 163 --ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 163 --FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp --EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred --ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 999999999999999999999999998743221 112234568899999999988899999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=261.96 Aligned_cols=194 Identities=24% Similarity=0.278 Sum_probs=159.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++........+.+.+|+.+++.++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 88 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLV-------------------EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEE-------------------EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred CeEEEEEEEecCCCCeEEEEE-------------------EecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 468999999999999877654 4456899999999987766777889999999999999999
Q ss_pred cceeeeEe----cCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 317 VRLLGCCL----DGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 317 v~l~~~~~----~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
+++++++. .....++||||+++++|.+++... .....+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 89 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NI 165 (317)
T 2buj_A 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNI 165 (317)
T ss_dssp CCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred eeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHE
Confidence 99999987 345789999999999999888542 23467999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccc-------cccccccccccccccccccCC---CceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEA-------NTNRVVGTYGYMAPEYAMEGV---FSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||++|
T Consensus 166 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp EECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred EEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 99999999999999987643211110 112346799999999987544 68899999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=255.69 Aligned_cols=187 Identities=24% Similarity=0.452 Sum_probs=154.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-------cHHHHHHHHHHHH
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-------GLQEFKNEVTLIA 309 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-------~~~~~~~E~~~l~ 309 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++...... ..+.+.+|+.+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 78 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKG-------------------RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEE-------------------EETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHT
T ss_pred hccceehhccccCCceeEEEE-------------------EEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHH
Confidence 457888888888888777654 45568999999998654322 1267899999999
Q ss_pred cCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 310 KLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 310 ~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++||||+++++++.... ++||||+++++|.+.+.. ....+++..++.++.||+.||+|||+++ .+|+||||||+
T Consensus 79 ~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~ 153 (287)
T 4f0f_A 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSP 153 (287)
T ss_dssp TCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGG
T ss_pred hCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcc
Confidence 999999999999987765 699999999999887743 3457999999999999999999999875 34999999999
Q ss_pred CeEECCCCC-----eeEccccccccccCCCcccccccccccccccccccc--ccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMN-----PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA--MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~-----~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~DvwSlG~il 452 (452)
|||++.++. +||+|||+++.... ......||+.|+|||++ ....++.++||||||++|
T Consensus 154 Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l 218 (287)
T 4f0f_A 154 NIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218 (287)
T ss_dssp GEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHH
T ss_pred eEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHH
Confidence 999988876 99999999975432 23345789999999998 456678999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=262.23 Aligned_cols=183 Identities=26% Similarity=0.362 Sum_probs=150.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+. ..++.||||++... ...+.+.+|+.++++++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~---------------------~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~i 63 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAK---------------------WRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNI 63 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEE---------------------ETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTB
T ss_pred HhHeeeeeEeecCCCceEEEEE---------------------ECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCc
Confidence 4578899999999998887552 24788999998643 345789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc---CCCCCeEecCCCCCCeEE
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE---DSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~---~g~~~ivH~Dlkp~NIll 393 (452)
+++++++.+ ..++||||+++++|.+++........+++..++.++.||++||+|||+ ++ |+||||||+|||+
T Consensus 64 v~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll 138 (307)
T 2eva_A 64 VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLL 138 (307)
T ss_dssp CCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEE
T ss_pred CeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEE
Confidence 999998774 479999999999999999655444568999999999999999999999 66 9999999999999
Q ss_pred CCCCC-eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMN-PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~-~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++. +||+|||++...... .....||+.|+|||++.+..++.++||||||++|
T Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 193 (307)
T 2eva_A 139 VAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193 (307)
T ss_dssp ETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHH
T ss_pred eCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHH
Confidence 98887 799999999765322 2234689999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=256.90 Aligned_cols=188 Identities=23% Similarity=0.360 Sum_probs=153.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++.+.+|.|++|.|+.+ ....+++.||||++... .....+.+.+|+.+++.++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 70 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIG-------------------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC
T ss_pred eccEEEEeeecCCCCeEEEEE-------------------EECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC
Confidence 358899999999998777654 44557899999998754 23345688999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||++
T Consensus 71 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~ 144 (276)
T 2h6d_A 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLL 144 (276)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEE
T ss_pred CCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEE
Confidence 9999999999999999999999999999998843 345899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
+.++.+||+|||++........ .....||+.|+|||.+.+..+ +.++||||||++|
T Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 201 (276)
T 2h6d_A 145 DAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201 (276)
T ss_dssp CTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHH
T ss_pred CCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHH
Confidence 9999999999999987643321 233468999999999987765 6899999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=262.26 Aligned_cols=191 Identities=23% Similarity=0.367 Sum_probs=157.4
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-.-+|++...+|.|++|.|+.+ ....+++.||+|++........+.+.+|+.+++.++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~-------------------~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ 77 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKA-------------------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEE-------------------EETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTT
T ss_pred CccceeecceeccCCCeEEEEE-------------------EEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCC
Confidence 3568999999999999877755 444578999999998777777889999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++..++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 78 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~ 152 (302)
T 2j7t_A 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTL 152 (302)
T ss_dssp BCCEEEEEECC-CEEEEEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECT
T ss_pred EeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECC
Confidence 99999999999999999999999999988743 2356999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccc-----ccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA-----MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||++....... .......||+.|+|||++ .+..++.++||||||++|
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 153 EGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212 (302)
T ss_dssp TSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHH
T ss_pred CCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHH
Confidence 9999999999876432111 112335789999999998 367789999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=267.62 Aligned_cols=188 Identities=24% Similarity=0.336 Sum_probs=150.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-cHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-GLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++...... ....+.+|+.+++.++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 62 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKG-------------------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTB
T ss_pred CceEEEEEEcCCCCEEEEEE-------------------EECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCC
Confidence 37888999999999877755 44557899999998754322 12245679999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++...+..++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~ 136 (324)
T 3mtl_A 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINER 136 (324)
T ss_dssp CCEEEEEECSSCEEEEEECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTT
T ss_pred CeeeeEEeeCCEEEEEeccccc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCC
Confidence 9999999999999999999975 77777743 3456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++||||||++|
T Consensus 137 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 191 (324)
T 3mtl_A 137 GELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 191 (324)
T ss_dssp CCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred CCEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHH
Confidence 999999999997654322 12234578999999999876 5689999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=256.01 Aligned_cols=189 Identities=23% Similarity=0.355 Sum_probs=161.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|+..+.+|.|++|.|+.+. ..+++.||+|++..... ..+.+.+|+.++++++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~--------------------~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i 65 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGY--------------------WLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKL 65 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEE--------------------ETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTB
T ss_pred hhheeeeeEecCCCceeEEEEE--------------------ecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCE
Confidence 3578889999999998887542 23678899999976533 44789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++..++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~ 140 (267)
T 3t9t_A 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN 140 (267)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGG
T ss_pred eeEEEEEccCCCeEEEEeCCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCC
Confidence 9999999999999999999999999998854 2356899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... .......||+.|+|||++.+..++.++||||||++|
T Consensus 141 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 195 (267)
T 3t9t_A 141 QVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195 (267)
T ss_dssp GCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCEEEcccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHH
Confidence 9999999999986543221 122334568899999999988999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=257.42 Aligned_cols=191 Identities=23% Similarity=0.317 Sum_probs=161.6
Q ss_pred cccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---------cccHHHHHHH
Q 012989 234 PSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---------GQGLQEFKNE 304 (452)
Q Consensus 234 ~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~~E 304 (452)
....-+|++...+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e 73 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRC-------------------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHH
T ss_pred cchhhccceeeeecCCCceEEEEE-------------------EEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHH
Confidence 345678999999999999877654 455689999999997543 1224568899
Q ss_pred HHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 012989 305 VTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383 (452)
Q Consensus 305 ~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH 383 (452)
+.+++++. ||||+++++++..+...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|
T Consensus 74 ~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H 147 (298)
T 1phk_A 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVH 147 (298)
T ss_dssp HHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99999995 99999999999999999999999999999999843 356999999999999999999999999 999
Q ss_pred cCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccc------cCCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM------EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSlG~il 452 (452)
+||||+||+++.++.+||+|||++....... ......||+.|+|||++. ...++.++||||||++|
T Consensus 148 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l 219 (298)
T 1phk_A 148 RDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219 (298)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred CCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence 9999999999999999999999998765432 223457899999999985 45688999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=264.16 Aligned_cols=196 Identities=28% Similarity=0.454 Sum_probs=163.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|++.+.+|.|++|.|+.+.+.. ....+++.||||++........+.+.+|+.++++++||||
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 104 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP---------------LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT---------------TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTB
T ss_pred HHHceeeeeeccCCCeEEEEEEecc---------------ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe
Confidence 4578889999999998887653211 0234789999999987766667889999999999999999
Q ss_pred cceeeeEecCC--eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDGN--ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
+++++++...+ ..++||||+++++|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 105 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 179 (326)
T 2w1i_A 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVE 179 (326)
T ss_dssp CCEEEEECC----CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEE
T ss_pred eeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEc
Confidence 99999987654 789999999999999998542 345899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||++|
T Consensus 180 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 238 (326)
T 2w1i_A 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238 (326)
T ss_dssp ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHH
Confidence 99999999999998765443221 12234568889999999988999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=276.77 Aligned_cols=188 Identities=25% Similarity=0.392 Sum_probs=158.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++.+.+|.|++|.|+.+. ..++..||||+++... ...+.+.+|+.+|++++||||+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~--------------------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv 246 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMAT--------------------YNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 246 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEE--------------------ETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBC
T ss_pred HHeEEEEEcccCCceEEEEEE--------------------ECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEe
Confidence 467788889999988877552 3457889999997653 4568899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++. ....++||||+++++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 247 ~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~ 321 (454)
T 1qcf_A 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASL 321 (454)
T ss_dssp CEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTC
T ss_pred eEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCC
Confidence 9999986 56789999999999999998532 2235889999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++....... .......+|+.|+|||++.++.++.++||||||++|
T Consensus 322 ~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 375 (454)
T 1qcf_A 322 VCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375 (454)
T ss_dssp CEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHH
Confidence 999999999987643221 112233467899999999989999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=263.75 Aligned_cols=195 Identities=23% Similarity=0.293 Sum_probs=148.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 315 (452)
..||++...+|.|++|.|+.+ .+..+++.||||++........+.+.+|+.+++++. |||
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 87 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEA-------------------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEE-------------------EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTT
T ss_pred CceEEEEEEEccCCceEEEEE-------------------EECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCC
Confidence 458999999999999877755 445688999999997776666778999999999996 999
Q ss_pred ccceeeeEe--------cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 316 LVRLLGCCL--------DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 316 iv~l~~~~~--------~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
|+++++++. ....+++||||++ ++|.+++........+++.+++.++.||+.||.|||+++ .+|+|||||
T Consensus 88 iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dik 165 (337)
T 3ll6_A 88 IVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLK 165 (337)
T ss_dssp BCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCC
T ss_pred hhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCC
Confidence 999999984 3446899999996 588777754344567999999999999999999999874 349999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccc----------ccccccccccccccccc---ccCCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEA----------NTNRVVGTYGYMAPEYA---MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwSlG~il 452 (452)
|+|||++.++.+||+|||+++......... ......||+.|+|||++ .+..++.++||||||++|
T Consensus 166 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp GGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred cccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence 999999999999999999998765432211 11234689999999998 567789999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=260.04 Aligned_cols=192 Identities=23% Similarity=0.338 Sum_probs=157.7
Q ss_pred Ccccccee-eecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQ-FYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~-f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h 313 (452)
..+|++.. .+|.|++|.|+.+.. ....+++.||||++.... ....+.+.+|+.+++.++|
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h 77 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYY-----------------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 77 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEE-----------------ECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC
T ss_pred chhhhhccCccccccCeeeEeeee-----------------cCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC
Confidence 45888887 899999988886521 223467899999997653 2335779999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++ ..+..++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+||++
T Consensus 78 ~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~ 150 (291)
T 1xbb_A 78 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLL 150 (291)
T ss_dssp TTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEE
Confidence 9999999998 56678999999999999999843 456999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++......... ......+|+.|+|||.+.+..++.++||||||++|
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 210 (291)
T 1xbb_A 151 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210 (291)
T ss_dssp EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHH
Confidence 999999999999998765443221 12223467899999999988999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=259.37 Aligned_cols=193 Identities=20% Similarity=0.329 Sum_probs=153.1
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~ 312 (452)
-..+|++.+.+|.|++|.||.+ ....+++.||||++... .....+.+.+|+.++++++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~ 90 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRA-------------------ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEE-------------------EETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC
T ss_pred cccceEEEEeecCCCCceEEEE-------------------EEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC
Confidence 3458999999999999877754 44567899999999753 3344667899999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
||||+++++++...+..++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 91 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NI 167 (310)
T 2wqm_A 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANV 167 (310)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred CCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHE
Confidence 999999999999999999999999999999888532 13456899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||++|
T Consensus 168 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 226 (310)
T 2wqm_A 168 FITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226 (310)
T ss_dssp EECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred EEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHH
Confidence 999999999999999886543322 22345789999999999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=271.05 Aligned_cols=197 Identities=22% Similarity=0.329 Sum_probs=151.3
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h 313 (452)
.-..+|+..+.+|.|++|.||.+... .....+..||||.+... .....+++.+|+.++++++|
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~----------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h 149 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLL----------------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEE----------------ETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCC
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEE----------------CCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC
Confidence 34567888899999999988865310 00112356899998754 33456789999999999999
Q ss_pred CCccceeeeEe-cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 314 KNLVRLLGCCL-DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 ~~iv~l~~~~~-~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|||+++++++. .++..++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||
T Consensus 150 pnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 224 (373)
T 3c1x_A 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCM 224 (373)
T ss_dssp TTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEE
Confidence 99999999865 45678999999999999999853 3456899999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccc--cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||++|
T Consensus 225 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il 286 (373)
T 3c1x_A 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286 (373)
T ss_dssp ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999998664332211 12334678899999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=259.94 Aligned_cols=190 Identities=25% Similarity=0.391 Sum_probs=153.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++... ....+.+.+|+.++++++||||+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~ 65 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKA-------------------RNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVV 65 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccchhhheeccCCcEEEEEE-------------------EEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHH
Confidence 47888999999999877755 44567899999998643 34457789999999999999999
Q ss_pred ceeeeEec-------------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 012989 318 RLLGCCLD-------------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384 (452)
Q Consensus 318 ~l~~~~~~-------------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~ 384 (452)
++++++.. ....++||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~ 140 (303)
T 1zy4_A 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHR 140 (303)
T ss_dssp CEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 99998764 4578999999999999999854 3345788999999999999999999999 9999
Q ss_pred CCCCCCeEECCCCCeeEccccccccccCCCc------------cccccccccccccccccccccC-CCceeeeeeeeeee
Q 012989 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQN------------EANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFF 451 (452)
Q Consensus 385 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~i 451 (452)
||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+. .++.++||||||++
T Consensus 141 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 220 (303)
T 1zy4_A 141 DLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHH
T ss_pred cCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHH
Confidence 9999999999999999999999986543211 1122345789999999999754 68999999999997
Q ss_pred C
Q 012989 452 F 452 (452)
Q Consensus 452 l 452 (452)
|
T Consensus 221 l 221 (303)
T 1zy4_A 221 F 221 (303)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=260.20 Aligned_cols=183 Identities=20% Similarity=0.319 Sum_probs=157.5
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HK 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ 314 (452)
-.-+|++...+|.|++|.|+.+ .+..+++.||||++... ..+.+.+|+.+++.++ ||
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~ 91 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEA-------------------INITNNEKVVVKILKPV---KKKKIKREIKILENLRGGP 91 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTST
T ss_pred CCCceEEEEEecccCCeEEEEE-------------------EECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCC
Confidence 3468999999999999877754 45568899999998643 3477899999999997 99
Q ss_pred CccceeeeEec--CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 315 NLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 315 ~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||+++++++.. ....++||||+++++|..++. .+++.+++.++.||+.||+|||++| |+||||||+|||
T Consensus 92 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil 162 (330)
T 3nsz_A 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVM 162 (330)
T ss_dssp TBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CEEEeeeeeccCCCCceEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEE
Confidence 99999999997 667999999999999998872 3899999999999999999999999 999999999999
Q ss_pred ECCCC-CeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 393 LDHEM-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
++.++ .+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||+|
T Consensus 163 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 221 (330)
T 3nsz_A 163 IDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 221 (330)
T ss_dssp EETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred EcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHH
Confidence 99777 799999999987654332 234578999999999876 6789999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=258.66 Aligned_cols=191 Identities=20% Similarity=0.276 Sum_probs=156.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC----cccHHHHHHHHHHHHcCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS----GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~~E~~~l~~l~h 313 (452)
-||++...+|.|++|.|+.+ .+..+++.||||++.... ....+.+.+|+.++++++|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~-------------------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 65 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEV-------------------LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEE-------------------EBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC
T ss_pred cceeEeeEEecCCCeEEEEE-------------------EECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC
Confidence 47888899999998777654 344578999999997542 3446789999999999999
Q ss_pred CCccceeeeEe--cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 314 KNLVRLLGCCL--DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 314 ~~iv~l~~~~~--~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
|||+++++++. .....++||||++++ |.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 66 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NI 140 (305)
T 2wtk_C 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNL 140 (305)
T ss_dssp TTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred CCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccE
Confidence 99999999984 456799999999886 65555432 3456999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCC--CceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV--FSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwSlG~il 452 (452)
+++.++.+||+|||++................||+.|+|||++.+.. ++.++||||||++|
T Consensus 141 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp EECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred EEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 99999999999999998765433333334557899999999987644 47799999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=261.45 Aligned_cols=186 Identities=22% Similarity=0.299 Sum_probs=153.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--------cccHHHHHHHHHHHH
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--------GQGLQEFKNEVTLIA 309 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--------~~~~~~~~~E~~~l~ 309 (452)
-+|++...+|.|++|.|+.+ ....+++.||||++.... ......+.+|+.+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 70 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLA-------------------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECC---------------CHHHHHHHHH
T ss_pred hceeEeeEEecCCCEEEEEE-------------------EEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHH
Confidence 57899999999999877754 455678999999986542 122345889999999
Q ss_pred cCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 310 KLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 310 ~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++||||+++++++..+. .++||||+++++|.+++ .....+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 71 ~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~ 143 (322)
T 2ycf_A 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPE 143 (322)
T ss_dssp HCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHH---STTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred hCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 999999999999987665 89999999999999888 34567999999999999999999999999 999999999
Q ss_pred CeEECCCCC---eeEccccccccccCCCccccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMN---PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
|||++.++. +||+|||+++...... ......||+.|+|||++. ...++.++||||||++|
T Consensus 144 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 209 (322)
T 2ycf_A 144 NVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209 (322)
T ss_dssp GEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHH
T ss_pred HEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHH
Confidence 999987665 9999999998764321 123357899999999974 56789999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=259.08 Aligned_cols=189 Identities=24% Similarity=0.359 Sum_probs=152.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-||++.+.+|.|++|.|+.+ ....+++.||||++...+....+.+.+|+.++++++||||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i 70 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSA-------------------VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70 (320)
T ss_dssp TTTEEEEEECC-----CEEEE-------------------EETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred CCceeEEEEeccCCCeEEEEE-------------------EECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCe
Confidence 468999999999998877754 4456799999999987776777889999999999999999
Q ss_pred cceeeeEe--------------cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 317 VRLLGCCL--------------DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 317 v~l~~~~~--------------~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
+++++++. .....++||||++ ++|.+++. ...+++..++.++.||+.||+|||++| |+
T Consensus 71 v~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 142 (320)
T 2i6l_A 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VL 142 (320)
T ss_dssp CCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred eEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 99999874 3467899999998 48988883 356899999999999999999999999 99
Q ss_pred ecCCCCCCeEEC-CCCCeeEccccccccccCCCc-ccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQN-EANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||||||+|||++ .++.+||+|||+++....... ........||+.|+|||.+.+ ..++.++||||||++|
T Consensus 143 H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 215 (320)
T 2i6l_A 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHH
Confidence 999999999997 567899999999987643221 112234567999999998865 6789999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=261.78 Aligned_cols=187 Identities=25% Similarity=0.398 Sum_probs=159.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCccc-----------------HH
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQG-----------------LQ 299 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~-----------------~~ 299 (452)
.-+|++...+|.|++|.|+.+ .. +++.||||++....... .+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~-------------------~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILC-------------------EK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEE-------------------EE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHH
T ss_pred cCceEEEEEEcCCCCeEEEEE-------------------Ec--CCceEEEEEeecccccchhhhccccchhhhHHhHHH
Confidence 358999999999999887755 22 89999999987542111 17
Q ss_pred HHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhh------hccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012989 300 EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF------LFDSTKGAQLDWKRRISIINGIARGLLYL 373 (452)
Q Consensus 300 ~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~------l~~~~~~~~l~~~~~~~i~~ql~~aL~~L 373 (452)
.+.+|+.++++++||||+++++++...+..++||||+++++|.++ +.. .....+++..++.++.||+.||.||
T Consensus 89 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999999998 522 2256799999999999999999999
Q ss_pred hc-CCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCce-eeeeeeeee
Q 012989 374 HE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSV-NRMFLVSEF 450 (452)
Q Consensus 374 H~-~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DvwSlG~ 450 (452)
|+ +| |+||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+
T Consensus 168 H~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 240 (348)
T 2pml_X 168 HNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240 (348)
T ss_dssp HHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHH
T ss_pred hccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHH
Confidence 99 88 999999999999999999999999999876443 23345789999999999877 6666 999999999
Q ss_pred eC
Q 012989 451 FF 452 (452)
Q Consensus 451 il 452 (452)
+|
T Consensus 241 il 242 (348)
T 2pml_X 241 CL 242 (348)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-33 Score=275.16 Aligned_cols=187 Identities=15% Similarity=0.162 Sum_probs=150.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHH---HHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVT---LIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~---~l~~ 310 (452)
.-+|++...+|.|++|.|+.+. ...+++.||||++... .....+.+.+|+. +++.
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 132 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEAT-------------------DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEE-------------------C-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT
T ss_pred CceEEEcceeecCCCEEEEEEE-------------------ECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc
Confidence 4689999999999998887653 3457899999999743 3445678999995 4555
Q ss_pred CCCCCcccee-------eeEecCC-----------------eEEEEEEecCCCChhhhhccCCC----CCCCCHHHHHHH
Q 012989 311 LQHKNLVRLL-------GCCLDGN-----------------ELLLIYEYMPNKSLDLFLFDSTK----GAQLDWKRRISI 362 (452)
Q Consensus 311 l~h~~iv~l~-------~~~~~~~-----------------~~~lv~E~~~~~~L~~~l~~~~~----~~~l~~~~~~~i 362 (452)
++||||++++ +++..++ ..+|||||+ +++|.+++..... ...+++..++.|
T Consensus 133 l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i 211 (377)
T 3byv_A 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQL 211 (377)
T ss_dssp CCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHH
T ss_pred cCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHH
Confidence 5899999998 6665543 288999999 5799998854211 123445888899
Q ss_pred HHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-----
Q 012989 363 INGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG----- 437 (452)
Q Consensus 363 ~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 437 (452)
+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 212 ~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~ 282 (377)
T 3byv_A 212 TLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISY 282 (377)
T ss_dssp HHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHH
T ss_pred HHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccc
Confidence 999999999999999 99999999999999999999999999985322 2334567 999999999887
Q ss_pred ------CCceeeeeeeeeeeC
Q 012989 438 ------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 438 ------~~s~~~DvwSlG~il 452 (452)
.++.++|||||||+|
T Consensus 283 ~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 283 HRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp HHCCEEECCHHHHHHHHHHHH
T ss_pred cccccccCChhhhHHHHHHHH
Confidence 899999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=272.30 Aligned_cols=186 Identities=23% Similarity=0.314 Sum_probs=150.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|+..+.+|.|++|.||.+ ....+++.||||++..... ...+|+++++.++||||
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~-------------------~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpni 109 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQA-------------------KLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNI 109 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTB
T ss_pred cceEEeeeEEeeCCCEEEEEE-------------------EECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCc
Confidence 458999999999999887755 4445789999999875432 23479999999999999
Q ss_pred cceeeeEecC------CeEEEEEEecCCCChhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 317 VRLLGCCLDG------NELLLIYEYMPNKSLDLFLFD-STKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 317 v~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++++++... .++++||||+++ +|...+.. ......+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 110 v~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 185 (420)
T 1j1b_A 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQ 185 (420)
T ss_dssp CCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGG
T ss_pred cceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChh
Confidence 9999998532 247799999987 45444422 123567999999999999999999999999 999999999
Q ss_pred CeEECCC-CCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 390 NVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|||++.+ +.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||||
T Consensus 186 NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 247 (420)
T 1j1b_A 186 NLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247 (420)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred hEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence 9999965 5689999999987643322 2345789999999998764 789999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=258.61 Aligned_cols=195 Identities=18% Similarity=0.285 Sum_probs=158.4
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h 313 (452)
...-+|++.+.+|.|++|.|+.+... ....++..||+|.+... .....+.+.+|+.+++.++|
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 72 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYT----------------NHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEE----------------CTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEc----------------CCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC
Confidence 34568999999999999988865321 11123557999998765 34456789999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++..+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 73 ~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~ 146 (281)
T 3cc6_A 73 PHIVKLIGIIEEE-PTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILV 146 (281)
T ss_dssp TTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEE
T ss_pred CCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEE
Confidence 9999999998754 56899999999999998853 2345899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||++|
T Consensus 147 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 204 (281)
T 3cc6_A 147 ASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCM 204 (281)
T ss_dssp EETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHH
Confidence 99999999999999876543221 22334568899999999989999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=254.39 Aligned_cols=190 Identities=24% Similarity=0.282 Sum_probs=158.2
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~ 312 (452)
.-..+|++...+|.|++|.|+.+ ....++..||+|++... .....+.+.+|+.+++.++
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~ 83 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKG-------------------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC
T ss_pred cCceeEEeeeeccCCCCeEEEEe-------------------EecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC
Confidence 34456788888999999877755 44567899999998754 3445677999999999999
Q ss_pred CCCccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 313 HKNLVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 313 h~~iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||||+++++++.. ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ .+|+||||||
T Consensus 84 h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp 159 (290)
T 1t4h_A 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKC 159 (290)
T ss_dssp CTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCG
T ss_pred CCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCH
Confidence 9999999999875 4569999999999999999843 356899999999999999999999874 3499999999
Q ss_pred CCeEEC-CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++ .++.+||+|||++...... ......||+.|+|||++. +.++.++||||||++|
T Consensus 160 ~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l 219 (290)
T 1t4h_A 160 DNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCM 219 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHH
T ss_pred HHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHH
Confidence 999998 7899999999999754332 223456899999999876 4689999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=261.99 Aligned_cols=194 Identities=23% Similarity=0.346 Sum_probs=142.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++.+.+|.|++|.|+.+ ....+++.||||++.... ....+.+.+|+.++++++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 74 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAA-------------------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74 (303)
T ss_dssp CCCCEEEEECC---CCCEEEE-------------------EC----CEEEEECCC----------------CCCCCCCTT
T ss_pred hhhhhhhheeccccceEEEEE-------------------EECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCC
Confidence 458888999999998877755 334578899999986542 334567889999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-----TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-----~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|+++++++...+..++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 75 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~N 151 (303)
T 2vwi_A 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGN 151 (303)
T ss_dssp BCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred EeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhh
Confidence 999999999999999999999999999888531 13456999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCc---ccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQN---EANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|+++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++||||||++|
T Consensus 152 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 217 (303)
T 2vwi_A 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217 (303)
T ss_dssp EEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHH
T ss_pred EEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHH
Confidence 9999999999999999876543321 112234578999999999865 5689999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=269.73 Aligned_cols=188 Identities=19% Similarity=0.255 Sum_probs=158.9
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC---
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL--- 311 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l--- 311 (452)
.-..||++...+|.|++|.|+.+ .+..+++.||||++... ......+.+|+.+++.+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a-------------------~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~ 153 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKA-------------------YDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQ 153 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEE-------------------EETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTT
T ss_pred cccCcEEEEEEcccCccEEEEEE-------------------EECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhc
Confidence 34568999999999999887755 45567899999999654 33446678899998887
Q ss_pred ---CCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 312 ---QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 312 ---~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
+|+||+++++.+....+.++|||+++ ++|.+++... ....+++..++.|+.||+.||+|||+++ |+||||||
T Consensus 154 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp 228 (429)
T 3kvw_A 154 DKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKP 228 (429)
T ss_dssp CTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSG
T ss_pred cccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 46799999999999999999999996 4787777543 3345999999999999999999999999 99999999
Q ss_pred CCeEECCCCC--eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMN--PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 229 ~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 289 (429)
T 3kvw_A 229 ENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289 (429)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHH
T ss_pred HHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHH
Confidence 9999999987 999999999754322 2345789999999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=253.64 Aligned_cols=189 Identities=28% Similarity=0.431 Sum_probs=158.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+. ..+++.||||++.... ...+.+.+|+++++.++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~--------------------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i 70 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGY--------------------YNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRL 70 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEE--------------------ETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTB
T ss_pred HHhhhheeeecCCCCeEEEEEE--------------------EcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCc
Confidence 3588899999999998887542 3467789999987543 346789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++. .+..++||||+++++|.+++... ....+++.+++.++.||+.||+|||++| |+||||||+||+++.+
T Consensus 71 ~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~ 145 (279)
T 1qpc_A 71 VRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT 145 (279)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred ceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCC
Confidence 99999876 45689999999999999988431 1236999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||++........ .......+|+.|+|||++.+..++.++||||||++|
T Consensus 146 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 200 (279)
T 1qpc_A 146 LSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (279)
T ss_dssp SCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHH
Confidence 9999999999987654322 122334568899999999988999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=274.60 Aligned_cols=189 Identities=24% Similarity=0.396 Sum_probs=153.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+. ..++..||||+++... ...+.+.+|+.+|++++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~--------------------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~i 241 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGT--------------------WNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKL 241 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE--------------------ETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTB
T ss_pred hhHceeeeeecCCCCeEEEEEE--------------------ECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCE
Confidence 3578888899999998887552 2346779999997653 345789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++.. +..++||||+++++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 242 v~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~ 316 (452)
T 1fmk_A 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 316 (452)
T ss_dssp CCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred eeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCC
Confidence 999999876 6789999999999999998431 2345899999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... .......+|+.|+|||.+.++.++.++||||||++|
T Consensus 317 ~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l 371 (452)
T 1fmk_A 317 LVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371 (452)
T ss_dssp GCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHH
Confidence 9999999999987643321 112234568899999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=266.66 Aligned_cols=186 Identities=22% Similarity=0.340 Sum_probs=152.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..||++...+|.|++|.|+.+ .+..+++.||||++...... ..+|+.+++.++||||
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a-------------------~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnI 62 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEV-------------------FDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNI 62 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEE-------------------EETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTB
T ss_pred cceEEEEEEEEeccCEEEEEE-------------------EECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCc
Confidence 458999999999999887755 45568999999998755322 3479999999999999
Q ss_pred cceeeeEec--------------------------------------CCeEEEEEEecCCCChhhhhcc-CCCCCCCCHH
Q 012989 317 VRLLGCCLD--------------------------------------GNELLLIYEYMPNKSLDLFLFD-STKGAQLDWK 357 (452)
Q Consensus 317 v~l~~~~~~--------------------------------------~~~~~lv~E~~~~~~L~~~l~~-~~~~~~l~~~ 357 (452)
+++++++.. ....++||||+++ +|.+.+.. ......+++.
T Consensus 63 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~ 141 (383)
T 3eb0_A 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMN 141 (383)
T ss_dssp CCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHH
T ss_pred cchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHH
Confidence 999999843 3348999999985 77666543 1245679999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC-CCCCeeEccccccccccCCCcccccccccccccccccccccc
Q 012989 358 RRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 436 (452)
.++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+
T Consensus 142 ~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 142 LISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLG 215 (383)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcC
Confidence 99999999999999999999 99999999999998 678999999999987644332 234578999999999876
Q ss_pred C-CCceeeeeeeeeeeC
Q 012989 437 G-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 437 ~-~~s~~~DvwSlG~il 452 (452)
. .++.++||||+||+|
T Consensus 216 ~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 216 ATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp CSSCCTHHHHHHHHHHH
T ss_pred CCCCCcchhhhhHHHHH
Confidence 5 489999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=257.12 Aligned_cols=197 Identities=27% Similarity=0.357 Sum_probs=159.8
Q ss_pred ccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCC
Q 012989 235 SCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 235 ~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~ 312 (452)
+..-+|++...+|.|++|.|+.+ ....+++.||+|++... .....+.+.+|+.++++++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~ 63 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKI-------------------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC
T ss_pred CchhheeeehhccCCCCcEEEEE-------------------EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC
Confidence 34568999999999999877754 44567899999999765 3344567999999999999
Q ss_pred CCCccceeeeEe--cCCeEEEEEEecCCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCC
Q 012989 313 HKNLVRLLGCCL--DGNELLLIYEYMPNKSLDLFLFDST-KGAQLDWKRRISIINGIARGLLYLHEDS--RLRVIHRDLK 387 (452)
Q Consensus 313 h~~iv~l~~~~~--~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g--~~~ivH~Dlk 387 (452)
||||+++++++. .....++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+|||||
T Consensus 64 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp CTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred CCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 999999999875 4578999999999999999885432 2345999999999999999999999875 2349999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||++|
T Consensus 144 p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 206 (279)
T 2w5a_A 144 PANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206 (279)
T ss_dssp GGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHH
T ss_pred hhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHH
Confidence 9999999999999999999987543321 12235789999999999988999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=264.88 Aligned_cols=185 Identities=29% Similarity=0.437 Sum_probs=147.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHH--HcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLI--AKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l--~~l~h~ 314 (452)
.-+|++...+|.|++|.||.+. .+++.||||++.... ...+..|.+++ ..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~---------------------~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~ 67 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGS---------------------LDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHD 67 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEE---------------------ETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCT
T ss_pred hHHhheeeecccCCCeEEEEEE---------------------ECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCc
Confidence 4588999999999998887542 368999999997543 34445555554 458999
Q ss_pred CccceeeeEe-----cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCC
Q 012989 315 NLVRLLGCCL-----DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED---------SRLR 380 (452)
Q Consensus 315 ~iv~l~~~~~-----~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---------g~~~ 380 (452)
||+++++.+. ....+++||||+++++|.+++.. ...++..++.++.||+.||.|||+. +
T Consensus 68 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--- 140 (336)
T 3g2f_A 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--- 140 (336)
T ss_dssp TBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---
T ss_pred chhhheecccccccCCCceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---
Confidence 9999998554 23468999999999999999843 3358999999999999999999998 8
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCc------ccccccccccccccccccccc-------CCCceeeeeee
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN------EANTNRVVGTYGYMAPEYAME-------GVFSVNRMFLV 447 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwS 447 (452)
|+||||||+|||++.++.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++||||
T Consensus 141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws 220 (336)
T 3g2f_A 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220 (336)
T ss_dssp EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence 99999999999999999999999999987654321 112234579999999999976 46778999999
Q ss_pred eeeeC
Q 012989 448 SEFFF 452 (452)
Q Consensus 448 lG~il 452 (452)
|||+|
T Consensus 221 lG~il 225 (336)
T 3g2f_A 221 LGLIY 225 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=276.82 Aligned_cols=164 Identities=18% Similarity=0.231 Sum_probs=124.8
Q ss_pred EEecCCeeeEEEEeecCC----------cccHHHHHHHHHHHHcC-CCCCccceeeeEecCCeEEEEEEecCCCChhhhh
Q 012989 277 GILADGKEIAVKRLSRSS----------GQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFL 345 (452)
Q Consensus 277 ~~~~~~~~vAiK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l 345 (452)
+....|+.+++|.+.+.. ....++|.+|+++|+++ .|+||++++++++++...||||||++|++|.+++
T Consensus 254 rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i 333 (569)
T 4azs_A 254 RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDML 333 (569)
T ss_dssp EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHH
T ss_pred ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence 444568999999997541 23356799999999999 7999999999999999999999999999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccc
Q 012989 346 FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGT 425 (452)
Q Consensus 346 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 425 (452)
. ...++++. .|+.||+.||+|+|++| ||||||||+|||++.++++||+|||+++...... ......+||
T Consensus 334 ~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGT 402 (569)
T 4azs_A 334 A---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQS 402 (569)
T ss_dssp H---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHH
T ss_pred H---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceec
Confidence 4 44567764 47899999999999999 9999999999999999999999999998765432 223456899
Q ss_pred cccccccccccCCCceeeeeeeeeeeC
Q 012989 426 YGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 426 ~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.|||||++.+ .+..++|+||+|+++
T Consensus 403 p~YmAPE~l~g-~~~~~~d~~s~g~~~ 428 (569)
T 4azs_A 403 FFVFVNELFAE-NKSWNGFWRSAPVHP 428 (569)
T ss_dssp HHHHHHHHC------------------
T ss_pred hhhccHHHhCC-CCCCcccccccccch
Confidence 99999999875 467789999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=280.86 Aligned_cols=167 Identities=24% Similarity=0.389 Sum_probs=138.9
Q ss_pred cCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHH
Q 012989 280 ADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKR 358 (452)
Q Consensus 280 ~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~ 358 (452)
.++..||||+++.. .....+.+.+|+++|++++||||+++++++.. +..++||||+++++|.+++.. ....+++.+
T Consensus 361 ~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~ 437 (613)
T 2ozo_A 361 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSN 437 (613)
T ss_dssp SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT--CTTTSCHHH
T ss_pred CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh--ccCCCCHHH
Confidence 35678999999765 33456889999999999999999999999876 568999999999999998843 345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccc-cccccccccccccccccccC
Q 012989 359 RISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEG 437 (452)
Q Consensus 359 ~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 437 (452)
++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....... ......+|+.|+|||++.+.
T Consensus 438 ~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~ 514 (613)
T 2ozo_A 438 VAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514 (613)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC
Confidence 9999999999999999999 9999999999999999999999999998764332211 12223457899999999999
Q ss_pred CCceeeeeeeeeeeC
Q 012989 438 VFSVNRMFLVSEFFF 452 (452)
Q Consensus 438 ~~s~~~DvwSlG~il 452 (452)
.++.++|||||||+|
T Consensus 515 ~~~~~sDvwSlGv~l 529 (613)
T 2ozo_A 515 KFSSRSDVWSYGVTM 529 (613)
T ss_dssp CCCHHHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHH
Confidence 999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=254.26 Aligned_cols=189 Identities=19% Similarity=0.261 Sum_probs=153.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-||++.+.+|.|++|.|+.+ .+..+++.||||++...... +.+.+|+.+++.++|+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~ 66 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLG-------------------TDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEE-------------------EETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTT
T ss_pred CCceEEeeeecCCCCeEEEEE-------------------EEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCC
Confidence 358999999999999877754 45568999999987654322 458889999999988776
Q ss_pred cceeee-EecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE--
Q 012989 317 VRLLGC-CLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-- 393 (452)
Q Consensus 317 v~l~~~-~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll-- 393 (452)
+..+.. +......++||||+ +++|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~ 140 (296)
T 4hgt_A 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGL 140 (296)
T ss_dssp CCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECC
T ss_pred CCeeeeecCCCCceEEEEEcc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeec
Confidence 666555 46778899999999 8899998853 2346999999999999999999999999 9999999999999
Q ss_pred -CCCCCeeEccccccccccCCCccc-----cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 -DHEMNPKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 -~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||++|
T Consensus 141 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHH
Confidence 788999999999998765543221 22346789999999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=258.79 Aligned_cols=190 Identities=25% Similarity=0.407 Sum_probs=153.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.... ...+.+.+|+.+++++ +|||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~ 82 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKG-------------------RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRN 82 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTT
T ss_pred CCcEEEEEEeccCCCEEEEEE-------------------EECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCC
Confidence 457899999999999877754 445678999999987543 3457789999999999 8999
Q ss_pred ccceeeeEec------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLD------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++.. ....++||||+++++|.+++... ....+++..++.++.||+.||.|||++| |+|+||||+
T Consensus 83 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~ 158 (326)
T 2x7f_A 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQ 158 (326)
T ss_dssp BCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG
T ss_pred eeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHH
Confidence 9999999986 46899999999999999998543 3356999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||++........ ......||+.|+|||++. +..++.++||||||++|
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 224 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224 (326)
T ss_dssp GEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred HEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence 99999999999999999886543221 223457899999999986 56789999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=267.19 Aligned_cols=186 Identities=20% Similarity=0.271 Sum_probs=154.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC----
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ---- 312 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---- 312 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++... ....+.+.+|+.+++.++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~ 95 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLS-------------------WDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDP 95 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCT
T ss_pred CCeEEEEEEeeecCCeeEEEE-------------------EecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCC
Confidence 468999999999999877755 45567999999999644 344577889999999995
Q ss_pred ----CCCccceeeeEe----cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEe
Q 012989 313 ----HKNLVRLLGCCL----DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIH 383 (452)
Q Consensus 313 ----h~~iv~l~~~~~----~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH 383 (452)
|+||+++++.+. ...+.++||||+.+..+..+. . .....+++..++.|+.||+.||.|||++ | |+|
T Consensus 96 ~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivH 170 (397)
T 1wak_A 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII-K-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIH 170 (397)
T ss_dssp TCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHH-H-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EEC
T ss_pred CCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHH-h-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 788999999988 566899999999554444444 2 2335699999999999999999999998 8 999
Q ss_pred cCCCCCCeEECCCC-------------------------------------------------CeeEccccccccccCCC
Q 012989 384 RDLKTSNVLLDHEM-------------------------------------------------NPKISDFGMARIFSGNQ 414 (452)
Q Consensus 384 ~Dlkp~NIll~~~~-------------------------------------------------~~kl~DFG~a~~~~~~~ 414 (452)
|||||+|||++.++ .+||+|||+++.....
T Consensus 171 rDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~- 249 (397)
T 1wak_A 171 TDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH- 249 (397)
T ss_dssp CCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-
T ss_pred CCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-
Confidence 99999999999775 7999999999865432
Q ss_pred ccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 415 NEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 415 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.....||+.|+|||++.+..++.++|||||||+|
T Consensus 250 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 283 (397)
T 1wak_A 250 ----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMA 283 (397)
T ss_dssp ----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHH
T ss_pred ----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHH
Confidence 2335789999999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=258.61 Aligned_cols=185 Identities=25% Similarity=0.370 Sum_probs=151.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC--CCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL--QHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l--~h~ 314 (452)
.-+|++.+.+|.|++|.|+.+. .+++.||||++... ....+..|.+++..+ +||
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~---------------------~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~ 91 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGK---------------------WRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHE 91 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEE---------------------ETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCT
T ss_pred ccceEEEeEeecCCCeEEEEEE---------------------ECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCC
Confidence 3589999999999998887552 24889999998644 234455666666655 899
Q ss_pred CccceeeeEecC----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCeE
Q 012989 315 NLVRLLGCCLDG----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED--------SRLRVI 382 (452)
Q Consensus 315 ~iv~l~~~~~~~----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------g~~~iv 382 (452)
||+++++++... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + |+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---iv 164 (337)
T 3mdy_A 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IA 164 (337)
T ss_dssp TBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EE
T ss_pred CeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EE
Confidence 999999999877 789999999999999999843 3589999999999999999999988 7 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccc--cccccccccccccccccccCCCcee------eeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEGVFSVN------RMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------~DvwSlG~il 452 (452)
||||||+|||++.++.+||+|||+++.+....... ......||+.|+|||++.+...+.+ +|||||||+|
T Consensus 165 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 242 (337)
T 3mdy_A 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242 (337)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHH
T ss_pred ecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHH
Confidence 99999999999999999999999997765433221 1234579999999999987766655 9999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=256.67 Aligned_cols=190 Identities=24% Similarity=0.270 Sum_probs=143.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-c-ccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-G-QGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~-~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|+....+|.|++|.|+.+ ....+++.||||++.... . ...+.+.+|...++.++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~ 66 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKM-------------------RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCT
T ss_pred HHhhhhHHhcCCCCCeEEEEE-------------------EecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCC
Confidence 357888899999999877654 455689999999997652 2 2233345555667888999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeE
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD-STKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVL 392 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NIl 392 (452)
||+++++++..++..++||||+++ +|.+++.. ......+++..++.++.||+.||.|||++ | |+||||||+||+
T Consensus 67 ~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil 142 (290)
T 3fme_A 67 FTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVL 142 (290)
T ss_dssp TBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCE
T ss_pred eEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEE
Confidence 999999999999999999999975 77666533 12456799999999999999999999998 8 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCcccccccccccccccccccc----ccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA----MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++....... .....||+.|+|||++ .+..++.++||||||++|
T Consensus 143 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 203 (290)
T 3fme_A 143 INALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203 (290)
T ss_dssp ECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHH
T ss_pred ECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHH
Confidence 99999999999999987644322 2234689999999996 566789999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=283.18 Aligned_cols=167 Identities=25% Similarity=0.363 Sum_probs=139.1
Q ss_pred ecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCH
Q 012989 279 LADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDW 356 (452)
Q Consensus 279 ~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~ 356 (452)
..+++.||||+++... ....+++.+|+.++++++||||+++++++.. +..++||||+++++|.+++. ....+++
T Consensus 393 ~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~---~~~~l~~ 468 (635)
T 4fl3_A 393 KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ---QNRHVKD 468 (635)
T ss_dssp SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH---HCTTCCH
T ss_pred CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh---hCCCCCH
Confidence 3467899999997652 3446789999999999999999999999865 45889999999999999994 3456999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcc-ccccccccccccccccccc
Q 012989 357 KRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAM 435 (452)
Q Consensus 357 ~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 435 (452)
.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .......||+.|+|||++.
T Consensus 469 ~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~ 545 (635)
T 4fl3_A 469 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 545 (635)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc
Confidence 999999999999999999999 999999999999999999999999999876544322 1222345688999999999
Q ss_pred cCCCceeeeeeeeeeeC
Q 012989 436 EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 436 ~~~~s~~~DvwSlG~il 452 (452)
+..++.++|||||||+|
T Consensus 546 ~~~~~~~sDvwSlGv~l 562 (635)
T 4fl3_A 546 YYKFSSKSDVWSFGVLM 562 (635)
T ss_dssp HCCCCHHHHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHH
Confidence 99999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=266.16 Aligned_cols=187 Identities=22% Similarity=0.318 Sum_probs=150.8
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
...+|+..+.+|.|++|.|+.+. ..++..||+|++...... ..+|+.+++.++|||
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~--------------------~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~n 93 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAK--------------------LVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPN 93 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEE--------------------ETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTT
T ss_pred ccceEEEeEEEeeCCCeEEEEEE--------------------ECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCC
Confidence 35689999999999998887552 234455899988654322 236999999999999
Q ss_pred ccceeeeEecCC------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++.... ..++||||++++.+............+++..++.++.||+.||+|||++| |+||||||+
T Consensus 94 iv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 170 (394)
T 4e7w_A 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQ 170 (394)
T ss_dssp BCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred cceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHH
Confidence 999999986433 38899999988655444322234567999999999999999999999999 999999999
Q ss_pred CeEEC-CCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 390 NVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||+|
T Consensus 171 Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 171 NLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232 (394)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 99999 789999999999987644332 2345789999999998764 589999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=264.98 Aligned_cols=203 Identities=15% Similarity=0.192 Sum_probs=159.8
Q ss_pred cEEEccccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHH
Q 012989 229 GRVRYPSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLI 308 (452)
Q Consensus 229 ~~i~~~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l 308 (452)
|.++.+.-.-+|++.+.+|.|++|.||.+....... .....+++.||||++... +.+.+|+.++
T Consensus 33 g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~-----------~~~~~~~~~vavK~~~~~-----~~~~~E~~~l 96 (352)
T 2jii_A 33 GTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLT-----------CDSGPQKQKFSLKLDAKD-----GRLFNEQNFF 96 (352)
T ss_dssp TCEEECTTSCEEEEEEEEEEETTEEEEEEEECC----------------------CEEEEEEETT-----STHHHHHHHH
T ss_pred CceeecccCCeEEEEEEecCCCCeEEEEEeecCCcc-----------ccccccCceEEEEEeccc-----chHHHHHHHH
Confidence 344444556799999999999999888664211000 000114889999998754 4688999999
Q ss_pred HcCCCCCccc---------------eeeeEec-CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 012989 309 AKLQHKNLVR---------------LLGCCLD-GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLY 372 (452)
Q Consensus 309 ~~l~h~~iv~---------------l~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~ 372 (452)
++++||||++ +++++.. +...++||||+ +++|.+++... ....+++.+++.++.||+.||.|
T Consensus 97 ~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp HHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHH
Confidence 9999999988 5666665 67899999999 99999999542 23679999999999999999999
Q ss_pred HhcCCCCCeEecCCCCCCeEECCCC--CeeEccccccccccCCCccc-----cccccccccccccccccccCCCceeeee
Q 012989 373 LHEDSRLRVIHRDLKTSNVLLDHEM--NPKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPEYAMEGVFSVNRMF 445 (452)
Q Consensus 373 LH~~g~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 445 (452)
||+++ |+||||||+|||++.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++||
T Consensus 175 LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 175 LHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp HHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred HHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99999 99999999999999998 89999999998765432211 1233578999999999999999999999
Q ss_pred eeeeeeC
Q 012989 446 LVSEFFF 452 (452)
Q Consensus 446 wSlG~il 452 (452)
||||++|
T Consensus 252 ~slG~il 258 (352)
T 2jii_A 252 QSLGYCM 258 (352)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=252.55 Aligned_cols=189 Identities=19% Similarity=0.261 Sum_probs=156.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+ .+..+++.||||++...... +.+.+|+.+++.++|+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~ 66 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLG-------------------TDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEE-------------------EETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTT
T ss_pred ccEEEEEEEEccCCCeEEEEE-------------------EEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCC
Confidence 458999999999999877754 44568999999998765432 468899999999998876
Q ss_pred cceeee-EecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE--
Q 012989 317 VRLLGC-CLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL-- 393 (452)
Q Consensus 317 v~l~~~-~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll-- 393 (452)
+..+.. .......++||||+ +++|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~ 140 (296)
T 3uzp_A 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGL 140 (296)
T ss_dssp CCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECC
T ss_pred CCccccccCCCCceEEEEEec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEec
Confidence 655554 46677899999999 8899998853 2356999999999999999999999999 9999999999999
Q ss_pred -CCCCCeeEccccccccccCCCccc-----cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 -DHEMNPKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 -~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||++|
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHH
Confidence 488899999999998765543221 12345789999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=262.47 Aligned_cols=182 Identities=25% Similarity=0.373 Sum_probs=151.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|.....+|.|++|.|+.+ .+..+++.||||++... .....+.+.+|+.+++.++|||
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 102 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSA-------------------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccEEEEeEEecCCCeEEEEE-------------------EECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCC
Confidence 48888899999999877754 45568999999999764 3334577889999999999999
Q ss_pred ccceeeeEecCCeE------EEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDGNEL------LLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~~~~------~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++...+.. ++||||++ ++|..++ ...+++..++.++.||+.||.|||++| |+||||||+
T Consensus 103 iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 173 (371)
T 4exu_A 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPG 173 (371)
T ss_dssp BCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred chhhhhheeccCCcccceeEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHH
Confidence 99999999877654 99999997 4777766 234999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||+|
T Consensus 174 NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (371)
T 4exu_A 174 NLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232 (371)
T ss_dssp GEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred HeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence 999999999999999999865332 234578999999999977 7789999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=262.67 Aligned_cols=187 Identities=25% Similarity=0.341 Sum_probs=147.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc-----------ccHHHHHHHH
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG-----------QGLQEFKNEV 305 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~-----------~~~~~~~~E~ 305 (452)
.-+|++...+|.|++|.|+.+. ..+++.||||++..... ...+.+.+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~--------------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 80 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGV--------------------DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEE--------------------CTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHH
T ss_pred ccceEEeEEeccCCCEEEEEEE--------------------CCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHH
Confidence 4589999999999998887552 24588999999865321 1237799999
Q ss_pred HHHHcCCCCCccceeeeEec-----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 306 TLIAKLQHKNLVRLLGCCLD-----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 306 ~~l~~l~h~~iv~l~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
.++++++||||+++++++.. ....++||||+++ +|.+.+. .....+++..++.++.||+.||.|||+++
T Consensus 81 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 154 (362)
T 3pg1_A 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAG--- 154 (362)
T ss_dssp HHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCc---
Confidence 99999999999999999853 3468999999985 6666664 23456999999999999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 155 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 9999999999999999999999999997543322 2234578999999999876 6789999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=251.57 Aligned_cols=186 Identities=21% Similarity=0.295 Sum_probs=156.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|+....+|.|++|.|+.+. .+++.||||++... .....+.+.+|+.++++++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~---------------------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 67 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGR---------------------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEE---------------------ETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCT
T ss_pred HHHhHHHHHhcCCCcceEEEEE---------------------ECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCC
Confidence 3588889999999998887552 25889999999765 334456799999999999999
Q ss_pred CccceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 315 NLVRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 315 ~iv~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||+++++++... ...++||||+++++|.+++... ....+++.+++.++.||+.||.|||+++ .+|+||||||+||+
T Consensus 68 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil 145 (271)
T 3kmu_A 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVM 145 (271)
T ss_dssp TEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEE
T ss_pred chhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEE
Confidence 999999999887 7899999999999999999542 2336999999999999999999999864 45999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCce---eeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV---NRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DvwSlG~il 452 (452)
++.++.++|.|||++.... .....||+.|+|||++.+..++. ++||||||++|
T Consensus 146 ~~~~~~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il 201 (271)
T 3kmu_A 146 IDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201 (271)
T ss_dssp ECTTSCEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHH
T ss_pred EcCCcceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHH
Confidence 9999999999988875422 12346799999999998765554 79999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=260.65 Aligned_cols=189 Identities=23% Similarity=0.340 Sum_probs=155.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++... .......+.+|+.+++.++|||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 70 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSA-------------------THKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccceEEeeEEcCCCCeEEEEE-------------------EECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCC
Confidence 458889999999999877754 44567999999999754 3334567889999999999999
Q ss_pred ccceeeeEecC-----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 316 LVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 316 iv~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|+++++++... ...++||||+++ +|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 71 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~N 142 (353)
T 2b9h_A 71 IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSN 142 (353)
T ss_dssp BCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred cCCeeeeecccccCccceEEEEEeccCc-cHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 99999987654 679999999974 88887743 46999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCccc--------ccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEA--------NTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||++.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213 (353)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHH
T ss_pred eEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHH
Confidence 999999999999999998765332111 1223578999999998764 7789999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=252.23 Aligned_cols=186 Identities=25% Similarity=0.400 Sum_probs=158.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|.|+.+ ....+++.||||++... .....+.+.+|+.++++++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~-------------------~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 82 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKC-------------------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTT
T ss_pred hcceeeEEEcCCCCEEEEEE-------------------EEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCC
Confidence 58999999999999877754 44557899999998754 3345678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++......++|||++++++|.+.+.. ...+++.+++.++.||+.||.|||+++ |+|+||||+||+++.
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLES 156 (287)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESC
T ss_pred ccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEec
Confidence 99999999999999999999999999887743 346899999999999999999999999 999999999999976
Q ss_pred C---CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 E---MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~---~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ +.+||+|||++........ .....||+.|+|||.+.+ .++.++||||||++|
T Consensus 157 ~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l 212 (287)
T 2wei_A 157 KEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212 (287)
T ss_dssp SSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHH
T ss_pred CCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHH
Confidence 4 4699999999987643322 223468999999998865 589999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=259.34 Aligned_cols=185 Identities=25% Similarity=0.317 Sum_probs=156.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHc--CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAK--LQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~--l~h~ 314 (452)
.-+|++.+.+|.|++|.|+.+. .+++.||||++... ....+.+|.++++. ++||
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~---------------------~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ 96 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGK---------------------WRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHE 96 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEE---------------------ETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCT
T ss_pred cccEEEEeeecCCCCcEEEEEE---------------------EcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCC
Confidence 3589999999999998887552 25899999998643 34667889999887 7899
Q ss_pred CccceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeE
Q 012989 315 NLVRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLH--------EDSRLRVI 382 (452)
Q Consensus 315 ~iv~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~g~~~iv 382 (452)
||+++++++.... ..++||||+++++|.+++.. ..+++.+++.++.||+.||.||| +.+ |+
T Consensus 97 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---iv 169 (342)
T 1b6c_B 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IA 169 (342)
T ss_dssp TBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EE
T ss_pred cEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---ee
Confidence 9999999998876 79999999999999999843 35899999999999999999999 788 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccc--cccccccccccccccccccC------CCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEG------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlG~il 452 (452)
||||||+|||++.++++||+|||+++......... ......||+.|+|||++.+. .++.++||||||++|
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence 99999999999999999999999998765443221 23345789999999999765 345789999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=275.86 Aligned_cols=188 Identities=24% Similarity=0.397 Sum_probs=156.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++...+|.|++|.|+.+. ..++..||||+++... ...+.|.+|+++|++++||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~--------------------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv 325 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGT--------------------WNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 325 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEE--------------------ETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhheecccCCCeEEEEEE--------------------ECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEe
Confidence 467777888888888776542 3446779999997653 3457899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++.. ...+|||||+++++|.+++... ....+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++
T Consensus 326 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~ 400 (535)
T 2h8h_A 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENL 400 (535)
T ss_dssp CEEEEECS-SSCEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred eEEEEEee-ccceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCC
Confidence 99999876 6789999999999999998432 2345899999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++....... .......+|..|+|||++.++.++.++||||||++|
T Consensus 401 ~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l 454 (535)
T 2h8h_A 401 VCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454 (535)
T ss_dssp CEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHH
Confidence 999999999987543211 112233568899999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=255.83 Aligned_cols=194 Identities=25% Similarity=0.309 Sum_probs=150.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++.+.+|.|++|.|+.+.... ....+..||||++... .....+.+.+|+.++++++|
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 80 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDA----------------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEEC----------------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC
T ss_pred hhHeeeeeeecCCCceeEEEEEecc----------------CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC
Confidence 4589999999999999888653100 0112346899998754 23456789999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++..+. .++||||+++++|.+++... ...+++.+++.++.||+.||.|||+++ |+|+||||+||++
T Consensus 81 ~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili 154 (291)
T 1u46_A 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLL 154 (291)
T ss_dssp TTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCcccEEEEEccCC-ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEE
Confidence 99999999998765 88999999999999988542 345899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||++|
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 999999999999998765443221 22334678899999999988999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=260.72 Aligned_cols=190 Identities=20% Similarity=0.232 Sum_probs=143.5
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.-+|++...+|.|++|.|+.+ ....+++.||||++.... .......+|++.++.++||||
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~ni 81 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLG-------------------KEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNI 81 (360)
T ss_dssp HTTEEEC----------CEEE-------------------EETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTB
T ss_pred ccceEEEEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCc
Confidence 347888888999999887755 445678999999986543 333566788888999999999
Q ss_pred cceeeeEecCC-------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEecCCC
Q 012989 317 VRLLGCCLDGN-------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLH--EDSRLRVIHRDLK 387 (452)
Q Consensus 317 v~l~~~~~~~~-------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH--~~g~~~ivH~Dlk 387 (452)
+++++++.... ..++||||++++.+..+.........+++..++.++.||+.||.||| +++ |+|||||
T Consensus 82 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlk 158 (360)
T 3e3p_A 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIK 158 (360)
T ss_dssp CCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCC
T ss_pred ccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCC
Confidence 99999987533 38899999987533332222235567899999999999999999999 888 9999999
Q ss_pred CCCeEECC-CCCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 388 TSNVLLDH-EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
|+|||++. ++.+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||+|
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 222 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 99999997 89999999999987654332 23457899999999986654 89999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=256.01 Aligned_cols=186 Identities=20% Similarity=0.288 Sum_probs=157.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEE-ecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCC-
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGI-LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK- 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~-~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~- 314 (452)
.-||++...+|.|++|.|+.+ .+ ..+++.||||++... ....+.+.+|+.+++.++|+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~ 72 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVEC-------------------IDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTD 72 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEE-------------------EETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHC
T ss_pred cCceEEEEEEecCCCeEEEEE-------------------EecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcC
Confidence 348999999999999888755 22 346899999998644 34457788999999998655
Q ss_pred -----CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 315 -----NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 315 -----~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++++++++...++.++||||+ +++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+
T Consensus 73 ~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 147 (339)
T 1z57_A 73 PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPE 147 (339)
T ss_dssp TTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred CCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 4999999999999999999999 78898888543 2346899999999999999999999999 999999999
Q ss_pred CeEECC-------------------CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeee
Q 012989 390 NVLLDH-------------------EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEF 450 (452)
Q Consensus 390 NIll~~-------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 450 (452)
|||++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||
T Consensus 148 Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 222 (339)
T 1z57_A 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGC 222 (339)
T ss_dssp GEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHH
T ss_pred HEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHH
Confidence 999987 668999999999764322 23457899999999999999999999999999
Q ss_pred eC
Q 012989 451 FF 452 (452)
Q Consensus 451 il 452 (452)
+|
T Consensus 223 il 224 (339)
T 1z57_A 223 IL 224 (339)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=258.55 Aligned_cols=182 Identities=25% Similarity=0.369 Sum_probs=151.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|.....+|.|++|.|+.+ .+..+|+.||||++... .....+.+.+|+.+++.++|||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 84 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSA-------------------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred ceEEEeeeEecCCCeEEEEE-------------------EECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCC
Confidence 47888899999999877754 45568999999999754 2334567899999999999999
Q ss_pred ccceeeeEecCCe------EEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLDGNE------LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~~~~------~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++..... .++||||+++ +|.+++ ...+++.+++.++.||+.||.|||++| |+||||||+
T Consensus 85 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~ 155 (353)
T 3coi_A 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPG 155 (353)
T ss_dssp BCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGG
T ss_pred cccHhheEecccccccceeEEEEeccccC-CHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 9999999987654 5999999974 777766 234999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||||++|
T Consensus 156 NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 214 (353)
T 3coi_A 156 NLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214 (353)
T ss_dssp GEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred HEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence 999999999999999999864322 234578999999999876 6789999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=282.15 Aligned_cols=180 Identities=22% Similarity=0.291 Sum_probs=150.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEec-CCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILA-DGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~-~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|.||.+ .+.. +++.||||++... .....+.+.+|+.++++++|||
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a-------------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 140 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLA-------------------LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEE-------------------EEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTT
T ss_pred CceEEEEEEeeCCCeEEEEE-------------------EEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCC
Confidence 57888888888888777644 3433 6899999998654 3344567899999999999999
Q ss_pred ccceeeeEecCCe-----EEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 316 LVRLLGCCLDGNE-----LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 316 iv~l~~~~~~~~~-----~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|+++++++...+. .||||||++|++|.+++. ..+++.+++.|+.||+.+|.|||++| |+||||||+|
T Consensus 141 iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~N 212 (681)
T 2pzi_A 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPEN 212 (681)
T ss_dssp BCCEEEEEEEECTTSCEEEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred cCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHH
Confidence 9999999987655 799999999999988762 26999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.+ .+||+|||+++..... ....||+.|+|||++.++. +.++|||||||+|
T Consensus 213 Ill~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l 266 (681)
T 2pzi_A 213 IMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTL 266 (681)
T ss_dssp EEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHH
T ss_pred eEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHH
Confidence 999885 8999999999875432 3457899999999987654 8999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=253.91 Aligned_cols=185 Identities=26% Similarity=0.369 Sum_probs=150.0
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..-+|++...+|.|++|.|+.+. .+++.||||++.... ..+.+.+|+.++++++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~---------------------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~ 75 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGD---------------------YRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSN 75 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEE---------------------ETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTT
T ss_pred ChhhceEEeEEecCCCceEEEEE---------------------EcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCC
Confidence 35689999999999998887542 358899999987543 4578999999999999999
Q ss_pred ccceeeeEecC-CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 316 LVRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 316 iv~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|+++++++... +..++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 76 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~ 151 (278)
T 1byg_A 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVS 151 (278)
T ss_dssp BCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEe
Confidence 99999987654 5799999999999999988432 1223889999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||++....... ....+++.|+|||.+.+..++.++||||||++|
T Consensus 152 ~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 204 (278)
T 1byg_A 152 EDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204 (278)
T ss_dssp TTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHH
Confidence 99999999999987644321 223568899999999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-31 Score=265.34 Aligned_cols=184 Identities=10% Similarity=0.083 Sum_probs=137.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc---ccHHHHHHHHHHHHcC--CC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG---QGLQEFKNEVTLIAKL--QH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l--~h 313 (452)
.|+....+|.|++|.|+.+ .+..+++.||||++..... ...+.+.+|+.+++.| +|
T Consensus 63 ~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~h 123 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLV-------------------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123 (371)
T ss_dssp EEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC--
T ss_pred eeeeeeeccCCCCEEEEEE-------------------EECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccC
Confidence 4888999999999887755 4456899999999987532 3455678886555555 69
Q ss_pred CCcccee-------eeEecC-----------------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHH------HHHH
Q 012989 314 KNLVRLL-------GCCLDG-----------------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRR------ISII 363 (452)
Q Consensus 314 ~~iv~l~-------~~~~~~-----------------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~------~~i~ 363 (452)
|||++++ +.+... ..++|||||++ ++|.+++... ...+++..+ +.++
T Consensus 124 p~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~ 200 (371)
T 3q60_A 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILT 200 (371)
T ss_dssp --------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHH
T ss_pred hhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHH
Confidence 9988755 444332 34899999998 7999988542 223444455 6777
Q ss_pred HHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccccccc--CCCce
Q 012989 364 NGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME--GVFSV 441 (452)
Q Consensus 364 ~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ 441 (452)
.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.
T Consensus 201 ~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~ 272 (371)
T 3q60_A 201 AQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTH 272 (371)
T ss_dssp HHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCH
T ss_pred HHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCc
Confidence 99999999999999 999999999999999999999999999865322 113456799999999987 77999
Q ss_pred eeeeeeeeeeC
Q 012989 442 NRMFLVSEFFF 452 (452)
Q Consensus 442 ~~DvwSlG~il 452 (452)
++|||||||+|
T Consensus 273 ~~DiwSlG~il 283 (371)
T 3q60_A 273 ALNAWQLGLSI 283 (371)
T ss_dssp HHHHHHHHHHH
T ss_pred cccHHHHHHHH
Confidence 99999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-31 Score=267.08 Aligned_cols=190 Identities=17% Similarity=0.254 Sum_probs=157.5
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCC-C
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH-K 314 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h-~ 314 (452)
..-+|++...+|.|++|.||.+ ....+++.||||++...... +.+.+|+++++.|+| +
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a-------------------~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~ 63 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLG-------------------TNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGT 63 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEE-------------------EETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTST
T ss_pred cCCcEEEEEEEeeCCCEEEEEE-------------------EECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCC
Confidence 3457888888888888777644 45568999999988755332 458899999999976 5
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE-
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL- 393 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll- 393 (452)
+++.+..++......+|||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+|||+
T Consensus 64 ~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~ 137 (483)
T 3sv0_A 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMG 137 (483)
T ss_dssp TCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred CCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEe
Confidence 6666777777888999999999 8899998853 2456999999999999999999999999 9999999999999
Q ss_pred --CCCCCeeEccccccccccCCCccc-----cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 --DHEMNPKISDFGMARIFSGNQNEA-----NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 --~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||||
T Consensus 138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil 203 (483)
T 3sv0_A 138 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL 203 (483)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHH
Confidence 688999999999998776543321 12356899999999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-31 Score=254.07 Aligned_cols=190 Identities=27% Similarity=0.413 Sum_probs=156.4
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEe-cCCeeeEEEEeecCC--cccHHHHHHHHHHHHcC-
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGIL-ADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKL- 311 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~-~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l- 311 (452)
..-+|++...+|.|++|.|+.+. .. .+++.||||++.... ......+.+|+.+++.+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~ 69 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKAR-------------------DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEE-------------------ETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHH
T ss_pred chhceeeeeeecccccEEEEEEE-------------------ecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhh
Confidence 34689999999999998887552 32 468899999987542 22234567788877776
Q ss_pred --CCCCccceeeeEe-----cCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 012989 312 --QHKNLVRLLGCCL-----DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384 (452)
Q Consensus 312 --~h~~iv~l~~~~~-----~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~ 384 (452)
+||||+++++++. .....++||||++ ++|.+++... ....+++..++.++.||+.||.|||++| |+||
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~ 144 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHR 144 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 8999999999987 5567999999998 4898888543 2345899999999999999999999999 9999
Q ss_pred CCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 385 DLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 385 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||++|
T Consensus 145 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 209 (326)
T 1blx_A 145 DLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 209 (326)
T ss_dssp CCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHH
Confidence 999999999999999999999998654322 23345789999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-31 Score=254.49 Aligned_cols=189 Identities=21% Similarity=0.310 Sum_probs=151.8
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCC-
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQ- 312 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~- 312 (452)
...+|++...+|.|++|.|+.+. ..+++.||||++... .....+.+.+|+.++++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~--------------------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~ 85 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVL--------------------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEE--------------------CTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG
T ss_pred ccceEEEEEEecCCCCEEEEEEE--------------------cCCCcEEEEEEeccccccccchHHHHHHHHHHHhccc
Confidence 34689999999999998887552 245889999999754 3345677899999999997
Q ss_pred -CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 313 -HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 313 -h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
||||+++++++..+...++||| +.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 86 ~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 158 (313)
T 3cek_A 86 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANF 158 (313)
T ss_dssp GCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccE
Confidence 5999999999999999999999 567899998843 456899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCcccccccccccccccccccccc-----------CCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-----------GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwSlG~il 452 (452)
|++. +.+||+|||+++.+.............||+.|+|||++.+ ..++.++||||||++|
T Consensus 159 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il 229 (313)
T 3cek_A 159 LIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229 (313)
T ss_dssp EEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHH
T ss_pred EEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHH
Confidence 9964 8899999999987654443333345678999999999865 4788999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=273.31 Aligned_cols=191 Identities=25% Similarity=0.346 Sum_probs=162.2
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-||++...+|.|++|.|+.+.. ..+++.||||++... .....+.+.+|+.++++++|||
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~-------------------~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~Hpn 73 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIH-------------------QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCC-------------------TTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEE-------------------CCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCC
Confidence 36899999999999999998743 346889999998764 4445677999999999999999
Q ss_pred ccceeeeEec------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLD------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|+++++++.. .+..++||||+++++|.+++........+++..++.++.||+.||.|||+.| |+||||||+
T Consensus 74 IV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~ 150 (676)
T 3qa8_A 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPE 150 (676)
T ss_dssp BCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCST
T ss_pred CCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHH
Confidence 9999998765 6778999999999999999976555557999999999999999999999999 999999999
Q ss_pred CeEECCCCC---eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMN---PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+++.++. +||+|||++........ .....||+.|+|||++.+..++.++||||||++|
T Consensus 151 NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviL 213 (676)
T 3qa8_A 151 NIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213 (676)
T ss_dssp TEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHH
T ss_pred HeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHH
Confidence 999997765 89999999987654322 2345789999999999999999999999999975
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=206.73 Aligned_cols=106 Identities=19% Similarity=0.489 Sum_probs=97.7
Q ss_pred CCcccccCCCCCccCCCChhHHHHHHHHHHHhhcccCCCCCCcccCeeeeccCC-CCCeEEEEEeccCCCCccchHHHHH
Q 012989 25 KPTYIYHNCPSTNFTPNSAYQSNLNLLLSTLRSNATRGSSDKFSKGFYNTTAGH-EPNKVYGLFLCRGDLGTENCQSCVN 103 (452)
Q Consensus 25 ~~~~~~~~C~~~~~~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~~~f~~~~~g~-~~~~vyg~~~C~~D~~~~~C~~Cl~ 103 (452)
.+.++++.|++++|+++++|++||+.||++|+++++.++ .+|++...|. ++++||||+|||+|+++++|..||+
T Consensus 2 ~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~-----~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~ 76 (108)
T 3a2e_A 2 NTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSG-----YDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLS 76 (108)
T ss_dssp CCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTT-----SEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHH
T ss_pred CcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCcccc-----CCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHH
Confidence 568999999999999999999999999999999987652 5677777664 4589999999999999999999999
Q ss_pred HHHHHHhhhCCCCceEEEEccceEEEEcCCCc
Q 012989 104 FATSETAQLCPFGKEYIIGYEECLLRYSNISF 135 (452)
Q Consensus 104 ~a~~~~~~~C~~~~~a~~~~~~C~lry~~~~f 135 (452)
.|+.+++++||++++|+||++.|+||||+++|
T Consensus 77 ~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 77 NLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=262.39 Aligned_cols=167 Identities=28% Similarity=0.412 Sum_probs=129.4
Q ss_pred cCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccceeeeEe--cCCeEEEEEEecCCCChhhhhccC------CCC
Q 012989 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL--DGNELLLIYEYMPNKSLDLFLFDS------TKG 351 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~~lv~E~~~~~~L~~~l~~~------~~~ 351 (452)
.+++.||||++.... ....+.+|+.+|+.++||||+++++++. .....++||||+++ +|.+++... ...
T Consensus 46 ~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 122 (405)
T 3rgf_A 46 KDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122 (405)
T ss_dssp SCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-----
T ss_pred CCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccc
Confidence 468899999997543 2357889999999999999999999995 46789999999976 666655321 122
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----CCCCCeeEccccccccccCCCc-ccccccccccc
Q 012989 352 AQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL----DHEMNPKISDFGMARIFSGNQN-EANTNRVVGTY 426 (452)
Q Consensus 352 ~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~ 426 (452)
..+++..++.|+.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+..... ........||+
T Consensus 123 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~ 199 (405)
T 3rgf_A 123 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199 (405)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecC
Confidence 35999999999999999999999999 9999999999999 6778999999999987654321 12234468899
Q ss_pred cccccccccc-CCCceeeeeeeeeeeC
Q 012989 427 GYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 427 ~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
.|+|||++.+ ..++.++|||||||||
T Consensus 200 ~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 200 WYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp TTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred cccCchhhcCCCcccchhhhHHHHHHH
Confidence 9999999987 4589999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-31 Score=277.38 Aligned_cols=193 Identities=21% Similarity=0.295 Sum_probs=156.6
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
..+|++...+|.|++|.|+.+.... ....+..||||++... .....+.+.+|+.++++++|||
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~Hpn 452 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMS----------------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECC----------------SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccEEEeeEEeeCCCEEEEEEEEec----------------CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCC
Confidence 4678888999999999888663211 1124678999998754 3344577999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++. ++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 453 Iv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~ 526 (656)
T 2j0j_A 453 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSS 526 (656)
T ss_dssp BCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEE
T ss_pred CCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeC
Confidence 999999985 4568999999999999999853 2346899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++|
T Consensus 527 ~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 582 (656)
T 2j0j_A 527 NDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 582 (656)
T ss_dssp TTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHH
Confidence 99999999999987644322 122234568899999999989999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=261.48 Aligned_cols=187 Identities=22% Similarity=0.321 Sum_probs=145.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
..+|+....+|.|++|.|+ + ....+++.||||++...... .+.+|+.+++.+ +|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~-------------------~-~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~Hpn 79 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIV-------------------Y-RGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPN 79 (432)
T ss_dssp TEEEEEEEEEEECGGGCEE-------------------E-EEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTT
T ss_pred cEEEecCCeeecCcCEEEE-------------------E-EEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCC
Confidence 3579999999999998753 1 33457899999999754332 356899999999 7999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++......+||||++++ +|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 80 Iv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 80 VIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISM 153 (432)
T ss_dssp BCCEEEEEEETTEEEEEEECCSE-EHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECC
T ss_pred cCeEEEEEecCCEEEEEEECCCC-CHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEec
Confidence 99999999999999999999975 888888542 233555567899999999999999999 999999999999953
Q ss_pred -----CCCeeEccccccccccCCCcc-ccccccccccccccccccc---cCCCceeeeeeeeeeeC
Q 012989 396 -----EMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAM---EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 -----~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwSlG~il 452 (452)
...+||+|||+++........ .......||+.|+|||++. ...++.++|||||||+|
T Consensus 154 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il 219 (432)
T 3p23_A 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219 (432)
T ss_dssp CBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred CCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence 235789999999876543221 2233467999999999997 46678899999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-31 Score=255.28 Aligned_cols=190 Identities=19% Similarity=0.278 Sum_probs=159.4
Q ss_pred cccCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc------cHHHHHHHHHH
Q 012989 234 PSCNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ------GLQEFKNEVTL 307 (452)
Q Consensus 234 ~~c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~------~~~~~~~E~~~ 307 (452)
....-+|++.+.+|.|++|.||.+ ....+++.||||++...... ..+.+.+|+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 99 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSG-------------------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 99 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEE-------------------EETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHH
T ss_pred CCccCceEEEEEEeeCCCeEEEEE-------------------EECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHH
Confidence 345678999999999999877755 44568999999999765321 22457789999
Q ss_pred HHcCC--CCCccceeeeEecCCeEEEEEEecCC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 012989 308 IAKLQ--HKNLVRLLGCCLDGNELLLIYEYMPN-KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384 (452)
Q Consensus 308 l~~l~--h~~iv~l~~~~~~~~~~~lv~E~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~ 384 (452)
+++++ ||||+++++++..++..++|||++.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||
T Consensus 100 l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 173 (320)
T 3a99_A 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHR 173 (320)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeC
Confidence 99996 59999999999999999999999976 899988843 456899999999999999999999999 9999
Q ss_pred CCCCCCeEEC-CCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 385 DLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 385 Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
||||+|||++ .++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||++|
T Consensus 174 Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 239 (320)
T 3a99_A 174 DIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHH
Confidence 9999999999 77899999999998765332 233568999999999977665 7889999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=256.24 Aligned_cols=186 Identities=22% Similarity=0.264 Sum_probs=155.3
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CC-
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HK- 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~- 314 (452)
.-||++...+|.|++|.|+.+ .+..+++.||||++... ......+..|+.+++.++ |+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~ 112 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKA-------------------YDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDT 112 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEE-------------------EETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSS
T ss_pred eeeEEEEEEEeecCCEEEEEE-------------------EEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhccc
Confidence 458999999999999887755 44567899999999743 334566788999998885 54
Q ss_pred ----CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCCCeEecCCCC
Q 012989 315 ----NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKT 388 (452)
Q Consensus 315 ----~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~--~g~~~ivH~Dlkp 388 (452)
+|+++++.+...++.++||||+++ +|.+++... ....+++..++.++.||+.||.|||. .+ |+||||||
T Consensus 113 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp 187 (382)
T 2vx3_A 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKP 187 (382)
T ss_dssp GGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSG
T ss_pred ccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCc
Confidence 499999999999999999999965 888888543 23459999999999999999999994 56 99999999
Q ss_pred CCeEEC--CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLD--HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~--~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 188 ~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 248 (382)
T 2vx3_A 188 ENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCIL 248 (382)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred ccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHH
Confidence 999995 4778999999999876432 2345789999999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=253.72 Aligned_cols=186 Identities=19% Similarity=0.274 Sum_probs=153.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCC-eeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADG-KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-||++...+|.|++|.|+.+ ....++ +.||||++... ....+.+.+|+.+++.++|++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~ 77 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVEC-------------------LDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKD 77 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEE-------------------EETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHC
T ss_pred cccEEEEEEeeccCCeEEEEE-------------------EecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcC
Confidence 569999999999999888755 233344 78999998643 344567889999999997655
Q ss_pred ------ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 ------LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 ------iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
++.+++++....+.++||||+.+ +|.+.+.. .....+++.+++.++.||+.||.|||+++ |+||||||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~ 152 (355)
T 2eu9_A 78 KENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPE 152 (355)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEEECCCC-BHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGG
T ss_pred CCCceeEEEeeeeeeeCCeEEEEEeccCC-ChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 89999999999999999999955 55555533 23346999999999999999999999999 999999999
Q ss_pred CeEE-------------------CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeee
Q 012989 390 NVLL-------------------DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEF 450 (452)
Q Consensus 390 NIll-------------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~ 450 (452)
|||+ +.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||
T Consensus 153 NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 227 (355)
T 2eu9_A 153 NILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGC 227 (355)
T ss_dssp GEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHH
Confidence 9999 56788999999999764322 23457899999999999999999999999999
Q ss_pred eC
Q 012989 451 FF 452 (452)
Q Consensus 451 il 452 (452)
+|
T Consensus 228 il 229 (355)
T 2eu9_A 228 IL 229 (355)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=252.42 Aligned_cols=190 Identities=22% Similarity=0.262 Sum_probs=136.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHH-HHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVT-LIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~-~l~~l~h~ 314 (452)
.-+|+....+|.|++|.|+.+ ....+++.||||++.... ......+..|+. +++.++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~ 81 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKM-------------------VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEE-------------------EETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCT
T ss_pred HHHhhehheeccCCCEEEEEE-------------------EEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCC
Confidence 457777888888888777644 455679999999997653 333445566666 67778999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCe
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFD--STKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNV 391 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NI 391 (452)
||+++++++..++..++||||+++ +|.+++.. ......+++..++.++.|++.||.|||+. + |+||||||+||
T Consensus 82 niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NI 157 (327)
T 3aln_A 82 YIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNI 157 (327)
T ss_dssp TBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGE
T ss_pred cEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHE
Confidence 999999999999999999999986 77666632 11246799999999999999999999998 8 99999999999
Q ss_pred EECCCCCeeEccccccccccCCCcccccccccccccccccccc----ccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA----MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||+++.+..... .....||+.|+|||++ .+..++.++||||||++|
T Consensus 158 ll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 158 LLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp EEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHH
T ss_pred EEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence 999999999999999987643321 2234689999999998 466789999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=252.46 Aligned_cols=185 Identities=21% Similarity=0.223 Sum_probs=133.6
Q ss_pred Cccccc-eeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 237 NFRYEL-YQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 237 ~~ry~~-~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.-+|++ .+.+|.|++|.|+.+ .+..+++.||||++.... ....+....++.++|||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~ 83 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLEC-------------------FHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPH 83 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTT
T ss_pred cceeEecceeeeeCCCeEEEEE-------------------EECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCC
Confidence 457887 457899999877754 455679999999986531 22223334466779999
Q ss_pred ccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 316 LVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 316 iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
|+++++++.. +...++||||+++++|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 84 i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NI 159 (336)
T 3fhr_A 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENL 159 (336)
T ss_dssp BCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred hHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999886 45689999999999999998542 2356999999999999999999999999 99999999999
Q ss_pred EECCC---CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHE---MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.+ +.+||+|||+++...... .....||+.|+|||++.+..++.++||||||++|
T Consensus 160 ll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 219 (336)
T 3fhr_A 160 LYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219 (336)
T ss_dssp EESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHH
T ss_pred EEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHH
Confidence 99864 459999999998654322 2345789999999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=260.32 Aligned_cols=188 Identities=25% Similarity=0.280 Sum_probs=141.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 316 (452)
-+|.....+|.|++|+|+ + ....+|+.||||++... ..+.+.+|+.+++++ +||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~-------------------~-~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnI 71 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVV-------------------F-QGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNV 71 (434)
T ss_dssp SCEEEEEEEEECSTTCEE-------------------E-EEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTB
T ss_pred heeeccCeEeeCCCeEEE-------------------E-EEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCc
Confidence 356666778888887664 2 23457899999998654 245678999999886 89999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGA----QLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
+++++.+..+...++||||++ ++|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 72 v~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NIL 147 (434)
T 2rio_A 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNIL 147 (434)
T ss_dssp CCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEE
Confidence 999999999999999999996 59999885432211 1133456789999999999999999 999999999999
Q ss_pred ECCC-------------CCeeEccccccccccCCCccc--ccccccccccccccccccc-------CCCceeeeeeeeee
Q 012989 393 LDHE-------------MNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAME-------GVFSVNRMFLVSEF 450 (452)
Q Consensus 393 l~~~-------------~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwSlG~ 450 (452)
++.+ +.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 148 l~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~ 227 (434)
T 2rio_A 148 VSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227 (434)
T ss_dssp EECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHH
T ss_pred EecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHH
Confidence 9754 479999999998765443221 2234579999999999965 67899999999999
Q ss_pred eC
Q 012989 451 FF 452 (452)
Q Consensus 451 il 452 (452)
+|
T Consensus 228 il 229 (434)
T 2rio_A 228 VF 229 (434)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=256.61 Aligned_cols=187 Identities=18% Similarity=0.294 Sum_probs=156.5
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC---
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ--- 312 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~--- 312 (452)
..-||++...+|.|++|.|+.+ .+..+++.||||++... ....+.+.+|+.++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~ 76 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLA-------------------KDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDAD 76 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTC
T ss_pred cCCeEEEEEeeeecCCeEEEEE-------------------EecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhccc
Confidence 3468999999999999877754 45568999999998643 334567889999999886
Q ss_pred --------CCCccceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCC
Q 012989 313 --------HKNLVRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-SRL 379 (452)
Q Consensus 313 --------h~~iv~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~ 379 (452)
||||+++++++.... ..++|||++ +++|.+++... ....+++..++.++.||+.||+|||++ |
T Consensus 77 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~-- 152 (373)
T 1q8y_A 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG-- 152 (373)
T ss_dssp CSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--
T ss_pred ccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC--
Confidence 889999999998654 799999999 88998888543 334599999999999999999999998 8
Q ss_pred CeEecCCCCCCeEEC------CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 380 RVIHRDLKTSNVLLD------HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+|||++ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||++|
T Consensus 153 -ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 225 (373)
T 1q8y_A 153 -IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 225 (373)
T ss_dssp -EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHH
T ss_pred -EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHH
Confidence 99999999999994 3447999999999875432 2234789999999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-31 Score=254.73 Aligned_cols=188 Identities=24% Similarity=0.345 Sum_probs=149.7
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-+|++...+|.|++|.|+.+. ++..+|+|++... .....+.+.+|+.++++++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~----------------------~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 89 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGR----------------------WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEE----------------------ESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCT
T ss_pred HHHeEEeeEeccCCceEEEEEE----------------------EcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCC
Confidence 3567888888888888777542 1335999998754 233345678899999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++......++||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||+++
T Consensus 90 ~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~ 164 (319)
T 2y4i_B 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD 164 (319)
T ss_dssp TBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC
T ss_pred CEeEEEEEEecCCceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe
Confidence 999999999999999999999999999999843 3346899999999999999999999999 99999999999998
Q ss_pred CCCCeeEccccccccccCCC---cccccccccccccccccccccc---------CCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQ---NEANTNRVVGTYGYMAPEYAME---------GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++...... .........||+.|+|||++.+ ..++.++||||||++|
T Consensus 165 -~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp ---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred -CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 6899999999987643221 1122233468999999999864 4578999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-31 Score=253.41 Aligned_cols=188 Identities=21% Similarity=0.338 Sum_probs=150.4
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc------cHHHHHHHHHHHH
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ------GLQEFKNEVTLIA 309 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~------~~~~~~~E~~~l~ 309 (452)
-.-+|++.+.+|.|++|.||.+ .+..+++.||||++...... ....+.+|+.++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~ 89 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAG-------------------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEE-------------------ECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHH
T ss_pred hhhceEEeeEEEcCCCEEEEEE-------------------EEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHH
Confidence 3568999999999999887755 34457899999999755321 2234567999999
Q ss_pred cC----CCCCccceeeeEecCCeEEEEEEe-cCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 012989 310 KL----QHKNLVRLLGCCLDGNELLLIYEY-MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHR 384 (452)
Q Consensus 310 ~l----~h~~iv~l~~~~~~~~~~~lv~E~-~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~ 384 (452)
++ +||||+++++++...+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||+|||+++ |+||
T Consensus 90 ~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 163 (312)
T 2iwi_A 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHR 163 (312)
T ss_dssp HHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECC
T ss_pred hhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 98 899999999999999999999999 789999998843 346999999999999999999999999 9999
Q ss_pred CCCCCCeEEC-CCCCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 385 DLKTSNVLLD-HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 385 Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
||||+||+++ .++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||++|
T Consensus 164 dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 229 (312)
T 2iwi_A 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229 (312)
T ss_dssp CCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred CCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHH
Confidence 9999999999 78999999999998765432 234568999999999977666 5589999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=247.81 Aligned_cols=189 Identities=21% Similarity=0.293 Sum_probs=138.5
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc-cc-HHHHHHHHHHHHcCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG-QG-LQEFKNEVTLIAKLQH 313 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~-~~-~~~~~~E~~~l~~l~h 313 (452)
-.-+|+....+|.|++|.|+.+ ....+++.||||++..... .. .+.+.++..+++.++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h 83 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKM-------------------RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83 (318)
T ss_dssp CGGGEEEEEEC------CEEEE-------------------EETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTC
T ss_pred hhccccccceeeecCCeeEEEE-------------------EEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCC
Confidence 3457888888999998777654 4456799999999976532 22 2334555567888899
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-SRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-g~~~ivH~Dlkp~NIl 392 (452)
|||+++++++..++..++||||+ ++.+..+... ....+++..++.++.||+.||.|||+. + |+|+||||+||+
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil 157 (318)
T 2dyl_A 84 PYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNIL 157 (318)
T ss_dssp TTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEE
T ss_pred CceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEE
Confidence 99999999999999999999999 5555555422 245699999999999999999999985 8 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||++..+..... .....||+.|+|||++. ...++.++||||||++|
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 219 (318)
T 2dyl_A 158 LDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219 (318)
T ss_dssp ECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHH
T ss_pred ECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHH
Confidence 99999999999999976544322 23346899999999984 56688999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=232.54 Aligned_cols=160 Identities=15% Similarity=0.050 Sum_probs=137.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-||++...+|.|++|.||.+ .+..+++.||||++.... ....+.+.+|+.++++++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a-------------------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 90 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQA-------------------LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEE-------------------EETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC
T ss_pred cCcEEEEEEEcccCCeEEEEE-------------------EecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC
Confidence 358999999999999877755 445679999999997653 2334778999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++..++..|+||||++|++|.+++.. . ....++..|+.||+.||+|||++| |+||||||+|||+
T Consensus 91 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll 162 (286)
T 3uqc_A 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRV 162 (286)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEE
T ss_pred CCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEE
Confidence 9999999999999999999999999999999832 2 356678999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++.+||++++ |++ .++.++|||||||+|
T Consensus 163 ~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il 192 (286)
T 3uqc_A 163 SIDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASL 192 (286)
T ss_dssp ETTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHH
T ss_pred cCCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHH
Confidence 999999998543 333 368899999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=228.35 Aligned_cols=166 Identities=20% Similarity=0.252 Sum_probs=138.3
Q ss_pred ccCccccce-eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHH-HcCC
Q 012989 235 SCNFRYELY-QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLI-AKLQ 312 (452)
Q Consensus 235 ~c~~ry~~~-~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l-~~l~ 312 (452)
...-+|++. +.+|.|++|.|+.+ .+..+++.||||++... ..+.+|+.++ +.++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~-------------------~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~ 69 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQI-------------------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQ 69 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTT
T ss_pred ccccchhhcCcccccCCCeEEEEE-------------------EEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhcc
Confidence 344567765 77888888777654 45568999999998643 5677899888 5569
Q ss_pred CCCccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 313 HKNLVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 313 h~~iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
||||+++++++.. ....++||||+++++|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||
T Consensus 70 h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp 145 (299)
T 3m2w_A 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 145 (299)
T ss_dssp STTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCH
Confidence 9999999999887 67899999999999999998653 3346999999999999999999999999 99999999
Q ss_pred CCeEECC---CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 389 SNVLLDH---EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||++. ++.+||+|||++.... +..++.++|||||||+|
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il 188 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIM 188 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHH
T ss_pred HHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHH
Confidence 9999998 7889999999986432 24568899999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-28 Score=244.40 Aligned_cols=185 Identities=17% Similarity=0.171 Sum_probs=139.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC-C
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH-K 314 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h-~ 314 (452)
.|...+.+|.|++|.||.+ .+..+|+.||||++.... ....+.+.+|+.+++.++| +
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a-------------------~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~ 139 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEA-------------------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139 (413)
T ss_dssp EEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCC
T ss_pred eEEEecccccCCCEEEEEE-------------------EecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCC
Confidence 3667788999999887755 455689999999987432 2336789999999999987 3
Q ss_pred Cccce---------e------------eeEec-----CCeEEEEEEecCCCChhhhhcc----CCCCCCCCHHHHHHHHH
Q 012989 315 NLVRL---------L------------GCCLD-----GNELLLIYEYMPNKSLDLFLFD----STKGAQLDWKRRISIIN 364 (452)
Q Consensus 315 ~iv~l---------~------------~~~~~-----~~~~~lv~E~~~~~~L~~~l~~----~~~~~~l~~~~~~~i~~ 364 (452)
|...+ . ..+.. ...++++|+.. +++|.+++.. ......+++..++.++.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~ 218 (413)
T 3dzo_A 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTL 218 (413)
T ss_dssp SHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHH
T ss_pred CHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHH
Confidence 22111 1 11111 12467777766 5688887731 12345688889999999
Q ss_pred HHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccccccccccccccccccc----------
Q 012989 365 GIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYA---------- 434 (452)
Q Consensus 365 ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------- 434 (452)
||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++
T Consensus 219 qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 219 QVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp HHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred HHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccc
Confidence 9999999999999 999999999999999999999999998764322 334577 999999999
Q ss_pred ccCCCceeeeeeeeeeeC
Q 012989 435 MEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 435 ~~~~~s~~~DvwSlG~il 452 (452)
.+..++.++|||||||+|
T Consensus 290 ~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CCEEECHHHHHHHHHHHH
T ss_pred cCcCCCchhhHHHHHHHH
Confidence 555688999999999975
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=232.90 Aligned_cols=168 Identities=18% Similarity=0.119 Sum_probs=131.3
Q ss_pred CCCCCCCccEEEEEEecCCeeeEEEEeecCCc--------ccHHHHHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEe
Q 012989 264 PGSVTSSKEICVQGILADGKEIAVKRLSRSSG--------QGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335 (452)
Q Consensus 264 ~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~ 335 (452)
..+.|.++.|+.. ...++.+++|+...... ...+++.+|++++++++||||+++..++...++.+|||||
T Consensus 343 ~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 343 LIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -----CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred EEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4456666777655 45678899998654321 1234589999999999999999666666677778999999
Q ss_pred cCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCc
Q 012989 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQN 415 (452)
Q Consensus 336 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 415 (452)
+++++|.+++.. ++.++.||+++|+|||+++ |+||||||+|||++. ++||+|||+++.......
T Consensus 421 ~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 421 INGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999998832 5689999999999999999 999999999999998 999999999998754322
Q ss_pred cc-----ccccccccccccccccccc--CCCceeeeeeeee
Q 012989 416 EA-----NTNRVVGTYGYMAPEYAME--GVFSVNRMFLVSE 449 (452)
Q Consensus 416 ~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwSlG 449 (452)
.. ......||+.|||||++.. ..|+..+|+||..
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v 525 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII 525 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence 11 1235689999999999976 6678889999853
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=169.10 Aligned_cols=105 Identities=23% Similarity=0.454 Sum_probs=94.7
Q ss_pred ccceeeecCCCC-CChhhhHHHHHHHHHHHHHHhhccCCceeeeeecccCCccEEEEEEeecCCChhhhhHHHHhccccC
Q 012989 141 TSFRLSQWNAEN-SPGRLFDQLVWNLMNEAVNQALSTTKMFTTVKKNYTASQTLYSLVQCTPDLSRDDCSRCLRLAISPL 219 (452)
Q Consensus 141 ~~~~~~~~~~~~-~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~~~~~~~~~~~vyglaQC~~Dls~~~C~~Cl~~~~~~~ 219 (452)
+......|+..+ ++++.|+++++.||..|+..|+.++.+|+++.....+.++||||+||+||+++++|+.||+.++.++
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 445667788777 7888999999999999999998877788887766556789999999999999999999999999999
Q ss_pred cccCCCccccEEEccccCccccceee
Q 012989 220 DGCCSIKIGGRVRYPSCNFRYELYQF 245 (452)
Q Consensus 220 ~~~~~~~~g~~i~~~~c~~ry~~~~f 245 (452)
+++|++++|++|++++|++|||.++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999987
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.2e-23 Score=194.57 Aligned_cols=144 Identities=16% Similarity=0.076 Sum_probs=111.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc------------------ccHHH
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG------------------QGLQE 300 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~------------------~~~~~ 300 (452)
.|++...+|.|++|.|+.+ .. .+|+.||||.+..... .....
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~-------------------~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~ 150 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNC-------------------YS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150 (282)
T ss_dssp CSEEEEEEEECSSEEEEEE-------------------EE-TTTEEEEEEEECC------CCCC-------CHHHHHHHH
T ss_pred EEEecCEeccCCCceEEEE-------------------Ee-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHH
Confidence 3445577888887766644 44 6799999999864321 13456
Q ss_pred HHHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 301 FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 301 ~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
+.+|+.++++++ | +++.+.+.. +..++||||++|++|.+ +.. .....++.||+.||.|||++|
T Consensus 151 ~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--- 213 (282)
T 1zar_A 151 ARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--- 213 (282)
T ss_dssp HHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---
Confidence 899999999999 4 666665543 55699999999999987 411 234579999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccc
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 435 (452)
|+||||||+|||++ ++.+||+|||+++. +..++|||++.
T Consensus 214 iiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 214 IVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999999 99999999999864 44567888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=9.4e-19 Score=164.02 Aligned_cols=139 Identities=17% Similarity=0.160 Sum_probs=103.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCee--eEEEEeecCCcc--------------------
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKE--IAVKRLSRSSGQ-------------------- 296 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~--vAiK~~~~~~~~-------------------- 296 (452)
-|++...+|.|++|.||.+ ....+|+. ||||++......
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a-------------------~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYA-------------------DGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108 (258)
T ss_dssp EEEEEEEEEECSSEEEEEE-------------------EEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----
T ss_pred chhhCCEEeecceEEEEEE-------------------EEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccC
Confidence 4667778888888777644 34467888 999987543111
Q ss_pred ----cHHHHHHHHHHHHcCCCCCc--cceeeeEecCCeEEEEEEecCC-C----ChhhhhccCCCCCCCCHHHHHHHHHH
Q 012989 297 ----GLQEFKNEVTLIAKLQHKNL--VRLLGCCLDGNELLLIYEYMPN-K----SLDLFLFDSTKGAQLDWKRRISIING 365 (452)
Q Consensus 297 ----~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~~~~lv~E~~~~-~----~L~~~l~~~~~~~~l~~~~~~~i~~q 365 (452)
....+.+|+.+++.++|+++ +.+++. ...+|||||+.+ + +|.+.... .++..+..++.|
T Consensus 109 ~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~q 178 (258)
T 1zth_A 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFND 178 (258)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHH
Confidence 11368899999999988754 444442 356899999942 3 55554411 234567889999
Q ss_pred HHHHHHHHh-cCCCCCeEecCCCCCCeEECCCCCeeEcccccccccc
Q 012989 366 IARGLLYLH-EDSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFS 411 (452)
Q Consensus 366 l~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 411 (452)
|+.+|.+|| +.| |+||||||+|||++. .++|+|||++....
T Consensus 179 i~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 179 VVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp HHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred HHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999 998 999999999999998 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=155.81 Aligned_cols=137 Identities=13% Similarity=0.152 Sum_probs=92.5
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--------------cccHHHH----
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--------------GQGLQEF---- 301 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~---- 301 (452)
|++...+|.|++|.||.+. ..+|+.||||+++... .......
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~--------------------d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~ 156 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVA--------------------DEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLS 156 (397)
T ss_dssp SEEEEEEEECSSEEEEEEE--------------------CTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEE--------------------CCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHH
Confidence 6777777777777776542 2478999999875321 0011112
Q ss_pred ----HHHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 012989 302 ----KNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDS 377 (452)
Q Consensus 302 ----~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g 377 (452)
.+|...|.++.+.++....- +.. ...+|||||++|.+|..+.. . .....++.||+.+|.+||++|
T Consensus 157 rl~A~kE~~nL~rL~~~gv~vp~p-~~~-~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g 225 (397)
T 4gyi_A 157 RLAAIKEFAFMKALYEEGFPVPEP-IAQ-SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG 225 (397)
T ss_dssp HHHHHHHHHHHHHHHHTTCSCCCE-EEE-ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCCee-eec-cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC
Confidence 34555666664433321111 111 12379999999988866541 1 234578899999999999999
Q ss_pred CCCeEecCCCCCCeEECCCCC----------eeEccccccccc
Q 012989 378 RLRVIHRDLKTSNVLLDHEMN----------PKISDFGMARIF 410 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~----------~kl~DFG~a~~~ 410 (452)
||||||||.|||++.++. +.||||+.+...
T Consensus 226 ---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 226 ---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred ---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999999988763 899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.9e-12 Score=119.73 Aligned_cols=121 Identities=15% Similarity=0.081 Sum_probs=94.2
Q ss_pred CCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHH
Q 012989 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRR 359 (452)
Q Consensus 281 ~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~ 359 (452)
+++.+++|+...........+.+|+.+++.+. +..+++++++....+..|+|||+++|.+|.+.+. +....
T Consensus 36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~--------~~~~~ 107 (263)
T 3tm0_A 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE--------DEQSP 107 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC--------TTTCH
T ss_pred CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC--------CcccH
Confidence 46889999986532223346889999999994 6778899999998899999999999999876541 11223
Q ss_pred HHHHHHHHHHHHHHhcC--------------------------------------------------------CCCCeEe
Q 012989 360 ISIINGIARGLLYLHED--------------------------------------------------------SRLRVIH 383 (452)
Q Consensus 360 ~~i~~ql~~aL~~LH~~--------------------------------------------------------g~~~ivH 383 (452)
..++.++.++|..||+. .+..++|
T Consensus 108 ~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~H 187 (263)
T 3tm0_A 108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH 187 (263)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEEC
Confidence 47889999999999981 1134899
Q ss_pred cCCCCCCeEECCCCCeeEcccccccc
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+|++|.|||++.+..+.|+||+.+..
T Consensus 188 gDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 188 GDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCcCcEEEECCcEEEEEEchhccc
Confidence 99999999998765567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-10 Score=108.54 Aligned_cols=121 Identities=17% Similarity=0.174 Sum_probs=90.4
Q ss_pred EEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC--ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCC
Q 012989 275 VQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN--LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGA 352 (452)
Q Consensus 275 ~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~ 352 (452)
+.....+|+.+++|+.... ....+..|+.+++.+.+.+ +++++++...++..++||||++|.+|. .. .
T Consensus 37 ~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~-- 106 (264)
T 1nd4_A 37 FRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---H-- 106 (264)
T ss_dssp EEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---C--
T ss_pred EEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---c--
Confidence 4444566788999987543 2245788999999995444 567888888888899999999998884 21 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------
Q 012989 353 QLDWKRRISIINGIARGLLYLHEDS------------------------------------------------------- 377 (452)
Q Consensus 353 ~l~~~~~~~i~~ql~~aL~~LH~~g------------------------------------------------------- 377 (452)
.+ ...++.++++.|..||+..
T Consensus 107 -~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 182 (264)
T 1nd4_A 107 -LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 182 (264)
T ss_dssp -CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred -CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCC
Confidence 12 2356788888888888743
Q ss_pred CCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+..++|+|++|+|||++.++.+.|+||+.+..
T Consensus 183 ~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 183 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=9.6e-10 Score=107.53 Aligned_cols=123 Identities=14% Similarity=0.254 Sum_probs=92.2
Q ss_pred CeeeEEEEee--cCC-cccHHHHHHHHHHHHcCC--CCCccceeeeEecC---CeEEEEEEecCCCChhhhhccCCCCCC
Q 012989 282 GKEIAVKRLS--RSS-GQGLQEFKNEVTLIAKLQ--HKNLVRLLGCCLDG---NELLLIYEYMPNKSLDLFLFDSTKGAQ 353 (452)
Q Consensus 282 ~~~vAiK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~---~~~~lv~E~~~~~~L~~~l~~~~~~~~ 353 (452)
+..+++|+.. ... ......+.+|+.+++.|. +..+++++..+.+. +..|+|||+++|..+.+.. ...
T Consensus 61 ~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-----~~~ 135 (359)
T 3dxp_A 61 GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-----LPG 135 (359)
T ss_dssp SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-----CTT
T ss_pred CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-----ccc
Confidence 4678888765 321 122356889999999996 45578888888766 4589999999998875422 234
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------C
Q 012989 354 LDWKRRISIINGIARGLLYLHEDS-------------------------------------------------------R 378 (452)
Q Consensus 354 l~~~~~~~i~~ql~~aL~~LH~~g-------------------------------------------------------~ 378 (452)
++..+...++.++++.|..||+.. +
T Consensus 136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 215 (359)
T 3dxp_A 136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL 215 (359)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence 788888999999999999999731 2
Q ss_pred CCeEecCCCCCCeEECCCCC--eeEcccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMN--PKISDFGMARI 409 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~ 409 (452)
..++|+|++|+|||++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 45999999999999997754 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.55 E-value=9.4e-08 Score=91.02 Aligned_cols=120 Identities=20% Similarity=0.263 Sum_probs=87.2
Q ss_pred eeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCC--ccceeeeEecCC---eEEEEEEecCCCChhhhhccCCCCCCCCH
Q 012989 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKN--LVRLLGCCLDGN---ELLLIYEYMPNKSLDLFLFDSTKGAQLDW 356 (452)
Q Consensus 283 ~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~l~~~~~~~~---~~~lv~E~~~~~~L~~~l~~~~~~~~l~~ 356 (452)
+.+++|+... ......+.+|..+++.+. +.. +++++....... ..|+|||+++|.+|..... ..++.
T Consensus 41 ~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-----~~l~~ 113 (304)
T 3sg8_A 41 RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-----NNLPK 113 (304)
T ss_dssp TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-----HTSCH
T ss_pred CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-----ccCCH
Confidence 4688887532 234567899999999884 332 455555443333 3589999999988865331 24677
Q ss_pred HHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------CCCe
Q 012989 357 KRRISIINGIARGLLYLHEDS-------------------------------------------------------RLRV 381 (452)
Q Consensus 357 ~~~~~i~~ql~~aL~~LH~~g-------------------------------------------------------~~~i 381 (452)
.+...++.|++..|..||+.. +..+
T Consensus 114 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 193 (304)
T 3sg8_A 114 QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCL 193 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEE
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCcee
Confidence 888888999999998888621 1348
Q ss_pred EecCCCCCCeEECC--CCCeeEcccccccc
Q 012989 382 IHRDLKTSNVLLDH--EMNPKISDFGMARI 409 (452)
Q Consensus 382 vH~Dlkp~NIll~~--~~~~kl~DFG~a~~ 409 (452)
+|+|++|.||+++. ...+.|+||+.+..
T Consensus 194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 194 IHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp ECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred EeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 99999999999998 45688999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=4.4e-07 Score=84.61 Aligned_cols=120 Identities=19% Similarity=0.158 Sum_probs=88.7
Q ss_pred cCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHH
Q 012989 280 ADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKR 358 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~ 358 (452)
.++..+.+|+-... ....+..|...|+.|. +-.+++++.+....+..++|||+++|.++.+.... ....
T Consensus 48 ~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-------~~~~ 117 (272)
T 4gkh_A 48 PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-------YPDS 117 (272)
T ss_dssp TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-------CGGG
T ss_pred CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC-------CHHH
Confidence 45678899976432 3456888999999884 33478889999999999999999999887665421 1123
Q ss_pred HHHHHHHHHHHHHHHhcCC-------------------------------------------------------CCCeEe
Q 012989 359 RISIINGIARGLLYLHEDS-------------------------------------------------------RLRVIH 383 (452)
Q Consensus 359 ~~~i~~ql~~aL~~LH~~g-------------------------------------------------------~~~ivH 383 (452)
...+..++...|..||+.. +..++|
T Consensus 118 ~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 197 (272)
T 4gkh_A 118 GENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTH 197 (272)
T ss_dssp HHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEc
Confidence 3456677777777777521 113799
Q ss_pred cCCCCCCeEECCCCCeeEcccccccc
Q 012989 384 RDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+|+.|.|||++.++.+-|+||+.+..
T Consensus 198 GDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 198 GDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp SCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCeEEEECCeEEEEEECccccc
Confidence 99999999999877777999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=6.9e-07 Score=85.17 Aligned_cols=121 Identities=21% Similarity=0.185 Sum_probs=85.7
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCC---CccceeeeEe-cCCeEEEEEEecCCCChhhhhccCCCCCCCCHH
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK---NLVRLLGCCL-DGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWK 357 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~-~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~ 357 (452)
++.+++|+-. .......+..|..+|+.|.+. .+++++.+.. ..+..++|||+++|..+..... ..++..
T Consensus 39 g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~-----~~l~~~ 111 (306)
T 3tdw_A 39 NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM-----AVLPDD 111 (306)
T ss_dssp TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH-----TTSCHH
T ss_pred CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh-----hhCCHH
Confidence 5678888742 233456789999999999652 3667777664 4556789999999988865321 124555
Q ss_pred HHHHHHHHHHHHHHHHhcCC---------------------------------------------------------CCC
Q 012989 358 RRISIINGIARGLLYLHEDS---------------------------------------------------------RLR 380 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g---------------------------------------------------------~~~ 380 (452)
+...++.|+.+.|..||+.. +..
T Consensus 112 ~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~ 191 (306)
T 3tdw_A 112 AKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPR 191 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCE
T ss_pred HHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCe
Confidence 66666666666666666432 224
Q ss_pred eEecCCCCCCeEECC---CCC-eeEcccccccc
Q 012989 381 VIHRDLKTSNVLLDH---EMN-PKISDFGMARI 409 (452)
Q Consensus 381 ivH~Dlkp~NIll~~---~~~-~kl~DFG~a~~ 409 (452)
++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 699999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.7e-06 Score=84.10 Aligned_cols=62 Identities=6% Similarity=0.048 Sum_probs=43.2
Q ss_pred CeeeEEEEeecCC---cccHHHHHHHHHHHHcCC-C--CCccceeeeEecC---CeEEEEEEecCCCChhh
Q 012989 282 GKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQ-H--KNLVRLLGCCLDG---NELLLIYEYMPNKSLDL 343 (452)
Q Consensus 282 ~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~---~~~~lv~E~~~~~~L~~ 343 (452)
++.+++|+..... ......+.+|+.+++.|. + -.+++++.+.... +..++|||+++|..+.+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 6788899764322 001245788999999884 3 3577888877655 35789999999987754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-05 Score=74.14 Aligned_cols=30 Identities=23% Similarity=0.289 Sum_probs=27.1
Q ss_pred CCeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 349999999999999888899999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=5e-05 Score=74.83 Aligned_cols=58 Identities=9% Similarity=0.124 Sum_probs=35.7
Q ss_pred cCCeeeEEEEeecCCc-------ccHHHHHHHHHHHHcCCC--C-CccceeeeEecCCeEEEEEEecCCC
Q 012989 280 ADGKEIAVKRLSRSSG-------QGLQEFKNEVTLIAKLQH--K-NLVRLLGCCLDGNELLLIYEYMPNK 339 (452)
Q Consensus 280 ~~~~~vAiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-~iv~l~~~~~~~~~~~lv~E~~~~~ 339 (452)
.+++.++||....... ...+++..|.++++.+.. + .+++++.+ +....++|||++++.
T Consensus 53 ~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 53 EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp ---CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence 3567899997653211 234567889999988742 3 34566644 344568999999773
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00028 Score=67.03 Aligned_cols=58 Identities=21% Similarity=0.175 Sum_probs=46.5
Q ss_pred CCeeeEEEEeecCCcccHHHHHHHHHHHHcCC---CCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 281 ~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
+++.+++|+-... ....+..|...|+.|. ...+++++.+....+..++|||+++|..+
T Consensus 58 ~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 58 EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 5678889986533 3567889999999883 35688999988888899999999999765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00051 Score=68.14 Aligned_cols=30 Identities=23% Similarity=0.379 Sum_probs=26.3
Q ss_pred CCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
..++|+|++|.|||++.++ ++|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3499999999999998876 99999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00075 Score=64.57 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=26.7
Q ss_pred CCeEecCCCCCCeEECCC----CCeeEcccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHE----MNPKISDFGMARI 409 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~ 409 (452)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 459999999999999875 6789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00088 Score=63.65 Aligned_cols=124 Identities=17% Similarity=0.132 Sum_probs=68.0
Q ss_pred eeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC--ccceeee------EecCCeEEEEEEecCCCChhhh----------
Q 012989 283 KEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN--LVRLLGC------CLDGNELLLIYEYMPNKSLDLF---------- 344 (452)
Q Consensus 283 ~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~------~~~~~~~~lv~E~~~~~~L~~~---------- 344 (452)
..+++|+..... ..+.+..|+.+++.|...+ +++++.. ....+..+++||+++|..+...
T Consensus 46 g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~ 123 (322)
T 2ppq_A 46 DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGK 123 (322)
T ss_dssp CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHH
T ss_pred ccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHH
Confidence 368899876521 2245667888888774222 3444422 1234567999999998764210
Q ss_pred ----hccC-CC---C--CCCC---HHHHHH------------HHHHHHHHHHHHhcC----CCCCeEecCCCCCCeEECC
Q 012989 345 ----LFDS-TK---G--AQLD---WKRRIS------------IINGIARGLLYLHED----SRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 345 ----l~~~-~~---~--~~l~---~~~~~~------------i~~ql~~aL~~LH~~----g~~~ivH~Dlkp~NIll~~ 395 (452)
++.. .. . .... |...+. +...+...++.+++. .+..++|+|++|+|||++.
T Consensus 124 ~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~ 203 (322)
T 2ppq_A 124 ALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLG 203 (322)
T ss_dssp HHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEET
T ss_pred HHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeC
Confidence 1100 00 0 0011 111000 001133444555421 1335999999999999988
Q ss_pred CCCeeEccccccc
Q 012989 396 EMNPKISDFGMAR 408 (452)
Q Consensus 396 ~~~~kl~DFG~a~ 408 (452)
++.+.|+||+.+.
T Consensus 204 ~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 204 DELSGLIDFYFAC 216 (322)
T ss_dssp TEEEEECCCTTCE
T ss_pred CceEEEecchhcc
Confidence 7656899998774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00072 Score=63.33 Aligned_cols=64 Identities=20% Similarity=0.182 Sum_probs=44.8
Q ss_pred EEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCC---CCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 274 CVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH---KNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 274 ~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
.|+....||+.|.+|+-..........+..|...|+.|.. -.+++++... ..++|||++++...
T Consensus 31 vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 31 LYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred EEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 3556678999999998765544445578899999998842 2355566542 34789999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0025 Score=60.61 Aligned_cols=129 Identities=11% Similarity=0.154 Sum_probs=72.2
Q ss_pred EecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCC--Cccceeee-----EecCCeEEEEEEecCCCChhh-----h-
Q 012989 278 ILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHK--NLVRLLGC-----CLDGNELLLIYEYMPNKSLDL-----F- 344 (452)
Q Consensus 278 ~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~-----~~~~~~~~lv~E~~~~~~L~~-----~- 344 (452)
...+|+.+++|...... .....+..|..+++.|... .+++++.. ....+..+++||+++|..+.. .
T Consensus 45 ~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~ 123 (328)
T 1zyl_A 45 QDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQME 123 (328)
T ss_dssp CCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHH
T ss_pred EcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHH
Confidence 33457789999886331 2346677899888888422 24444443 223456789999999865421 0
Q ss_pred --------hcc----CC--CCCCCCHHHH----------------------HHHHHHHHHHHHHHhc-CCCCCeEecCCC
Q 012989 345 --------LFD----ST--KGAQLDWKRR----------------------ISIINGIARGLLYLHE-DSRLRVIHRDLK 387 (452)
Q Consensus 345 --------l~~----~~--~~~~l~~~~~----------------------~~i~~ql~~aL~~LH~-~g~~~ivH~Dlk 387 (452)
++. .. ....+++... ...+.+++..++.+.. ..+..++|+|++
T Consensus 124 ~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~ 203 (328)
T 1zyl_A 124 AVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCH 203 (328)
T ss_dssp HHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCS
T ss_pred HHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCC
Confidence 000 00 0011222111 1122222222332211 123458999999
Q ss_pred CCCeEECCCCCeeEcccccccc
Q 012989 388 TSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~ 409 (452)
|.|||++ + .+.|+||+.+..
T Consensus 204 ~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 204 AGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp GGGEEES-S-SEEECCCTTCCE
T ss_pred cccEeEc-C-CCEEEECCCCCc
Confidence 9999999 4 899999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0011 Score=64.66 Aligned_cols=123 Identities=19% Similarity=0.233 Sum_probs=75.5
Q ss_pred CCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhh-h-------------
Q 012989 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLF-L------------- 345 (452)
Q Consensus 281 ~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~-l------------- 345 (452)
+++.+.+|+.... ......+.+|..+++.|. +.-.+++++.+.. .+||||++|..|..- +
T Consensus 81 ~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 81 EPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHH
T ss_pred CCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHH
Confidence 3567888875322 234566778999998884 3334677766654 299999999766421 1
Q ss_pred ---ccC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHh----cC-CCCCeEecCCCCCCeEEC
Q 012989 346 ---FDS--TKGAQLD--WKRRISIINGIAR-------------------GLLYLH----ED-SRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 346 ---~~~--~~~~~l~--~~~~~~i~~ql~~-------------------aL~~LH----~~-g~~~ivH~Dlkp~NIll~ 394 (452)
+.. ...+... +.++.++..|+-. .+++|. +. .+..++|+|+.++|||++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 000 0111222 4555656554422 123332 21 234589999999999998
Q ss_pred CC----CCeeEccccccc
Q 012989 395 HE----MNPKISDFGMAR 408 (452)
Q Consensus 395 ~~----~~~kl~DFG~a~ 408 (452)
.+ +.+.|+||..+.
T Consensus 236 ~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 236 SEPENADSLMLVDFEYSS 253 (379)
T ss_dssp SCC---CCEEECCCTTCE
T ss_pred CCCCccCcEEEEecccCC
Confidence 76 689999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0035 Score=60.16 Aligned_cols=31 Identities=26% Similarity=0.385 Sum_probs=27.4
Q ss_pred CCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0021 Score=64.34 Aligned_cols=55 Identities=16% Similarity=0.146 Sum_probs=35.4
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc-cceeeeEecCCeEEEEEEecCCCCh
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL-VRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
++.+.+|+........ ..-..|..+++.|...++ +++++.+. + .+||||++|.+|
T Consensus 133 ~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 133 QAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp TEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred CceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4788899864432211 112579999999864444 67777663 2 359999998655
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.001 Score=66.28 Aligned_cols=54 Identities=15% Similarity=0.253 Sum_probs=35.8
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC-ccceeeeEecCCeEEEEEEecCCCCh
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN-LVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
++.+.+|+.... ...+.+..|..+++.|...+ .+++++.+.. .+||||++|.+|
T Consensus 105 ~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp CSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 567888987332 11245668999999884333 4677766543 389999988555
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0011 Score=62.46 Aligned_cols=30 Identities=27% Similarity=0.257 Sum_probs=25.3
Q ss_pred CCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 45899999999999 5667889999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0042 Score=60.25 Aligned_cols=29 Identities=21% Similarity=0.432 Sum_probs=24.1
Q ss_pred CCeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
..++|+|++|.|||++.++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 4589999999999998654 8999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.035 Score=54.80 Aligned_cols=29 Identities=28% Similarity=0.486 Sum_probs=25.8
Q ss_pred CCeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 379 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
..++|+|+.++||+ +.++.+.|+||..+.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 45899999999999 778889999998875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.47 E-value=0.32 Score=47.54 Aligned_cols=29 Identities=24% Similarity=0.392 Sum_probs=24.4
Q ss_pred CeEecCCCCCCeEE------CCCCCeeEccccccc
Q 012989 380 RVIHRDLKTSNVLL------DHEMNPKISDFGMAR 408 (452)
Q Consensus 380 ~ivH~Dlkp~NIll------~~~~~~kl~DFG~a~ 408 (452)
.++|+|+.+.|||+ +.+..++++||-.+.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 445679999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.73 E-value=1.1 Score=39.53 Aligned_cols=86 Identities=7% Similarity=0.072 Sum_probs=63.1
Q ss_pred CCCCccceeeeEecCCeEEEEEEecC-CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMP-NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~-~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
.||++++. .+-+..+.+.+.++.-+ +.++.. + +.++....++++.+|+....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888876 56666677666666543 222222 2 347888999999999988855553 5788999999
Q ss_pred eEECCCCCeeEccccccccc
Q 012989 391 VLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~ 410 (452)
|+++.++.+++.-.|+-..+
T Consensus 110 L~f~~~~~p~i~~RGik~~l 129 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV 129 (215)
T ss_dssp EEECTTSCEEESCCEETTTB
T ss_pred EEEcCCCCEEEEEccCccCC
Confidence 99999999999998875443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.56 E-value=1.6 Score=38.52 Aligned_cols=85 Identities=7% Similarity=0.086 Sum_probs=61.1
Q ss_pred CCCCccceeeeEecCCeEEEEEEecCC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEecCCCCC
Q 012989 312 QHKNLVRLLGCCLDGNELLLIYEYMPN-KSLDLFLFDSTKGAQLDWKRRISIINGIARGLL-YLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 312 ~h~~iv~l~~~~~~~~~~~lv~E~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~-~LH~~g~~~ivH~Dlkp~ 389 (452)
.||++ -...-.+.+.+.+.++.-++ .++.. + +.++..+.++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57888 34444677777777775433 22222 2 34778889999888888766 4543 688899999
Q ss_pred CeEECCCCCeeEccccccccc
Q 012989 390 NVLLDHEMNPKISDFGMARIF 410 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~ 410 (452)
||+++.++.++|.-.|+-..+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB
T ss_pred eEEEeCCCcEEEEEcCCcccC
Confidence 999999999999998875543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=87.15 E-value=0.16 Score=44.86 Aligned_cols=92 Identities=9% Similarity=0.009 Sum_probs=56.2
Q ss_pred ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCcccc
Q 012989 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEAN 418 (452)
Q Consensus 340 ~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 418 (452)
+|.+++. ..+.+++++++|.++.|.+..|.-+-. +. -..+=+.|..|++..+|++-+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc----------
Confidence 5677773 356789999999999999999887621 11 11233457899999999987653 1110
Q ss_pred ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 419 TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 419 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.....+.|||... ...+.+.=|||||.+|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tL 126 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIII 126 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHH
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHH
Confidence 0123466888763 2345677788888753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 452 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-47
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G + + ++ + Q LQ FKNEV ++ K +H N++ +G +L ++ ++
Sbjct: 27 GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 85
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
SL L + + + I I A+G+ YLH S +IHRDLK++N+ L +
Sbjct: 86 EGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHED 140
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
+ KI DFG+A + S ++ G+ +MAPE
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-46
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 10/164 (6%)
Query: 279 LADGKEIAVKRLSRSSGQGL-QEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
G +A K + + + E+ ++ + +V G E+ + E+M
Sbjct: 28 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
SLD L K ++ + + + +GL YL + +++HRD+K SN+L++
Sbjct: 88 GGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 142
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSV 441
K+ DFG++ + N VGT YM+PE +SV
Sbjct: 143 EIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSV 182
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 1e-44
Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 279 LADGKEIAVKRLSRSSGQG---LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+ + + +A+K++S S Q Q+ EV + KL+H N ++ GC L + L+ EY
Sbjct: 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ DL L ++ +G +GL YLH +IHRD+K N+LL
Sbjct: 97 CLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSE 150
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
K+ DFG A I + N VGT +MAPE +
Sbjct: 151 PGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVIL 184
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
A K + S + L+++ E+ ++A H N+V+LL N L ++ E+ +
Sbjct: 36 TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
+D + + L + + L YLH+ ++IHRDLK N+L + + K
Sbjct: 96 VDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIK 150
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
++DFG++ + ++ +GT +MAPE M
Sbjct: 151 LADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-44
Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 7/164 (4%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G ++AVK L + S F E L+ +LQH+ LVRL + +I EYM
Sbjct: 32 GYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYM 89
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
N SL FL G +L + + + IA G+ ++ E + IHRDL+ +N+L+
Sbjct: 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT 145
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
++ KI+DFG+AR+ N+ A + APE G F+
Sbjct: 146 LSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFT 188
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 7/163 (4%)
Query: 279 LADGKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+ +AVK + E K E+ + L H+N+V+ G +GN L EY
Sbjct: 27 RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
L + + + + G++YLH + + HRD+K N+LLD
Sbjct: 87 GGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERD 140
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
N KISDFG+A +F N E N++ GT Y+APE F
Sbjct: 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-42
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 7/164 (4%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G + ++A+K + + ++F E ++ KL H LV+L G CL+ + L++E+M
Sbjct: 24 GYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
+ L + T+ + + + + G+ YL E VIHRDL N L+
Sbjct: 83 EHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGEN 137
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
K+SDFGM R +Q ++ + +PE +S
Sbjct: 138 QVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYS 180
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-41
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 7/164 (4%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G ++A+K + S EF E ++ L H+ LV+L G C + +I EYM
Sbjct: 23 GKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
N L +L + + ++ + + + + YL + +HRDL N L++ +
Sbjct: 82 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQ 136
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
K+SDFG++R ++ ++ + PE M FS
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFS 179
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-41
Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 9/169 (5%)
Query: 279 LADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD--GNELLLIYE 334
+DGK + K L S Q +EV L+ +L+H N+VR +D L ++ E
Sbjct: 26 KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85
Query: 335 YMPNKSLDLFLFDSTKGAQ-LDWKRRISIINGIARGLLYLHE--DSRLRVIHRDLKTSNV 391
Y L + TK Q LD + + ++ + L H D V+HRDLK +NV
Sbjct: 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145
Query: 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
LD + N K+ DFG+ARI + + + A VGT YM+PE ++
Sbjct: 146 FLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYN 192
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-40
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 6/160 (3%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+AVK L + + ++EF E ++ +++H NLV+LLG C +I E+M +
Sbjct: 41 YSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
L +L + + ++ + + I+ + YL + IHRDL N L+ K
Sbjct: 100 LLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 155
Query: 401 ISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
++DFG++R+ +G+ A+ + APE FS
Sbjct: 156 VADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFS 194
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-40
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 8/162 (4%)
Query: 281 DGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
++A+K L + + + +E E ++ +L + +VRL+G C L+L+ E
Sbjct: 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 93
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L FL K ++ +++ ++ G+ YL +HRDL NVLL +
Sbjct: 94 PLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA 148
Query: 400 KISDFGMARIFSGNQNEAN-TNRVVGTYGYMAPEYAMEGVFS 440
KISDFG+++ + + + + APE FS
Sbjct: 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-40
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 25/184 (13%)
Query: 279 LADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYM 336
++AVK L + + +E+ ++ +L H+N+V LLG C + LI+EY
Sbjct: 64 TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123
Query: 337 PNKSLDLFLFDSTK--------------------GAQLDWKRRISIINGIARGLLYLHED 376
L +L + L ++ + +A+G+ +L
Sbjct: 124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF- 182
Query: 377 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436
+HRDL NVL+ H KI DFG+AR + N +MAPE E
Sbjct: 183 --KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240
Query: 437 GVFS 440
G+++
Sbjct: 241 GIYT 244
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-40
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 13/163 (7%)
Query: 281 DGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+A+K L ++ + + EV + + L+H N++RL G D + LI EY P
Sbjct: 30 SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
++ L +K D +R + I +A L Y H RVIHRD+K N+LL
Sbjct: 90 LGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAG 143
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
KI+DFG + ++ + GT Y+ PE +
Sbjct: 144 ELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHD 182
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-40
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 12/161 (7%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG-NELLLIYEYMPNK 339
G ++AVK + + Q F E +++ +L+H NLV+LLG ++ L ++ EYM
Sbjct: 29 RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
SL +L + L + + + YL +HRDL NVL+ +
Sbjct: 87 SLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVA 142
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
K+SDFG+ + S Q + + APE E FS
Sbjct: 143 KVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFS 178
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 9e-40
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN----ELLLIYEYM 336
G+E+AVK S + + E+ L+H+N++ + N +L L+ +Y
Sbjct: 25 RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHED-----SRLRVIHRDLKTSNV 391
+ SL +L + + I + A GL +LH + + + HRDLK+ N+
Sbjct: 84 EHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139
Query: 392 LLDHEMNPKISDFGMARIFSGNQN--EANTNRVVGTYGYMAPEYAMEGVFS 440
L+ I+D G+A + + N VGT YMAPE + +
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 9e-40
Identities = 50/177 (28%), Positives = 72/177 (40%), Gaps = 20/177 (11%)
Query: 281 DGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPN 338
+AVK L S+ + +E+ +++ L H N+V LLG C G L+I EY
Sbjct: 52 AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 111
Query: 339 KSLDLFLFDSTKG---------------AQLDWKRRISIINGIARGLLYLHEDSRLRVIH 383
L FL LD + +S +A+G+ +L IH
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIH 168
Query: 384 RDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
RDL N+LL H KI DFG+AR + N +MAPE V++
Sbjct: 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 1e-39
Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 25/182 (13%)
Query: 281 DGKEIAVKRLSRSSGQGLQ-EFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
+AVK L + +Q +F+ E L+A+ + N+V+LLG C G + L++EYM
Sbjct: 42 PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 101
Query: 340 SLDLFLFDSTK---------------------GAQLDWKRRISIINGIARGLLYLHEDSR 378
L+ FL + L ++ I +A G+ YL E
Sbjct: 102 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159
Query: 379 LRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV 438
+ +HRDL T N L+ M KI+DFG++R +M PE
Sbjct: 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218
Query: 439 FS 440
++
Sbjct: 219 YT 220
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-39
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 15/165 (9%)
Query: 281 DGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLD----GNELLLIYE 334
E+A L + Q FK E ++ LQH N+VR ++L+ E
Sbjct: 33 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
M + +L +L + + K S I +GL +LH + +IHRDLK N+ +
Sbjct: 93 LMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFIT 148
Query: 395 HE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV 438
+ KI D G+A + + V+GT +MAPE E
Sbjct: 149 GPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEEKY 189
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-39
Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 7/164 (4%)
Query: 277 GILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
G +A+K L + + F E ++ KL+H+ LV+L + ++ EYM
Sbjct: 36 GTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYM 93
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
SL FL T + + + IA G+ Y+ R+ +HRDL+ +N+L+
Sbjct: 94 SKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGEN 149
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ K++DFG+AR+ N+ A + APE A+ G F+
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFT 192
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-39
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 10/163 (6%)
Query: 281 DGKEIAVKRLSRSSGQG--LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
K +AVK L + E E ++ +L + +VR++G C + +L+ E
Sbjct: 33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 91
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
L+ +L + + K I +++ ++ G+ YL +HRDL NVLL +
Sbjct: 92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHY 145
Query: 399 PKISDFGMARIFSGNQNEANTN-RVVGTYGYMAPEYAMEGVFS 440
KISDFG+++ ++N + APE FS
Sbjct: 146 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-39
Identities = 43/162 (26%), Positives = 86/162 (53%), Gaps = 9/162 (5%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+A G+E+A+++++ + NE+ ++ + ++ N+V L L G+EL ++ EY+
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
SL + ++ D + ++ + L +LH +VIHRD+K+ N+LL + +
Sbjct: 102 GSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGS 154
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
K++DFG + Q++ +T +VGT +MAPE +
Sbjct: 155 VKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 194
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-38
Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 9/163 (5%)
Query: 281 DGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
+A+K L + + ++F +E +++ + H N++ L G +++I E+M N
Sbjct: 53 REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 112
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
SLD FL + Q + + ++ GIA G+ YL + +HRDL N+L++ +
Sbjct: 113 SLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVC 167
Query: 400 KISDFGMARIFSGNQNEANTNRVVG---TYGYMAPEYAMEGVF 439
K+SDFG++R + ++ +G + APE F
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-38
Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 9/165 (5%)
Query: 279 LADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
LA +E A+K L + + E ++++L H V+L D +L Y
Sbjct: 30 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
N L ++ K D I L YLH +IHRDLK N+LL+
Sbjct: 90 AKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNE 143
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+M+ +I+DFG A++ S +A N VGT Y++PE E
Sbjct: 144 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (349), Expect = 1e-37
Identities = 35/164 (21%), Positives = 69/164 (42%), Gaps = 10/164 (6%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
A G+ K ++ KNE++++ +L H L+ L D E++LI E++
Sbjct: 51 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
L + + + ++ I+ + GL ++HE ++H D+K N++ + +
Sbjct: 111 GELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKA 165
Query: 399 P--KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
KI DFG+A + ++ T + APE
Sbjct: 166 SSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVG 206
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (348), Expect = 1e-37
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 10/164 (6%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
A G A K + + + E+ ++ L+H LV L D NE+++IYE+M
Sbjct: 48 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
L + D + ++ + + + +GL ++HE +H DLK N++ + +
Sbjct: 108 GELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRS 162
Query: 399 P--KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
K+ DFG+ Q + GT + APE A
Sbjct: 163 NELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVG 203
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-36
Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 285 IAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDL 343
+A+K L + S + +E +E ++A + + ++ RLLG CL + LI + MP L
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 99
Query: 344 FLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKISD 403
++ + + + ++ IA+G+ YL R++HRDL NVL+ + KI+D
Sbjct: 100 YVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITD 154
Query: 404 FGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
FG+A++ + E + +MA E + +++
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-36
Identities = 46/164 (28%), Positives = 63/164 (38%), Gaps = 10/164 (6%)
Query: 281 DGKEIAVKRLSR---SSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+AVK L S + + +F EV + L H+NL+RL G L + ++ E P
Sbjct: 35 KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAP 93
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
SL L +A G+ YL R IHRDL N+LL
Sbjct: 94 LGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRD 148
Query: 398 NPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFS 440
KI DFG+ R N + + + APE FS
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-36
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 281 DGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
+A+K ++ + S + EF NE +++ + ++VRLLG G L+I E M
Sbjct: 49 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG 108
Query: 340 SLDLFLF-------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
L +L ++ A + I + IA G+ YL+ + + +HRDL N +
Sbjct: 109 DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 165
Query: 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRM 444
+ + KI DFGM R + + +M+PE +GVF+
Sbjct: 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 217
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-35
Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 9/163 (5%)
Query: 282 GKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDG-NELLLIYEYMPNK 339
AVK L+R + G + +F E ++ H N++ LLG CL L++ YM +
Sbjct: 55 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L F+ + T + + + + + +HRDL N +LD +
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTV 169
Query: 400 KISDFGMARIFSGNQNEANTNR--VVGTYGYMAPEYAMEGVFS 440
K++DFG+AR + ++ N+ +MA E F+
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 5/161 (3%)
Query: 279 LADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
+ +A+K++S Q Q E+ ++ + +H+N++ + + Y+
Sbjct: 30 NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
+ L+ K L + I RGL Y+H V+HRDLK SN+LL+
Sbjct: 90 THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTC 146
Query: 398 NPKISDFGMARIFSGNQNEANT-NRVVGTYGYMAPEYAMEG 437
+ KI DFG+AR+ + + V T Y APE +
Sbjct: 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-35
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 283 KEIAVKRLSR-SSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+ A+KR+ +S ++F E+ ++ KL H N++ LLG C L L EY P+ +
Sbjct: 38 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 341 LDLFL-------------FDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387
L FL ++ + L ++ + +ARG+ YL + + IHRDL
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLA 154
Query: 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
N+L+ KI+DFG++R G + +MA E V++
Sbjct: 155 ARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYT 204
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 8/160 (5%)
Query: 281 DGKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
+A+K + ++E F E + + H ++V+L+G + + +I E
Sbjct: 34 PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLG 92
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L FL LD I ++ L YL R +HRD+ NVL+
Sbjct: 93 ELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCV 147
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF 439
K+ DFG++R + ++ +MAPE F
Sbjct: 148 KLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 186
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-34
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 282 GKEIAVKRLSRSSGQG-LQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKS 340
+A+K L + +F E ++ + H N++RL G +++I EYM N +
Sbjct: 36 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95
Query: 341 LDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400
LD FL + K + + + ++ GIA G+ YL + +HRDL N+L++ + K
Sbjct: 96 LDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCK 150
Query: 401 ISDFGMARIFSGNQNEANT-NRVVGTYGYMAPEYAMEGVF 439
+SDFG++R+ + T + + APE F
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-34
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 19/178 (10%)
Query: 279 LADGKEIAVKRLSRSSGQG-LQEFKNEVTLIAK-LQHKNLVRLLGCCL-DGNELLLIYEY 335
A + +AVK L + + +E+ ++ H N+V LLG C G L++I E+
Sbjct: 40 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 99
Query: 336 MPNKSLDLFLF-------------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382
+L +L + L + I +A+G+ +L + I
Sbjct: 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCI 156
Query: 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
HRDL N+LL + KI DFG+AR + + +MAPE + V++
Sbjct: 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-33
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 18/175 (10%)
Query: 281 DGKEIAVKRLSR-SSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLDGNELLLIYEYMPN 338
++AVK L ++ + L + +E+ ++ + +HKN++ LLG C L +I EY
Sbjct: 44 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 103
Query: 339 KSLDLFLF-------------DSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385
+L +L QL K +S +ARG+ YL + IHRD
Sbjct: 104 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRD 160
Query: 386 LKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
L NVL+ + KI+DFG+AR T +MAPE + +++
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (310), Expect = 4e-32
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 16/163 (9%)
Query: 281 DGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQ---HKNLVRLLGCCLDGNELLLIYE 334
GK A+K L + QG NE +++ + +V + ++L I +
Sbjct: 28 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
M L L + I GL ++H V++RDLK +N+LLD
Sbjct: 88 LMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLD 141
Query: 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
+ +ISD G+A FS + + VGT+GYMAPE +G
Sbjct: 142 EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKG 180
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (305), Expect = 7e-32
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 14/165 (8%)
Query: 279 LADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+G+ A+K L + + ++ +E +++ + H ++R+ G D ++ +I +Y
Sbjct: 26 RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ L L S + K + + L L +I+RDLK N+LLD
Sbjct: 86 IEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSKDIIYRDLKPENILLDK 139
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ KI+DFG A+ + GT Y+APE ++
Sbjct: 140 NGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN 179
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 119 bits (299), Expect = 2e-31
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 19/169 (11%)
Query: 279 LADGKEIAVKRLSRSSGQGL---------QEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNE 328
KE AVK + + G + EV ++ K+ H N+++L
Sbjct: 25 KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
L+++ M L +L T+ L K I+ + + LH+ L ++HRDLK
Sbjct: 85 FFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKP 138
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
N+LLD +MN K++DFG + + V GT Y+APE
Sbjct: 139 ENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECS 184
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 34/164 (20%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ K K + + G K E++++ +H+N++ L EL++I+E++
Sbjct: 27 TSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
+ + +T +L+ + +S ++ + L +LH + H D++ N++ +
Sbjct: 86 LDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRS 140
Query: 399 P--KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
KI +FG AR N + Y APE V S
Sbjct: 141 STIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVS 181
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 118 bits (297), Expect = 4e-31
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 14/170 (8%)
Query: 279 LADGKEIAVKRLSRSSGQG---LQEFKNEVTLIAKLQHKNLVRLLGCCLD----GNELLL 331
L +++AVK L + F+ E A L H +V + G +
Sbjct: 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88
Query: 332 IYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391
+ EY+ +L + + KR I +I + L + H+ +IHRD+K +N+
Sbjct: 89 VMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANI 142
Query: 392 LLDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFS 440
++ K+ DFG+AR + + N T V+GT Y++PE A
Sbjct: 143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 192
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 8e-31
Identities = 35/161 (21%), Positives = 70/161 (43%), Gaps = 7/161 (4%)
Query: 281 DGKEIAVKRLSRSSGQGLQE-FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNK 339
K +A+K +++ + +G + +NE+ ++ K++H N+V L G L LI + +
Sbjct: 33 TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92
Query: 340 SLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399
L + + + +I + + YLH+ + + LD +
Sbjct: 93 ELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 149
Query: 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
ISDFG++++ + GT GY+APE + +S
Sbjct: 150 MISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYS 187
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-29
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 13/160 (8%)
Query: 281 DGKEIAVKRLSRSSGQGLQE-----FKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
+ +A+K++ ++ E+ L+ +L H N++ LL + + L++++
Sbjct: 22 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
M + L + + +GL YLH+ ++HRDLK +N+LLD
Sbjct: 82 METDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE 135
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
K++DFG+A+ F V T Y APE
Sbjct: 136 NGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLF 173
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-29
Identities = 42/164 (25%), Positives = 66/164 (40%), Gaps = 12/164 (7%)
Query: 281 DGKEIAVKRLSRSSG---QGLQEFKNEV-TLIAKLQHKNLVRLLGCCLDGNELLLIYEYM 336
+ A+K L + ++ E L +H L + L + EY+
Sbjct: 26 TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85
Query: 337 PNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396
L + K D R I GL +LH +++RDLK N+LLD +
Sbjct: 86 NGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKD 139
Query: 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ KI+DFGM + +A TN GT Y+APE + ++
Sbjct: 140 GHIKIADFGMCKENM--LGDAKTNTFCGTPDYIAPEILLGQKYN 181
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (273), Expect = 9e-28
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 10/162 (6%)
Query: 276 QGILADGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIY 333
+ G+ A+K RL + E++++ +L+H N+V+L L+L++
Sbjct: 20 KAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79
Query: 334 EYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393
E++ L L+ S + + G+ Y H+ RV+HRDLK N+L+
Sbjct: 80 EHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLI 133
Query: 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
+ E KI+DFG+AR F + + T Y AP+ M
Sbjct: 134 NREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-27
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 17/164 (10%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNE------LLLIYE 334
G+ +A+K++ + + E+ ++ KL H N+VRL E L L+ +
Sbjct: 44 SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 335 YMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394
Y+P + S L + + R L Y+H + HRD+K N+LLD
Sbjct: 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLD 156
Query: 395 HE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
+ K+ DFG A+ + + + + Y APE
Sbjct: 157 PDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGA 197
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-27
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 281 DGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
G+ +A+K RL + E++L+ +L H N+V+LL N+L L++E++
Sbjct: 26 TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
+ G + S + + +GL + H RV+HRDLK N+L++ E
Sbjct: 86 DLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGA 140
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
K++DFG+AR F V T Y APE +
Sbjct: 141 IKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGC 177
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 35/168 (20%), Positives = 59/168 (35%), Gaps = 18/168 (10%)
Query: 279 LADGKEIAVKRLSRSSGQGLQE------FKNEVTLIAKLQ--HKNLVRLLGCCLDGNELL 330
++D +A+K + + E EV L+ K+ ++RLL + +
Sbjct: 26 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
LI E T+ L + S + + + H V+HRD+K N
Sbjct: 86 LILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDEN 140
Query: 391 VLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
+L+D K+ DFG + GT Y PE+
Sbjct: 141 ILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYH 184
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-27
Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 275 VQGILADGKEIAVKRLSRSSGQG--LQEFKNEVTLIAKL---QHKNLVRLLGCCLDGNEL 329
+ + G+ +A+KR+ +G+ EV ++ L +H N+VRL C
Sbjct: 26 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85
Query: 330 LLIYEYMPNKSLD---LFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386
+ + +D D + + ++ + RGL +LH RV+HRDL
Sbjct: 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDL 142
Query: 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
K N+L+ K++DFG+ARI+S VV T Y APE ++ ++
Sbjct: 143 KPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYA 193
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-27
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 19/172 (11%)
Query: 279 LADGKEIAVKRLSRSS------GQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI 332
+ G + A K + + G ++ + EV+++ ++QH N++ L + +++LI
Sbjct: 32 KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91
Query: 333 YEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392
E + L + L + + I G+ YLH L++ H DLK N++
Sbjct: 92 LELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIM 145
Query: 393 LDHEMNP----KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
L P KI DFG+A + GT ++APE
Sbjct: 146 LLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLG 194
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-26
Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 279 LADGKEIAVKRLSRSSGQG--LQEFKNEVTLIAKLQHKNLVRLLGCCLDG--------NE 328
G+++A+K++ + + E+ ++ L+H+N+V L+ C
Sbjct: 32 RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91
Query: 329 LLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388
+ L++++ + L K + KR + ++ L L+ R +++HRD+K
Sbjct: 92 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNGLYYIHRNKILHRDMKA 145
Query: 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNR--VVGTYGYMAPEYAMEG 437
+NVL+ + K++DFG+AR FS +N V T Y PE +
Sbjct: 146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (266), Expect = 1e-26
Identities = 30/171 (17%), Positives = 63/171 (36%), Gaps = 17/171 (9%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLG-CCLDGNELLLIYEYMP 337
+A G+E+A+K + + E + +Q + + C +G+ +++ E +
Sbjct: 29 IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL---LD 394
L + + K + + + + + Y+H IHRD+K N L
Sbjct: 87 P---SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGK 140
Query: 395 HEMNPKISDFGMARIFSGNQNEAN-----TNRVVGTYGYMAPEYAMEGVFS 440
I DFG+A+ + + + + GT Y + + S
Sbjct: 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 20/168 (11%)
Query: 281 DGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKNLVRLLGCCLD----GNELLLIYEY 335
++ A+K L + + EV L + Q ++VR++ + LL++ E
Sbjct: 36 TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ L + D + I+ I + YLH + + HRD+K N+L
Sbjct: 91 LDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTS 146
Query: 396 EMNP---KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ K++DFG A+ + + + T Y+APE +
Sbjct: 147 KRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYD 191
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 103 bits (257), Expect = 2e-25
Identities = 29/173 (16%), Positives = 62/173 (35%), Gaps = 19/173 (10%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH-KNLVRLLGCCLDGNELLLIYEYMP 337
L + +++A+K R S + ++E L + + +G +L+ + +
Sbjct: 27 LLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 84
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
DL G + K + + +HE +++RD+K N L+
Sbjct: 85 PSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPN 138
Query: 398 NP-----KISDFGMARIFSGNQNEAN-----TNRVVGTYGYMAPEYAMEGVFS 440
+ + DFGM + + + + + GT YM+ + S
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 191
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 11/165 (6%)
Query: 279 LADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEY 335
A G+ A+K L + + + E ++ +H L L + L + EY
Sbjct: 27 KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
L L ++ +R I L YLH V++RD+K N++LD
Sbjct: 87 ANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDK 140
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+ + KI+DFG+ + G + A GT Y+APE + +
Sbjct: 141 DGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 9e-25
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 21/167 (12%)
Query: 279 LADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGN------ELL 330
G ++A+K+L R S + E+ L+ ++H+N++ LL +
Sbjct: 40 GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L+ +M L K +L R ++ + +GL Y+H +IHRDLK N
Sbjct: 100 LVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGN 151
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
+ ++ + KI DFG+AR Q ++ V T Y APE +
Sbjct: 152 LAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNW 193
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.3 bits (244), Expect = 2e-23
Identities = 37/163 (22%), Positives = 67/163 (41%), Gaps = 14/163 (8%)
Query: 281 DGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMP 337
G A+K L + + ++ NE ++ + LV+L D + L ++ EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 338 NKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397
+ L + + I YLH L +I+RDLK N+L+D +
Sbjct: 125 GGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+++DFG A+ G + GT +APE + ++
Sbjct: 179 YIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYN 216
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 8e-23
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 281 DGKEIAVK--RLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPN 338
+ +A+K RL E+ L+ +L+HKN+VRL +L L++E+
Sbjct: 26 THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85
Query: 339 KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398
F + LD + S + + +GL + H V+HRDLK N+L++
Sbjct: 86 DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGE 139
Query: 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
K+++FG+AR F + V T Y P+
Sbjct: 140 LKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA 176
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.4 bits (231), Expect = 1e-21
Identities = 34/162 (20%), Positives = 68/162 (41%), Gaps = 19/162 (11%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNE--LLLIYEY 335
+ + +++ VK L ++ K E+ ++ L+ N++ L D L++E+
Sbjct: 57 ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ N L + I + L Y H + ++HRD+K NV++DH
Sbjct: 114 VNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDH 164
Query: 396 E-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME 436
E ++ D+G+A + Q N V + + PE ++
Sbjct: 165 EHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVD 203
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 1e-21
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 279 LADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCL------DGNELL 330
+ +A+K+LSR + + E+ L+ + HKN++ LL + ++
Sbjct: 39 AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98
Query: 331 LIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390
L+ E M + +LD +R ++ + G+ +LH +IHRDLK SN
Sbjct: 99 LVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 149
Query: 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM 435
+++ + KI DFG+AR + V T Y APE +
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVIL 191
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 38/162 (23%), Positives = 72/162 (44%), Gaps = 12/162 (7%)
Query: 281 DGKEIAVKRLSRSS----GQGLQEFKNEVTLIAKLQHK-NLVRLLGCCLDGNELLLIYEY 335
GK A+K L +++ + + + E ++ ++ LV L +L LI +Y
Sbjct: 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ L L + + + + + +L L +L +I+RD+K N+LLD
Sbjct: 111 INGGELFTHLSQRERFTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDS 164
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
+ ++DFG+++ F ++ E GT YMAP+ G
Sbjct: 165 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGG 205
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 5e-19
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 11/162 (6%)
Query: 279 LADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDGNELLLI-YEY 335
G +AVK+LSR S + E+ L+ ++H+N++ LL L Y
Sbjct: 40 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99
Query: 336 MPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395
+ + L + K +L +I I RGL Y+H +IHRDLK SN+ ++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 156
Query: 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG 437
+ KI DFG+AR R Y APE +
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.9 bits (191), Expect = 2e-17
Identities = 26/183 (14%), Positives = 52/183 (28%), Gaps = 43/183 (23%)
Query: 277 GILADGKEIAVK--RLSRSSGQ--------GLQEFKNEVTLIAKLQHKNLVRLLGCC--- 323
E VK ++ +S + G F A+ + + L +L G
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78
Query: 324 -LDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382
++ E + K + ++ + +++ I + + ++
Sbjct: 79 VYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEVAKFYHR---GIV 125
Query: 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVN 442
H DL NVL+ E I DF + E V ++
Sbjct: 126 HGDLSQYNVLV-SEEGIWIIDFPQSVEVGEE---------------GWREILERDVRNII 169
Query: 443 RMF 445
F
Sbjct: 170 TYF 172
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.4 bits (189), Expect = 4e-16
Identities = 25/176 (14%), Positives = 62/176 (35%), Gaps = 17/176 (9%)
Query: 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRLLGCCLDG------------ 326
+ + +A+K + + ++E+ L+ ++ + + +
Sbjct: 35 MVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93
Query: 327 -NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRD 385
N + ++ + L L + + I + GL Y+H R +IH D
Sbjct: 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTD 151
Query: 386 LKTSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFS 440
+K NVL++ + +A + + + + + T Y +PE + +
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWG 207
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 452 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.1 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=330.34 Aligned_cols=190 Identities=27% Similarity=0.357 Sum_probs=163.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|+|++|.|+.+ .+..+|+.||||++.... ....+.+.+|+.++++++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnI 65 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLA-------------------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTB
T ss_pred cceEEEEEEecCcCeEEEEE-------------------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCE
Confidence 46888999999999877755 455689999999997653 3345678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++.+++..||||||+++++|.+++. ....+++.+++.++.||++||+|||++| |+||||||+|||++.+
T Consensus 66 v~~~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~ 139 (271)
T d1nvra_ 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDER 139 (271)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred eeEeeeeccCceeEEEEeccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCC
Confidence 999999999999999999999999999983 4567999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
+++||+|||+++.+............+||+.|||||++.+..+ +.++||||+||+|
T Consensus 140 ~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvil 196 (271)
T d1nvra_ 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196 (271)
T ss_dssp CCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHH
T ss_pred CCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHH
Confidence 9999999999998765544444556789999999999988776 6789999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=329.35 Aligned_cols=187 Identities=25% Similarity=0.397 Sum_probs=166.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-||+..+.+|.|++|.||.+ .+..+|+.||||++........+.+.+|+.++++++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a-------------------~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv 80 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTA-------------------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEE-------------------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBC
T ss_pred cccEEEEEEecCcCcEEEEE-------------------EECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEe
Confidence 47999999999999887765 44568999999999877666678899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++.+++++||||||++|++|.+++.. ..+++.+++.|+.||+.||+|||++| |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~ 153 (293)
T d1yhwa1 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDG 153 (293)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTC
T ss_pred eEeEEEEECCEEEEEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCC
Confidence 999999999999999999999999988743 45999999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||+|||+++.+..... .....+||+.|+|||++.+..++.++|||||||+|
T Consensus 154 ~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 206 (293)
T d1yhwa1 154 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206 (293)
T ss_dssp CEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHH
T ss_pred cEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHH
Confidence 999999999987654332 23456899999999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=326.67 Aligned_cols=189 Identities=27% Similarity=0.387 Sum_probs=162.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
+|++.+.+|+|++|.|+.+ .+..+++.||||++.+. .....+.+.+|++++++++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn 69 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLA-------------------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69 (288)
T ss_dssp GEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTT
T ss_pred CCEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCC
Confidence 5888899999999877755 45568999999999754 2345678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++.+++.+|+||||++|++|.+++. ..+.+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 70 Iv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~ 143 (288)
T d1uu3a_ 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNE 143 (288)
T ss_dssp BCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred eeEEEEEEEECCEEEEEEEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCC
Confidence 9999999999999999999999999998873 3456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||+|
T Consensus 144 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvil 200 (288)
T d1uu3a_ 144 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 200 (288)
T ss_dssp TSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred CceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHH
Confidence 999999999999987655444444556899999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=319.94 Aligned_cols=188 Identities=26% Similarity=0.348 Sum_probs=165.0
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQ 312 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~ 312 (452)
+.-+|++.+.+|+|++|.|+.+ .+..+++.||||++.+. .....+.+.+|+.++++++
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~ 64 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLA-------------------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC
T ss_pred chhHeEEEEEEecCCCcEEEEE-------------------EECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC
Confidence 3457888899999999877755 45568999999998754 2344677899999999999
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
||||+++++++.+++..++||||+++++|.+++. ....+++.+++.|+.||++||+|||+++ |+||||||+|||
T Consensus 65 hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nil 138 (263)
T d2j4za1 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLL 138 (263)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccce
Confidence 9999999999999999999999999999999884 3456999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++...... .....||+.|||||++.+..++.++|||||||+|
T Consensus 139 l~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvil 194 (263)
T d2j4za1 139 LGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 194 (263)
T ss_dssp ECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHH
Confidence 9999999999999998654332 3346799999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=330.93 Aligned_cols=186 Identities=22% Similarity=0.297 Sum_probs=162.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|.|++|.|+.+ .+..+|+.||||+++.. .....+++.+|+.+|++++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 66 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKV-------------------SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEE-------------------EETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTB
T ss_pred cCCEEEEEEecCCCeEEEEE-------------------EECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCC
Confidence 47889999999999888765 44568999999999765 34445779999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEECC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~ 395 (452)
|++++++.++++++|||||++|++|.+++.. ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.
T Consensus 67 v~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~ 140 (322)
T d1s9ja_ 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNS 140 (322)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECT
T ss_pred CcEEEEEEECCEEEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECC
Confidence 9999999999999999999999999999843 3569999999999999999999997 48 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++++||+|||+|+.+... .....+||+.|+|||++.+..|+.++||||+||+|
T Consensus 141 ~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 193 (322)
T d1s9ja_ 141 RGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 193 (322)
T ss_dssp TCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHH
T ss_pred CCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHH
Confidence 999999999999876432 23346899999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=321.66 Aligned_cols=188 Identities=23% Similarity=0.366 Sum_probs=163.8
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|++...+|.|++|.|+.+ .+..+++.||||+++.......+.+.+|+++|++++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~ 73 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKA-------------------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73 (288)
T ss_dssp TEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCC
T ss_pred CeEEeEEEeeCCCcEEEEE-------------------EECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 5888888999999887755 455689999999998877777788999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++.+++..+|||||+++++|.+++.. ....+++.+++.++.||+.||.|||++| |+||||||+|||++.+++
T Consensus 74 l~~~~~~~~~~~lvmEy~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~ 148 (288)
T d2jfla1 74 LLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGD 148 (288)
T ss_dssp EEEEEEETTEEEEEEECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEEeeCCeEEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCC
Confidence 99999999999999999999999988743 2456999999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccc-----cCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM-----EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwSlG~il 452 (452)
+||+|||+++...... .......||+.|+|||++. +..++.++|||||||+|
T Consensus 149 ~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvil 205 (288)
T d2jfla1 149 IKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205 (288)
T ss_dssp EEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHH
T ss_pred EEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHH
Confidence 9999999997653321 1223467999999999984 45689999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-41 Score=319.81 Aligned_cols=187 Identities=22% Similarity=0.303 Sum_probs=147.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|.|++|.|+.+ .+..+++.||||++.+.. ....+.+.+|+.+|++++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 69 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILA-------------------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEE-------------------EETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTB
T ss_pred cceEEEEEEeeccCeEEEEE-------------------EECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCC
Confidence 46999999999999887755 455689999999997653 2334568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC--
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD-- 394 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~-- 394 (452)
+++++++.+++.+||||||++|++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+.
T Consensus 70 v~l~~~~~~~~~~~lvmE~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~ 143 (307)
T d1a06a_ 70 VALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSL 143 (307)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSS
T ss_pred CcEEEEEEECCEEEEEEeccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeeccc
Confidence 999999999999999999999999999984 3567999999999999999999999999 99999999999995
Q ss_pred -CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 -HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++...... .....+||+.|||||++.+..++.++|||||||+|
T Consensus 144 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvil 199 (307)
T d1a06a_ 144 DEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 199 (307)
T ss_dssp STTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHH
Confidence 57889999999998754332 23346899999999999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=321.64 Aligned_cols=187 Identities=21% Similarity=0.294 Sum_probs=165.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|++.+.+|.|++|.|+.+ .+..+|+.||||++++. .....+.+.+|+.+|++++|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~-------------------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~ 66 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILV-------------------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66 (337)
T ss_dssp GEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTT
T ss_pred hcEEEEEEecCcCeEEEEE-------------------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCC
Confidence 5888889999999877754 55678999999999764 2345678899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++++++.+|+||||++|++|..++. +...+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 67 Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~ 140 (337)
T d1o6la_ 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDK 140 (337)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECT
T ss_pred EEEEEeeeccccccccceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecC
Confidence 9999999999999999999999999999884 4456999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|.+||+|||+++...... ......+||+.|+|||++.+..|+.++||||+||+|
T Consensus 141 ~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvil 195 (337)
T d1o6la_ 141 DGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195 (337)
T ss_dssp TSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHH
T ss_pred CCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHH
Confidence 9999999999998654322 223457899999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-40 Score=321.74 Aligned_cols=188 Identities=22% Similarity=0.337 Sum_probs=166.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-||++.+.+|.|++|.|+.+ .+..+|+.||||++........+.+.+|+.+|++++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~-------------------~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv 86 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRV-------------------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEE-------------------EETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBC
T ss_pred cCeEEEEEEecCcCeEEEEE-------------------EECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 38999999999999887755 45568999999999877666778899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC--
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH-- 395 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-- 395 (452)
++++++.+++++||||||++|++|.+++.. ....+++.+++.|+.||+.||+|||++| ||||||||+|||++.
T Consensus 87 ~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~ 161 (350)
T d1koaa2 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKR 161 (350)
T ss_dssp CEEEEEEETTEEEEEECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTT
T ss_pred cEEEEEEECCEEEEEEEcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCC
Confidence 999999999999999999999999988843 3456999999999999999999999999 999999999999964
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+..... .....||+.|||||++.+..++.++|||||||+|
T Consensus 162 ~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvil 215 (350)
T d1koaa2 162 SNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 215 (350)
T ss_dssp SCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHH
T ss_pred CCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHH
Confidence 57899999999987654332 3346889999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-40 Score=320.48 Aligned_cols=190 Identities=20% Similarity=0.280 Sum_probs=166.8
Q ss_pred cCccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC
Q 012989 236 CNFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 236 c~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.+-+|++.+.+|.|++|.|+.+ .+..+|+.||||++........+.+.+|+.+|++++|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~Hpn 87 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRC-------------------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 87 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTT
T ss_pred cccceEEEEEEecCCCeEEEEE-------------------EECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCC
Confidence 4557999999999999877755 456689999999998776666678899999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC-
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD- 394 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~- 394 (452)
||++++++.+++.+||||||++|++|.+.+. .....+++.+++.|+.||+.||+|||++| |+||||||+|||++
T Consensus 88 Iv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCET 162 (352)
T ss_dssp BCCEEEEEECSSEEEEEEECCCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESS
T ss_pred CCcEEEEEEECCEEEEEEEcCCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccc
Confidence 9999999999999999999999999987763 23456999999999999999999999999 99999999999998
Q ss_pred -CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 -HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 163 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 218 (352)
T d1koba_ 163 KKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 218 (352)
T ss_dssp TTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHH
T ss_pred cCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHH
Confidence 568899999999988754322 3345789999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=318.50 Aligned_cols=184 Identities=28% Similarity=0.415 Sum_probs=159.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 314 (452)
.+|+..+.+|.|++|.|+.+ .+..+++.||||++.... ....+.+.+|+.+|++++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp 75 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFA-------------------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEE-------------------EETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCT
T ss_pred HhcEeeEEEecCCCeEEEEE-------------------EECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCC
Confidence 36888889999999887755 455689999999997653 23346789999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
|||++++++.+++..|+||||+++++|..++. ....+++.+++.|+.||+.||.|||++| |+||||||+|||++
T Consensus 76 nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~ 149 (309)
T d1u5ra_ 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLS 149 (309)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred CEeeEEEEEEECCEEEEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEC
Confidence 99999999999999999999999999987663 3457999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCcccccccccccccccccccccc---CCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME---GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il 452 (452)
.++++||+|||+++.... .....||+.|||||++.+ +.|+.++|||||||+|
T Consensus 150 ~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvil 204 (309)
T d1u5ra_ 150 EPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (309)
T ss_dssp TTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHH
T ss_pred CCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHH
Confidence 999999999999986432 234579999999999863 5689999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=309.39 Aligned_cols=186 Identities=26% Similarity=0.328 Sum_probs=155.4
Q ss_pred cc-cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RY-ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry-~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
|| +....+|+|++|.||.+ .+..+++.||+|++... .....+.+.+|+++|++++|||
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~-------------------~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~Hpn 69 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKG-------------------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTT
T ss_pred CEEEeeeEEecCcCcEEEEE-------------------EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCC
Confidence 44 44456899999887755 44567899999998765 3445677999999999999999
Q ss_pred ccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 316 LVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 316 iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
||+++++++. +..+++||||+++++|.+++.. ...+++.+++.|+.||++||+|||+++ .+|+||||||+||
T Consensus 70 Iv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNI 145 (270)
T ss_dssp BCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGE
T ss_pred eeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhc
Confidence 9999999875 4568999999999999999843 456999999999999999999999875 4599999999999
Q ss_pred EEC-CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLD-HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++ .++.+||+|||+++..... .....+||+.|||||++.+ .++.++|||||||+|
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvil 202 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM 202 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred eeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHH
Confidence 996 5789999999999864322 2335689999999998865 699999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-40 Score=313.66 Aligned_cols=189 Identities=22% Similarity=0.350 Sum_probs=163.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|++.+.+|.|++|.||.+ ....+++.||||+++.. ....+++.+|+.+|++++|||||+
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a-------------------~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEG-------------------VWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp GEEEEEETTTTTTSSEEEE-------------------EEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred HeEEeeEEeeCCCeEEEEE-------------------EECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEec
Confidence 5666777888888777655 45567999999998754 345678999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++.+++..+|||||+++|+|..++... ....+++..++.|+.||++||+|||+++ |+||||||+|||++.+++
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~ 153 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHL 153 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCc
Confidence 999999999999999999999999988543 3457999999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||+++........ ......||+.|+|||++.++.++.++|||||||+|
T Consensus 154 ~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l 206 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 206 (287)
T ss_dssp EEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred EEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHH
Confidence 999999999876544322 22334689999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=313.82 Aligned_cols=193 Identities=27% Similarity=0.375 Sum_probs=151.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.|++.+.+|.|++|.|+.+ .+..+|+.||||++... ++...+.+.+|++++++++||||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI 65 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKI-------------------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65 (269)
T ss_dssp GEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTB
T ss_pred hCEEeEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCE
Confidence 4778888899999877755 45568999999999765 33445678999999999999999
Q ss_pred cceeeeEec--CCeEEEEEEecCCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCe
Q 012989 317 VRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDS-TKGAQLDWKRRISIINGIARGLLYLHEDS--RLRVIHRDLKTSNV 391 (452)
Q Consensus 317 v~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--~~~ivH~Dlkp~NI 391 (452)
+++++++.+ +..+||||||+++++|.+++... .....+++.+++.++.||+.||+|||+++ ..+|+||||||+||
T Consensus 66 v~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NI 145 (269)
T d2java1 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145 (269)
T ss_dssp CCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGE
T ss_pred eeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhc
Confidence 999999865 45689999999999999988542 23467999999999999999999999854 12499999999999
Q ss_pred EECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++.++.+||+|||+++.+..... ......||+.|||||++.+..++.++|||||||+|
T Consensus 146 ll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvil 204 (269)
T d2java1 146 FLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 204 (269)
T ss_dssp EECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHH
Confidence 999999999999999987654322 23346899999999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-40 Score=315.74 Aligned_cols=184 Identities=23% Similarity=0.361 Sum_probs=162.6
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
.|++.+.+|.|++|.|+.+ .+..+|+.||||++++. .....+.+.+|+.+++.++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a-------------------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn 65 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLI-------------------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65 (316)
T ss_dssp GEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTT
T ss_pred HeEEEEEEecCcCcEEEEE-------------------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcC
Confidence 4788888999998777654 45568999999999754 2345678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++.+++.+|+||||++|++|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 66 Iv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~ 139 (316)
T d1fota_ 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDK 139 (316)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECT
T ss_pred hhheeeeEeeCCeeeeEeeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcC
Confidence 9999999999999999999999999988883 4556899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++..... ....+||+.|||||++.+..++.++|||||||+|
T Consensus 140 ~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvil 191 (316)
T d1fota_ 140 NGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 191 (316)
T ss_dssp TSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHH
T ss_pred CCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhH
Confidence 999999999999876432 2346899999999999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=311.51 Aligned_cols=187 Identities=28% Similarity=0.401 Sum_probs=152.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-+|++.+.+|+|++|.||.+. .+..||||+++.. +....+.|.+|+.++++++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~----------------------~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn 65 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGK----------------------WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEE----------------------SSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTT
T ss_pred ccEEEEEEEeeCCCcEEEEEE----------------------ECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCC
Confidence 467778889999998887653 2345999998754 4556678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
||++++++. .+.++|||||+++++|.+++.. ....+++.+++.|+.||++||+|||+++ ||||||||+|||++.
T Consensus 66 Iv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~ 139 (276)
T d1uwha_ 66 ILLFMGYST-APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHE 139 (276)
T ss_dssp BCCEEEEEC-SSSCEEEEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EeeeeEEEe-ccEEEEEEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcC
Confidence 999999865 4568999999999999998853 3356999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc---CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME---GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwSlG~il 452 (452)
++++||+|||+++...............||+.|||||++.+ ..++.++|||||||+|
T Consensus 140 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l 199 (276)
T d1uwha_ 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199 (276)
T ss_dssp TSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHH
T ss_pred CCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHH
Confidence 99999999999987655444444456789999999999864 4589999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=310.28 Aligned_cols=188 Identities=21% Similarity=0.311 Sum_probs=164.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC------cccHHHHHHHHHHHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS------GQGLQEFKNEVTLIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~~E~~~l~~ 310 (452)
.-||++.+.+|.|++|.|+.+ .+..+|+.||||++++.. ....+.+.+|+.+|++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~-------------------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~ 69 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKC-------------------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEE-------------------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHH
T ss_pred ccCEEEeEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHh
Confidence 358999999999999888755 445689999999997542 2246789999999999
Q ss_pred CCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 311 LQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 311 l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
++|||||++++++.+++.+||||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|
T Consensus 70 l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~N 143 (293)
T d1jksa_ 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPEN 143 (293)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccce
Confidence 9999999999999999999999999999999999843 356999999999999999999999999 9999999999
Q ss_pred eEECCCC----CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 391 VLLDHEM----NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++||||+||+|
T Consensus 144 ill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 144 IMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206 (293)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred EEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHH
Confidence 9998776 499999999987654322 2345789999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=304.26 Aligned_cols=187 Identities=23% Similarity=0.381 Sum_probs=152.7
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
+|+..+.+|.|++|.|+.+ ...+++.||||+++.. ....++|.+|++++++++||||++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~--------------------~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 64 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLG--------------------YWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQ 64 (263)
T ss_dssp CEEEEEEEECCSSCCEEEE--------------------EETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred HcEEEEEEeeCCCeEEEEE--------------------EECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCccc
Confidence 5777888999999888755 2356788999999754 344578999999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++..++..++||||+++++|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++.+++
T Consensus 65 ~~g~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~ 139 (263)
T d1sm2a_ 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQV 139 (263)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGC
T ss_pred ccceeccCCceEEEEEecCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCC
Confidence 99999999999999999999999998743 3456899999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+|
T Consensus 140 ~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil 192 (263)
T d1sm2a_ 140 IKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 192 (263)
T ss_dssp EEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHH
Confidence 999999999876543322 22345789999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-40 Score=313.08 Aligned_cols=194 Identities=22% Similarity=0.361 Sum_probs=151.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|+..+.+|.|++|.||.+.... .......||||++... .....+.|.+|+++|++++||||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~----------------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 89 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKL----------------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC-------------------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeC----------------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCC
Confidence 468888999999999888663211 1122346899988754 44456789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|++++++..++..++||||+++++|.+++.. ....+++.+++.|+.||++||+|||+++ |+||||||+|||++.+
T Consensus 90 v~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~ 164 (299)
T d1jpaa_ 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSN 164 (299)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred ccEEEEEeeCCEEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCC
Confidence 9999999999999999999999999998743 3456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcccc---ccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEAN---TNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+++||+|||+++.+........ .....||+.|||||++.++.++.++|||||||+|
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 9999999999987654433222 2234679999999999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-39 Score=316.40 Aligned_cols=186 Identities=21% Similarity=0.268 Sum_probs=165.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h 313 (452)
.-+|++.+.+|.|++|.|+.+ .+..+|+.||||++.+. .....+.+.+|+.+|+.++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a-------------------~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h 100 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLV-------------------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC
T ss_pred ccCeEEEEEeecCcCcEEEEE-------------------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC
Confidence 348999999999999877755 45568999999999754 23456779999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
|||+++++++......++||||+.+++|..++.. ...+++.+++.|+.||+.||.|||+++ ||||||||+|||+
T Consensus 101 pnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl 174 (350)
T d1rdqe_ 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLI 174 (350)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CcEeecccccccccccccccccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHccc
Confidence 9999999999999999999999999999888843 356999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++.+... .....||+.|||||++.+..++.++|||||||+|
T Consensus 175 ~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvil 228 (350)
T d1rdqe_ 175 DQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228 (350)
T ss_dssp CTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHH
Confidence 99999999999999876432 2346899999999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=306.94 Aligned_cols=191 Identities=23% Similarity=0.374 Sum_probs=158.9
Q ss_pred cccceee-ecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQF-YNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f-~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
.|.+.++ +|.|++|.||.+.. ....++..||||+++.. .....++|.+|+++|++++||||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~-----------------~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnI 71 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVY-----------------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEE-----------------C---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CeEECCcEEecccCeEEEEEEE-----------------ecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCE
Confidence 3555665 89999999887632 12345678999999765 34456789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|++++++.. +.++|||||+++++|.+++.. ....+++.+++.|+.||++||+|||+++ |+||||||+|||++.+
T Consensus 72 v~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~ 145 (285)
T d1u59a_ 72 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNR 145 (285)
T ss_dssp CCEEEEEES-SSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEET
T ss_pred eeEeeeecc-CeEEEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccC
Confidence 999999875 468999999999999998732 3456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCcc-ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++.+...... .......||+.|+|||++.++.++.++|||||||+|
T Consensus 146 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l 202 (285)
T d1u59a_ 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 202 (285)
T ss_dssp TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHH
Confidence 99999999999877544322 223345689999999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=312.72 Aligned_cols=197 Identities=25% Similarity=0.392 Sum_probs=161.0
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i 316 (452)
+|++.+.+|.|++|.|+.+...... .......||+|++... .......+.+|+.++.++ +||||
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~--------------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI 103 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGIS--------------KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCS--------------SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCC--------------cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcE
Confidence 6777888999999998876421100 0112347999998654 344556789999999998 89999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTK--------------------GAQLDWKRRISIINGIARGLLYLHED 376 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--------------------~~~l~~~~~~~i~~ql~~aL~~LH~~ 376 (452)
|++++++.+.+..++||||+++|+|.++++.... ...+++.+++.|+.||++||+|||++
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999865321 24589999999999999999999999
Q ss_pred CCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 377 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 377 g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ ||||||||+|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||+|
T Consensus 184 ~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 184 S---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp T---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred C---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHH
Confidence 9 999999999999999999999999999876655444444456789999999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=305.12 Aligned_cols=188 Identities=28% Similarity=0.436 Sum_probs=159.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++.+.+|.|++|.||.+ ...+++.||||+++... ...+.|.+|+.++++++|||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~--------------------~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv 71 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMG--------------------YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEE--------------------EETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBC
T ss_pred HHeEEeEEEecCCCcEEEEE--------------------EECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEe
Confidence 47788888999999888755 23567899999997543 4457899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++.. +..++||||+++|+|.+++... ....+++.+++.|+.||++||.|||+++ |+||||||+|||++.++
T Consensus 72 ~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~ 146 (272)
T d1qpca_ 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTL 146 (272)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTS
T ss_pred EEEeeecc-CCeEEEEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeeccc
Confidence 99998754 5679999999999998877432 2345999999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||+|
T Consensus 147 ~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl 200 (272)
T d1qpca_ 147 SCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (272)
T ss_dssp CEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred ceeeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHH
Confidence 9999999999876544322 23345789999999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=305.49 Aligned_cols=185 Identities=24% Similarity=0.344 Sum_probs=152.7
Q ss_pred eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCCccceee
Q 012989 244 QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKNLVRLLG 321 (452)
Q Consensus 244 ~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~ 321 (452)
+.+|+|++|.||.+.. ....+++.||||+++.. ++...+++.+|+.+|++++|||||++++
T Consensus 13 k~iG~G~fG~Vy~~~~-----------------~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g 75 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYY-----------------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 75 (277)
T ss_dssp EEEEECSSEEEEEEEE-----------------ECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCcccCCCeEEEEEEE-----------------ccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEE
Confidence 3589999988886632 12235688999999754 2334567999999999999999999999
Q ss_pred eEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCeeE
Q 012989 322 CCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPKI 401 (452)
Q Consensus 322 ~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kl 401 (452)
++..+ ..+|||||+++++|.+++. ....+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 76 ~~~~~-~~~lvmE~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl 148 (277)
T d1xbba_ 76 ICEAE-SWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKI 148 (277)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred EeccC-CEEEEEEcCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccc
Confidence 98654 5789999999999999984 3456999999999999999999999999 999999999999999999999
Q ss_pred ccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 402 SDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 402 ~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+|
T Consensus 149 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l 200 (277)
T d1xbba_ 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 200 (277)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred cchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhh
Confidence 9999998765443222 23345789999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.1e-39 Score=304.12 Aligned_cols=191 Identities=24% Similarity=0.332 Sum_probs=155.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHHHHHHHHcCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~h 313 (452)
.-||++.+.+|.|++|.||.+ .+..+++.||||++++.. ....+++.+|+++++.++|
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~h 66 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLA-------------------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCC
T ss_pred cceeEEeEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCC
Confidence 358999999999999887755 456789999999997653 3345679999999999999
Q ss_pred CCccceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 314 KNLVRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 314 ~~iv~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|||+++++++...+ .+||||||++|++|..++. ..+.+++.+++.|+.||+.||+|||++| |+||||||+
T Consensus 67 pniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~ 140 (277)
T d1o6ya_ 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 140 (277)
T ss_dssp TTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred CCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCc
Confidence 99999999988653 4899999999999998873 3456999999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCc-cccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQN-EANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||++.++..+|+|||.++....... .......+||+.|+|||++.+..++.++|||||||+|
T Consensus 141 NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 204 (277)
T d1o6ya_ 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 204 (277)
T ss_dssp GEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHH
Confidence 99999999999999999876543322 2233456899999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=303.44 Aligned_cols=193 Identities=23% Similarity=0.385 Sum_probs=153.2
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccc
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
|+..+.+|.|++|.||.+.... ........||||++... ......+|++|+.++++++|||||+
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~---------------~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~ 73 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKT---------------SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC------------------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred eEeeeEEeeCCCeEEEEEEEeC---------------CCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEee
Confidence 6677889999999988763211 01112357999999765 3344567899999999999999999
Q ss_pred eeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCC
Q 012989 319 LLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMN 398 (452)
Q Consensus 319 l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~ 398 (452)
+++++...+..++||||+.++++.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 74 ~~g~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 74 LEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLV 148 (283)
T ss_dssp EEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred eeEEEecCCceEEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCe
Confidence 99999999999999999999999887743 3456999999999999999999999999 999999999999999999
Q ss_pred eeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 399 PKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 399 ~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+||+|||+++......... ......||+.|+|||++.++.++.++|||||||+|
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil 203 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 203 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHH
Confidence 9999999998765433222 23345789999999999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=304.67 Aligned_cols=188 Identities=18% Similarity=0.257 Sum_probs=162.9
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+-||++.+.+|.|++|.|+.+ .+..+++.||||+++.... ....+.+|+++|+.++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~-------------------~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnI 63 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRC-------------------VETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNI 63 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTB
T ss_pred ccceEEEEEEecCCCeEEEEE-------------------EECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCC
Confidence 458999999999999887755 4556899999999976543 34568899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++++++++||||||++|++|.+++.. ....+++.+++.|+.||+.||+|||++| |+||||||+|||++.+
T Consensus 64 v~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~ 138 (321)
T d1tkia_ 64 LHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTR 138 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS
T ss_pred CeEEEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCC
Confidence 9999999999999999999999999998843 3346999999999999999999999999 9999999999999854
Q ss_pred --CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 --MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 --~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
..+||+|||+++....... .....||+.|+|||.+.+..++.++||||+||||
T Consensus 139 ~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvil 193 (321)
T d1tkia_ 139 RSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193 (321)
T ss_dssp SCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHH
T ss_pred CceEEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHH
Confidence 4799999999987643322 3345789999999999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=305.42 Aligned_cols=187 Identities=24% Similarity=0.354 Sum_probs=161.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHH-cCCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIA-KLQHK 314 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~-~l~h~ 314 (452)
.|++.+.+|.|++|.|+.+ .+..+++.||||++.+. .....+.+..|..++. .++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~-------------------~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp 63 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLA-------------------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63 (320)
T ss_dssp TEEEEEEEEECSSSEEEEE-------------------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCT
T ss_pred CeEEeeEEecCCCcEEEEE-------------------EECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCC
Confidence 5888889999999877755 45668999999999754 2344566777777765 68999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++.+++..||||||+++|+|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 64 ~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~ 137 (320)
T d1xjda_ 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLD 137 (320)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred cEEEEEEEEccCCceeEEEeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeec
Confidence 99999999999999999999999999999984 3456899999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++++||+|||+++...... .......||+.|+|||++.+..++.++||||+||+|
T Consensus 138 ~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 193 (320)
T d1xjda_ 138 KDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193 (320)
T ss_dssp TTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHH
Confidence 99999999999998654332 223446899999999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-38 Score=297.52 Aligned_cols=188 Identities=24% Similarity=0.338 Sum_probs=161.8
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc---------ccHHHHHHHHHH
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG---------QGLQEFKNEVTL 307 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~~E~~~ 307 (452)
+-+|++.+.+|+|++|.|+.+ .+..+++.||||++.+... ...+.+.+|+.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~-------------------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~ 62 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRC-------------------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHH
T ss_pred cccCEEceEEecCcCeEEEEE-------------------EECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHH
Confidence 358999999999999887755 4556899999999976531 123468899999
Q ss_pred HHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 308 IAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 308 l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
+++++ ||||+++++++.++++.||||||+++++|.+++.. ...+++.+++.++.||++||+|||++| |+||||
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDl 136 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDL 136 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---Cccccc
Confidence 99996 99999999999999999999999999999999943 456999999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccc------cCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAM------EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwSlG~il 452 (452)
||+|||++.++.+||+|||+++.+..... .....||+.|+|||.+. ...++.++||||+||+|
T Consensus 137 kp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvil 205 (277)
T d1phka_ 137 KPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 205 (277)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred ccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhh
Confidence 99999999999999999999987654322 23457999999999985 34468899999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-38 Score=309.82 Aligned_cols=185 Identities=24% Similarity=0.299 Sum_probs=156.4
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC---cccHHHHHH---HHHHHHcCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS---GQGLQEFKN---EVTLIAKLQ 312 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~~---E~~~l~~l~ 312 (452)
.|++.+.+|.|++|.||.+ .+..+|+.||||++.+.. ......+.+ |+.+++.++
T Consensus 5 dy~i~~~lG~G~fg~Vy~~-------------------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~ 65 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGC-------------------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65 (364)
T ss_dssp TEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC
T ss_pred hCeeeeEEecCCCeEEEEE-------------------EECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC
Confidence 5888889999999877754 456689999999987531 222333444 466777778
Q ss_pred CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 313 HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 313 h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|||||++++++..++.+|+||||++|++|.+++. +...+++.+++.++.||+.||+|||+++ ||||||||+|||
T Consensus 66 hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NIL 139 (364)
T d1omwa3 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANIL 139 (364)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeE
Confidence 9999999999999999999999999999999984 3456899999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++.+.... .....||+.|+|||++.. ..++.++|||||||+|
T Consensus 140 l~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvil 196 (364)
T d1omwa3 140 LDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 196 (364)
T ss_dssp ECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHH
T ss_pred EcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHH
Confidence 9999999999999998765432 334579999999999964 5689999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=302.27 Aligned_cols=184 Identities=23% Similarity=0.336 Sum_probs=152.0
Q ss_pred ceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcc-----cHHHHHHHHHHHHcCCCCCc
Q 012989 242 LYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQ-----GLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 242 ~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i 316 (452)
..+++|.|++|.|+.+ .+..+|+.||||+++..... ..+.+.+|+.++++++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 62 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKA-------------------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62 (299)
T ss_dssp EEEEEEEETTEEEEEE-------------------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB
T ss_pred cceEeccCcCeEEEEE-------------------EECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCE
Confidence 3467888888777655 44567999999998754221 23468899999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
|++++++..+++++|||||+.++++..+. .....+++.+++.+++||+.||+|||++| |+||||||+|||++.+
T Consensus 63 v~~~~~~~~~~~~~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~ 136 (299)
T d1ua2a_ 63 IGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN 136 (299)
T ss_dssp CCEEEEECCTTCCEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eEEEeeeccCCceeehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCC
Confidence 99999999999999999999998777665 44567999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... .....+||+.|+|||++.+. .++.++||||+||+|
T Consensus 137 ~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil 191 (299)
T d1ua2a_ 137 GVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 191 (299)
T ss_dssp CCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHH
T ss_pred CccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHH
Confidence 9999999999987654322 22345799999999998654 579999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=290.84 Aligned_cols=186 Identities=22% Similarity=0.361 Sum_probs=157.2
Q ss_pred ccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccce
Q 012989 240 YELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVRL 319 (452)
Q Consensus 240 y~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l 319 (452)
|+..+-+|+|++|.|+.+ . .++++.||||++++.. ...+.|++|+.++++++||||+++
T Consensus 6 ~~~~~~iG~G~fg~Vy~~-------------------~-~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~ 64 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYG-------------------K-WRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64 (258)
T ss_dssp CCCCCCCCEETTEEEEEE-------------------E-ETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CEEeEEEecCCCeEEEEE-------------------E-ECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeE
Confidence 444455666666655533 3 3578899999998653 345789999999999999999999
Q ss_pred eeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCe
Q 012989 320 LGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNP 399 (452)
Q Consensus 320 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~ 399 (452)
++++.+++.+++||||+++|+|..++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 65 ~g~~~~~~~~~iv~Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~ 139 (258)
T d1k2pa_ 65 YGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVV 139 (258)
T ss_dssp EEEECCSSSEEEEEECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCceEEEEEccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcE
Confidence 9999999999999999999999888743 3456899999999999999999999999 9999999999999999999
Q ss_pred eEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 400 KISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 400 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++
T Consensus 140 kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l 191 (258)
T d1k2pa_ 140 KVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191 (258)
T ss_dssp EECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhh
Confidence 99999999876544322 23346789999999999999999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-38 Score=301.36 Aligned_cols=197 Identities=25% Similarity=0.380 Sum_probs=164.9
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCcc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
+|++.+.+|+|++|.||.+..... ....+++.||||+++... ....+++.+|++++++++||||+
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~--------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv 79 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGL--------------LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETS--------------STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HcEEeEEEeeCCCeEEEEEEECCC--------------ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcc
Confidence 688899999999999987742110 012357889999997653 33456799999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDST---------------------KGAQLDWKRRISIINGIARGLLYLHED 376 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~ 376 (452)
++++++...+..++||||+++++|.++++... ....+++..++.|+.||+.||+|||++
T Consensus 80 ~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence 99999999999999999999999999885422 123589999999999999999999999
Q ss_pred CCCCeEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 377 SRLRVIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 377 g~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+ ||||||||+|||++.++++||+|||+++...............||+.|+|||.+.+..++.++|||||||+|
T Consensus 160 ~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 160 K---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232 (301)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred C---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhH
Confidence 9 999999999999999999999999999876555444444556789999999999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=301.35 Aligned_cols=184 Identities=21% Similarity=0.252 Sum_probs=155.7
Q ss_pred ccccce-eeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELY-QFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~-~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
-+|++. +.+|.|++|.||.+ .+..+++.||||+++.. +.+.+|+.++.++ +|||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a-------------------~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpn 66 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQI-------------------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 66 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEE-------------------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTT
T ss_pred cCEEEeeEEeeeccCeEEEEE-------------------EECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCC
Confidence 468775 46899999887755 45678999999998643 5678899987654 8999
Q ss_pred ccceeeeEec----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 012989 316 LVRLLGCCLD----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNV 391 (452)
Q Consensus 316 iv~l~~~~~~----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NI 391 (452)
||+++++|++ +.++||||||++||+|.+++... ....+++.+++.|+.||+.||+|||++| |+||||||+||
T Consensus 67 Iv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NI 142 (335)
T d2ozaa1 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENL 142 (335)
T ss_dssp BCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred CCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccc
Confidence 9999999875 46799999999999999998542 2356999999999999999999999999 99999999999
Q ss_pred EECC---CCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 392 LLDH---EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 392 ll~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|++. .+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||||
T Consensus 143 ll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvil 203 (335)
T d2ozaa1 143 LYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 203 (335)
T ss_dssp EESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHH
T ss_pred ccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhH
Confidence 9985 45699999999987654332 3345799999999999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=300.98 Aligned_cols=198 Identities=24% Similarity=0.341 Sum_probs=155.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
-+|++.+.+|.|++|.|+.+..... ....+++.||||+++.. .....+.+.+|..++.++ +|+|
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~--------------~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGI--------------DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEEST--------------TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCC--------------CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCe
Confidence 3788899999999999987642110 01235678999999754 334456788888888877 6899
Q ss_pred ccceeeeEecC-CeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 012989 316 LVRLLGCCLDG-NELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRV 381 (452)
Q Consensus 316 iv~l~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~i 381 (452)
|+.+++.+... ..+++||||+++++|.++++... ....+++.+++.++.||++||.|||+++ |
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---i 155 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 155 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 99999987754 56899999999999999986432 1345899999999999999999999999 9
Q ss_pred EecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||||+|||++.++++||+|||+++...............||+.|+|||++.++.++.++|||||||+|
T Consensus 156 vHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226 (299)
T ss_dssp CCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHH
Confidence 99999999999999999999999999876655544445567899999999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=294.95 Aligned_cols=188 Identities=24% Similarity=0.392 Sum_probs=154.4
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCcc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLV 317 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 317 (452)
-+|++.+.+|+|++|.|+.+ ...+++.||||+++.. ....+.|.+|+.++++++|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~--------------------~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv 75 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMG--------------------TWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEE--------------------EETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBC
T ss_pred HHEEEeeEEeeCCCeEEEEE--------------------EECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEe
Confidence 47888899999999888755 3356678999999754 34557899999999999999999
Q ss_pred ceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 318 RLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 318 ~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
++++++.. +..++||||+++|+|..++... ....+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++
T Consensus 76 ~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~ 150 (285)
T d1fmka3 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENL 150 (285)
T ss_dssp CEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEEec-CCeEEEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCC
Confidence 99999854 5689999999999998888542 2346999999999999999999999999 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++||+|||+++.+..... .......||+.|+|||.+.++.++.++|||||||+|
T Consensus 151 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil 204 (285)
T d1fmka3 151 VCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204 (285)
T ss_dssp CEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHH
Confidence 999999999987644332 223345789999999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-38 Score=300.98 Aligned_cols=189 Identities=23% Similarity=0.409 Sum_probs=154.5
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCC----eeeEEEEeecC-CcccHHHHHHHHHHHHcCCC
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADG----KEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~----~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h 313 (452)
.|+..+.+|.|++|.||.+.. ..+| .+||+|+++.. +....+++.+|+.++++++|
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~-------------------~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 70 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLW-------------------IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEE-------------------CC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC
T ss_pred HCEEeeEEecCCCeEEEEEEE-------------------cCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC
Confidence 488888999999998886632 2333 36899988654 44567789999999999999
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLL 393 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll 393 (452)
||||++++++.++ ..+++||++.+++|.+.+.. ....+++..++.|+.||+.||+|||+++ ||||||||+|||+
T Consensus 71 pnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll 144 (317)
T d1xkka_ 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLV 144 (317)
T ss_dssp TTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCEeeEEEEEecC-CeeEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhccee
Confidence 9999999999875 56788899999999887744 3556999999999999999999999999 9999999999999
Q ss_pred CCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 394 DHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 394 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.++++||+|||+++...............||+.|+|||++.++.++.++|||||||+|
T Consensus 145 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 145 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203 (317)
T ss_dssp EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHH
Confidence 99999999999999987655544444456789999999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-38 Score=294.87 Aligned_cols=192 Identities=21% Similarity=0.295 Sum_probs=150.0
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|.|++|.|+.+.... ....+..||||.++.. .....+.+.+|+.++++++||||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~----------------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 70 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMS----------------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC----------------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred HHeEEEEEEeeCCCcEEEEEEEec----------------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE
Confidence 489999999999999998764211 1223567999998654 34446779999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++. ++..++||||+++++|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||+++.+
T Consensus 71 v~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~ 144 (273)
T d1mp8a_ 71 VKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN 144 (273)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET
T ss_pred eeEEEEEe-cCeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCC
Confidence 99999985 4678999999999999887743 3456999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||+|
T Consensus 145 ~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 145 DCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 199 (273)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred CcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHH
Confidence 9999999999987654322 223345789999999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=294.46 Aligned_cols=188 Identities=24% Similarity=0.349 Sum_probs=156.2
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i 316 (452)
+|+..+.+|+|++|.|+.+ .+..+++.||||+++... ....+.+.+|+++|++++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~I 63 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKA-------------------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63 (298)
T ss_dssp TEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTB
T ss_pred CCEeccEEecCcCeEEEEE-------------------EECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE
Confidence 6888888999998777655 556789999999996542 3346789999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHE 396 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~ 396 (452)
+++++++.++++.|+||||+.++.+.... . .....+++.+++.++.||+.||+|||+++ ||||||||+|||++.+
T Consensus 64 v~~~~~~~~~~~~~iv~e~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~ 138 (298)
T d1gz8a_ 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTE 138 (298)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred EEeccccccccceeEEEeecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeeccc
Confidence 99999999999999999999775554433 2 34566999999999999999999999999 9999999999999999
Q ss_pred CCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 397 MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 397 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
+++||+|||+++...... .......||+.|+|||++.... ++.++||||+||+|
T Consensus 139 ~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvil 193 (298)
T d1gz8a_ 139 GAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193 (298)
T ss_dssp SCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred CcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhh
Confidence 999999999998764332 2233457899999999886655 58899999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=293.87 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=163.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
-+|++.+.+|.|++|.||.+...... +....++..||||+++++. .....++.+|...+.++ +|||
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~------------~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLD------------KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----------------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCC------------cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCe
Confidence 48889999999999999877432110 0112345689999997663 34457788899999888 8999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST-------------KGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
||++++++.+++..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+++ ||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---iv 157 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CI 157 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EE
Confidence 9999999999999999999999999999996543 1346899999999999999999999999 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||||+|||++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||++|
T Consensus 158 HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227 (299)
T ss_dssp CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHH
Confidence 9999999999999999999999999987666555555667889999999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=293.60 Aligned_cols=187 Identities=20% Similarity=0.276 Sum_probs=156.1
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc------ccHHHHHHHHHHHHc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG------QGLQEFKNEVTLIAK 310 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~~E~~~l~~ 310 (452)
.-||++.+.+|+|++|.|+.+ .+..+++.||||++.+... ....++.+|+.++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~ 63 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSG-------------------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHH
T ss_pred CCeEEEeEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHH
Confidence 458999999999999888755 4556899999999975421 112346789999999
Q ss_pred CC--CCCccceeeeEecCCeEEEEEEecCC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 311 LQ--HKNLVRLLGCCLDGNELLLIYEYMPN-KSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 311 l~--h~~iv~l~~~~~~~~~~~lv~E~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
++ ||||+++++++.+++..++|||++.+ +++.+++. ....+++.+++.++.||+.||+|||+++ |+|||||
T Consensus 64 l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiK 137 (273)
T d1xwsa_ 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIK 137 (273)
T ss_dssp HCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred hccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCc
Confidence 96 89999999999999999999999976 56666663 3456999999999999999999999999 9999999
Q ss_pred CCCeEECCC-CCeeEccccccccccCCCccccccccccccccccccccccCCC-ceeeeeeeeeeeC
Q 012989 388 TSNVLLDHE-MNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVF-SVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwSlG~il 452 (452)
|+|||++.+ +.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||+||+|
T Consensus 138 p~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvil 200 (273)
T d1xwsa_ 138 DENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200 (273)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred ccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeee
Confidence 999999854 78999999999865432 2334679999999999987665 6779999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=294.43 Aligned_cols=198 Identities=27% Similarity=0.357 Sum_probs=168.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcC-CCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ 315 (452)
-+|++.+.+|.|++|.|+.+..... ....+++.||||+++.. .......+.+|+.+++++ +|||
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~--------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hpn 88 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGL--------------IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESS--------------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHeEEeeEEeecCCeEEEEEEEecc--------------ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCC
Confidence 4788888999999999987642110 01246789999999765 334456799999999999 6999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDST---------------KGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
||++++++..++..++||||+++++|.++++... ....+++.+++.++.||+.||+|||+++
T Consensus 89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--- 165 (311)
T d1t46a_ 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--- 165 (311)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 9999999999999999999999999999986532 2236899999999999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||||||||+||+++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||+|
T Consensus 166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (311)
T ss_dssp CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHH
Confidence 999999999999999999999999999987655544455567899999999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-36 Score=289.19 Aligned_cols=190 Identities=28% Similarity=0.420 Sum_probs=156.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCe--eeEEEEeecC-CcccHHHHHHHHHHHHcC-CC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGK--EIAVKRLSRS-SGQGLQEFKNEVTLIAKL-QH 313 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~--~vAiK~~~~~-~~~~~~~~~~E~~~l~~l-~h 313 (452)
-.|+..+.+|.|++|.|+.+ ....++. .||||++... .....+.+.+|+++|+++ +|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~-------------------~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~H 70 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKA-------------------RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEE-------------------EEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCC
T ss_pred HHcEEEEEEeeCCCcEEEEE-------------------EECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCC
Confidence 36667778999999888755 3344555 5788887654 444567799999999999 79
Q ss_pred CCccceeeeEecCCeEEEEEEecCCCChhhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 012989 314 KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-------------TKGAQLDWKRRISIINGIARGLLYLHEDSRLR 380 (452)
Q Consensus 314 ~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ 380 (452)
|||+++++++.+++..++||||+++|+|.++++.. .....+++..++.++.||+.||.|||+++
T Consensus 71 pnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--- 147 (309)
T d1fvra_ 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--- 147 (309)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred CCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---
Confidence 99999999999999999999999999999998643 23467999999999999999999999999
Q ss_pred eEecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.++.++.++|||||||+|
T Consensus 148 iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 148 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 9999999999999999999999999997653322 22345689999999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-37 Score=288.42 Aligned_cols=193 Identities=25% Similarity=0.312 Sum_probs=149.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC---CcccHHHHHHHHHHHHcCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS---SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ 314 (452)
-+|++.+-+|.|++|.|+.+.... .......||||++++. .....++|.+|+.+|++++||
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~----------------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~ 71 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDA----------------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEEC----------------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCT
T ss_pred HHeEEEEEEecCCCeEEEEEEEEC----------------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCC
Confidence 357777789999999988764211 1123457999998764 334457899999999999999
Q ss_pred CccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 315 NLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 315 ~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
||+++++++.+ ...++||||++++++.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 72 nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~ 145 (273)
T d1u46a_ 72 NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLA 145 (273)
T ss_dssp TBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEE
T ss_pred CEEEEEEEEee-cchheeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccc
Confidence 99999999976 467899999999999887743 3456999999999999999999999999 99999999999999
Q ss_pred CCCCeeEccccccccccCCCccc-cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 395 HEMNPKISDFGMARIFSGNQNEA-NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.++.+||+|||+++.+....... ......||..|+|||.+.+..++.++||||||++|
T Consensus 146 ~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil 204 (273)
T d1u46a_ 146 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204 (273)
T ss_dssp ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHH
Confidence 99999999999999875543332 22334678899999999999999999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-37 Score=286.56 Aligned_cols=182 Identities=26% Similarity=0.380 Sum_probs=148.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCccc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNLVR 318 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 318 (452)
.|+..+.+|.|++|.||.+. ..|++||||+++.. ...+.+.+|++++++++||||++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~---------------------~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~ 64 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGD---------------------YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQ 64 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEE---------------------ETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCC
T ss_pred HeEEeEEEecCCCeEEEEEE---------------------ECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEee
Confidence 46677889999998887653 25788999999654 34578999999999999999999
Q ss_pred eeeeEec-CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCC
Q 012989 319 LLGCCLD-GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEM 397 (452)
Q Consensus 319 l~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~ 397 (452)
+++++.+ ++.+++||||+++++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 65 ~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~ 140 (262)
T d1byga_ 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN 140 (262)
T ss_dssp EEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred EEEEEEecCCcEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCC
Confidence 9998864 46789999999999999998542 2235899999999999999999999998 99999999999999999
Q ss_pred CeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 398 NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 398 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
.+||+|||+++..... .....+|+.|+|||++.++.++.++|||||||+|
T Consensus 141 ~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il 190 (262)
T d1byga_ 141 VAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190 (262)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHH
Confidence 9999999999865432 2234578999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-36 Score=286.83 Aligned_cols=187 Identities=24% Similarity=0.349 Sum_probs=157.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++.+.+|.|++|.|+.+. ..+++.||||++.... ....+.+.+|+.+|++++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~--------------------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpn 61 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQ--------------------NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEE--------------------ETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTT
T ss_pred CCceeccEEecCCCcEEEEEE--------------------eCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCc
Confidence 389999999999998887652 2478999999997652 334678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++.+..++..+++||++.++.+..+. ...+.+++.+++.|+.||+.||+|||+++ ||||||||+|||++.
T Consensus 62 Iv~~~~~~~~~~~~~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINR 135 (286)
T ss_dssp BCCEEEEEECSSCEEEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred EEeeeeecccCCceeEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcC
Confidence 999999999999999999999888777766 44567999999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
++.+||+|||.+........ ......|++.|+|||.+.+ ..++.++|||||||+|
T Consensus 136 ~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l 191 (286)
T d1ob3a_ 136 EGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191 (286)
T ss_dssp TSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred CCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHH
Confidence 99999999999987654322 2334568999999999865 4569999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=289.29 Aligned_cols=188 Identities=27% Similarity=0.379 Sum_probs=154.9
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEec-CCeeeEEEEeecC--CcccHHHHHHHHHHHHcC---
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILA-DGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKL--- 311 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~-~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l--- 311 (452)
-||++...+|.|++|.|+.+ .+.. +++.||||++... .......+.+|+.+++.|
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a-------------------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~ 67 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKA-------------------RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEE-------------------EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT
T ss_pred CCEEEEEEEecccCeEEEEE-------------------EEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc
Confidence 68999999999999888765 3333 3678999998754 222334567788887766
Q ss_pred CCCCccceeeeEec-----CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 012989 312 QHKNLVRLLGCCLD-----GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDL 386 (452)
Q Consensus 312 ~h~~iv~l~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dl 386 (452)
+||||+++++++.. ..+.+++||+++++++..... .....+++..++.++.||+.||+|||+++ |+||||
T Consensus 68 ~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDi 142 (305)
T d1blxa_ 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDL 142 (305)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred CCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCC
Confidence 79999999999863 347899999999887754442 34567999999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 387 KTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 387 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..++.++||||+||+|
T Consensus 143 Kp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il 205 (305)
T d1blxa_ 143 KPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 205 (305)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHH
Confidence 999999999999999999998765332 223456899999999999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-36 Score=287.16 Aligned_cols=190 Identities=22% Similarity=0.365 Sum_probs=156.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|+|++|+|+.+ .+..+|+.||||++... .....+++.+|+.+|++++|||
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~n 70 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKA-------------------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTT
T ss_pred CCEEEEEEEecCcCeEEEEE-------------------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCC
Confidence 69999999999999888755 45568999999998654 3445677899999999999999
Q ss_pred ccceeeeEec--------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 012989 316 LVRLLGCCLD--------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLK 387 (452)
Q Consensus 316 iv~l~~~~~~--------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlk 387 (452)
|+++++.+.. ..+.++|||+++++++.... .....+++..++.+++||++||+|||+++ |+|||||
T Consensus 71 ii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlK 144 (318)
T d3blha1 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMK 144 (318)
T ss_dssp BCCEEEEEEC----------CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred ccceEeeeecccccccccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcC
Confidence 9999999865 34689999999887776554 44567999999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCcc--ccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNE--ANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
|+|||++.++.+||+|||+++.+...... ......+||+.|+|||++.+. .++.++||||+||+|
T Consensus 145 p~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil 212 (318)
T d3blha1 145 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212 (318)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred chheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCcee
Confidence 99999999999999999999876543322 122335799999999998765 689999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-36 Score=286.57 Aligned_cols=198 Identities=24% Similarity=0.339 Sum_probs=166.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-+|++.+.+|+|++|.||.+.... .....+++.||||+++.. .......+.+|+.++++++||||
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~--------------~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKG--------------VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEE--------------EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred HHeEEeeEEeeCCCeEEEEEEECC--------------cccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCE
Confidence 478888899999999998763210 011134678999999754 34445678999999999999999
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDS-------TKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-------~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
+++++++..+...++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~ 162 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR 162 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCC
Confidence 99999999999999999999999999887532 12345799999999999999999999998 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||++.++++||+|||+++...............||+.|+|||.+.++.++.++||||||++|
T Consensus 163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 225 (308)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHH
Confidence 999999999999999999877655544445556789999999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-36 Score=285.78 Aligned_cols=189 Identities=23% Similarity=0.336 Sum_probs=156.7
Q ss_pred eeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC-CcccHHHHHHHHHHHHcCCCCCccceee
Q 012989 243 YQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS-SGQGLQEFKNEVTLIAKLQHKNLVRLLG 321 (452)
Q Consensus 243 ~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~ 321 (452)
.+.+|.|+||.||.+.... .......||||++++. +....++|.+|+++|++++||||+++++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~----------------~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g 95 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLD----------------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 95 (311)
T ss_dssp EEEEEEETTEEEEEEEECC--------------------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ceEEeecCCeEEEEEEEEC----------------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeE
Confidence 4679999999998764321 1112346899999754 4556688999999999999999999999
Q ss_pred eEec-CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECCCCCee
Q 012989 322 CCLD-GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDHEMNPK 400 (452)
Q Consensus 322 ~~~~-~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~k 400 (452)
++.. +...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~~~lv~E~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~k 170 (311)
T d1r0pa_ 96 ICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVK 170 (311)
T ss_dssp EEEETTTEEEEEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEE
T ss_pred EEEecCCceEEEEEEeecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEE
Confidence 9765 5689999999999999998853 3456788999999999999999999999 99999999999999999999
Q ss_pred EccccccccccCCCccc--cccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 401 ISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 401 l~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|+|||+++......... ......||+.|+|||.+..+.++.++||||||++|
T Consensus 171 L~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224 (311)
T ss_dssp ECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence 99999998765443222 22335789999999999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-35 Score=282.35 Aligned_cols=188 Identities=19% Similarity=0.257 Sum_probs=159.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCC-CCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH-KNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i 316 (452)
-||++.+.+|.|++|.||.+ .+..+|+.||||++..... .+.+.+|+++++.|+| +|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a-------------------~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i 63 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEG-------------------TNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGI 63 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEE-------------------EETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTC
T ss_pred CceEEEEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCC
Confidence 48999999999999888765 4556899999999865532 2457889999999965 899
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH- 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~- 395 (452)
+.+++++..+...++||||+ +++|.+++.. ....+++.++..++.|++.||+|||++| |+||||||+|||++.
T Consensus 64 ~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~ 137 (293)
T d1csna_ 64 PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRP 137 (293)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCS
T ss_pred CEEEEEeecCCccEEEEEec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCc
Confidence 99999999999999999998 6788887743 3456999999999999999999999999 999999999999974
Q ss_pred ----CCCeeEccccccccccCCCcc-----ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 ----EMNPKISDFGMARIFSGNQNE-----ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ----~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
++.+||+|||+++.+...... ......+||+.|||||++.+..++.++||||||++|
T Consensus 138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203 (293)
T ss_dssp SSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHH
Confidence 567999999999887544222 123346899999999999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=288.97 Aligned_cols=189 Identities=23% Similarity=0.320 Sum_probs=153.8
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC-cccHHHHHHHHHHHHcCCCCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS-GQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i 316 (452)
-||++...+|.|++|.|+.+ .+..+|+.||||++.+.. ....+++++|+.+|++++||||
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~i 68 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSA-------------------YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68 (345)
T ss_dssp TTEEEEEECC---CCCEEEE-------------------EETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCeEEEEEEeeccCeEEEEE-------------------EECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCC
Confidence 47999999999999887755 456789999999997553 3445678999999999999999
Q ss_pred cceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 317 VRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 317 v~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
+++++++.... ..+++||++.+++|.+++.. ..+++..++.++.||+.||+|||++| ||||||||+|||
T Consensus 69 v~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NIL 141 (345)
T d1pmea_ 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLL 141 (345)
T ss_dssp CCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CcEEEEEeeccccccceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEE
Confidence 99999987643 23444556678999999843 35999999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCcc-ccccccccccccccccccc-cCCCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNE-ANTNRVVGTYGYMAPEYAM-EGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++........ ......+||+.|+|||++. +..++.++||||+||+|
T Consensus 142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 203 (345)
T d1pmea_ 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203 (345)
T ss_dssp ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHH
T ss_pred ECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCcee
Confidence 999999999999999876544322 2234567999999999984 45678999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=290.07 Aligned_cols=187 Identities=22% Similarity=0.309 Sum_probs=153.4
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL 316 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i 316 (452)
..+|+..+.+|.|++|+||.+ .+..+|+.||||++.+.... ..+|+.+|++++||||
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a-------------------~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~ni 75 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQA-------------------KLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEE-------------------EETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTB
T ss_pred cCCcEeeeEEeeCcCeEEEEE-------------------EECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCC
Confidence 347888888999999877755 45668999999999765322 3479999999999999
Q ss_pred cceeeeEecC------CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 317 VRLLGCCLDG------NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 317 v~l~~~~~~~------~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
+++++++... .+++|||||++++.+..+.........+++.+++.|+.||+.||+|||++| |+||||||+|
T Consensus 76 v~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~N 152 (350)
T d1q5ka_ 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQN 152 (350)
T ss_dssp CCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGG
T ss_pred CcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcce
Confidence 9999998643 358999999987655554433345567999999999999999999999999 9999999999
Q ss_pred eEECCCC-CeeEccccccccccCCCcccccccccccccccccccccc-CCCceeeeeeeeeeeC
Q 012989 391 VLLDHEM-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAME-GVFSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwSlG~il 452 (452)
||++.++ .+||+|||+++.+..... ....+||+.|+|||.+.+ ..++.++||||+||+|
T Consensus 153 ILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 153 LLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213 (350)
T ss_dssp EEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred EEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEE
Confidence 9999775 899999999987654332 234578999999998865 5689999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=289.45 Aligned_cols=184 Identities=24% Similarity=0.346 Sum_probs=151.0
Q ss_pred CccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCC
Q 012989 237 NFRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHK 314 (452)
Q Consensus 237 ~~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 314 (452)
.-||++...+|.|++|.|+.+ .+..+|+.||||++.+. +....+.+.+|+.+|++++||
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hp 77 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSA-------------------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77 (346)
T ss_dssp BSSEEEEEEC------CEEEE-------------------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBT
T ss_pred CCcEEEEEEEecCCCeEEEEE-------------------EECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCC
Confidence 458998899999999877755 45568999999999754 334456789999999999999
Q ss_pred CccceeeeEecCC------eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 012989 315 NLVRLLGCCLDGN------ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKT 388 (452)
Q Consensus 315 ~iv~l~~~~~~~~------~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp 388 (452)
|||++++++...+ ++++||||+ +.+|..+.. ...+++..++.++.||+.||+|||++| |+||||||
T Consensus 78 niv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp 149 (346)
T d1cm8a_ 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKP 149 (346)
T ss_dssp TBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCc
Confidence 9999999998654 579999999 567777663 346999999999999999999999999 99999999
Q ss_pred CCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 389 SNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 389 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
+|||++.++.+||+|||+++..... .....||+.|+|||++.+. .++.++||||+||+|
T Consensus 150 ~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 150 GNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred chhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 9999999999999999999875432 2345789999999998764 568999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-35 Score=282.56 Aligned_cols=181 Identities=20% Similarity=0.319 Sum_probs=154.1
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCc
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNL 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i 316 (452)
-+|++.+.+|.|++|+|+.+ .+..+++.||||+++.. ..+++.+|+.+|+.++ ||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a-------------------~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnI 92 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEA-------------------INITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNI 92 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTB
T ss_pred cCeEEEEEEecCcCeEEEEE-------------------EECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCC
Confidence 47899999999999877755 45668999999998654 3467899999999995 9999
Q ss_pred cceeeeEecC--CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEC
Q 012989 317 VRLLGCCLDG--NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLD 394 (452)
Q Consensus 317 v~l~~~~~~~--~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~ 394 (452)
+++++++... ...++||||+++++|..+. +.+++.+++.+++||+.||+|||++| |+||||||+|||++
T Consensus 93 v~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~ 163 (328)
T d3bqca1 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMID 163 (328)
T ss_dssp CCEEEEEECTTTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred cEEEEEEEecCCCceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEc
Confidence 9999999844 5699999999999987654 35999999999999999999999999 99999999999998
Q ss_pred CCC-CeeEccccccccccCCCccccccccccccccccccccccC-CCceeeeeeeeeeeC
Q 012989 395 HEM-NPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG-VFSVNRMFLVSEFFF 452 (452)
Q Consensus 395 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwSlG~il 452 (452)
.++ .+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||+|
T Consensus 164 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l 220 (328)
T d3bqca1 164 HEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220 (328)
T ss_dssp TTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred CCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhh
Confidence 765 589999999987654332 3345789999999998765 479999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-35 Score=278.24 Aligned_cols=188 Identities=25% Similarity=0.347 Sum_probs=162.2
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCC--cccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSS--GQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++.+.+|.|++|+|+.+ .+..+++.||||+++... ....+++.+|+.+|+.++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~-------------------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~n 62 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKA-------------------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEE-------------------EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTT
T ss_pred CCCEeeeEEecCcCeEEEEE-------------------EECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCC
Confidence 38999999999999877754 556789999999997553 344678999999999999999
Q ss_pred ccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC
Q 012989 316 LVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH 395 (452)
Q Consensus 316 iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~ 395 (452)
|+++++++......++|||++.+++|..++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 63 iv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~ 136 (292)
T d1unla_ 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINR 136 (292)
T ss_dssp BCCEEEEEECSSEEEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred EEeeccccccccceeEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCccccccc
Confidence 9999999999999999999999999888773 4567899999999999999999999999 999999999999999
Q ss_pred CCCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 396 EMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 396 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
++.+||+|||.++....... ......+++.|+|||++.+.. ++.++||||+||+|
T Consensus 137 ~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il 192 (292)
T d1unla_ 137 NGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192 (292)
T ss_dssp TCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred CCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHH
Confidence 99999999999987654332 223346789999999987655 68999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=283.01 Aligned_cols=186 Identities=25% Similarity=0.310 Sum_probs=147.1
Q ss_pred cccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHH--HHHHHHHcCCCCCc
Q 012989 239 RYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFK--NEVTLIAKLQHKNL 316 (452)
Q Consensus 239 ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~--~E~~~l~~l~h~~i 316 (452)
+|-+.+-+|+|++|.||.+. .+|+.||||+++... .+.+. .|+..+.+++||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~---------------------~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnI 59 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGK---------------------WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 59 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEE---------------------ETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTB
T ss_pred EEEEEEEEeeCCCeEEEEEE---------------------ECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcC
Confidence 56667788999998877552 368999999986442 23333 45555567899999
Q ss_pred cceeeeEecCC----eEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCC
Q 012989 317 VRLLGCCLDGN----ELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDS-----RLRVIHRDLK 387 (452)
Q Consensus 317 v~l~~~~~~~~----~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g-----~~~ivH~Dlk 387 (452)
+++++++..++ .+++||||+++++|.++++. ..+++..++.++.|++.||.|||+.. ..+|+|||||
T Consensus 60 v~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlK 135 (303)
T d1vjya_ 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 135 (303)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCC
T ss_pred cceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccC
Confidence 99999988643 68999999999999999953 35899999999999999999999731 1239999999
Q ss_pred CCCeEECCCCCeeEccccccccccCCCccc--cccccccccccccccccccC------CCceeeeeeeeeeeC
Q 012989 388 TSNVLLDHEMNPKISDFGMARIFSGNQNEA--NTNRVVGTYGYMAPEYAMEG------VFSVNRMFLVSEFFF 452 (452)
Q Consensus 388 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwSlG~il 452 (452)
|+|||++.++++||+|||+++......... ......||+.|+|||++.+. .++.++|||||||+|
T Consensus 136 p~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 136 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred ccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence 999999999999999999998775543222 23456899999999998653 367899999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-35 Score=279.03 Aligned_cols=188 Identities=19% Similarity=0.276 Sum_probs=153.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCC-c
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKN-L 316 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i 316 (452)
-||++.+.+|.|++|.||.+ .+..+|+.||||++...... +++..|+++++.++|++ |
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a-------------------~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i 65 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLG-------------------TDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGI 65 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEE-------------------EETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTC
T ss_pred CEEEEeEEEeeCCCcEEEEE-------------------EECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcc
Confidence 37999999999999888755 45568999999998765332 45789999999998766 5
Q ss_pred cceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEECC-
Q 012989 317 VRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVLLDH- 395 (452)
Q Consensus 317 v~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIll~~- 395 (452)
+.+.+++..++..++||||+++ +|...+. .....+++..++.++.|++.||+|||++| |+||||||+|||++.
T Consensus 66 ~~~~~~~~~~~~~~ivme~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~ 139 (299)
T d1ckia_ 66 PTIRWCGAEGDYNVMVMELLGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLG 139 (299)
T ss_dssp CCEEEEEEETTEEEEEEECCCC-BHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCG
T ss_pred cEEEEEEecCCEEEEEEEEcCC-chhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhcccccc
Confidence 5556667788899999999955 5555442 23456999999999999999999999999 999999999999864
Q ss_pred --CCCeeEccccccccccCCCcc-----ccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 396 --EMNPKISDFGMARIFSGNQNE-----ANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 396 --~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
+..+||+|||+++.+...... .......||+.|||||++.+..++.++|||||||+|
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 456999999999987654322 123456899999999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=282.02 Aligned_cols=184 Identities=26% Similarity=0.324 Sum_probs=147.7
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|+|+.+ .+..+|+.||||++.+. +....+++.+|+.++++++|||
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~-------------------~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn 77 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAA-------------------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77 (355)
T ss_dssp TTEEEEEECSCC--CEEEEE-------------------EETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCeEEEEEeecCcCeEEEEE-------------------EECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCC
Confidence 48999999999999777754 55668999999999765 3444567899999999999999
Q ss_pred ccceeeeEec------CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 012989 316 LVRLLGCCLD------GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTS 389 (452)
Q Consensus 316 iv~l~~~~~~------~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~ 389 (452)
|++++++|.. ..++|+||||+.++++..+. ..+++..++.+++||+.||+|||++| |+||||||+
T Consensus 78 Iv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~ 148 (355)
T d2b1pa1 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 148 (355)
T ss_dssp BCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eeEEEEEEecccccccCceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcc
Confidence 9999999964 36899999999876655432 35899999999999999999999999 999999999
Q ss_pred CeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 390 NVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 390 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||++.++.+|++|||+++...... ......||+.|+|||++.+..++.++||||+||++
T Consensus 149 Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l 208 (355)
T d2b1pa1 149 NIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208 (355)
T ss_dssp GEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchH
Confidence 9999999999999999988654332 23345789999999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-34 Score=279.80 Aligned_cols=184 Identities=26% Similarity=0.327 Sum_probs=151.5
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC--CcccHHHHHHHHHHHHcCCCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS--SGQGLQEFKNEVTLIAKLQHKN 315 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~ 315 (452)
-||++...+|.|++|+|+.+ .+..+|+.||||++.+. +....+++.+|+++|++++|||
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a-------------------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~ 78 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAA-------------------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEE-------------------EETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCeEEEEEEecCCCeEEEEE-------------------EECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCC
Confidence 48999999999999877755 55678999999999765 3344567899999999999999
Q ss_pred ccceeeeEecC-----CeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 012989 316 LVRLLGCCLDG-----NELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSN 390 (452)
Q Consensus 316 iv~l~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~N 390 (452)
|+++++++... ...+++||++.+++|.+++. .+.+++.+++.++.||+.||+|||++| |+||||||+|
T Consensus 79 iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~N 151 (348)
T d2gfsa1 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSN 151 (348)
T ss_dssp BCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred eeeEEEEEeeccccccCceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcc
Confidence 99999998743 33466677788999999883 346999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEccccccccccCCCccccccccccccccccccccccCC-CceeeeeeeeeeeC
Q 012989 391 VLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGV-FSVNRMFLVSEFFF 452 (452)
Q Consensus 391 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwSlG~il 452 (452)
||++.++.+|++|||++..... ......||+.|+|||.+.+.. ++.++||||+||+|
T Consensus 152 ILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l 209 (348)
T d2gfsa1 152 LAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 209 (348)
T ss_dssp EEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHH
T ss_pred ccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHH
Confidence 9999999999999999875432 233457899999999876654 68899999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-35 Score=281.63 Aligned_cols=192 Identities=22% Similarity=0.297 Sum_probs=159.3
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecC----CcccHHHHHHHHHHHHcCCC
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRS----SGQGLQEFKNEVTLIAKLQH 313 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~~E~~~l~~l~h 313 (452)
-+|++.+-+|+|++|.||.+... ....+|+.||||++++. +....+.+.+|++++++++|
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~----------------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h 87 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKI----------------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEEC----------------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT
T ss_pred hceEEEEEEecCCCeEEEEEEEC----------------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC
Confidence 46888899999999988865311 11236899999998654 22345678899999999966
Q ss_pred -CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 012989 314 -KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVIHRDLKTSNVL 392 (452)
Q Consensus 314 -~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~ivH~Dlkp~NIl 392 (452)
|||+++++.+.+....+++|||+.+++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 88 ~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nil 161 (322)
T d1vzoa_ 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENIL 161 (322)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred CCeEEEeeeeeccCCceeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCcccee
Confidence 899999999999999999999999999999884 3456789999999999999999999999 999999999999
Q ss_pred ECCCCCeeEccccccccccCCCccccccccccccccccccccccC--CCceeeeeeeeeeeC
Q 012989 393 LDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEG--VFSVNRMFLVSEFFF 452 (452)
Q Consensus 393 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwSlG~il 452 (452)
++.++.+||+|||+++.+...... ......|++.|++||.+.+. .++.++||||+||+|
T Consensus 162 l~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iL 222 (322)
T d1vzoa_ 162 LDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 222 (322)
T ss_dssp ECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHH
T ss_pred ecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHH
Confidence 999999999999999876543322 23346789999999999754 468899999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=7.1e-30 Score=249.61 Aligned_cols=187 Identities=19% Similarity=0.241 Sum_probs=150.6
Q ss_pred ccccceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-----
Q 012989 238 FRYELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ----- 312 (452)
Q Consensus 238 ~ry~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~----- 312 (452)
-||++...+|.|++|+|+.+ .+..+|+.||||++++.. ...+.+.+|+.+++.++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~-------------------~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~ 72 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLA-------------------KDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNT 72 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEE-------------------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCS
T ss_pred CcEEEEEEEeeCCCeEEEEE-------------------EECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhh
Confidence 47999999999999887755 455689999999997542 33467788999998875
Q ss_pred ------CCCccceeeeEec--CCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEe
Q 012989 313 ------HKNLVRLLGCCLD--GNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHE-DSRLRVIH 383 (452)
Q Consensus 313 ------h~~iv~l~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~-~g~~~ivH 383 (452)
|+||+++++++.. ....+++|++..................+++..++.++.||+.||+|||+ .| |+|
T Consensus 73 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvH 149 (362)
T d1q8ya_ 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIH 149 (362)
T ss_dssp HHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EEC
T ss_pred hhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---ccc
Confidence 5789999988864 35677777776655443333333456779999999999999999999997 77 999
Q ss_pred cCCCCCCeEECCCCC------eeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeeeeeeC
Q 012989 384 RDLKTSNVLLDHEMN------PKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVSEFFF 452 (452)
Q Consensus 384 ~Dlkp~NIll~~~~~------~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSlG~il 452 (452)
|||||+|||++.++. +|++|||.+...... ....+||+.|+|||++.+..++.++|+||+||+|
T Consensus 150 rDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 219 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 219 (362)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHH
T ss_pred ccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHH
Confidence 999999999986654 999999998764322 2345789999999999999999999999999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1.2e-22 Score=179.59 Aligned_cols=165 Identities=15% Similarity=0.130 Sum_probs=113.7
Q ss_pred cceeeecCccccccCCCCCCCCCCCCCCCCccEEEEEEecCCeeeEEEEeecCCc------------------ccHHHHH
Q 012989 241 ELYQFYNDTSIGTLLPAVFSPPSPGSVTSSKEICVQGILADGKEIAVKRLSRSSG------------------QGLQEFK 302 (452)
Q Consensus 241 ~~~~f~g~g~~g~v~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~vAiK~~~~~~~------------------~~~~~~~ 302 (452)
.+.+-+|.|++|.||.+ ...+|++||||++..... .......
T Consensus 3 ~vg~~IG~G~~g~Vy~a--------------------~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 62 (191)
T d1zara2 3 AIGKLMGEGKESAVFNC--------------------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62 (191)
T ss_dssp EEEEEEEECSSEEEEEE--------------------EETTTEEEEEEEECC------CCCC-------CHHHHHHHHHH
T ss_pred hhCCEeeeCcceEEEEE--------------------ECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHH
Confidence 34567788888777654 235789999998753210 0123345
Q ss_pred HHHHHHHcCCCCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 012989 303 NEVTLIAKLQHKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWKRRISIINGIARGLLYLHEDSRLRVI 382 (452)
Q Consensus 303 ~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~g~~~iv 382 (452)
+|...+.++.|.+++..++... .+++||++++..+.. ++...+..++.||+.+|.|||++| |+
T Consensus 63 ~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---ii 125 (191)
T d1zara2 63 NEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IV 125 (191)
T ss_dssp HHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EE
Confidence 6889999999999998876532 379999998865433 334456789999999999999999 99
Q ss_pred ecCCCCCCeEECCCCCeeEccccccccccCCCccccccccccccccccccccccCCCceeeeeeee
Q 012989 383 HRDLKTSNVLLDHEMNPKISDFGMARIFSGNQNEANTNRVVGTYGYMAPEYAMEGVFSVNRMFLVS 448 (452)
Q Consensus 383 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwSl 448 (452)
||||||+|||+++++ ++|+|||++.....+.......+.+.. -.|. ..+.|+.++|+||+
T Consensus 126 HrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~ 185 (191)
T d1zara2 126 HGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSA 185 (191)
T ss_dssp CSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHH
T ss_pred EccCChhheeeeCCC-EEEEECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHH
Confidence 999999999998654 899999999765432211100000000 0111 13678889999996
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=1.3e-07 Score=85.48 Aligned_cols=123 Identities=15% Similarity=0.087 Sum_probs=88.2
Q ss_pred ecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCCCCCHH
Q 012989 279 LADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGAQLDWK 357 (452)
Q Consensus 279 ~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~l~~~ 357 (452)
..++..+.+|+...........+.+|...++.+. +--+++++.+...++..++|||+++|.++...... ..
T Consensus 34 ~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--------~~ 105 (263)
T d1j7la_ 34 VGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQ 105 (263)
T ss_dssp ECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT--------CS
T ss_pred EeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc--------cc
Confidence 4567778889887654444556788999988874 44478888888888999999999999887654411 11
Q ss_pred HHHHHHHHHHHHHHHHhcCC--------------------------------------------------------CCCe
Q 012989 358 RRISIINGIARGLLYLHEDS--------------------------------------------------------RLRV 381 (452)
Q Consensus 358 ~~~~i~~ql~~aL~~LH~~g--------------------------------------------------------~~~i 381 (452)
....++.++.+.|..||+.. +..+
T Consensus 106 ~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l 185 (263)
T d1j7la_ 106 SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVF 185 (263)
T ss_dssp CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEE
T ss_pred cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEE
Confidence 12334566666666676421 1137
Q ss_pred EecCCCCCCeEECCCCCeeEcccccccc
Q 012989 382 IHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 382 vH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+|+|+.|.|||+++++.+-|+||+.+..
T Consensus 186 ~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 186 SHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp ECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEeeccCcceeecCCceEEEeechhccc
Confidence 8999999999999776677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=4.8e-06 Score=74.44 Aligned_cols=121 Identities=17% Similarity=0.150 Sum_probs=81.6
Q ss_pred EEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCC--CCccceeeeEecCCeEEEEEEecCCCChhhhhccCCCCC
Q 012989 275 VQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQH--KNLVRLLGCCLDGNELLLIYEYMPNKSLDLFLFDSTKGA 352 (452)
Q Consensus 275 ~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~ 352 (452)
+.....++..+.+|.-.... ...+..|...++.|.. -.+++++....+++..++|||+++|.++....
T Consensus 28 ~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~------- 97 (255)
T d1nd4a_ 28 FRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH------- 97 (255)
T ss_dssp EEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC-------
T ss_pred EEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc-------
Confidence 44445567778888765432 2346778888887742 34678888888888999999999997664321
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------
Q 012989 353 QLDWKRRISIINGIARGLLYLHEDS------------------------------------------------------- 377 (452)
Q Consensus 353 ~l~~~~~~~i~~ql~~aL~~LH~~g------------------------------------------------------- 377 (452)
.... .++.++.+.|..||+..
T Consensus 98 -~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 98 -LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp -CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred -ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 1211 12334445555555311
Q ss_pred CCCeEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12379999999999999876678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=0.00012 Score=69.71 Aligned_cols=28 Identities=29% Similarity=0.387 Sum_probs=24.6
Q ss_pred CeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 380 RVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 380 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
.++|+|++|.|||+++++ ++|+||-.+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 499999999999998764 8999998774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.51 E-value=0.00016 Score=66.83 Aligned_cols=136 Identities=12% Similarity=0.089 Sum_probs=78.0
Q ss_pred ccEEEEEEecCCeeeEEEEeecCCcccHHHHHHHHHHHHcCCCCCc--ccee-----eeEecCCeEEEEEEecCCCChhh
Q 012989 271 KEICVQGILADGKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQHKNL--VRLL-----GCCLDGNELLLIYEYMPNKSLDL 343 (452)
Q Consensus 271 ~~v~~~~~~~~~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~l~-----~~~~~~~~~~lv~E~~~~~~L~~ 343 (452)
-+..|.....+|+.+++|+.... ....+++..|...+..|....+ +..+ ..+......+.++++++|..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 34456666778999999987543 3345678889999988843222 1111 22345667889999998754421
Q ss_pred hh------------------ccC--CCCCCCCH----------------------HHHHHHHHHHHHHHHHHh-cCCCCC
Q 012989 344 FL------------------FDS--TKGAQLDW----------------------KRRISIINGIARGLLYLH-EDSRLR 380 (452)
Q Consensus 344 ~l------------------~~~--~~~~~l~~----------------------~~~~~i~~ql~~aL~~LH-~~g~~~ 380 (452)
.- ... ......+. ......+.++...+.-.- +..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 000 00011111 112223333333333321 222345
Q ss_pred eEecCCCCCCeEECCCCCeeEcccccccc
Q 012989 381 VIHRDLKTSNVLLDHEMNPKISDFGMARI 409 (452)
Q Consensus 381 ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 409 (452)
+||+|+.|.|||++.+ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 56899998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.93 E-value=0.0014 Score=61.94 Aligned_cols=54 Identities=15% Similarity=0.207 Sum_probs=36.1
Q ss_pred CeeeEEEEeecCCcccHHHHHHHHHHHHcCC-CCCccceeeeEecCCeEEEEEEecCCCCh
Q 012989 282 GKEIAVKRLSRSSGQGLQEFKNEVTLIAKLQ-HKNLVRLLGCCLDGNELLLIYEYMPNKSL 341 (452)
Q Consensus 282 ~~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~~~~L 341 (452)
.+.|.+++.. . ........+|..+++.+. +.-.+++++++.. .+||||++|..+
T Consensus 74 ~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3456666654 2 223345678999999884 4445677777653 689999988655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.10 E-value=0.0083 Score=54.38 Aligned_cols=31 Identities=32% Similarity=0.312 Sum_probs=27.1
Q ss_pred CCCeEecCCCCCCeEECCCCCeeEccccccc
Q 012989 378 RLRVIHRDLKTSNVLLDHEMNPKISDFGMAR 408 (452)
Q Consensus 378 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 408 (452)
+.++||+|+.++||+++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3459999999999999988777899999875
|